General Introduction to In Situ Hybridization
General Introduction to In Situ Hybridization General Introduction to In Situ Hybridization
CONTENTS INDEX General Introduction to In Situ Hybridization
- Page 2 and 3: 1 8 General Introduction to In Situ
- Page 4 and 5: 1 *Sold under the tradename of Geni
- Page 6 and 7: Figure 4: Fluorescein-dUTP. 12 Intr
- Page 8 and 9: 14 Choosing the Right Labeling Meth
- Page 10 and 11: 1 16 Choosing the Right Labeling Me
- Page 12 and 13: 2 18 Guidelines for In Situ Hybridi
- Page 14 and 15: 2 20 Details of the Technique Prote
- Page 16 and 17: 2 22 Details of the Technique Fluor
- Page 18 and 19: 2 24 Fluorescence microscopy for pr
- Page 20 and 21: CONTENTS INDEX Nucleic Acid Hybridi
- Page 22 and 23: Formamide DNA melts (denatures) at
- Page 24 and 25: Standard in situ hybridization cond
- Page 26 and 27: 4 34 Procedures for Labeling DNA, R
- Page 28 and 29: 4 36 Procedures for Labeling DNA, R
- Page 30 and 31: 4 38 Procedures for Labeling DNA, R
- Page 32 and 33: 4 40 Procedures for Labeling DNA, R
- Page 34 and 35: Procedures for Labeling DNA, RNA, a
- Page 36 and 37: 4 42 Procedures for Labeling DNA, R
- Page 38 and 39: 4 44 ProceduresforLabelingDNA,RNA,a
- Page 40 and 41: 4 *Sold under the tradename of Geni
- Page 42 and 43: Procedures for Labeling DNA, RNA, a
- Page 44 and 45: Procedures for Labeling DNA, RNA, a
- Page 46 and 47: Procedures for Labeling DNA, RNA, a
- Page 48 and 49: Procedures for Labeling DNA, RNA, a
- Page 50 and 51: Procedures for Labeling DNA, RNA, a
CONTENTS<br />
INDEX<br />
<strong>General</strong> <strong><strong>In</strong>troduction</strong> <strong>to</strong><br />
<strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong>
1<br />
8<br />
<strong>General</strong> <strong><strong>In</strong>troduction</strong> <strong>to</strong> <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong><br />
<strong>In</strong> situ hybridization techniques allow<br />
specific nucleic acid sequences <strong>to</strong> be<br />
detected in morphologically preserved<br />
chromosomes, cells or tissue sections. <strong>In</strong><br />
combination with immunocy<strong>to</strong>chemistry,<br />
in situ hybridization can relate microscopic<br />
<strong>to</strong>pological information <strong>to</strong> gene activity at<br />
the DNA, mRNA, and protein level.<br />
The technique was originally developed by<br />
Pardue and Gall (1969) and (independently)<br />
by John et al. (1969). At this time<br />
radioiso<strong>to</strong>pes were the only labels available<br />
for nucleic acids, and au<strong>to</strong>radiography was<br />
the only means of detecting hybridized<br />
sequences. Furthermore, as molecular cloning<br />
was not possible in those days, in situ<br />
hybridization was restricted <strong>to</strong> those<br />
sequences that could be purified and isolated<br />
by conventional biochemical methods (e.g.,<br />
mouse satellite DNA, viral DNA, ribosomal<br />
RNAs).<br />
Molecular cloning of nucleic acids and<br />
improved radiolabeling techniques have<br />
changed this picture dramatically. For<br />
example, DNA sequences a few hundred<br />
base pairs long can be detected in metaphase<br />
chromosomes by au<strong>to</strong>radiography<br />
(Harper et al., 1981; Jhanwag et al., 1984;<br />
Rabin et al., 1984; Schroeder et al., 1984).<br />
Also radioactive in situ techniques can detect<br />
low copy number mRNA molecules in<br />
individual cells (Harper et al., 1986). Some<br />
years ago, chemically synthesized, radioactively<br />
labeled oligonucleotides began <strong>to</strong> be<br />
used, especially for in situ mRNA detection<br />
(Coghlan et al., 1985).<br />
<strong>In</strong> spite of the high sensitivity and wide<br />
applicability of in situ hybridization techniques,<br />
their use has been limited <strong>to</strong> research<br />
labora<strong>to</strong>ries. This is probably due <strong>to</strong> the<br />
problems associated with radioactive<br />
probes, such as the safety measures required,<br />
limited shelf life, and extensive time required<br />
for au<strong>to</strong>radiography. <strong>In</strong> addition, the scatter<br />
inherent in radioactive decay limits the<br />
spatial resolution of the technique.<br />
However, preparing nucleic acid probes<br />
with a stable nonradioactive label removes<br />
the major obstacles which hinder the general<br />
application of in situ hybridization. Furthermore,<br />
it opens new opportunities for combining<br />
different labels in one experiment.<br />
The many sensitive antibody detection<br />
systems available for such probes further<br />
enhances the flexibility of this method. <strong>In</strong><br />
this manual, therefore, we describe nonradioactive<br />
alternatives for in situ hybridization.<br />
CONTENTS<br />
INDEX
Direct and indirect methods<br />
There are two types of nonradioactive<br />
hybridization methods: direct and indirect.<br />
<strong>In</strong> the direct method, the detectable molecule<br />
(reporter) is bound directly <strong>to</strong> the<br />
nucleic acid probe so that probe-target<br />
hybrids can be visualized under a microscope<br />
immediately after the hybridization<br />
reaction. For such methods it is essential that<br />
the probe-reporter bond survives the rather<br />
harsh hybridization and washing conditions.<br />
Perhaps more important, however, is, that<br />
the reporter molecule does not interfere<br />
with the hybridization reaction. The<br />
terminal fluorochrome labeling procedure of<br />
RNA probes developed by Bauman et al.<br />
(1980, 1984), and the direct enzyme labeling<br />
procedure of nucleic acids described by<br />
Renz and Kurz (1984) meet these criteria.<br />
Boehringer Mannheim has introduced<br />
several fluorochrome-labeled nucleotides<br />
that can be used for labeling and direct<br />
detection of DNA or RNA probes.<br />
If antibodies against the reporter molecules<br />
are available, direct methods may also be<br />
converted <strong>to</strong> indirect immunochemical<br />
amplification methods (Bauman et al.,<br />
1981; Lansdorp et al., 1984; Pinkel et al.,<br />
1986).<br />
<strong>In</strong>direct procedures require the probe <strong>to</strong><br />
contain a reporter molecule, introduced<br />
chemically or enzymatically, that can be<br />
detected by affinity cy<strong>to</strong>chemistry. Again,<br />
the presence of the label should not<br />
interfere with the hybridization reaction or<br />
the stability of the resulting hybrid. The<br />
reporter molecule should, however, be<br />
accessible <strong>to</strong> antibodies. A number of such<br />
hapten modifications has been described<br />
(Langer et al., 1981; Leary et al., 1983;<br />
Landegent et al., 1984; Tchen et al., 1984;<br />
Hopman et al., 1986; Hopman et al., 1987;<br />
Shroyer and Nakane, 1983; Van Prooijen et<br />
al., 1982; Viscidi et al., 1986; Rudkin and<br />
S<strong>to</strong>llar, 1977; Raap et al., 1989). One of the<br />
most popular is the biotin-streptavidin<br />
system. Boehringer Mannheim offers an<br />
alternative, the Digoxigenin (DIG/Genius)<br />
System which is described in detail later in<br />
this chapter.<br />
CONTENTS<br />
INDEX<br />
<strong>General</strong> <strong><strong>In</strong>troduction</strong> <strong>to</strong> <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong><br />
A few years ago, the chemical synthesis<br />
of oligonucleotides containing functional<br />
groups (e.g., primary aliphatic amines or<br />
sulfhydryl groups) was described. These<br />
can react with haptens, fluorochromes or<br />
enzymes <strong>to</strong> produce a stable probe which<br />
can be used for in situ hybridization experiments<br />
(Agrawal et al., 1986; Chollet and<br />
Kawashima, 1985; Haralambidis et al.,<br />
1987; Jablonski et al., 1986). Modified<br />
oligonucleotides can also be obtained with<br />
the DIG/Genius system (Mühlegger et<br />
al., 1990). Such oligonucleotide probes will<br />
undoubtedly be widely used as au<strong>to</strong>mated<br />
oligonucleotide synthesis makes them<br />
available <strong>to</strong> researchers not familiar with<br />
DNA recombinant technology.<br />
This manual concentrates on two labeling<br />
systems:<br />
<strong>In</strong>direct methods using digoxigenin<br />
(detected by specific antibodies) and<br />
biotin (detected by streptavidin)<br />
Direct methods using fluorescein or<br />
other fluorochromes directly coupled <strong>to</strong><br />
the nucleotide<br />
The ordering information in Chapter 7 lists<br />
all the kits and single reagents Boehringer<br />
Mannheim offers for nonradioactive<br />
labeling and detection.<br />
9<br />
1
1<br />
*Sold under the tradename of Genius<br />
in the US.<br />
–<br />
10<br />
O O O<br />
O P O P O P<br />
O –<br />
O –<br />
O –<br />
O<br />
R1<br />
<strong><strong>In</strong>troduction</strong> <strong>to</strong> Hapten Labeling and Detection<br />
of Nucleic Acids<br />
A wide variety of labels are available for<br />
in situ hybridization experiments. This<br />
manual presents (Chapter 5) examples for<br />
all the labels described below.<br />
Digoxigenin (DIG) labeling<br />
The Digoxigenin (DIG/Genius) System<br />
is emphasized in this manual. It was developed<br />
and continues <strong>to</strong> be expanded by<br />
Boehringer Mannheim (Kessler, 1990, 1991;<br />
Kessler et al., 1990; Mühlegger et al., 1989;<br />
Höltke et al., 1990; Seibl et al., 1990; Mühlegger,<br />
et al., 1990; Höltke and Kessler, 1990;<br />
Rüger et al., 1990; Martin et al., 1990;<br />
Schmitz et al., 1991; Höltke et al., 1992).<br />
The first kit, the DIG DNA Labeling and<br />
Detection Kit*, was introduced in 1987.<br />
The DIG labeling method is based on a<br />
steroid isolated from digitalis plants<br />
(Digitalis purpurea and Digitalis lanata,<br />
Figure 1). As the blossoms and the leaves<br />
of these plants are the only natural source<br />
of digoxigenin, the anti-DIG antibody<br />
does not bind <strong>to</strong> other biological material.<br />
Digoxigenin is linked <strong>to</strong> the C-5 position<br />
of uridine nucleotides via a spacer arm<br />
containing eleven carbon a<strong>to</strong>ms (Figure 2).<br />
The DIG-labeled nucleotides may be<br />
incorporated, at a defined density, in<strong>to</strong><br />
nucleic acid probes by DNA polymerases<br />
(such as E. coli DNA Polymerase I, T4<br />
DNA Polymerase, T7 DNA Polymerase,<br />
Reverse Transcriptase, and Taq DNA<br />
Polymerase) as well as RNA Polymerases<br />
(SP6, T3, or T7 RNA Polymerase), and<br />
Terminal Transferase. DIG label may be<br />
added by random primed labeling, nick<br />
translation, PCR, 3'-end labeling/tailing,<br />
or in vitro transcription.<br />
O<br />
O<br />
NH<br />
R2<br />
O<br />
N<br />
N H<br />
O<br />
Nucleic acids can also be labeled chemically<br />
with DIG-NHS ester. However, we recommend<br />
enzymatic labeling methods for preparing<br />
hybridization probes because they<br />
are more convenient and more efficient.<br />
Hybridized DIG-labeled probes may be<br />
detected with high affinity anti-digoxigenin<br />
(anti-DIG) antibodies that are conjugated<br />
<strong>to</strong> alkaline phosphatase, peroxidase, fluorescein,<br />
rhodamine, AMCA, or colloidal gold.<br />
Alternatively, unconjugated anti-digoxigenin<br />
antibodies and conjugated secondary<br />
antibodies may be used.<br />
Detection sensitivity depends upon the<br />
method used <strong>to</strong> visualize the ant-DIG antibody<br />
conjugate. For instance, when an<br />
anti-DIG antibody conjugated <strong>to</strong> alkaline<br />
phosphatase is visualized with colorimetric<br />
(NBT and BCIP) or fluorescent (HNPP)<br />
alkaline phosphatase substrates, the sensitivity<br />
of the detection reaction is routinely<br />
0.1 pg (on a Southern blot).<br />
H<br />
N<br />
O<br />
O<br />
CONTENTS<br />
CH 3<br />
H<br />
OH<br />
H<br />
Figure 1:<br />
Digitalis<br />
purpurea.<br />
CH 3<br />
OH<br />
Figure 2: Digoxigenin-UTP/dUTP/ddUTP, alkali-stable.<br />
Digoxigenin-UTP (R1 = OH, R2 = OH)<br />
Digoxigenin-dUTP (R1 = OH, R2 = H)<br />
Digoxigenin-ddUTP (R1 = H, R2 = H)<br />
O<br />
INDEX<br />
O
The labeling mixtures in the DIG/Genius<br />
labeling kits contain a ratio of DIG-labeled<br />
uridine <strong>to</strong> dTTP which produces an<br />
optimally sensitive hybridization probe.<br />
For most applications, that ratio produces a<br />
DNA with a DIG-labeled nucleotide incorporated<br />
every 20th <strong>to</strong> 25th nucleotide. This<br />
labeling density permits optimal steric<br />
interaction between the hapten and anti-<br />
DIG antibody conjugate; the antibody<br />
conjugate is large enough <strong>to</strong> cover about<br />
20 nucleotides.<br />
To see the full line of DIG/Genius kits<br />
and reagents, turn <strong>to</strong> Chapter 7.<br />
HN<br />
H<br />
O<br />
S<br />
NH<br />
H<br />
CONTENTS<br />
<strong><strong>In</strong>troduction</strong> <strong>to</strong> Hapten Labeling and Detection of Nucleic Acids<br />
O<br />
NH<br />
INDEX<br />
Biotin labeling of nucleic acids<br />
Enzymatic labeling of nucleic acids with<br />
biotin-dUTP (Figure 3) was developed by<br />
David Ward and coworkers at Yale<br />
University (Langer et al., 1981). More<br />
recently, labora<strong>to</strong>ries have synthesized other<br />
biotinylated nucleotides such as biotinylated<br />
adenosine and cy<strong>to</strong>sine triphosphates<br />
(Gebeyehu et al., 1987). Also, a pho<strong>to</strong>chemical<br />
procedure (Forster et al., 1985) and a<br />
number of chemical biotinylation procedures<br />
(Sverdlov et al., 1974) has been<br />
described (Gillam and Tener, 1986; Reisfeld<br />
et al., 1987; Viscidi et al., 1986)<br />
O<br />
NH<br />
NH<br />
O<br />
O O O<br />
–<br />
O P O P O P O<br />
O –<br />
O –<br />
x 4 Li +<br />
OH<br />
<strong>In</strong> principle biotin can be used in the same<br />
way as digoxigenin; it can be detected by<br />
anti-biotin antibodies. However, streptavidin<br />
or avidin is more frequently used<br />
because these molecules have a high binding<br />
capacity for biotin. Avidin, from egg white,<br />
is a 68 kd glycoprotein with a binding constant<br />
of 10 –15 M –1 at 25°C.<br />
To see the selection of biotin reagents offered<br />
by Boehringer Mannheim, turn <strong>to</strong> Chapter 7.<br />
O –<br />
O<br />
O<br />
NH<br />
NO<br />
Figure 3: Biotin-dUTP.<br />
11<br />
1
Figure 4: Fluorescein-dUTP.<br />
12<br />
<strong><strong>In</strong>troduction</strong> <strong>to</strong> Hapten Labeling and Detection of Nucleic Acids<br />
1 Fluorescent labeling of nucleic acids Multiple labeling and detection<br />
–<br />
Fluorescein-labeled nucleotides (Figure 4)<br />
were released by Boehringer Mannheim<br />
in 1991 as a new nonradioactive labeling<br />
alternative. Fluorescein nucleotide analogues<br />
can be used for direct as well<br />
as indirect in situ hybridization experiments<br />
(Dirks et al., 1991; Wiegant et al., 1991).<br />
Fluorescein-dUTP/UTP/ddUTP can be incorporated<br />
enzymatically in<strong>to</strong> nucleic acids<br />
according <strong>to</strong> standard techniques (as listed<br />
in Chapter 4). Since fluorescein is a direct<br />
label, no immunocy<strong>to</strong>chemical visualization<br />
procedure is necessary and the<br />
background is low. <strong>General</strong> drawbacks of<br />
direct methods are, however, that they can<br />
be less sensitive than the indirect methods<br />
described above.<br />
O O O<br />
O P O P O P<br />
O –<br />
O –<br />
x 4 Li +<br />
O –<br />
O<br />
OH<br />
O<br />
O<br />
HN N<br />
Alternatively, fluorescein-labeled nucleotides<br />
can be detected with an anti-fluorescein<br />
antibody-enzyme conjugate or with an<br />
unconjugated antibody and a fluoresceinlabeled<br />
secondary antibody. The sensitivity<br />
of such experiments corresponds <strong>to</strong> that of<br />
other indirect methods.<br />
Other fluorochrome-labeled nucleotides,<br />
Tetramethylrhodamine-6-dUTP (red fluorescent<br />
dye) and Amino-methylcoumarin-<br />
6-dUTP (blue fluorescent dye) are also<br />
available from Boehringer Mannheim.<br />
O<br />
N<br />
By using combinations of digoxigenin-,<br />
biotin- and fluorochrome-labeled probes,<br />
labora<strong>to</strong>ries can perform multiple simultaneous<br />
hybridizations <strong>to</strong> localize different<br />
chromosomal regions or different RNA<br />
sequences in one preparation. Such multiprobe<br />
experiments are made possible by the<br />
availability of different fluorescent dyes<br />
coupled <strong>to</strong> antibodies; these include fluorescein<br />
or FITC (fluorescein isothiocyanate;<br />
yellow), rhodamine or TRITC (tetramethylrhodamine<br />
isothiocyanate; red) and AMCA<br />
(amino-methylcoumarinaceticacid; blue).<br />
Chapter 5 contains several detailed examples<br />
of such multiple labeling and detection<br />
experiments. These use two, three, and even<br />
twelvedifferentprobesinasingleexperiment.<br />
H<br />
O<br />
Antibody conjugates<br />
CONTENTS<br />
H<br />
N O<br />
OOHO<br />
C<br />
INDEX<br />
O<br />
OH<br />
Various reporter molecules can be coupled<br />
<strong>to</strong> detecting antibodies <strong>to</strong> visualize the<br />
specific probe-target hybridization. Commonly<br />
used conjugates include:<br />
Enzyme-coupled antibodies require substrates<br />
which usually generate a precipitating,<br />
colored product. Alternatively,<br />
Boehringer Mannheim recently introduced<br />
an alkaline phosphatase substrate<br />
(HNPP) that produces a precipitating,<br />
fluorescent product. These conjugates<br />
are most commonly used for in situ<br />
hybridization experiments.<br />
Fluorochrome-labeled antibodies require<br />
the availability of a fluorescent microscope<br />
and specific filters which allow<br />
visualization of the wavelength emitted<br />
by the fluorescent dye.<br />
Antibodies coupled <strong>to</strong> colloidal gold are<br />
mainly used for electron microscopy on<br />
cryostatic sections.
Choosing the Right Labeling Method for your<br />
<strong>Hybridization</strong> Experiment<br />
Note: For details on the labeling methods described here, see Chapter IV.<br />
Homogeneous labeling methods<br />
for DNA<br />
Probes prepared by random primed labeling<br />
are often preferred for blot applications<br />
because of the high incorporation rate of<br />
nucleotides and the high yield of labeled<br />
probe. <strong>In</strong> the random primed labeling<br />
reaction, the template DNA is linearized,<br />
denatured, and annealed <strong>to</strong> a primer. Starting<br />
from the 3'-OH end of the annealed primer,<br />
Klenow enzyme synthesizes new DNA<br />
along the single-stranded substrate. The size<br />
of the probe is about 200 <strong>to</strong> 1000 bp. With<br />
the help of a premixed labeling reagent (such<br />
as DIG-, Biotin-, or Fluorescein High<br />
Prime), the random primed reaction can<br />
produce from 30–70 ng (for 10 ng template<br />
and 1 h incubation) <strong>to</strong> 2.10–2.65 µg (for 3 µg<br />
template and 20 h incubation) of nonradioactively<br />
labeled DNA.<br />
<strong>In</strong> the nick translation reaction the DNA<br />
template can be supercoiled or linear. After<br />
the DNA is nicked with DNase I, the<br />
5'→3' exonuclease activity of DNA Polymerase<br />
I extends the nicks <strong>to</strong> gaps; then the<br />
polymerase replaces the excised nucleotides<br />
with labeled ones. The reaction<br />
produces optimal labeling after 60 <strong>to</strong> 90<br />
min. The size of the probe after the<br />
reaction should be about 200 <strong>to</strong> 500 bp.<br />
Probes can also be prepared by the Polymerase<br />
Chain Reaction (PCR). <strong>In</strong> PCR,<br />
two oligonucleotide primers hybridize <strong>to</strong><br />
opposite DNA strands and flank a specific<br />
target sequence. Then, a thermostable polymerase<br />
(such as Taq DNA Polymerase)<br />
elongates the two PCR primers. A repetitive<br />
series of cycles (template denaturation,<br />
primer annealing, and extension of primers)<br />
results in an exponential accumulation of<br />
copies of the target sequence (about a<br />
million copies in twenty cycles). <strong>In</strong>corporation<br />
of a labeled nucleotide during PCR can<br />
produce large amounts of labeled probe<br />
from minimal amounts (10–100 pg) of<br />
linearized plasmid or even from nanogram<br />
amounts of genomic DNA. The length of<br />
the amplified probe is precisely defined by<br />
the 5' ends of the PCR primers, so PCR<br />
allows easy production of optimally sized<br />
hybridization probes.<br />
Note: A variant of PCR, in situ PCR,<br />
actually allows PCR amplification (and<br />
labeling) of target sequences inside intact<br />
cells or tissue slices. For details of the<br />
potential and problems of in situ PCR, see<br />
Komminoth and Long (1995) and “PCR<br />
Applications Manual” published by<br />
Boehringer Mannheim.<br />
All three DNA labeling methods allow<br />
great flexibility with regard <strong>to</strong> length of the<br />
labeled fragments. <strong>In</strong> the nick translation<br />
reaction, changing the DNase concentration<br />
alters the fragment length. <strong>In</strong> the<br />
random primed labeling reaction, changing<br />
the primer concentration affects fragment<br />
length. <strong>In</strong> the PCR, changing the sequence<br />
of the PCR primers controls fragment<br />
length.<br />
<strong>In</strong> both nick translation and random primed<br />
labeling, a heterogeneous population of<br />
probe strands, many of which have overlapping<br />
complementary regions, are<br />
produced. This may lead <strong>to</strong> a signal amplification<br />
in the hybridization experiment.<br />
Homogeneous labeling methods<br />
for RNA<br />
<strong>In</strong> contrast <strong>to</strong> DNA probes, RNA probes<br />
are generated by in vitro transcription from<br />
a linearized template. <strong>In</strong> this case a promoter<br />
for RNA polymerases must be available on<br />
the vec<strong>to</strong>r DNA containing the template.<br />
SP6, T3, or T7 RNA Polymerase is<br />
commonly used <strong>to</strong> synthesize RNA<br />
complementary <strong>to</strong> the DNA substrate. The<br />
synthesis is complete after 1 <strong>to</strong> 2 h. The<br />
synthesized transcripts are an exact copy of<br />
the sequence from the promoter site <strong>to</strong> the<br />
restriction site used for linearization. Thus,<br />
the size of the probe can be adjusted by<br />
choice of the linearizing restriction enzyme<br />
and probes all have the same length. RNA<br />
probes are inherently single-stranded. The<br />
amount of nonradioactively labeled RNA<br />
probe is about 10 µg for about 1 µg of input<br />
DNA.<br />
CONTENTS INDEX<br />
13<br />
1
14<br />
Choosing the Right Labeling Method for your <strong>Hybridization</strong> Experiment<br />
1 Stability of probe-target interaction Using unlabeled, rather than<br />
<strong>In</strong> hybridization experiments the strength<br />
of the bond between probe and target plays<br />
an important role. The strength decreases in<br />
the order RNA-RNA, DNA-RNA, DNA-<br />
DNA (Wetmur et al., 1981). Stability of the<br />
hybrids is also influenced by the hybridization<br />
conditions, e.g., the concentration of<br />
labeled probes<br />
formamide, salt concentration, or the<br />
hybridization temperature (as detailed in<br />
Chapter 3).<br />
Nonradioactive labeling of<br />
oligonucleotides<br />
Synthetic oligonucleotides have several<br />
advantages. They are readily available<br />
through au<strong>to</strong>mated synthesis, small, and<br />
single-stranded. Their size gives them good<br />
penetration properties, which is considered<br />
one of the main fac<strong>to</strong>rs for successful in situ<br />
hybridization.<br />
The small size of oligonucleotides can also<br />
be a disadvantage because they usually<br />
cover less target than conventional cDNA<br />
probes. Recent studies, however, suggest<br />
that their good penetration properties<br />
largely compensate for the smaller target<br />
they cover. The fact that they are singlestranded<br />
also excludes the possibility of<br />
renaturation. (See Chapter 3).<br />
Oligonucleotides may be labeled either<br />
directly with a fluorochrome or enzyme, or<br />
with a hapten such as biotin and digoxigenin,<br />
which is visualized by affinity<br />
cy<strong>to</strong>chemistry after hybridization. Such<br />
labeling can be carried out either chemically<br />
or enzymatically.<br />
The chemical approach uses synthetic oligonucleotides<br />
which have reactive amine or<br />
thiol groups added in the final step of<br />
au<strong>to</strong>mated synthesis. After purification, the<br />
reactive oligonucleotide is modified with a<br />
hapten, e.g. DIG-NHS-ester, or with<br />
reporter molecules.<br />
<strong>In</strong> this manual we describe only the<br />
enzymatic approach, which uses terminal<br />
deoxynucleotidyl transferase <strong>to</strong> label<br />
synthetic oligonucleotides enzymatically at<br />
the 3' end using digoxigenin-labeled deoxyand<br />
dideoxyuridine triphosphate. Such<br />
methods are advantageous for small scale<br />
probe production because they do not<br />
require the synthesis and derivatization of<br />
oligonucleotides.<br />
A special labeling method, PRINS (primed<br />
in situ labeling), begins with the hybridization<br />
of an unlabeled oligonucleotide <strong>to</strong><br />
the target sequence in chromosome preparations.<br />
Then, using the hybridized oligonucleotide<br />
as a primer site, a thermostable<br />
polymerase synthesizes a nonradioactively<br />
labeled copy of the target sequence itself.<br />
The labeled site may then be detected with<br />
a suitable fluorescence-conjugated antibody.<br />
Because the hybridization reaction is<br />
performed before the labeling reaction,<br />
PRINS offers the advantages of low background<br />
and speedy reactions. For details of<br />
the PRINS technique, see Chapter 5.<br />
Double-stranded versus<br />
single-stranded probes<br />
As detailed in Chapter 3, a number of<br />
competing reactions occur during in situ<br />
hybridization with double-stranded probes.<br />
Thus, single-stranded probes provide the<br />
following advantages:<br />
The probe is not exhausted by selfannealing<br />
in solution.<br />
Large concatenates are not formed in<br />
solution. Such concatenates would penetrate<br />
the section or chromosomes<br />
poorly.<br />
With DNA-DNA in situ hybridization, the<br />
in situ renaturation of target DNA<br />
sequences cannot be prevented because in<br />
situ hybrids and renatured sequences have<br />
similar thermal stability. However, in situ<br />
renaturation is probably limited <strong>to</strong><br />
repetitive sequences since they have the<br />
greatest chance of being in partial register.<br />
<strong>In</strong> situ renaturation of target DNA can,<br />
however, bepreventedwiththeuseofsinglestranded<br />
RNA probes. Since DNA-RNA<br />
hybrids are more thermally stable than<br />
DNA-DNA hybrids, hybridization conditions<br />
can be designed in which DNA-DNA<br />
hybrid formation is not favored but DNA-<br />
RNA hybrid formation is.<br />
CONTENTS<br />
INDEX
References<br />
CONTENTS<br />
Choosing the Right Labeling Method for your <strong>Hybridization</strong> Experiment<br />
Agrawal, S.; Chris<strong>to</strong>doulow, C.; Gait, M. J. (1986)<br />
Efficient methods for attaching nonradioactive<br />
labels <strong>to</strong> the 5'-ends of synthetic oligodeoxyribonucleotides.<br />
Nucleic Acids Res. 14, 6227–6245.<br />
Baumann, J. G. J.; Van der Ploeg, M.; Van Duijn, P.<br />
(1984) Fluorescent hybridocy<strong>to</strong>chemical procedures:<br />
DNA-RNA hybridization in situ. <strong>In</strong>: Chayen,<br />
J.; Bitensky, L. (Eds.) <strong>In</strong>vestigative Microtechniques<br />
in Medicine and Microbiology. New York: Marcel<br />
Dekker, 41–48.<br />
Baumann, J. G. J.; Wiegant, J.; Borst, P.; Van Duijn, P.<br />
(1980) A new method for fluorescence microscopical<br />
localization of specific DNA sequences by in situ<br />
hybridization of fluorochrome-labeled RNA. Exp. Cell<br />
Res. 138, 485–490.<br />
Baumann, J. G. J.; Wiegant, J.; Van Duijn, P. (1981)<br />
Cy<strong>to</strong>chemical hybridization with fluorochromelabeled<br />
RNA. III. <strong>In</strong>creased sensitivity by the use of<br />
anti-fluorescein antibodies. His<strong>to</strong>chemistry 73,<br />
181–193.<br />
Chollet, A.; Kawashima, E. M. (1985) Biotin-labeled<br />
synthetic oligodeoxyribonucleotides: synthesis and<br />
uses as hybridization probes. Nucleic Acids Res. 13,<br />
1529–1541.<br />
Coghlan, J. P.; Aldred, P.; Haralambridis, J.;<br />
Niall, H. D.; Penschow, J. D.; Tregear, G. W. (1985)<br />
<strong>Hybridization</strong> his<strong>to</strong>chemistry. Anal. Biochem. 149,<br />
1–28.<br />
Dirks, R. W.; Van Gijlswijk, R. P. M.; Vooijs, M. A.;<br />
Smit, A. B.; Bogerd, J.; Van Minnen, J.; Raap, A. K.;<br />
Van der Ploeg, M. (1991) 3'-end fluorochromized and<br />
haptenized oligonucleotides as in situ hybridization<br />
probes for multiple simultaneous RNA detection.<br />
Exp. Cell Res. 194, 310–315.<br />
Forster, A. C.; Mc<strong>In</strong>nes, J. L.; Skingle, D. C.;<br />
Symons, R. H. (1985) Nonradioactive hybridization<br />
probes prepared by the chemical labeling of DNA<br />
and RNA with a novel reagent, pho<strong>to</strong>biotin. Nucleic<br />
Acids Res. 13, 745–761.<br />
Gebeyehu, G.; Rao, P. Y.; SooChan, P.; Simms, D.;<br />
Klevan, L. (1987) Novel biotinylated nucleotide<br />
analogs for labeling and colorimetric detection of<br />
DNA. Nucleic Acids Res. 15, 4513–4534.<br />
Gillam, I. C.; Tener, G. M. (1986) N4-(6-aminohexyl) cytidine and deoxycytidine nucleotides can be used<br />
<strong>to</strong> label DNA. Anal. Biochem. 157, 199–207.<br />
Haralambidis, J.; Chai, M.; Tregear, G. W. (1987)<br />
Preparation of base-modified nucleosides suitable<br />
for nonradioactive label attachment and their<br />
incorporation on<strong>to</strong> synthetic oligodeoxyribonucleotides.<br />
Nucleic Acids Res. 15, 4857–4876.<br />
Harper, M. E.; Marselle, L. M.; Gallo, R. C.;<br />
Wong-Stahl, F. (1986) Detection of lymphocytes<br />
expressing human T-lymphotropic virus type III in<br />
lymph nodes and peripheral blood from infected<br />
individuals by in situ hybridization. Proc. Natl. Acad.<br />
Sci. USA 83, 772–776.<br />
INDEX<br />
Harper, M. E.; Ullrich, A.; Saunders, G. F. (1981)<br />
Localization of the human insulin gene <strong>to</strong> the<br />
distal end of the short arm of chromosome 11.<br />
Chromosoma 83, 431–439.<br />
Höltke, H.-J.; Kessler, C. (1990) Nonradioactive<br />
labeling of RNA transcripts in vitro with the hapten<br />
digoxigenin (DIG); hybridization and ELISA-based<br />
detection. Nucleic Acids Res. 18, 5843–5851.<br />
Höltke, H.-J.; Seibl, R.; Burg, J.; Mühlegger, K.;<br />
Kessler, C. (1990) Nonradioactive labeling and<br />
detection of nucleic acids: II. Optimization of the<br />
digoxigenin system. Biol. Chem. Hoppe-Seyler 371,<br />
929–938.<br />
Höltke, H.-J.; Sagner, G.; Kessler, C.; Schmitz, G.<br />
(1992) Sensitive chemiluminescent detection of<br />
digoxigenin-labeled nucleic acids: a fast and simple<br />
pro<strong>to</strong>col and its applications. BioTechniques 12 (1),<br />
104–114.<br />
Hopman, A. H. N.; Wiegant, J.; Tesser, G. I.; Van<br />
Duijn, P. (1986) A nonradioactive in situ hybridization<br />
method based on mercurated nucleic acid probes<br />
and sulfhydryl-hapten ligands. Nucleic Acids Res.<br />
14, 6471–6488.<br />
Hopman, A. H. N.; Wiegant, J.; Van Duijn, P. (1987)<br />
Mercurated nucleic acid probes, a new principle for<br />
nonradioactive in situ hybridization. Exp. Cell Res.<br />
169, 357–368.<br />
Jablonski, E.; Moomaw, E. W.; Tullis, R. H.; Ruth,<br />
J. L. (1986) Preparation of oligonucleotide-alkaline<br />
phosphatase conjugates and their use as hybridization<br />
probes. Nucleic Acids Res. 14, 6115–6129.<br />
Jhanwag, S. C.; Neel, B. G.; Hayward, W. S.;<br />
Chaganti, R. S. K. (1984) Localization of the cellular<br />
oncogenes ABL, SIS and FES on human germ-line<br />
chromosomes. Cy<strong>to</strong>genet. Cell Genet. 38, 73–75.<br />
John, H.; Birnstiel, M.; Jones, K. (1969) RNA-DNA<br />
hybrids at the cy<strong>to</strong>logical level. Nature 223,<br />
582–587.<br />
Kessler, C. (1990) The digoxigenin system: principle<br />
and applications of the novel nonradioactive DNA<br />
labeling and detection system. BioTechnology <strong>In</strong>t.<br />
1990, 183–194.<br />
Kessler, C. (1991) The digoxigenin system: anti-digoxigenin<br />
technology – a survey on the concept and<br />
realization of a novel bioanalytic indica<strong>to</strong>r system.<br />
Mol. Cell. Probes 5, 161–205.<br />
Kessler, C.; Höltke, H.-J.; Seibl, R.; Burg, J.;<br />
Mühlegger, K. (1990) Nonradioactive labeling and<br />
detection of nucleic acids: I. A novel DNA labeling<br />
and detection system based on digoxigenin: antidigoxigenin<br />
ELISA principle. Biol. Chem. Hoppe-<br />
Seyler 371, 917–927.<br />
Komminoth, P.; Long, A. A. (1995) <strong>In</strong> situ Polymerase<br />
Chain Reaction – methodology, applications and<br />
nonspecific pathways. <strong>In</strong>: PCR Applications Manual.<br />
Mannheim, Germany: Boehringer Mannheim,<br />
97–106.<br />
15<br />
1
1<br />
16<br />
Choosing the Right Labeling Method for your <strong>Hybridization</strong> Experiment<br />
Landegent, J. E.; Jansen in de Wal, N.; Baan, R. A.;<br />
Hoeijmakers, J. H. J.; Van der Ploeg, M. (1984)<br />
2-Acetylaminofluorene-modified probes for the<br />
indirect hybridocy<strong>to</strong>chemical detection of specific<br />
nucleic acid sequences. Exp. Cell Res. 153, 61–72.<br />
Langer, P. R.; Waldrop, A. A.; Ward, D. A. (1981)<br />
Enzymatic synthesis of biotin-labeled polynucleotides:<br />
novel nucleic acid affinity probes. Proc. Natl.<br />
Acad. Sci. USA 78, 6633–6637.<br />
Lansdorp, P. M.; Van der Kwast, T. H.; de Boer, M.;<br />
Zeijlemaker, W. P. (1984) Stepwise amplified<br />
immunoperoxidase (PAP) staining. I. Cellular<br />
morphology in relation <strong>to</strong> membrane markers.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 32, 172–178.<br />
Leary, J. L.; Brigati, D. J.; Ward, D. C. (1983) Rapid<br />
and sensitive colorimetric method for visualizing<br />
biotin-labeled DNA probes hybridized <strong>to</strong> DNA or RNA<br />
immobilized on nitrocellulose: Bio-blots. Proc. Natl.<br />
Acad. Sci. USA 80, 4045–4049.<br />
Martin, R.; Hoover, C.; Grimme, S.; Grogan, C.;<br />
Höltke, J.; Kessler, C. (1990) A highly sensitive,<br />
nonradioactive DNA labeling and detection system.<br />
BioTechniques 9, 762–768.<br />
Mühlegger, K.; Huber, E.; von der Eltz, H.; Rüger, R.;<br />
Kessler, C. (1990) Nonradioactive labeling and<br />
detection of nucleic acids: IV. Synthesis and<br />
properties of digoxigenin-modified 2'-deoxyuridine-5'-triphosphates<br />
and a pho<strong>to</strong>activatable<br />
analog of digoxigenin (pho<strong>to</strong>digoxigenin). Biol.<br />
Chem. Hoppe-Seyler 371, 953–965.<br />
Mühlegger, K.; Batz, H.-G.; Böhm, S.; von der Eltz,<br />
H.; Höltke, H.-J.; Kessler, C. (1990) Synthesis and<br />
use of new digoxigenin-labeled nucleotides in<br />
nonradioactive labeling and detection of nucleic<br />
acids. Nucleosides & Nucleotides 8, 1161–1163.<br />
Pardue, M. L.; Gall, J. G. (1969) Molecular hybridization<br />
of radioactive DNA <strong>to</strong> the DNA of cy<strong>to</strong>logical<br />
preparations. Proc. Natl. Acad. Sci. USA 64,<br />
600–604.<br />
Pinkel, D.; Straume, T.; Gray, J. W. (1986)<br />
Cy<strong>to</strong>genetic analysis using quantitative, high<br />
sensitivity fluorescence hybridization. Proc. Natl.<br />
Acad. Sci. USA 83, 2934–2938.<br />
Raap, A. K.; Hopman, A. H. N., Van der Ploeg, M.<br />
(1989) Use of hapten modified nucleic acid probes<br />
in DNA in situ hybridization. Techniques<br />
Immunocy<strong>to</strong>chem. 4, 167–197.<br />
Rabin, M.; Watson, M.; Barker, P. E.; Ryan, J.; Breg,<br />
W. R.; Ruddle, F. H. (1984) N-ras transforming gene<br />
maps <strong>to</strong> region p11–p13 on chromosome 1 by in<br />
situ hybridization. Cy<strong>to</strong>genet. Cell Genet. 38,<br />
70–72.<br />
Reisfeld, A.; Rothenberg, J. M.; Bayer, E. A.;<br />
Wilchek, M. (1987) Nonradioactive hybridization<br />
probes prepared by the reaction of biotin hydrazide<br />
with DNA. Biochem. Biophys. Res. Commun. 142,<br />
519–526.<br />
Renz, M.; Kurz, C. (1984) A colorimetric method for<br />
DNA hybridization. Nucleic Acid Res. 12,<br />
3435–3444.<br />
Rüger, R.; Höltke, H.-J.; Reischl, U.; Sagner, G.;<br />
Kessler, C. (1990) Use of the Polymerase Chain<br />
Reaction for labeling specific DNA sequences with<br />
digoxigenin. J. Clin. Chem. Clin. Biochem. 28, 566.<br />
Rudkin, G. T.; S<strong>to</strong>llar, B. D. (1977) High resolution<br />
detection of DNA:RNA hybrids in situ by indirect<br />
immunofluorescence. Nature 265, 472–473.<br />
Schmitz, G. G.; Walter, T.; Seibl, R.; Kessler, C.<br />
(1991) Nonradioactive labeling of oligonucleotides<br />
in vitro with the hapten digoxigenin by tailing with<br />
terminal transferase. Anal. Biochem. 192, 222–231.<br />
Schroeder, W. T.; Lopez, L. C.; Harper, M. E.;<br />
Saunders, G. F. (1984) Localization of the human<br />
glucagon gene (GCG) <strong>to</strong> chromosome segment<br />
2936–37. Cy<strong>to</strong>genet. Cell Genet. 38, 76–79.<br />
Seibl, R.; Höltke, H.-J.; Rüger, R.; Meindl, A.;<br />
Zachau, H. G.; Raßhofer, R.; Roggendorf, M.;<br />
Wolf, H.; Arnold, N.; Wienberg, J.; Kessler, C. (1990)<br />
Nonradioactive labeling and detection of nucleic<br />
acids: III. Applications of the digoxigenin system.<br />
Biol. Chem. Hoppe-Seyler 371, 939–951.<br />
Shroyer, K. R.; Nakane, P. K. (1983) Use of DNPlabeled<br />
cDNA in in situ hybridization. J. Cell Biol.<br />
97, 377a.<br />
Sverdlov, E. D.; Monastyrskaya, G. S.; Guskova, L. I.;<br />
Levitan, T. L.; Scheichenko, V. I.; Budowski, E. I.<br />
(1974) Modification of cytidin residues with a<br />
bisulphite-O-methylhydroxylamine mixture.<br />
Biochim. Biophys. Acta 340, 153–165.<br />
Tchen, P.; Fuch, R. P. P.; Sage, E.; Leng, M. (1984)<br />
Chemically modified nucleic acids as immunodetectable<br />
probes in hybridization experiments.<br />
Proc. Natl. Acad. Sci. USA 81, 3466–3470.<br />
Van Prooijen-Knegt, A. C.; Van Hoek, J. F. M.;<br />
Baumann, J. G. J.; Van Duijn, P.; Wool, I. G.;<br />
Van der Ploeg, M. (1982) <strong>In</strong> situ hybridization of DNA<br />
sequences in human metaphase chromosomes<br />
visualized by an indirect fluorescent immunocy<strong>to</strong>chemical<br />
procedure. Exp. Cell Res. 141, 397–407.<br />
Viscidi, R. P.; Connelly, C. J.; Yolken, R. H. (1986)<br />
Novel chemical method for the preparation of<br />
nucleic acids for non-iso<strong>to</strong>pic hybridization.<br />
J. Clin. Microbiol. 23, 311–317.<br />
Wetmur, J. G.; Ruyechan, W. T.; Douthart, R. J.<br />
(1981) Denaturation and renaturation of Penicillium<br />
chrysogenum mycophage double-stranded<br />
ribonucleic acid in tetraalkylammonium salt<br />
solutions. Biochemistry 20, 2999–3002.<br />
Wiegant, J.; Ried, T.; Nederlof, P. M.; Van der Ploeg,<br />
M.; Tanke, H. J.; Raap, A. K. (1991) <strong>In</strong> situ<br />
hybridization with fluoresceinated DNA. Nucleic<br />
Acids Res. 19 (12), 3237–3241.<br />
CONTENTS<br />
INDEX
CONTENTS<br />
INDEX<br />
Guidelines for<br />
<strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong>
2<br />
18<br />
Guidelines for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong><br />
An in situ hybridization pro<strong>to</strong>col follows<br />
this general outline:<br />
Preparation of slides and fixation of<br />
material<br />
Pretreatments of material on slides, e.g.,<br />
permeabilization of cells and tissues<br />
Denaturation of in situ target DNA (not<br />
necessary for mRNA target)<br />
Preparation of probe<br />
<strong>In</strong> situ hybridization<br />
Posthybridization washes<br />
Immunocy<strong>to</strong>chemistry<br />
Microscopy<br />
All these steps are discussed below in<br />
detail. The information provided will make<br />
it easier <strong>to</strong> decide whether a certain step<br />
should or should not be included in a given<br />
in situ hybridization pro<strong>to</strong>col.<br />
CONTENTS<br />
INDEX
Details of the Technique<br />
Slide preparation<br />
For chromosome spreads, alcohol/ether<br />
(1:1) cleaned slides are sufficient. However,<br />
since tissue sections may be lost during the<br />
procedure, use either polylysine or<br />
glutaraldehyde-activated gelatin chrome<br />
aluminum slides for these sections.<br />
Fixation<br />
To preserve morphology, the biological<br />
material must be fixed. From a chemical<br />
point of view, there is little limitation in the<br />
type of fixation used because one of the<br />
following will be true:<br />
The functional groups involved in base<br />
pairing are protected in the double helix<br />
structure of duplex DNA.<br />
RNA is fairly unreactive <strong>to</strong> crosslinking<br />
agents.<br />
The reaction is reversible (e.g., with<br />
formaldehyde).<br />
For metaphase chromosome spreads, methanol/acetic<br />
acid fixation is usually sufficient.<br />
For paraffin-embedded tissue sections, use<br />
formalin fixation. Cryostat sections fixed for<br />
30 min with 4% formaldehyde or with<br />
Bouin’s fixative have been used successfully,<br />
as well as paraformaldehyde vapor fixation.<br />
Tissues can also be freeze-dried.<br />
It should be noted that the DNA and RNA<br />
target sequences are surrounded by<br />
proteins and that extensive crosslinking of<br />
these proteins masks the target nucleic<br />
acid. Therefore, permeabilization procedures<br />
are often required.<br />
Unfortunately, a fixation pro<strong>to</strong>col which<br />
can be used for all substrates has not yet<br />
been described. The fixation and pretreatment<br />
pro<strong>to</strong>cols must be optimized for<br />
different applications.<br />
CONTENTS<br />
INDEX<br />
Pretreatments of material on the slide<br />
Endogenous enzyme inactivation<br />
When an enzyme is used as the label, the<br />
endogenous enzyme activity may have <strong>to</strong> be<br />
inactivated. For peroxidase, this is done by<br />
treating the sections with 1% H2O2 in<br />
methanol for 30 min. For alkaline phosphatase,<br />
levamisole may be added <strong>to</strong> the<br />
substrate solution, but this may be unnecessary<br />
since residual alkaline phosphatase<br />
activity is usually lost during hybridization.<br />
RNase treatment<br />
RNase treatment serves <strong>to</strong> remove endogenous<br />
RNA and may improve the signal-<strong>to</strong>noise<br />
ratio in DNA-DNA hybridizations.<br />
This treatment can also be used as a control in<br />
hybridizations with (m)RNA as target. It is<br />
done by incubating the preparations in<br />
DNase-free RNase (100 µg/ml) in 2 x SSC at<br />
37°C for 60 min. (SSC = 150 mM NaCl,<br />
15 mM sodium citrate, pH 7.4).<br />
HCl treatment<br />
<strong>In</strong> several pro<strong>to</strong>cols a 20–30 min treatment<br />
with 200 mM HCl is included. The precise<br />
action of the acid is not known, but<br />
extraction of proteins and partial hydrolysis<br />
of the target sequences may contribute <strong>to</strong> an<br />
improvement in the signal-<strong>to</strong>-noise ratio.<br />
Detergent treatment<br />
Preparations may be pretreated with Tri<strong>to</strong>n ®<br />
X-100, sodium dodecyl sulfate, or other<br />
detergents if lipid membrane components<br />
have not been extracted by other procedures<br />
such as fixation, dehydration, embedding,<br />
and endogenous enzyme inactivation<br />
procedures.<br />
19<br />
2
2<br />
20<br />
Details of the Technique<br />
Protease treatment<br />
Protease treatment serves <strong>to</strong> increase target<br />
accessibility by digesting the protein that<br />
surrounds the target nucleic acid. To digest<br />
the sample, incubate the preparations with<br />
up <strong>to</strong> 500 µg/ml Proteinase K (the optimal<br />
amount must be determined) in 20 mM<br />
Tris-HCl, 2 mM CaCl2, pH 7.4, for 7.5–30<br />
min at 37°C. For example, with chromosomes<br />
or isolated preparations of nuclei,<br />
a reasonable starting point for protease<br />
digestion is up <strong>to</strong> 1 µg/ml Proteinase K<br />
for 7.5 min. For formalin-fixed material,<br />
5–15 µg/ml for 15–30 min usually gives<br />
good results.<br />
The use of pepsin has been shown <strong>to</strong> give<br />
excellent results for formalin-fixed, paraffinembedded<br />
tissue sections. Routine pepsin<br />
digestion involves incubating the preparations<br />
for 30 min at 37°C in 200 mM HCl<br />
containing 500 µg/ml pepsin. For the<br />
pretreatment of chromosome spreads with<br />
pepsin see page 70.<br />
Other hydrolases, such as Collagenase and<br />
diastase, may be tried if preparations of<br />
connective tissue and liver give high<br />
background reactions.<br />
Also, freeze/thaw cycles have been used <strong>to</strong><br />
improve the penetration of probes in<strong>to</strong><br />
tissues.<br />
Prehybridization<br />
A prehybridization incubation is often necessary<br />
<strong>to</strong> prevent background staining. The<br />
prehybridization mixture contains all components<br />
of a hybridization mixture except<br />
for probe and dextran sulfate.<br />
Denaturation of probe and target<br />
For in situ hybridization <strong>to</strong> chromosomal<br />
DNA, the DNA target must be denatured.<br />
<strong>In</strong> general such treatments may lead <strong>to</strong> loss<br />
of morphology, so in practice, a compromise<br />
must be found between hybridization<br />
signal and morphology. Alkaline denaturations<br />
have traditionally been used. Heat<br />
denaturations have also become popular,<br />
because of their experimental simplicity and<br />
greater effectiveness. Variations in time and<br />
temperature should be evaluated <strong>to</strong> find the<br />
best conditions for denaturation.<br />
For heat denaturation, the probe and target<br />
chromosomal DNA may be denatured<br />
simultaneously. To accomplish this, put the<br />
probe on the slide and cover with a<br />
coverslip. Bring the slide <strong>to</strong> 80°C for 2 min<br />
in an oven for the denaturation and then<br />
cool <strong>to</strong> 37°C. For tissue sections, if<br />
necessary, extend the time of denaturation<br />
at 80°C <strong>to</strong> 10 min.<br />
For competition in situ hybridization,<br />
where the labeled probe is allowed <strong>to</strong><br />
reanneal with unlabeled competi<strong>to</strong>r DNA,<br />
denature the chromosomal preparation<br />
and probe separately.<br />
<strong>Hybridization</strong><br />
See Chapter 3 for the composition of the<br />
hybridization solution, and the fac<strong>to</strong>rs<br />
affecting hybridization kinetics and hybrid<br />
stability.<br />
CONTENTS<br />
INDEX
Posthybridization washes<br />
Labeled probe can hybridize nonspecifically<br />
<strong>to</strong> sequences which are partially but<br />
not entirely homologous <strong>to</strong> the probe<br />
sequence. Such hybrids are less stable than<br />
perfectly matched hybrids. They can be<br />
dissociated by performing washes of various<br />
stringencies (as described in Chapter 3). The<br />
stringency of the washes can be manipulated<br />
by varying the formamide concentration,<br />
salt concentration, and temperature. Often a<br />
wash in 2 x SSC containing 50% formamide<br />
suffices. For some applications the stringency<br />
of the washes should be higher.<br />
However, we recommend hybridizing<br />
stringently rather than washing stringently.<br />
Immunocy<strong>to</strong>chemistry<br />
<strong>In</strong> this manual immunocy<strong>to</strong>chemical procedures<br />
using digoxigenin, biotin, and<br />
fluorochromes are described. These allow<br />
flexibility in the choice of the final reporter<br />
molecule and type of microscopy.<br />
Blocking reaction<br />
Use a blocking step prior <strong>to</strong> the immunological<br />
procedure <strong>to</strong> remove high background.<br />
For example, perform biotin detection<br />
steps in PBS containing Tween ® 20 and<br />
BSA (when using monoclonal antisera) or<br />
normal serum (when using polyclonal<br />
antisera).<br />
Perform routine digoxigenin detection in<br />
Tris-HCl buffer containing Blocking Reagent<br />
(instead of BSA or normal serum) <strong>to</strong><br />
remove background. Also the addition of<br />
0.4 M NaCl can help prevent background<br />
staining if the antigen/hapten bond can<br />
survive the high salt conditions.<br />
<strong>In</strong> a standard reaction, block the target<br />
tissue, cell, or chromosome preparation<br />
and then incubate it with the antibodyconjugate<br />
solution for 30 min at 37°C (or 2<br />
h at room temperature) in a moist chamber.<br />
Afterwards, wash the slide three times<br />
(5–10 min each) with buffer containing<br />
Tween ® 20.<br />
CONTENTS<br />
INDEX<br />
Fluorescence<br />
Details of the Technique<br />
Useful fluorochromes for fluorescence in<br />
situ hybridization (FISH) include the blue<br />
fluorochrome AMCA (amino-methylcoumarin-acetic<br />
acid), the green fluorophore<br />
fluorescein, and the red fluorochromes CY3,<br />
rhodamine, and Texas Red. Recently, the<br />
FISH application of an infrared dye has been<br />
reported (Ried et al., 1992), although it can<br />
only be visualized with infrared-sensitive<br />
cameras. For routine experiments, several<br />
immunofluorophores with good spectral<br />
separation properties can be used for FISH<br />
analysis (Table 1). Chapter 5 contains<br />
detailed procedures for using all these<br />
fluorochromes.<br />
Color Excitation max. (nm) Emission max. (nm)<br />
AMCA Blue 399 446<br />
Fluorescein Green 494 523<br />
CY3 Red 552 565<br />
Rhodamine Red 555 580<br />
Texas Red Red 590 615<br />
Rhodamine-, fluorescein-, and coumarinbased<br />
dyes cover the three primary colors<br />
of the visible part of the electro-magnetic<br />
spectrum. By using selective excitation and<br />
emission filters, and dichroic mirrors, these<br />
colors can be visualized without “crosstalk”,<br />
making triple color FISH feasible.<br />
To increase the identification of targets by<br />
color, a combina<strong>to</strong>rial labeling approach<br />
has been developed (Niederlof et al., 1990;<br />
Ried et al., 1992; Wiegant et al., 1993).<br />
Multiplicity is then given by 2n – 1, where<br />
n is the number of colors.<br />
After establishing that hybridized probes<br />
labeled with two haptens in different ratios<br />
stillfluoresceatfairlyconstantratios,labora<strong>to</strong>ries<br />
extended the combina<strong>to</strong>rial approach<br />
<strong>to</strong> ratio-labeling (Nederlof et al., 1992). <strong>In</strong><br />
ratio-labeling, the ratio of fluorescence<br />
intensities of the various color combinations<br />
is used for color identification of the<br />
probes. This approach allowed simultaneous<br />
identification of twelve different<br />
probes (Dauwerse et al., 1992). For detailed<br />
information, refer <strong>to</strong> the literature<br />
describing combina<strong>to</strong>rial and ratio labeling<br />
(Wiegant and Dauwerse, 1995).<br />
<br />
Table 1: Spectral properties of<br />
fluorophores used in FISH analysis.<br />
21<br />
2
2<br />
22<br />
Details of the Technique<br />
Fluorescent DNA counterstaining is usually<br />
performed with red fluorescent propidium<br />
iodide (PI) or with blue fluorescent DAPI.<br />
Currently, new counterstains are being<br />
introduced, e.g., green fluorescent YOYO-1<br />
(Molecular Probes, <strong>In</strong>c., USA).<br />
An antifading agent should be added <strong>to</strong> the<br />
embedding medium <strong>to</strong> retard fading. When<br />
fluorescent labels are used, the recommended<br />
antifading agent is Vectashield<br />
(Vec<strong>to</strong>r Labora<strong>to</strong>ries). The different DNA<br />
counterstains can be directly dissolved in<br />
the embedding medium (40 ng DAPI/ml;<br />
100 ng PI/ml; or 0.1 µM YOYO-1/ml) or<br />
the fluorescent specimen can first be<br />
counterstained and then embedded in<br />
Vectashield. If desired, the coverslip may<br />
be sealed with nail varnish.<br />
Enzymes<br />
Use any enzyme commonly used in<br />
immunocy<strong>to</strong>chemistry. We show examples<br />
for peroxidase and alkaline phosphatase.<br />
With peroxidase (POD), use the diaminobenzidine<br />
(DAB)/imidazole reaction (Graham<br />
and Karnovsky, 1966). With alkaline phosphatase<br />
(AP), use the 5-Bromo-4-chloro-3indolylphosphate/Nitro-blue<br />
tetrazolium<br />
(BCIP/NBT) reaction. The advantages of<br />
these colorimetric detection methods are good<br />
localization properties, high sensitivity (De Jong<br />
et al., 1985; Straus, 1982; Scopsi and Larson,<br />
1986) and stability of the precipitates. As<br />
the DAB reaction produces a color which<br />
contrasts with the blue alkaline phosphatase<br />
staining reaction (and vice versa), one can<br />
use both enzymes in double hybridizations.<br />
Furthermore, both detection methods have<br />
bright reflective properties. They can be<br />
amplified by gold/silver (Gallyas et al.,<br />
1982; Burns et al., 1985) and the color can be<br />
modified with heavy metal ions (Hsu and<br />
Soban, 1982; Cremers et al., 1987).<br />
When using brightfield microscopy with<br />
peroxidase, prepare the following peroxidase<br />
substrate solution: 0.5 mg/ml diaminobenzidine<br />
in 50 mM Tris-HCl, pH 7.4,<br />
containing 10 mM imidazole. Shortly before<br />
use, add 0.05% H2O2. <strong>In</strong>cubate with substrate<br />
from 2–30 min (depending on the<br />
signal-<strong>to</strong>-noise ratio). We advise inspecting<br />
sections microscopically during the peroxidase<br />
reaction. S<strong>to</strong>p the reaction by washing<br />
the sample with water. Counterstain with<br />
Giemsa if desired.<br />
<strong>In</strong> the case of reflection contrast microscopy<br />
with peroxidase, prepare the following<br />
peroxidase substrate solution: 0.1 mg/<br />
ml diaminobenzidine in 50 mM Tris-HCl,<br />
pH 7.4. Shortly before use, add 0.01%<br />
H2O2. The usual reaction time is 10 min.<br />
After s<strong>to</strong>pping the reaction with H2O and<br />
dehydrating with ethanol, evaluate slides<br />
by oil-immersion microscopy without<br />
embedding.<br />
When using Alkaline Phosphatase, prepare<br />
the following substrate: 0.16 mg/ml 5-Bromo-<br />
4-chloro-3-indolyl-phosphate (BCIP) and<br />
0.33 mg/ml Nitro-blue tetrazolium salt<br />
(NBT) in 200 mM Tris-HCl, 10 mM<br />
MgCl2, pH 9.2. Determine reaction times<br />
by evaluating the signal-<strong>to</strong>-noise ratio,<br />
which should be checked microscopically<br />
during the enzyme reaction. The reaction<br />
medium itself is stable (in the dark). The<br />
final product (NBT formazan) also has<br />
reflective properties.<br />
A recently introduced alkaline phosphatase<br />
substrate (HNPP/Fast Red TR) also<br />
allows fluorescent detection of alkaline<br />
phosphatase label. For fluorescence microscopy,<br />
prepare the following substrate:<br />
10 mg/ml HNPP (in dimethylformamide)<br />
and 25 mg/ml Fast Red TR in redist H2O.<br />
For details on the use of HNPP/Fast Red<br />
TR, see the article in Chapter 5, page 108.<br />
CONTENTS<br />
INDEX
Microscopy<br />
Brightfield microscopy<br />
<strong>In</strong> brightfield microscopy the image is<br />
obtained by the direct transmission of light<br />
through the sample.<br />
Evaluation of in situ hybridization results<br />
by brightfield microscopy is preferred for<br />
most routine applications because the preparations<br />
are permanent. However, the sensitivity<br />
demanded by many applications (e.g.,<br />
single copy gene localization requires the<br />
detection of a few at<strong>to</strong>grams of DNA) may<br />
require more sophisticated microscopy.<br />
Darkfield microscopy<br />
<strong>In</strong> the darkfield microscope, the illuminating<br />
rays of light are directed from the side,<br />
so that only scattered light enters the<br />
microscope lenses. Consequently, the<br />
material appears as an illuminated object<br />
against a black background.<br />
Darkfield microscopy is extensively used for<br />
radioactive in situ hybridization experiments<br />
because large fields can be examined at low<br />
magnification. The distribution of the silver<br />
grains can be seen with high contrast. <strong>In</strong> contrast,<br />
these types of microscopy are seldom<br />
used <strong>to</strong> localize reaction products of nonradioactive<br />
hybridization procedures (Heyting<br />
et al., 1985). However, Garson et al. (1987)<br />
shows the application of phase contrast<br />
microscopy <strong>to</strong> single copy gene detection.<br />
Phase contrast microscopy<br />
Phase contrast microscopy exploits the<br />
interference effects produced when two sets<br />
of waves combine. This is the case when<br />
light passing e.g., through a relatively thick<br />
or dense part of the cell (such as the nucleus)<br />
is retarded and its phase consequently<br />
shifted relative <strong>to</strong> light that has passed<br />
through an adjacent (thinner) region of the<br />
cy<strong>to</strong>plasm. Phase contrast microscopy is<br />
often used for enzyme detection.<br />
Reflection contrast microscopy<br />
Reflection contrast microscopy is similar<br />
<strong>to</strong> phase contrast microscopy. This technique<br />
measures the shift of wavelength of<br />
the light reflected from the sample relative<br />
<strong>to</strong> that of directly emitted light.<br />
Bonnet (personal communication) made<br />
the crucial observation that with reflection<br />
contrast microscopy (Ploem, 1975; Van der<br />
Ploeg and Van Duijn, 1979; Landegent et<br />
CONTENTS<br />
INDEX<br />
Details of the Technique<br />
al., 1985a) the DAB/peroxidase product displays<br />
bright reflection when present in<br />
extremely low amounts (i.e., low local<br />
absorption, typically A < 0.05). This property<br />
has made reflection contrast microscopy<br />
instrumental in detecting the first single copy<br />
gene by nonradioactive means (Landegent et<br />
al., 1985b; Hopman et al., 1986b; Ambros et<br />
al., 1986). Studies of DAB image formation in<br />
reflection contrast microscopy have shown<br />
that best results require thin objects and low<br />
local absorbances of the DAB product<br />
(Cornelese ten Velde et al., 1988).<br />
Fluorescence microscopy<br />
A fluorescence microscope contains a lamp<br />
for excitation of the fluorescent dye and a<br />
special filter which transmits a high percentage<br />
of light emitted by the fluorescent dye.<br />
Usually antifading reagents have <strong>to</strong> be added<br />
before analysis.<br />
Fluorescence microscopy is of great value<br />
for nonradioactive in situ hybridization. It is<br />
highly sensitive. Furthermore, it can be used<br />
<strong>to</strong> excite three different immunofluorophores<br />
with spectrally well-separated emissions<br />
(which allows multiple detection).<br />
Also the option of using highly sensitive<br />
image acquisition systems and the relative<br />
ease of quantitation of fluorescence signals<br />
adds <strong>to</strong> its attractiveness.<br />
Digital imaging microscopy<br />
Digital imaging microscopes can detect signals<br />
that cannot be seen with conventional<br />
microscopes. Also, image processing technology<br />
provides enhancement of signal-<strong>to</strong>noise<br />
ratios as well as measurement of quantitative<br />
data. The most sensitive system <strong>to</strong><br />
date, the cooled CCD (charged coupled<br />
device) camera, counts emitted pho<strong>to</strong>ns with<br />
a high efficiency over a broad spectral range of<br />
wavelengths, and thus is the instrument of<br />
choice for two-dimensional analysis. For<br />
three-dimensional analysis, confocal laser<br />
scanning microscopy is used.<br />
Electron microscopy<br />
The resolution of microscopy is enhanced<br />
when electrons instead of light are used,<br />
since electrons have a much shorter wavelength<br />
(0.004 nm). The practical resolving<br />
power of most modern electron microscopes<br />
is 0.1 nm. With the electron microscope,<br />
the fine structure of a cell can be<br />
resolved. Such analysis requires special preparative<br />
procedures which are described in<br />
detail in Chapter 5.<br />
23<br />
2
2<br />
24<br />
Fluorescence microscopy<br />
for probes directly labeled<br />
with a fluorochrome<br />
Details of the Technique<br />
Flow cy<strong>to</strong>metry<br />
The enormous speed with which fluorescence<br />
of individual cells can be measured<br />
with a flow cy<strong>to</strong>meter has many advantages<br />
for quantitating in situ hybridization<br />
Flow diagram for in situ hybridization<br />
Preparation of slides/coverslips<br />
– e.g., gelatin or poly-lysine treatment of slides<br />
– siliconization of coverslips<br />
Fixation of material on slide<br />
– by precipitation (e.g., ethanol)<br />
– by cross-linkage (e.g., formaldehyde)<br />
Pretreatment of specimen (optional)<br />
a) Treatments <strong>to</strong> prevent background staining<br />
– endogenous enzyme inactivation<br />
– RNase-treatment<br />
b) Permeabilization<br />
– diluted acids<br />
– detergent/alcohol<br />
– proteases<br />
Prehybridization (optional)<br />
<strong>In</strong>cubation of specimen with a pre-hybridization<br />
solution (= hybridization solution minus probe) is<br />
performed at the same temperature as hybridization<br />
Denaturation of probe and target<br />
– pH or heat<br />
– simultaneous or separate denaturation of probe<br />
and target (if double stranded)<br />
<strong>Hybridization</strong><br />
Components of the solution are mainly:<br />
– Denhardt’s Mix (Ficoll, BSA, PVP)<br />
– heterologous nucleic acids<br />
(e.g., herring sperm DNA/tRNA/competi<strong>to</strong>r DNA)<br />
– sodium phosphate, EDTA, SDS, salt<br />
– formamide<br />
– dextran sulfate<br />
Post-hybridization steps<br />
– treatment with single strand specific nuclease<br />
(optional)<br />
– stringency washes<br />
Immunological detection<br />
– blocking step<br />
– antibody incubation<br />
– colorimetric substrate or fluorescence microscopy<br />
– counterstaining<br />
– mounting<br />
Microscopy<br />
– microscopic analysis of results and documentation<br />
Evaluation<br />
signals. Procedures for fluorescence in situ<br />
hybridization in suspension have been<br />
described (Trask et al., 1985) and further<br />
developments in this field will be very<br />
important.<br />
Probe<br />
a) Choice of the probe<br />
– ds: DNA, cDNA<br />
– ss: RNA, oligonucleotide ss-DNA<br />
b) Preparation of the probe<br />
– DNA: fragment isolation (optional)<br />
– cDNA: cloning<br />
– RNA: cloning in transcription vec<strong>to</strong>rs<br />
– oligonucleotides: chemical synthesis<br />
c) Labeling of the probe<br />
– ds DNA: random primed DNA labeling,<br />
nick translation, PCR<br />
– RNA: <strong>In</strong> vitro transcription, RT-PCR<br />
– oligonucleotides: endlabeling or tailing<br />
Determination of hybridization conditions,<br />
e.g.,<br />
– determination of hybridization temperature,<br />
pH, use of formamide, salt concentration<br />
– composition of hybridization solution<br />
– probe concentration<br />
Determination of hybridization specificity<br />
(controls)<br />
– nuclease treatment<br />
– use of multiple probes<br />
– use of heterologous nucleic acid/vec<strong>to</strong>rs<br />
CONTENTS<br />
INDEX
References<br />
Ambros, P. F.; Matzke, M. A.; Matzke, A. J. M.<br />
(1986) Detection of a 17 kb unique (T-DNA) in plant<br />
chromosomes by in situ hybridization. Chromosoma<br />
94, 11–16.<br />
Burns, J.; Chan, V. T. W.; Jonasson, J. A.; Fleming,<br />
K. A.; Taylor, S.; McGee, J. O. D. (1985) Sensitive<br />
system for visualizing biotinylated DNA probes<br />
hybridized in situ: rapid sex determination of intact<br />
cells. J. Clin. Pathol. 38, 1085–1092.<br />
Cornelese ten Velde, I.; Bonnet, J.; Tanke, H. J.;<br />
Ploem, J. S. (1988) Reflection contrast microscopy.<br />
Visualization of (peroxidase generated) diaminobenzidine<br />
polymer products and its underlying<br />
optical phenomena. His<strong>to</strong>chemistry 89, 141–150.<br />
Cremers, A. F. M.; Jansen in de Wal, N.; Wiegant, J.;<br />
Dirks, R. W.; Weisbeek, P.; Van der Ploeg, M.;<br />
Landegent, J. E. (1987) Nonradioactive in situ<br />
hybridization. A comparison of several immunocy<strong>to</strong>chemical<br />
detection systems using reflection<br />
contrast microscopy and electron microscopy.<br />
His<strong>to</strong>chemistry 86, 609–615.<br />
Dauwerse, J. G.; Wiegant, J.; Raap, A. K.; Breuning,<br />
M. H.; Van Ommen, G. J. B. (1992) Multiple colors<br />
by fluorescence in situ hybridization using ratiolabeled<br />
DNA probes create a molecular karyotype.<br />
Hum. Molec. Genet. 1, 593–598.<br />
De Jong, A. S. H.; Van Kessel-Van Vark, M.; Raap, A.<br />
K. (1985) Sensitivity of various visualization methods<br />
for peroxidase and alkaline phosphatase activity in<br />
immunoenzyme his<strong>to</strong>chemistry. His<strong>to</strong>chem. J. 17,<br />
1119–1130.<br />
Gallyas, F.; Gorcs, T.; Merchenthaler, I. (1982)<br />
High grade intensification of the end-product of<br />
the diaminobenzidine reaction for peroxidase his<strong>to</strong>chemistry.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 30, 183–184.<br />
Garson, J. A.; Van den Berghe, J. A.; Kemshead,<br />
J. T. (1987) Novel non-iso<strong>to</strong>pic in situ hybridization<br />
technique detects small (1 kb) unique sequences<br />
in routinely G-banded human chromosomes: fine<br />
mapping of N-myc and b-NGF genes. Nucleic Acids<br />
Res. 15, 4761–4770.<br />
Graham, R. C.; Karnovsky, M. J. (1966) The early<br />
stages of absorption of injected horseradish peroxidase<br />
in the proximal tubules of mouse kidney:<br />
ultrastructural cy<strong>to</strong>chemistry by a new technique.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 14, 291–302.<br />
Heyting, C.; Kroes, W. G. M.; Kriek, E.; Meyer, I.;<br />
Slater, R. (1985) <strong>Hybridization</strong> of N-ace<strong>to</strong>xy-N-acetyl-<br />
2-aminofluorene labeled RNA <strong>to</strong> Q-banded metaphase<br />
chromosomes. Acta His<strong>to</strong>chem. 77, 177–184.<br />
Hopman, A. H. N.; Wiegant, J.; Raap, A. K.;<br />
Landegent, J. E.; Van der Ploeg, M.; Van Duijn, P.<br />
(1986b) Bi-color detection of two target DNAs by<br />
nonradioactive in situ hybridization. His<strong>to</strong>chemistry<br />
85, 1–4.<br />
Hsu, S. M.; Soban, E. (1982) Color modification of<br />
diaminobenzidine (DAB) precipitation by metallic<br />
ions and its application for double immunohis<strong>to</strong>chemistry.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 30, 1079–1082.<br />
CONTENTS<br />
INDEX<br />
Details of the Technique<br />
Landegent, J. E., Jansen in de Wal, N.; Ommen,<br />
G. J. B.; Baas, F.; De Vijlder, J. J. M.; Van Duijn, P.;<br />
Van der Ploeg, M. (1985b) Chromosomal localization<br />
of a unique gene by non-au<strong>to</strong>radiographic in situ<br />
hybridization. Nature 317, 175–177.<br />
Landegent, J. E.; Jansen in de Wal, N.; Ploem, J. S.;<br />
Van der Ploeg, M. (1985a) Sensitive detection of<br />
hybridocy<strong>to</strong>chemical results by means of reflection<br />
contrast microscopy. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 33,<br />
1241–1246.<br />
Nederlof, P .M.; Van der Flier, S.; Wiegant, J.; Raap,<br />
A. K.; Tanke, H. J.; Ploem, J. S.; Van der Ploeg, M.<br />
(1990) Multiple fluorescence in situ hybridization.<br />
Cy<strong>to</strong>metry 11, 126–131.<br />
Nederlof, P. M.; Van der Flier, S.; Vrolijk, J.; Tanke,<br />
H. J.; Raap, A. K. (1992) Quantification of in situ<br />
hybridization signals by fluorescence digital imaging<br />
microscopy. III. Fluorescence ratio measurements<br />
of double labeled probes. Cy<strong>to</strong>metry 13, 838–845.<br />
Ploem, J. S. (1975) Reflection contrast microscopy<br />
as a <strong>to</strong>ol for investigation of the attachment of living<br />
cells <strong>to</strong> a glass surface. <strong>In</strong>: Van Furth, R. (Ed.)<br />
Mononuclear Phagocytes in Immunity, <strong>In</strong>fection and<br />
Pathology. Oxford: Blackwell, 405–421.<br />
Reid, T.; Baldini, A.; Rand, T. C.; Ward, D. C. (1992)<br />
Simultaneous visualization of seven different probes<br />
by in situ hybridization using combina<strong>to</strong>rial<br />
fluorescence and digital imaging microscopy. Proc.<br />
Natl. Acad. Sci. USA 89, 1388–1392.<br />
Scopsi, L.; Larsson, L. I. (1986) <strong>In</strong>creased sensitivity<br />
in peroxidase immunocy<strong>to</strong>chemistry. A comparative<br />
study of a number of peroxidase visualization<br />
methods employing a model system. His<strong>to</strong>chemistry<br />
84, 221–230.<br />
Straus, W. (1982) Imidazole increases the sensitivity<br />
of the cy<strong>to</strong>chemical reaction for peroxidase with<br />
diaminobenzidine at a neutral pH. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 30, 491–493.<br />
Trask, B.; Van den Engh, G.; Landegent, J.; Jansen<br />
in de Wal, N.; Van der Ploeg, M. (1985) Detection of<br />
DNA sequences in nuclei in suspension by in situ<br />
hybridization and dual beam flow cy<strong>to</strong>metry.<br />
Science 230, 1401–1403.<br />
Van der Ploeg, M.; Van Duijn, P. (1979) Reflection<br />
versus fluorescence. His<strong>to</strong>chemistry 62, 227–232.<br />
Wiegant, J.; Wiesmeijer, C. C.; Hoovers, J. M. N.;<br />
Schuuring, E.; D’Azzo, A.; Vrolijk, J.; Tanke, H. J.;<br />
Raap, A. K. (1993) Multiple and sensitive in situ<br />
hybridization with rhodamine-, fluorescein-, and<br />
coumarin-labeled DNAs. Cy<strong>to</strong>genet. Cell Genet. 63,<br />
73–76.<br />
Wiegant, J.; Dauwerse, J. G. (1995) Multiple-colored<br />
chromosomes by fluorescence in situ hybridization.<br />
<strong>In</strong>: Verma, R. S.; Babu, A. (Eds.) Human Chromosomes:<br />
Principles and Techniques, 2nd ed.<br />
New York: McGraw-Hill, <strong>In</strong>c.<br />
25<br />
2
CONTENTS<br />
INDEX<br />
Nucleic Acid <strong>Hybridization</strong><br />
– <strong>General</strong> Aspects
3<br />
28<br />
This chapter discusses the effects of various<br />
components of the hybridization solution<br />
on the rate of renaturation and thermal<br />
stability of DNA hybrids free in solution.<br />
The features will be more or less identical <strong>to</strong><br />
those of immobilized nucleic acids, such as<br />
in filter and in situ hybridizations. The<br />
largest deviation probably occurs in the<br />
kinetics. The reader is referred <strong>to</strong> the<br />
following literature for more background<br />
information: Casey and Davidson (1976),<br />
Cox et al. (1984), Flavell et al. (1974), Hames<br />
and Higgins (1985), Maniatis et al. (1982),<br />
Raap et al. (1986), Schildkraut and Lifson<br />
(1965), Spiegelman et al. (1973), Wetmur and<br />
Davidson (1968), Wetmur (1975).<br />
The main parameters that influence<br />
hybridization<br />
<strong>Hybridization</strong> depends on the ability of<br />
denatured DNA <strong>to</strong> reanneal with complementary<br />
strands in an environment just<br />
below their melting point (Tm).<br />
The Tm is the temperature at which half the<br />
DNA is present in a single-stranded<br />
(denatured) form. The Tm value is different<br />
for genomic DNA isolated from various<br />
organisms, e.g., for Pneumococcus DNA it<br />
is 85°C, for Serratia DNA it is 94°C. The<br />
Tm can be calculated by measuring the<br />
absorption of ultraviolet light at 260 nm.<br />
The stability of the DNA is directly<br />
dependent on the GC content. The higher<br />
the molar ratio of GC pairs in a DNA, the<br />
higher the melting point.<br />
Tm and renaturation of DNA are primarily<br />
influenced by four parameters:<br />
Temperature<br />
pH<br />
Concentration of monovalent cations<br />
Presence of organic solvents<br />
Temperature<br />
Themaximumrateofrenaturation(hybridization)<br />
of DNA is at 25°C. However, the<br />
bell-shaped curve relating renaturation rate<br />
and temperature is broad, with a rather<br />
flat maximum from about 16°C <strong>to</strong> 32°C<br />
below Tm.<br />
pH<br />
From pH 5–9, the rate of renaturation is<br />
fairly independent of pH. Buffers containing<br />
20–50 mM phosphate, pH 6.5–7.5 are<br />
frequently used. Note: Higher pH can be<br />
used <strong>to</strong> produce more stringent hybridization<br />
conditions.<br />
Monovalent cations<br />
Monovalent cations (e.g., sodium ions)<br />
interact electrostatically with nucleic acids<br />
(mainly at the phosphate groups) so that<br />
the electrostatic repulsion between the two<br />
strands of the duplex decreases with<br />
increasing salt concentration, i.e. higher<br />
salt concentrations increase the stability of<br />
the hybrid. Low sodium concentrations<br />
affect the Tm, as well as the renaturation<br />
rate, drastically.<br />
Sodium ion (Na + ) concentrations above<br />
0.4 M only slightly affect the rate of<br />
renaturation and the melting temperature.<br />
The following equation has been given for<br />
the dependence of Tm on the GC content<br />
and the salt concentration (for salt<br />
concentrations from 0.01 <strong>to</strong> 0.20 M):<br />
Tm = 16.6 log M + 0.41 (GC) + 81.5<br />
where M is the salt concentration (molar)<br />
and GC, the molar percentage of guanine<br />
plus cy<strong>to</strong>sine. Above 0.4 M Na + , the<br />
following formula holds:<br />
Tm = 81.5 + 0.41 (GC)<br />
Free divalent cations strongly stabilize<br />
duplex DNA. Remove them from the<br />
hybridization mixture or complex them<br />
(e.g., with agents like citrate or EDTA).<br />
CONTENTS<br />
<strong>General</strong> Guidelines for PCR<br />
Nucleic Acid <strong>Hybridization</strong> – <strong>General</strong> Aspects<br />
INDEX
Formamide<br />
DNA melts (denatures) at 90°–100°C in<br />
0.1–0.2 M Na + . For in situ hybridization<br />
this implies that microscopic preparations<br />
must be hybridized at 65°–75°C for prolonged<br />
periods. This may lead <strong>to</strong> deterioration<br />
of morphology. Fortunately, organic<br />
solvents reduce the thermal stability of<br />
double-stranded polynucleotides, so that<br />
hybridization can be performed at lower<br />
temperatures in the presence of formamide.<br />
Formamide has for years been the organic<br />
solvent of choice. It reduces the melting<br />
temperature of DNA-DNA and DNA-<br />
RNA duplexes in a linear fashion by 0.72°C<br />
for each percent formamide. Thus, hybridization<br />
can be performed at 30°–<br />
45°C with 50% formamide present in the<br />
hybridization mixture. The rate of renaturation<br />
decreases in the presence of formamide.<br />
The melting temperature of hybrids<br />
in the presence of formamide can be calculated<br />
according <strong>to</strong> the following equation:<br />
For 0.01–0.2 M Na + :<br />
Tm = 16.6 log M + 0.41 (GC) + 81.5 – 0.72<br />
(% formamide)<br />
For Na + concentrations above 0.4 M:<br />
Tm = 81.5 + 0.41 (GC) – 0.72 (% formamide)<br />
To obtain a large increase of in situ hybridization<br />
signal for rDNA, hybridize with<br />
rRNA in 80% formamide at 50°–55°C,<br />
instead of 70% formamide at 37°C.<br />
Finally, it should be mentioned that during<br />
the in situ hybridization procedure, relatively<br />
large amounts of DNA can be lost<br />
(Raap et al., 1986).<br />
CONTENTS<br />
INDEX<br />
Nucleic Acid <strong>Hybridization</strong> – <strong>General</strong> Aspects<br />
Additional hybridization variables<br />
Additional parameters must be considered<br />
when calculating the optimal hybridization<br />
conditions including the probe length, probe<br />
concentration, the inclusion of dextran<br />
sulfate, the extent of mismatch between<br />
probe and target, the washing conditions,<br />
and whether the probes will be single- or<br />
double-stranded.<br />
Probe length<br />
The rate of the renaturation of DNA in<br />
solution is proportional <strong>to</strong> the square root<br />
of the (single-stranded) fragment length.<br />
Consequently, maximal hybridization rates<br />
are obtained with long probes. However,<br />
short probes are required for in situ hybridization<br />
because the probe has <strong>to</strong> diffuse in<strong>to</strong><br />
the dense matrix of cells or chromosomes.<br />
The fragment length also influences<br />
thermal stability. The following formula,<br />
which relates the shortest fragment length<br />
in a duplex molecule <strong>to</strong> change in Tm, has<br />
been derived:<br />
Change in Tm · n = 500 (n = nucleotides).<br />
Probe concentration<br />
The probe concentration affects the rate at<br />
which the first few base pairs are formed<br />
(nucleation reaction). The adjacent base<br />
pairs are formed afterwards, provided they<br />
are in register (zippering). The nucleation<br />
reaction is the rate limiting step in hybridization.<br />
The kinetics of hybridization is<br />
considered <strong>to</strong> be a second order reaction<br />
[r = k2 (DNA) (DNA)]. Therefore, the<br />
higher the concentration of the probe, the<br />
higher the reannealing rate.<br />
Dextran sulfate<br />
<strong>In</strong> aqueous solutions dextran sulfate is<br />
strongly hydrated. Thus, macromolecules<br />
have no access <strong>to</strong> the hydrating water,<br />
which causes an apparent increase in probe<br />
concentration and consequently higher<br />
hybridization rates.<br />
29<br />
3
3<br />
30<br />
Nucleic Acid <strong>Hybridization</strong> – <strong>General</strong> Aspects<br />
Base mismatch<br />
Mismatching of base pairs results in<br />
reduction of both hybridization rates and<br />
thermal stability of the resulting duplexes.<br />
To discriminate maximally between closely<br />
related DNA sequences, hybridize under<br />
fairly stringent conditions (e.g. at Tm –<br />
15°C). On the average, the Tm decreases<br />
about 1°C per % (base mismatch) for large<br />
probes. Mismatching in oligonucleotides<br />
greatly influences hybrid stability; this<br />
forms the basis of point mutation detection.<br />
Stringency washes<br />
During hybridization, duplexes form<br />
between perfectly matched sequences and<br />
between imperfectly matched sequences.<br />
The extent <strong>to</strong> which the latter occurs can be<br />
manipulated <strong>to</strong> some extent by varying the<br />
stringency of the hybridization reaction.<br />
(See above.)<br />
To remove the background associated with<br />
nonspecific hybridization, wash the sample<br />
with a dilute solution of salt. The lower the<br />
salt concentration and the higher the wash<br />
temperature, the more stringent the wash.<br />
<strong>In</strong> general, greater specificity is obtained<br />
when hybridization is performed at a high<br />
stringency and washing at similar or lower<br />
stringency, rather than hybridizing at low<br />
stringency and washing at high stringency.<br />
Use of single-stranded versus<br />
double-stranded probes<br />
A number of competing reactions occur<br />
during in situ hybridization with doublestranded<br />
probes. These include:<br />
Probe renaturation in solution<br />
<strong>In</strong> situ hybridization<br />
<strong>In</strong> situ renaturation (possibly, for ds<br />
targets)<br />
Consequently, the use of single-stranded<br />
probes has advantages for in situ hybridization.<br />
Such probes can be made by using<br />
the single-stranded M13 (or like bacteriophage<br />
cloning vec<strong>to</strong>rs) as template, or by<br />
using transcription vec<strong>to</strong>rs which permit<br />
the production of large amounts of singlestranded<br />
RNA. (See Chapter 4 for a detailed<br />
description).<br />
Competition in situ hybridization<br />
Recombinant DNA isolated from eukaryotic<br />
DNA often contains genomic repetitive<br />
sequences (e.g., the Alu sequence in humans).<br />
<strong>In</strong> situ hybridization <strong>to</strong> chromosomes with a<br />
probe which contains repetitive DNA<br />
usually results in uniform staining. However,<br />
unlabeled competi<strong>to</strong>r DNA (usually <strong>to</strong>tal<br />
genomic DNA) prevents the repetitive probe<br />
sequences from annealing <strong>to</strong> the target, and<br />
leads <strong>to</strong> stronger in situ hybridization signals<br />
from the unique sequences in the probe.<br />
(This approach was first described for in situ<br />
hybridization by Landegent et al., 1987;<br />
Lichter et al., 1988a; Pinkel et al., 1988.)<br />
Obviously, the greater the complexity of<br />
probe (plasmids < phages < cosmids < yeast<br />
artificial chromosomes < chromosome<br />
libraries), the greater the need for competition<br />
in situ hybridization. This approach has<br />
proved particularly useful for in situ<br />
hybridization with DNA isolated from<br />
chromosome-specific libraries (CISS-hybridization);<br />
a specific chromosome can be<br />
fluorescently labeled over its full length<br />
(Lichter et al., 1988a,b; Cremer et al., 1988;<br />
Pinkel et al., 1988).<br />
Oligonucleotide hybridization<br />
The rules given for hybrid stability and<br />
kinetics of hybridization can probably not<br />
be extrapolated <strong>to</strong> hybridization with oligodeoxynucleotides.<br />
For in situ hybridization,<br />
the advantages of oligonucleotides<br />
include their small size (good penetration<br />
properties) and their single-strandedness<br />
(<strong>to</strong> prevent probe reannealing, as outlined<br />
in Chapter 1).<br />
The small size, however, is also a disadvantage<br />
because it covers less target. The<br />
nonradioactive label should be positioned<br />
at the 3' or the 5' end; internal labeling<br />
affects the Tm <strong>to</strong>o much.<br />
<strong>In</strong> an experiment with 20-mers of 40–60%<br />
GC content, start with the hybridization<br />
conditions described below. Depending on<br />
the results obtained, you may decide <strong>to</strong> use<br />
other stringency conditions.<br />
CONTENTS<br />
INDEX
Standard in situ hybridization<br />
conditions<br />
Department of Cy<strong>to</strong>chemistry and Cy<strong>to</strong>metry,<br />
University of Leiden, Netherlands.<br />
For “large” DNA probes (≥ 100 bp):<br />
– 50% deionized formamide<br />
– 2 x SSC (see below)<br />
– 50 mM NaH2PO4/Na2HPO4 buffer;<br />
pH 7.0<br />
– 1 mM EDTA<br />
– carrier DNA/RNA (1 mg/ml each)<br />
– probe (1–10 ng/ml)<br />
Optional components:<br />
– 1 x Denhardt’s (see below)<br />
– dextran sulfate, 5–10%<br />
– Temperature: 37°–42°C<br />
– <strong>Hybridization</strong> time: 5 min–16 h<br />
For synthetic oligonucleotides:<br />
– 25% formamide<br />
– 4 x SSC (see below)<br />
– 50 mM NaH2PO4/Na2HPO4 buffer;<br />
pH 7.0<br />
– 1 mM EDTA<br />
– carrier DNA/RNA (1 mg/ml each)<br />
– probe (1 ng/ml)<br />
– 5 x Denhardt’s (see below)<br />
– Temperature: room temperature<br />
– <strong>Hybridization</strong> time: 2–16 h<br />
Composition of SSC and Denhardt’s<br />
solution<br />
1 x SSC: 150 mM NaCl, 15 mM sodium<br />
citrate; pH 7.0:<br />
Make a 20 x s<strong>to</strong>ck solution (3 M NaCl,<br />
0.3 M sodium citrate).<br />
50 x Denhardt’s:<br />
1% polyvinylchloride, 1% pyrrolidone,<br />
2% BSA.<br />
CONTENTS<br />
INDEX<br />
Nucleic Acid <strong>Hybridization</strong> – <strong>General</strong> Aspects<br />
References<br />
Casey, J.; Davidson, N. (1976) Rates of formation<br />
and thermal stabilities of RNA-DNA and DNA-DNA<br />
duplexes at high concentrations of formamide.<br />
Nucleic Acids Res. 4, 1539–1552.<br />
Cox, K. H.; DeLeon, D. V.; Angerer, L. M.; Angerer,<br />
R. C. (1984) Detection of mRNAs in sea urchin<br />
embryos by in situ hybridization using asymmetric<br />
RNA probes. Develop. Biol. 101, 485–503.<br />
Cremer, T.; Lichter, P.; Borden, J.; Ward, D. C.;<br />
Manuelidis, L. (1988) Detection of chromosome<br />
aberrations in metaphase and interphase tumor<br />
cells by in situ hybridization using chromosome<br />
specific library probes. Hum. Genet. 80, 235–246.<br />
Flavell, R. A.; Birfelder, J. E.; Sanders, J. P. M.,<br />
Borst, P. (1974) DNA-DNA hybridization on nitrocellulose<br />
filters. I. <strong>General</strong> considerations and nonideal<br />
kinetics. Eur. J. Biochem. 47, 535–543.<br />
Hames, B. D.; Higgins, S. J. (1985) Nucleic Acid<br />
<strong>Hybridization</strong>: A Practical Approach. Oxford: IRL<br />
Press.<br />
Landegent, J. E.; Jansen in de Wal; Dirks, R. W.;<br />
Baas, F.; van der Ploeg, M. (1987) Use of whole<br />
cosmid cloned genomic sequences for<br />
chromosomal localization by nonradioactive in situ<br />
hybridization. Hum. Genet. 77, 366–370.<br />
Lichter, P.; Cremer, T.; Borden, J.; Manuelidis, L.;<br />
Ward, D. C. (1988a) Delineation of individual human<br />
chromosomes in metaphase and interphase cells by<br />
in situ suppression hybridization using recombinant<br />
DNA libraries. Hum. Genet. 80, 224–234.<br />
Lichter, P.; Cremer, T.; Tang, C. C.; Watkins, P. C.;<br />
Manuelidis, L.; Ward, D. C. (1988b) Rapid detection<br />
of human chromosomes 21 aberrations by in situ<br />
hybridization. Proc. Natl. Acad. Sci. USA 85,<br />
9664–9668.<br />
Maniatis, T.; Fritsch, E. F.; Sambrook, J. (1982)<br />
Molecular Cloning: A Labora<strong>to</strong>ry Manual. Cold<br />
Spring Harbor Labora<strong>to</strong>ries.<br />
Pinkel, D.; Landegent, J.; Collins, C.; Fuscoe, J.;<br />
Segraves, R.; Lucas, J.; Gray, J. W. (1988)<br />
Fluorescence in situ hybridization with human<br />
chromosome specific libraries: detection of trisomy<br />
21 and translocations of chromosome 4. Proc. Natl.<br />
Acad. Sci. USA 85, 9138–9142.<br />
Raap, A. K.; Marijnen, J. G. J.; Vrolijk, J.; Van der<br />
Ploeg, M. (1986) Denaturation, renaturation, and<br />
loss of DNA during in situ hybridization procedures.<br />
Cy<strong>to</strong>metry 7, 235–242.<br />
Schildkraut, C.; Lifson, S. (1965) Dependence of the<br />
melting temperature of DNA on salt concentration.<br />
Biopolymers 3, 195–208.<br />
Spiegelman, G. B.; Haber, J. E.; Halvorson, H. O.<br />
(1973) Kinetics of ribonucleic acid-deoxyribonucleic<br />
acid membrane filter hybridization. Biochemistry<br />
12, 1234–1242.<br />
Wetmur, J. G. (1975) Acceleration of DNA<br />
renaturation rates. Biopolymers 14, 2517–2524.<br />
Wetmur, J. G.; Davidson, N. (1986) Kinetics of<br />
renaturation of DNA. J. Mol. Biol. 31, 349–370.<br />
31<br />
3
CONTENTS<br />
Procedures for Labeling<br />
DNA, RNA, and Oligonucleotides<br />
with DIG, Biotin,<br />
or Fluorochromes<br />
INDEX
4<br />
34<br />
Procedures for Labeling DNA, RNA, and<br />
Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
Note: Most of the following procedures have<br />
been taken from pack inserts of different<br />
kits available from Boehringer Mannheim.<br />
The exception is procedure IV, which is an<br />
optimized version of nick translation<br />
developed at the Department of Cy<strong>to</strong>chemistry<br />
and Cy<strong>to</strong>metry, University of<br />
Leiden, and the Department of Genetics,<br />
Yale University. The labeling procedures<br />
for digoxigenin, biotin, and fluorochromes<br />
are essentially identical.<br />
The determination of the labeling efficiency<br />
for DIG-labeled nucleic acids is<br />
described under IX “Estimating the Yield<br />
of DIG-labeled Nucleic Acids”, page 51.<br />
I. Random primed labeling of ds DNA<br />
with DIG-, Biotin- or Fluorescein-High<br />
Prime reaction mix<br />
The random primed DNA labeling method<br />
(Feinberg and Vogelstein, 1984) allows<br />
efficient labeling of small (10 ng) and large<br />
(up <strong>to</strong> 3 µg) amounts of DNA. The labeling<br />
method also works with both short<br />
DNA (200 bp fragments) and long DNA<br />
(cosmid or DNA).<br />
The standard labeling reaction is fast<br />
(1 hour) and incorporates one modified<br />
nucleotide (DIG-, biotin-, or fluoresceindUTP)<br />
at every 20–25th position in the<br />
newly synthesized DNA probe. This labeling<br />
density produces the most sensitive targets<br />
for indirect (immunological) detection.<br />
The amount of newly synthesized labeled<br />
DNA depends on the amount and purity<br />
of the template DNA, the label used, and<br />
the incubation time (Table 1).<br />
The size of the labeled DNA fragments<br />
obtained by random primed DNA labeling<br />
depends on the amount and size of the<br />
template DNA. With linear pBR328<br />
plasmid DNA, the standard (1 h) reaction<br />
produces labeled DNA fragments which<br />
are approximately 200–1000 bp long.<br />
Note: Linear DNA is labeled more<br />
efficiently than circular and supercoiled<br />
DNA. <strong>In</strong> all cases the template DNA<br />
should be thoroughly heat-denatured prior<br />
<strong>to</strong> random primed labeling. DNA fragments<br />
in low melting point agarose are also<br />
labeled efficiently, but often with slower<br />
kinetics.<br />
A. Standard labeling reaction for<br />
DNA in solution<br />
1 To a 1.5 ml microcentrifuge tube, add<br />
16 µl sterile, redistilled H2O containing<br />
1 µg template DNA (linear or supercoiled).<br />
Note: For this standard reaction, the<br />
amount of DNA in the 16 µl sample can<br />
vary from 10 ng <strong>to</strong> 3 µg of DNA.<br />
To label > 3 µg of DNA, scale up the<br />
volume of the sample as well as the<br />
amounts and volumes of all reaction<br />
components below.<br />
DIG label Fluorescein label Biotin label<br />
Template Yield (ng) Yield (ng) Yield (ng) Yield (ng) Yield (ng) Yield (ng)<br />
DNA (ng) in 1 h in 20 h in 1 h in 20 h in 1 h in 20 h<br />
10 45 600 30 250 70 850<br />
30 130 1050 70 320 160 1350<br />
100 270 1500 200 650 350 1650<br />
300 450 2000 320 1350 700 2200<br />
1000 850 2300 850 1700 1250 2600<br />
3000 1350 2650 1200 2100 1600 2600<br />
Table 1: Effect of template amount and labeling time on probe yield in the High Prime labeling reactions.<br />
Labeling reactions were performed with Biotin-, DIG-, or Fluorescein-High Prime labeling mix and varying<br />
amounts of purified template. The amounts of labeled DNA synthesized after a 1 h incubation and after a<br />
20 h incubation were determined by the incorporation of a radioactive tracer and confirmed by a dot blot.<br />
Data shown for each label is the average of ten independent labeling assays. Experimental yield may vary<br />
from the above because of template purity, sequence, etc.<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
2 Denature the DNA by heating the tube<br />
in a boiling water bath for 10 min, then<br />
chilling quickly in an ice/NaCl or ice/<br />
ethanol bath.<br />
Caution: Complete denaturation is<br />
essential for efficient labeling.<br />
3 Add 4 µl of<br />
either DIG-High Prime<br />
or Biotin-High Prime<br />
or Fluorescein-High Prime<br />
Note: Each High Prime reaction mix<br />
contains 5x concentrated reaction buffer;<br />
50% glycerol; 1 unit/µl Klenow enzyme,<br />
labeling grade; 5x concentrated random<br />
primer mix; 1 mM each of dATP, dCTP,<br />
and dGTP; 0.65 mM dTTP; and<br />
0.35 mM X-dUTP [X = DIG (alkalilabile),<br />
biotin, or fluorescein].<br />
4 Mix the reagents, then centrifuge briefly<br />
<strong>to</strong> collect the reaction mixture at the<br />
bot<strong>to</strong>m of the tube.<br />
5 <strong>In</strong>cubate the tube at least 1 h at 37°C.<br />
Note: Longer incubations (up <strong>to</strong> 20 h)<br />
increase the yield of labeled DNA<br />
(Table 1).<br />
6 To s<strong>to</strong>p the reaction, add 2 µl 0.2 M<br />
EDTA (pH 8.0) <strong>to</strong> the reaction tube<br />
and/or heat the tube <strong>to</strong> 65°C for 10 min.<br />
7 Precipitate the labeled probe by performing<br />
the following steps:<br />
Note: As an alternative <strong>to</strong> the ethanol<br />
precipitation procedure below you may<br />
purify labeled probes which are 100 bp<br />
of longer with the High Pure PCR Product<br />
Purification Kit. See the procedure<br />
on page 50 in this chapter.<br />
To the labeled DNA, add 2.5 µl 4 M<br />
LiCl and 75 µl prechilled (–20°C)<br />
100% ethanol. Mix well.<br />
Let the precipitate form for at least<br />
30 min at –70°C or 2 h at –20°C.<br />
Centrifuge the tube (at 13,000 x g) for<br />
15 min at 4°C.<br />
Discard the supernatant.<br />
Wash the pellet with 50 µl ice-cold<br />
70% (v/v) ethanol.<br />
Centrifuge the tube (at 13,000 x g) for<br />
5 min at 4°C.<br />
Discard the supernatant.<br />
Dry the pellet under vacuum.<br />
Caution: Drying the pellet is important<br />
because small traces of residual<br />
ethanol will cause precipitation if the<br />
hybridization mixture contains dextran<br />
sulfate. Trace ethanol can also lead <strong>to</strong><br />
serious background problems.<br />
Dissolve the pellet in a minimal<br />
amount of TE (10 mM Tris-HCl,<br />
1 mM EDTA, pH 8.0) buffer.<br />
8 Do one of the following:<br />
If you are not going <strong>to</strong> use the probe<br />
immediately, s<strong>to</strong>re the probe solution<br />
at –20°C.<br />
If you are going <strong>to</strong> use the probe<br />
immediately, dilute an aliquot of the<br />
probe solution <strong>to</strong> a convenient s<strong>to</strong>ck<br />
concentration (e.g., 10–40 ng/ml) in<br />
the hybridization buffer <strong>to</strong> be used for<br />
the in situ experiment (as described in<br />
Chapters 2 and 5 of this manual).<br />
Caution: The DIG-dUTP used in this<br />
procedure is alkali-labile. Avoid exposing<br />
DIG-labeled probes <strong>to</strong> strong<br />
alkali (e.g., 0.2 mM NaOH). Standard<br />
in situ procedures should not<br />
detach the DIG label from the probe.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG-High Prime* , ** , *** 5 x solution with: 1 mM dATP, dCTP, dGTP 1 585 606 160 µl<br />
(each); 0.65 mM dTTP; 0.35 mM DIG-11dUTP,<br />
alkali-labile; random primer mixture;<br />
1 unit/µl Klenow enzyme, labeling grade,<br />
in reaction buffer, 50% glycerol (v/v).<br />
(40 reactions)<br />
Biotin-High Prime* 5 x solution with: 1 mM dATP, dCTP, dGTP 1 585 649 100 µl<br />
(each); 0.65 mM dTTP; 0.35 mM biotin- (25 reactions)<br />
16-dUTP; random primer mixture;<br />
1 unit/µl Klenow enzyme, labeling grade,<br />
in reaction buffer, 50% glycerol (v/v).<br />
Fluorescein-High 5 x solution with: 1 mM dATP, dCTP, dGTP 1 585 622 100 µl<br />
Prime* (each); 0.65 mM dTTP; 0.35 mM fluorescein- (25 reactions)<br />
12-dUTP; random primer mixture;<br />
1 unit/µl Klenow enzyme, labeling grade,<br />
in reaction buffer, 50% glycerol (v/v).<br />
CONTENTS<br />
INDEX<br />
***EP Patent 0 324 474 granted<br />
<strong>to</strong> and EP Patent application<br />
0 371 262 pending for Boehringer<br />
Mannheim GmbH.<br />
***This product or the use of this<br />
product may be covered by one<br />
or more patents of Boehringer<br />
Mannheim GmbH, including the<br />
following: EP patent 0 649 909<br />
(application pending).<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
35<br />
4
4<br />
36<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
II. PCR labeling of ds DNA with the<br />
PCR DIG Probe Synthesis Kit or<br />
PCR Labeling Mixes<br />
Note: The procedures given here are necessarily<br />
generalized. Optimal PCR reaction<br />
conditions are very dependent on the<br />
sequence of the template DNA and the<br />
primer. The optimal concentrations of template,<br />
primer, Mg2+ ion, and polymerase, as<br />
well as the optimal incubation times and<br />
temperatures should be determined empirically<br />
for each new primer/template combination<br />
(<strong>In</strong>nis et al., 1990).<br />
The three procedures in this section use<br />
PCR <strong>to</strong> produce probes that are directly<br />
labeled with digoxigenin (DIG) or fluorescein.<br />
The procedures will be especially<br />
useful for producing highly labeled probes<br />
from limited amounts of template DNA.<br />
Each procedure takes advantage of a<br />
premixed labeling solution or kit that has<br />
been optimized for the production of<br />
certain types of probes. They are:<br />
PCR DIG Probe Synthesis Kit, which<br />
contains a 2+1 ratio of dTTP:DIGdUTP<br />
and is ideal for generating highly<br />
labeled hybridization probes containing<br />
unique sequences. Such probes can<br />
detect target sequences present at a low<br />
copy number in complex genomes.<br />
PCR DIG Labeling Mix, which contains<br />
a 19+1 ratio of dTTP:DIG-dUTP and is<br />
ideal for generating moderately labeled<br />
hybridization probes containing repetitive<br />
elements. Such probes can detect<br />
target sequences (e.g., human alphoid<br />
sequences) which are present at a high<br />
copy number in complex genomes.<br />
PCR Fluorescein Labeling Mix, which<br />
contains a 3+1 ratio of dTTP:<br />
fluorescein-dUTP and produces optimally<br />
labeled hybridization probes suitable for<br />
direct in situ detection experiments.<br />
A. PCR DIG labeling reaction for<br />
highly labeled probes containing<br />
unique sequences<br />
Note: This labeling reaction produces 50 µl<br />
of DIG-labeled probe solution. <strong>In</strong> a<br />
control experiment, 50 µl of DIG-labeled<br />
probe was enough <strong>to</strong> perform 25 hybridization<br />
reactions. To produce less probe,<br />
scale the reaction volume and components<br />
down proportionally.<br />
1 Place a sterile microcentrifuge tube on<br />
ice and, for each PCR, add <strong>to</strong> the tube:<br />
5 µl 10 x concentrated PCR buffer<br />
without MgCl2 (100 mM Tris-HCl,<br />
500 mM KCl, pH 8.3) (vial 3).<br />
Note: Numbered vials are included in<br />
the PCR DIG Probe Synthesis Kit.<br />
2–10 µl 25 mM MgCl2 (vial 4).<br />
Note: The concentration of MgCl2 must<br />
be determined empirically. <strong>In</strong>itially,<br />
try 1.5 mM MgCl2 (3 µl vial 4).<br />
5 µl 10 x concentrated PCR DIG<br />
Labeling Mix containing a 2:1 ratio of<br />
dTTP:DIG-dUTP (2 mM each of<br />
dATP, dCTP, and dGTP; 1.3 mM<br />
dTTP; 0.7 mM DIG-dUTP, alkalilabile;<br />
pH 7.0) (vial 2).<br />
0.1–1.0 µM PCR primer 1.<br />
0.1–1.0 µM PCR primer 2.<br />
Note: The concentration of PCR primers<br />
must be determined empirically (<strong>In</strong>nis<br />
et al., 1990). <strong>In</strong>itially, try a 0.3 mM<br />
concentration of each primer in the<br />
reaction mixture.<br />
Template DNA (1–100 ng human<br />
genomic DNA or 10–100 pg plasmid<br />
DNA).<br />
Note: The amount of template DNA<br />
must be determined empirically (<strong>In</strong>nis<br />
et al., 1990). <strong>In</strong>itially, try 50 ng human<br />
genomic DNA or 50 pg plasmid DNA.<br />
0.5–2.5 µl (0.5–2.5 units) Taq DNA<br />
Polymerase (vial 1).<br />
Note: The amount of polymerase must<br />
be determined empirically. <strong>In</strong>itially,<br />
try 2.0 units Taq DNA Polymerase<br />
(2 µl vial 1).<br />
Enough sterile, redistilled water <strong>to</strong><br />
make a <strong>to</strong>tal reaction volume of 50 µl.<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
2 Mix the reagents and centrifuge briefly<br />
<strong>to</strong> collect the mixture at the bot<strong>to</strong>m of<br />
the tube.<br />
3 Overlay with 100 µl mineral oil <strong>to</strong> reduce<br />
evaporation of the mixture during<br />
amplification.<br />
4 Place samples in a thermocycler and<br />
start the PCR. Use the following<br />
thermal profile:<br />
Denaturation before the first cycle:<br />
7 min at 95°C.<br />
30 cycles of:<br />
denaturation, 45 s at 95°C<br />
annealing, 1 min at 60°C<br />
elongation, 2 min at 72°C.<br />
Final elongation after the last cycle:<br />
7 min at 72°C.<br />
Note: Since cycling conditions depend<br />
on the template, primers and thermocycler,<br />
you may have <strong>to</strong> use a different<br />
thermal pro<strong>to</strong>col <strong>to</strong> get optimal results.<br />
For general information, see <strong>In</strong>nis et<br />
al., 1990.<br />
5 S<strong>to</strong>p the reaction by chilling the tubes <strong>to</strong><br />
4°C.<br />
6 Precipitate the labeled probe by performing<br />
the following steps:<br />
Note: As an alternative <strong>to</strong> the ethanol<br />
precipitation procedure below, you may<br />
purify labeled probes which are 100 bp<br />
orlongerwiththeHighPurePCRProduct<br />
Purification Kit. See the procedure on<br />
page 50 in this chapter.<br />
To the labeled DNA, add 5 µl 4 M<br />
LiCl and 150 µl prechilled (–20°C)<br />
100% ethanol. Mix well.<br />
Let the precipitate form for at least<br />
30 min at –70°C or 2 h at –20°C.<br />
Centrifuge the tube (at 13,000 x g) for<br />
15 min at 4°C.<br />
Discard the supernatant.<br />
Wash the pellet with 100 µl ice-cold<br />
70% (v/v) ethanol.<br />
Centrifuge the tube (at 13,000 x g) for<br />
5 min at 4°C.<br />
Discard the supernatant.<br />
CONTENTS<br />
INDEX<br />
Dry the pellet under vacuum.<br />
Caution: Drying the pellet is important<br />
because small traces of residual ethanol<br />
will cause precipitation if the hybridization<br />
mixture contains dextran sulfate.<br />
Trace ethanol can also lead <strong>to</strong> serious<br />
background problems.<br />
Dissolve the pellet in 50 µl TE (10 mM<br />
Tris-HCl, 1 mM EDTA, pH 8.0)<br />
buffer.<br />
Note: If the hybridization buffer (used<br />
in Step 7 below) contains a high<br />
percentage formamide, dissolve the<br />
probe pellet in a smaller amount of<br />
TE buffer <strong>to</strong> form a more concentrated<br />
probe s<strong>to</strong>ck solution.<br />
7 Do one of the following:<br />
If you are not going <strong>to</strong> use the probe<br />
immediately, s<strong>to</strong>re the probe solution<br />
at –20°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the probe<br />
immediately, dilute an aliquot of the<br />
probe solution in the hybridization<br />
buffer <strong>to</strong> be used for the in situ<br />
experiment (as described in Chapters<br />
2 and 5 of this manual).<br />
Note: The amount of probe solution <strong>to</strong><br />
use in the hybridization reaction must<br />
be determined empirically. <strong>In</strong>itially,<br />
try using 2 µl of probe solution (out<br />
of the original 50 µl <strong>to</strong>tal) in 20 µl<br />
hybridization solution foreach hybridization<br />
reaction (under a 24 x 24 mm<br />
coverslip). If the probe was dissolved<br />
in
4<br />
38<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
B. PCR DIG labeling reaction for<br />
moderately labeled probes<br />
Note: This labeling reaction produces 100 µl<br />
of DIG-labeled probe solution. <strong>In</strong> a control<br />
experiment, 100 µl of DIG-labeled probe<br />
was enough <strong>to</strong> perform 20–50 indirect in situ<br />
detections of repetitive (human alphoid)<br />
sequences in metaphase chromosomes. To<br />
produce less probe, scale the reaction volume<br />
and components down proportionally.<br />
1 Place a sterile 1.5 ml microcentrifuge<br />
tube on ice and, for each PCR, add <strong>to</strong><br />
the tube:<br />
10 µl 10 x concentrated PCR buffer<br />
without MgCl2 (100 mM Tris-HCl,<br />
500 mM KCl, pH 8.3).<br />
4–20 µl 25 mM MgCl2.<br />
Note:The concentrationofMgCl2must<br />
be determined empirically. <strong>In</strong>itially,<br />
try 1.5 mM MgCl2 (6 µl 25 mM s<strong>to</strong>ck).<br />
10 µl 10 x concentrated PCR DIG<br />
Labeling Mix containing a 19:1 ratio<br />
of dTTP:DIG-dUTP (2 mM each of<br />
dATP, dCTP, and dGTP; 1.9 mM<br />
dTTP; 0.1 mM DIG-dUTP; pH 7.0)<br />
0.1–1.0 µM PCR primer 1.<br />
0.1–1.0 µM PCR primer 2.<br />
Note: The concentration of PCR primers<br />
must be determined empirically (<strong>In</strong>nis<br />
et al., 1990). <strong>In</strong>itially, try a 0.3 µM<br />
concentration of each primer in the<br />
reaction mixture.<br />
Template DNA (1–100 ng human<br />
genomic DNA or 10–100 pg plasmid<br />
DNA).<br />
Note: The amount of template DNA<br />
must be determined empirically (<strong>In</strong>nis<br />
et al., 1990). <strong>In</strong>itially, try 50 ng human<br />
genomic DNA or 50 pg plasmid DNA.<br />
1–5 units Taq DNA Polymerase.<br />
Note: The amount of polymerase must<br />
be determined empirically. As a starting<br />
amount, try 2.5 units.<br />
Enough sterile, redistilled water <strong>to</strong><br />
make a <strong>to</strong>tal reaction volume of 100 µl.<br />
2 Mix the reagents, overlay with oil, and<br />
perform PCR exactly as in Steps 2–5 of<br />
Procedure IIA above (for labeling of<br />
probes containing unique sequences).<br />
3 Precipitate the labeled probe by performing<br />
the following steps:<br />
Note: As an alternative <strong>to</strong> the ethanol<br />
precipitation procedure below, you may<br />
purify labeled probes which are 100 bp<br />
or longer with the High Pure PCR Product<br />
Purification Kit. See the procedure on<br />
page 50 in this chapter.<br />
To the labeled DNA, add 10 µl 4 M<br />
LiCl and 300 µl prechilled (–20°C)<br />
100% ethanol. Mix well.<br />
Let the precipitate form for at least<br />
30 min at –70°C or 2 h at –20°C.<br />
Centrifuge the tube (at 13,000 x g) for<br />
15 min at 4°C.<br />
Discard the supernatant.<br />
Wash the pellet with 100 µl ice-cold<br />
70% (v/v) ethanol.<br />
Centrifuge the tube (at 13,000 x g) for<br />
5 min at 4°C.<br />
Discard the supernatant.<br />
Dry the pellet under vacuum.<br />
Caution: Drying the pellet is important<br />
because small traces of residual ethanol<br />
will cause precipitation if the hybridization<br />
mixture contains dextran sulfate.<br />
Trace ethanol can also lead <strong>to</strong> serious<br />
background problems.<br />
Dissolve the pellet in 100 µl TE<br />
(10 mM Tris-HCl, 1 mM EDTA, pH<br />
8.0) buffer.<br />
Note: If the hybridization buffer (used<br />
in Step 4 below) contains a high percentage<br />
formamide, dissolve the probe<br />
pellet in a smaller amount of TE buffer<br />
<strong>to</strong> form a more concentrated probe<br />
s<strong>to</strong>ck solution.<br />
4 Do one of the following:<br />
If you are not going <strong>to</strong> use the probe<br />
immediately, s<strong>to</strong>re the probe solution<br />
at –20°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the probe<br />
immediately, dilute an aliquot of the<br />
probe solution in the hybridization<br />
buffer <strong>to</strong> be used for the in situ experiment<br />
(as described in Chapters 2 and<br />
5 of this manual).<br />
Note: The amount of probe solution <strong>to</strong><br />
use in the hybridization reaction must<br />
be determined empirically. <strong>In</strong>itially,<br />
try using 2–5 µl of probe solution (out<br />
of the original 100 µl <strong>to</strong>tal) in 20 µl<br />
hybridization solution for each hybridization<br />
reaction (under a 24 x 24 mm<br />
coverslip). If the probe was dissolved<br />
in < 100 µl TE (in Step 3 above), add<br />
correspondingly less of the concentrated<br />
probe s<strong>to</strong>ck <strong>to</strong> the hybridization buffer.<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
C. PCR fluorescein labeling reaction for<br />
direct in situ probes<br />
Note: This labeling reaction produces<br />
100 µl of fluorescein-labeled probe solution.<br />
<strong>In</strong> a control experiment, 100 µl of fluorescein-labeled<br />
probe was enough <strong>to</strong> perform<br />
20–50 direct in situ detections of repetitive<br />
(human alphoid) sequences in metaphase<br />
chromosomes. To produce less probe, scale<br />
the reaction volume and components down<br />
proportionally.<br />
1 Place a sterile 1.5 ml microcentrifuge<br />
tube on ice and add <strong>to</strong> the tube:<br />
10 µl 10 x concentrated PCR buffer<br />
without MgCl2 (100 mM Tris-HCl,<br />
500 mM KCl, pH 8.3) (vial 2).<br />
Note: Numbered vials are included<br />
with the PCR Fluorescein Labeling<br />
Mix.<br />
12–20 µl 25 mM MgCl2 (vial 3).<br />
Note: The concentration of MgCl2<br />
must be determined empirically. We<br />
use 4 mM MgCl2 (16 µl vial 3) as our<br />
standard concentration.<br />
10 µl 10 x concentrated PCR<br />
Fluorescein Labeling Mix (2 mM each<br />
of dATP, dCTP, and dGTP; 1.5 mM<br />
dTTP; 0.5 mM fluorescein-dUTP;<br />
pH 7.0) (vial 1).<br />
0.1–1.0 µM PCR primer 1.<br />
0.1–1.0 µM PCR primer 2.<br />
Note: The concentration of PCR primers<br />
must be determined empirically (<strong>In</strong>nis<br />
et al., 1990). <strong>In</strong>itially, try a 0.3 mM<br />
concentration of each primer in the<br />
reaction mixture.<br />
Template DNA (1–100 ng human<br />
genomic DNA or 10–100 pg plasmid<br />
DNA).<br />
Note: The amount of template DNA<br />
must be determined empirically (<strong>In</strong>nis<br />
et al., 1990). <strong>In</strong>itially, try 50 ng human<br />
genomic DNA or 50 pg plasmid DNA.<br />
1–5 units Taq DNA Polymerase.<br />
CONTENTS<br />
INDEX<br />
Note: The amount of polymerase must<br />
be determined empirically. As a starting<br />
amount, try 2.5 units.<br />
Enough sterile, redistilled water <strong>to</strong><br />
make a <strong>to</strong>tal reaction volume of100 µl.<br />
2 Mix the reagents, overlay with oil, and<br />
perform PCR exactly as in Steps 2–5 of<br />
Procedure IIA above (for labeling of<br />
probes containing unique sequences).<br />
3 Precipitate the labeled probe by performing<br />
the following steps:<br />
Note: As an alternative <strong>to</strong> the ethanol<br />
precipitation procedure below, you may<br />
purify labeled probes which are 100 bp<br />
or longer with the High Pure PCR Product<br />
Purification Kit. See the procedure<br />
on page 50 in this chapter.<br />
To the labeled DNA, add 10 µl 4 M<br />
LiCl and 300 µl prechilled (–20°C)<br />
100% ethanol. Mix well.<br />
Let the precipitate form for at least<br />
30 min at –70°C or 2 h at –20°C.<br />
Centrifuge the tube (at 13,000 x g) for<br />
15 min at 4°C.<br />
Discard the supernatant.<br />
Wash the pellet with 100 µl ice-cold<br />
70% (v/v) ethanol.<br />
Centrifuge the tube (at 13,000 x g) for<br />
5 min at 4°C.<br />
Discard the supernatant.<br />
Dry the pellet under vacuum.<br />
Caution: Drying the pellet is important<br />
because small traces of residual ethanol<br />
will cause precipitation if the hybridization<br />
mixture contains dextran sulfate.<br />
Trace ethanol can also lead <strong>to</strong> serious<br />
background problems.<br />
Dissolve the pellet in 100 µl TE<br />
(10 mM Tris-HCl, 1 mM EDTA,<br />
pH 8.0) buffer.<br />
Note: If the hybridization buffer (used<br />
in Step 4 below) contains a high percentage<br />
formamide, dissolve the probe<br />
pellet in a smaller amount of TE buffer<br />
<strong>to</strong> form a more concentrated probe<br />
s<strong>to</strong>ck solution.<br />
39<br />
4
4<br />
40<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
4 Do one of the following:<br />
If you are not going <strong>to</strong> use the probe<br />
immediately, s<strong>to</strong>re the probe solution<br />
at –20°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the probe<br />
immediately, dilute an aliquot of the<br />
probe solution in the hybridization<br />
buffer <strong>to</strong> be used for the in situ experiment<br />
(as described in Chapters 2 and<br />
5 of this manual).<br />
Note: The amount of probe solution <strong>to</strong><br />
use in the hybridization reaction must<br />
be determined empirically. <strong>In</strong>itially, try<br />
using 2–5 µl of probe solution (out of the<br />
original 100 µl <strong>to</strong>tal) in 20 µl hybridization<br />
solution for each hybridization<br />
reaction (under a 24x24mm coverslip).<br />
If the probe was dissolved in < 100 µl<br />
TE (in Step 3 above), add correspondingly<br />
less of the concentrated probe<br />
s<strong>to</strong>ck <strong>to</strong> the hybridization buffer.<br />
Reagents available from Boehringer<br />
Mannheim for these procedures<br />
III. Nick-translation labeling of ds<br />
DNA with Nick Translation Mixes<br />
for in situ Probes<br />
The nick translation procedure was originally<br />
described by Rigby et al. (1977) and<br />
used for incorporating nucleotide analogs<br />
by Langer et al. (1981). The procedure<br />
described here incorporates one modified<br />
nucleotide (DIG-, biotin-, fluorescein-,<br />
AMCA-, or tetramethylrhodamine-dUTP)<br />
at approximately every 20–25th position in<br />
the newly synthesized DNA. This labeling<br />
density allows optimal enzymatic incorporation<br />
of the modified nucleotide and<br />
produces the most sensitive targets for<br />
indirect (immunological) detection.<br />
For in situ hybridization procedures, the<br />
length of the labeled fragments obtained<br />
from this procedure should be about<br />
200–500 bases.<br />
Note: DNA does not need <strong>to</strong> be denatured<br />
before it is labeled by nick translation.<br />
Reagent Description Cat. No. Pack size<br />
PCR DIG Probe Kit for 25 labeling reactions 1636 090 1 kit<br />
Synthesis Kit* which incorporate alkali-labile<br />
DIG-dUTP by PCR<br />
(25 reactions)<br />
PCR DIG Labeling Mix* dATP, dCTP, dGTP, 2 mM each; 1 585 550 for 2 x 25 PCR<br />
dTTP 1.9 mM; alkali-stable DIG-dUTP, reactions<br />
0.1 mM; pH 7.0<br />
PCR-Fluorescein Contents: dATP, dCTP, dGTP, 1 636 154 for 10 PCR<br />
Labeling Mix* (for rapid 2 mM each; dTTP, 1.5 mM; reactions<br />
and reliable synthesis of fluorescein-dUTP, 0.5 mM;<br />
fluorescein-dUTP labeled premixed<br />
probes that are particular 10x PCR buffer without MgCl2<br />
useful for fluorescence in 25 mM MgCl2 s<strong>to</strong>ck solution<br />
situ hybridization [FISH])<br />
Taq DNA Polymerase, 10 x concentrated PCR buffer included 1 146 165 100 U<br />
5 units/µl* 1 146 173 500 U<br />
1 418 432 1000 U<br />
1 596 594 2500 U<br />
1 435 094 3000 U<br />
Taq DNA Polymerase PCR buffer included 1 647 679 250 U<br />
1 unit/µl* 1 647 687 1000 U<br />
*These products are sold under licensing arrangements with Roche Molecular Systems and The Perkin-<br />
Elmer Corporation. Purchase of these products are accompanied by a license <strong>to</strong> use it in the Polymerase<br />
Chain Reaction (PCR) process in conjunction with an Authorized Thermal Cycler. For complete license<br />
disclaimer, see inside back cover page + .<br />
CONTENTS<br />
INDEX
4<br />
40<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
4 Do one of the following:<br />
If you are not going <strong>to</strong> use the probe<br />
immediately, s<strong>to</strong>re the probe solution<br />
at –20°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the probe<br />
immediately, dilute an aliquot of the<br />
probe solution in the hybridization<br />
buffer <strong>to</strong> be used for the in situ experiment<br />
(as described in Chapters 2 and<br />
5 of this manual).<br />
Note: The amount of probe solution <strong>to</strong><br />
use in the hybridization reaction must<br />
be determined empirically. <strong>In</strong>itially, try<br />
using 2–5 µl of probe solution (out of the<br />
original 100 µl <strong>to</strong>tal) in 20 µl hybridization<br />
solution for each hybridization<br />
reaction (under a 24x24mm coverslip).<br />
If the probe was dissolved in < 100 µl<br />
TE (in Step 3 above), add correspondingly<br />
less of the concentrated probe<br />
s<strong>to</strong>ck <strong>to</strong> the hybridization buffer.<br />
Reagents available from Boehringer<br />
Mannheim for these procedures<br />
III. Nick-translation labeling of ds<br />
DNA with Nick Translation Mixes<br />
for in situ Probes<br />
The nick translation procedure was originally<br />
described by Rigby et al. (1977) and<br />
used for incorporating nucleotide analogs<br />
by Langer et al. (1981). The procedure<br />
described here incorporates one modified<br />
nucleotide (DIG-, biotin-, fluorescein-,<br />
AMCA-, or tetramethylrhodamine-dUTP)<br />
at approximately every 20–25th position in<br />
the newly synthesized DNA. This labeling<br />
density allows optimal enzymatic incorporation<br />
of the modified nucleotide and<br />
produces the most sensitive targets for<br />
indirect (immunological) detection.<br />
For in situ hybridization procedures, the<br />
length of the labeled fragments obtained<br />
from this procedure should be about<br />
200–500 bases.<br />
Note: DNA does not need <strong>to</strong> be denatured<br />
before it is labeled by nick translation.<br />
Reagent Description Cat. No. Pack size<br />
PCR DIG Probe Kit for 25 labeling reactions 1636 090 1 kit<br />
Synthesis Kit* which incorporate alkali-labile<br />
DIG-dUTP by PCR<br />
(25 reactions)<br />
PCR DIG Labeling Mix* dATP, dCTP, dGTP, 2 mM each; 1 585 550 for 2 x 25 PCR<br />
dTTP 1.9 mM; alkali-stable DIG-dUTP, reactions<br />
0.1 mM; pH 7.0<br />
PCR-Fluorescein Contents: dATP, dCTP, dGTP, 1 636 154 for 10 PCR<br />
Labeling Mix* (for rapid 2 mM each; dTTP, 1.5 mM; reactions<br />
and reliable synthesis of fluorescein-dUTP, 0.5 mM;<br />
fluorescein-dUTP labeled premixed<br />
probes that are particular 10x PCR buffer without MgCl2<br />
useful for fluorescence in 25 mM MgCl2 s<strong>to</strong>ck solution<br />
situ hybridization [FISH])<br />
Taq DNA Polymerase, 10 x concentrated PCR buffer included 1 146 165 100 U<br />
5 units/µl* 1 146 173 500 U<br />
1 418 432 1000 U<br />
1 596 594 2500 U<br />
1 435 094 3000 U<br />
Taq DNA Polymerase PCR buffer included 1 647 679 250 U<br />
1 unit/µl* 1 647 687 1000 U<br />
*These products are sold under licensing arrangements with Roche Molecular Systems and The Perkin-<br />
Elmer Corporation. Purchase of these products are accompanied by a license <strong>to</strong> use it in the Polymerase<br />
Chain Reaction (PCR) process in conjunction with an Authorized Thermal Cycler. For complete license<br />
disclaimer, see inside back cover page + .<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
A. Labeling reaction with DIG-dUTP or<br />
Biotin-dUTP<br />
1 Place a 1.5 ml microcentrifuge tube on<br />
ice and add <strong>to</strong> the tube:<br />
16 µl sterile redistilled H2O containing<br />
1 µg template DNA (either linear<br />
or supercoiled).<br />
4 µl of either DIG-Nick Translation<br />
Mix for in situ Probes<br />
or<br />
Biotin-Nick Translation Mix for in<br />
situ Probes<br />
Note: Each Nick Translation Mix contains<br />
5 x concentrated reaction buffer;<br />
50% glycerol; DNA Polymerase I;<br />
DNase I; 0.25 mM each of dATP,<br />
dCTP, and dGTP; 0.17 mM dTTP; and<br />
0.08 mM X-dUTP (X = DIG or biotin).<br />
2 Mix ingredients and centrifuge tube<br />
briefly.<br />
3 <strong>In</strong>cubate at 15°C for 90 min.<br />
4 Chill the reaction tube <strong>to</strong> 0°C.<br />
5 Take a 3 µl aliquot from the tube and<br />
analyze it as follows:<br />
Mix the aliquot with enough gel loading<br />
buffer <strong>to</strong> make a sample which will<br />
fit in one well of an agarose minigel.<br />
Denature the sample (DNA aliquot +<br />
gel loading buffer) for 3 min at 95°C.<br />
Place the denatured sample on ice for<br />
3 min.<br />
Run the sample on an agarose minigel<br />
with a DNA molecular weight marker.<br />
6 Depending on the average size of the<br />
probe, do one of the following:<br />
If the probe is between 200 and 500<br />
nucleotides long, go <strong>to</strong> Step 7.<br />
If the probe is longer than 500<br />
nucleotides, incubate the reaction<br />
tube further at 15°C until the fragments<br />
are the proper size.<br />
Note: If the fragment is <strong>to</strong>o long, the<br />
labeled probe can also be sonicated <strong>to</strong><br />
the proper size.<br />
7 S<strong>to</strong>p the reaction as follows:<br />
Add 1 µl 0.5 M EDTA (pH 8.0) <strong>to</strong> the<br />
tube.<br />
Heat the tube <strong>to</strong> 65°C for 10 min.<br />
CONTENTS<br />
INDEX<br />
B. Labeling reaction with FluoresceindUTP,<br />
AMCA-dUTP, or Tetramethylrhodamine-dUTP<br />
1 Prepare 50 µl of a 5 x fluorophore labeling<br />
mixture (enough for about 12 labeling<br />
reactions) by mixing the following<br />
in a 1.5 ml microcentrifuge tube on ice:<br />
5 µl 2.5 mM dATP.<br />
5 µl 2.5 mM dCTP.<br />
5 µl 2.5 mM dGTP.<br />
3.4 µl 2.5 mM dTTP.<br />
4µlofeither 1mM Fluorescein-dUTP<br />
or<br />
1 mM AMCA-dUTP<br />
or<br />
1 mM Tetramethylrhodamine-dUTP<br />
27.6 µl sterile redistilled H2O.<br />
2 Place a 1.5 ml microcentrifuge tube on<br />
ice and add <strong>to</strong> the tube:<br />
12 µl sterile redistilled H2O containing<br />
1 mg template DNA (either linear<br />
or supercoiled).<br />
4 µl 5 x concentrated fluorophore<br />
labeling mixture (from Step 1).<br />
4 µl of Nick Translation Mix for in<br />
situ Probes.<br />
Note: Nick Translation Mix contains<br />
5x concentrated reaction buffer; 50%<br />
glycerol; DNA Polymerase I; and<br />
DNase I.<br />
3 Mix, incubate and s<strong>to</strong>p the reaction as in<br />
Steps 2–7 for DIG- and biotin-labeling<br />
above.<br />
C. Purification of labeled probe<br />
1 Precipitate the labeled probe (from either<br />
procedure above) by performing the following<br />
steps.<br />
As alternative <strong>to</strong> the ethanol precipitation<br />
procedure below, you may purify<br />
labeled probes which are 100 bp or<br />
longer with the High Pure PCR Product<br />
Purification Kit. See the procedure on<br />
page 50 in this chapter.<br />
To the labeled DNA, add 2.5 µl 4 M<br />
LiCl and 75 µl prechilled (–20°C)<br />
100% ethanol. Mix well.<br />
Let the precipitate form for at least<br />
30 min at –70°C or 2 h at –20°C.<br />
Centrifuge the tube (at 13,000 x g) for<br />
15 min at 4°C.<br />
41<br />
4
4<br />
42<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
Discard the supernatant.<br />
Wash the pellet with 50 µl ice-cold<br />
70% (v/v) ethanol.<br />
Centrifuge the tube (at 13,000 x g) for<br />
5 min at 4°C.<br />
Discard the supernatant.<br />
Dry the pellet under vacuum.<br />
Caution: Drying the pellet is important<br />
because small traces of residual ethanol<br />
will cause precipitation if the hybridization<br />
mixture contains dextran sulfate.<br />
Trace ethanol can also lead <strong>to</strong> serious<br />
background problems.<br />
2 Do one of the following:<br />
If you are not going <strong>to</strong> use the probe<br />
immediately, dissolve the pellet in a<br />
minimal amount of TE (10 mM Tris-<br />
HCl, 1 mM EDTA, pH 8.0) buffer<br />
and s<strong>to</strong>re the probe solution at –20°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the probe<br />
immediately, dissolve the pellet in a<br />
minimal amount of an appropriate<br />
buffer (TE, sodium phosphate, etc.),<br />
then dilute the probe solution <strong>to</strong> a<br />
convenient s<strong>to</strong>ck concentration (e.g.,<br />
10–40 ng/µl) in the hybridization<br />
buffer <strong>to</strong> be used for the in situ experiment<br />
(as described in Chapters 2 and<br />
5 of this manual).<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
IV. Nick-translation labeling of ds DNA<br />
with DIG-, Biotin-, or Fluorochromelabeled<br />
dUTP<br />
Department of Cy<strong>to</strong>chemistry and Cy<strong>to</strong>metry,<br />
University of Leiden, Netherlands,<br />
and Department of Genetics, Yale<br />
University, U.S.A.<br />
Note: For in situ hybridization procedures,<br />
the length of the labeled fragments obtained<br />
from this procedure should be about<br />
200–400 bases.<br />
1 Place a 1.5 ml microcentrifuge tube on<br />
ice and add <strong>to</strong> the tube:<br />
27 µl sterile, redistilled H2O.<br />
5 µl 10 x concentrated nick translation<br />
buffer [500 mM Tris-HCl (pH 7.8),<br />
50 mM MgCl2, 0.5 mg/ml Bovine<br />
Serum Albumin (nuclease-free)].<br />
5 µl 100 mM Dithiothrei<strong>to</strong>l.<br />
4 µl Nucleotide Mixture (0.5 mM each<br />
of dATP, dGTP, and dCTP; 0.1 mM<br />
dTTP).<br />
2 µl 1 mM DIG-dUTP<br />
or<br />
1 mM Biotin-dUTP<br />
or<br />
1 mM fluorochrome-labeled dUTP.<br />
1 µg template DNA.<br />
5 µl (5 ng) DNase I.<br />
1 µl (10 units) DNA Polymerase I.<br />
Reagent Description Cat. No. Pack size<br />
DIG-Nick Translation 5 x conc. stabilized reaction buffer in 1745 816 160 µl<br />
Mix* for in situ probes 50% glycerol (v/v) and DNA Polymerase I,<br />
DNase I, 0.25 mM dATP, 0.25 mM dCTP,<br />
0.25 mM dGTP, 0.17 mM dTTP and<br />
0.08 mM alkali-stable DIG-11-dUTP.<br />
Biotin-Nick Translation 5 x conc. stabilized reaction buffer in 1745 824 160 µl<br />
Mix* for in situ probes 50% glycerol (v/v) and DNA Polymerase I,<br />
DNase I, 0.25 mM dATP, 0.25 mM dCTP,<br />
0.25 mM dGTP, 0.17 mM dTTP and<br />
0.08 mM biotin-16-dUTP.<br />
Nick Translation Mix* 5 x conc. stabilized reaction buffer in 1745 808 200 µl<br />
for in situ probes 50% glycerol, DNA Polymerase I and DNase I.<br />
dNTP Set Set of dATP, dCTP, dGTP, dTTP 1 277 049 4 x10 µmol<br />
100 mM solutions, lithium salts. (100 µl)<br />
Fluorescein-12-dUTP Tetralithium salt, 1 mM solution 1 373 242 25 nmol (25 µl)<br />
Tetramethyl- Tetralithium salt, 1 mM solution 1 534 378 25 nmol (25 µl)<br />
rhodamine-6-dUTP<br />
AMCA-6-dUTP Tetralithium salt, 1 mM solution 1 534 386 25 nmol (25 µl)<br />
*These products or the use of these products may be covered by one or more patents of<br />
Boehringer Mannheim GmbH, including the following: EP patent 0 649 909 (application pending).<br />
CONTENTS<br />
INDEX
4<br />
42<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
Discard the supernatant.<br />
Wash the pellet with 50 µl ice-cold<br />
70% (v/v) ethanol.<br />
Centrifuge the tube (at 13,000 x g) for<br />
5 min at 4°C.<br />
Discard the supernatant.<br />
Dry the pellet under vacuum.<br />
Caution: Drying the pellet is important<br />
because small traces of residual ethanol<br />
will cause precipitation if the hybridization<br />
mixture contains dextran sulfate.<br />
Trace ethanol can also lead <strong>to</strong> serious<br />
background problems.<br />
2 Do one of the following:<br />
If you are not going <strong>to</strong> use the probe<br />
immediately, dissolve the pellet in a<br />
minimal amount of TE (10 mM Tris-<br />
HCl, 1 mM EDTA, pH 8.0) buffer<br />
and s<strong>to</strong>re the probe solution at –20°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the probe<br />
immediately, dissolve the pellet in a<br />
minimal amount of an appropriate<br />
buffer (TE, sodium phosphate, etc.),<br />
then dilute the probe solution <strong>to</strong> a<br />
convenient s<strong>to</strong>ck concentration (e.g.,<br />
10–40 ng/µl) in the hybridization<br />
buffer <strong>to</strong> be used for the in situ experiment<br />
(as described in Chapters 2 and<br />
5 of this manual).<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
IV. Nick-translation labeling of ds DNA<br />
with DIG-, Biotin-, or Fluorochromelabeled<br />
dUTP<br />
Department of Cy<strong>to</strong>chemistry and Cy<strong>to</strong>metry,<br />
University of Leiden, Netherlands,<br />
and Department of Genetics, Yale<br />
University, U.S.A.<br />
Note: For in situ hybridization procedures,<br />
the length of the labeled fragments obtained<br />
from this procedure should be about<br />
200–400 bases.<br />
1 Place a 1.5 ml microcentrifuge tube on<br />
ice and add <strong>to</strong> the tube:<br />
27 µl sterile, redistilled H2O.<br />
5 µl 10 x concentrated nick translation<br />
buffer [500 mM Tris-HCl (pH 7.8),<br />
50 mM MgCl2, 0.5 mg/ml Bovine<br />
Serum Albumin (nuclease-free)].<br />
5 µl 100 mM Dithiothrei<strong>to</strong>l.<br />
4 µl Nucleotide Mixture (0.5 mM each<br />
of dATP, dGTP, and dCTP; 0.1 mM<br />
dTTP).<br />
2 µl 1 mM DIG-dUTP<br />
or<br />
1 mM Biotin-dUTP<br />
or<br />
1 mM fluorochrome-labeled dUTP.<br />
1 µg template DNA.<br />
5 µl (5 ng) DNase I.<br />
1 µl (10 units) DNA Polymerase I.<br />
Reagent Description Cat. No. Pack size<br />
DIG-Nick Translation 5 x conc. stabilized reaction buffer in 1745 816 160 µl<br />
Mix* for in situ probes 50% glycerol (v/v) and DNA Polymerase I,<br />
DNase I, 0.25 mM dATP, 0.25 mM dCTP,<br />
0.25 mM dGTP, 0.17 mM dTTP and<br />
0.08 mM alkali-stable DIG-11-dUTP.<br />
Biotin-Nick Translation 5 x conc. stabilized reaction buffer in 1745 824 160 µl<br />
Mix* for in situ probes 50% glycerol (v/v) and DNA Polymerase I,<br />
DNase I, 0.25 mM dATP, 0.25 mM dCTP,<br />
0.25 mM dGTP, 0.17 mM dTTP and<br />
0.08 mM biotin-16-dUTP.<br />
Nick Translation Mix* 5 x conc. stabilized reaction buffer in 1745 808 200 µl<br />
for in situ probes 50% glycerol, DNA Polymerase I and DNase I.<br />
dNTP Set Set of dATP, dCTP, dGTP, dTTP 1 277 049 4 x10 µmol<br />
100 mM solutions, lithium salts. (100 µl)<br />
Fluorescein-12-dUTP Tetralithium salt, 1 mM solution 1 373 242 25 nmol (25 µl)<br />
Tetramethyl- Tetralithium salt, 1 mM solution 1 534 378 25 nmol (25 µl)<br />
rhodamine-6-dUTP<br />
AMCA-6-dUTP Tetralithium salt, 1 mM solution 1 534 386 25 nmol (25 µl)<br />
*These products or the use of these products may be covered by one or more patents of<br />
Boehringer Mannheim GmbH, including the following: EP patent 0 649 909 (application pending).<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
2 Mix ingredients and centrifuge tube<br />
briefly.<br />
3 <strong>In</strong>cubate at 15°C for 2 h.<br />
4 Chill the reaction tube <strong>to</strong> 0°C.<br />
5 Take a 3 µl aliquot from the tube and<br />
run the sample on an agarose minigel<br />
with a DNA Molecular Weight Marker.<br />
6 Depending on the average size of the<br />
probe, do one of the following:<br />
If the probe is between 200 and 400<br />
nucleotides long, go <strong>to</strong> Step 7.<br />
If the probe is longer than 400 nucleotides,<br />
incubate the reaction tube<br />
further at 15°C until the fragments are<br />
the proper size.<br />
Note: If the fragment is <strong>to</strong>o long, the<br />
labeled probe can also be sonicated <strong>to</strong><br />
the proper size.<br />
7 S<strong>to</strong>p the reaction as follows:<br />
To the tube, add carrier DNA (e.g.,<br />
50-fold excess of fragmented herring<br />
sperm DNA) and carrier RNA (e.g.,<br />
50-fold excess of yeast tRNA).<br />
Add 0.1 volume 3 M sodium acetate,<br />
pH 5.6.<br />
Add 2.5 volumes prechilled (–20°C)<br />
100% ethanol.<br />
Mix reagents well. Caution: Do not<br />
use a pipette tip <strong>to</strong> mix.<br />
Place tube on ice for 30 min.<br />
Centrifuge tube for 30 min in a<br />
microcentrifuge at 4°C.<br />
Discard the supernatant.<br />
Dry the pellet under vacuum.<br />
Caution: Drying the pellet is important<br />
because small traces of residual<br />
ethanol will cause precipitation if the<br />
hybridization mixture contains dextran<br />
sulfate. Trace ethanol can also lead <strong>to</strong><br />
serious background problems.<br />
8 Do one of the following:<br />
If you are not going <strong>to</strong> use the probe<br />
immediately, dissolve the pellet in a<br />
minimal amount of TE (10 mM Tris-<br />
HCl, 1 mM EDTA, pH 8.0) buffer<br />
and s<strong>to</strong>re the probe solution at –20°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the probe<br />
immediately, dissolve the pellet in a<br />
minimal amount of an appropriate<br />
buffer (TE, sodium phosphate, etc.),<br />
then dilute an aliquot of the probe<br />
solution <strong>to</strong> a convenient s<strong>to</strong>ck concentration<br />
(e.g., 10–40 ng/µl) in the<br />
hybridization buffer <strong>to</strong> be used for the<br />
in situ experiment (as described in<br />
Chapters 2 and 5 of this manual).<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
Digoxigenin-11-dUTP, Tetralithium salt, 1 mM solution 1 093 088 25 nmol (25 µl)<br />
alkali-stable 1 558 706 125 nmol (125 µl)<br />
1 570 013 5 x125 nmol<br />
(5 x125 µl)<br />
Fluorescein-12-dUTP Tetralithium salt, 1 mM solution 1 373 242 25 nmol (25 µl)<br />
Tetramethyl- Tetralithium salt, 1 mM solution 1 534 378 25 nmol (25 µl)<br />
rhodamine-6-dUTP<br />
AMCA-6-dUTP Tetralithium salt, 1 mM solution 1 534 386 25 nmol (25 µl)<br />
Biotin-16-dUTP Tetralithium salt, 1 mM solution 1 093 070 50 nmol (50 µl)<br />
DNase I Lyophilizate 104 159 100 mg<br />
DNA Polymerase I Nick Translation Grade 104 485 500 units<br />
104 493 1000 units<br />
CONTENTS<br />
INDEX<br />
43<br />
4
4<br />
44<br />
ProceduresforLabelingDNA,RNA,andOligonucleotideswithDIG,Biotin,orFluorochromes<br />
V. RNA labeling by in vitro transcription<br />
of DNA with DIG, Biotin or Fluorescein<br />
RNA Labeling Mix<br />
The DNA <strong>to</strong> be transcribed should be<br />
cloned in<strong>to</strong> the polylinker site of a transcription<br />
vec<strong>to</strong>r which contains a promoter<br />
for SP6,T7,orT3RNAPolymerase(Dunn<br />
andStudier,1983;Kassavetis,1982).Tosynthesize<br />
“run-off” transcripts, use a restriction<br />
enzyme that creates a 5'-overhang <strong>to</strong><br />
linearize the template before transcription.<br />
Alternatively, use the circular vec<strong>to</strong>r DNA as<br />
template <strong>to</strong> create “run-around” transcripts.<br />
A PCR fragment that has the appropriate<br />
promoter ligated <strong>to</strong> its 5'-ends can also<br />
serve as a transcription template.<br />
The procedure described here incorporates<br />
one modified nucleotide (DIG-, Biotin-, or<br />
Fluorescein-UTP) at approximately every<br />
20–25th position in the transcripts. Since<br />
the nucleotide concentration does not<br />
become limiting in the following reaction,<br />
1 µg linear plasmid DNA (with a 1 kb insert)<br />
can produce approximately 10 µg of<br />
full-length labeled RNA transcript in a<br />
two hour incubation. Larger amounts of<br />
labeled RNA can be synthesized by scaling<br />
up the reaction components.<br />
Note: The amount of newly synthesized<br />
labeled RNA depends on the amount, size,<br />
site of linearization, and purity of the<br />
template DNA.<br />
1 Purify template DNA in one of the<br />
following ways:<br />
Use phenol/chloroform extraction<br />
and ethanol precipitation <strong>to</strong> purify<br />
linearized plasmid DNA after the<br />
linearizing restriction digestion. Resuspend<br />
the pellet in 10 mM Tris-HCl,<br />
pH 8.0.<br />
Ethanol precipitate circular plasmid<br />
DNAand resuspend it in 10 mM Tris-<br />
HCl, pH 8.0.<br />
Use acrylamide gel electrophoresis<br />
and elution (in 10 mM Tris-HCl, pH<br />
8.0) <strong>to</strong> purify a PCR fragment which<br />
has an RNA polymerase promoter<br />
ligated <strong>to</strong> its 5'-ends.<br />
2 Add the following <strong>to</strong> a 1.5 ml microcentrifuge<br />
tube on ice:<br />
1µgpurified,linearizedplasmidDNA<br />
or<br />
1 µg purified, circular plasmid DNA<br />
or<br />
100–200 ng purified PCR fragment.<br />
2 µl of either 10 x concentrated DIG<br />
RNA Labeling Mix<br />
or<br />
10 x concentrated Biotin RNA Labeling<br />
Mix<br />
or<br />
10xconcentrated Fluorescein RNA<br />
Labeling Mix.<br />
Note: Concentrated RNA Labeling<br />
Mix contains 10 mM each of ATP,<br />
CTP,andGTP;6.5mMUTP;3.5mM<br />
X-UTP (X = DIG, Biotin or Fluorescein);<br />
pH 7.5 (20°C)].<br />
2 µl 10xconcentrated Transcription<br />
Buffer [400 mM Tris-HCl (pH 8.0,<br />
20°C),60mMMgCl2,100mMDithiothrei<strong>to</strong>l<br />
(DTT), 20 mM spermidine].<br />
Note: 10xconcentrated Transcription<br />
Buffer is supplied with SP6, T3, or T7<br />
RNA Polymerase.<br />
2µlRNAPolymerase(SP6,T7,orT3).<br />
Enough sterile, redistilled water <strong>to</strong><br />
make a <strong>to</strong>tal reaction volume of20µl.<br />
3 Mix the components and centrifuge the<br />
tube briefly.<br />
4 <strong>In</strong>cubate the tube for 2 h at 37°C.<br />
Note:Longerincubationsdonotincrease<br />
the yield of labeled RNA. To produce<br />
larger amounts of RNA, scale up the<br />
reaction components.<br />
5 Do one of the following:<br />
If you want <strong>to</strong> remove the template<br />
DNA, add 2 units DNase I, RNasefree<br />
<strong>to</strong> the tube and incubate for<br />
15 min at 37°C. Then, go <strong>to</strong> Step 6.<br />
If you do not want <strong>to</strong> remove the<br />
template DNA, go <strong>to</strong> Step 6.<br />
Note: Since the amount of labeled RNA<br />
transcript is far in excess of the template<br />
DNA (by a fac<strong>to</strong>r of approx. 10), it is<br />
usually not necessary <strong>to</strong> remove the template<br />
DNA by DNase treatment before<br />
an in situ hybridization experiment.<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
6 Add 2 µl 0.2 M EDTA (pH 8.0) <strong>to</strong> the<br />
tube <strong>to</strong> s<strong>to</strong>p the polymerase reaction.<br />
7 Precipitate the labeled RNA transcript<br />
by performing the following steps.<br />
Note: As an alternative <strong>to</strong> the ethanol<br />
procedure below you may purify labeled<br />
probes which are 100 bp or longer with<br />
the High Pure PCR Purification Kit. See<br />
the procedure on page 50 in this chapter.<br />
To the reaction tube, add 2.5 µl 4 M<br />
LiCl and 75 µl prechilled (–20°C)<br />
100% ethanol. Mix well.<br />
Let the precipitate form for at least<br />
30 min at –70°C or 2 h at –20°C.<br />
Centrifuge the tube (at 13,000 x g) for<br />
15 min at 4°C.<br />
Discard the supernatant.<br />
Wash the pellet with 50 µl ice-cold<br />
70% (v/v) ethanol.<br />
Centrifuge the tube (at 13,000 x g) for<br />
5 min at 4°C.<br />
Discard the supernatant.<br />
Dry the pellet under vacuum.<br />
Dissolve the RNA pellet for 30 min at<br />
37°C in 100 µl DEPC (diethylpyrocarbonate)-treated<br />
(or sterile) redistilled<br />
water.<br />
8 To estimate the yield of the transcript,<br />
do the following:<br />
Run an aliquot of the transcript on an<br />
agarose or acrylamide gel beside an<br />
RNA standard of known concentration.<br />
Stain with ethidium bromide.<br />
Compare the relative intensity of<br />
staining between the labeled transcripts<br />
and the known standard.<br />
9 Do one of the following:<br />
If you are not going <strong>to</strong> use the labeled<br />
probe immediately, s<strong>to</strong>re the probe<br />
solution at –70°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the probe<br />
immediately, dilute an aliquot of the<br />
probe solution <strong>to</strong> its working concentration<br />
(e.g., 0.2–10 ng/µl) in the<br />
hybridization buffer <strong>to</strong> be used for<br />
the in situ experiment (as described in<br />
Chapter 5 of this manual).<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Available as<br />
DIG RNA Labeling Mix 10 mM ATP, 10 mM CTP, 10 mM GTP, 6.5 mM UTP, • Vial 7, DIG RNA Labeling Kit (SP6/T7)*<br />
3.5 mM DIG-UTP; in Tris-HCl, pH 7.5 (+20°C) (Cat. No. 1175 025)<br />
• DIG RNA Labeling Mix (Cat. No. 1277073)<br />
or<br />
One of the following<br />
Biotin RNA Labeling Mix 10 mM ATP, 10 mM CTP, 10 mM GTP, 6.5 mM UTP, Cat. No. 1 685 597<br />
3.5 mM biotin-16-UTP; in Tris-HCl, pH 7.5 (+20°C)<br />
Fluorescein RNA Labeling Mix 10 mM ATP, 10 mM CTP, 10 mM GTP, 6.5 mM UTP, Cat. No. 1 685 619<br />
3.5 mM fluorescein-12-UTP<br />
CONTENTS<br />
INDEX<br />
*Sold under the tradename of Genius<br />
in the US.<br />
10x Transcription buffer 400 mM Tris-HCl, pH 8.0; 60 mM MgCl2, 100 mM • Vial 8, DIG RNA Labeling Kit (SP6/T7)*<br />
dithioerythri<strong>to</strong>l (DTE), 20 mM spermidine, (Cat. No. 1175 025)<br />
100 mM NaCl, 1 unit/ml RNase inhibi<strong>to</strong>r • Supplied with the RNA polymerase<br />
DNase I, RNase-free 10 units/µl DNase I, RNase-free • Vial 9, DIG RNA Labeling Kit (SP6/T7)*<br />
(Cat. No. 1175 025)<br />
• DNase I, RNase-free (Cat. No. 776785)<br />
RNase <strong>In</strong>hibi<strong>to</strong>r 20 units/µl RNase inhibi<strong>to</strong>r • Vial 10, DIG RNA Labeling Kit (SP6/T7)*<br />
(Cat. No. 1175 025)<br />
• RNase inhibi<strong>to</strong>r (Cat. Nos. 799 017, 799 025)<br />
One of the following<br />
SP6 RNA Polymerase 20 units/µl SP6 RNA Polymerase • Vial 11, DIG RNA Labeling Kit (SP6/T7)*<br />
(Cat. No. 1175 025)<br />
• SP6 RNA Polymerase (Cat. Nos. 810 274, 1487671)<br />
T7 RNA Polymerase 20 units/µl T7 RNA Polymerase • Vial 12, DIG RNA Labeling Kit (SP6/T7)*<br />
(Cat. No. 1175 025)<br />
• T7 RNA Polymerase (Cat. Nos. 881767, 881775)<br />
T3 RNA Polymerase 20 units/µl T3 RNA Polymerase • T3 RNA Polymerase (Cat. Nos. 1031163, 1031171)<br />
45<br />
4
4<br />
*Sold under the tradename of Genius<br />
in the US.<br />
46<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
VI. Oligonucleotide 3'-end labeling<br />
with DIG-ddUTP, Biotin-ddUTP, or<br />
Fluorescein-ddUTP<br />
Terminal Transferase is used <strong>to</strong> add a single<br />
modified dideoxyuridine-triphosphate (e.g.,<br />
DIG-ddUTP) <strong>to</strong> the 3' ends of an oligonucleotide<br />
(Schmitz et al., 1990).<br />
Note: HPLC- or gel-purified oligonucleotides<br />
from 14–100 nucleotides long can be<br />
labeled in this procedure.<br />
1 Dissolve the purified oligonucleotide in<br />
sterile H2O.<br />
2 Prepare a 1 mM solution of X-ddUTP<br />
(X = DIG, Biotin, or Fluorescein) in redistilled<br />
H2O.<br />
3 Add the following <strong>to</strong> a microcentrifuge<br />
tube on ice:<br />
4 µl of 5x concentrated reaction<br />
buffer [1 M potassium cacodylate,<br />
0.125 M Tris-HCl, 1.25 mg/ml Bovine<br />
Serum Albumin; pH 6.6 (25°C)]<br />
(vial1).<br />
Note: Numbered vials are included<br />
in the DIG Oligonucleotide 3'-End<br />
Labeling Kit*.<br />
4 µl of 25 mM CoCl2 (vial 2).<br />
100 pmol oligonucleotide.<br />
Note: Do not increase the concentration<br />
of oligonucleotide in this standard<br />
reaction. To make larger amounts<br />
of labeled oligonucleotide, scale up all<br />
reaction components and volumes.<br />
1 µl of either 1 mM DIG-ddUTP<br />
(vial 3)<br />
or<br />
1 mM Biotin-ddUTP<br />
or<br />
1 mM Fluorescein-ddUTP.<br />
1 µl (50 units) Terminal Transferase<br />
[supplied in 200 mM potassium cacodylate,<br />
1 mM EDTA, 200 mM KCl,<br />
0.2 mg/ml Bovine Serum Albumin,<br />
50% glycerol; pH 6.5 (25°C)] (vial 4).<br />
Enough redistilled H2O <strong>to</strong> make a<br />
final reaction volume of 20 µl.<br />
4 Mix the reaction components well and<br />
centrifuge briefly.<br />
5 <strong>In</strong>cubate the tube at 37°C for 15 min.<br />
6 Place the tube on ice.<br />
7 S<strong>to</strong>p the reaction by doing the following:<br />
Mix 200 µl 0.2 M EDTA (pH 8.0)<br />
with 1 µl of glycogen solution (20 mg/<br />
ml, in redistilled H2O) (vial 8).<br />
Add 2 µl of the glycogen-EDTA mixture<br />
<strong>to</strong> the reaction mixture.<br />
Note: Do not use phenol/CHCl3 extraction<br />
<strong>to</strong> s<strong>to</strong>p the reaction, since the labeled<br />
oligonucleotide will migrate <strong>to</strong> the organic<br />
layer during such extraction.<br />
8 Precipitate the labeled oligonucleotide<br />
by performing the following steps:<br />
To the reaction tube, add 2.5 µl 4 M<br />
LiCl and 75 µl prechilled (–20°C)<br />
100% ethanol. Mix well.<br />
Let the precipitate form for at least<br />
30 min at –70°C or 2 h at –20° C.<br />
Centrifuge the tube (at 13,000 x g) for<br />
15 min at 4°C.<br />
Discard the supernatant.<br />
Wash the pellet with 50 µl ice-cold<br />
70% (v/v) ethanol.<br />
Centrifuge the tube (at 13,000 x g) for<br />
5 min at 4°C.<br />
Discard the supernatant.<br />
Dry the pellet under vacuum.<br />
9 Do one of the following:<br />
If you are not going <strong>to</strong> use the labeled<br />
oligonucleotide probe immediately,<br />
dissolve the pellet in a minimal<br />
amount of sterile, redistilled H2O and<br />
s<strong>to</strong>re the probe solution at –20°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the labeled<br />
oligonucleotide probe immediately,<br />
dissolve the pellet in a minimal<br />
amount of sterile, redistilled H2O,<br />
then dilute an aliquot of the probe<br />
solution <strong>to</strong> a convenient s<strong>to</strong>ck concentration<br />
(e.g., 1–7 ng/µl) in the<br />
hybridization buffer <strong>to</strong> be used for<br />
the in situ experiment (as described in<br />
Chapters 2 and 5 of this manual).<br />
10 The efficiency of the labeling reaction<br />
can be checked by comparison with the<br />
labeled control-oligonucleotide (vial 6)<br />
in hybridization or direct detection. It is<br />
recommended <strong>to</strong> routinely check the<br />
labeling efficiency by direct detection<br />
(see page 51).<br />
11 The labeled oligonucleotide can be<br />
analyzed by polyacrylamide-gel electrophoresis<br />
and subsequent silver staining<br />
in comparison <strong>to</strong> the unlabeled oligonucleotide.<br />
DIG labeled oligonucleotides<br />
are shifted <strong>to</strong> higher molecular<br />
weight due <strong>to</strong> the addition of the label.<br />
The control oligonucleotide labeled in<br />
the standard reaction is completely<br />
shifted <strong>to</strong> the end labeled form.<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
12 It is not recommended <strong>to</strong> increase the<br />
amount of oligonucleotide in the<br />
labeling reaction. Larger amounts of<br />
oligonucleotide can be labeled by<br />
increas-ing the reaction volume and all<br />
components proportionally.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Available as<br />
5x Reaction buffer 1 M potassium cacodylate, 125 mM Tris-HCl, • Vial 1, DIG Oligonucleotide 3'-End Labeling Kit*<br />
1.25 mg/ml bovine serum albumin, pH 6.6 (+25°C) (Cat. No. 1 362 372)<br />
• Supplied with terminal transferase<br />
CoCl2 solution 25 mM cobalt chloride (CoCl2) • Vial 2, DIG Oligonucleotide 3'-End Labeling Kit*<br />
(Cat. No. 1 362 372)<br />
• Supplied with terminal transferase<br />
DIG-ddUTP 1 mM Digoxigenin-11-ddUTP (2',3'-dideoxyuridine-5'- • Vial 2, DIG Oligonucleotide 3'-End Labeling Kit*<br />
triphosphate, coupled <strong>to</strong> digoxigenin via an 11-a<strong>to</strong>m (Cat. No. 1 362 372)<br />
spacer arm) in redistilled water • DIG-ddUTP (Cat. No. 1363 905)<br />
Biotin-16-ddUTP 1 mM tetralithium salt, solution • Cat. No. 1 427 598, 25 nmol (25 µl)<br />
Fluorescein-12-ddUTP 1 mM tetralithium salt, solution • Cat. No. 1 427 849, 25 nmol (25 µl)<br />
Terminal Transferase 50 units/µl terminal transferase, in 200 mM potassium • Vial 4, DIG Oligonucleotide 3'-End Labeling Kit*<br />
cacodylate, 1 mM EDTA, 200 mM KCl, 0.2 mg/ml bovine (Cat. No. 1 362 372)<br />
serum albumin; 50% (v/v) glycerol; pH 6.5 (+25°C) • Terminal Transferase (Cat. No. 220 582,<br />
contains 5x reaction buffer and cobalt chloride)<br />
VII. Oligonucleotide tailing with a<br />
DIG-dUTP, Biotin-dUTP, or FluoresceindUTP<br />
mixture<br />
Terminal Transferase is used <strong>to</strong> add a mixture<br />
of labeled dUTP and dATP <strong>to</strong> the<br />
3' ends of an oligonucleotide in a templateindependent<br />
reaction (Schmitz et al., 1990).<br />
<strong>In</strong> the tailing reaction, the concentrations of<br />
labeled dUTP and unlabeled dATP are<br />
adjusted <strong>to</strong> produce the highest hapten<br />
incorporation, optimal spacing of the hapten,<br />
and (ultimately) the highest sensitivity.<br />
This procedure produces a tail which ranges<br />
in length from 10–100 nucleotides (average:<br />
50), and contains, on average, 5 labeled<br />
dUTP molecules. Alternatively, this procedure<br />
may be modified <strong>to</strong> add only 2–3 labeled<br />
dUTP molecules, without any intervening<br />
dATP. (For details on modifying the<br />
length and composition of the tail, see the<br />
pack insert from the DIG Oligonucleotide<br />
Tailing Kit*).<br />
Note: HPLC- or gel-purified oligonucleotides<br />
from 14–100 nucleotides long can be<br />
labeled in this procedure.<br />
CONTENTS<br />
INDEX<br />
1 Dissolve the purified oligonucleotide in<br />
sterile H2O.<br />
2 Prepare a 1 mM solution of X-dUTP<br />
(X = DIG, Biotin, or Fluorescein) in<br />
redistilled H2O.<br />
3 Add the following <strong>to</strong> a microcentrifuge<br />
tube on ice:<br />
4 µl of 5 x concentrated reaction buffer<br />
[1 M potassium cacodylate, 0.125 M<br />
Tris-HCl, 1.25 mg/ml Bovine Serum<br />
Albumin; pH 6.6 (25°C)] (vial 1)<br />
Note: Numbered vials are included in<br />
the DIG Oligonucleotide Tailing Kit*.<br />
4 µl of 25 mM CoCl2 (vial 2).<br />
100 pmol oligonucleotide.<br />
Note: Do not increase the concentration<br />
of oligonucleotide in this standard<br />
reaction. To make larger amounts<br />
of labeled oligonucleotide, scale up all<br />
reaction components and volumes.<br />
*Sold under the tradename of Genius<br />
in the US.<br />
47<br />
4
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
12 It is not recommended <strong>to</strong> increase the<br />
amount of oligonucleotide in the<br />
labeling reaction. Larger amounts of<br />
oligonucleotide can be labeled by<br />
increas-ing the reaction volume and all<br />
components proportionally.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Available as<br />
5x Reaction buffer 1 M potassium cacodylate, 125 mM Tris-HCl, • Vial 1, DIG Oligonucleotide 3'-End Labeling Kit*<br />
1.25 mg/ml bovine serum albumin, pH 6.6 (+25°C) (Cat. No. 1 362 372)<br />
• Supplied with terminal transferase<br />
CoCl2 solution 25 mM cobalt chloride (CoCl2) • Vial 2, DIG Oligonucleotide 3'-End Labeling Kit*<br />
(Cat. No. 1 362 372)<br />
• Supplied with terminal transferase<br />
DIG-ddUTP 1 mM Digoxigenin-11-ddUTP (2',3'-dideoxyuridine-5'- • Vial 2, DIG Oligonucleotide 3'-End Labeling Kit*<br />
triphosphate, coupled <strong>to</strong> digoxigenin via an 11-a<strong>to</strong>m (Cat. No. 1 362 372)<br />
spacer arm) in redistilled water • DIG-ddUTP (Cat. No. 1363 905)<br />
Biotin-16-ddUTP 1 mM tetralithium salt, solution • Cat. No. 1 427 598, 25 nmol (25 µl)<br />
Fluorescein-12-ddUTP 1 mM tetralithium salt, solution • Cat. No. 1 427 849, 25 nmol (25 µl)<br />
Terminal Transferase 50 units/µl terminal transferase, in 200 mM potassium • Vial 4, DIG Oligonucleotide 3'-End Labeling Kit*<br />
cacodylate, 1 mM EDTA, 200 mM KCl, 0.2 mg/ml bovine (Cat. No. 1 362 372)<br />
serum albumin; 50% (v/v) glycerol; pH 6.5 (+25°C) • Terminal Transferase (Cat. No. 220 582,<br />
contains 5x reaction buffer and cobalt chloride)<br />
VII. Oligonucleotide tailing with a<br />
DIG-dUTP, Biotin-dUTP, or FluoresceindUTP<br />
mixture<br />
Terminal Transferase is used <strong>to</strong> add a mixture<br />
of labeled dUTP and dATP <strong>to</strong> the<br />
3' ends of an oligonucleotide in a templateindependent<br />
reaction (Schmitz et al., 1990).<br />
<strong>In</strong> the tailing reaction, the concentrations of<br />
labeled dUTP and unlabeled dATP are<br />
adjusted <strong>to</strong> produce the highest hapten<br />
incorporation, optimal spacing of the hapten,<br />
and (ultimately) the highest sensitivity.<br />
This procedure produces a tail which ranges<br />
in length from 10–100 nucleotides (average:<br />
50), and contains, on average, 5 labeled<br />
dUTP molecules. Alternatively, this procedure<br />
may be modified <strong>to</strong> add only 2–3 labeled<br />
dUTP molecules, without any intervening<br />
dATP. (For details on modifying the<br />
length and composition of the tail, see the<br />
pack insert from the DIG Oligonucleotide<br />
Tailing Kit*).<br />
Note: HPLC- or gel-purified oligonucleotides<br />
from 14–100 nucleotides long can be<br />
labeled in this procedure.<br />
CONTENTS<br />
INDEX<br />
1 Dissolve the purified oligonucleotide in<br />
sterile H2O.<br />
2 Prepare a 1 mM solution of X-dUTP<br />
(X = DIG, Biotin, or Fluorescein) in<br />
redistilled H2O.<br />
3 Add the following <strong>to</strong> a microcentrifuge<br />
tube on ice:<br />
4 µl of 5 x concentrated reaction buffer<br />
[1 M potassium cacodylate, 0.125 M<br />
Tris-HCl, 1.25 mg/ml Bovine Serum<br />
Albumin; pH 6.6 (25°C)] (vial 1)<br />
Note: Numbered vials are included in<br />
the DIG Oligonucleotide Tailing Kit*.<br />
4 µl of 25 mM CoCl2 (vial 2).<br />
100 pmol oligonucleotide.<br />
Note: Do not increase the concentration<br />
of oligonucleotide in this standard<br />
reaction. To make larger amounts<br />
of labeled oligonucleotide, scale up all<br />
reaction components and volumes.<br />
*Sold under the tradename of Genius<br />
in the US.<br />
47<br />
4
4<br />
48<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
1 µl of either 1 mM DIG-dUTP<br />
(vial 3)<br />
or<br />
1 mM Biotin-dUTP<br />
or<br />
1 mM Fluorescein-dUTP.<br />
1 µl of 10 mM dATP [in Tris buffer,<br />
pH 7.5 (25°C)] (vial 4).<br />
1 µl (50 units) Terminal Transferase<br />
[supplied in 200 mM potassium cacodylate,<br />
1 mM EDTA, 200 mM KCl,<br />
0.2 mg/ml Bovine Serum Albumin,<br />
50% glycerol; pH 6.5 (25°C)] (vial 5).<br />
Enough redistilled H2O <strong>to</strong> make a<br />
final reaction volume of 20 µl.<br />
4 Mix the reaction components well and<br />
centrifuge briefly.<br />
5 <strong>In</strong>cubate the tube at 37°C for 15 min.<br />
6 Place the tube on ice.<br />
7 S<strong>to</strong>p the reaction by doing the following:<br />
Mix 200 µl 0.2 M EDTA (pH 8.0)<br />
with 1 µl of glycogen solution (20 mg/<br />
ml, in redistilled H2O) (vial 9).<br />
Add 2 µl of the glycogen-EDTA<br />
mixture <strong>to</strong> the reaction mixture.<br />
Note: Do not use phenol/CHCl3<br />
extraction <strong>to</strong> s<strong>to</strong>p the reaction, since the<br />
labeled oligonucleotide will migrate <strong>to</strong><br />
the organic layer during such<br />
extraction.<br />
8 Precipitate the labeled oligonucleotide<br />
by performing the following steps:<br />
To the reaction tube, add 2.5 µl 4 M<br />
LiCl and 75 µl prechilled (–20°C)<br />
100% ethanol. Mix well.<br />
Let the precipitate form for at least<br />
30 min at –70°C or 2 h at –20°C.<br />
Centrifuge the tube (at 13,000 x g) for<br />
15 min at 4°C.<br />
Discard the supernatant.<br />
Wash the pellet with 50 µl ice-cold<br />
70% (v/v) ethanol.<br />
Centrifuge the tube (at 13,000 x g) for<br />
5 min at 4°C.<br />
Discard the supernatant.<br />
Dry the pellet under vacuum.<br />
9 Do one of the following:<br />
If you are not going <strong>to</strong> use the labeled<br />
oligonucleotide probe immediately,<br />
dissolve the pellet in a minimal<br />
amount of sterile, redistilled H2O and<br />
s<strong>to</strong>re the probe solution at –20°C.<br />
Caution: Avoid repeated freezing and<br />
thawing of the probe.<br />
If you are going <strong>to</strong> use the labeled<br />
oligonucleotide probe immediately,<br />
dissolve the pellet in a minimal amount<br />
of sterile, redistilled H2O, then dilute<br />
an aliquot of the probe solution <strong>to</strong> a<br />
convenient s<strong>to</strong>ck concentration (e.g.,<br />
1–7 ng/µl) in the hybridization buffer<br />
<strong>to</strong> be used for the in situ experiment<br />
(as described in Chapters 2 and 5 of<br />
this manual).<br />
10 The efficiency of the tailing reaction<br />
can be checked by comparison with the<br />
tailed control-oligonucleotide (vial 8) in<br />
hybridization or direct detection. It is<br />
recommended <strong>to</strong> routinely check the<br />
tailing efficiency by direct detection (see<br />
DIG Nucleic Acid Detection Kit).<br />
11 The tailed oligonucleotide can be analyzed<br />
by polyacrylamide-gel electrophoresis and<br />
subsequent silver staining in comparison<br />
<strong>to</strong> the untailed oligonucleotide (vial 7).<br />
DIG-tailing of oligonucleotides results in<br />
a heterogeneous shift <strong>to</strong> higher molecular<br />
weight and is detectable as a smear in<br />
polyacrylamide gels. The control oligonucleotide<br />
tailed in the standard reaction is<br />
completely shifted <strong>to</strong> the labeled form.<br />
12 It is not recommended <strong>to</strong> increase the<br />
amount of oligonucleotide in the tailing<br />
reaction. Larger amounts of oligonucleotide<br />
may be labeled by increasing<br />
the reaction volume and all components<br />
proportionally.<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Available as<br />
5x Reaction buffer 1 M potassium cacodylate, 125 mM Tris-HCl, • Vial 1, DIG Oligonucleotide Tailing Kit*<br />
1.25 mg/ml bovine serum albumin, pH 6.6 (+25°C) (Cat. No. 1 417 231)<br />
• Supplied with terminal transferase<br />
CoCl2 solution 25 mM cobalt chloride (CoCl2) • Vial 2, DIG Oligonucleotide Tailing Kit*<br />
(Cat. No. 1 417 231)<br />
• Supplied with terminal transferase<br />
DIG-dUTP 1 mM Digoxigenin-11-dUTP (2'-dideoxyuridine-5'- • Vial 3, DIG Oligonucleotide Tailing Kit*<br />
triphosphate, coupled <strong>to</strong> digoxigenin via an 11-a<strong>to</strong>m (Cat. No. 1 417 231)<br />
spacer arm) in redistilled water • DIG-dUTP, alkali-labile<br />
• (Cat. Nos. 1573152, 1573179)<br />
• DIG-dUTP, alkali-stable<br />
(Cat. Nos. 1093 088, 1558706, 1570 013)<br />
dATP Lithium salt, 10 mM dATP solution; in Tris buffer, pH 7.5 • Vial 4, DIG Oligonucleotide Tailing Kit*<br />
(Cat. No. 1 417 231)<br />
• dATP [Cat. No. 1051440 (sold as a 100 mM<br />
solution; must be diluted before use)]<br />
Terminal Transferase 50 units/µl terminal transferase, in 200 mM potassium • Vial 5, DIG Oligonucleotide Tailing Kit*<br />
cacodylate, 1 mM EDTA, 200 mM KCl, 0.2 mg/ml bovine (Cat. No. 1 417 231)<br />
serum albumin; 50% (v/v) glycerol; pH 6.5 (+25°C) • Terminal Transferase [Cat. No. 220 582<br />
(contains 5x reaction buffer and cobalt chloride)]<br />
Stability of labeled probes<br />
DIG-labeled probes can be s<strong>to</strong>red at –20°C<br />
for at least 1 year.<br />
References<br />
Dunn, J. J.; Studier, F. W. (1983) Complete nucleotides<br />
sequence of bacteriophage T7 DNA and the<br />
locations of T7 genetic elements. J. Mol. Biol. 166,<br />
477–535.<br />
Feinberg, P.; Vogelstein, B. (1984) A technique for<br />
radiolabeling DNA restriction enzyme fragments <strong>to</strong><br />
high specific activity. Anal. Biochem. 137, 266–267.<br />
<strong>In</strong>nis, M. A.; Gelfand, D. H.; Sninsky, J. J.; White, T.<br />
J. (Eds.) (1990) PCR Pro<strong>to</strong>cols: A Guide <strong>to</strong> Methods<br />
and Applications. San Diego, CA: Academic Press.<br />
Kassavetis, G. A.; Butler, E. T.; Roulland, D.;<br />
Chamberlin, M. J. (1982) Bacteriophage SP6-specific<br />
RNA polymerase. J. Biol. Chem. 257, 5779–5788.<br />
Langer, P. R.; Waldrop, A. A.; Ward, D. C. (1981)<br />
Enzymatic synthesis of biotin-labeled polynucleotides:<br />
Novel nucleic acid affinity probes. Proc. Natl.<br />
Acad. Sci. USA 78, 6633–6637.<br />
Rigby, P. W. J.; Dieckmann, M.; Rhodes, C.; Berg, P.<br />
(1977) Labeling deoxyribonucleic acid <strong>to</strong> high<br />
specific activity in vitro by nick translation with<br />
DNA polymerase I. J. Mol. Biol. 113, 237–241.<br />
Schmitz, G. G.; Walter, T.; Seibl, R.; Kessler, C.<br />
(1991) Nonradioactive labeling of oligonucleotides<br />
in vitro with the hapten digoxigenin by tailing with<br />
terminal transferase. Anal. Biochem. 192, 222–231.<br />
CONTENTS<br />
INDEX<br />
*Sold under the tradename of Genius<br />
in the US.<br />
49<br />
4
4<br />
*This product is sold under licensing<br />
arrangements with Roche<br />
Molecular Systems and The Perkin-<br />
Elmer Corporation. Purchase of this<br />
product is accompanied by a<br />
license <strong>to</strong> use it in the Polymerase<br />
Chain Reaction (PCR) process in<br />
conjunction with an Authorized<br />
Thermal Cycler. For complete<br />
license disclaimer, see inside back<br />
cover page.<br />
50<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
VIII. Purification of labeled probes<br />
using the High Pure PCR Product<br />
Purification Kit<br />
The High Pure PCR Product Purification<br />
Kit is designed for the efficient and convenient<br />
isolation of PCR products from amplification<br />
reactions, but is also suited for the<br />
removal of unincorporated nucleotides from<br />
DIG DNA and RNA labeling reactions.<br />
The DNA binds specifically <strong>to</strong> the surface of<br />
glass fibres in the presence of chaotrope<br />
salts. Primers, unincorporated nucleotides,<br />
contaminating agarose particles and proteins<br />
are removed by a simple washing step. The<br />
bound DIG-labeled DNA is subsequently<br />
eluted in a low-salt buffer.<br />
Note: A minimum length of approx. 100 bp<br />
is required for efficient binding. The kit<br />
can therefore not be used for the removal<br />
of unincorporated nucleotides from oligonucleotide<br />
labeling reactions.<br />
Products required<br />
2 Add 500 µl binding buffer (vial 1, green<br />
cap) and mix well.<br />
Note: It is important that the volume<br />
ratio between sample and binding buffer<br />
is 1:5. When using other sample volumes<br />
than 100 µl, adjust the volume of binding<br />
buffer accordingly.<br />
3 <strong>In</strong>sert a High Pure filter in a collection<br />
tube and pipette the sample in<strong>to</strong> the upper<br />
buffer reservoir.<br />
4 Centrifuge at 13.000 x g in a microcentrifuge<br />
for 30 sec.<br />
5 Discard the flow through and combine<br />
the filter tube again with the same collection<br />
tube.<br />
6 Add 500 µl wash buffer (vial 2, blue cap)<br />
<strong>to</strong> the upper reservoir and centrifuge as<br />
in step 4.<br />
7 Discard the wash buffer flow through<br />
and recombine the filter tube again with<br />
the same collection tube.<br />
8 Add 200 µl wash buffer (vial 2, blue cap)<br />
<strong>to</strong> the upper reservoir and centrifuge as<br />
in step 4.<br />
Reagent Description Available as<br />
High Pure PCR Product Kit for 50 purifications Cat. No. 1 732 668<br />
Purification Kit* Kit for 250 purifications Cat. No. 1 732 676<br />
consisting of:<br />
• Binding buffer, nucleic acids binding buffer; 3 M guanidine-thiocyanate, • Vial 1<br />
green cap 10 mM Tris-HCl, 5% (v/v) ethanol, pH 6.6 (25°C)<br />
• Wash buffer, wash buffer; add 4 volumes of absolute ethanol • Vial 2<br />
blue cap before use! Final concentrations; 20 mM NaCl,<br />
2 mM Tris-HCl, pH 7.5 (25°C), 80% ethanol<br />
• Elution buffer elution buffer; 10 mM Tris-HCl, 1 mM EDTA, • Vial 3<br />
pH 8.5 (25°C)<br />
• High Pure filter tubes Polypropylene tubes, containing two layers of a<br />
specially pre-treated glass fibre fleece; maximum<br />
sample volume: 700 µl<br />
• Collection tubes 2 ml polypropylene tubes<br />
Procedure<br />
Note: Make sure that 4 volumes ethanol<br />
have been added <strong>to</strong> the wash buffer (vial 2,<br />
blue cap). The binding buffer (vial 1,<br />
green cap) contains guanidine-thiocyanate<br />
which is an irritant. Wear gloves and<br />
follow labora<strong>to</strong>ry safety conditions during<br />
handling.<br />
1 Fill up the labeling reaction <strong>to</strong> 100 µl<br />
with redistilled water.<br />
9 Discard the collection tube and insert<br />
the filter tube in a clean 1.5 ml reaction<br />
tube (not provided).<br />
10 Add 50–100 µl elution buffer (vial 3) or<br />
redist. water (pH 8.0–8.5) <strong>to</strong> the upper<br />
reservoir for the elution of the DNA.<br />
Centrifuge as in step 4.<br />
Note: The elution efficiency is increased<br />
with higher volume of elution buffer<br />
applied. At least 68% and 79% recovery<br />
are found with 50 and 100 µl elution<br />
buffer, respectively. Normally, almost<br />
quantitative recovery can be found, as can<br />
be determined in a direct detection assay.<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
IX. Estimating the Yield of<br />
DIG-labeled Nucleic Acids<br />
An accurate quantification of DIG-labeled<br />
DNA obtained in the labeling reaction is<br />
most important for optimal and reproducible<br />
results in various membrane or in situ<br />
hybridization techniques. Too high of a<br />
probe concentration in the hybridization<br />
mix usually causes background, while <strong>to</strong>o<br />
low of a concentration leads <strong>to</strong> weak<br />
signals.<br />
There are two ways <strong>to</strong> estimate the yield<br />
of DIG-labeling. The first option is a<br />
30 min procedure in which dilutions of<br />
the labeling reaction are spotted on DIG<br />
Quantification Teststrips. After detection<br />
the intensities are compared <strong>to</strong> a simultaneous<br />
detected DIG Control Teststrip,<br />
that has defined amounts of DIG-labeled<br />
DNA already spotted on it.<br />
<strong>In</strong> the second procedure dilution series of<br />
the labeling reaction and dilutions of an<br />
appropriate standard are both spotted on<br />
nylon membranes. The membrane is then<br />
processed in a short detection procedure.<br />
Estimating the yield with DIG<br />
Quantification and DIG Control Teststrips<br />
Quantification using teststrips consists of<br />
two basic steps. First, a series of dilutions<br />
of DIG-labeled DNA is applied <strong>to</strong> the<br />
squares on the DIG Quantification Teststrips.<br />
DIG Control Teststrips are already<br />
loaded with 5 defined dilutions of a control<br />
DNA and are used as standards.<br />
The teststrips are then subjected <strong>to</strong> immunological<br />
detection with Anti-Digoxigenin-AP<br />
and the color substrates NBT/BCIP. After<br />
approx. 30 min the test procedure is completed<br />
and the DIG-labeling efficiency can<br />
be determined by comparing the signal<br />
intensities of the spots on the quantification<br />
teststrip with the control teststrip.<br />
Note: The DIG control teststrips can be<br />
used for the estimation of yield for DIG<br />
DNA probes labeled by random primed<br />
labeling, nick translation or for DIG RNA<br />
probes. They are not recommended for the<br />
quantification of DIG-labeled PCR or<br />
oligonucleotide probes.<br />
Products required<br />
Reagent Description Available as<br />
DIG Quantification Teststrips of 0.6 x 8 cm, coated with positively charged • DIG Quantification Teststrips<br />
Teststrips nylon membrane, unloaded • (Cat. No. 1669 958)<br />
DIG Control Teststrips of 0.6 x 8 cm, coated with positively charged • DIG Control Teststrips (Cat. No. 1669 966)<br />
Teststrips nylon membrane, loaded with DIG labeled control DNA<br />
in the quantities 300, 10, 30, 10 and 3 pg<br />
DNA Dilution buffer 10 mM Tris-HCl, pH 8.0 (20°C), 50 µg/ml DNA from • Vial 3, DIG DNA Labeling Kit* (Cat. No. 1175 033)<br />
herring sperm • Vial 3, DIG DNA Labeling and Detection Kit*<br />
(Cat. No. 1093 657)<br />
• Vial 2, DIG Nucleic Acid Detection Kit* (Cat. No. 1175 041)<br />
• Vial 9, DIG Oligonucleotide 3'-End Labeling Kit*<br />
(Cat. No. 1362 372)<br />
• Vial 10, DIG Oligonucleotide Tailing Kit*<br />
(Cat. No. 1417 231)<br />
RNA Dilution buffer DMPC-treated H2O, 20 x SSC and formaldehyde, mixed<br />
in a volume ratio of 5 + 3 + 2<br />
CONTENTS<br />
INDEX<br />
*Sold under the tradename of Genius<br />
in the US.<br />
Blocking Reagent Blocking reagent for nucleic acid hybridization; • Vial 11, DIG DNA Labeling and Detection Kit*<br />
white powder • (Cat. No. 1093 657)<br />
• Vial 6, DIG Nucleic Acid Detection Kit* (Cat. No. 1175 041)<br />
• Blocking Reagent (Cat. No. 1096176)<br />
Anti-Digoxigenin-AP Anti-digoxigenin [Fab] conjugated <strong>to</strong> alkaline • Vial 8, DIG DNA Labeling and Detection Kit*<br />
phosphatase • (Cat. No. 1093 657)<br />
• Vial 3, DIG Nucleic Acid Detection Kit* (Cat. No. 1175 041)<br />
• Anti-Digoxigenin-AP, Fab fragments (Cat. No. 1093 274)<br />
NBT solution 75 mg/ml nitroblue tetrazolium salt in dimethylformamide • Vial 9, DIG DNA Labeling and Detection Kit*<br />
(Cat. No. 1093 657)<br />
• Vial 4, DIG Nucleic Acid Detection Kit* (Cat. No. 1175 041)<br />
• NBT [Cat. No. 1383 213) (dilute from 100 mg/ml)]<br />
BCIP solution 50 mg/ml 5-bromo-4-chloro-3-indolyl phosphate • Vial 10, DIG DNA Labeling and Detection Kit*<br />
(BCIP), <strong>to</strong>luidinium salt in dimethylformamide • (Cat. No. 1093 657)<br />
• Vial 5, DIG Nucleic Acid Detection Kit* (Cat. No. 1175 041)<br />
• BCIP (Cat. No. 1383 221)<br />
51<br />
4
4<br />
Additionally required solutions<br />
Except TE buffer, all of the following<br />
required solutions are available in a ready<strong>to</strong>-use<br />
form in the DIG Wash and Block<br />
Buffer Set (Cat. No. 1585762). Bottle<br />
numbers for this set are indicated in parentheses.<br />
Alternatively they can be prepared<br />
from separate reagents according <strong>to</strong> procedures<br />
described in the respective pack<br />
inserts.<br />
Additionally required solutions Description<br />
Washing buffer (Bottle 1; 100 mM maleic acid, 150 mM NaCl;<br />
dilute 1:10 with H2O) pH 7.5 (+20°C); 0.3% (v/v) Tween ® 20<br />
Maleic acid buffer (Bottle 2; 100 mM maleic acid, 150 mM NaCl;<br />
dilute 1:10 with H2O) pH 7.5 (+20°C)<br />
52<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
Blocking solution (Bottle 3; 1% (w/v) Blocking reagent for nucleic acid<br />
dilute 1:10 with 1 x hybridization, dissolved in Maleic acid buffer.<br />
maleic acid buffer) Blocking solution is cloudy and should not be<br />
filtered. It is stable for at least two weeks when<br />
s<strong>to</strong>red at +4°C, but must then be brought <strong>to</strong> room<br />
temperature before use<br />
Detection buffer (Bottle 4; 100 mM Tris-HCl, 100 mM NaCl;<br />
dilute 1:10 with H2O) pH 9.5 (+20°C)<br />
TE buffer 10 mM Tris-HCl, 0.1 mM EDTA;<br />
pH 8.0 (+20°C)<br />
Procedure<br />
Preparation of a dilution series<br />
1 Dilute your labeling reaction <strong>to</strong> an<br />
approximate concentration of 1 µg/ml.<br />
The approximate concentration of your<br />
DIG-labeled DNA can be estimated<br />
according <strong>to</strong> the standard yields of the<br />
respective labeling kit or reagent used,<br />
that are given in the pack insert. (Example:<br />
A DIG-High Prime reaction yields<br />
approx. 40 µg/ml of DIG-labeled DNA<br />
after 1 h incubation, starting from 1 µg<br />
template. Dilute 1 µl of your labeling<br />
reaction with 39 µl DNA dilution buffer<br />
<strong>to</strong> obtain a final concentration of 1 µg/ml).<br />
2 Dilute the 1 µg/ml predilution from step<br />
1 according <strong>to</strong> the following scheme:<br />
<br />
Dilution steps Dilution in DNA Final Name of<br />
dilution buffer Concentration dilution<br />
1. 1:3.3 10 µl + 23 µl buffer 300 pg/µl A<br />
2. 1:10 5 µl + 45 µl buffer 100 pg/µl B<br />
3. A diluted 1:10 5 µl A + 45 µl buffer 30 pg/µl C<br />
4. B diluted 1:10 5 µl B + 45 µl buffer 10 pg/µl D<br />
5. C diluted 1:10 5 µl C + 45 µl buffer 3 pg/µl E<br />
3 Apply a 1 µl spot of dilutions A–E on<strong>to</strong><br />
the marked squares of a DIG Quantification<br />
Teststrip.<br />
If you want <strong>to</strong> mark the teststrip use the<br />
polyester carrier area. Avoid writing on<br />
the membrane itself. Touch only with<br />
gloves.<br />
4 Airdry for approx. 2 min.<br />
Preparation for the detection procedure<br />
The small format of the teststrips allows<br />
that only very low volume of test solutions<br />
must be used.<br />
5 Prepare an antibody solution by diluting<br />
1 µl of Anti-Digoxigenin-alkaline<br />
phosphatase in 2 ml blocking solution.<br />
6 Prepare color-substrate by adding 9 µl<br />
NBT solution and 7 µl BCIP solution <strong>to</strong><br />
2 ml of detection buffer.<br />
7 Foreachdetectionseriesprepare5microcuvettes<br />
or 2.5 ml reaction vials and<br />
label them from 1 <strong>to</strong> 5.<br />
To vial 1: add 2 ml of blocking solution.<br />
To vial 2: add 2 ml of antibody solution<br />
(prepared under 5.).<br />
To vial 3: add 2 ml of washing buffer.<br />
To vial 4: add 2 ml of detection buffer.<br />
To vial 5: add 2 ml of color-substrate<br />
solution (prepared under 6.).<br />
Detection<br />
Note: This short detection pro<strong>to</strong>col is exclusively<br />
suited for the quantification of DIGlabeled<br />
nucleic acids. It cannot replace the<br />
standard detection pro<strong>to</strong>col given in this<br />
manual or in the pack inserts of the DIG<br />
detection kits or substrates. The limits of<br />
detection using the short pro<strong>to</strong>col are a fac<strong>to</strong>r<br />
10–30 below the sensitivity achieved with<br />
the standard detection pro<strong>to</strong>cols.<br />
8 Dip the prepared teststrips (one Quantification<br />
Teststrip and one Control Teststrip<br />
should be developed back <strong>to</strong> back<br />
in one vial) in the prepared solution in<br />
the following sequence and for the given<br />
incubation times. Between steps, let<br />
excessive fluid drip on<strong>to</strong> a paper tissue.<br />
vial 1 blocking 2 min<br />
vial 2 antibody binding 3 min<br />
vial 1 blocking 1 min<br />
vial 3 washing 1 min<br />
vial 4 equilibration 1 min<br />
vial 5 color reaction<br />
(in the dark)<br />
5–30 min<br />
CONTENTS<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
9 S<strong>to</strong>p the color reaction after a maximum<br />
of 30 min by briefly rinsing the teststrips<br />
in water. Air dry on Whatman 3 MM<br />
paper, protected from light. Extended<br />
color reaction time leads <strong>to</strong> increased<br />
background.<br />
Evaluation of results<br />
The first spots should be visible after 5–10<br />
min of the color reaction; the 30 pg spot<br />
should be visible by then. After 30 min<br />
incubation the 3 pg spot should be visible<br />
on both the Quantification and the<br />
Control Teststrip.<br />
You can now determine the quantity of<br />
DIG labeled DNA or RNA in the squares<br />
of the Quantification Teststrip by comparing<br />
the color intensity with the Control<br />
Teststrip. Calculate the quantity of DIGlabeled<br />
DNA in your labeling reaction by<br />
taking the dilution steps in<strong>to</strong> account.<br />
CONTENTS<br />
INDEX<br />
Estimating the yield in a spot test<br />
with a DIG-labeled control<br />
The estimation of yield can also be performed<br />
in a side by side comparison of the<br />
DIG-labeled sample nucleic acid with a<br />
DIG-labeled control, that is provided in<br />
the labeling kits. Dilution series of both<br />
are prepared and spotted on a piece of<br />
membrane. Subsequently, the membrane is<br />
colorimetrically detected. Direct comparison<br />
of the intensities of sample and control<br />
allows the estimation of labeling yield.<br />
Products required<br />
DIG-labeled controls for estimating the<br />
yield of DNA, RNA and end-labeled oligonucleotides<br />
are available as separate reagents<br />
or in the respective labeling kits. The<br />
DIG-dUTP/dATP-tailed Oligonucleotide<br />
Control is only available in the DIG Oligonucleotide<br />
Tailing Kit.<br />
Reagent Description Available as<br />
Labeled Control DNA Digoxigenin-labeled pBR328 DNA that has been random • Vial 4, DIG DNA Labeling and Detection Kit*<br />
primed labeled according <strong>to</strong> the standard labeling procedure; • (Cat. No. 1093 657)<br />
the <strong>to</strong>talDNA concentration in the vial is 25 µg/ml, but only • Vial 4, DIG DNA Labeling Kit*<br />
5 µg/ml of it is DIG-labeled DNA • (Cat. No. 1175 033)<br />
• Vial 1, DIG Nucleic Acid Detection Kit*<br />
(Cat. No. 1175 041)<br />
• DIG-labeled Control DNA** , ***<br />
(Cat. No. 1585738)<br />
Control Oligonucleotide, 2.5 pmol/µl oligonucleotide, labeled with Digoxigenin-11-ddUTP • Vial 6, DIG Oligonucleotide 3'-End Labeling Kit*<br />
DIG-ddUTP-labeled according <strong>to</strong> the standard labeling procedure • (Cat. No. 1362 372)<br />
• DIG-3'-End labeled Control<br />
Oligonucleotide** , *** (Cat. No. 1585754)<br />
Control Oligonucleotide, 2.5 pmol/µl oligonucleotide, tailed with Digoxigenin-11-dUTP • Vial 6, DIG Oligonucleotide Tailing Kit*<br />
DIG-dUTP/dATP tailed and dATP according <strong>to</strong> the standard labeling procedure • (Cat. No. 1417 231)<br />
Labeled Control RNA Digoxigenin-labeled “antisense”-Neo RNA, transcribed with • Vial 5, DIG RNA Labeling Kit*<br />
T7RNA polymerase from 1 µg template DNA, according <strong>to</strong> • (Cat. No. 1175 025)<br />
the standard labeling procedure. The solution contains approx. • DIG-labeled Control RNA ** , ***<br />
100 µg/ml DIG-labeled RNA and 10 µg/ml unlabeled DNA template. • (Cat. No. 1585746)<br />
***Sold under the tradename of Genius in the US.<br />
***EP Patent 0 324 474 granted <strong>to</strong> Boehringer<br />
Mannheim GmbH.<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
<strong>In</strong> addition <strong>to</strong> the DIG-labeled control<br />
you will need the Reagents and the<br />
Additionally required reagents, listed<br />
above under “Estimating the yield with<br />
DIG Quantification and DIG Control<br />
Teststrips”.<br />
53<br />
4
4<br />
Dilutions A–E can be s<strong>to</strong>red at –20°C for at least 1 year.<br />
54<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
Dilution Scheme A (for DNA probes) <br />
DIG-labeled Control DNA Stepwise Final Concentration Total<br />
Starting Concentration Dilution (dilution name) Dilution<br />
1 ng/µl 5 µl/45 µl DNA dilution buffer 100 pg/µl (A) 1:10<br />
100 pg/µl (dilution A) 5 µl/45 µl DNA dilution buffer 10 pg/µl (B) 1:100<br />
10 pg/µl (dilution B) 5 µl/45 µl DNA dilution buffer 1 pg/µl (C) 1:1,000<br />
1 pg/µl (dilution C) 5 µl/45 µl DNA dilution buffer 0.1 pg/µl (D) 1:10,000<br />
0.1 pg/µl (dilution D) 5 µl/45 µl DNA dilution buffer 0.01 pg/µl (E) 1:100,000<br />
Concentration 1 ng/μl<br />
5 μl<br />
Procedure<br />
Dilution<br />
Prediluted DIG-labeled<br />
Control DNA<br />
A<br />
Volume of<br />
DNA Dilution<br />
Buffer in tube 45 μl<br />
1 Make a predilution of the DIG-labeled<br />
Control DNA by mixing 5 µl DIGlabeled<br />
Control DNA with 20 µl<br />
DNA dilution buffer (final concentration1ng/µl).<br />
or<br />
Make a predilution of the DIG-labeled<br />
Control DNA by mixing 5 µl DIGlabeled<br />
Control RNA with 20 µl<br />
DMPC-treated H2O (final concentration<br />
20 ng/µl).<br />
For the DIG-3'-end labeled or tailed<br />
control oligonucleotide a predilution is<br />
not required.<br />
2 Make serial dilutions of the (prediluted)<br />
controls, according <strong>to</strong> the appropriate<br />
dilution scheme. Mix thoroughly between<br />
dilution steps.<br />
100 pg/μl<br />
5 μl<br />
B<br />
10 pg/μl<br />
45 μl<br />
5 μl<br />
C<br />
1 pg/μl<br />
45 μl<br />
5 μl<br />
D<br />
0.1 pg/μl<br />
45 μl<br />
CONTENTS<br />
5 μl<br />
E<br />
0.01 pg/μl<br />
45 μl<br />
INDEX
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
Dilution Scheme B (for Oligonucleotide probes) <br />
DIG-tailed- or end-labeled Control Stepwise Final Concentration Total<br />
Oligo Starting Concentration Dilution (dilution name) Dilution<br />
2.5 pmol/µl 2 µl/98 µl DNA dilution buffer 50 fmol/µl (A) 1:50<br />
50 fmol/µl (dilution A) 10 µl/40 µl DNA dilution buffer 10 fmol/µl (B) 1:250<br />
10 fmol/µl (dilution B) 10 µl/40 µl DNA dilution buffer 2 fmol/µl (C) 1:1,250<br />
2 fmol/µl (dilution C) 10 µl/40 µl DNA dilution buffer 0.4 fmol/µl (D) 1:6,250<br />
0.4 fmol/µl (dilution D) 10 µl/40 µl DNA dilution buffer 0.08 fmol/µl (E) 1:31,250<br />
Dilutions A–E can be s<strong>to</strong>red at –20°C for at least 1 year.<br />
Dilution<br />
DIG-labeled Control<br />
Oligo<br />
A<br />
Concentration 2.5 pmol/μl<br />
Dilution Scheme C (for RNA probes) <br />
DIG-labeled Control RNA Stepwise Final Concentration Total<br />
Starting Concentration Dilution (dilution name) Dilution<br />
20 ng/µl 2 µl/38 µl H2O 1 ng/µl (A) 1:20<br />
1 ng/µl (dilution A) 5 µl/45 µl H2O 100 pg/µl (B) 1:200<br />
100 pg/µl (dilution B) 5 µl/45 µl H2O 10 pg/µl (C) 1:2,000<br />
10 pg/µl (dilution C) 5 µl/45 µl H2O 1 pg/µl (D) 1:20,000<br />
1 pg/µl (dilution D) 5 µl/45 µl H2O 0.1 pg/µl (E) 1:200,000<br />
0.1 pg/µl (dilution E) 5 µl/45 µl H2O 0.01 pg/µl (F) 1:2,000,000<br />
Highly diluted solutions of RNA in H2O are not very<br />
stable. Spots have <strong>to</strong> be made immediately after<br />
preparing the dilutions. Alternatively the RNA can<br />
be diluted in RNA dilution buffer (DMPC-treated<br />
H2O, 20 x SSC and formaldehyde, mixed in a<br />
volume ratio of 5 + 3 + 2) for greater stability.<br />
Dilution<br />
Prediluted DIG-labeled<br />
Control RNA A<br />
Concentration 20 ng/μl<br />
CONTENTS<br />
2 μl<br />
2 μl<br />
Volume of<br />
DNA Dilution<br />
Buffer in tube 98 μl<br />
Volume of<br />
DMPC-treated<br />
H 2 O in tube 38 μl<br />
1 ng/μl<br />
INDEX<br />
50 fmol/μl<br />
5 μl<br />
5 μl<br />
B<br />
100 pg/μl<br />
B<br />
10 fmol/μl<br />
45 μl<br />
45 μl<br />
5 μl<br />
C<br />
10 pg/μl<br />
C<br />
2 fmol/μl<br />
45 μl<br />
D<br />
5 μl<br />
5 μl 5 μl 5 μl 5 μl<br />
45 μl 45 μl 45 μl 45 μl<br />
1 pg/μl<br />
D<br />
0.4 fmol/μl<br />
45 μl<br />
E<br />
0.1 pg/μl<br />
5 μl<br />
E<br />
0.08 fmol/μl<br />
F<br />
45 μl<br />
0.01 pg/μl<br />
55<br />
4
4<br />
Figure 1: Estimating the Yield of<br />
DIG-labeled DNA. Dilutions of the<br />
Labeled Control DNA and the newly<br />
labeled (experimental) DNA were<br />
spotted on, fixed <strong>to</strong>, and directly<br />
detected on a Boehringer Mannheim<br />
Nylon Membrane, with colorimetric<br />
(Panel A) or chemiluminescent<br />
detection (Panel B).<br />
56<br />
Procedures for Labeling DNA, RNA, and Oligonucleotides with DIG, Biotin, or Fluorochromes<br />
3 Use table 1 on page 34 <strong>to</strong> estimate the<br />
expected yield of DNA labeling reactions.<br />
Predilute an aliquot of the newly<br />
labeled experimental DNA probe <strong>to</strong> an<br />
expected final concentration of approx.<br />
1 ng/µl.<br />
or<br />
Predilute an aliquot of the newly labeled<br />
experimental oligonucleotide probe <strong>to</strong><br />
a final concentration of 2.5 pmol/µl.<br />
or<br />
Predilute an aliquot of the newly<br />
synthesized experimental RNA probe<br />
<strong>to</strong> an expected final concentration of<br />
approx. 20 ng/µl. <strong>In</strong> a standard RNA<br />
labeling reaction approx. 10 µg newly<br />
synthesized DIG-RNA probe is transcribed<br />
from 1 µg DNA template<br />
4 Make serial dilutions of the prediluted<br />
experimental probe, according <strong>to</strong> the<br />
appropriate dilution scheme:<br />
– for DNA probes, use dilution scheme A,<br />
– for oligonucleotide probes, use dilution<br />
scheme B,<br />
– for RNA probes, use dilution scheme C,<br />
5 Spot 1 µl of the diluted controls on a<br />
piece of nylon membrane:<br />
– for DNA probes, spot dilutions B–E,<br />
– for oligonucleotide probes, spot dilution<br />
A–E,<br />
– for RNA probes, spot dilutions C–F.<br />
6 <strong>In</strong> a second row, spot 1 µl of the corresponding<br />
dilutions of the experimental<br />
probe.<br />
7 Fix the nucleic acids <strong>to</strong> the membrane by<br />
cross-linking with UV-light or by baking<br />
for 30 min at +120°C (Boehringer<br />
Mannheim Nylon Membrane).<br />
8 Wash the membrane briefly in washing<br />
buffer.<br />
A<br />
B<br />
10 3 1 0.3 0.1 0.03 0.01 0 pg<br />
100 10 1 0.1 0.01 0 pg<br />
Control<br />
9 <strong>In</strong>cubate the membrane in blocking<br />
solution for 30 min at room temperature.<br />
10 Dilute Anti-DIG-alkaline phosphatase<br />
1:5,000 in blocking solution.<br />
11 <strong>In</strong>cubate the membrane in the diluted<br />
antibody solution for 30 min at room<br />
temperature. The diluted antibody solution<br />
must cover the entire membrane.<br />
12 Wash the membrane twice, 15 min per<br />
wash, in washing buffer at room temperature.<br />
13 <strong>In</strong>cubate the membrane in detection<br />
buffer for 2 min.<br />
14 Mix 45 µl NBT solution and 35 µl BCIP<br />
solution in 10 ml of detection buffer.<br />
This color substrate solution must be<br />
prepared freshly.<br />
Note: Alternatively, chemiluminescent<br />
detection can be performed, using the<br />
DIG Luminescent Detection Kit*.<br />
15 Pour off the detection buffer and add<br />
the color substrate solution. Allow the<br />
color development <strong>to</strong> occur in the dark.<br />
The color precipitate starts <strong>to</strong> form<br />
within a few minutes and continues for<br />
approx. 16 h.<br />
Do not shake while the color is developing.<br />
16 When the spots appear in sufficient<br />
intensity, s<strong>to</strong>p the reaction by washing<br />
the membrane with TE buffer or sterile<br />
H2O for 5 min.<br />
17 Compare spot intensities of the control<br />
and experimental dilutions <strong>to</strong> estimate<br />
the concentration of the experimental<br />
probe (See Figure 1).<br />
Experimental<br />
Control<br />
Experimental<br />
*Sold under the tradename of Genius in the US.<br />
CONTENTS<br />
INDEX
CONTENTS<br />
INDEX<br />
Procedures<br />
for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong><br />
<strong>to</strong> Chromosomes ,<br />
Cells, and Tissue Sections
5<br />
58<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong><br />
Chromosomes, Cells, and Tissue Sections<br />
This chapter includes contributions from<br />
several leading scientists, from researchers<br />
in molecular biology <strong>to</strong> clinical pathologists,<br />
who practice in situ hybridization.<br />
Pro<strong>to</strong>cols are given for in situ hybridizations<br />
on widely varying substrates, e.g.,<br />
chromosome spreads, chromosomes in<br />
suspension, single cells, paraffin-embedded<br />
tissue sections, ultrathin tissue sections, and<br />
whole mount preparations. <strong>Hybridization</strong><br />
methods are described for both DNA and<br />
RNA targets.<br />
Applications covered include gene mapping,<br />
gene expression, developmental biology,<br />
tumor biology, cell sorting, clinical cy<strong>to</strong>genetics,<br />
and analysis of infectious diseases.<br />
These procedures use digoxigenin, biotin,<br />
and fluorochromes for labeling DNA,<br />
RNA and oligonucleotides. Labeling techniques<br />
include the classical methods, such as<br />
random primed DNA labeling, nick translation,<br />
and oligonucleotide tailing with<br />
terminal transferase, as well as more modern<br />
methods such as PCR and “PRINS”, a<br />
novel and highly sensitive approach <strong>to</strong> in<br />
situ hybridization, in which the probe is<br />
labeled after its hybridization <strong>to</strong> the target<br />
nucleic acid.<br />
Please note that the pro<strong>to</strong>cols have been<br />
optimized by members of the individual<br />
labora<strong>to</strong>ries and can be varied if necessary.<br />
CONTENTS<br />
INDEX
Contents<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
<strong>In</strong> situ hybridization <strong>to</strong> human metaphase chromosomes using DIG-, biotin- or<br />
fluorochrome-labeled DNA probes and detection with fluorochrome conjugates. 62<br />
J. Wiegant, Department of Cy<strong>to</strong>chemistry and Cy<strong>to</strong>metry, University of Leiden, The<br />
Netherlands; U. Mathieu and P. Lichter, German Cancer Research Center,<br />
Heidelberg, Germany; J. Wienberg and N. Arnold, <strong>In</strong>stitute for Anthropology and<br />
Human Genetics, University of Munich, Germany; S. Popp and T. Cremer, <strong>In</strong>stitute<br />
for Human Genetics and Anthropology, University of Heidelberg, Germany; D. C.<br />
Ward, Human Genetics Department, Yale University, New Haven, Connecticut,<br />
USA; S. Joos and P. Lichter, German Cancer Research Center, Heidelberg, Germany.<br />
Detection of chromosomal imbalances using DOP-PCR<br />
and comparative genomic hybridization (CGH). 72<br />
S. Joos, B. Schütz, M. Bentz, and P. Lichter, German Cancer Research Center,<br />
Heidelberg, Germany.<br />
Identification of chromosomes in metaphase spreads and interphase nuclei<br />
with PRINS Oligonucleotide Primers and DIG- or rhodamine-labeled nucleotides. 79<br />
R. Seibl, Research Labora<strong>to</strong>ries, Boehringer Mannheim GmbH, Penzberg, Germany.<br />
Identification of chromosomes in metaphase spreads with DIG- or<br />
fluorescein-labeled human chromosome-specific satellite DNA probes. 88<br />
G.Sagner,ResearchLabora<strong>to</strong>ries, Boehringer Mannheim GmbH, Penzberg, Germany.<br />
Fluorescence in situ hybridization of a repetitive DNA probe <strong>to</strong> human<br />
chromosomes in suspension. 94<br />
D. Celeda, U. Bettag, and C. Cremer, <strong>In</strong>stitute for Applied Physics and <strong>In</strong>stitute for<br />
Human Genetics and Anthropology, University of Heidelberg, Germany.<br />
A simplified and efficient pro<strong>to</strong>col for nonradioactive in situ hybridization<br />
<strong>to</strong> polytene chromosomes with a DIG-labeled DNA probe. 97<br />
E. R. Schmidt, <strong>In</strong>stitute for Genetics, Johannes Gutenberg-University of Mainz,<br />
Germany.<br />
Multiple-target DNA in situ hybridization with enzyme-based cy<strong>to</strong>chemical<br />
detection systems. 100<br />
E. J. M. Speel, F. C. S. Rameaekers, and A. H. N. Hopman, Department of Molecular<br />
Cell Biology & Genetics, University of Limburg, Maastricht, The Netherlands.<br />
DNA in situ hybridization with an alkaline phosphatase-based<br />
fluorescent detection system. 108<br />
G. Sagner, Research Labora<strong>to</strong>ries, Boehringer Mannheim GmbH, Penzberg, Germany.<br />
CONTENTS<br />
INDEX<br />
59<br />
5
5<br />
60<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
Combined DNA in situ hybridization and immunocy<strong>to</strong>chemistry<br />
for the simultaneous detection of nucleic acid sequences, proteins,<br />
and incorporated BrdU in cell preparations. 110<br />
E. J. M. Speel, F. C. S. Rameaekers, and A. H. N. Hopman, Department of Molecular<br />
Cell Biology & Genetics, University of Limburg, Maastricht, The Netherlands.<br />
<strong>In</strong> situ hybridization <strong>to</strong> mRNA in in vitro cultured cells with DNA probes. 116<br />
Department of Cy<strong>to</strong>chemistry and Cy<strong>to</strong>metry, University of Leiden, The<br />
Netherlands.<br />
Identification of single bacterial cells using DIG-labeled oligonucleotides. 119<br />
B. Zarda, R. Amann, and K.-H. Schleifer, <strong>In</strong>stitute for Microbiology, Technical<br />
University of Munich, Germany.<br />
ISH <strong>to</strong> tissues<br />
Detection of HPV11 DNA in paraffin-embedded laryngeal tissue<br />
with a DIG-labeled DNA probe. 122<br />
J. Rolighed and H. Lindeberg, ENT-department and <strong>In</strong>stitute for Pathology Aarhus<br />
University Hospital, Denmark.<br />
Detection of mRNA in tissue sections using DIG-labeled RNA<br />
and oligonucleotide probes. 126<br />
P. Komminoth, Division of Cell and Molecular Pathology, Department of Pathology,<br />
University of Zürich, Switzerland.<br />
Detection of mRNA on paraffin embedded material of the central nervous<br />
system with DIG-labeled RNA probes. 136<br />
H. Breitschopf and G. Suchanek, Research Unit for Experimental Neuropathology,<br />
Austrian Academy of Sciences, Vienna, Austria.<br />
RNA-RNA in situ hybridization using DIG-labeled probes: the effect of high<br />
molecular weight polyvinyl alcohol on the alkaline phosphatase<br />
indoxyl-nitroblue tetrazolium reaction. 141<br />
M. De Block and D. Debrouwer, Plant Genetic Systems N.V., Gent, Belgium.<br />
Detection of neuropeptide mRNAs in tissue sections using<br />
oligonucleotides tailed with fluorescein-12-dUTP or DIG-dUTP. 146<br />
Department of Cy<strong>to</strong>chemistry and Cy<strong>to</strong>metry, University of Leiden, The<br />
Netherlands.<br />
<strong>In</strong> situ hybridization of DIG-labeled rRNA probes <strong>to</strong> mouse liver ultrathin sections. 148<br />
D. Fischer, D. Weisenberger, and U. Scheer, <strong>In</strong>stitute for Zoology I, University of<br />
Würzburg, Germany.<br />
RNA in situ hybridization using DIG-labeled cRNA probes. 152<br />
H. B. P. M. Dijkman, S. Mentzel, A. S. de Jong, and K. J. M. Assmann, Department of<br />
Pathology, Nijmegen University Hospital, Nijmegen, The Netherlands.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
Localization of the expression of the segmentation gene hunchback<br />
in Drosophila embryos with DIG-labeled DNA probes. 158<br />
D. Tautz, <strong>In</strong>stitute for Genetics and Microbiology, University of Munich, Germany.<br />
Detection of even-skipped transcripts in Drosophila embryos<br />
with PCR/DIG-labeled DNA probes. 162<br />
N. Patel and C. Goodman, Carnegie <strong>In</strong>stitute of Washing<strong>to</strong>n, Embryology<br />
Department, Baltimore, Maryland, USA.<br />
Whole mount fluorescence in situ hybridization (FISH) of repetitive DNA<br />
sequences on interphase nuclei of the small cruciferous plant Arabidopsis<br />
thaliana. 165<br />
Serge Bauwens and Patrick Van Oostveldt, Labora<strong>to</strong>ry for Genetics and Labora<strong>to</strong>ry<br />
for Biochemistry and Molecular Cy<strong>to</strong>logy, Gent University, Gent, Belgium.<br />
CONTENTS<br />
INDEX<br />
61<br />
5
5<br />
62<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
<strong>In</strong> situ hybridization <strong>to</strong> human metaphase<br />
chromosomes using DIG-, biotin-, or fluorochromelabeled<br />
DNA probes and detection with fluorochrome<br />
conjugates<br />
J. Wiegant, Department of Cy<strong>to</strong>chemistry and Cy<strong>to</strong>metry, Leiden University, Netherlands.<br />
<strong>In</strong> recent years, a number of improvements<br />
in chromosomal in situ hybridization pro<strong>to</strong>cols<br />
have been achieved. These have<br />
allowed a fairly high success rate for single<br />
copy gene localization as well as competition<br />
in situ hybridization. Here we present<br />
a detailed outline of the procedure that has<br />
been successfully applied in various<br />
labora<strong>to</strong>ries.<br />
The procedures have been optimized for<br />
fluorescent detection. For the second edition<br />
of this manual, we have included new<br />
procedures and new illustrations for multicolor,<br />
multitarget fluorescent detection.<br />
The procedures have also been used with<br />
slight modifications by the groups of Dr. P.<br />
Lichter, Dr. J. Wienberg, Dr. T. Cremer<br />
and Dr. D. Ward. The illustrative material<br />
they have provided below demonstrates<br />
the flexibility and wide applicability of the<br />
technique.<br />
At the end of the article, Dr. Lichter’s<br />
group has provided a troubleshooting<br />
guide <strong>to</strong> help solve hybridization problems<br />
that may occur.<br />
I. Pretreatment of metaphase<br />
spreads on slides (optional)<br />
1 <strong>In</strong>cubate metaphase spreads with 100 µl<br />
of 100 µg/ml RNase A (in 2 x SSC)<br />
under a coverslip for 1 h at 37°C.<br />
2 Wash slides 3 x 5 min with 2 x SSC.<br />
3 Dehydrate slides in an ethanol series<br />
(increasing ethanol concentrations).<br />
4 <strong>In</strong>cubate with 0.005–0.02% pepsin in<br />
10 mM HCl for 10 min at 37°C.<br />
5 Wash slides as follows:<br />
2 x 5 min with PBS.<br />
Once with PBS containing 50 mM<br />
MgCl2.<br />
6 Post-fix for 10 min at room temperature<br />
with a solution of PBS containing 50 mM<br />
MgCl2 and 1% formaldehyde.<br />
7 Wash with PBS and dehydrate (as in<br />
Step 3 above).<br />
II. Denaturation and hybridization<br />
For denaturation and hybridization three<br />
alternative pro<strong>to</strong>cols are given:<br />
A. For probes recognizing repetitive<br />
targets such as the alphoid sequences<br />
B. For probes recognizing unique<br />
sequences<br />
C. For probes or probe cocktails which<br />
contain repetitive sequences occurring<br />
throughout the genome (e.g., Alu<br />
sequences) [competition hybridization]<br />
A. For repetitive probes<br />
1 Using digoxigenin- (DIG-), biotin-, or<br />
any fluorochrome-labeled nucleotide,<br />
label 1 µg of DNA probe according <strong>to</strong><br />
the procedures described in Chapter 4<br />
of this manual.<br />
2 Precipitate the labeled probe with<br />
ethanol.<br />
3 Prepare a probe s<strong>to</strong>ck solution as follows:<br />
Resuspend the precipitated probe at a<br />
concentration of 10 ng/µl in a solution<br />
containing 60% deionized formamide,<br />
2 x SSC, 50 mM sodium<br />
phosphate; pH 7.0.<br />
<strong>In</strong>cubate the tube for 15 min at 37°C<br />
with occasional vortexing until the<br />
precipitated DNA dissolves.<br />
4 Dilute the probe from the s<strong>to</strong>ck <strong>to</strong> the<br />
desired concentration (typically 2 ng/µl)<br />
in a solution containing 60% deionized<br />
formamide, 2 x SSC, 50 mM sodium<br />
phosphate; pH 7.0.<br />
5 Apply 5 µl diluted probe under a coverslip<br />
on the object slide and place the<br />
slide in an oven at 80°C for 2–4 min <strong>to</strong><br />
denature the probe and target.<br />
Note: Sealing with rubber cement is not<br />
manda<strong>to</strong>ry.<br />
6 To hybridize, place the slides in a moist<br />
chamber at 37°C overnight.<br />
7 Wash the slide as follows:<br />
3 x 5 min at 37°C with 2 x SSC containing<br />
60% formamide.<br />
1 x 5 min with the buffer <strong>to</strong> be used<br />
for immunological detection.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
B. For unique probes<br />
1 Prepare the probe s<strong>to</strong>ck solution as<br />
described under Procedure IIA, but use<br />
a solution containing 50% deionized<br />
formamide, 2 x SSC, 10% dextran sulfate,<br />
50 mM sodium phosphate; pH 7.<br />
2 Dilute 2–5 µl of the probe s<strong>to</strong>ck solution<br />
<strong>to</strong> 10 µl with a solution containing<br />
50% deionized formamide, 2 x SSC,<br />
10% dextran sulfate, 50 mM sodium<br />
phosphate; pH 7. Mix well!<br />
3 To denature probe and target, do the<br />
following:<br />
Apply 10 µl of the dilute hybridization<br />
solution under a coverslip on the<br />
object slide.<br />
Seal coverslip <strong>to</strong> slide with rubber<br />
cement.<br />
Place the slide in an oven at 80°C for<br />
2–4 min.<br />
4 To hybridize, place the slides in a moist<br />
chamber at 37°C overnight.<br />
5 Wash the slide as follows:<br />
3 x 5 min at 45°C with 2 x SSC containing<br />
50% formamide.<br />
5 x 2 min with 2 x SSC.<br />
1 x 5 min with the buffer used in<br />
detection.<br />
C. For probes containing repetitive<br />
elements [competitive hybridization]<br />
1 Using DIG-, biotin-, or any fluorochrome-labeled<br />
nucleotides, label 1 µg<br />
of DNA probe according <strong>to</strong> the<br />
procedures described in Chapter 4 of<br />
this manual.<br />
2 To precipitate the labeled probe, do the<br />
following:<br />
Add a 50-fold excess of human Cot-1<br />
DNA (or 500-fold excess fragmented<br />
human placenta DNA), a 50-fold<br />
excess of fragmented herring sperm<br />
DNA, a 50-fold excess of yeast<br />
tRNA, 1/10th volume of 3 M sodium<br />
acetate ( pH 5.6), and 2.5 volumes of<br />
cold (–20°C) ethanol.<br />
<strong>In</strong>cubate for 30 min on ice.<br />
Centrifuge for 30 min at 4°C.<br />
Discard the supernatant and dry the<br />
pellet.<br />
CONTENTS<br />
INDEX<br />
3 Prepare a probe s<strong>to</strong>ck solution by<br />
dissolving the pellet in a solution of<br />
50% deionized formamide, 2 x SSC,<br />
10% dextran sulfate, 50 mM sodium<br />
phosphate; pH 7. Depending on the<br />
probe cocktail, the final concentration<br />
ranges from 10–40 ng/µl. Mix well!<br />
Examples: Prepare a 10 ng/µl s<strong>to</strong>ck<br />
solution of cosmid probes, a 20 ng/µl<br />
s<strong>to</strong>ck of chromosome specific libraries,<br />
or a 40 ng/µl s<strong>to</strong>ck of YAC probes.<br />
4 For hybridization, dilute the probe from<br />
the s<strong>to</strong>ck <strong>to</strong> the desired concentration in<br />
a solution of 50% deionized formamide,<br />
2 x SSC, 10% dextran sulfate, 50 mM<br />
sodium phosphate; pH 7.<br />
Examples: For hybridization, use<br />
2–5 ng/µl of cosmid probes, 10–20 ng/µl<br />
of chromosome specific libraries, or<br />
20–40 ng/µl of YAC probes.<br />
5 Denature the probe at 75°C for 5 min,<br />
chill on ice, and allow annealing of<br />
the repetitive elements at 37°C for<br />
either 30 min (if Cot-1 DNA is used as<br />
competi<strong>to</strong>r) or 2 h (if <strong>to</strong>tal human<br />
placenta DNA is used as competi<strong>to</strong>r).<br />
6 Prepare the chromosomes on the slide<br />
by performing the following steps:<br />
To the chromosomes, add a solution<br />
of 70% formamide, 2 x SSC, 50 mM<br />
sodium phosphate; pH 7. Cover with<br />
a coverslip.<br />
<strong>In</strong>cubate in an oven at 80°C for 2–4<br />
min <strong>to</strong> denature the chromosomes.<br />
Remove the coverslip and quench the<br />
chromosomes in chilled 70% ethanol.<br />
Dehydrate the slide by passing<br />
it through 90% ethanol, then 100%<br />
alcohol.<br />
Air dry the slide, preferably on a<br />
metal plate at 37°C.<br />
7 Hybridize the chromosomes overnight<br />
with 10 µl of the pre-annealed probe<br />
(from Step 5) under a sealed coverslip.<br />
8 Wash the slide as follows:<br />
3 x 5 min at 45°C with 2 x SSC containing<br />
50% formamide.<br />
3 x 5 min at 60°C with 0.1 x SSC.<br />
1 x 5 min with the buffer <strong>to</strong> be used in<br />
immunological detection.<br />
63<br />
5
5<br />
64<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
III. Single color fluorescent detection<br />
with immunological amplification<br />
A1. Biotin-labeled probe, low sensitivity<br />
1 Wash slides briefly with TNT buffer<br />
[100 mM Tris-HCl (pH 7.5), 150 mM<br />
NaCl, 0.05% Tween ® 20].<br />
2 <strong>In</strong>cubate for 30 min at 37°C with TNB<br />
buffer [100 mM Tris-HCl (pH 7.5),<br />
150 mM NaCl, 0.5% blocking reagent].<br />
3 <strong>In</strong>cubate for 30 min at 37°C with the<br />
proper dilution (typically 10 µg/ml) of a<br />
fluorescently labeled streptavidin conjugate<br />
in TNB.<br />
4 Wash the slides (3 x 5 min) with TNT.<br />
5 Prepare the slides for viewing by performing<br />
the following steps:<br />
Dehydrate through an ethanol series<br />
(70%, then 90%, then 100% ethanol;<br />
5 min each).<br />
Air dry.<br />
Stain with the appropriate DNA<br />
counterstain.<br />
Embed in Vectashield (Vec<strong>to</strong>r).<br />
6 View the slides by fluorescence microscopy,<br />
using appropriate filters.<br />
A2. Biotin-labeled probe, high sensitivity<br />
1 Wash slides briefly with TNT buffer<br />
[100 mM Tris-HCl (pH 7.5), 150 mM<br />
NaCl, 0.05% Tween ® 20].<br />
2 <strong>In</strong>cubate for 30 min at 37°C with TNB<br />
buffer [100 mM Tris-HCl (pH 7.5),<br />
150 mM NaCl, 0.5% blocking reagent].<br />
3 <strong>In</strong>cubate for 30 min at 37°C with the<br />
proper dilution (typically 10 µg/ml) of a<br />
fluorescently labeled streptavidin conjugate<br />
in TNB.<br />
4 Wash the slides (3 x 5 min) with TNT.<br />
5 <strong>In</strong>cubate the slides for 30 min at 37°C<br />
with the proper dilution of biotinylated<br />
goat anti-streptavidin (5 µg/ml) in TNB.<br />
6 Repeat the washes as in Step 4.<br />
7 Repeat Step 3.<br />
8 Repeat the washes as in Step 4.<br />
9 Prepare the slides for viewing as in the<br />
biotin low sensitivity procedure (Procedure<br />
IIIA1), Step 5.<br />
B1. Digoxigenin-labeled probe,<br />
low sensitivity<br />
1 Wash slides briefly with TNT buffer<br />
[100 mM Tris-HCl (pH 7.5), 150 mM<br />
NaCl, 0.05% Tween 20].<br />
2 <strong>In</strong>cubate for 30 min at 37°C with TNB<br />
buffer [100 mM Tris-HCl (pH 7.5),<br />
150 mM NaCl, 0.5% blocking reagent].<br />
3 <strong>In</strong>cubate for 30 min at 37°C with the<br />
proper dilution (typically 2 µg/ml, in<br />
TNB) of a fluorescently labeled sheep<br />
anti-DIG antibody.<br />
4 Wash the slides (3 x 5 min) with TNT.<br />
5 Prepare the slides for viewing as in the<br />
biotin low sensitivity procedure (Procedure<br />
IIIA1), Step 5.<br />
B2. Digoxigenin-labeled probe,<br />
high sensitivity<br />
1 Wash slides briefly with TNT buffer<br />
[100 mM Tris-HCl (pH 7.5), 150 mM<br />
NaCl, 0.05% Tween ® 20].<br />
2 Pipette 100 µl of TNB buffer [100 mM<br />
Tris-HCl (pH 7.5), 150 mM NaCl,<br />
0.5% blocking reagent] on<strong>to</strong> each slide<br />
and cover with a 24 x 50 mm coverslip.<br />
<strong>In</strong>cubate for 30 min at 37°C in a moist<br />
chamber (1 L beaker containing moistened<br />
tissues, covered with aluminum<br />
foil).<br />
3 Immerse the slides for 5 min in TNT <strong>to</strong><br />
loosen the coverslips.<br />
4 Prepare fresh working solutions of three<br />
antibodies:<br />
Antibody 1 working solution: mouse<br />
monoclonal anti-DIG, 0.5 µg/ml in<br />
TNB.<br />
Antibody 2 working solution: DIGconjugated<br />
sheep anti-mouse Ig,<br />
2µg/ml in TNB.<br />
Antibody 3 working solution: fluorescein-<br />
or rhodamine-conjugated sheep<br />
anti-DIG, 2 µg/ml in TNB.<br />
Note: The three antibodies used in<br />
this procedure are also available in the<br />
Fluorescent Antibody Enhancer Set<br />
for DIG Detection.<br />
5 Pipette 100 µl of antibody 1 working solution<br />
on<strong>to</strong> each slide and cover with a<br />
24 x50mmcoverslip.<strong>In</strong>cubatefor30min at<br />
37°C in a moist chamber.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
6 Wash the slides (3 x 5 min) at room<br />
temperature with TNT.<br />
7 Pipette 100 µl of antibody 2 working<br />
solution on<strong>to</strong> each slide and add a 24 x<br />
50 mm coverslip. <strong>In</strong>cubate for 30 min at<br />
37°C in a moist chamber.<br />
8 Repeat the washes as in Step 6.<br />
9 Pipette 100 µl of antibody 3 working<br />
solution on<strong>to</strong> each slide and add a 24 x<br />
50 mm coverslip. <strong>In</strong>cubate for 30 min at<br />
37°C in a moist chamber.<br />
Note: For even higher sensitivity, repeat<br />
Steps 5–8 before performing the incubation<br />
with antibody 3 (Step 9).<br />
10 Repeat the washes as in Step 6.<br />
11 Prepare the slides for viewing as in the<br />
biotin low sensitivity procedure (Procedure<br />
IIIA1), Step 5.<br />
C1. Fluorescently labeled probes<br />
(fluorescein, coumarin, CY3, rhodamine,<br />
Texas Red), low sensitivity<br />
After the posthybridization washes (Procedure<br />
II), prepare the slides for viewing as<br />
in the biotin low sensitivity procedure<br />
(Procedure IIIA1), Step 5.<br />
C2. Fluorescein-labeled probes,<br />
high sensitivity<br />
1 Wash slides briefly with TNT buffer<br />
[100 mM Tris-HCl (pH 7.5), 150 mM<br />
NaCl, 0.05% Tween ® 20].<br />
2 <strong>In</strong>cubate for 30 min at 37°C with TNB<br />
buffer [100 mM Tris-HCl (pH 7.5),<br />
150 mM NaCl, 0.5% blocking reagent].<br />
3 <strong>In</strong>cubate for 30 min at 37°C with the<br />
proper dilution of an anti-fluorescein<br />
antibody (either polyclonal or monoclonal)<br />
in TNB.<br />
4 Wash the slides (3 x 5 min) with TNT.<br />
5 Depending on the antibody used in Step 3,<br />
incubate with the proper dilution of a<br />
fluorescently labeled rabbit anti-mouse<br />
or goat anti-rabbit antibody in TNB for<br />
30 min at 37°C.<br />
6 Repeat the washes as in Step 4.<br />
7 Prepare the slides for viewing as in the<br />
biotin low sensitivity procedure (Procedure<br />
IIIA1), Step 5.<br />
CONTENTS<br />
INDEX<br />
IV. Multicolor fluorescence in situ<br />
hybridization (Multicolor FISH)<br />
For multicolor FISH, several sets of probes<br />
with different labels must be hybridized<br />
simultaneously <strong>to</strong> the target and visualized<br />
with combinations of antibodies.<br />
Table 1 lists an antibody-probe matrix<br />
which allows a triple color detection of<br />
three differently labeled chromosome<br />
specific libraries (so-called chromosome<br />
painting probes).<br />
<strong>In</strong>cubation Probe 1 Probe 2 Probe 3<br />
Biotin Digoxigenin Fluorescein<br />
1 Streptavidin- Mouse anti- Rabbit anti-<br />
Texas Red DIG antibody fluorescein antibody<br />
2 Biotin-labeled Sheep anti-mouse FITC-labeled goat<br />
anti-streptavidin antibody anti-rabbit antibody<br />
3 Streptavidin- AMCA-labeled<br />
Texas Red sheep anti-DIG<br />
antibody<br />
Note: Be careful that the selected antibodies<br />
do not cross-react.<br />
Outline of pro<strong>to</strong>col for multicolor FISH<br />
1 Simultaneously hybridize all probes<br />
listed in Table 1 <strong>to</strong> the target.<br />
2 For each of the 3 detection incubations,<br />
perform the following steps:<br />
Prepare the antibodies needed in the<br />
incubation (as listed in Table 1) at the<br />
proper dilution in the correct buffer.<br />
Note: Use the procedures in Section<br />
III above as a guideline.<br />
Mix all antibodies needed in the<br />
incubation and incubate simultaneously<br />
with the slide.<br />
Perform blocking and washing steps<br />
as in Section III above.<br />
3 Repeat Step 2 until all incubations are<br />
complete.<br />
4 Do not counterstain the slides, but<br />
dehydrate, air dry, and mount the slides<br />
as in the biotin low sensitivity procedure<br />
(Procedure IIIA1), Step 5.<br />
65<br />
5
5<br />
Figure 1: FISH of CY3-labeled<br />
satellite III probe pUC1.77 (chromosome<br />
1) <strong>to</strong> human lymphocyte<br />
metaphase and interphase cells.<br />
The slides were counterstained with<br />
YOYO-1. The pho<strong>to</strong>micrograph was<br />
taken with a double band-pass<br />
fluorescence filter <strong>to</strong> allow simultaneous<br />
visualization of fluorescein<br />
and Texas Red.<br />
66<br />
<br />
Figure 2: Triple color FISH of <br />
coumarin-labeled satellite III<br />
probe pUC1.77 (chromosome 1),<br />
fluorescein-labeled alphoid probe<br />
pBamX5 (chromosome X), and<br />
rhodamine-labeled alphoid probe<br />
p17H8 (chromosome 17) <strong>to</strong> human<br />
lymphocyte metaphase and<br />
interphase cells. The<br />
pho<strong>to</strong>micrograph was taken by<br />
superimposing the coumarin,<br />
fluorescein, and rhodamine images.<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
V. Results obtained with human<br />
metaphase chromosome spreads<br />
The following examples (from our<br />
labora<strong>to</strong>ry and other labora<strong>to</strong>ries) show<br />
different applications of the procedures<br />
described in this section .<br />
A. Multicolor FISH of human lymphocyte<br />
metaphase and interphase cells<br />
from the Department of Cy<strong>to</strong>chemistry<br />
and Cy<strong>to</strong>metry, Leiden University, Netherlands<br />
The techniques described above allow the<br />
detection of two, three, or many different<br />
probes simultaneously (Figures 1–4).<br />
<br />
Figure 3: Double color FISH of a biotin-labeled<br />
chromosome1-specific library and a digoxigeninlabeled<br />
chromosome 4-specific library <strong>to</strong> human<br />
lymphocyte metaphase and interphase cells.<br />
The libraries were visualized by a combined<br />
immunocy<strong>to</strong>chemical reaction using fluoresceinlabeled<br />
anti-digoxigenin and Texas Red-labeled<br />
streptavidin. The pho<strong>to</strong>micrograph was taken with a<br />
double band-pass fluorescence filter <strong>to</strong> allow<br />
simultaneous visualization of fluorescein and Texas<br />
B. Detection of a trisomy in a leukemia<br />
patient in interphase nuclei using double<br />
in situ hybridization<br />
from U. Mathieu and Dr. P. Lichter,<br />
German Cancer Research Center,<br />
Heidelberg, Germany.<br />
Nick translation was used <strong>to</strong> label a<br />
chromosome 17-specific alphoid DNA (with<br />
digoxigenin) and a chromosome 18-specific<br />
alphoid DNA (with biotin). Both the digoxigenin-labeled<br />
and the biotin-labeled<br />
probes were hybridized <strong>to</strong> a chromosome<br />
sample from a leukemia patient. The procedures<br />
described above for repetitive DNA<br />
(Procedure IIA of this article) were used for<br />
slide preparation, labeling, and hybridization,<br />
except the following minor modifications<br />
were necessary for alphoid DNA:<br />
1 After nick translation labeling, concentrate<br />
the probe (approx. 10–30 ng DNA)<br />
by drying the DNA directly in the tube.<br />
Note: Ethanol precipitation is not<br />
necessary.<br />
2 Dissolve the dried DNA pellet in 60%<br />
formamide, 2 x SSC.<br />
Note: Do not use dextran sulfate in the<br />
resuspension buffer. Omission of<br />
dextran sulfate reduces the chance of<br />
cross-hybridization.<br />
3 After hybridization, use the following<br />
washes:<br />
3 x 5 min at 42°C with 60% formamide,<br />
2 x SSC; pH 7.<br />
Note: Compared <strong>to</strong> the standard<br />
pro<strong>to</strong>col the concentration of formamide<br />
is increased up <strong>to</strong> 60%.<br />
Figure 4: Twelve color FISH of 12 different ratiolabeled<br />
chromosome-specific libraries <strong>to</strong> human<br />
lymphocyte metaphase and interphase cells.<br />
For details of the experiment, see Dauwerse et al.<br />
(1992). The pho<strong>to</strong>micrograph was created by superimposing<br />
the coumarin image and the image obtained<br />
with a double band-pass fluorescence filter<br />
(<strong>to</strong> allow simultaneous visualization of fluorescein<br />
and Texas Red).<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Figure 5 shows the result of the hybridization.<br />
The digoxigenin-labeled probe was<br />
visualized with anti-DIG-rhodamine; the<br />
biotin-labeled probe, with avidin-FITC.<br />
<br />
Figure 5: Double color FISH of a digoxigeninlabeled<br />
chromosome 17-specific probe and a<br />
biotin-labeled chromosome 18-specific probe<br />
<strong>to</strong> a human chromosome preparation containing<br />
a trisomy. Each alphoid DNA probe was specific<br />
for the centromere of its target chromosome. <strong>In</strong> the<br />
metaphase and in the interphase, the probes detected<br />
three signals (green) from chromosome 18<br />
and two signals (red) from chromosome 17. DAPI<br />
was used for counterstaining.<br />
C. Detection of a trisomy and a tetrasomy<br />
in interphase nuclei of a leukemia patient<br />
with two different cosmid probes<br />
from U. Mathieu and Dr. P. Lichter<br />
A digoxigenin-labeled cosmid probe specific<br />
for chromosome 14 and a biotin-labeled<br />
cosmid probe specific for chromosome 21<br />
were used <strong>to</strong> detect polyploidy in a<br />
leukemia patient (Figure 6). Probes were<br />
labeled by nick translation and visualized<br />
with either anti-DIG-rhodamine (chromosome<br />
14-specific probe) or avidin-FITC<br />
(chromosome 21-specific probe).<br />
<br />
Figure 6: Double color FISH of a digoxigeninlabeled<br />
chromosome 14-specific cosmid probe<br />
and a biotin-labeled chromosome 21-specific<br />
cosmid probe <strong>to</strong> a human chromosome preparation<br />
of a leukemia patient containing a trisomy<br />
and a tetrasomy. <strong>In</strong> the interphase nuclei, the<br />
cosmid DNA probes detected three copies (red) of<br />
chromosome 14 and four copies (green) of<br />
chromosome 21. DAPI was used for<br />
CONTENTS<br />
INDEX<br />
D. <strong>In</strong>terphase nuclei of a patient with<br />
Ph1-positive ALL (acute lymphoblastic<br />
leukemia)<br />
from M. Bentz, P. Lichter, H. Döhner and<br />
G. Cabot.<br />
The Philadelphia chromosome (Ph1) is the<br />
derivative of a translocation between<br />
chromosome 9 and chromosome 22 [(t9;22)<br />
(q34;q11)]. Figure 7 shows the use of two<br />
probes, one specific for chromosome 9 and<br />
the other specific for chromosome 22, <strong>to</strong><br />
detect Ph1.<br />
E. Chromosomal in situ suppression (CISS)<br />
hybridization of the human DNA library<br />
specific for chromosome 2 <strong>to</strong> chromosomes<br />
of Gorilla gorilla<br />
from Dr. J. Wienberg and Dr. N. Arnold,<br />
<strong>In</strong>stitute for Anthropology and Human<br />
Genetics, University of Munich, Germany.<br />
The hybridization pattern (Figure 8) obtained<br />
with specific DNA probe sets<br />
(Weinberg et al., 1990) confirms the<br />
assumed fusion of two submetacentric<br />
chromosomes during human evolution.<br />
<br />
Figure 8: FISH of a chromosome 2-specific library<br />
<strong>to</strong> chromosomes of Gorilla gorilla. Standard<br />
chromosome preparations were obtained from EBVtransformed<br />
lymphoblas<strong>to</strong>id cell lines. DNA probes<br />
were from flow-sorted human chromosomes cloned<br />
<strong>to</strong> phages or plasmids. Probes were labeled with<br />
digoxigenin by nick translation. Detection was performed<br />
with monoclonal mouse anti-DIG antibody,<br />
rabbit anti-mouse-TRITC, and goat anti-rabbit-TRITC.<br />
<br />
Figure 7: Double color FISH <strong>to</strong><br />
detect the Philadelphia<br />
chromosome (Ph1) in a patient<br />
with ALL. A cosmid probe specific<br />
for chromosome 9 and a YAC probe<br />
specific for chromosome 22 were<br />
hybridized <strong>to</strong> interphase nuclei<br />
(Bentz et al., 1994). These two<br />
probes detected two red<br />
(rhodamine) signals from<br />
chromosomes 22, one green (FITC)<br />
signal from chromosome 9 and one<br />
yellow signal caused by the<br />
overlapping of red (chromosome 22)<br />
and green (chromosome 9) signals<br />
on Ph1. DAPI was used for counterstaining.<br />
Reprinted from Bentz et al. (1994)<br />
Detection of Chimeric BCR–ABL genes on<br />
Bone Marrow Samples and Blood Smears<br />
in Chronic Myeloid and Acute<br />
Lymphoblastic Leukemia by <strong>In</strong> <strong>Situ</strong><br />
<strong>Hybridization</strong>,<br />
Blood 83 (7); 1922–1928 with permission<br />
of the Journal Permissions Department,<br />
W. B. Saunder’s Company.<br />
67<br />
5
5<br />
Figure 10: FISH of an ATPasespecific<br />
probe and a probe<br />
containing L1-repetitive<br />
sequences <strong>to</strong> female mouse<br />
chromosomes. Yellow color<br />
(banding) is due <strong>to</strong> the biotin-labeled<br />
probe containing L1-repetitive<br />
sequences, which was detected<br />
with FITC. Red „dots“ indicate a<br />
signal from each of the four (look<br />
closely) chromatids obtained with<br />
the digoxigenin-labeled ATPasespecific<br />
probe, which was detected<br />
with anti-DIG Fab fragments (from<br />
sheep) and Texas Red-conjugated<br />
anti-sheep Ig Fab. The blue color is<br />
the DAPI counterstain.<br />
68<br />
<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
F. Illustration of a chromosomal<br />
translocation from a patient with<br />
chronic myeloid leukemia<br />
from S. Popp and Dr. T. Cremer, <strong>In</strong>stitute<br />
for Human Genetics and Anthropology,<br />
University of Heidelberg, Germany.<br />
The chromosomal translocation was detected<br />
by using library probes from sorted<br />
chromosomes 9 and 22 (Figure 9). <strong>In</strong> Panel a,<br />
the chromosome 22-specific probe has<br />
➞<br />
clearly painted the normal chromosome 22<br />
(bot<strong>to</strong>m), the Philadelphia chromosome<br />
(triangle) and the translocated material<br />
22q11 → 22qter contained in the derivative<br />
chromosome 9 (arrow). <strong>In</strong> Panel b, the<br />
chromosome 9-specific probe has stained<br />
the normal chromosome 9 blue except for<br />
the centromeric region, while in the derivative<br />
chromosome 9, the region 9pter →<br />
9q34 is also painted. The arrow points <strong>to</strong><br />
the breakpoint on chromosome 9.<br />
<br />
Figure 9: Two-color chromosomal in situ suppression (CISS)-hybridization of a metaphase spread<br />
obtained from a patient with chronic myeloid leukemia 46, XY, t(9;22) (q34;q11). <strong>In</strong> Panel a, the probe<br />
was a digoxigenin-labeled chromosome 22-specific library, which was detected with a mouse anti-DIG<br />
antibody and a FITC-conjugated sheep anti-mouse antibody. The same metaphase spread was<br />
simultaneously painted (Panel b) with a biotin-labeled chromosome 9-specific library, which was detected<br />
with avidin conjugated <strong>to</strong> the fluorochrome AMCA (aminocoumarin). Chromosomes were counterstained with<br />
propidium iodide. Chromosomal analysis using GTG-banded chromosomes was kindly performed by<br />
R. Becher, Westdeutsches Tumorzentrum, Essen.<br />
➞<br />
<br />
➞<br />
➞<br />
a b<br />
G. Digitized images of female mouse<br />
chromosomes visualized with a Zeiss<br />
epifluorescent microscope equipped with a<br />
cooled CCD camera<br />
from Dr. D. C. Ward, Human Genetics<br />
Department, Yale University, New<br />
Haven, CT, USA.<br />
<strong>In</strong> Figure 10, a probe specific for Na + /K +<br />
ATPase alpha subunits and a probe containing<br />
an L1-repetitive sequence were hybridized<br />
<strong>to</strong> female mouse chromosomes.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Reagents available from Boehringer Mannheim for these procedures<br />
Reagent Description Cat. No. Pack size<br />
DIG-Nick Translation 5 x conc. stabilized reaction buffer in 50% 1745 816 160 µl<br />
Mix* for in situ probes glycerol (v/v) and DNA Polymerase I, DNase I, (40 labeling<br />
0.25 mM dATP, 0.25 mM dCTP, 0.25 mM dGTP,<br />
0.17 mM dTTP and 0.08 mM DIG-11-dUTP.<br />
reactions)<br />
Biotin-Nick Translation 5 x conc. stabilized reaction buffer in 50% 1745 824 160 µl<br />
Mix* for in situ probes glycerol (v/v) and DNA Polymerase I, DNase I, (40 labeling<br />
0.25 mM dATP, 0.25 mM dCTP, 0.25 mM dGTP, reactions)<br />
0.17 mM dTTP and 0.08 mM biotin-16-dUTP.<br />
Nick Translation Mix* 5 x conc. stabilized reaction buffer in 50% 1745 808 200 µl<br />
for in situ probes glycerol, DNA Polymerase I and DNase I.<br />
dNTP Set Set of dATP, dCTP, dGTP, dTTP, 1 277 049 4 x10 µmol<br />
100 mM solutions, lithium salts. (100 µl)<br />
Fluorescein-12-dUTP Tetralithium salt, 1 mM solution 1 373 242 25 nmol<br />
(25 µl)<br />
Tetramethyl- Tetralithium salt, 1 mM solution 1 534 378 25 nmol<br />
rhodamine-6-dUTP (25 µl)<br />
AMCA-6-dUTP Tetralithium salt, 1 mM solution 1 534 386 25 nmol<br />
(25 µl)<br />
RNase A Pyrimidine specific endoribonuclease 109 142 25 mg<br />
which acts on single-stranded RNA. 109 169 100 mg<br />
Pepsin Aspartic endopeptidase with broad 108 057 1 g<br />
specificity. 1 693 387 5 g<br />
DNA, COT-1, human COT-1 DNA is used in chromosomal in situ 1 581 074 500 µg<br />
suppression [CISS] hybridization. (500 µl)<br />
DNA, MB-grade The ready-<strong>to</strong>-use solution is directly 1 467 140 500 mg<br />
from fish sperm added <strong>to</strong> the hybridization mix. (50 ml)<br />
tRNA Lyophilizate, 1 mg of dry substance 109 495 100 mg<br />
from baker’s yeast corresponds <strong>to</strong> 16 A260 units. 109 509 500 mg<br />
Tween ® 20 Aqueous solution, 10% (w/v) 1 332 465 5 x10 ml<br />
Tris Powder 127 434 100 g<br />
708 968 500 g<br />
708 976 1 kg<br />
Blocking Reagent, Powder 1 096 176 50 g<br />
for nucleic acid<br />
hybridization<br />
Anti-Digoxigenin, For the detection of digoxigenin-labeled 1 333 062 100 µg<br />
clone 1.71.256, compounds<br />
mouse IgG1, <br />
Anti-Digoxigenin- For the detection of digoxigenin-labeled 1 207 741 200 µg<br />
Fluorescein, Fab compounds<br />
fragments from sheep<br />
Anti-Digoxigenin- For the detection of digoxigenin-labeled 1 207 750 200 µg<br />
Rhodamine, Fab compounds<br />
fragments from sheep<br />
Anti-Mouse Ig-Digoxi- Antibody for triple color FISH 1 214 624 200 µg<br />
genin, F(ab)2 fragment<br />
Streptavidin-AMCA For the detection of biotin-labeled compounds. 1 428 578 1 mg<br />
Streptavidin-Fluorescein For the detection of biotin-labeled compounds. 1 055 097 1 mg<br />
DAPI Fluorescence dye for staining of 236 276 10 mg<br />
4',6-Diamidine-2'-Phenyl- chromosomes<br />
indole Dihydrochloride<br />
CONTENTS<br />
INDEX<br />
*This product or the use of this<br />
product may be covered by one<br />
or more patents of Boehringer<br />
Mannheim GmbH, including the<br />
following: EP patent 0 649 909<br />
(application pending).<br />
69<br />
5
5<br />
70<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
VI. Troubleshooting guide<br />
for in situ hybridization on<br />
chromosome spreads<br />
from Stefan Joos and Peter Lichter, German<br />
Cancer Research Center, Heidelberg,<br />
Germany.<br />
Use the following tips <strong>to</strong> diagnose and<br />
correct commonly occurring problems in<br />
the FISH pro<strong>to</strong>cols described above.<br />
A. If no signal is observed, then:<br />
1 Amplify signal.<br />
2 Check probe labeling by performing the<br />
following dot blot assay:<br />
Spot serial dilutions of labeled<br />
control.<br />
Spot serial dilutions of labeled sample.<br />
Compare intensities of the spots.<br />
Note: For the detailed procedure on<br />
how <strong>to</strong> estimate the labeling efficiency<br />
please refer <strong>to</strong> Chapter 4, IX, page 51.<br />
3 After labeling the probe according <strong>to</strong><br />
Steps 1–4 of the nick translation<br />
procedure (Procedure III) in Chapter 4<br />
of this manual, check the size of the<br />
labeled probe molecules as follows:<br />
To a 5–10 µl aliquot of probe, add gel<br />
loading buffer and denature the probe<br />
by incubating it in a boiling water<br />
bath for 3 min, then cool it on ice for<br />
3 min.<br />
Note: Keep the remainder of the probe<br />
sample on ice while running the gel.<br />
Load the aliquot on a standard 1–2%<br />
agarose minigel along with a suitable<br />
size marker.<br />
Quickly run the gel (e.g. 15 volts per<br />
cm for 30 min) <strong>to</strong> avoid renaturation<br />
of the probe in the gel.<br />
Visualize DNA in the gel, e.g. by<br />
staining gel in 0.5 µg/ml ethidium<br />
bromide, and take pho<strong>to</strong>graph during<br />
UV illumination.<br />
Note: The probe molecules will be<br />
visible as a smear. The smear should<br />
contain only fragments smaller than<br />
500 nucleotides (nt) and larger than<br />
100 nt. A peak intensity at 250–<br />
300 nt seems optimal.<br />
Depending on the size of the probe<br />
molecules, do one of the following:<br />
If the DNA is between 100–500 nt,<br />
proceed with the EDTA inactivation<br />
of the reaction mixture (as in Step 7 of<br />
the nick translation procedure,<br />
Chapter 4).<br />
If the probe is larger than 500 nt,<br />
add more DNase I (roughly about<br />
1–10 ng) <strong>to</strong> the probe sample kept on<br />
ice, then incubate longer at 15°C.<br />
Note: Usually higher concentrations<br />
of DNase must be added for an<br />
additional 30 min incubation. After<br />
the incubation, analyze the probe on<br />
a gel as above.<br />
If the DNA is almost or completely<br />
undigested, purify the probe and<br />
repeat the labeling step.<br />
If part of the DNA is smaller than<br />
100 nt, repeat the labeling step using<br />
less DNase I.<br />
If all the DNA is smaller than 100 nt,<br />
repurify the probe (<strong>to</strong> remove any<br />
possible contaminating DNase) and<br />
repeat the labeling step.<br />
4 Check whether the fluorochromes have<br />
separated from the detecting molecules<br />
by passing the solution of fluorochromeconjugated<br />
molecules through a Quick<br />
Spin column (G-50). Then determine<br />
the state of the molecules:<br />
If color remains in flow through,<br />
fluorochromes are still conjugated.<br />
If color remains in the upper part<br />
of the column, fluorochromes have<br />
separated from the detecting molecules.<br />
5 Modify chromosome denaturation<br />
procedure (Procedure II in this article)<br />
by either varying the time and temperature<br />
of the denaturation step or by<br />
further pepsin digestion according <strong>to</strong> the<br />
following pro<strong>to</strong>col:<br />
Note: Digestion with pepsin can<br />
significantly improve probe penetration,<br />
but overdigestion can also occur.<br />
Pepsin treatment is often useful when<br />
specimen preparations are suboptimal,<br />
e.g., in many clinical samples.<br />
Mark the area of interest on the back<br />
of the slide using a diamond stylus.<br />
Wash slide in 2 x SSC at 37°C for<br />
5 min (in a Coplin jar).<br />
Apply 120 µl RNase A solution<br />
(100 µg/ml RNase A in 2 x SSC) <strong>to</strong><br />
slide, cover with larger coverslip (e.g.<br />
22 x 50 mm), and incubate for 1 h at<br />
37°C in a moist chamber.<br />
Wash slide in 2 x SSC (or PBS) for 3 x<br />
5 min (Coplin jar).<br />
Wash slide in prewarmed PBS for<br />
5 min at 37°C.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
<strong>In</strong>cubate slide in pepsin solution<br />
(10 mg pepsin in 100 ml 10 mM HCl)<br />
for 10 min at 37°C (in a water bath).<br />
Wash slide in PBS for 5 min at room<br />
temperature (RT).<br />
<strong>In</strong>cubate slide for 10 min at RT in a<br />
solution of 1% acid-free formaldehyde,<br />
PBS, 50 mM MgCl2.<br />
Wash slide again in PBS for 5 min at<br />
RT.<br />
Dehydrate slide in a series of ethanol<br />
baths (70%, then 90%, then 100%;<br />
≥ 5 min each) and air dry.<br />
6 Check quality of the formamide.<br />
Deionize formamide (several batches<br />
from several sources should be tested)<br />
using ion exchange resin (e.g. Donex<br />
XG8).<br />
7 Check microscope.<br />
Be sure that mercury (Hg2) lamp of the<br />
microscope is in good condition and<br />
well adjusted. Old lamps don’t have<br />
good excitation properties.<br />
8 Perform control experiments with<br />
alphoid DNA probes.<br />
B. If the hybridization signal fades, then:<br />
1 Change <strong>to</strong> a different batch of fluorochrome-conjugated<br />
antibody.<br />
2 Amplify with a secondary and/or<br />
tertiary antibody <strong>to</strong> increase the signal.<br />
Note: Be aware of the background,<br />
which will also be amplified. Before<br />
amplification, remove embedding medium<br />
by washing (2 x SSC, 37°–42°C, 4 x 10<br />
min).<br />
3 Try different antifading solutions [e.g.<br />
1,4-diazobicyclo-(2,2,2)-octane (DAPCO)<br />
or Vectastain (Vec<strong>to</strong>r)].<br />
C. If there is a milky background<br />
fluorescence, then: <br />
CONTENTS<br />
INDEX<br />
D. If there is a starry background<br />
fluorescence, then: <br />
Possible cause Remedy<br />
<strong>In</strong>adequate quality of Treat with pepsin <strong>to</strong> remove cell debris<br />
chromosome preparation (see pro<strong>to</strong>col in Step A5 above).<br />
<strong>In</strong>sufficient blocking Try <strong>to</strong> block with different reagents such as 3% BSA,<br />
human serum, or 3–5% dry milk.<br />
Dirty glass slides Wash the slide with ethanol and rinse with water before<br />
spreading chromosomes.<br />
Bad quality of embedding Change embedding medium.<br />
medium<br />
Possible cause Remedy<br />
Agglutination of Perform a control experiment in the absence of<br />
fluorochromes probe <strong>to</strong> see if you get a non-specific signal from<br />
coupled <strong>to</strong> anti- the fluorochrome-conjugated antibody alone.<br />
bodies If you do, spin the detection solution briefly and take<br />
only the supernatant.<br />
Alternatively pass the detection solution through a<br />
G-50 Quick Spin column <strong>to</strong> remove the agglutinates.<br />
Labeled probe Check the size of the probe as described in Step A3<br />
molecules are above and label again.<br />
<strong>to</strong>o long<br />
E. If there is a general strong staining of<br />
chromosomes and nuclei, then:<br />
Check the size of the labeled probe (as in<br />
Step A3 above). It is most likely <strong>to</strong>o<br />
small.<br />
If the probe is <strong>to</strong>o small, repurify (<strong>to</strong><br />
remove any contaminating DNase) and<br />
relabel the probe.<br />
References<br />
Bentz, M.; Cabot, G.; Moos, M.; Speicher, M. R.,<br />
Ganser, A.; Lichter, P.; Döhner, H. (1994) Detection<br />
of chimeric BCR-ABL genes on bone marrow<br />
samples and blood smears in chronic myeloid and<br />
acute lymphoblastic leukemia by in situ<br />
hybridization. Blood 83, 1922–1928.<br />
Dauwerse, J. G.; Wiegant, J.; Raap, A. K.; Breuning,<br />
M. H.; Van Ommen, G. J. B. (1992) Multiple colors<br />
by fluorescence in situ hybridization using ratiolabeled<br />
DNA probes create a molecular karyotype.<br />
Hum. Mol. Genet. 1, 593–598.<br />
Wienberg, J.; Jauch, A.; Stanyon, R.; Cremer, T.<br />
(1990) Molecular cy<strong>to</strong>taxonomy of primates by<br />
chromosomal in situ suppression hybridization.<br />
Genomics 8, 347–350.<br />
71<br />
5
5<br />
72<br />
<strong>to</strong>tal genomic DNA from cells <strong>to</strong> analyze<br />
(test DNA) labeled with biotin<br />
DNA from:<br />
cells with<br />
amplified DNA<br />
or polysomies<br />
cells with<br />
deletions or<br />
monosomies<br />
Figure 1: Schematic illustration<br />
of “comparative genomic hybridization”<br />
(CGH) for chromosome<br />
analysis. For explanation, see text.<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Detection of chromosomal imbalances using DOP-<br />
PCR and comparative genomic hybridization (CGH)<br />
Stefan Joos, Barbara Schütz, Martin Bentz, and Peter Lichter,<br />
German Cancer Research Center, Heidelberg, Germany.<br />
Recently, a new approach of fluorescence in<br />
situ hybridization was introduced, called<br />
“comparative genomic hybridization”<br />
(CGH) (Kallioniemi et al., 1992), which<br />
allows the comprehensive analysis of<br />
chromosomal imbalances in entire genomes<br />
(Du Manoir et al., 1993; Joos et al., 1993;<br />
Kallioniemi et al., 1992; Kallioniemi et al.,<br />
1993). The principle of CGH is shown in<br />
Figure 1. The genomic DNA from cell<br />
populations <strong>to</strong> be tested, such as fresh or<br />
paraffin-embedded tumor tissue, is labeled<br />
with modified nucleotides (e.g., biotinylated<br />
dUTP) and used as a probe for in situ<br />
hybridization <strong>to</strong> normal metaphase chromosomes.<br />
This probe is called “test DNA”. As an<br />
co-hybridization<br />
(normal chromosomes)<br />
<strong>to</strong>tal genomic DNA from normal cells<br />
(control DNA) labeled with digoxigenin<br />
detection<br />
results in signals on normal chromosomes (partial karyotype)<br />
signals from hybridized test DNA signals from co-hybridized control DNA<br />
internal control, genomic DNA derived from<br />
cells with a normal karyotype is differentially<br />
labeled and hybridized simultaneously<br />
(“control DNA”). For detection of the<br />
hybridized test and control DNA, different<br />
fluorochromes are used, and each is<br />
visualized by epifluorescence microscopy<br />
with selective filters. <strong>Hybridization</strong> with genomic<br />
DNA results in a general staining of all<br />
chromosomes. However, if the tissue<br />
analyzed harbors additional chromosomal<br />
material (e.g., a trisomy, amplifications etc.),<br />
hybridization reveals higher signal intensities<br />
at the corresponding target regions of the<br />
hybridized chromosomes (Figure 1). Correspondingly,<br />
deletions in the test sample are<br />
visible as lower signal intensities (Figure 1).<br />
By comparing the hybridization patterns of<br />
test and control DNA, the changes in signal<br />
intensities caused by imbalances within the<br />
analyzed tissue can be identified.<br />
Thus, CGH provides a comprehensive<br />
picture of all chromosomal gains and losses<br />
within a single experiment. <strong>In</strong> contrast <strong>to</strong><br />
banding analysis, CGH requires no preparation<br />
of metaphase chromosomes from<br />
the cells <strong>to</strong> be analyzed (which in certain<br />
tumor types may be difficult or even<br />
impossible).<br />
<strong>In</strong> many cases, only small amounts of<br />
tumor tissue are available for cy<strong>to</strong>genetic<br />
analysis. Therefore it is advantageous <strong>to</strong><br />
combine CGH with universal PCR<br />
pro<strong>to</strong>cols (as shown in Figures 4 and 5<br />
under “Results”) (Speicher et al., 1993).<br />
Both sequence independent amplification<br />
(“SIA”) (Bohlander et al., 1992) and<br />
“DOP-PCR” (degenerate oligonucleotide<br />
primer PCR) (Telenius et al., 1992) can be<br />
combined with CGH.<br />
As is shown in Figure 2, the DOP primer<br />
contains a central cassette of 6 degenerated<br />
nucleotides and is flanked by specific<br />
sequences at the 3' end (6 nucleotides) and<br />
at the 5' end (10 nucleotides). The amplification<br />
procedure is divided in<strong>to</strong> two steps.<br />
During the first step, five PCR cycles are<br />
performed at low stringency conditions<br />
(annealing temperature, Ta = 30°C). These<br />
conditions allow a frequent annealing of<br />
the DOP primer, which is primarily<br />
mediated by the short specific sequence at<br />
its 3' end and by the adjacent central cassette<br />
of degenerated nucleotides. Eventually a<br />
pool of many different DNA sequences is<br />
generated which should represent a statistically<br />
distributed subpopulation of the<br />
genomic DNA. During the second step (35<br />
cycles) the annealing temperature is raised<br />
<strong>to</strong> 62°C, allowing amplification only after<br />
specific base pairing of the full length primer<br />
sequence. Therefore, all the sequences<br />
that have been synthesized in the first step<br />
are now exponentially amplified, resulting<br />
in a large amount of DNA that can be used<br />
as probe for CGH.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Pro<strong>to</strong>cols for DOP-PCR and CGH analysis<br />
are described below. Amplified sequences<br />
can be detected directly by visual inspection<br />
using an epifluorescence microscope<br />
(“Results” Figures 3 and 4). However, the<br />
comprehensive analysis of gains and losses<br />
of single chromosomes (or parts thereof)<br />
requires digital image analysis with sophisticated<br />
software programs. For further<br />
description of the evaluation of CGH<br />
experiments as well as the different steps of<br />
the CGH pro<strong>to</strong>col, see the literature (Du<br />
Manoir et al., 1995; Kallioniemi et al., 1994;<br />
Lichter et al., 1994; Lundsteen et al., 1995;<br />
Piper et al., 1995).<br />
I. Preparation and labeling of<br />
DOP-PCR products<br />
1 Prepare a DNA template by isolating<br />
genomic DNA from small amounts of<br />
tissue (Maniatis, Fritsch, and Sambrook,<br />
1986). One mg of tissue results in about<br />
1 µg of genomic DNA.<br />
Note: See the literature (Kawasaki, 1990;<br />
Speicher et al., 1993) for pro<strong>to</strong>cols on<br />
DNA isolation from smaller amounts of<br />
tissue (down <strong>to</strong> only a few hundred cells)<br />
or from paraffin-embedded material.<br />
2 For each reaction, mix the following<br />
components in a PCR reaction tube on<br />
ice:<br />
5.0 µl 10 x concentrated DOP-PCR<br />
buffer (20 mM MgCl2; 500 mM KCl;<br />
100 mM Tris-HCl, pH 8.4; 1 mg/ml<br />
gelatin).<br />
5.0 µl 10 x concentrated nucleotide<br />
mix (dATP, dCTP, dGTP, dTTP,<br />
2 mM each).<br />
1–10 µl genomic DNA (0.1–1 ng/µl).<br />
5.0 µl 10 x concentrated DOP-PCR<br />
primer [5'-CCGACTCGAGNNNN<br />
NNATGTGG-3'(N=A,C,G, or T),<br />
20 µM].<br />
enough sterile water <strong>to</strong> make a final<br />
reaction volume of 50 µl.<br />
0.25 µlTaq DNA Polymerase (5 units/<br />
µl) (should be added last).<br />
3 Prepare a negative control by combining<br />
the same solutions as in Step 2, but<br />
omitting the template DNA.<br />
4 Overlay reaction mixtures with 50 µl<br />
mineral oil.<br />
CONTENTS<br />
INDEX<br />
1.<br />
5´<br />
DOP-PCR<br />
Telenius et al., 1992<br />
CCGACTCGAG NNNNNN ATGTGG 3´<br />
Low stringency PCR (Ta = 30°C; 5 cycles)<br />
➝ frequent priming at multiple sites<br />
5´<br />
3´<br />
5 Transfer the reaction tubes <strong>to</strong> a thermocycler<br />
and start the PCR. Use the following<br />
thermal profile:<br />
<strong>In</strong>itial denaturation: 10 min at 94°C.<br />
5 Cycles, each consisting of:<br />
1 min denaturation at 94°C<br />
1.5 min annealing (low stringency) at<br />
30°C<br />
3 min temperature ramping, from<br />
30°C <strong>to</strong> 72°C<br />
3 min elongation at 72°C.<br />
35 Cycles, each consisting of:<br />
1 min denaturation at 94°C<br />
1 min annealing (high stringency) at<br />
62°C<br />
3 min elongation at 72°C, with the<br />
elongation time increased by 1 second<br />
every cycle [i.e., the 1st high stringency<br />
cycle has an elongation time of 3 min;<br />
the 2nd, 3 min and 1 s; the 3rd, 3 min<br />
and 2 s, etc.]<br />
Final elongation: 10 min at 72°C.<br />
3´<br />
5´<br />
Higher stringency PCR (Ta = 62°C; 35 cycles)<br />
2. ➝ specific priming of pre-amplified sequences<br />
Figure 2:<br />
Schematic<br />
illustration of<br />
DOP-PCR.<br />
For explanation,<br />
see text.<br />
73<br />
5
5<br />
74<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
6 Analyze aliquots of the reaction mixtures<br />
on an agarose gel by performing<br />
the following steps:<br />
Mix the aliquots with gel loading<br />
buffer (0.25% bromophenol blue and<br />
30% glycerol).<br />
Load samples on a minigel. As a size<br />
marker use a 1 kb ladder or other<br />
suitable size standard.<br />
Run the gel in 1x TBE buffer (89 mM<br />
Tris base, 89 mM boric acid, 2 mM<br />
EDTA; pH 8.0) for 30 min at 100<br />
volts.<br />
7 Stain the gel with ethidium bromide and<br />
pho<strong>to</strong>graph. <strong>In</strong> the reaction samples, you<br />
should see a smear of DNA, ranging in<br />
size from about 200 bp <strong>to</strong> 2000 bp. No<br />
smear should be visible in the negative<br />
control.<br />
8 Collect the amplified DNA products<br />
from the reaction mix by using the High<br />
Pure PCR Product Purification Kit, see<br />
page 50.<br />
9 Label the amplified DNA by standard<br />
nick translation procedures (Lichter and<br />
Cremer; Lichter et al., 1994).<br />
II. Comparative genomic<br />
hybridization (CGH)<br />
1 Prepare slides of normal metaphase<br />
chromosomes as described in the<br />
literature (Lichter and Cremer; Lichter<br />
et al., 1990).<br />
2 Prepare the following solutions:<br />
3 M sodium acetate, pH 5.2.<br />
Deionized formamide (molecular<br />
biology grade): For deionization, use<br />
ion exchange resin. The conductivity<br />
of the formamide should be below<br />
100 µSiemens.<br />
<strong>Hybridization</strong> buffer (4 x SSC, 20%<br />
dextran sulfate): Prepare 20 x SSC.<br />
Carefully dissolve dextran sulfate in<br />
water <strong>to</strong> make a 50% dextran sulfate<br />
solution. Au<strong>to</strong>clave the dextran sulfate<br />
solution or filter it through a<br />
nitrocellulose filter. Mix 200 µl of<br />
20 x SSC, 400 µl of 50% dextran sulfate<br />
and 400 µl of double-distilled<br />
water. S<strong>to</strong>re the hybridization buffer<br />
at 4°C until you use it.<br />
3 To prepare probe DNA, combine 1 µg<br />
of each labeled test and control DNA<br />
with 50–100 µg of human Cot-1 DNA.<br />
4 Co-precipitate the probe DNAs in each<br />
tube by adding 1/20 volume of 3 M<br />
sodium acetate and 2.5 volumes of<br />
100% ethanol. Mix well and incubate at<br />
–70°C for 30 min.<br />
5 Spin the precipitated DNA in a<br />
microcentrifuge at 12,000 rpm for 10<br />
min at 4°C. Discard the supernatant and<br />
wash the pellet with 500 µl of 70%<br />
ethanol.<br />
6 Spin the precipitated DNA again (12,000<br />
rpm, 10 min, 4°C). Discard the<br />
supernatant and lyophilize the pellet.<br />
7 Add 6 µl deionized formamide <strong>to</strong> the<br />
lyophilizate and resuspend the probe<br />
DNA by vigorously shaking the tube<br />
for > 30 min at room temperature.<br />
8 Add 6 µl of hybridization buffer <strong>to</strong> the<br />
tube containing probe DNA and again<br />
shake for > 30 min.<br />
9 Denature and dehydrate normal metaphase<br />
chromosomal DNA on slides as<br />
described in the literature (Lichter and<br />
Cremer; Lichter et al., 1990).<br />
10 Prepare the probe (from Step 8) for<br />
hybridization by performing the<br />
following steps:<br />
Denature probe DNA at 75°C for<br />
5 min.<br />
Preanneal repetitive sequences by<br />
incubating the probe at 37°C for<br />
20–30 min.<br />
11 Add prepared probe (from Step 10) <strong>to</strong><br />
denatured chromosomal spreads (from<br />
Step 9). Proceed with in situ hybridization<br />
and probe detection as described<br />
in the literature (Lichter and Cremer;<br />
Lichter et al., 1990).<br />
12 Evaluate the CGH experiment with an<br />
epifluorescence microscope.<br />
Results<br />
The CGH procedure was used <strong>to</strong> reveal<br />
chromosomal imbalances (Figure 3) in a<br />
T-cell prolymphocytic leukemia (T-PLL).<br />
Chromosomal regions 6q, 8p, and 11qter<br />
are stained more weakly in the tumor<br />
DNA than in the control DNA, indicating<br />
deletions of all or part of the chromosomal<br />
arms in the tumor DNA. CGH also<br />
identified overrepresented chromosomal<br />
regions (6p, 8q, and 14q) which stain more<br />
heavily in the tumor than in the control.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
The DOP-PCR and CGH procedures<br />
described in this article were used <strong>to</strong> detect<br />
amplified sequences in genomic DNA from<br />
spinal fluid of patients who have a tumor of<br />
the central nervous system (Figure 4).<br />
DOP-PCR and CGH also revealed an<br />
amplification of the c-myc oncogene<br />
(which maps <strong>to</strong> chromosomal band 8q24)<br />
in cell line HL60 (Figure 5).<br />
CONTENTS<br />
<br />
INDEX<br />
<br />
<br />
<br />
Figure 3: Comparative genomic<br />
hybridization (CGH) experiment<br />
revealing chromosomal imbalances<br />
in a T-cell prolymphocytic<br />
leukemia (T-PLL).<br />
DNA from tumor cells was labeled<br />
with biotin and detected via a FITClabeled<br />
antibody (green) whereas<br />
the control DNA was labeled with<br />
digoxigenin and detected via a<br />
rhodamine-labeled antibody (red).<br />
For explanation, see the text.<br />
This pho<strong>to</strong>graph was taken by<br />
S. Joos and P. Lichter with<br />
permission of Springer Verlag,<br />
Heidelberg and New York.<br />
<br />
Figure 4: Detection of amplified<br />
sequences in the genomic DNA of<br />
patients with a central nervous<br />
system (CNS) tumor.<br />
Genomic DNA was isolated from a<br />
small number of cells harvested<br />
from the spinal fluid of the patients.<br />
The DNA was amplified by DOP-PCR<br />
and analyzed by CGH as described<br />
in the text. CGH reveals a strong<br />
amplification signal on both homologues<br />
of chromosome 8q (arrows).<br />
The image was pho<strong>to</strong>graphed<br />
directly using a conventional camera<br />
on an epifluorescence microscope.<br />
<br />
Figure 5: Detection of amplified<br />
c-myc oncogene sequences in<br />
cell line HL60.<br />
Genomic DNA (equivalent <strong>to</strong> the<br />
DNA from only 3– 4 HL60 cells) was<br />
diluted in TE buffer, amplified by<br />
DOP-PCR, and analyzed by CGH as<br />
described in the text. After CGH, the<br />
amplification signal is clearly visible<br />
on both chromosome 8 homologues<br />
(arrows). The image was captured<br />
as a gray scale image using a CCD<br />
camera (Pho<strong>to</strong>metrix), pseudocolored,<br />
and pho<strong>to</strong>graphed directly<br />
from the computer screen.<br />
75<br />
5
5<br />
**This product or the use of this<br />
product may be covered by one<br />
or more patents of Boehringer<br />
Mannheim GmbH, including the<br />
following: EP patent 0 649 909<br />
(application pending).<br />
**This product is sold under<br />
licensing arrangements with<br />
Roche Molecular Systems and<br />
The Perkin-Elmer Corporation.<br />
Purchase of this product is accompanied<br />
by a license <strong>to</strong> use it in the<br />
Polymerase Chain Reaction (PCR)<br />
process in conjunction with an<br />
Authorized Thermal Cycler. For<br />
complete license disclaimer, see<br />
inside back cover page + .<br />
76<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Reagents available from Boehringer Mannheim for these procedures<br />
Product Description Cat. No.<br />
DOP-PCR Master* , ** for 25 amplification reactions and 5 control reactions 1 644 963<br />
The DOP-PCR Master contains:<br />
Reagent Description Available as<br />
DOP-PCR mix, 25 units Taq DNA Polymerase/500 µl; 3 mM MgCl2; Three vials No. 1,<br />
2 x concentrated dATP, dGTP, dCTP, dTTP, 0.4 mM each; 100 mM KCl;<br />
20 mM Tris-HCl; 0.01% (v/v) Brij<br />
3 x 500 µl<br />
® 35; pH 8.3 (20°C)<br />
DOP-PCR primer (Sequence, 40 µM in double distilled H2O One vial No. 2,<br />
5'-CCG ACT CGA GNN NNN 150 µl<br />
NAT GTG G-3' (N = A, G, C,<br />
or T, in approximately<br />
equal proportions)<br />
Double distilled H2O, Two vials No. 3, 2 x 1000 µl<br />
PCR grade<br />
Control DNA Human genomic DNA from the lymphoblas<strong>to</strong>id One vial No. 4,<br />
cell line BJA, 1 ng/µl, in double distilled H2O 50 µl<br />
Other reagents:<br />
Reagent Description Cat. No. Pack size<br />
DIG-Nick Translation 5 x conc. stabilized reaction buffer in 50% 1745 816 160 µl<br />
Mix* for in situ probes glycerol (v/v) and DNA Polymerase I, DNase I,<br />
0.25 mM dATP, 0.25 mM dCTP, 0.25 mM dGTP,<br />
0.17 mM dTTP and 0.08 mM DIG-11-dUTP.<br />
Biotin-Nick Translation 5 x conc. stabilized reaction buffer in 50% 1745 824 160 µl<br />
Mix* for in situ probes glycerol (v/v) and DNA Polymerase I, DNase I,<br />
0.25 mM dATP, 0.25 mM dCTP, 0.25 mM dGTP<br />
0.17 mM dTTP and 0.08 mM biotin-16-dUTP.<br />
Streptavidin-Fluorescein 1 428 578 1 mg<br />
Anti-Digoxigenin-Rhodamine 1 207 750 200 µg<br />
Product Description Cat. No.<br />
High Pure PCR Product Kit for 50 purifications 1732 668<br />
Purification Kit** Kit for 250 purifications 1732 676<br />
The High Pure PCR Product Purification Kit contains:<br />
Reagent Description Available as<br />
• Binding buffer, • nucleic acids binding buffer; 3 M guanidine-thiocyanate, • Vial 1<br />
green cap 10 mM Tris-HCl, 5% (v/v) ethanol, pH 6.6 (25°C)<br />
• Wash buffer, • wash buffer; add 4 volumes of absolute ethanol • Vial 2<br />
blue cap before use! Final concentrations; 20 mM NaCl,<br />
2 mM Tris-HCl, pH 7.5 (25°C), 80% ethanol<br />
• Elution buffer • elution buffer; 10 mM Tris-HCl, 1 mM EDTA,<br />
pH 8.5 (25°C)<br />
• Vial 3<br />
• High Pure filter tubes • Polypropylene tubes, containing two layers of a<br />
specially pre-treated glass fibre fleece; maximum<br />
sample volume: 700 µl<br />
• Collection tubes • 2 ml polypropylene tubes<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Troubleshooting CGH experiments<br />
Control <strong>to</strong> detect CGH of<br />
insufficient quality<br />
<strong>Hybridization</strong> of a DOP-PCR probe <strong>to</strong><br />
normal human male metaphase chromosomes<br />
should show a markedly weaker<br />
staining of the X chromosome than of<br />
other chromosomes. If there is not a<br />
marked difference between the X chromosome<br />
and other chromosomes, the control<br />
indicates a defective or poor quality CGH<br />
experiment.<br />
Usually these poor hybridization results<br />
are accompanied by other hallmarks of poor<br />
quality, like a speckled, non-homogeneous<br />
staining pattern or high background fluorescence,<br />
both of which may considerably<br />
disturb the quantitative image analysis by<br />
causing high variability within the ratio<br />
profiles.<br />
Such poor hybridization results can be due<br />
<strong>to</strong> many causes. Several are listed below.<br />
Potential problems with chromosomal<br />
preparations<br />
<strong>In</strong> our experience, the most important<br />
fac<strong>to</strong>r for good hybridization experiments<br />
is the careful preparation of metaphase<br />
spreads. Therefore, every new batch of<br />
chromosomes needs <strong>to</strong> be tested. If good<br />
hybridization results are not obtained,<br />
discard the whole batch and start a new<br />
slide preparation procedure.<br />
Note: Although impaired hybridization is<br />
mainly due <strong>to</strong> residual cell debris on the<br />
slides, proteolytic digestion of the chromosomes<br />
will not lead <strong>to</strong> high quality CGH<br />
experiments. Although proteolytic digestion<br />
will improve the hybridization pattern on<br />
suboptimal slides, the results are considerably<br />
worse than those obtained on<br />
optimum slides which have not been<br />
pretreated with protease.<br />
Potential problems with probes<br />
Two important causes for granular and<br />
non-homogeneous staining patterns are:<br />
Probe DNA preparations may be contaminated<br />
with high amounts of protein.<br />
The size of the labeled probe fragments<br />
after nick translation may be inappropriate.<br />
Fragments which are <strong>to</strong>o large<br />
CONTENTS<br />
INDEX<br />
typically result in a starry background<br />
outside of the chromosomes. <strong>In</strong> contrast,<br />
probes which are <strong>to</strong>o small produce a<br />
homogeneous background distributed over<br />
all chromosomes. Smaller probes may also<br />
lead <strong>to</strong> a homogeneously strong staining<br />
pattern in regions which are over- or<br />
under-represented in the tumor genome.<br />
Problems which may hinder<br />
evaluation of CGH<br />
<strong>In</strong> contrast <strong>to</strong> conventional FISH experiments,<br />
strong fluorescence on the chromosomes<br />
and little or no fluorescence in the<br />
areas where no chromosomes or nuclei are<br />
located, are no guarantee that a hybridization<br />
experiment will be useful for a CGH<br />
analysis. Even in cases where a bright and<br />
smooth staining is observed, other fac<strong>to</strong>rs<br />
can severely impair evaluation of the<br />
hybridization experiment. Such impairment<br />
has two principal causes:<br />
<strong>In</strong>sufficient suppression of repetitive<br />
sequences may lead <strong>to</strong> incorrect measurements<br />
of ratios in chromosomal regions<br />
which contain many highly variable<br />
repetitive sequences, e.g., sequences on<br />
chromosome 19. Strong staining of the<br />
heterochromatin blocks on chromosomes<br />
1, 9, 16, and 19 can serve as an<br />
indica<strong>to</strong>r for poor suppression.<br />
Note: Good suppression will lead <strong>to</strong> very<br />
low FITC and rhodamine fluorescence<br />
intensities in the heterochromatic<br />
chromosome regions. Consequently, even<br />
very small variations of fluorescence<br />
intensities may cause gross ratio variations<br />
within these chromosomal regions.<br />
Thus, they are excluded from evaluation.<br />
Remedy: Either increase the amount of<br />
the Cot-1 DNA fraction or use longer<br />
preannealing times (the latter being less<br />
effective) <strong>to</strong> achieve adequate suppression<br />
of signals in such regions of the<br />
genome.<br />
Non-homogeneous illumination of the<br />
optical field leads <strong>to</strong> considerable regional<br />
variations within the ratio image.<br />
Such variations make a quantitative evaluation<br />
of the CGH experiment completely<br />
impossible.<br />
Remedy: Center the light source of the<br />
microscope carefully.<br />
77<br />
5
5<br />
78<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Problems inherent in sample composition<br />
Apart from the experimental fac<strong>to</strong>rs listed<br />
above, the validity of a CGH experiment<br />
critically depends on the percentage of cells<br />
carrying chromosomal imbalances. If no<br />
gains or losses of chromosomes are<br />
detected, the sample may contain only a<br />
low proportion of tumor cells. Therefore,<br />
adequate information from the his<strong>to</strong>logical<br />
labora<strong>to</strong>ry is crucial for any type of CGH<br />
analysis.<br />
References<br />
Bohlander, S. K.; Espinosa, R.; Le Beau, M. M.;<br />
Rowley, J. D.; Diaz, M. O. (1992) A method for the<br />
rapid sequence-independent amplification of<br />
microdissected chromosomal material. Genomics<br />
13, 1322–1324.<br />
Du Manoir, S.; Schröck, E.; Bentz, M.; Speicher,<br />
M. R.; Joos, S.; Ried, T.; Lichter, P.; Cremer, T. (1995)<br />
Quantitative analysis of comparative genomic<br />
hybridization. Cy<strong>to</strong>metry 19, 27–41.<br />
Du Manoir, S.; Speicher, M. R.; Joos, S.; Schröck,<br />
E.; Popp, S.; Döhner, H.; Kovacs, G.; Robert-Nicoud,<br />
M.; Lichter, P.; Cremer, T. (1993) Detection of<br />
complete and partial chromosome gains and losses<br />
by comparative genomic in situ hybridization.<br />
Hum. Genet. 90, 590–610.<br />
Joos, S.; Scherthan, H.; Speicher, M. R.; Schlegel, J.;<br />
Cremer, T.; Lichter, P. (1993) Detection of amplified<br />
genomic sequences by reverse chromosome<br />
painting using genomic tumor DNA as probe.<br />
Hum. Genet. 90, 584–589.<br />
Kallioniemi, A.; Kallioniemi, O.-P.; Sudar, D.;<br />
Ru<strong>to</strong>vitz, D.; Gray, J. W.; Waldman, F.; Pinkel, D.<br />
(1992) Comparative genomic hybridization for<br />
molecular cy<strong>to</strong>genetic analysis of solid tumors.<br />
Science 258, 818–821.<br />
Kallioniemi, O-P.; Kallioniemi, A; Piper, J.; Isola, J.;<br />
Waldman, F.; Gray, J. W.; Pinkel, D. (1994)<br />
Optimizing comparative genomic hybridization for<br />
analysis of DNA sequence copy number changes in<br />
solid tumors. Genes, Chromosomes and Cancer 10,<br />
231–243.<br />
Kallioniemi, O.-P.; Kallioniemi, A.; Sudar, D.;<br />
Ru<strong>to</strong>vitz, D.; Gray, J. W.; Waldman, F.; Pinkel, D.<br />
(1993) Comparative genomic hybridization: a rapid<br />
new method for detecting and mapping DNA<br />
amplification in tumors. Seminars in Cancer Biology<br />
4, 41–46.<br />
Kawasaki, E. S. (1990) Sample preparation from<br />
blood, cells, and other fluids. <strong>In</strong>: <strong>In</strong>nis, M. A.;<br />
Gelfand, D. H.; Sninsky, J. J.; White, T. J. (eds)<br />
PCR Pro<strong>to</strong>cols: A Guide <strong>to</strong> Methods and Applications.<br />
San Diego, CA: Academic Press, 146–152.<br />
Lichter, P.; Bentz, M.; du Manoir, S.; Joos, S. (1994)<br />
Comparative genomic hybridization. <strong>In</strong>: Verma, R;<br />
Babu S. (eds) Human Chromosomes. New York:<br />
McGraw Hill, 191–210.<br />
Lichter, P.; Cremer, T. Chromosome analysis by<br />
non-iso<strong>to</strong>pic in situ hybridization. <strong>In</strong>: Human<br />
Cy<strong>to</strong>genetics: Constitutional Analysis. IRL Press.<br />
Lichter, P.; Tang, C. C.; Call, K.; Hermanson, G.;<br />
Evans, G. A.; Housman, D.; Ward, D. C. (1990) High<br />
resolution mapping of human chromosome 11 by in<br />
situ hybridization with cosmid clones. Science 247,<br />
64–69.<br />
Lundsteen, C.; Maahr, J.; Christensen, B.; Bryndorf,<br />
T.; Bentz, M.; Lichter, P.; Gerdes, T. (1995) Image<br />
analysis in comparative genomic hybridization.<br />
Cy<strong>to</strong>metry 19, 42–50.<br />
Maniatis, T.; Fritsch, E. F.; Sambrook, J. (1986)<br />
Molecular Cloning: A Labora<strong>to</strong>ry Manual. Cold<br />
Spring Harbor, New York: Cold Spring Harbor<br />
Labora<strong>to</strong>ry Press.<br />
Piper, J.; Ru<strong>to</strong>vitz, D.; Sudar, D.; Kallioniemi, A.;<br />
Kallioniemi, O.-P.; Waldmann, F. M.; Gray, J. W.;<br />
Pinkel, D. (1995) Computer image analysis of<br />
comparative genomic hybridization. Cy<strong>to</strong>metry 19,<br />
10–26.<br />
Speicher, M. R.; du Manoir, S.; Schröck, E.; Holtgreve-<br />
Grez, H.; Schoell, B.; Lengauer, C.; Cremer, T.; Ried,<br />
T. (1993) Molecular cy<strong>to</strong>genetic analysis of<br />
formalin-fixed, paraffin-embedded solid tumors by<br />
comparative genomic hybridization after universal<br />
DNA amplification. Hum. Mol. Genet. 2, 1907–1914.<br />
Telenius, H.; Pelmear, A. H.; Tunnacliffe, A.; Carter,<br />
N. P.; Behmel, A.; Ferguson-Smith, M. A.;<br />
Nordenskjöld, M.; Pfragner, R. (1992) Ponder BAJP:<br />
Cy<strong>to</strong>genetic analysis by chromosome painting using<br />
DOP-PCR amplified flow-sorted chromosomes.<br />
Genes, Chromosomes and Cancer 4, 257–263.<br />
CONTENTS<br />
INDEX
5<br />
72<br />
<strong>to</strong>tal genomic DNA from cells <strong>to</strong> analyze<br />
(test DNA) labeled with biotin<br />
DNA from:<br />
cells with<br />
amplified DNA<br />
or polysomies<br />
cells with<br />
deletions or<br />
monosomies<br />
Figure 1: Schematic illustration<br />
of “comparative genomic hybridization”<br />
(CGH) for chromosome<br />
analysis. For explanation, see text.<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Detection of chromosomal imbalances using DOP-<br />
PCR and comparative genomic hybridization (CGH)<br />
Stefan Joos, Barbara Schütz, Martin Bentz, and Peter Lichter,<br />
German Cancer Research Center, Heidelberg, Germany.<br />
Recently, a new approach of fluorescence in<br />
situ hybridization was introduced, called<br />
“comparative genomic hybridization”<br />
(CGH) (Kallioniemi et al., 1992), which<br />
allows the comprehensive analysis of<br />
chromosomal imbalances in entire genomes<br />
(Du Manoir et al., 1993; Joos et al., 1993;<br />
Kallioniemi et al., 1992; Kallioniemi et al.,<br />
1993). The principle of CGH is shown in<br />
Figure 1. The genomic DNA from cell<br />
populations <strong>to</strong> be tested, such as fresh or<br />
paraffin-embedded tumor tissue, is labeled<br />
with modified nucleotides (e.g., biotinylated<br />
dUTP) and used as a probe for in situ<br />
hybridization <strong>to</strong> normal metaphase chromosomes.<br />
This probe is called “test DNA”. As an<br />
co-hybridization<br />
(normal chromosomes)<br />
<strong>to</strong>tal genomic DNA from normal cells<br />
(control DNA) labeled with digoxigenin<br />
detection<br />
results in signals on normal chromosomes (partial karyotype)<br />
signals from hybridized test DNA signals from co-hybridized control DNA<br />
internal control, genomic DNA derived from<br />
cells with a normal karyotype is differentially<br />
labeled and hybridized simultaneously<br />
(“control DNA”). For detection of the<br />
hybridized test and control DNA, different<br />
fluorochromes are used, and each is<br />
visualized by epifluorescence microscopy<br />
with selective filters. <strong>Hybridization</strong> with genomic<br />
DNA results in a general staining of all<br />
chromosomes. However, if the tissue<br />
analyzed harbors additional chromosomal<br />
material (e.g., a trisomy, amplifications etc.),<br />
hybridization reveals higher signal intensities<br />
at the corresponding target regions of the<br />
hybridized chromosomes (Figure 1). Correspondingly,<br />
deletions in the test sample are<br />
visible as lower signal intensities (Figure 1).<br />
By comparing the hybridization patterns of<br />
test and control DNA, the changes in signal<br />
intensities caused by imbalances within the<br />
analyzed tissue can be identified.<br />
Thus, CGH provides a comprehensive<br />
picture of all chromosomal gains and losses<br />
within a single experiment. <strong>In</strong> contrast <strong>to</strong><br />
banding analysis, CGH requires no preparation<br />
of metaphase chromosomes from<br />
the cells <strong>to</strong> be analyzed (which in certain<br />
tumor types may be difficult or even<br />
impossible).<br />
<strong>In</strong> many cases, only small amounts of<br />
tumor tissue are available for cy<strong>to</strong>genetic<br />
analysis. Therefore it is advantageous <strong>to</strong><br />
combine CGH with universal PCR<br />
pro<strong>to</strong>cols (as shown in Figures 4 and 5<br />
under “Results”) (Speicher et al., 1993).<br />
Both sequence independent amplification<br />
(“SIA”) (Bohlander et al., 1992) and<br />
“DOP-PCR” (degenerate oligonucleotide<br />
primer PCR) (Telenius et al., 1992) can be<br />
combined with CGH.<br />
As is shown in Figure 2, the DOP primer<br />
contains a central cassette of 6 degenerated<br />
nucleotides and is flanked by specific<br />
sequences at the 3' end (6 nucleotides) and<br />
at the 5' end (10 nucleotides). The amplification<br />
procedure is divided in<strong>to</strong> two steps.<br />
During the first step, five PCR cycles are<br />
performed at low stringency conditions<br />
(annealing temperature, Ta = 30°C). These<br />
conditions allow a frequent annealing of<br />
the DOP primer, which is primarily<br />
mediated by the short specific sequence at<br />
its 3' end and by the adjacent central cassette<br />
of degenerated nucleotides. Eventually a<br />
pool of many different DNA sequences is<br />
generated which should represent a statistically<br />
distributed subpopulation of the<br />
genomic DNA. During the second step (35<br />
cycles) the annealing temperature is raised<br />
<strong>to</strong> 62°C, allowing amplification only after<br />
specific base pairing of the full length primer<br />
sequence. Therefore, all the sequences<br />
that have been synthesized in the first step<br />
are now exponentially amplified, resulting<br />
in a large amount of DNA that can be used<br />
as probe for CGH.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Pro<strong>to</strong>cols for DOP-PCR and CGH analysis<br />
are described below. Amplified sequences<br />
can be detected directly by visual inspection<br />
using an epifluorescence microscope<br />
(“Results” Figures 3 and 4). However, the<br />
comprehensive analysis of gains and losses<br />
of single chromosomes (or parts thereof)<br />
requires digital image analysis with sophisticated<br />
software programs. For further<br />
description of the evaluation of CGH<br />
experiments as well as the different steps of<br />
the CGH pro<strong>to</strong>col, see the literature (Du<br />
Manoir et al., 1995; Kallioniemi et al., 1994;<br />
Lichter et al., 1994; Lundsteen et al., 1995;<br />
Piper et al., 1995).<br />
I. Preparation and labeling of<br />
DOP-PCR products<br />
1 Prepare a DNA template by isolating<br />
genomic DNA from small amounts of<br />
tissue (Maniatis, Fritsch, and Sambrook,<br />
1986). One mg of tissue results in about<br />
1 µg of genomic DNA.<br />
Note: See the literature (Kawasaki, 1990;<br />
Speicher et al., 1993) for pro<strong>to</strong>cols on<br />
DNA isolation from smaller amounts of<br />
tissue (down <strong>to</strong> only a few hundred cells)<br />
or from paraffin-embedded material.<br />
2 For each reaction, mix the following<br />
components in a PCR reaction tube on<br />
ice:<br />
5.0 µl 10 x concentrated DOP-PCR<br />
buffer (20 mM MgCl2; 500 mM KCl;<br />
100 mM Tris-HCl, pH 8.4; 1 mg/ml<br />
gelatin).<br />
5.0 µl 10 x concentrated nucleotide<br />
mix (dATP, dCTP, dGTP, dTTP,<br />
2 mM each).<br />
1–10 µl genomic DNA (0.1–1 ng/µl).<br />
5.0 µl 10 x concentrated DOP-PCR<br />
primer [5'-CCGACTCGAGNNNN<br />
NNATGTGG-3'(N=A,C,G, or T),<br />
20 µM].<br />
enough sterile water <strong>to</strong> make a final<br />
reaction volume of 50 µl.<br />
0.25 µlTaq DNA Polymerase (5 units/<br />
µl) (should be added last).<br />
3 Prepare a negative control by combining<br />
the same solutions as in Step 2, but<br />
omitting the template DNA.<br />
4 Overlay reaction mixtures with 50 µl<br />
mineral oil.<br />
CONTENTS<br />
INDEX<br />
1.<br />
5´<br />
DOP-PCR<br />
Telenius et al., 1992<br />
CCGACTCGAG NNNNNN ATGTGG 3´<br />
Low stringency PCR (Ta = 30°C; 5 cycles)<br />
➝ frequent priming at multiple sites<br />
5´<br />
3´<br />
5 Transfer the reaction tubes <strong>to</strong> a thermocycler<br />
and start the PCR. Use the following<br />
thermal profile:<br />
<strong>In</strong>itial denaturation: 10 min at 94°C.<br />
5 Cycles, each consisting of:<br />
1 min denaturation at 94°C<br />
1.5 min annealing (low stringency) at<br />
30°C<br />
3 min temperature ramping, from<br />
30°C <strong>to</strong> 72°C<br />
3 min elongation at 72°C.<br />
35 Cycles, each consisting of:<br />
1 min denaturation at 94°C<br />
1 min annealing (high stringency) at<br />
62°C<br />
3 min elongation at 72°C, with the<br />
elongation time increased by 1 second<br />
every cycle [i.e., the 1st high stringency<br />
cycle has an elongation time of 3 min;<br />
the 2nd, 3 min and 1 s; the 3rd, 3 min<br />
and 2 s, etc.]<br />
Final elongation: 10 min at 72°C.<br />
3´<br />
5´<br />
Higher stringency PCR (Ta = 62°C; 35 cycles)<br />
2. ➝ specific priming of pre-amplified sequences<br />
Figure 2:<br />
Schematic<br />
illustration of<br />
DOP-PCR.<br />
For explanation,<br />
see text.<br />
73<br />
5
5<br />
74<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
6 Analyze aliquots of the reaction mixtures<br />
on an agarose gel by performing<br />
the following steps:<br />
Mix the aliquots with gel loading<br />
buffer (0.25% bromophenol blue and<br />
30% glycerol).<br />
Load samples on a minigel. As a size<br />
marker use a 1 kb ladder or other<br />
suitable size standard.<br />
Run the gel in 1x TBE buffer (89 mM<br />
Tris base, 89 mM boric acid, 2 mM<br />
EDTA; pH 8.0) for 30 min at 100<br />
volts.<br />
7 Stain the gel with ethidium bromide and<br />
pho<strong>to</strong>graph. <strong>In</strong> the reaction samples, you<br />
should see a smear of DNA, ranging in<br />
size from about 200 bp <strong>to</strong> 2000 bp. No<br />
smear should be visible in the negative<br />
control.<br />
8 Collect the amplified DNA products<br />
from the reaction mix by using the High<br />
Pure PCR Product Purification Kit, see<br />
page 50.<br />
9 Label the amplified DNA by standard<br />
nick translation procedures (Lichter and<br />
Cremer; Lichter et al., 1994).<br />
II. Comparative genomic<br />
hybridization (CGH)<br />
1 Prepare slides of normal metaphase<br />
chromosomes as described in the<br />
literature (Lichter and Cremer; Lichter<br />
et al., 1990).<br />
2 Prepare the following solutions:<br />
3 M sodium acetate, pH 5.2.<br />
Deionized formamide (molecular<br />
biology grade): For deionization, use<br />
ion exchange resin. The conductivity<br />
of the formamide should be below<br />
100 µSiemens.<br />
<strong>Hybridization</strong> buffer (4 x SSC, 20%<br />
dextran sulfate): Prepare 20 x SSC.<br />
Carefully dissolve dextran sulfate in<br />
water <strong>to</strong> make a 50% dextran sulfate<br />
solution. Au<strong>to</strong>clave the dextran sulfate<br />
solution or filter it through a<br />
nitrocellulose filter. Mix 200 µl of<br />
20 x SSC, 400 µl of 50% dextran sulfate<br />
and 400 µl of double-distilled<br />
water. S<strong>to</strong>re the hybridization buffer<br />
at 4°C until you use it.<br />
3 To prepare probe DNA, combine 1 µg<br />
of each labeled test and control DNA<br />
with 50–100 µg of human Cot-1 DNA.<br />
4 Co-precipitate the probe DNAs in each<br />
tube by adding 1/20 volume of 3 M<br />
sodium acetate and 2.5 volumes of<br />
100% ethanol. Mix well and incubate at<br />
–70°C for 30 min.<br />
5 Spin the precipitated DNA in a<br />
microcentrifuge at 12,000 rpm for 10<br />
min at 4°C. Discard the supernatant and<br />
wash the pellet with 500 µl of 70%<br />
ethanol.<br />
6 Spin the precipitated DNA again (12,000<br />
rpm, 10 min, 4°C). Discard the<br />
supernatant and lyophilize the pellet.<br />
7 Add 6 µl deionized formamide <strong>to</strong> the<br />
lyophilizate and resuspend the probe<br />
DNA by vigorously shaking the tube<br />
for > 30 min at room temperature.<br />
8 Add 6 µl of hybridization buffer <strong>to</strong> the<br />
tube containing probe DNA and again<br />
shake for > 30 min.<br />
9 Denature and dehydrate normal metaphase<br />
chromosomal DNA on slides as<br />
described in the literature (Lichter and<br />
Cremer; Lichter et al., 1990).<br />
10 Prepare the probe (from Step 8) for<br />
hybridization by performing the<br />
following steps:<br />
Denature probe DNA at 75°C for<br />
5 min.<br />
Preanneal repetitive sequences by<br />
incubating the probe at 37°C for<br />
20–30 min.<br />
11 Add prepared probe (from Step 10) <strong>to</strong><br />
denatured chromosomal spreads (from<br />
Step 9). Proceed with in situ hybridization<br />
and probe detection as described<br />
in the literature (Lichter and Cremer;<br />
Lichter et al., 1990).<br />
12 Evaluate the CGH experiment with an<br />
epifluorescence microscope.<br />
Results<br />
The CGH procedure was used <strong>to</strong> reveal<br />
chromosomal imbalances (Figure 3) in a<br />
T-cell prolymphocytic leukemia (T-PLL).<br />
Chromosomal regions 6q, 8p, and 11qter<br />
are stained more weakly in the tumor<br />
DNA than in the control DNA, indicating<br />
deletions of all or part of the chromosomal<br />
arms in the tumor DNA. CGH also<br />
identified overrepresented chromosomal<br />
regions (6p, 8q, and 14q) which stain more<br />
heavily in the tumor than in the control.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
The DOP-PCR and CGH procedures<br />
described in this article were used <strong>to</strong> detect<br />
amplified sequences in genomic DNA from<br />
spinal fluid of patients who have a tumor of<br />
the central nervous system (Figure 4).<br />
DOP-PCR and CGH also revealed an<br />
amplification of the c-myc oncogene<br />
(which maps <strong>to</strong> chromosomal band 8q24)<br />
in cell line HL60 (Figure 5).<br />
CONTENTS<br />
<br />
INDEX<br />
<br />
<br />
<br />
Figure 3: Comparative genomic<br />
hybridization (CGH) experiment<br />
revealing chromosomal imbalances<br />
in a T-cell prolymphocytic<br />
leukemia (T-PLL).<br />
DNA from tumor cells was labeled<br />
with biotin and detected via a FITClabeled<br />
antibody (green) whereas<br />
the control DNA was labeled with<br />
digoxigenin and detected via a<br />
rhodamine-labeled antibody (red).<br />
For explanation, see the text.<br />
This pho<strong>to</strong>graph was taken by<br />
S. Joos and P. Lichter with<br />
permission of Springer Verlag,<br />
Heidelberg and New York.<br />
<br />
Figure 4: Detection of amplified<br />
sequences in the genomic DNA of<br />
patients with a central nervous<br />
system (CNS) tumor.<br />
Genomic DNA was isolated from a<br />
small number of cells harvested<br />
from the spinal fluid of the patients.<br />
The DNA was amplified by DOP-PCR<br />
and analyzed by CGH as described<br />
in the text. CGH reveals a strong<br />
amplification signal on both homologues<br />
of chromosome 8q (arrows).<br />
The image was pho<strong>to</strong>graphed<br />
directly using a conventional camera<br />
on an epifluorescence microscope.<br />
<br />
Figure 5: Detection of amplified<br />
c-myc oncogene sequences in<br />
cell line HL60.<br />
Genomic DNA (equivalent <strong>to</strong> the<br />
DNA from only 3– 4 HL60 cells) was<br />
diluted in TE buffer, amplified by<br />
DOP-PCR, and analyzed by CGH as<br />
described in the text. After CGH, the<br />
amplification signal is clearly visible<br />
on both chromosome 8 homologues<br />
(arrows). The image was captured<br />
as a gray scale image using a CCD<br />
camera (Pho<strong>to</strong>metrix), pseudocolored,<br />
and pho<strong>to</strong>graphed directly<br />
from the computer screen.<br />
75<br />
5
5<br />
**This product or the use of this<br />
product may be covered by one<br />
or more patents of Boehringer<br />
Mannheim GmbH, including the<br />
following: EP patent 0 649 909<br />
(application pending).<br />
**This product is sold under<br />
licensing arrangements with<br />
Roche Molecular Systems and<br />
The Perkin-Elmer Corporation.<br />
Purchase of this product is accompanied<br />
by a license <strong>to</strong> use it in the<br />
Polymerase Chain Reaction (PCR)<br />
process in conjunction with an<br />
Authorized Thermal Cycler. For<br />
complete license disclaimer, see<br />
inside back cover page + .<br />
76<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Reagents available from Boehringer Mannheim for these procedures<br />
Product Description Cat. No.<br />
DOP-PCR Master* , ** for 25 amplification reactions and 5 control reactions 1 644 963<br />
The DOP-PCR Master contains:<br />
Reagent Description Available as<br />
DOP-PCR mix, 25 units Taq DNA Polymerase/500 µl; 3 mM MgCl2; Three vials No. 1,<br />
2 x concentrated dATP, dGTP, dCTP, dTTP, 0.4 mM each; 100 mM KCl;<br />
20 mM Tris-HCl; 0.01% (v/v) Brij<br />
3 x 500 µl<br />
® 35; pH 8.3 (20°C)<br />
DOP-PCR primer (Sequence, 40 µM in double distilled H2O One vial No. 2,<br />
5'-CCG ACT CGA GNN NNN 150 µl<br />
NAT GTG G-3' (N = A, G, C,<br />
or T, in approximately<br />
equal proportions)<br />
Double distilled H2O, Two vials No. 3, 2 x 1000 µl<br />
PCR grade<br />
Control DNA Human genomic DNA from the lymphoblas<strong>to</strong>id One vial No. 4,<br />
cell line BJA, 1 ng/µl, in double distilled H2O 50 µl<br />
Other reagents:<br />
Reagent Description Cat. No. Pack size<br />
DIG-Nick Translation 5 x conc. stabilized reaction buffer in 50% 1745 816 160 µl<br />
Mix* for in situ probes glycerol (v/v) and DNA Polymerase I, DNase I,<br />
0.25 mM dATP, 0.25 mM dCTP, 0.25 mM dGTP,<br />
0.17 mM dTTP and 0.08 mM DIG-11-dUTP.<br />
Biotin-Nick Translation 5 x conc. stabilized reaction buffer in 50% 1745 824 160 µl<br />
Mix* for in situ probes glycerol (v/v) and DNA Polymerase I, DNase I,<br />
0.25 mM dATP, 0.25 mM dCTP, 0.25 mM dGTP<br />
0.17 mM dTTP and 0.08 mM biotin-16-dUTP.<br />
Streptavidin-Fluorescein 1 428 578 1 mg<br />
Anti-Digoxigenin-Rhodamine 1 207 750 200 µg<br />
Product Description Cat. No.<br />
High Pure PCR Product Kit for 50 purifications 1732 668<br />
Purification Kit** Kit for 250 purifications 1732 676<br />
The High Pure PCR Product Purification Kit contains:<br />
Reagent Description Available as<br />
• Binding buffer, • nucleic acids binding buffer; 3 M guanidine-thiocyanate, • Vial 1<br />
green cap 10 mM Tris-HCl, 5% (v/v) ethanol, pH 6.6 (25°C)<br />
• Wash buffer, • wash buffer; add 4 volumes of absolute ethanol • Vial 2<br />
blue cap before use! Final concentrations; 20 mM NaCl,<br />
2 mM Tris-HCl, pH 7.5 (25°C), 80% ethanol<br />
• Elution buffer • elution buffer; 10 mM Tris-HCl, 1 mM EDTA,<br />
pH 8.5 (25°C)<br />
• Vial 3<br />
• High Pure filter tubes • Polypropylene tubes, containing two layers of a<br />
specially pre-treated glass fibre fleece; maximum<br />
sample volume: 700 µl<br />
• Collection tubes • 2 ml polypropylene tubes<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Troubleshooting CGH experiments<br />
Control <strong>to</strong> detect CGH of<br />
insufficient quality<br />
<strong>Hybridization</strong> of a DOP-PCR probe <strong>to</strong><br />
normal human male metaphase chromosomes<br />
should show a markedly weaker<br />
staining of the X chromosome than of<br />
other chromosomes. If there is not a<br />
marked difference between the X chromosome<br />
and other chromosomes, the control<br />
indicates a defective or poor quality CGH<br />
experiment.<br />
Usually these poor hybridization results<br />
are accompanied by other hallmarks of poor<br />
quality, like a speckled, non-homogeneous<br />
staining pattern or high background fluorescence,<br />
both of which may considerably<br />
disturb the quantitative image analysis by<br />
causing high variability within the ratio<br />
profiles.<br />
Such poor hybridization results can be due<br />
<strong>to</strong> many causes. Several are listed below.<br />
Potential problems with chromosomal<br />
preparations<br />
<strong>In</strong> our experience, the most important<br />
fac<strong>to</strong>r for good hybridization experiments<br />
is the careful preparation of metaphase<br />
spreads. Therefore, every new batch of<br />
chromosomes needs <strong>to</strong> be tested. If good<br />
hybridization results are not obtained,<br />
discard the whole batch and start a new<br />
slide preparation procedure.<br />
Note: Although impaired hybridization is<br />
mainly due <strong>to</strong> residual cell debris on the<br />
slides, proteolytic digestion of the chromosomes<br />
will not lead <strong>to</strong> high quality CGH<br />
experiments. Although proteolytic digestion<br />
will improve the hybridization pattern on<br />
suboptimal slides, the results are considerably<br />
worse than those obtained on<br />
optimum slides which have not been<br />
pretreated with protease.<br />
Potential problems with probes<br />
Two important causes for granular and<br />
non-homogeneous staining patterns are:<br />
Probe DNA preparations may be contaminated<br />
with high amounts of protein.<br />
The size of the labeled probe fragments<br />
after nick translation may be inappropriate.<br />
Fragments which are <strong>to</strong>o large<br />
CONTENTS<br />
INDEX<br />
typically result in a starry background<br />
outside of the chromosomes. <strong>In</strong> contrast,<br />
probes which are <strong>to</strong>o small produce a<br />
homogeneous background distributed over<br />
all chromosomes. Smaller probes may also<br />
lead <strong>to</strong> a homogeneously strong staining<br />
pattern in regions which are over- or<br />
under-represented in the tumor genome.<br />
Problems which may hinder<br />
evaluation of CGH<br />
<strong>In</strong> contrast <strong>to</strong> conventional FISH experiments,<br />
strong fluorescence on the chromosomes<br />
and little or no fluorescence in the<br />
areas where no chromosomes or nuclei are<br />
located, are no guarantee that a hybridization<br />
experiment will be useful for a CGH<br />
analysis. Even in cases where a bright and<br />
smooth staining is observed, other fac<strong>to</strong>rs<br />
can severely impair evaluation of the<br />
hybridization experiment. Such impairment<br />
has two principal causes:<br />
<strong>In</strong>sufficient suppression of repetitive<br />
sequences may lead <strong>to</strong> incorrect measurements<br />
of ratios in chromosomal regions<br />
which contain many highly variable<br />
repetitive sequences, e.g., sequences on<br />
chromosome 19. Strong staining of the<br />
heterochromatin blocks on chromosomes<br />
1, 9, 16, and 19 can serve as an<br />
indica<strong>to</strong>r for poor suppression.<br />
Note: Good suppression will lead <strong>to</strong> very<br />
low FITC and rhodamine fluorescence<br />
intensities in the heterochromatic<br />
chromosome regions. Consequently, even<br />
very small variations of fluorescence<br />
intensities may cause gross ratio variations<br />
within these chromosomal regions.<br />
Thus, they are excluded from evaluation.<br />
Remedy: Either increase the amount of<br />
the Cot-1 DNA fraction or use longer<br />
preannealing times (the latter being less<br />
effective) <strong>to</strong> achieve adequate suppression<br />
of signals in such regions of the<br />
genome.<br />
Non-homogeneous illumination of the<br />
optical field leads <strong>to</strong> considerable regional<br />
variations within the ratio image.<br />
Such variations make a quantitative evaluation<br />
of the CGH experiment completely<br />
impossible.<br />
Remedy: Center the light source of the<br />
microscope carefully.<br />
77<br />
5
5<br />
78<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Problems inherent in sample composition<br />
Apart from the experimental fac<strong>to</strong>rs listed<br />
above, the validity of a CGH experiment<br />
critically depends on the percentage of cells<br />
carrying chromosomal imbalances. If no<br />
gains or losses of chromosomes are<br />
detected, the sample may contain only a<br />
low proportion of tumor cells. Therefore,<br />
adequate information from the his<strong>to</strong>logical<br />
labora<strong>to</strong>ry is crucial for any type of CGH<br />
analysis.<br />
References<br />
Bohlander, S. K.; Espinosa, R.; Le Beau, M. M.;<br />
Rowley, J. D.; Diaz, M. O. (1992) A method for the<br />
rapid sequence-independent amplification of<br />
microdissected chromosomal material. Genomics<br />
13, 1322–1324.<br />
Du Manoir, S.; Schröck, E.; Bentz, M.; Speicher,<br />
M. R.; Joos, S.; Ried, T.; Lichter, P.; Cremer, T. (1995)<br />
Quantitative analysis of comparative genomic<br />
hybridization. Cy<strong>to</strong>metry 19, 27–41.<br />
Du Manoir, S.; Speicher, M. R.; Joos, S.; Schröck,<br />
E.; Popp, S.; Döhner, H.; Kovacs, G.; Robert-Nicoud,<br />
M.; Lichter, P.; Cremer, T. (1993) Detection of<br />
complete and partial chromosome gains and losses<br />
by comparative genomic in situ hybridization.<br />
Hum. Genet. 90, 590–610.<br />
Joos, S.; Scherthan, H.; Speicher, M. R.; Schlegel, J.;<br />
Cremer, T.; Lichter, P. (1993) Detection of amplified<br />
genomic sequences by reverse chromosome<br />
painting using genomic tumor DNA as probe.<br />
Hum. Genet. 90, 584–589.<br />
Kallioniemi, A.; Kallioniemi, O.-P.; Sudar, D.;<br />
Ru<strong>to</strong>vitz, D.; Gray, J. W.; Waldman, F.; Pinkel, D.<br />
(1992) Comparative genomic hybridization for<br />
molecular cy<strong>to</strong>genetic analysis of solid tumors.<br />
Science 258, 818–821.<br />
Kallioniemi, O-P.; Kallioniemi, A; Piper, J.; Isola, J.;<br />
Waldman, F.; Gray, J. W.; Pinkel, D. (1994)<br />
Optimizing comparative genomic hybridization for<br />
analysis of DNA sequence copy number changes in<br />
solid tumors. Genes, Chromosomes and Cancer 10,<br />
231–243.<br />
Kallioniemi, O.-P.; Kallioniemi, A.; Sudar, D.;<br />
Ru<strong>to</strong>vitz, D.; Gray, J. W.; Waldman, F.; Pinkel, D.<br />
(1993) Comparative genomic hybridization: a rapid<br />
new method for detecting and mapping DNA<br />
amplification in tumors. Seminars in Cancer Biology<br />
4, 41–46.<br />
Kawasaki, E. S. (1990) Sample preparation from<br />
blood, cells, and other fluids. <strong>In</strong>: <strong>In</strong>nis, M. A.;<br />
Gelfand, D. H.; Sninsky, J. J.; White, T. J. (eds)<br />
PCR Pro<strong>to</strong>cols: A Guide <strong>to</strong> Methods and Applications.<br />
San Diego, CA: Academic Press, 146–152.<br />
Lichter, P.; Bentz, M.; du Manoir, S.; Joos, S. (1994)<br />
Comparative genomic hybridization. <strong>In</strong>: Verma, R;<br />
Babu S. (eds) Human Chromosomes. New York:<br />
McGraw Hill, 191–210.<br />
Lichter, P.; Cremer, T. Chromosome analysis by<br />
non-iso<strong>to</strong>pic in situ hybridization. <strong>In</strong>: Human<br />
Cy<strong>to</strong>genetics: Constitutional Analysis. IRL Press.<br />
Lichter, P.; Tang, C. C.; Call, K.; Hermanson, G.;<br />
Evans, G. A.; Housman, D.; Ward, D. C. (1990) High<br />
resolution mapping of human chromosome 11 by in<br />
situ hybridization with cosmid clones. Science 247,<br />
64–69.<br />
Lundsteen, C.; Maahr, J.; Christensen, B.; Bryndorf,<br />
T.; Bentz, M.; Lichter, P.; Gerdes, T. (1995) Image<br />
analysis in comparative genomic hybridization.<br />
Cy<strong>to</strong>metry 19, 42–50.<br />
Maniatis, T.; Fritsch, E. F.; Sambrook, J. (1986)<br />
Molecular Cloning: A Labora<strong>to</strong>ry Manual. Cold<br />
Spring Harbor, New York: Cold Spring Harbor<br />
Labora<strong>to</strong>ry Press.<br />
Piper, J.; Ru<strong>to</strong>vitz, D.; Sudar, D.; Kallioniemi, A.;<br />
Kallioniemi, O.-P.; Waldmann, F. M.; Gray, J. W.;<br />
Pinkel, D. (1995) Computer image analysis of<br />
comparative genomic hybridization. Cy<strong>to</strong>metry 19,<br />
10–26.<br />
Speicher, M. R.; du Manoir, S.; Schröck, E.; Holtgreve-<br />
Grez, H.; Schoell, B.; Lengauer, C.; Cremer, T.; Ried,<br />
T. (1993) Molecular cy<strong>to</strong>genetic analysis of<br />
formalin-fixed, paraffin-embedded solid tumors by<br />
comparative genomic hybridization after universal<br />
DNA amplification. Hum. Mol. Genet. 2, 1907–1914.<br />
Telenius, H.; Pelmear, A. H.; Tunnacliffe, A.; Carter,<br />
N. P.; Behmel, A.; Ferguson-Smith, M. A.;<br />
Nordenskjöld, M.; Pfragner, R. (1992) Ponder BAJP:<br />
Cy<strong>to</strong>genetic analysis by chromosome painting using<br />
DOP-PCR amplified flow-sorted chromosomes.<br />
Genes, Chromosomes and Cancer 4, 257–263.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Identification of chromosomes in metaphase spreads<br />
and interphase nuclei with PRINS oligonucleotide<br />
primers and DIG- or rhodamine-labeled nucleotides<br />
Dr. R. Seibl, Research Labora<strong>to</strong>ries, Boehringer Mannheim GmbH, Penzberg, Germany.<br />
PRimed IN <strong>Situ</strong> Labeling (PRINS) is a fast<br />
alternative <strong>to</strong> traditional in situ hybridization<br />
(Koch et al., 1989). PRINS starts<br />
with in situ hybridization (annealing) of an<br />
unlabeled synthetic oligonucleotide (e.g.,<br />
one of the PRINS oligonucleotide primers<br />
in Table 1) <strong>to</strong> denatured chromosomes in<br />
metaphase spreads or interphase nuclei on<br />
microscope slides. Then, the hybridized<br />
oligonucleotide serves as primer which a<br />
thermostable DNA polymerase (Gosden<br />
et al., 1991) elongates in situ. During the<br />
primer elongation reaction, the polymerase<br />
incorporates nonradioactively labeled<br />
nucleotides in<strong>to</strong> the newly synthesized<br />
DNA (Gosden and Hanratty, 1993).<br />
Depending on the label, the newly synthesized<br />
DNA may be detected by one of two<br />
methods:<br />
<strong>In</strong>direct detection using the DIG PRINS<br />
Reaction Set or direct detection using the<br />
Rhodamine PRINS Reaction Set.<br />
<strong>In</strong>direct detection uses a fluorochromeconjugated<br />
anti-DIG antibody (for<br />
example, Anti-Digoxigenin-Fluorescein<br />
from the DIG PRINS Reaction Set) <strong>to</strong><br />
locate digoxigenin-(DIG-)labeled DNA.<br />
For indirect detection, we offer the DIG<br />
PRINS Reaction Set, which combines<br />
the high sensitivity of digoxigenin labeling<br />
with the power of the PRINS<br />
reaction. <strong>In</strong> the Digoxigenin PRINS<br />
Reaction Set the sensitivity of the<br />
PRINS reaction can be optimized by<br />
adjusting the dTTP-concentration individually<br />
according <strong>to</strong> experimental<br />
requirements.<br />
Direct detection uses fluorochromelabeled<br />
nucleotides (e.g. RhodaminedUTP<br />
from the Rhodamine-PRINS<br />
Reaction Set) that are directly visible<br />
under a fluorescence microscope.<br />
For direct detection, we offer the<br />
Rhodamine PRINS Reaction Set, which<br />
combines the labeling intensity of our<br />
improved rhodamine which is the<br />
CONTENTS<br />
INDEX<br />
optimal fluorochrome for the PRINS<br />
reaction with the convenience of the<br />
PRINS reaction. This combination produces<br />
extremely rapid results as there is no<br />
conjugate incubation step required and the<br />
best sensitivity in direct detection comparable<br />
<strong>to</strong> indirect detection.<br />
<strong>In</strong> the Rhodamine PRINS Reaction Set,<br />
dTTP is provided at an optimized concentration<br />
in the Rhodamine Labeling Mix<br />
because dTTP variation has only minor<br />
influence on rhodamine labeling intensity.<br />
PRINS oligo- Specific for<br />
nucleotide<br />
primer<br />
Table 1: Specificity of PRINS oligonucleotide<br />
primers.<br />
1 Satellite II DNA in the pericentromeric heterochromatin<br />
on the long arm of human chromosome 1<br />
3 Centromere of human chromosome 3, Alpha satellite<br />
7 Centromere of human chromosome 7, Alpha satellite<br />
8 Centromere of human chromosome 8, Alpha satellite<br />
9 (Sat) Satellite III DNA in the pericentric heterochromatin<br />
on the proximal long arm of human chromosome 9<br />
10 Centromere of human chromosome 10, Alpha satellite<br />
11 Centromere of human chromosome 11, Alpha satellite<br />
12 Centromere of human chromosome 12, Alpha satellite<br />
14 + 22 Centromeres of human chromosomes 14 and 22,<br />
Alpha satellite<br />
1 + 16 Satellite II DNA of human chromosomes 1 and 16 in<br />
both cases located <strong>to</strong> the proximal long arm of that<br />
chromosome.<br />
17 Centromere of human chromosome 17, Alpha satellite<br />
18 Centromere of human chromosome 18, Alpha satellite<br />
X Centromere of human chromosome X, Alpha satellite<br />
Y Long arm of human chromosome Y. Stains most of the<br />
long arm of the Y-chromosome.<br />
T Telomeres of all human chromosomes 1<br />
Control primer All human chromosomes<br />
1 Please note the Telomere Primer is only for use with the Digoxigenin PRINS Reaction Set,<br />
because the Rhodamine PRINS Reaction Set contains dTTP in the Rhodamine Labeling Mix.<br />
79<br />
5
5<br />
80<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Compared <strong>to</strong> traditional ISH methods<br />
(where probe labeling is performed before<br />
the probe is added <strong>to</strong> the slide), PRINS has<br />
two advantages:<br />
Convenience. PRINS circumvents the<br />
laborious probe isolation and labeling<br />
needed in other approaches.<br />
Speed. Since high probe concentrations<br />
are possible, hybridization and chain<br />
elongation (in one reaction) usually takes<br />
30 min. For many PRINS primer the<br />
reaction time can even be reduced. The<br />
complete procedure, including fluorescent<br />
antibody detection, is complete in<br />
approximately 2 h. When using the<br />
Rhodamine PRINS Reaction Set for<br />
direct detection results are already available<br />
after 60 min.<br />
This article describes the use of the PRINS<br />
Reaction Set, the Rhodamine-PRINS<br />
Reaction Set, and PRINS oligonucleotide<br />
primers <strong>to</strong> rapidly identify human chromosomes.<br />
It also details how <strong>to</strong> combine<br />
PRINS and FISH (fluorescence in situ<br />
hybridization) for a multiple labeling<br />
experiment.<br />
I. Preparation of slides<br />
1 Using standard methods (e.g. Gosden,<br />
1994; Roonea and Czepulkowski, 1992),<br />
prepare fresh microscope slides containing<br />
fixed metaphase chromosomes and/<br />
or interphase nuclei.<br />
Caution: For best results, prepare the<br />
slides containing the fixed metaphase<br />
chromosomes either immediately before<br />
use or on the day before the PRINS<br />
reaction. If slides have been prepared a<br />
day early, s<strong>to</strong>re them at 4°C until use.<br />
Such slides may be used in the PRINS<br />
reaction without formamide pretreatment<br />
(Step 2 below).<br />
2 (Optional) If slides have been s<strong>to</strong>red for<br />
3 or more days at room temperature in<br />
70% ethanol at 4°C, denature the preparations<br />
with formamide directly before<br />
the PRINS reaction. For the formamide<br />
treatment, perform the following steps:<br />
Prepare a solution containing:<br />
– 70 ml deionized formamide<br />
– 10 ml 20 x SSC<br />
– 10 ml 500 mM sodium phosphate<br />
buffer, pH 7.0<br />
– 10 ml H2O<br />
Adjust the pH of the formamide solution<br />
<strong>to</strong> 7.0 with HCl.<br />
<strong>In</strong>cubate the slides for 45 s at 68°C in<br />
the formamide solution. Check the<br />
temperature of the formamide solution,<br />
as it is important that it be<br />
68°C.<br />
Wash the slides in a series of ice-cold<br />
ethanol solutions (70%, then 90%,<br />
then 100% ethanol).<br />
Caution: The ethanol solutions must<br />
be ice-cold during this step.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
II. Preparation of PRINS<br />
reaction mixes<br />
Note: For a single reaction under a 22 x<br />
22 mm coverslip, prepare 30 µl of DIG-<br />
PRINS reaction mix or Rhodamine-PRINS<br />
reaction mix. Adjust the volume of the<br />
reaction mix (but not the concentration of<br />
the components) if you are preparing more<br />
than one reaction, or if you use coverslips<br />
of a different size. For 18 x 18 mm coverslips,<br />
prepare 15 ml reaction mix per<br />
reaction; for 24 x 60 mm or 22 x 40 mm<br />
coverslips, prepare 60 ml per reaction.<br />
1 Depending on the type of PRINS<br />
reaction desired, do one of the following:<br />
A. If you want <strong>to</strong> use Digoxigenin for in<br />
situ labeling and detect the PRINS target<br />
by indirect fluorescence (immunological)<br />
methods, prepare 30 µl of DIG-PRINS<br />
reaction mix (for each reaction) by<br />
adding the following components <strong>to</strong> a<br />
sterile microcentrifuge tube (on ice):<br />
Note: Most of the components (numbered<br />
vials) used in the DIG-PRINS<br />
reaction mix are from the PRINS<br />
Reaction Set.<br />
13.5 µl sterile redistilled H2O.<br />
3.0 µl 10 x concentrated PRINS<br />
reaction buffer (PRINS vial 3).<br />
3.0 µl 10 x concentrated DIG-PRINS<br />
labeling mix (500 µM each of dATP,<br />
dCTP, and dGTP; 50 µM DIGdUTP;<br />
50% glycerol) (PRINS vial 1).<br />
5.0 µl PRINS oligonucleotide primer<br />
[either control primer (PRINS vial 4) or<br />
a human chromosome-specific PRINS<br />
oligonucleotide primer (Table 1).<br />
3.0 µl 450 mM dTTP (PRINS vial 2).<br />
Caution: The concentration of dTTP<br />
used in the DIG-PRINS reaction<br />
mix depends upon the PRINS oligonucleotide<br />
primer used.<br />
Using the PRINS Oligonucleotide<br />
Primer T, no -dTTP has <strong>to</strong> be added<br />
<strong>to</strong> the reaction mix.<br />
For the PRINS Oligonucleotide Primer<br />
9, the final concentration of dTTP in<br />
the DIG-PRINS reaction mix must be<br />
90 µM.<br />
For all other PRINS primers listed in<br />
Table 1 the final concentration of<br />
dTTP in the DIG-PRINS reaction<br />
mix must be 45 µM.<br />
The correct dTTP concentration for<br />
other primers must be determined<br />
empirically.<br />
CONTENTS<br />
INDEX<br />
The dTTP concentration can be<br />
adjusted individually <strong>to</strong> increase the<br />
signal strength by reducing the dTTP<br />
concentration or <strong>to</strong> decrease the<br />
signal strength by increasing the<br />
dTTP concentration.<br />
2.5 µl Taq DNA Polymerase (1 unit/µl).<br />
B. If you want <strong>to</strong> use rhodamine-labeled<br />
DNA and detect the PRINS target by<br />
direct fluorescence methods, prepare<br />
30 µl of Rhodamine-PRINS reaction<br />
mix (for each reaction) by adding the<br />
following components <strong>to</strong> a sterile<br />
microcentrifuge tube (on ice):<br />
Note: Most of the components (numbered<br />
vials) used in the Rhodamine-<br />
PRINS reaction mix are from the<br />
Rhodamine-PRINS Reaction Set.<br />
16.5 µl sterile redistilled H2O.<br />
3.0 µl 10 x concentrated PRINS<br />
reaction buffer (Rh-PRINS vial 2).<br />
3.0 µl 10 x concentrated Rhodamine-<br />
PRINS labeling mix (500 µM each of<br />
dATP, dCTP, and dGTP; 50 µM<br />
dTTP; 10 µM rhodamine-dUTP; 50%<br />
glycerol) (Rh-PRINS vial 1).<br />
Note: The correct dTTP concentration<br />
(5 µM) for most primers is provided<br />
as part of the Rhodamine-PRINS<br />
labeling mix (in the Rhodamine-<br />
PRINS Reaction Set). Variations in<br />
dTTP do not significantly affect the<br />
intensity of rhodamine labeling.<br />
Since dTTP is included in the<br />
Rhodamine-PRINS labeling mix and<br />
because for the PRINS Oligonucleotide<br />
Primer T, no dTTP has <strong>to</strong> be added<br />
<strong>to</strong> the reaction mix, the T primer is<br />
incompatible with the components of<br />
the Rhodamine-PRINS Reaction Set.<br />
5.0 µl PRINS oligonucleotide primer<br />
[either control primer (Rh-PRINS<br />
vial 3) or a human chromosomespecific<br />
PRINS oligonucleotide<br />
primer (Table 1).<br />
2.5 µl Taq DNA Polymerase (1 unit/µl).<br />
2 Gently vortex the reaction solution <strong>to</strong><br />
mix the components.<br />
3 Centrifuge the reaction mixture briefly<br />
<strong>to</strong> collect the liquid on the bot<strong>to</strong>m of<br />
the tube.<br />
81<br />
5
5<br />
82<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
III. Primer annealing and elongation<br />
1 Place the dry slides containing fixed<br />
chromosomes and/or interphase nuclei<br />
on either a heating block or a special<br />
thermal cycler for slides.<br />
Note: To guarantee specificity and<br />
sensitivity of the reaction, the denaturation<br />
step and the annealing/elongation<br />
step need precisely controlled elevated<br />
temperatures. For reproducible results,<br />
we recommend that, instead of a heating<br />
block, you use a temperature cycler that<br />
is specially designed for slides, such as the<br />
OmniSlide or OmniGene Temperature<br />
Cycler (Hybaid Ltd., Tedding<strong>to</strong>n,<br />
Middlesex, England) or an equivalent<br />
instrument from another manufacturer.<br />
2 Depending on the age of the slides, do<br />
one of the following:<br />
If slides are freshly prepared (one day<br />
old or less), incubate them at 94°C<br />
for 1 min.<br />
If slides are 3 or more days old and<br />
have been treated with formamide<br />
(Procedure I, Step 2 above), incubate<br />
them at 60°C for 1 min.<br />
3 Without removing the slides from the<br />
heating block, do the following:<br />
On<strong>to</strong> each sample, immediately<br />
pipette:<br />
– 25 µl of DIG-PRINS reaction mix<br />
or<br />
– 27 µl of Rhodamine-PRINS<br />
reaction mix<br />
Cover sample with a 22 x 22 mm<br />
coverslip.<br />
Caution: If you use coverslips of a<br />
different size than 22 x 22 mm, adjust<br />
the volume of the DIG-PRINS or<br />
Rhodamine-PRINS reaction mix in<br />
this step so it covers the sample well<br />
and completely wets the coverslip.<br />
4 Depending on the age of the slides, do<br />
one of the following:<br />
If slides are freshly prepared (1 day old<br />
or less), incubate them at 91°–94°C for<br />
3 min <strong>to</strong> denature the chromosomal<br />
DNA, then go <strong>to</strong> Step 5.<br />
Caution: The slides generally reach<br />
91°–94°C when the surface of a heating<br />
block reaches 94°–97°C. However,<br />
if you are using a temperature<br />
cycler designed for slides, the cycler<br />
may au<strong>to</strong>matically take in<strong>to</strong> account<br />
this temperature differential.<br />
If slides are 3 or more days old and<br />
have been treated with formamide,<br />
skip this step, leave the heating block<br />
set at 60°C and go <strong>to</strong> Step 5.<br />
5 Reduce the temperature of the heating<br />
block <strong>to</strong> 60°C and incubate the slides<br />
for 30 min at 60°C while the primer<br />
anneals and the polymerase elongates it.<br />
Caution: Be sure the temperature of the<br />
slides is exactly as indicated for the<br />
individual primers. Even a few seconds<br />
of exposure <strong>to</strong> a temperature below the<br />
stringent annealing temperature can<br />
lead <strong>to</strong> an unwanted background signal.<br />
The slides are usually at the correct<br />
temperature when the surface of the<br />
heating block reaches 60°C.<br />
Note: The stringent annealing/ elongation<br />
temperature for the PRINS reaction<br />
depends on the sequence of the primer<br />
used.<br />
The annealing temperature in the PRINS<br />
reaction using the Oligonucleotide<br />
Primer T is 60°C.<br />
The annealing temperature for all other<br />
PRINS Oligonucleotide Primer in the<br />
PRINS reaction is 60°–65°C.<br />
6 Remove the slides from the heating<br />
block and place them immediately in a<br />
Coplin jar containing s<strong>to</strong>p buffer which<br />
has been prewarmed <strong>to</strong> the temperature<br />
of the hybridization/elongation reaction<br />
(60°C).<br />
7 S<strong>to</strong>p the reaction by washing the slides<br />
for 3–5 min at the temperature of the hybridization/elongation<br />
reaction (60°C)<br />
with prewarmed s<strong>to</strong>p buffer.<br />
Note: Coverslips should drop off the<br />
slides during this step.<br />
Caution: Be sure the temperature remains<br />
the temperature of the hybridization/<br />
elongation reaction (60°C) throughout<br />
the wash.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
IV. Detection of hybridized sequences<br />
1 <strong>In</strong> a Coplin jar, wash the slides as follows:<br />
3 x 5 min at 37°C with wash buffer<br />
[0.2% Tween ® 20 in phosphate buffered<br />
saline (PBS)].<br />
About 1 min with PBS at room<br />
temperature.<br />
2 Depending on the label used in the<br />
PRINSreaction,dooneofthefollowing:<br />
If you produced DIG-labeled DNA<br />
in Procedure III, go <strong>to</strong> Step 3.<br />
If you produced rhodamine-labeled<br />
DNA in Procedure III, go <strong>to</strong> Step 6.<br />
3 Prepare the antibody working solution<br />
by diluting the Anti-Digoxigenin-<br />
Fluorescein conjugate (PRINS vial 5)<br />
1:1000 with PBS containing 1% blocking<br />
solution.<br />
Note: Anti-DIG-Fluorescein conjugate is<br />
a included in the PRINS Reaction Set.<br />
10 x blocking solution is included in the<br />
DIG Wash and Block Set*; it contains<br />
100 mM maleic acid (pH 7.5), 150 mM<br />
NaCl, and 10% blocking reagent. PBS<br />
containing 1% blocking solution can be<br />
prepared by diluting the 10 x blocking<br />
solution 1:10 with PBS.<br />
4 <strong>In</strong> a Coplin jar, incubate the slides with<br />
antibody working solution for 30 min<br />
in the dark at 37°C.<br />
5 Repeat Step 1 washes.<br />
6 For counterstaining, add the counterstain<br />
working solution (e.g., PBS containing<br />
either 20 ng/ml propidium iodide or<br />
20 ng/ml DAPI) <strong>to</strong> the Coplin jar and<br />
incubate the slides with the counterstain<br />
for 5 min in the dark at room temperature.<br />
Caution: If the target DNA is labeled<br />
with rhodamine-dUTP, do not use<br />
propidium iodide counterstain, since the<br />
emission of propidium iodide and rhodamine<br />
overlap. Use DAPI as a counterstain<br />
for rhodamine-labeled DNA.<br />
Wash the slides for 2–3 min under<br />
running water.<br />
7 Air-dry the slides in the dark.<br />
8 Prepare the slides for viewing by doing<br />
the following:<br />
Apply 20 µl antifade solution [e.g.,<br />
Vectashield (Vec<strong>to</strong>r) or Slow Fade-<br />
Light (Molecular Probes)] <strong>to</strong> each<br />
slide.<br />
Add a coverslip.<br />
Note: For long term s<strong>to</strong>rage of the slides<br />
seal the edges of the coverslip with nail<br />
polish and s<strong>to</strong>re in the dark at –20°C.<br />
9 Analyze the slides under a fluorescence<br />
microscope with the appropriate filters.<br />
CONTENTS<br />
INDEX<br />
V. Combining PRINS and FISH<br />
1 Label a DNA probe with digoxigenin,<br />
biotin, or any fluorochrome (except the<br />
one used in the PRINS procedure),<br />
according <strong>to</strong> procedures described in<br />
Chapter 4 of this manual.<br />
2 Perform the PRINS reaction as described<br />
in Procedure I–III of this article.<br />
3 After washing the PRINS slides in s<strong>to</strong>p<br />
buffer (Procedure III, Step 6), dehydrate<br />
the slides in an ethanol series (increasing<br />
concentrations of ice-cold ethanol).<br />
Caution: The ethanol solutions must be<br />
ice-cold during this step.<br />
4 Hybridize the labeled DNA probe<br />
(from Step 1) <strong>to</strong> the PRINS slides,<br />
according <strong>to</strong> FISH procedures described<br />
elsewhere (Procedure IIA, IIB, or IIC<br />
from the article “<strong>In</strong> situ hybridization <strong>to</strong><br />
human metaphase chromosomes using<br />
DIG-, biotin-, or fluorochrome-labeled<br />
DNA probes and detection with fluorochrome<br />
conjugates”, in Chapter 5 of this<br />
manual, pages 62, 63). Modify the<br />
hybridization procedure as follows:<br />
Denature the labeled probe DNA<br />
before adding it <strong>to</strong> the slides.<br />
Do not heat the slides <strong>to</strong> 80°C after<br />
adding the probe <strong>to</strong> the slides.<br />
5 After the incubation step, wash the slides<br />
with the formamide/SSC washes described<br />
in the FISH procedure, then perform a<br />
final wash in PBS.<br />
6 Depending on the label used in the<br />
PRINS reaction, do one of the following:<br />
For PRINS targets labeled with DIGdUTP,<br />
perform the PRINS antibody<br />
detection and wash steps as above<br />
(this article, Procedure IV, Steps 3–5).<br />
For PRINS targets labeled with<br />
rhodamine-dUTP, skip this step and<br />
go <strong>to</strong> Step 7.<br />
7 Depending on the label used in the FISH<br />
procedure, do one of the following:<br />
For biotin- or digoxigenin-labeled<br />
FISH probes, perform the immunological<br />
detection step according <strong>to</strong><br />
procedures described elsewhere (Procedure<br />
IIIA1/IIIA2 or IIIB1/IIIB2<br />
from the article “<strong>In</strong> situ hybridization<br />
<strong>to</strong> human metaphase chromosomes<br />
using DIG-, biotin-, or fluorochromelabeled<br />
DNA probes and detection<br />
with fluorochrome conjugates”, in<br />
Chapter 5 of this manual, page 64).<br />
For fluorochrome-labeled FISH<br />
probes, skip this step and go <strong>to</strong> Step 8.<br />
*Sold under the tradename of Genius<br />
in the US.<br />
83<br />
5
5<br />
84<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
8 Counterstain and prepare the slides as<br />
above (this article, Procedure IV, steps<br />
6–7).<br />
9 Analyze the slides under a fluorescence<br />
microscope with the appropriate filters.<br />
Possible cause Possible solution<br />
Denaturation temperature does not reach <strong>In</strong>crease the temperature of the block<br />
91°–94°C at the surface of the slide. slightly during denaturation.<br />
Annealing/elongation temperature Lower the annealing/elongation temperature<br />
is <strong>to</strong>o high. by 3°C and repeat experiment. If signal is<br />
inadequate, reduce the temperature further<br />
(in 3°C steps).<br />
(For DIG-labeling only) Not enough 1. Reduce the dTTP concentration in the<br />
DIG-dUTP was incorporated in<strong>to</strong> reaction solution <strong>to</strong> 30 µM, 15 µM or zero<br />
sample. by adding 2 µl, 1 µl, or no dTTP solution<br />
(DIG PRINS Reaction Set vial 2) <strong>to</strong> each<br />
30 µl reaction<br />
Primer concentration <strong>to</strong>o low 1. <strong>In</strong>crease the amount of primer in the<br />
reaction solution.<br />
Use the control primer (DIG PRINS<br />
Reaction Set vial 4) <strong>to</strong> check the sensitivity<br />
of the reaction.<br />
B. If signal is strong, then:<br />
Possible cause Possible solution<br />
VI. Troubleshooting guide for PRINS<br />
Use the following tips <strong>to</strong> diagnose and<br />
correct commonly occurring problems in<br />
the PRINS procedure described above.<br />
A. If signal is weak or missing, then:<br />
(For DIG-labeling only) Too much 1. <strong>In</strong>crease the dTTP concentration in the<br />
DIG-dUTP was incorporated in<strong>to</strong> reaction solution <strong>to</strong> 60 µM, 90 µM or<br />
sample. 135 µM by adding 4 µl, 6 µl, or 9 µl dTTP<br />
solution (DIG PRINS Reaction Set vial 2)<br />
<strong>to</strong> each 30 µl reaction<br />
Primer concentration <strong>to</strong>o high 1. Decrease the amount of primer in the<br />
reaction solution.<br />
Use the control primer (DIG PRINS<br />
Reaction Set vial 4) <strong>to</strong> check the sensitivity<br />
of the reaction.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
C. If chromosomes or nuclei contain<br />
unwanted background signals, then:<br />
Possible cause Possible solution<br />
The slide was exposed <strong>to</strong> temperatures Do not allow the temperature on the slide<br />
below the stringent annealing/ <strong>to</strong> ever fall below the stringent annealing/<br />
elongation temperature for a few<br />
seconds after the denaturation step.<br />
elongation temperature.<br />
Annealing/elongation temperature is Raise the annealing/elongation temperature<br />
<strong>to</strong>o low. by 3°C and repeat experiment. If background<br />
is still high, increase the temperature further<br />
(in 3°C steps) until the reaction is specific.<br />
The slide was exposed <strong>to</strong> temperatures Prewarm the s<strong>to</strong>p buffer <strong>to</strong> the stringent<br />
below the stringent annealing/elonga- annealing/elongation temperature and<br />
tion temperature for a few seconds transfer the slides directly from the heating<br />
between the elongation step and the block <strong>to</strong> the warm s<strong>to</strong>p solution.<br />
addition of s<strong>to</strong>p buffer.<br />
Primer-independent elongation of nicks Perform a control PRINS reaction without<br />
and chromosomal breaks occurred. added primer. If you obtain a signal, either<br />
Such nicks and breaks can occur during block the 3' ends of the chromosomal breaks<br />
long term s<strong>to</strong>rage of the chromosomal by incubating the chromosomal preparations<br />
preparation. with DNA polymerase and a mixture of<br />
ddNTPS or (preferably) discard the<br />
chromosomal preparations and prepare fresh<br />
chromosomes or fresh chromosomal spreads.<br />
(For DIG-labeling only) When the <strong>In</strong>crease the dTTP concentration in the<br />
primary signal is strong, minor primer- reaction solution <strong>to</strong> 60 µM, 90 µM or<br />
dependent signals may be seen at 135 µM by adding 4 µl, 6 µl, or 9 µl<br />
secondary binding sites for the primer. dTTP solution (DIG PRINS Reaction Set<br />
vial 2) <strong>to</strong> each 30 µl reaction<br />
or<br />
Decrease the amount of primer in the reaction<br />
solution.<br />
D. If the entire slide (not just the chromosomes and nuclei)<br />
contain unwanted background signals, then:<br />
Possible cause Possible solution<br />
(For DIG-labeling only) The antibody Perform a control detection reaction by<br />
conjugate (anti-digoxigenin-fluores- incubating an unhybridized sample slide<br />
cein) bound nonspecifically <strong>to</strong> the slide directly with the antibody conjugate, then<br />
or <strong>to</strong> cellular proteins and matrix in washing and analyzing the slide as in<br />
the chromosomal preparation. Procedure IV. If background is observed,<br />
either increase the number and duration of<br />
the washing steps or (preferably) repeat the<br />
chromosomal preparation <strong>to</strong> remove excess<br />
cellular proteins and matrix responsible for<br />
nonspecific binding.<br />
DIG-dUTP or rhodamine-dUTP Perform a control PRINS reaction in the<br />
bound nonspecifically during the absence of Taq polymerase and primer.<br />
PRINS reaction. If background is observed, either increase<br />
the number and duration of the washes or<br />
(preferably) repeat the chromosomal<br />
preparation <strong>to</strong> remove excess cellular proteins<br />
and matrix responsible for nonspecific binding.<br />
CONTENTS<br />
INDEX<br />
85<br />
5
5<br />
86<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Results<br />
a b<br />
<br />
Figure 1: PRINS labeling and indirect fluorescent detection of human chromosomes.<br />
The PRINS primers specific for (Panel a) human chromosome 11 and (Panel b) human chromosome 7 were<br />
hybridized <strong>to</strong> human chromosomal preparations. The hybridized primers were elongated in situ and the<br />
newly synthesized DNA labeled with DIG-dUTP according <strong>to</strong> the procedure described in the text. Labeled<br />
DNA was visualized with anti-DIG-fluorescein. Propidium iodide was used as a counterstain.<br />
a<br />
b2<br />
References<br />
Gosden, J. R., ed. (1994) Chromosome Analysis<br />
Pro<strong>to</strong>cols (Methods Mol. Biol., Vol. 29). To<strong>to</strong>wa, NJ:<br />
Humana Press.<br />
Gosden, J.; Hanratty, D.; Starling, J.; Fantes, J.;<br />
Mitchell, A.; Porteus, D. (1991) Oligonucleotide<br />
primed in situ DNA synthesis (PRINS): A method for<br />
chromosome mapping, banding and investigation of<br />
sequence organization. Cy<strong>to</strong>genet. Cell Genet. 57,<br />
100–104.<br />
b1<br />
<br />
Figure 2: Rhodamine PRINS labeling and direct<br />
fluorescent detection of human chromosomes.<br />
The PRINS primers specific for (Panel a) human<br />
chromosome 1 and (Panel b1, b2) human<br />
chromosome 9 were hybridized <strong>to</strong> human<br />
chromosomal preparations. The hybridized primers<br />
were used <strong>to</strong> label target DNA in situ with<br />
rhodamine-dUTP according <strong>to</strong> the procedure<br />
described in the text. Labeled DNA was viewed<br />
directly under a fluorescence microscope. DAPI was<br />
used as a counterstain.<br />
Gosden, J.; Hanratty, D. (1993) PCR in situ:<br />
A rapid alternative <strong>to</strong> in situ hybridization for<br />
mapping short, low-copy number sequences<br />
without iso<strong>to</strong>pes. BioTechniques 15, 78–80.<br />
Koch, J. E.; Kølvraa, S.; Petersen, K. B.; Gregersen,<br />
N.; Bolund, L. (1989) Oligonucleotide priming<br />
methods for the chromosome-specific labeling of<br />
alpha satellite DNA in situ. Chromosoma (Berl.) 98,<br />
259–265.<br />
Roonea, D. E.; Czepulkowski, B. H., eds. (1992)<br />
Human Cy<strong>to</strong>genetics, A Practical Approach, Vol. 1.<br />
Oxford, England: IRL Press.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Reagents available from Boehringer Mannheim for PRINS<br />
Product Description Cat. No.<br />
DIG PRINS Reaction Set For 40 PRINS labeling reactions and 5 control reactions 1 695 932<br />
The DIG PRINS Reaction Set includes a detailed working procedure and contains:<br />
Reagent Description Kit component<br />
10 x Concentrated<br />
PRINS labeling mix<br />
dNTPs including digoxigenin-11-dUTP One vial No. 1, 135 µl<br />
dTTP solution 450 µM dTTP One vial No. 2, 200 µl<br />
10 x Concentrated Buffer for 45 reactions One vial No. 3, 150 µl<br />
PRINS reaction buffer<br />
PRINS Control Primer for 5 control reactions One vial No. 4<br />
Oligonucleotide Primer<br />
Anti-Digoxigenin-Fluorescein Antibody (200 µg/ml) for 22 detection Two vials No. 5,<br />
Conjugate, Fab fragments reactions in a Coplin jar 2 x 550 µl<br />
Product Description Cat. No.<br />
Rhodamine PRINS Reaction Set For 40 PRINS labeling reactions and 5 control reactions 1 768 514<br />
The Rhodamine PRINS Reaction Set includes a detailed working procedure and<br />
contains:<br />
Reagent Description Kit component<br />
10 x Concentrated Rhodamine<br />
PRINS labeling mix<br />
dNTPs including Rhodamine-dUTP One vial No. 1, 135 µl<br />
10 x Concentrated Buffer for 50 reactions One vial No. 2, 150 µl<br />
PRINS reaction buffer<br />
PRINS Control Primer for 5 control reactions One vial No. 3, 25 µl<br />
Oligonucleotide Primer<br />
PRINS oligonucleotide primers<br />
The following PRINS oligonucleotide primers are available* (Pack size 100 µl each):<br />
Primer Cat. No.<br />
PRINS oligonucleotide primer 1, specific for human chromosome 1 1 695 959<br />
PRINS oligonucleotide primer 1+16, specific for human chromosome 1+16 1768 549<br />
PRINS oligonucleotide primer 3, specific for chromosome 3 1 695 967<br />
PRINS oligonucleotide primer 7, specific for human chromosome 7 1 695 975<br />
PRINS oligonucleotide primer 8, specific for human chromosome 8 1 695 983<br />
PRINS oligonucleotide primer 9 (Sat), specific for human chromosome 9 1768 565<br />
PRINS oligonucleotide primer 10, specific for human chromosome 10 1768 522<br />
PRINS oligonucleotide primer 11, specific for human chromosome 11 1 695 991<br />
PRINS oligonucleotide primer 12, specific for human chromosome 12 1 696 009<br />
PRINS oligonucleotide primer 14+22, specific for human chromosome 14+22 1768 557<br />
PRINS oligonucleotide primer 17, specific for human chromosome 17 1 696 017<br />
PRINS oligonucleotide primer 18, specific for human chromosome 18 1 696 025<br />
PRINS oligonucleotide primer X, specific for the human X chromosome 1 696 033<br />
PRINS oligonucleotide primer Y, specific for the human Y chromosome 1 696 041<br />
PRINS oligonucleotide primer T, specific for human telomeres 1 699 199<br />
PRINS control oligonucleotide primer, specific for all human chromosomes 1 699 172<br />
CONTENTS<br />
INDEX<br />
* Please note the Telomer Primer is<br />
only for use with the Digoxigenin<br />
PRINS Reaction Set because the<br />
Rhodamine PRINS Reaction Set<br />
contains dTTP in the Labeling Mix.<br />
87<br />
5
5<br />
88<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Identification of chromosomes in metaphase<br />
spreads with DIG- or fluorescein-labeled human<br />
chromosome-specific satellite DNA probes<br />
Dr. G. Sagner, Research Labora<strong>to</strong>ries, Boehringer Mannheim GmbH,<br />
Penzberg, Germany.<br />
Fluorescence in situ hybridization (FISH)<br />
with human chromosome-specific satellite<br />
DNA probes is a sensitive technique for<br />
identifying individual human chromosomes.<br />
Applications include:<br />
Analysis of aneuploidies in normal or<br />
tumor cells<br />
Identification of chromosomes in<br />
hybrid cells<br />
Production of genetic linkage maps<br />
Especially useful for such applications are<br />
fluorescein- or digoxigenin-labeled probes<br />
which recognize alphoid sequence variants<br />
that occur at the centromere of specific<br />
chromosomes (Willard and Waye, 1987;<br />
Choo, K. H. et al., 1991). Fluoresceinlabeled<br />
probes allow rapid, direct detection<br />
of a single chromosome. DIG-labeled<br />
probes allow sensitive, indirect detection<br />
of a chromosome with a variety of<br />
fluorochrome-labeled antibodies. Both<br />
fluorescein- and DIG-labeled probes can<br />
be combined in a multicolor labeling of<br />
different chromosomes on a single<br />
preparation.<br />
This article describes the use of such prelabeled<br />
probes <strong>to</strong> identify human chromosomes<br />
in chromosomal spreads from whole<br />
blood or from cell culture.<br />
I. Preparation of metaphase<br />
chromosomes<br />
1 Prepare chromosomes from either whole<br />
blood or cell culture as follows:<br />
For whole blood, do these steps:<br />
Mix 5 ml whole blood with 5 ml PBS.<br />
Pipette 7.5 ml of lymphocyte separation<br />
medium in<strong>to</strong> a 50 ml centrifuge<br />
tube.<br />
Carefully layer blood-PBS mixture<br />
a<strong>to</strong>p separation medium.<br />
Centrifuge for 30 min at 800 x g.<br />
Remove the interphase (middle part<br />
of the centrifuged mixture) that contains<br />
the lymphocytes.<br />
Place the lymphocytes in a fresh<br />
centrifuge tube.<br />
Mix lymphocytes with 50 ml PBS.<br />
Centrifuge for 10 min at 420 x g.<br />
Discard the supernatant and resuspend<br />
cells at approximately 10 6 cells per ml<br />
in chromosome medium (Gibco).<br />
Note: This step should require about<br />
5 ml chromosome medium.<br />
Go <strong>to</strong> Step 2.<br />
For cells in culture, do these steps:<br />
Harvest cells by centrifugation.<br />
Resuspend cells at approximately 10 6<br />
cells per ml in chromosome medium.<br />
Go <strong>to</strong> Step 2.<br />
2 <strong>In</strong>cubate cells in chromosome medium<br />
for 71 h in a CO2 incuba<strong>to</strong>r at 37°C and<br />
7% CO2.<br />
3 Add 12 µl Colcemid ® per ml medium.<br />
4 <strong>In</strong>cubate cells for 1 h at 37°C and 7%<br />
CO2.<br />
5 Centrifuge cells (210 x g) for 10 min at<br />
4°C.<br />
6 With a pipette, remove supernatant until<br />
only 1 ml remains a<strong>to</strong>p the cells.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
7 Resuspend the pellet in the remaining<br />
supernatant.<br />
8 Slowly add <strong>to</strong> the resuspended cells10ml<br />
of prewarmed (37°C) 75 mM KCl.<br />
9 Gently mix and incubate for 12–20 min<br />
at 37°C.<br />
10 To the mixture, add 7 drops of chilled<br />
methanol-acetic acid fixative (3 parts<br />
methanol <strong>to</strong> 1 part acetic acid, precooled<br />
<strong>to</strong> –20°C). Gently mix.<br />
11 Centrifuge mixture (210 x g) for 10 min<br />
at 4°C.<br />
12 With a pipette, remove supernatant until<br />
only 1 ml remains a<strong>to</strong>p the pellet.<br />
13 Carefully resuspend the pellet in the<br />
remaining supernatant and add 1 ml<br />
precooled (–20°C) methanol-acetic acid<br />
fixative. Gently mix.<br />
14 Add an additional 5–10 ml precooled<br />
(–20°C) methanol-acetic acid fixative.<br />
Mix thoroughly.<br />
15 Fix chromosomes for at least 30 min at<br />
–20°C.<br />
16 Repeat Steps 11–15 three <strong>to</strong> five times.<br />
17 S<strong>to</strong>re the metaphase chromosomes at<br />
least 24 h in methanol-acetic acid fixative<br />
at –20°C.<br />
18 Do either of the following:<br />
Go <strong>to</strong> Procedure II.<br />
S<strong>to</strong>re metaphase chromosomes in<br />
methanol-acetic acid fixative at –20°C<br />
up <strong>to</strong> several months.<br />
II. Preparation of chromosomal<br />
spreads<br />
1 Pretreat slides as follows:<br />
Wash slides briefly in a 1:1 mixture of<br />
100% ethanol and ether.<br />
Air dry slides.<br />
Wash briefly in redistilled H2O. (Do<br />
not dry.)<br />
2 Centrifuge metaphase chromosomes from<br />
Procedure I (210 x g) for 10 min at 4°C.<br />
3 Remove and discard all supernatant.<br />
4 Resuspend chromosomal pellet in1–2 ml<br />
of precooled (–20°C) methanol-acetic<br />
acid fixative.<br />
5 Drop the metaphase chromosomes on<strong>to</strong><br />
a moist, pretreated slide from a height of<br />
approximately 50 cm.<br />
6 Allow slides <strong>to</strong> air dry.<br />
7 For optimal metaphase spreads, s<strong>to</strong>re<br />
slides at least 5 days in 70% ethanol at<br />
4°C.<br />
Note: You may s<strong>to</strong>re slides up <strong>to</strong> several<br />
weeks in 70% ethanol at 4°C.<br />
CONTENTS<br />
INDEX<br />
III. <strong>In</strong> situ hybridization with chromosome-specific<br />
DNA probes<br />
Note: Perform the following procedure in<br />
a 50 ml Coplin jar which can hold a<br />
maximum of 8 slides.<br />
Caution: Prewarm all solutions in the<br />
following procedure <strong>to</strong> the appropriate<br />
temperature before using them.<br />
1 Remove slides from the 70% ethanol<br />
s<strong>to</strong>rage solution (from Procedure II,<br />
Step 7).<br />
2 Air dry slides completely (approximately<br />
30 min).<br />
3 For each slide, prepare 20 ml hybridization<br />
solution containing:<br />
10–13 µl deionized formamide (final<br />
concentration: 50–65% formamide)<br />
Note: Different probes require different<br />
concentrations of deionized formamide.<br />
See Table 1 for the correct formamide<br />
concentration <strong>to</strong> use with each probe.<br />
5 µl 4 x concentrated hybridization<br />
buffer [8 x SSC; 40% (v/v) dextran<br />
sulfate; 4 mg/ml MB-grade DNA<br />
(from fish sperm); pH 7.0].<br />
1–2 µl (20–40 ng) human chromosome-specific<br />
satellite DNA probe,<br />
either fluorescein- or DIG-labeled.<br />
Enough redistilled H2O <strong>to</strong> make a<br />
<strong>to</strong>tal volume of 20 µl.<br />
Caution: Twenty µl is enough hybridization<br />
solution if you are using a 24<br />
x 24 mm coverslip in Step 7 below. If<br />
you use a different size coverslip,<br />
adjust the volume of the hybridization<br />
solution (but not the concentration<br />
of the components) accordingly.<br />
4 Preheat a glass tray big enough <strong>to</strong> hold<br />
all slides in a 72°C oven.<br />
5 Prewarm a moist chamber <strong>to</strong> 37°C.<br />
6 Pipette 20 µl hybridization solution<br />
on<strong>to</strong> each slide, add a 24 x 24 mm coverslip,<br />
and seal the coverslip <strong>to</strong> the slide<br />
with rubber cement.<br />
7 Place the prepared slides on<strong>to</strong> the prewarmed<br />
glass tray in the oven and incubate<br />
5–10 min at 72°C <strong>to</strong> denature<br />
DNA.<br />
8 Transfer slides <strong>to</strong> the prewarmed moist<br />
chamber and incubate overnight at<br />
37°C.<br />
89<br />
5
5<br />
90<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
IV. Detection of hybridized sequences<br />
IVA. For detection of fluorescein-labeled<br />
chromosome-specific probes<br />
Note: Perform Steps 1 and 2 in a Coplin jar.<br />
1 After hybridization, wash slides according<br />
<strong>to</strong> one of the following wash<br />
schemes:<br />
15 min at 30°–48°C with 1 x SSC<br />
containing 50% formamide, pH 7.0;<br />
then: 2 x 5 min at room temperature<br />
with 2 x SSC, pH 7.0<br />
or<br />
15 min at 37°C with 2 x SSC, pH 7.0.<br />
Note: Different probes require different<br />
washes. See Table 1 for the correct<br />
washes <strong>to</strong> use with each probe.<br />
2 For counterstaining, add 50 ml of either<br />
propidium iodide solution (100 ng/ml<br />
propidium iodide in PBS) or DAPI<br />
solution (100 ng/ml DAPI in PBS) <strong>to</strong><br />
the slides, then incubate the slides for 2–5<br />
min in the dark at room temperature.<br />
3 Wash slides 2–3 min under running<br />
water.<br />
4 Air dry the slides in the dark.<br />
5 Apply 20 µl antifade solution [e.g., 2%<br />
DABCO (w/v) in PBS containing 50%<br />
glycerol] <strong>to</strong> each slide.<br />
6 Add a 24 x 24 mm coverslip.<br />
Note: For long term s<strong>to</strong>rage of the slides,<br />
seal the edges of the coverslip with nail<br />
polish and s<strong>to</strong>re in the dark at –20°C.<br />
7 Analyze the slides under a fluorescence<br />
microscope with the appropriate filters.<br />
Note: Maximum emission wavelength<br />
for fluorescein (FLUOS) is 523 nm; for<br />
propidium iodide, 610 nm; and for<br />
DAPI, 470 nm.<br />
IVB. For detection of DIG-labeled<br />
chromosome-specific probes<br />
1 After hybridization, wash slides in a<br />
Coplin jar according <strong>to</strong> one of the following<br />
wash schemes:<br />
15 min at 40°–48°C with 1 x SSC<br />
containing 50% formamide, pH 7.0;<br />
then: 2 x 5 min at room temperature<br />
with 2 x SSC, pH 7.0<br />
or<br />
15 min at 37°C with 2 x SSC, pH 7.0.<br />
Note: Different probes require different<br />
washes. See Table 1 for the correct<br />
washes <strong>to</strong> use with each probe.<br />
2 (Optional) <strong>In</strong>cubate slides for 30 min at<br />
37°C with 50 ml PBS containing 1%<br />
blocking reagent.<br />
3 Just before use, prepare 100 µl of a 1 µg/ml<br />
working solution of anti-DIG-fluorophore<br />
conjugate in PBS containing 1%<br />
blocking reagent.<br />
Note: Each slide <strong>to</strong> be analyzed requires<br />
100 µl of antibody working solution.<br />
Note: Anti-DIG-fluorophore conjugate<br />
can be Anti-DIG-Fluorescein, Anti-DIG-<br />
AMCA, or Anti-DIG-Rhodamine.<br />
4 Add 100 µl freshly prepared antibody<br />
working solution <strong>to</strong> each slide and cover<br />
the complete slide with a coverslip.<br />
5 <strong>In</strong>cubate slides for 30 min at 37°C in a<br />
moist chamber.<br />
6 <strong>In</strong> a Coplin jar, wash slides for 3 x 5 min<br />
at room temperature with 2 x SSC<br />
containing 0.1% Tween ® 20.<br />
7 Counterstain, mount and view slides<br />
as for fluorescein-labeled probes (Steps<br />
2–7, Procedure IVA).<br />
Exception: For experiments using anti-<br />
DIG-rhodamine conjugates, use DAPI<br />
rather than propidium iodide as a<br />
counterstain. The emission wavelength<br />
of propidium iodide is <strong>to</strong>o near that of<br />
rhodamine.<br />
Note: Maximum emission wavelength<br />
for AMCA is 474 nm; for rhodamine,<br />
570 nm.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Probe 1 for Labeled Formamide (%) in Posthybridization wash conditions<br />
chromosomes with hybridization solution Wash 1 (15 min) Wash 2 (2 x 5 min)<br />
1 DIG 2 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
2 DIG 65% 48°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 48°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
3 DIG 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
4 DIG 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
5 + 1 + 19 DIG 65% 46°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
6 DIG 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
7 DIG 65% 46°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
8 DIG 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
9 DIG 65% 46°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
10 DIG 65% 46°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
11 DIG 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
12 DIG 65% 46°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
13 + 21 DIG 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
14 + 22 DIG 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
15 DIG 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
16 DIG 65% 48°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
17 DIG 65% 48°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 30°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
18 DIG 65% 46°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 46°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
20 DIG 65% 48°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 43°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
22 DIG 65% 40°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
X DIG 65% 46°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
FLUOS 65% 46°C; 1x SSC + 50% formamide RT; 2 x SSC<br />
Y DIG 50% 37°C; 2 x SSC Omit<br />
FLUOS 50% 37°C; 2 x SSC Omit<br />
All human DIG 50% 37°C; 2 x SSC Omit<br />
FLUOS 50% 37°C; 2 x SSC Omit<br />
1 The probes all recognize a pattern of alphoid DNA on specific chromosomes, except for the chromosome 1<br />
probe (which recognizes satellite III DNA on chromosome 1) and the chromosome Y probe (which recognizes<br />
a repeat on the long arm of chromosome Y).<br />
2 Abbreviations used: DIG, digoxigenin; FLUOS, 5(6)-carboxyfluorescein-N-hydroxysuccinimide ester;<br />
1x SSC, buffer (pH 7.0) containing 150 mM NaCl and 15 mM sodium citrate; RT, room temperature.<br />
CONTENTS<br />
INDEX<br />
Table 1: <strong>Hybridization</strong> parameters<br />
for human chromosome-specific<br />
satellite DNA probes. Use the data<br />
given in this table in Procedures III<br />
and IV of this article. All probes are<br />
available from Boehringer<br />
Mannheim.<br />
91<br />
5
5<br />
92<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Results<br />
a<br />
c<br />
References<br />
Waye, J. S.; Willard, H. F. (1987) Nucleotide<br />
sequence heterogeneity of alpha satellite repetitive<br />
DNA: a survey of alphoid sequences from different<br />
human chromosomes. Nucl. Acids Res. 15,<br />
7549–7569.<br />
Choo, K. H.; Vissel, B.; Nagy, A.; Earle, E.; Kalitsis,<br />
P. (1991) A survey of the genomic distribution of<br />
alpha satellite DNA on all the human chromosomes,<br />
and derivation of a new consensus sequence.<br />
Nucl. Acids Res. 19, 1179–1182.<br />
b<br />
<br />
Figure 1: FISH of human chromosome-specific<br />
satellite DNA probes <strong>to</strong> metaphase spreads.<br />
Fluorescence signals have been pseudocolored<br />
with a CCD camera and a digital imaging system.<br />
<strong>In</strong> Panel a, a DIG-labeled probe specific for<br />
chromosomes 5 + 1 + 19 was detected with anti-<br />
DIG-rhodamine. Chromosomes were counterstained<br />
with DAPI. <strong>In</strong> Panel b, a DIG-labeled probe specific<br />
for chromosome 12 was detected with anti-DIGfluorescein.<br />
Chromosomes were counterstained<br />
with propidium iodide. Panel c shows the direct<br />
detection of chromosome 12 sequences with a<br />
fluorescein-labeled probe. Chromosomes were<br />
counterstained with propidium iodide.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DNA, MB-grade It prevents unspecific hybridization in all 1 467 140 500 mg<br />
from fish sperm types of membrane or in situ hybridization (50 ml)<br />
DAPI Fluorescence dye for staining of 236 276 10 mg<br />
chromosomes<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 741 200 µg<br />
Fluorescein<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 750 200 µg<br />
Rhodamine<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 533 878 200 µg<br />
AMCA<br />
These DNA probes are plasmids containing<br />
human satellite DNAs. Clones were<br />
isolated from human-hamster hybrid cell<br />
lines containing the respective human<br />
chromosomes as the only human compo-<br />
CONTENTS<br />
INDEX<br />
nent. The fragment length distribution of<br />
the labeled probes shows a maximum at<br />
200–500 bases. 1 µg probe is sufficient for<br />
20–50 hybridizations on 24 x 24 mm<br />
coverslips.<br />
Reagent Cat. No. Pack size<br />
DNA probes, human chromosome<br />
1 specific, digoxigenin-labeled 1558 765 1 µg (50 µl)<br />
1 specific, fluorescein-labeled 1558 684 1 µg (50 µl)<br />
1 + 5 + 19 specific, digoxigenin-labeled 1690 507 1 µg (50 µl)<br />
1 + 5 + 19 specific, fluorescein-labeled 1690 647 1 µg (50 µl)<br />
2 specific, digoxigenin-labeled 1666 479 1 µg (50 µl)<br />
2 specific, fluorescein-labeled 1666 380 1 µg (50 µl)<br />
3 specific, digoxigenin-labeled 1690 515 1 µg (50 µl)<br />
4 specific, digoxigenin-labeled 1690 523 1 µg (50 µl)<br />
6 specific, digoxigenin-labeled 1690 531 1 µg (50 µl)<br />
7 specific, digoxigenin-labeled 1690 639 1 µg (50 µl)<br />
7 specific, fluorescein-labeled 1694 375 1 µg (50 µl)<br />
8 specific, digoxigenin-labeled 1666 487 1 µg (50 µl)<br />
8 specific, fluorescein-labeled 1666 398 1 µg (50 µl)<br />
9 specific, digoxigenin-labeled 1690 540 1 µg (50 µl)<br />
10 specific, digoxigenin-labeled 1690 558 1 µg (50 µl)<br />
10 specific, fluorescein-labeled 1690 655 1 µg (50 µl)<br />
11 specific, digoxigenin-labeled 1690 566 1 µg (50 µl)<br />
11 specific, fluorescein-labeled 1690 663 1 µg (50 µl)<br />
12 specific, digoxigenin-labeled 1690 574 1 µg (50 µl)<br />
12 specific, fluorescein-labeled 1690 671 1 µg (50 µl)<br />
13 + 21 specific, digoxigenin-labeled 1690 582 1 µg (50 µl)<br />
14 + 22 specific, digoxigenin-labeled 1666 495 1 µg (50 µl)<br />
14 + 22 specific, fluorescein-labeled 1666 401 1 µg (50 µl)<br />
15 specific, digoxigenin-labeled 1690 604 1 µg (50 µl)<br />
16 specific, digoxigenin-labeled 1699 091 1 µg (50 µl)<br />
17 specific, digoxigenin-labeled 1666 452 1 µg (50 µl)<br />
17 specific, fluorescein-labeled 1666 371 1 µg (50 µl)<br />
18 specific, digoxigenin-labeled 1666 509 1 µg (50 µl)<br />
18 specific, fluorescein-labeled 1666 428 1 µg (50 µl)<br />
20 specific, digoxigenin-labeled 1666 517 1 µg (50 µl)<br />
20 specific, fluorescein-labeled 1666 436 1 µg (50 µl)<br />
22 specific, digoxigenin-labeled 1690 612 1 µg (50 µl)<br />
X specific, digoxigenin-labeled 1666 525 1 µg (50 µl)<br />
X specific, fluorescein-labeled 1666 444 1 µg (50 µl)<br />
Y specific, digoxigenin-labeled 1558 196 1 µg (50 µl)<br />
Y specific, fluorescein-labeled 1558 692 1 µg (50 µl)<br />
Specific for all human chromosomes, digoxigenin-labeled 1558 757 1 µg (50 µl)<br />
Specific for all human chromosomes, fluorescein-labeled 1558 676 1 µg (50 µl)<br />
93<br />
5
5<br />
94<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Fluorescence in situ hybridization of a repetitive<br />
DNA probe <strong>to</strong> human chromosomes in suspension<br />
D. Celeda1, 2 , U. Bettag1 , and C. Cremer1 1 <strong>In</strong>stitute for Applied Physics, University of Heidelberg.<br />
2 <strong>In</strong>stitute for Human Genetics and Anthropology, University of Heidelberg, Germany.<br />
Fluorescence in situ hybridization (FISH)<br />
has found widespread application in the<br />
analysis of chromosomes and interphase<br />
nuclei fixed on slides (Anastasi et al., 1990;<br />
Cremer et al., 1988, 1990; Dekken et al.,<br />
1990; Devilee et al., 1988; Kolluri et al.,<br />
1990; Lichter et al., 1991; Pinkel et al., 1988;<br />
Schardin et al., 1985; Wienberg et al., 1990).<br />
However, hybridization of specific DNA<br />
probes <strong>to</strong> isolated metaphase chromosomes<br />
in suspension offers a new approach <strong>to</strong><br />
chromosome analysis and chromosome<br />
separation. <strong>In</strong>itial investigations were done<br />
on chromosomes obtained from a (Chinese<br />
hamster X human) hybrid cell line with biotinylated<br />
human genomic DNA as the<br />
probe (Dudin et al., 1987, 1988; Hausmann<br />
et al., 1991).<br />
So far the technique for FISH in suspension<br />
has been a modification of FISH techniques<br />
used for metaphase chromosomes<br />
and interphase nuclei fixed on slides. Formamide<br />
(and <strong>to</strong> some extent dextran sulfate)<br />
are obliga<strong>to</strong>ry components of this method.<br />
Thus, the technique requires a certain number<br />
of washing steps after hybridization.<br />
The washing steps for FISH in suspension,<br />
however, are based on centrifugal steps.<br />
These steps are responsible for a considerable<br />
reduction in the final amount of<br />
chromosomal material.<br />
Additionally, the existing method for<br />
FISH in suspension appears <strong>to</strong> favor an<br />
aggregation of the chromosomal material<br />
in suspension.<br />
We report here a hybridization technique<br />
which does not need formamide and<br />
dextran sulfate. As a model system, we used<br />
the repetitive specific human DNA probe<br />
pUC 1.77 (Cooke and Hindley, 1979;<br />
Emmerich et al., 1989), labeled it with<br />
digoxigenin-11-dUTP by nick-translation,<br />
and hybridized it <strong>to</strong> metaphase chromosomes<br />
in suspension. These chromosomes<br />
were isolated by standard techniques from<br />
human lymphocytes.<br />
<strong>In</strong> preliminary experiments, this technique<br />
produced a large number of isolated<br />
metaphase chromosomes with satisfac<strong>to</strong>ry<br />
morphology and clear hybridization<br />
signals (Figure 1).<br />
Adapting the same method and probe <strong>to</strong><br />
metaphase spreads (Figure 2) allowed us <strong>to</strong><br />
determine hybridization efficiency.<br />
Procedure<br />
Note: The DNA probe pUC 1.77 is a clone<br />
of the plasmid vec<strong>to</strong>r pUC 9 that contains<br />
a 1.77 kb human Eco RI fragment. The<br />
inserted DNA was isolated from human<br />
satellite DNA fraction II/III. This insert<br />
contains mainly a tandemly organized<br />
repetitive sequence in the region q12 of<br />
chromosome 1 (Cooke and Hindley, 1979;<br />
Gosden et al., 1981).<br />
1 Label the DNA probe pUC 1.77 with<br />
Digoxigenin-11-dUTP according <strong>to</strong><br />
standard nick translation procedures (as<br />
described in Chapter 4 of this manual).<br />
2 Cultivate human lymphocytes from<br />
peripheral blood.<br />
3 Prepare chromosomes from the<br />
lymphocytes by standard techniques.<br />
4 Resuspend the chromosomes and interphase<br />
nuclei in methanol/acetic acid<br />
(3:1) and s<strong>to</strong>re at –20°C.<br />
5 Perform fluorescence detection with<br />
Anti-DIG-Fluorescein, Fab fragments<br />
as described (Lichter et al., 1990), with<br />
the following modifications:<br />
<strong>In</strong>cubate for approx. 1 h at 37°C.<br />
After the blocking step, do not use<br />
bovine serum albumin in the rest of<br />
the procedure.<br />
Modify as necessary <strong>to</strong> allow FISH in<br />
suspension.<br />
6 After labeling and FISH procedures,<br />
pipette 10 µl of the suspension on a slide<br />
for microscopic analysis. Counterstain<br />
with 15 µM propidium iodide (PI) and<br />
5 µM DAPI.<br />
7 Analyze with an epifluorescence microscope<br />
(Orthoplan equipped with a<br />
Planapo oil 63 x objective and a 1.40<br />
aperture, Leitz, Wetzlar, Germany).<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
8 Pho<strong>to</strong>graph with, for instance, Fujichrome<br />
P1600 D film at a final image<br />
magnification of about 630 x, using Leitz<br />
filter system “I 2/3” for detection of<br />
FITC fluorescence.<br />
Results<br />
<br />
Figure 1: FISH of digoxigenin-labeled DNA probe<br />
pUC 1.77 <strong>to</strong> isolated human chromosomes in<br />
suspension. For details of the hybridization<br />
procedure, see the text. The sites of hybridization<br />
on the chromosomes appear as yellowish-green<br />
“spots” in the centromeric regions. Counterstaining<br />
was with propidium iodide (PI) and DAPI.<br />
Figure 2: FISH of a human metaphase spread<br />
according <strong>to</strong> the same hybridization technique<br />
used in Figure 1. <strong>In</strong> this case the pUC 1.77 DNA<br />
probe binds <strong>to</strong> major hybridization sites (q12 region<br />
of human chromosome 1) that appear as two large<br />
yellowish-green “spots” on two of the largest<br />
chromosomes (large arrowheads). Additionally, a<br />
minor binding site of the DNA probe (chromosome<br />
16; Gosden et al., 1981) is indicated by two minor<br />
yellowish-green “spots” on two of the smaller<br />
chromosomes (small arrowheads).<br />
CONTENTS<br />
INDEX<br />
<br />
95<br />
5
5<br />
*This product or the use of this<br />
product may be covered by one<br />
or more patents of Boehringer<br />
Mannheim GmbH, including the<br />
following: EP patent 0 649 909<br />
(application pending).<br />
96<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG-Nick Translation 5 x conc. stabilized reaction buffer in 50% 1745 816 160 µl<br />
Mix* for in situ probes glycerol (v/v) and DNA Polymerase I, DNase I,<br />
0.25 mM dATP, 0.25 mM dCTP, 0.25 dGTP,<br />
0.17 mM dTTP and 0.08 mM DIG-11-dUTP<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 741 200 µg<br />
Fluorescein<br />
DAPI Fluorescence dye for staining of 236 276 10 mg<br />
chromosomes<br />
Acknowledgments<br />
We thank Prof. Dr. T. Cremer, <strong>In</strong>titute of<br />
Human Genetics and Anthropology,<br />
University of Heidelberg, for providing the<br />
plasmid pUC 9 and the human lymphocyte<br />
preparations. The work was supported by<br />
the Deutsche Forschungsgemeinschaft.<br />
References<br />
Anastasi, J.; Le Beau M. M.; Vardiman, J. W.;<br />
Westbrook, C. A. (1990) Detection of numerical<br />
chromosomal abnormalities in neoplastic<br />
hema<strong>to</strong>poietic cells by in situ hybridization with a<br />
chromosome-specific probe. Am. J. Pathol. 136,<br />
131–139.<br />
Cooke, H. J.; Hindley, J. (1979) Cloning of human<br />
satellite III DNA: different components are in<br />
different chromosomes. Nucleic Acids Res. 10,<br />
3177–3197.<br />
Cremer, T.; Lichter, P.; Borden, J.; Ward, D. C.;<br />
Manuelidis, L. (1988) Detection of chromosome<br />
aberrations in metaphase and interphase tumor<br />
cells by in situ hybridization using chromosomespecific<br />
library probes. Hum. Genet. 80, 235–246.<br />
Cremer, T.; Popp, S.; Emmerich, P.; Lichter, P.;<br />
Cremer, C. (1990) Rapid metaphase and interphase<br />
detection of radiation-induced chromosome<br />
aberrations in human lymphocytes by chromosomal<br />
suppression in situ hybridization. Cy<strong>to</strong>metry 11,<br />
110–118.<br />
Dekken van, H.; Pizzolo, J. G.; Reuter, V. E.;<br />
Melamed, M. R. (1990) Cy<strong>to</strong>genetic analysis of<br />
human solid tumors by in situ hybridization with<br />
a set of 12 chromosome specific DNA probes.<br />
Cy<strong>to</strong>genet. Cell Genet. 54, 103–107.<br />
Devilee, P.; Thierry, R. F.; Kievits, T.; Kolluri, R.;<br />
Hopman, A. H. N.; Willard, H. F.; Pearson, P. L.;<br />
Cornellisse, C. J. (1988) Detection of chromosome<br />
aneuploidy in interphase nuclei from human primary<br />
breast tumors using chromosome-specific repetitive<br />
DNA probes. Cancer Res. 48, 5825–5830.<br />
Dudin, G.; Cremer, T.; Schardin, M.; Hausmann, M.;<br />
Bier, F.; Cremer, C. (1987) A method for nucleic<br />
acid hybridization <strong>to</strong> isolated chromosomes in<br />
suspension. Hum. Genet. 76, 290–292.<br />
Dudin, G.; Steegmayer, E. W.; Vogt, P.; Schnitzer, H.;<br />
Diaz, E.; Howell, K. E.; Cremer, T.; Cremer, C. (1988)<br />
Sorting of chromosomes by magnetic separation.<br />
Human. Genet. 80, 111–116.<br />
Emmerich, P.; Loos, P.; Jauch, A.; Hopman, A. H. N.;<br />
Wiegant, J.; Higgins, M. J.; White, B. N.; van der<br />
Ploeg, M.; Cremer, C.; Cremer, T. (1989) Double in<br />
situ hybridization in combination with digital image<br />
analysis: a new approach <strong>to</strong> study interphase<br />
chromosome <strong>to</strong>pography. Exp. Cell Res. 181,<br />
126–149.<br />
Gosden, J. R.; Lawrie, S. S.; Cooke, H.J. (1981)<br />
A cloned repeated DNA sequence in human<br />
chromosome heteromorphisms. Cy<strong>to</strong>genet. Cell<br />
Genet. 29, 32–39.<br />
Hausmann, M.; Dudin, G.; Aten, J. A.; Heilig, R.;<br />
Diaz, E.; Cremer, C. (1991) Slit scan flow cy<strong>to</strong>metry<br />
of isolated chromosomes following fluorescence<br />
hybridization: an approach of online screening<br />
for specific chromosomes and chromosome translocations.<br />
Z. Naturforsch. 46c, 433–441.<br />
Kolluri, R. V.; Manuelidis, L.; Cremer, T.; Sait, S.;<br />
Gezer, S.; Raza, A. (1990) Detection of monosomy 7<br />
in interphase cells for patients with myeloid disorders.<br />
Am. J. Herma<strong>to</strong>l. 33 (2), 117–122.<br />
Lichter, P.; Boyle, A. L.; Cremer, T.: Ward, D. C.<br />
(1991) Analysis of genes and chromosomes by<br />
non-iso<strong>to</strong>pic in situ hybridization. Genet. Anal.<br />
Techn. Appl. 8, 24–35.<br />
Lichter, P.; Tang, C. C.; Call, K.; Hermanson, G.;<br />
Evans, H. J.; Housman, D.; Ward, D. C. (1990)<br />
High resolution mapping of human chromosome 11<br />
by in situ hybridization with cosmid clones.<br />
Science 247, 64–69.<br />
Pinkel, D.; Landegent, J.; Collins, C.; Fuscoe, J.;<br />
Segraves, R.; Lucas, J.; Gray, J. W. (1988)<br />
Fluorescence in situ hybridization with human<br />
chromosome-specific libraries: detection of trisomy<br />
21 and translocations of chromosome 4. Proc. Natl.<br />
Acad. Sci. USA 85, 9138–9142.<br />
Schardin, M.; Cremer, T.; Hager, H. D.; Lang, M.<br />
(1985) Specific staining of human chromosomes in<br />
Chinese hamster X human cell lines demonstrates<br />
interphase terri<strong>to</strong>ries. Hum. Genet. 71, 281–287.<br />
Wienberg, J.; Jauch, A.; Stanyon, R.; Cremer, T.<br />
(1990) Molecular cy<strong>to</strong>taxonomy of primates by<br />
chromosomal in situ suppression hybridization.<br />
Genomics 8, 347–350.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
A simplified and efficient pro<strong>to</strong>col for nonradioactive<br />
in situ hybridization <strong>to</strong> polytene chromosomes with<br />
a DIG-labeled DNA probe<br />
Prof. Dr. E. R. Schmidt, <strong>In</strong>stitute for Genetics,<br />
Johannes Gutenberg-University of Mainz, Germany.<br />
The pro<strong>to</strong>col given here is a derivative of<br />
several published methods (Langer-Safer et<br />
al., 1982; Schmidt et al., 1988) with some<br />
minor modifications that make the method<br />
of in situ hybridization easier, faster, more<br />
reliable, and available <strong>to</strong> anyone who can<br />
operate a microscope.<br />
I. Labeling the hybridization probe<br />
For best labeling results, follow the random<br />
primed DNA labeling procedure (Procedure<br />
IA) in Chapter 4 of this manual. We<br />
suggest a modification of this procedure as<br />
described below:<br />
1 Use 0.5–1 µg linearized DNA in 16 µl<br />
redistilled H2O.<br />
2 Denature in a boiling water bath for<br />
10 min and chill on ice.<br />
3 Add 4 µl DIG-High Prime reaction<br />
mix.<br />
4 Mix, centrifuge and incubate either 2 h at<br />
37°C or overnight at room temperature.<br />
5 S<strong>to</strong>p the labeling procedure by heating<br />
in boiling water for 10 min.<br />
6 Add water and 20 x SSC <strong>to</strong> give a final<br />
volume of 100 µl with a final concentration<br />
of 5 x SSC.<br />
Note: If a larger number of preparations<br />
is <strong>to</strong> be hybridized, increase the<br />
volume <strong>to</strong> 200 µl.<br />
7 Add 1 volume of 10% SDS <strong>to</strong> 100 volumes<br />
of the mixture in Step 6 (i.e., 1 µl SDS <strong>to</strong><br />
100 µl of mixture) <strong>to</strong> give a final concentration<br />
of 0.1% SDS.<br />
8 The mixture is ready for hybridization<br />
and can be s<strong>to</strong>red at –20°C for at least<br />
several years without any significant<br />
decrease in hybridization efficiency.<br />
Comment: <strong>In</strong> my experience, it is<br />
absolutely unnecessary <strong>to</strong> remove<br />
unincorporated dNTPs from the mixture<br />
before using the labeled probe. On the<br />
contrary, purification steps lead <strong>to</strong> the<br />
loss of hybridizable probe DNA and thus<br />
<strong>to</strong> a decrease in hybridization efficiency.<br />
CONTENTS<br />
INDEX<br />
II. Preparation and denaturation of<br />
polytene chromosomes from Drosophila,<br />
Chironomus, or other species<br />
Squash larval salivary glands in 40% acetic<br />
acid according <strong>to</strong> standard procedure.<br />
For long term s<strong>to</strong>rage, place slides with<br />
squashed chromosomes in 100% 2-propanol<br />
at –20°C.<br />
Prior <strong>to</strong> the in situ hybridization, denature<br />
the chromosomal DNA according <strong>to</strong> this<br />
procedure:<br />
1 Rehydrate the slides by incubating them,<br />
for 2 min each, in solutions containing<br />
decreasing amounts of ethanol: 70%<br />
ethanol, 50% ethanol, 30% ethanol,<br />
0.1 x SSC–2 x SSC.<br />
2 Digest with RNase if necessary.<br />
Note: This is usually not necessary.<br />
3 For better preservation of the chromosomes,<br />
include a “heat stabilization” step<br />
by incubating slides in 2 x SSC for at<br />
least 30 min at 80°C.<br />
4 <strong>In</strong>cubate the slides for 90 s in 0.1 N<br />
NaOH, at room temperature.<br />
5 Wash slides for 30 s in 2 x SSC.<br />
6 Dehydrate slides by incubating them,<br />
for 2 min each, in solutions containing<br />
increasing amounts of ethanol: 30%<br />
ethanol, 50% ethanol, 70% ethanol,<br />
95% ethanol.<br />
7 Air dry the slides for 5 min. The<br />
preparations are then ready for<br />
hybridization.<br />
Comment: If “denatured” chromosome<br />
preparations are <strong>to</strong> be s<strong>to</strong>red for a long<br />
time, s<strong>to</strong>re them in 95% ethanol or<br />
2-propanol at –20°C.<br />
97<br />
5
5<br />
98<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
III. <strong>Hybridization</strong> and detection<br />
1 Add 5 µl of the hybridization mixture<br />
containing the digoxigenin-labeled probe<br />
DNA (from Procedure I) <strong>to</strong> the chromosome<br />
preparation and cover with a<br />
coverslip (18 x 18 mm).<br />
2 Seal coverslip with rubber cement.<br />
3 <strong>In</strong>cubate slides at the appropriate<br />
hybridization temperature between<br />
50°C and 65°C (depending on the probe,<br />
AT-content, sequence homology, etc.)<br />
for 4–6 h (for single copy sequences) or<br />
for 1 h (for repetitive sequences).<br />
Note: Longer incubations do not markedly<br />
increase the hybridization signal!<br />
4 Remove rubber cement, then wash off<br />
the coverslip in 2 x SSC for 2–5 min at<br />
room temperature .<br />
5 Wash the slide in PBS for 2 min. Remove<br />
excess buffer from the slide by wiping<br />
with soft paper around the chromosome<br />
preparation.<br />
Note: Do not let the preparation dry<br />
completely; this produces background.<br />
6 Apply 5 µl of a 1:10 diluted solution of<br />
fluorescein- or rhodamine-labeled anti-<br />
DIG antibody. The antibodies should<br />
be diluted in PBS containing 1 mg/ml<br />
bovine serum albumin.<br />
Figure 1: Double in situ hybridization of a polytene chromosome of Chironomus with<br />
two different clones from a chromosomal walk within the sex-determining region of<br />
Chironomus piger. The two -clones contain genomic DNA fragments which are 60 kbp<br />
apart. One clone was labeled with digoxigenin and detected with rhodamine-labeled anti-DIG<br />
antibody (red); the second clone was labeled with biotin and detected with anti-biotin<br />
antibody and fluorescein-labeled secondary antibody (green). The red and green signals can<br />
be seen simultaneously if the fluorescence microscope is equipped with a filter system for<br />
simultaneous blue and green excitation (filter no. 513 803, Leica, Wetzlar). For the<br />
hybridization, the two probes are mixed 1:1, and the detection is performed with mixed<br />
antibody solutions. The method allows a very clear orientation for a chromosomal walk. We<br />
were able <strong>to</strong> discriminate the location of two clones which were only approximately 30 kb<br />
apart.<br />
<br />
7 <strong>In</strong>cubate 30 min with anti-DIG antibody<br />
at 37°C under a coverslip.<br />
8 Wash 5 min in PBS.<br />
9 Blot off excess buffer with paper.<br />
10 Finally, mount the chromosomal preparation<br />
in “glycerol-para-phenylenediamine-mixture”<br />
[1 mg p-phenylenediamine<br />
dissolved in 1 ml phosphate buffered<br />
saline (1 mM sodium phosphate, pH<br />
8.0; 15 mM NaCl) containing 50%<br />
glycerol].<br />
11 <strong>In</strong>spect with a fluorescence microscope<br />
with the appropriate set of filters.<br />
Comments: <strong>In</strong>stead of antibodies labeled<br />
with fluorescent dyes, any other antibody<br />
conjugates (enzyme conjugated, goldlabeled)<br />
can be used. <strong>In</strong> the case of<br />
biotin-labeled DNA, streptavidin can be<br />
used instead of antibodies <strong>to</strong> detect the<br />
hybridized DNA. I have tested a<br />
number of these possibilities, and all<br />
work very well (including gold-labeled<br />
anti-digoxigenin antibody followed by<br />
silver-enhancement). However, in my<br />
experience, the most precise localization<br />
is obtained with immunofluorescence. It<br />
seems <strong>to</strong> me that the sensitivity is also<br />
higher (or at least the signal/background<br />
ratio is improved) with fluorescently<br />
labeled antibodies. Admittedly, this<br />
might be a matter of personal preference.<br />
Results<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
<br />
Figure 2: Double hybridization of a single copy<br />
clone from the sex-determining region <strong>to</strong>gether<br />
with a highly repetitive DNA element. The single<br />
copy DNA fragment was labeled with digoxigenin<br />
and the repetitive element with biotin. The single<br />
copy DNA (red) hybridizes <strong>to</strong> a single band, while the<br />
repetitive element (green) produces signals over<br />
numerous chromosomal sites throughout the entire<br />
chromosome. <strong>Hybridization</strong> and detection of the<br />
hybridized DNA was essentially the same as in<br />
Figure 1.<br />
References<br />
Langer-Safer, P. R.; Levine, M.; Ward, D. C. (1982)<br />
Immunological method for mapping genes on<br />
Drosophila polytene chromosomes. Proc. Natl.<br />
Acad. Sci. USA 79, 4381–4385.<br />
Schmidt, E. R.; Keyl, H.-G.; Hankeln, T. (1988)<br />
<strong>In</strong> situ localization of two haemoglobin gene<br />
clusters in the chromosomes of 13 species of<br />
Chironomus. Chromosoma (Berl.) 96, 353–359.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG-High Prime* , ** , *** Complete reaction mixture for random 1 585 606 160 µl<br />
primed labeling of DNA with DIG-dUTP<br />
5 x solution with: 1 mM dATP, dCTP, dGTP<br />
(each), 0.65 mM dTTP, 0.35 mM<br />
DIG-11-dUTP, alkali-labile; random primer<br />
mixture; 1 unit/µl Klenow enzyme labeling<br />
grade, in reaction buffer, 50% glycerol (v/v)<br />
(40 reactions)<br />
Biotin-High Prime** Complete reaction mixture for random 1 585 649 100 µl<br />
primed labeling of DNA with Biotin-dUTP (25 reactions)<br />
5 x solution with: 1 mM dATP, dCTP, dGTP<br />
(each), 0.65 mM dTTP, 0.35 mM<br />
biotin-16-dUTP, random primer mixture,<br />
1 unit/µl Klenow enzyme labeling<br />
grade, in reaction buffer, 50% glycerol (v/v)<br />
RNase, DNase-free RNase, DNase-free, can be used directly 1119 915 500 µg (1 ml)<br />
without prior heat treatment in any DNA<br />
isolation technique<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 750 200 µg<br />
Rhodamine<br />
CONTENTS<br />
INDEX<br />
Figure 3: Double in situ hybridization of biotinand<br />
digoxigenin-labeled DNA probes from two<br />
different “DNA puffs” in the salivary gland polytene<br />
chromosome C of Trichosia pubescens<br />
(Sciaridae, Diptera). The probes were hybridized<br />
simultaneously as described in Figure 1. The two<br />
sites of hybridization were detected with rhodamine-labeled<br />
anti-DIG and anti-biotin antibodies<br />
plus fluorescein-labeled secondary antibody. The<br />
two differentially labeled sites are so-called “DNA<br />
puffs”, which are chromosomal regions with a<br />
developmentally regulated DNA amplification. The<br />
double in situ hybridization method allows very<br />
rapid mapping of the chromosomes, even when<br />
the banding structure of the chromosome is not<br />
analyzed in detail.<br />
***EP Patent 0 324 474 granted<br />
<strong>to</strong> and EP Patent application<br />
0 371 262 pending for Boehringer<br />
Mannheim GmbH.<br />
***This product or the use of this<br />
product may be covered by one<br />
or more patents of Boehringer<br />
Mannheim GmbH, including the<br />
following: EP patent 0 649 909<br />
(application pending).<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
99<br />
5
5<br />
100<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Multiple-target DNA in situ hybridization with<br />
enzyme-based cy<strong>to</strong>chemical detection systems<br />
E. J. M. Speel, F. C. S. Ramaekers, and A. H. N. Hopman, Department of Molecular<br />
Cell Biology & Genetics, University of Limburg, Maastricht, The Netherlands.<br />
Fluorescence in situ hybridization (ISH) is<br />
widely utilized because of its high sensitivity,<br />
resolution, and ability <strong>to</strong> detect<br />
multiple cellular nucleic acid sequences in<br />
different colors. Fluorescence ISH, however,<br />
has disadvantages, such as:<br />
Fluorescence signals fade when they are<br />
exposed <strong>to</strong> light.<br />
Au<strong>to</strong>fluorescence in, e.g., tissue sections<br />
can interfere with target analysis.<br />
Here we outline a multicolor enzyme-based<br />
cy<strong>to</strong>chemical detection pro<strong>to</strong>col for nucleic<br />
acids in situ. This pro<strong>to</strong>col produces permanent<br />
cell preparations with non-diffusible,<br />
nonfading reaction products. The reaction<br />
products can be analyzed with brightfield<br />
(Speel et al., 1994a), reflection-contrast<br />
(Speel et al., 1993), or, in one case (alkaline<br />
phosphatase-Fast Red reaction), fluorescence<br />
microscopy (Speel et al., 1992).<br />
We show examples of single- and multipletarget<br />
ISH experiments on standard human<br />
lymphocyte metaphase spreads, as well as on<br />
interphase cell preparations. These results<br />
demonstrate the potential of this detection<br />
methodology for metaphase and interphase<br />
cy<strong>to</strong>genetics, e.g., for studying chromosome<br />
aberrations in different cell types (Martini et<br />
al., 1995). <strong>In</strong> addition, this methodology can<br />
be applied in the area of pathology, since the<br />
universal detection pro<strong>to</strong>col described here<br />
can be combined with other sample preparation<br />
procedures, e.g., for tissue sections<br />
(Hopman et al., 1991, 1992).<br />
The procedures given below are modifications<br />
of previously published procedures<br />
(Speel et al., 1992, 1993, 1994a, 1994b).<br />
I. Cell preparations<br />
Lymphocytes: Prepare chromosomes from<br />
peripheral blood lymphocytes by standard<br />
methods. Fix in methanol:acetic acid (3:1,<br />
v/v), and drop chromosomes on<strong>to</strong> glass<br />
slides that have been cleaned with a 1:1 mix<br />
of ethanol and ether.<br />
Cultured cells: Make preparations from<br />
cultured normal diploid cells or tumor cell<br />
lines by one of the following methods:<br />
Ethanol suspension: Trypsinize cells (if<br />
necessary), harvest, wash in PBS, fix in<br />
cold 70% ethanol (–20°C), and drop<br />
on<strong>to</strong> glass slides that have been coated<br />
with poly-L-lysine.<br />
Slide and coverslip preparations: Grow<br />
cells on glass slides or coverslips. Fix in<br />
cold methanol (–20°C) for 5 s, then in<br />
cold ace<strong>to</strong>ne (4°C) for 3 x 5 s. Air dry<br />
samples and s<strong>to</strong>re at –20°C.<br />
Note: Alternatively, use other fixatives<br />
for the slide and coverslip preparations.<br />
Cy<strong>to</strong>spins: Cy<strong>to</strong>spin floating cells on<strong>to</strong><br />
glass slides at 1000 rpm for 5 min. Air<br />
dry samples for 1 h at room temperature.<br />
Fix and s<strong>to</strong>re as with slide and coverslip<br />
preparations above.<br />
II. Cell processing<br />
1 Decide whether samples need <strong>to</strong> be<br />
treated with RNase. Then do one of the<br />
following:<br />
If the cells need RNase, go <strong>to</strong> Step 2.<br />
If the cells do not need RNase, go <strong>to</strong><br />
Step 3.<br />
2 Treat slides with RNase as follows:<br />
Overlay each sample with 100 µl<br />
RNase solution (100 µg/ml RNase A<br />
in 2 x SSC) and a coverslip.<br />
<strong>In</strong>cubate cell samples for 1 h at 37°C.<br />
Remove coverslip and wash samples<br />
3 x 5 min with 2 x SSC.<br />
Go <strong>to</strong> Step 3.<br />
3 Treat slides with pepsin as follows:<br />
Overlay each sample with 100 µl pepsin<br />
solution (50–100 µg/ml pepsin in<br />
10 mM HCl) and a coverslip.<br />
<strong>In</strong>cubate cell samples for 10–20 min<br />
at 37°C.<br />
Wash samples as follows:<br />
– 2 min with 10 mM HCl<br />
– 2 x 5 min with PBS<br />
4 Post-fix samples as follows:<br />
<strong>In</strong>cubate samples with PBS containing<br />
1% (para)formaldehyde for either<br />
20 min at 4°C or 10 min at room<br />
temperature.<br />
Wash slides 2 x 5 min with PBS.<br />
Dehydrate samples by passing slides<br />
through a series of ethanol solutions<br />
(70%, then 96%, then 100% ethanol),<br />
incubating 10–60 s in each solution.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
III. Probe preparation<br />
1 Label the DNA probes (containing either<br />
repetitive or unique sequences) with<br />
Biotin-, Digoxigenin-, or FluoresceindUTP<br />
according <strong>to</strong> the nick translation<br />
procedure in Chapter 4 of this manual.<br />
2 Just before use, prepare hybridization<br />
buffer containing:<br />
50% or 60% formamide.<br />
10% dextran sulfate.<br />
2 x SSC.<br />
0.2 µg/µl sonicated herring sperm<br />
DNA.<br />
0.2 µg/µl yeast tRNA.<br />
1–2 ng labeled probe DNA/µl hybridization<br />
buffer [if the probe contains<br />
unique or highly repetitive (e.g.<br />
centromere probe) sequences]<br />
or<br />
2–4 ng labeled probe DNA/µl hybridization<br />
buffer, <strong>to</strong>gether with an excess<br />
(100–1000 fold) of <strong>to</strong>tal human DNA<br />
or Cot-1 DNA [if the probe contains<br />
repetitive(e.g.Alu)elements].<br />
3 Perform ISH by one of the following<br />
methods:<br />
If the probe contains unique or highly<br />
repetitive (e.g. centromere probe)<br />
sequences, follow procedure IVA.<br />
If the probe contains repetitive (e.g.<br />
Alu) elements, follow procedure IVB.<br />
For multiple-target in situ hybridization,<br />
prepare DNA probes labeled<br />
with different haptens (biotin, digoxigenin,<br />
or fluorescein), mix them<br />
<strong>to</strong>gether, and follow either Procedure<br />
IVA or Procedure IVB (depending on<br />
the nature of the probes).<br />
CONTENTS<br />
INDEX<br />
IV. Multiple-target in situ<br />
hybridization (ISH)<br />
IVA. ISH with simultaneous probe and target<br />
denaturation [for probes with unique or<br />
highly repetitive (e.g., centromere probe)<br />
sequences]<br />
1 On each sample, place 10 µl of hybridization<br />
buffer containing labeled probe<br />
DNA (prepared as in Procedure III,<br />
Step 2).<br />
2 Cover sample with a 20 x 20 mm coverslip<br />
and (if you wish) seal the coverslip<br />
<strong>to</strong> the slide with rubber cement.<br />
3 Denature probe and cellular DNA<br />
simultaneously by placing slides at 70°–<br />
75°C for 3–5 min on the bot<strong>to</strong>m of a<br />
metal box.<br />
4 <strong>In</strong>cubate hybridization samples overnight<br />
at 37°C.<br />
5 Go <strong>to</strong> Procedure V.<br />
IVB. ISH with separate probe and target<br />
denaturation [for probes with repetitive<br />
(e.g. Alu) elements]<br />
1 <strong>In</strong>cubate the probe mixture (labeled<br />
probe DNA, human or Cot-1 DNA,<br />
hybridization buffer; prepared as in<br />
Procedure III, Step 2) for 5 min at 75°C.<br />
2 Chill the denatured probe mixture on<br />
ice.<br />
3 <strong>In</strong>cubate the denatured probe mixture<br />
for 1–4 h at 37°C <strong>to</strong> pre-anneal the<br />
repetitive sequences in the mixture.<br />
4 Denature the cell samples as follows:<br />
Overlay the cell samples with 70%<br />
formamide in 2 x SSC.<br />
<strong>In</strong>cubate the slides for 2 min at 70°C<br />
<strong>to</strong> denature the cells.<br />
Dehydrate the cell samples in a series<br />
of chilled (–20°C) ethanol solutions<br />
(70%, then 96%, then 100% ethanol),<br />
incubating them for 5 min in each<br />
solution.<br />
Air dry the samples.<br />
5 On each denatured cell sample (from<br />
Step 4), place 10 µl denatured, preannealed<br />
probe mixture (from Step 3).<br />
6 <strong>In</strong>cubate hybridization samples overnight<br />
at 37°C.<br />
7 Go <strong>to</strong> Procedure V.<br />
101<br />
5
5<br />
Table 1: Frequently used detection<br />
systems for enzyme-based in situ<br />
hybridization.<br />
1 Abbreviations used: Ab, antibody;<br />
ABC, avidin-biotinylated enzyme<br />
(horseradish peroxidase or alkaline<br />
phosphatase) complex; E, enzyme<br />
(horseradish peroxidase or alkaline<br />
phosphatase).<br />
2 Hapten = biotin, digoxigenin, FITC,<br />
or DNP.<br />
3 Anti-hapten Ab raised in another<br />
species (e.g., rabbit, goat, swine)<br />
can also be used as primary Ab in<br />
probe detection schemes.<br />
102<br />
<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
V. Post-hybridization washes<br />
1 Perform the following stringent washes<br />
of the samples (from either Procedure<br />
IVA or Procedure IVB) at 42°C:<br />
2 x 5 min with 2 x SSC containing<br />
50% (or 60%) formamide and 0.05%<br />
Tween ® 20.<br />
2 x 5 min with 2 x SSC.<br />
2 Depending upon the nature of the<br />
probe, do one of the following:<br />
If the probe contains repetitive (e.g.<br />
Alu) elements, wash the samples 2 x<br />
5 min at 60°C with 0.01 x SSC.<br />
If the probe does not contain repetitive<br />
elements, skip this step.<br />
VI. Enzyme-based cy<strong>to</strong>chemical<br />
detection<br />
VIA. Single color detection<br />
6 Repeat Step 5 with the next incubation<br />
in the detection system (Table 1) until all<br />
incubations are complete.<br />
7 After all incubations in the detection system<br />
are complete, wash samples 5 min<br />
with PBS.<br />
8 Visualize according <strong>to</strong> one of the procedures<br />
in Section VII.<br />
9 If the detection procedure uses the same<br />
enzyme (peroxidase or alkaline phosphatase)<br />
<strong>to</strong> detect two different probes,<br />
do the following:<br />
<strong>In</strong>activate the enzyme on the first<br />
detecting molecule by incubating the<br />
sample for 10 min at room temperature<br />
with 10 mM HCl.<br />
Repeat Steps 5–8 with a second<br />
detection system that recognizes the<br />
sec-ond probe (Speel et al., 1994b).<br />
Probe <strong>In</strong>cubation<br />
label 1 2 3<br />
Biotin Avidin-E 1<br />
Biotin Avidin-E Biotinylated anti-avidin Ab Avidin-E<br />
Hapten 2 Anti-hapten Ab-E<br />
Hapten Mouse 3 anti-hapten Ab Anti-mouse Ab-E<br />
Hapten Mouse anti-hapten Ab Rabbit anti-mouse Ab-E Anti-rabbit Ab-E<br />
Hapten Mouse anti-hapten Ab Biotinylated anti-mouse Ab ABC<br />
Hapten Mouse anti-hapten Ab DIG-labeled anti-mouse Ab Anti-DIG Ab-E<br />
1 Wash samples briefly with 4 x SSC<br />
containing 0.05% Tween ® 20.<br />
2 <strong>In</strong>cubate samples for 10 min at 37°C<br />
with 4 x SSC containing 5% nonfat dry<br />
milk.<br />
3 Choose an appropriate enzyme-based<br />
detection system (Table 1).<br />
4 Dilute detecting molecules as follows:<br />
Dilute avidin conjugates in 4 x SSC<br />
containing 5% nonfat dry milk.<br />
Dilute antibody conjugates in PBS<br />
containing 2–5% normal serum and<br />
0.05% Tween ® 20.<br />
5 For the first incubation in the detection<br />
system (Table 1), do the following:<br />
<strong>In</strong>cubate samples with diluted detecting<br />
molecule for 30 min at 37°C.<br />
Wash samples 2 x 5 min in the appropriate<br />
wash buffer (4 x SSC for avidin;<br />
PBS for antibodies) containing 0.05%<br />
Tween ® 20.<br />
VIB. Multiple target, multicolor detection<br />
To detect multiple probes labeled with<br />
different haptens, use a combination of<br />
detection systems. For example, Table 2<br />
outlines a pro<strong>to</strong>col for triple-target in situ<br />
hybridization. For pro<strong>to</strong>cols with doubletarget<br />
in situ hybridizations, see Hopman<br />
et al. (1986), Emmerich et al. (1989),<br />
Mullink et al. (1989), Herring<strong>to</strong>n et al.<br />
(1989), Kerstens et al. (1994), and Speel et<br />
al. (1995).<br />
Note: Alternatively, if two peroxidase or<br />
phosphatase reactions are used in the<br />
detection pro<strong>to</strong>col (Speel et al., 1994b),<br />
inactivate the enzyme after the first<br />
detection reaction in 10 mM HCl for 10<br />
min at room temperature, then perform<br />
the second detection reaction (as in<br />
Procedure VIA above).<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Detection step <strong>In</strong>cubation <strong>In</strong>cubation<br />
time 2 temperature<br />
1. Detect biotin with AvPO1 (diluted 1:50) 20 min 37°C<br />
2. Visualize PO by Procedure VIIA<br />
(PO-DAB, brown signal)<br />
5 min 37°C<br />
3. <strong>In</strong>activate residual AvPO with 10 mM HCl. 10 min RT<br />
4. Detect digoxigenin and FITC with MADIG<br />
and RAFITC (each diluted 1:2000)<br />
30 min 37°C<br />
5. Detect anti-digoxigenin and anti-FITC with<br />
GAMAPase (diluted 1:25) and SWARPO<br />
(diluted 1:100)<br />
30 min 37°C<br />
6. Visualize APase activity by Procedure VIIC<br />
(APase-Fast Red, red signal)<br />
5–10 min 37°C<br />
7. Visualize PO activity by Procedure VIIB<br />
(PO-TMB, green signal)<br />
1–2 min 37°C<br />
8. Counterstain with hema<strong>to</strong>xylin 1 sec RT<br />
9. Air dry 10 min RT<br />
10. Embed in a protein matrix3 10 min 37°C<br />
VII. Visualization<br />
Enzyme label Substrate Precipitate colors in microscopy<br />
Brightfield Reflection-contrast Fluorescence<br />
PO 2 H2O2/DAB Brown White –<br />
H2O2/TMB Green Pink/Red –<br />
APase N-ASMX-P/FR Red Yellow Red<br />
BCIP/NBT Purple Yellow/Orange –<br />
Depending upon the type of microscopy<br />
<strong>to</strong> be used for analysis (Table 3) and the<br />
detecting molecule, choose one of the<br />
following procedures <strong>to</strong> visualize the<br />
hybrids. <strong>In</strong> our hands, each of these procedures<br />
is optimal for in situ hybridization.<br />
VIIA. Horseradish peroxidasediaminobenzidine<br />
(PO-DAB)<br />
1 Mix color reagent just before use:<br />
1 ml 3,3-diaminobenzidine tetrachloride<br />
(DAB; Sigma) s<strong>to</strong>ck (5 mg<br />
DAB/ml PBS).<br />
9 ml PBS containing 0.1 M imidazole,<br />
pH 7.6.<br />
10 µl 30% H2O2.<br />
2 Overlay each sample with 100 µl color<br />
reagent and a coverslip.<br />
3 <strong>In</strong>cubate samples for 5–15 min at 37°C.<br />
4 Wash samples 3 x 5 min with PBS and (if<br />
you wish) dehydrate them.<br />
5 Coverslip with an aqueous or organic<br />
mounting medium.<br />
CONTENTS<br />
INDEX<br />
VIIB. Horseradish peroxidasetetramethylbenzidine<br />
(PO-TMB)<br />
1 Dissolve 100 mg sodium tungstate<br />
(Sigma) in 7.5 ml 100 mM citratephosphate<br />
buffer (pH 5.1). Adjust the<br />
pH of the tungstate solution <strong>to</strong> pH<br />
5.0–5.5 with 37% HCl.<br />
2 Just before use, dissolve 20 mg dioctyl<br />
sodium sulfosuccinate (Sigma) and 6 mg<br />
3,3',5,5'-tetramethylbenzidine (TMB,<br />
Sigma) in 2.5 ml 100% ethanol at 80°C.<br />
3 Prepare 10 ml color reagent by combining<br />
the tungstate solution (Step 1), the<br />
TMB solution (Step 2), and 10 µl 30%<br />
H2O2.<br />
4 Overlay each sample with 100 µl color<br />
reagent and a coverslip.<br />
5 <strong>In</strong>cubate samples for 1–2 min at 37°C.<br />
6 Wash samples 3 x 1 min with ice-cold<br />
100 mM phosphate buffer (pH 6.0) and<br />
(if you wish) dehydrate them.<br />
7 Coverslip with an organic mounting<br />
medium or immersion oil.<br />
Table 2: Detection pro<strong>to</strong>col for<br />
triple-target in situ hybridization<br />
with a biotin-, digoxigenin-, and a<br />
FITC-labeled probe.<br />
1 Abbreviations used: Ab, antibody;<br />
APase, alkaline phosphatase;<br />
AvPO, PO-conjugated avidin<br />
(Vec<strong>to</strong>r); DAB, diaminobenzidine;<br />
GAMAPase, APase-conjugated<br />
goat anti-mouse Ab (DAKO);<br />
MADIG, mouse anti-digoxigenin<br />
Ab; PO, horseradish peroxidase;<br />
RAFITC, rabbit anti-FITC Ab<br />
(DAKO); RT, room temperature;<br />
SWARPO, PO-conjugated swine<br />
anti-rabbit Ab (DAKO).<br />
2 For details of detection reactions,<br />
see Procedure VIA. For details of<br />
visualization reactions, see<br />
Procedures VIIA–VIID.<br />
3 For details of protein matrix, see<br />
Procedure VIII.<br />
<br />
Table 3: Enzyme reaction<br />
pro<strong>to</strong>cols and colors in different<br />
types of light microscopy1 .<br />
1 Other enzyme reactions that have<br />
been used for ISH are described in<br />
Speel et al. (1993, 1995).<br />
2 Abbreviations used: APase, alkaline<br />
phosphatase; BCIP, bromochloro-indolyl<br />
phosphate; DAB,<br />
diaminobenzidine; FR, Fast Red<br />
TR; N-ASMX-P, naphthol-ASMXphosphate;<br />
NBT, nitroblue tetrazolium;<br />
PO, horseradish peroxidase;<br />
TMB, tetramethylbenzidine.<br />
103<br />
5
5<br />
104<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
VIIC. Alkaline phosphatase-Fast Red<br />
(APase-Fast Red)<br />
1 Mix color reagent just before use:<br />
4 ml TM buffer [200 mM Tris-HCl<br />
(pH 8.5), 10 mM MgCl2] containing<br />
5% polyvinyl alcohol (PVA, MW<br />
40,000; Sigma).<br />
250 µl TM buffer containing 1 mg<br />
naphthol-ASMX-phosphate (Sigma).<br />
750 µl TM buffer containing 5 mg<br />
Fast Red TR salt (Sigma).<br />
2 Overlay each sample with 100 µl color<br />
reagent and a coverslip.<br />
3 <strong>In</strong>cubate samples for 5–15 min at 37°C.<br />
4 Wash samples 3 x 5 min with PBS.<br />
5 Coverslip with an aqueous mounting<br />
medium.<br />
VIID. Alkaline phosphatase-bromochloroindolyl<br />
phosphate (APase-BCIP/NBT)<br />
Follow the standard procedure given in<br />
Chapter 2 of this manual.<br />
VIII. Embedding and light microscopy<br />
1 Prepare samples for microscopy by<br />
doing either of the following:<br />
If samples require a single mounting<br />
medium, embed stained samples as<br />
described in Procedure VII.<br />
If multiple precipitation reactions<br />
would require different (aqueous or<br />
organic) embedding mediums, apply<br />
instead a protein embedding layer by<br />
smearing 50 µl of a 1:1 mixture of<br />
BSA solution (40 mg/ml in deionized<br />
H2O) and 4% formaldehyde on<strong>to</strong> the<br />
slides. Air dry for 10 min at 37°C.<br />
Note: This protein embedding layer<br />
can be used <strong>to</strong> prevent solubilization<br />
of enzyme precipitates during all<br />
types of light microscopy (Speel et al.,<br />
1993, 1994a).<br />
2 Perform brightfield, fluorescence and<br />
reflection contrast microscopy as<br />
described in the literature (Speel et al.,<br />
1992, 1993, 1994b; Cornelese-Ten Velde et<br />
al., 1989).<br />
Results<br />
<br />
Figure 1: Single-target ISH on a normal human<br />
lymphocyte metaphase spread with a peroxidase<br />
detection system. The probe was a biotinylated<br />
cosmid that recognizes 40 kb of chromosome<br />
11q23. The detection system included monoclonal<br />
anti-biotin Ab (DAKO), rabbit anti-mouse Ab-PO,<br />
and the PO-DAB reaction. The sample was<br />
counterstained with hema<strong>to</strong>xylin and viewed by<br />
brightfield microscopy.<br />
<br />
Figure 2: Double-target ISH on normal human<br />
umbilical vein endothelial cells with brightfield<br />
viewing. The centromere of chromosome 1 (brown)<br />
was detected with a biotinylated probe; that of<br />
chromosome 7 (red), with a digoxigenin-labeled<br />
probe. The detection steps included (1) avidin-PO,<br />
(2) monoclonal anti-digoxigenin Ab and rabbit antimouse<br />
Ab-APase, (3) the APase-Fast Red reaction,<br />
and (4) the PO-DAB reaction. The sample was<br />
counterstained with hema<strong>to</strong>xylin and viewed by<br />
brightfield microscopy.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
<br />
Figure 3: Same ISH experiment as in Figure 1,<br />
but with a fluorescent alkaline phosphatase<br />
detection system. The detection system for the<br />
biotinylated cosmid probe included monoclonal<br />
anti-biotin, horse anti-mouse Ab-biotin, avidinbiotinylated<br />
APase complex, and the APase-Fast<br />
Red reaction (Speel et al., 1994a). The sample was<br />
counterstained with Thiazole Orange (Molecular<br />
Probes) and viewed by fluorescence microscopy.<br />
<br />
Figure 5: Triple-target ISH on human bladder<br />
tumor cell line T24. The probes and experimental<br />
procedures were the same as in Figure 4.<br />
Reprinted from Speel, E. J. M.; Kamps, M.; Bonnet, J.;<br />
Ramaekers, F. C. S.; Hopman, A. H. N.; (1993) Multicolor<br />
preparations for in situ hybridization using precipitating<br />
enzyme cy<strong>to</strong>chemistry in combination with reflection<br />
contrast microscopy. His<strong>to</strong>chemistry 100, 357–366 with<br />
permission of Springer-Verlag GmbH & Co. KG.<br />
CONTENTS<br />
INDEX<br />
Figure 4: Triple-target ISH on a normal human<br />
lymphocyte metaphase spread. Probes specific<br />
for the centromeres of chromosomes 1 (brown),<br />
7 (red), and 17 (green) were labeled with biotin,<br />
digoxigenin, and FITC, respectively. Detection,<br />
counterstaining, and embedding in a BSA protein<br />
layer was as outlined in the text (Table 2). The<br />
sample was viewed by brightfield microscopy.<br />
Figure 6: Double-target ISH on a normal human<br />
lymphocyte metaphase spread with reflection<br />
contrast viewing. The centromere of chromosome 1<br />
(yellow) was detected with a biotinylated probe;<br />
that of chromosome 17 (white), with a digoxigeninlabeled<br />
probe. The detection steps included (1)<br />
monoclonal anti-biotin Ab and rabbit anti-digoxigenin<br />
Ab, (2) horse anti-mouse Ab-biotin and swine<br />
anti-rabbit Ab-PO, (3) streptavidin-biotinylated<br />
APase complex, (4) the APase-Fast Red reaction,<br />
and (5) the PO-DAB reaction (Speel et al., 1993).<br />
The sample was not counterstained, but was<br />
embedded in a BSA protein layer and viewed by<br />
reflection contrast microscopy.<br />
105<br />
5
5<br />
106<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
References<br />
Cornelese-Ten Velde, I.; Wiegant, J.; Tanke, H. J.;<br />
Ploem, J. S. (1989) Improved detection and<br />
quantification of the (immuno)peroxidase product<br />
using reflection contrast microscopy. His<strong>to</strong>chemistry<br />
92, 153–160.<br />
Emmerich, P.; Loos, P.; Jauch, A.; Hopman, A. H. N.;<br />
Wiegant, J.; Higgins, M. J.; White, B. N.; Van der<br />
Ploeg, M.; Cremer, C.; Cremer, T. (1989) Double<br />
in situ hybridization in combination with digital<br />
image analysis: a new approach <strong>to</strong> study interphase<br />
chromosome <strong>to</strong>pography. Exp. Cell Res. 181,<br />
126–140.<br />
Herring<strong>to</strong>n, C. S.; Burns, J.; Graham, A. K.;<br />
Bhatt, B.; McGee, J. O’D. (1989) <strong>In</strong>terphase cy<strong>to</strong>genetics<br />
using biotin and digoxygenin labeled<br />
probes II: simultaneous differential detection of<br />
human and papilloma virus nucleic acids in<br />
individual nuclei. J. Clin. Pathol. 42, 601–606.<br />
Hopman, A. H. N.; Wiegant, J.; Raap, A. K.;<br />
Landegent, J. E.; Van der Ploeg, M.; Van Duijn, P.<br />
(1986) Bi-color detection of two target DNAs<br />
by non-radioactive in situ hybridization.<br />
His<strong>to</strong>chemistry 85, 1–4.<br />
Hopman, A. H. N.; Van Hooren, E.; Van de Kaa, C. A.;<br />
Vooijs, G. P.; Ramaekers, F. C. S. (1991) Detection<br />
of numerical chromosome aberrations using in situ<br />
hybridization in paraffin sections of routinely<br />
processed bladder cancers. Modern Pathol. 4,<br />
503–513.<br />
Hopman, A. H. N.; Poddighe, P. J.; Moesker, O.;<br />
Ramaekers, F. C. S. (1992) <strong>In</strong>terphase cy<strong>to</strong>genetics:<br />
an approach <strong>to</strong> the detection of genetic aberrations<br />
in tumours. <strong>In</strong>: McGee, J. O’D.; Herring<strong>to</strong>n, C. S.<br />
(Eds.) Diagnostic Molecular Pathology, A Practical<br />
Approach, 1st ed. New York: IRL Press, 141–167.<br />
Kerstens, H. M. J.; Poddighe, P. J.; Hanselaar,<br />
A. G. J. M. (1994) Double-target in situ hybridization<br />
in brightfield microscopy. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem.<br />
42, 1071–1077.<br />
Martini. E.; Speel, E. J. M.; Geraedts, J. P. M.;<br />
Ramaekers, F. C. S.; Hopman, A. H. N. (1995)<br />
Application of different in situ hybridization<br />
detection methods for human sperm analysis.<br />
Hum. Reprod. 10, 855–861.<br />
Mullink, H.; Walboomers, J. M. M.; Raap, A. K.;<br />
Meyer, C. J. L. M. (1989) Two colour DNA in situ<br />
hybridization for the detection of two viral genomes<br />
using non-radioactive probes. His<strong>to</strong>chemistry 91,<br />
195–198.<br />
Speel, E. J. M.; Schutte, B.; Wiegant, J.; Ramaekers,<br />
F. C. S.; Hopman, A. H. N. (1992) A novel fluorescence<br />
detection method for in situ hybridization,<br />
based on the alkaline phosphatase-Fast Red<br />
reaction. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 40, 1299–1308.<br />
Speel, E. J. M.; Kamps, M.; Bonnet, J.; Ramaekers,<br />
F. C. S.; Hopman, A. H. N. (1993) Multicolour<br />
preparations for in situ hybridization using<br />
precipitating enzyme cy<strong>to</strong>chemistry in combination<br />
with reflection contrast microscopy. His<strong>to</strong>chemistry<br />
100, 357–366.<br />
Speel, E. J. M.; Herbergs, J.; Ramaekers, F. C. S.;<br />
Hopman, A. H. N. (1994a) Combined immunocy<strong>to</strong>chemistry<br />
and fluorescence in situ hybridization<br />
for simultaneous tricolor detection of cell cycle,<br />
genomic, and phenotypic parameters of tumor cells.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 42, 961–966.<br />
Speel, E. J. M.; Jansen, M. P. H. M.; Ramaekers,<br />
F. C. S.; Hopman, A. H. N. (1994b) A novel triplecolor<br />
detection procedure for brightfield microscopy,<br />
combining in situ hybridization with immuocy<strong>to</strong>chemistry.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 42,<br />
1299–1307.<br />
Speel, E. J. M.; Ramaekers, F. C. S.; Hopman, A. H. N.<br />
(1995) Detection systems for in situ hybridization, and<br />
the combination with immunocy<strong>to</strong>chemistry.<br />
His<strong>to</strong>chem. J., in press.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
RNase A Dry powder 109 142 25 mg<br />
109 169 100 mg<br />
Pepsin Aspartic endopeptidase with broad 108 057 1 g<br />
specificity 1 693 387 5 g<br />
Digoxigenin-11-dUTP, Tetralithium salt, 1 mM solution 1 093 088 25 nmol<br />
alkali-stable (25 µl)<br />
1 558 706 125 nmol<br />
(125 µl)<br />
1 570 013 5 x125 nmol<br />
(5 x125 µl)<br />
Fluorescein-12-dUTP Tetralithium salt, 1 mM solution 1 373 242 25 nmol<br />
(25 µl)<br />
Tetramethyl- Tetralithium salt, 1 mM solution 1 534 378 25 nmol<br />
rhodamine-6-dUTP (25 µl)<br />
AMCA-6-dUTP Tetralithium salt, 1 mM solution 1 534 386 25 nmol<br />
(25 µl)<br />
Biotin-16-dUTP Tetralithium salt, 1 mM solution 1 093 070 50 nmol<br />
(50 µl)<br />
DNase I Lyophilizate 104 159 100 mg<br />
DNA Polymerase I Nick Translation Grade 104 485 500 units<br />
104 493 1000 units<br />
tRNA From baker’s yeast 109 495 100 mg<br />
109 509 500 mg<br />
DNA, Cot-1, human Solution in 10 mM Tris-HCl, 1 mM EDTA, 1 581 074 500 µg<br />
pH 7.4, Cot-1 DNA is used in chromosomal (500 µl)<br />
in situ suppression (CISS).<br />
Tween ® 20 1 332 465 5 x10 ml<br />
Anti-Digoxigenin Clone 1.71.256, mouse IgG 1, 1 333 062 100 µg<br />
Anti-Mouse Ig- F(ab)2 fragment 1 214 624 200 µg<br />
Digoxigenin<br />
Anti-Digoxigenin-POD Fab fragments from sheep 1 207 733 150 U<br />
Anti-Digoxigenin-AP Fab fragments from sheep 1 093 274 150 U<br />
NBT/BCIP, Solution of 18.75 mg/ml nitro-blue 1 681 451 8 ml<br />
(s<strong>to</strong>ck solution) tetrazolium chloride and 9.4 mg/ml<br />
5-bromo-4-chloro-3-indolyl phosphate,<br />
<strong>to</strong>luidine-salt in 67% DMSO (v/v)<br />
Tris Powder 127 434 100 g<br />
708 968 500 g<br />
708 976 1 kg<br />
BSA Highest quality, lyophilizate 238 031 1 g<br />
238 040 10 g<br />
CONTENTS<br />
INDEX<br />
107<br />
5
5<br />
108<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
DNA in situ hybridization with an alkaline<br />
phosphatase-based fluorescent detection system<br />
Dr. G. Sagner, Research Labora<strong>to</strong>ries, Boehringer Mannheim GmbH,<br />
Penzberg, Germany.<br />
We describe here a high sensitivity indirect<br />
detection procedure for DIG-labeled<br />
hybridization probes. The procedure uses<br />
the components of the HNPP Fluorescent<br />
Detection Set <strong>to</strong> form a fluorescent precipitate<br />
of HNPP (2-hydroxy-3-naphthoic<br />
acid-2'-phenylanilide phosphate) and Fast<br />
Red TR at the site of hybridization.<br />
This procedure can be used <strong>to</strong> detect single<br />
copy sequences as small as 1 kb on human<br />
metaphase chromosomes.<br />
I. <strong>In</strong> situ hybridization with<br />
DIG-labeled probes<br />
Prepare chromosomal spreads, label<br />
hybridization probes with digoxigenin<br />
(DIG), hybridize probes <strong>to</strong> chromosomes,<br />
and perform posthybridization washes of<br />
the sample according <strong>to</strong> standard procedures,<br />
e.g. those listed in Chapters 4 and 5<br />
of this manual.<br />
II. Detection of DIG-labeled probes<br />
1 Prepare a fresh 1:500 dilution of alkaline<br />
phosphatase-conjugated sheep anti-DIG<br />
antibody in blocking buffer [100 mM<br />
Tris-HCl, 150 mM NaCl, 0.5% blocking<br />
reagent; pH 7.5 (20°C)].<br />
Note: Do not s<strong>to</strong>re the diluted antibody<br />
conjugate more than 12 h at 4°C.<br />
2 Pipette 100 µl of diluted anti-DIG<br />
antibody conjugate on<strong>to</strong> each slide and<br />
add a coverslip.<br />
3 <strong>In</strong>cubate slides for 1 h at 37°C in a moist<br />
chamber.<br />
4 Wash the slides at room temperature as<br />
follows:<br />
3 x10 min with washing buffer<br />
[100 mM Tris-HCl, 150 mM NaCl,<br />
0.05% Tween ® 20; pH 7.5 (20°C)].<br />
2 x10 min with detection buffer<br />
[100 mM Tris-HCl,100 mM NaCl,<br />
10 mM MgCl2; pH 8.0 (20°C)].<br />
5 Prepare fresh HNPP/Fast Red TR mix<br />
as follows:<br />
Note: Numbered vials are components<br />
of the HNPP Fluorescent Detection Set.<br />
Prepare Fast Red TR s<strong>to</strong>ck solution<br />
by dissolving 5 mg Fast Red TR<br />
(vial 2) in 200 µl distilled H2O.<br />
Mix 10 µl HNPP s<strong>to</strong>ck solution (premixed,<br />
vial1),10 ml Fast Red TR s<strong>to</strong>ck<br />
solution, and 1 ml detection buffer<br />
[100 mM Tris-HCl, 100 mM NaCl,<br />
10 mM MgCl2; pH 8.0 (20°C)].<br />
Filter the HNPP/Fast Red TR mix<br />
through a 0.2 µm nylon filter.<br />
Caution: The Fast Red TR s<strong>to</strong>ck<br />
solution should be no more than 4<br />
weeks old. The HNPP/Fast Red TR<br />
mix should be no more than a few<br />
days old. Always filter the mix just<br />
before use.<br />
6 Cover each sample with 100 µl filtered<br />
HNPP/Fast Red TR mix and a coverslip,<br />
then incubate slides for 30 min at<br />
room temperature.<br />
7 Wash the slides 1x at room temperature<br />
with washing buffer [100 mM Tris-HCl,<br />
150 mM NaCl, 0.05% Tween ® 20; pH<br />
7.5 (20°C)].<br />
8 Repeat Steps 6 and 7 three times.<br />
Note: If you are detecting abundant or<br />
multiple copy sequences, skip Step 8.<br />
One incubation is enough.<br />
9 Wash the slides for 10 min with distilled<br />
H2O.<br />
III. Fluorescence microscopy<br />
1 <strong>In</strong> a Coplin jar, counterstain slides with<br />
50 ml DAPI solution (100 ng DAPI/ml<br />
PBS) for 5 min in the dark at room<br />
temperature.<br />
2 Wash slides under running water for<br />
2–3 min.<br />
3 Air dry slides in the dark.<br />
4 Add 20 µl DABCO antifading solution<br />
(PBS containing 50% glycerol and 2%<br />
DABCO) <strong>to</strong> each slide.<br />
5 Cover each slide with a 24 x 24 mm<br />
coverslip.<br />
Note: For long term s<strong>to</strong>rage of the slides,<br />
seal the edges of the coverslip with nail<br />
polish and s<strong>to</strong>re in the dark at –20°C.<br />
6 View the slides by fluorescence microscopy,<br />
using appropriate filters.<br />
CONTENTS<br />
INDEX
Note: The maximum emission wavelength<br />
of dephosphorylated HNPP/Fast<br />
Red TR is 562 nm. However, since the<br />
emission peak is broad (540–590 nm),<br />
you may use the filter sets for either<br />
fluorescein or rhodamine <strong>to</strong> analyze the<br />
HNPP/Fast Red TR product.<br />
a<br />
b<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> whole chromosomes<br />
CONTENTS<br />
INDEX<br />
<br />
Results<br />
The fluorescent signal obtained with the<br />
HNPP/Fast Red procedure described<br />
above is more intense than a direct signal<br />
from fluorescein. <strong>In</strong> a comparison experiment<br />
(Figure 1), the HNPP/Fast Red<br />
reaction product was visible after a 70-fold<br />
shorter exposure (0.2 sec exposure vs. 15 s<br />
exposure) than the fluorescein signal. Even<br />
when the HNPP/Fast Red signal is viewed<br />
under a less than optimal filter (Figure 2),<br />
the fluorescence is clearly visible.<br />
Figure 1: Comparison of fluorescein and HNPP signal intensity. A DIG-labeled painting<br />
probe specific for human chromosome 1 was hybridized <strong>to</strong> metaphase chromosomal<br />
spreads. The DIG-labeled probe was detected with (Panel a) anti-DIG-fluorescein conjugate or<br />
(Panel b) anti-DIG-alkaline phosphate conjugate and the HNPP/Fast Red detection reaction<br />
described in the text. The fluorescein signal (Panel a) required a 15 s exposure while the<br />
HNPP/Fast Red signal (Panel b) required a 0.2 s exposure. Fluorescent images were pseudocolored<br />
with a CCD camera and a digital imaging system. Chromosomes were counterstained<br />
with DAPI.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
Tris Powder 127 434 100 g<br />
708 968 500 g<br />
708 976 1 kg<br />
Blocking Reagent Powder 1 096 176 50 g<br />
Anti-Digoxigenin-AP Fab Fragments from sheep 1 093 274 150 U<br />
Tween ® 20 1 332 465 5 x10 ml<br />
HNPP Fluorescent For sensitive fluorescent detection of non- 1758 888 Set for 500<br />
Detection Set radioactively labeled nucleic acids in FISH reactions<br />
fluorescence in situ hybridization (FISH)<br />
and membrane hybridization<br />
DAPI Fluorescence dye for staining of 236 276 10 mg<br />
chromosomes<br />
<br />
Figure 2: HNPP/Fast Red<br />
fluorescence viewed with a filter<br />
for DAPI. A DIG-labeled painting<br />
probe specific for human<br />
chromosome 1 was hybridized <strong>to</strong><br />
metaphase chromosomal spreads,<br />
then detected with anti-DIG-alkaline<br />
phosphate conjugate and the<br />
HNPP/Fast Red detection reaction as<br />
in Figure 1. The HNPP/Fast Red<br />
signal was viewed under a filter that<br />
was optimal for DAPI (emission<br />
maximum, 470 nm), but not for<br />
HNPP (emission maximum, 562 nm).<br />
The fluorescence was pho<strong>to</strong>graphed<br />
directly without digital manipulation.<br />
Chromosomes were counterstained<br />
with DAPI.<br />
109<br />
5
5<br />
110<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
Combined DNA in situ hybridization and<br />
immunocy<strong>to</strong>chemistry for the simultaneous<br />
detection of nucleic acid sequences, proteins, and<br />
incorporated BrdU in cell preparations<br />
E. J. M. Speel, F. C. S. Ramaekers, and A. H. N. Hopman, Department of Molecular<br />
Cell Biology & Genetics, University of Limburg, Maastricht, The Netherlands.<br />
The combination of in situ hybridization<br />
(ISH) and immunocy<strong>to</strong>chemistry (ICC)<br />
enables us, e.g., <strong>to</strong> simultaneously demonstrate<br />
mRNA and its protein product in<br />
the same cell, <strong>to</strong> immunophenotype cells<br />
containing a specific chromosomal aberration<br />
or viral infection, or <strong>to</strong> characterize<br />
cy<strong>to</strong>kinetic parameters of tumor cell populations<br />
that are genetically or phenotypically<br />
aberrant. The fac<strong>to</strong>rs that<br />
determine the success and sensitivity of a<br />
combination ICC and nonradioactive ISH<br />
procedure include:<br />
Preservation of cell morphology and<br />
protein epi<strong>to</strong>pes<br />
Accessibility of nucleic acid targets<br />
Lack of cross-reaction between the<br />
different detection procedures<br />
Good color contrast<br />
Stability of enzyme cy<strong>to</strong>chemical precipitates<br />
and fluorochromes<br />
Since several steps in the ISH procedure<br />
(enzymatic digestion, post-fixation, denaturation<br />
at high temperatures, and hybridization<br />
in formamide) may destroy antigenic<br />
determinants, ICC usually precedes ISH in<br />
a combination procedure. A variety of such<br />
combined ICC/ISH procedures have been<br />
reported with either enzyme precipitation<br />
reactions (Mullink et al., 1989; Van den<br />
Brink et al., 1990; Knuutila et al., 1994;<br />
Speel et al., 1994b), fluorochromes (Van<br />
den Berg et al., 1991; Weber-Matthiesen et<br />
al., 1993), or a combination of both (Strehl<br />
& Ambros, 1993; Zheng et al., 1993;<br />
Herbergs et al., 1994; Speel et al., 1994a).<br />
The procedures can be subdivided in<strong>to</strong> two<br />
groups, those which use fluorochromes for<br />
ICC, and those which use enzyme reactions.<br />
Fluorochromes have been used mainly on<br />
ace<strong>to</strong>ne-fixed cell preparations, since the<br />
material can be mildly post-fixed (usually<br />
with paraformaldehyde) after antigen<br />
detection and used directly for fluorescence<br />
ISH without any further pretreatment<br />
(Weber-Matthiesen et al., 1993).<br />
However, amplification steps for both ICC<br />
and ISH signals are often necessary for<br />
clear visualization. <strong>In</strong> such cases, enzymatic<br />
ISH pre-treatment after ICC lowers<br />
fluorescent ICC staining dramatically<br />
(Speel et al., 1994a).<br />
Enzyme precipitation reactions have also<br />
been used efficiently for combined ICC/<br />
ISH staining of proteins in cell preparations<br />
and tissue sections. Enzyme precipitation<br />
products that withstand the<br />
proteolytic digestion and denaturation<br />
steps used in the ISH procedure include:<br />
Several precipitates (Fast Red, New<br />
Fuchsin, and BCIP/NBT) formed by<br />
alkaline phosphatase<br />
The diaminobenzidine precipitate formed<br />
by horseradish peroxidase<br />
The BCIG (X-Gal) precipitate formed<br />
by -galac<strong>to</strong>sidase<br />
<strong>In</strong> these cases, the digestion and denaturation<br />
steps of the ISH procedure remove<br />
the antibody and enzyme detection layers,<br />
but the precipitate remains firmly in place.<br />
The stability of the ICC precipitate thus<br />
prevents unwanted cross-reaction between<br />
the detection procedures for ISH and ICC.<br />
Here we present a combined ICC/ISH<br />
procedure which describes compatible<br />
detection systems for fluorescence or<br />
brightfield microscopy (Table 1). Additionally,<br />
this procedure allows the<br />
localization of incorporated BrdU by<br />
fluorescence microscopy.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
The procedures given below are<br />
modifications of previously published Table 1: Detection systems for combined<br />
procedures (Speel et al., 1994a, 1994b). ICC/ISH1 .<br />
<br />
For analysis by<br />
Fluorescence microscopy Brightfield microscopy<br />
ICC 2 Detection by Anti-antigen Ab-APase Anti-antigen--gal<br />
CONTENTS<br />
Visualization by APase-Fast Red -Gal-BCIG<br />
ISH Probe FITC- or AMCA-labeled DIG- or biotin-labeled<br />
nucleic acid nucleic acid<br />
Detection and Direct viewing PO- or APase-labeled antivisualization<br />
by DIG Ab or anti-biotin Ab<br />
plus<br />
PO-DAB, PO-TMB, or<br />
APase-Fast Red reaction<br />
BrdU Detection by AMCA- or FITC- –<br />
labeling labeled 3 anti-BrdU Ab<br />
Visualization by Direct viewing –<br />
I. Cell preparations and BrdU labeling<br />
1 (Optional) To label cells, add BrdU<br />
(final concentration, 10 µM) <strong>to</strong> the<br />
culture medium 30 min before<br />
harvesting the cells (Speel et al., 1994a).<br />
2 Prepare cultured normal diploid cells or<br />
tumor cell lines (labeled or unlabeled)<br />
by one of the following methods:<br />
Slide and coverslip preparations: Grow<br />
cells on glass slides or coverslips. Fix in<br />
cold methanol (–20°C) for 5 s, then in<br />
cold ace<strong>to</strong>ne (4°C) for 3 x 5 s. Air dry<br />
samples and s<strong>to</strong>re at –20°C.<br />
Note: Alternatively, use other fixatives<br />
for the slide and coverslip preparations.<br />
Cy<strong>to</strong>spins: Cy<strong>to</strong>spin floating cells<br />
on<strong>to</strong> glass slides at 1000 rpm for 5 min.<br />
Air dry samples for 1 h at room<br />
temperature. Fix and s<strong>to</strong>re as with<br />
slide and coverslip preparations above.<br />
II. Detection of antigen by<br />
immunocy<strong>to</strong>chemistry (ICC)<br />
1 <strong>In</strong>cubate slides for 10 min at room<br />
temperature with PBS-Tween-NGS (PBS<br />
buffer containing 0.05% Tween ® 20 and<br />
2–5% normal goat serum).<br />
2 <strong>In</strong>cubate slides for 45 min at room temperature<br />
with an appropriate dilution of<br />
antigen-specific primary antibody in<br />
PBS-Tween-NGS.<br />
3 Wash slides for 2 x 5 min with PBS<br />
containing 0.05% Tween ® 20.<br />
INDEX<br />
4 <strong>In</strong>cubate slides for 45 min at room<br />
temperature with an appropriate secondary<br />
antibody conjugate. Use the<br />
following <strong>to</strong> decide which antibody<br />
conjugate <strong>to</strong> use:<br />
If you wish <strong>to</strong> detect the ICC antigen,<br />
the ISH antigen, and (optionally)<br />
BrdU labeling by fluorescence microscopy,<br />
use a secondary antibody that is<br />
conjugated <strong>to</strong> alkaline phosphatase<br />
(APase).<br />
If you wish <strong>to</strong> detect the ICC antigen<br />
and the ISH antigen under brightfield<br />
microscopy, use a secondary antibody<br />
that is conjugated <strong>to</strong> -galac<strong>to</strong>sidase<br />
(-Gal).<br />
5 Wash slides as follows:<br />
5 min with PBS containing 0.05%<br />
Tween ® 20.<br />
5 min with PBS.<br />
Note: For amplification of the ICC<br />
signal, you may add a third antibody<br />
step after this wash. For details of<br />
possible antibodies <strong>to</strong> use in an amplified<br />
three-antibody detection procedure,<br />
see Table 1 of the article “Multiple<br />
target DNA in situ hybridization with<br />
enzyme-based cy<strong>to</strong>chemical detection<br />
systems” on page 102 of this manual.<br />
6 Visualize the antibody-antigen complexes<br />
according <strong>to</strong> either Procedure<br />
IIIA (for APase conjugates) or Procedure<br />
IIIB (for -Gal conjugates).<br />
1 Amplification steps may be<br />
necessary for detection of low<br />
amounts of antigen, nucleic acid<br />
target, or incorporated BrdU.<br />
2 Abbreviations used: Ab, antibody;<br />
AMCA, aminomethylcoumarin<br />
acetic acid; APase, alkaline<br />
phosphatase; BCIG,<br />
bromochloroindolyl-galac<strong>to</strong>side;<br />
BrdU, bromodeoxyuridine; DAB,<br />
diaminobenzidine; DIG,<br />
digoxigenin; FITC, fluorescein<br />
isothiocyanate; -Gal, galac<strong>to</strong>sidase;<br />
ICC,<br />
immunocy<strong>to</strong>chemistry; ISH, in situ<br />
hybridization; PO, peroxidase;<br />
TMB, tetramethylbenzidine<br />
3 The fluorochrome used in the BrdU<br />
visualization step should be different<br />
from the one used in the ISH<br />
visualization step.<br />
111<br />
5
5<br />
112<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
III. Visualization of ICC antigen<br />
IIIA. APase-Fast Red reaction (for producing<br />
a red precipitate visible under either<br />
fluorescence or brightfield microscopy)<br />
1 Mix color reagent just before use:<br />
4 ml TM buffer [200 mM Tris-HCl<br />
(pH 8.5), 10 mM MgCl2] containing<br />
5% polyvinyl alcohol (PVA, MW<br />
40,000; Sigma).<br />
250 µl TM buffer containing 1 mg<br />
naphthol-ASMX-phosphate (Sigma).<br />
750 µl TM buffer containing 5 mg<br />
Fast Red TR salt (Sigma).<br />
2 Overlay each sample with 100 µl color<br />
reagent and a coverslip.<br />
3 <strong>In</strong>cubate samples for 5–15 min at 37°C.<br />
Caution: Moni<strong>to</strong>r the enzyme reaction<br />
under a microscope and adjust the<br />
reaction time <strong>to</strong> keep the precipitate<br />
from becoming so dense that it shields<br />
nucleic acid sequences from the ISH<br />
detection step.<br />
4 Wash samples 3 x 5 min with PBS.<br />
Note: Do not dehydrate samples after<br />
washing.<br />
IIIB. -Gal-BCIG reaction (for producing<br />
a blue precipitate visible under brightfield<br />
microscopy)<br />
1 Mix color reagent:<br />
2.5 µl 5-bromo-4-chloro-3-indolyl-<br />
-D-galac<strong>to</strong>side (BCIG; X-Gal) s<strong>to</strong>ck<br />
solution [20 mg/ml BCIG (X-Gal) in<br />
N,N-dimethylformamide].<br />
100 µl diluent (PBS containing 0.9 mM<br />
MgCl2, 3 mM potassium ferricyanide,<br />
and 3 mM potassium ferrocyanide).<br />
2 Overlay each sample with 100 µl color<br />
reagent and a coverslip.<br />
3 <strong>In</strong>cubate samples for 15–60 min at 37°C.<br />
Caution: Moni<strong>to</strong>r the enzyme reaction<br />
under a microscope and adjust the<br />
reaction time <strong>to</strong> keep the precipitate<br />
from becoming so dense that it shields<br />
nucleic acid sequences from the ISH<br />
detection step.<br />
4 Wash samples 3 x 5 min with PBS.<br />
Note: If you wish, dehydrate the samples<br />
after washing.<br />
IV. Cell processing for in situ hybridization<br />
1 Wash slides for 2 min at 37°C with<br />
10 mM HCl.<br />
2 Digest samples with pepsin as follows:<br />
Overlay each sample with pepsin<br />
solution (100 µg/ml pepsin in 10 mM<br />
HCl).<br />
<strong>In</strong>cubate cell samples for 10–20 min<br />
at 37°C.<br />
3 Wash samples for 2 min at 37°C with<br />
10 mM HCl.<br />
Note: For cells stained with the -Gal-<br />
BCIG reaction, you may (if you wish)<br />
dehydrate the slides after washing them.<br />
4 Post-fix samples for 20 min at 4°C with<br />
PBS containing 1% paraformaldehyde.<br />
5 Wash samples as follows:<br />
5 min with PBS.<br />
5 min with 2 x SSC.<br />
V. <strong>In</strong> situ hybridization (ISH)<br />
1 Perform a standard ISH detection and<br />
visualization procedure on the slides as<br />
described elsewhere in this manual. Use<br />
either:<br />
Fluorescence-basedprocedures (FITC,<br />
AMCA) (when APase-conjugated<br />
antibodies were used for ICC).<br />
Enzyme-based procedures (PO-DAB,<br />
PO-TMB, APase-Fast Red) (when<br />
-Gal-conjugated antibodies were<br />
used for ICC).<br />
Example: For a detailed description<br />
of enzyme-based ISH procedures, see<br />
“Multiple target DNA in situ hybridization<br />
with enzyme-based cy<strong>to</strong>chemical<br />
detection systems” on page 100 of<br />
this manual.<br />
2 <strong>In</strong>clude appropriate controls in the ISH<br />
procedure <strong>to</strong> ensure the lack of crossreaction<br />
between ICC and ISH.<br />
Note: The ICC precipitate remains firmly<br />
in place during ISH. The stability of<br />
the ICC precipitate usually prevents<br />
unwanted cross-reaction between the<br />
detection procedures for ISH and ICC.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
VI. Fluorescence detection of BrdU<br />
(optional)<br />
1 After performing the APase-Fast Red<br />
ICC (Procedure IIIA) and fluorescence<br />
ISH (Procedure V) reactions on BrdUlabeled<br />
cells, incubate the cells for 45 min<br />
at room temperature with a specific anti-<br />
BrdU antibody.<br />
2 Wash slides for 2 x 5 min with PBS<br />
containing 0.05% Tween ® 20.<br />
3 <strong>In</strong>cubate samples with a secondary<br />
antibody that is conjugated <strong>to</strong> a fluorochrome<br />
not used in the ICC or ISH<br />
reactions.<br />
Example: Use an alkaline-phosphatase<br />
conjugated antibody and the APase-<br />
Fast Red for ICC; a FITC-conjugated<br />
antibody for ISH; and an AMCAconjugated<br />
antibody for BrdU detection.<br />
Note: If necessary, use an amplified<br />
three-antibody detection procedure as<br />
outlined in the article “Multiple target<br />
DNA in situ hybridization with enzymebased<br />
cy<strong>to</strong>chemical detection systems”<br />
on page 100 of this manual.<br />
4 Before embedding, wash slides as follows:<br />
2 x 5 min with PBS containing 0.05%<br />
Tween ® 20.<br />
5 min with PBS.<br />
5 <strong>In</strong>clude appropriate controls <strong>to</strong> ensure<br />
that the BrdU detection step does not<br />
cross-react with ISH detection.<br />
VII. Embedding<br />
For fluorescence microscopy (for detection<br />
of APase-Fast Red ICC, fluorescence<br />
ISH, and BrdU):<br />
Embed specimens in a Tris-glycerol mixture<br />
[1:9 (v/v) mix of 0.2 M Tris-HCl (pH<br />
7.6) and glycerol] containing 2% DABCO<br />
(Sigma) and (optionally) 0.5 µg/ml blue<br />
DAPI (Sigma).<br />
CONTENTS<br />
INDEX<br />
For brightfield microscopy (for detection<br />
of -Gal-BCIG ICC and enzyme-based<br />
ISH):<br />
Depending on the enzyme reactions used,<br />
embed specimens in one of the following:<br />
Aqueous, organic, or protein embedding<br />
medium, as described in the article<br />
“Multiple target DNA in situ hybridization<br />
with enzyme-based cy<strong>to</strong>chemical<br />
detection systems” on page 100 of this<br />
manual.<br />
Entellan (Merck) organic embedding<br />
medium and immersion oil (Zeiss) (for<br />
peroxidase-DAB or peroxidase-TMB<br />
reactions only).<br />
Tris-glycerol mixture [1:9 (v/v) mix of<br />
200 mM Tris-HCl (pH 7.6) and glycerol]<br />
(for peroxidase-DAB or phosphatase-<br />
Fast Red reactions only).<br />
Results<br />
a b<br />
<br />
Figure 1: Combined ICC and fluorescence<br />
ISH on lung tumor cell line EPLC 65, showing<br />
cy<strong>to</strong>keratin filaments, chromosome 1, and<br />
chromosome 17. The cy<strong>to</strong>keratins (red) were<br />
visualized with a monoclonal anti-cy<strong>to</strong>keratin<br />
antibody (Ab), an alkaline phosphatase-conjugated<br />
goat anti-mouse Ab, and the APase-Fast Red<br />
reaction. The centromere of chromosome 1 (blue)<br />
was visualized with a biotinylated probe, avidin-<br />
AMCA, a biotinylated goat anti-avidin Ab, and<br />
avidin-AMCA. The centromere of chromosome 17<br />
(green) was visualized directly with a FITC-labeled<br />
probe.<br />
<br />
Figure 2: Combined ICC and fluorescence<br />
ISH on EPLC 65 cells,<br />
showing the nuclear proliferation<br />
marker Ki67, chromosome 7, and<br />
incorporated BrdU. Panel a: The<br />
Ki67 antigen (red) was visualized<br />
with a rabbit anti-Ki67 Ab, alkaline<br />
phosphatase-conjugated swine antirabbit<br />
Ab, and the APase-Fast Red<br />
reaction. The centromere of<br />
chromosome 7 (green) was<br />
visualized directly with a FITClabeled<br />
probe. Panel b: <strong>In</strong>corporated<br />
BrdU (blue) was visualized with<br />
monoclonal anti-BrdU Ab,<br />
biotinylated horse anti-mouse Ab,<br />
and avidin-AMCA.<br />
113<br />
5
5<br />
114<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
<br />
Figure 3: Combined ICC and enzyme-based ISH on a human umbilical vein endothelial cell, showing<br />
the intermediate filament protein vimentin, chromosome 1, and chromosome 7. Vimentin (blue) was<br />
visualized with monoclonal anti-vimentin Ab, -galac<strong>to</strong>sidase-conjugated goat anti-mouse Ab, and the<br />
-galac<strong>to</strong>sidase-BCIG reaction. The centromeres of chromosome 1 (biotinylated probe, brown) and<br />
chromosome 7 (digoxigenin-labeled probe, red) were visualized with avidin-peroxidase, rabbit antidigoxigenin<br />
Ab and alkaline phosphatase-conjugated swine anti-rabbit Ab, the APase-Fast Red reaction, and<br />
the PO-DAB reaction. Samples were embedded in a Tris-glycerol mixture, but were not counterstained.<br />
Slides were viewed by brightfield microscopy.<br />
References<br />
Herbergs, J.; De Bruine, A. P.; Marx, P. T. J.;<br />
Vallinga, M. I. J.; S<strong>to</strong>ckbrügger, R. W.; Ramaekers,<br />
F. C. S.; Arends, J. W.; Hopman, A. H. N. (1994)<br />
Chromosome aberrations in adenomas of the<br />
colon. Proof of trisomy 7 in tumor cells by combined<br />
interphase cy<strong>to</strong>genetics and immunocy<strong>to</strong>chemistry.<br />
<strong>In</strong>t. J. Cancer 57, 781–785.<br />
Knuutila, S.; Nylund, S. J.; Wessman, M.;<br />
Larramendy, M. L. (1994) Analysis of genotype and<br />
phenotype on the same interphase or mi<strong>to</strong>tic cell.<br />
A manual of MAC (morphology antibody chromosomes)<br />
methodology. Cancer Genet. Cy<strong>to</strong>genet. 72,<br />
1–15.<br />
Mullink, H.; Walboomers, J. M. M.; Tadema, T. M.;<br />
Jansen, D. J.; Meijer, C. J. L. M. (1989) Combined<br />
immuno- and non-radioactive hybridocy<strong>to</strong>chemistry<br />
on cells and tissue sections: influence of fixation,<br />
enzyme pre-treatment, and choice of chromogen<br />
on detection of antigen and DNA sequences.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 37, 603–609.<br />
Speel, E. J. M.; Herbergs, J.; Ramaekers, F. C. S.;<br />
Hopman, A. H. N. (1994a) Combined immunocy<strong>to</strong>chemistry<br />
and fluorescence in situ hybridization for<br />
simultaneous tricolor detection of cell cycle,<br />
genomic, and phenotypic parameters of tumor cells.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 42, 961–966.<br />
Speel, E. J. M.; Jansen, M. P. H. M.; Ramaekers,<br />
F. C. S.; Hopman, A. H. N. (1994b) A novel triple-color<br />
detection procedure for brightfield microscopy,<br />
combining in situ hybridization with immunocy<strong>to</strong>chemistry.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 42, 1299–1307.<br />
Speel, E. J. M.; Ramaekers, F. C. S.; Hopman, A. H. N.<br />
(1995) Detection systems for in situ hybridization,<br />
and the combination with immunocy<strong>to</strong>chemistry.<br />
His<strong>to</strong>chem. J., in press.<br />
Strehl, S.; Ambros, P. F. (1993) Fluorescence in situ<br />
hybridization combined with immunohis<strong>to</strong>chemistry<br />
for highly sensitive detection of chromosome 1<br />
aberrations in neuroblas<strong>to</strong>ma. Cy<strong>to</strong>genet. Cell<br />
Genet. 63, 24–28.<br />
Van Den Berg, H.; Vossen, J. M.; Van Den Bergh,<br />
R. L.; Bayer, J.; Van Tol, M. J. D. (1991) Detection<br />
of Y chromosome by in situ hybridization in<br />
combination with membrane antigens by two-color<br />
immunofluorescence. Lab. <strong>In</strong>vest. 64, 623–628.<br />
Van Den Brink, W.; Van Der Loos, C.; Volkers, H.;<br />
Lauwen, R.; Van Den Berg, F.; Houthoff, H.; Das, P. K.<br />
(1990) Combined -galac<strong>to</strong>sidase and immunogold/<br />
silver staining for immunohis<strong>to</strong>chemistry and DNA in situ<br />
hybridization. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 38, 325–329.<br />
Weber-Matthiesen, K.; Deerberg, J.;<br />
Müller-Hermelink, A.; Schlegelberger, B.; Grote, W.<br />
(1993) Rapid immunophenotypic characterization of<br />
chromosomally aberrant cells by the new fiction<br />
method. Cy<strong>to</strong>genet. Cell. Genet. 63, 123–125.<br />
Zheng, Y.-L.; Carter, N. P.; Price, C. M.; Colman, S. M.;<br />
Mil<strong>to</strong>n, P. J.; Hackett, G. A.; Greaves, M. F.; Ferguson-<br />
Smith, M. A. (1993) Prenatal diagnosis from maternal<br />
blood: simultaneous immunophenotyping and FISH of<br />
fetal nucleated erythrocytes isolated by negative<br />
magnetic cell sorting. J. Med. Genet. 30, 1051–1056.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
5-Bromo-2'-deoxy- One tablet contains approx. 50 mg 586 064 50 tablets<br />
uridine 5-bromo-2'-deoxy-uridine and<br />
approx. 20 mg binder.<br />
Pepsin Aspartic endopeptidase with broad 108 057 1 g<br />
specificity 1 693 387 5 g<br />
Digoxigenin-11-dUTP, Tetralithium salt, 1 mM solution 1 093 088 25 nmol<br />
alkali-stable (25 µl)<br />
1 558 706 125 nmol<br />
(125 µl)<br />
1 570 013 5 x125 nmol<br />
(5 x125 µl)<br />
Fluorescein-12-dUTP Tetralithium salt, 1 mM solution 1 373 242 25 nmol<br />
(25 µl)<br />
Tetramethyl- Tetralithium salt, 1 mM solution 1 534 378 25 nmol<br />
rhodamine-6-dUTP (25 µl)<br />
AMCA-6-dUTP Tetralithium salt, 1 mM solution 1 534 386 25 nmol<br />
(25 µl)<br />
Biotin-16-dUTP Tetralithium salt, 1 mM solution 1 093 070 50 nmol<br />
(50 µl)<br />
DNase I Lyophilizate 104 159 100 mg<br />
DNA Polymerase I Nick Translation Grade 104 485 500 units<br />
104 493 1000 units<br />
Anti-Digoxigenin-AP Fab Fragments from sheep 1 093 274 150 U<br />
(200 µl)<br />
CONTENTS<br />
INDEX<br />
115<br />
5
5<br />
116<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
<strong>In</strong> situ hybridization <strong>to</strong> mRNA in in vitro cultured<br />
cells with DNA probes<br />
Department of Cy<strong>to</strong>chemistry and Cy<strong>to</strong>metry, University of Leiden, The Netherlands.<br />
The pro<strong>to</strong>col given below has been developed<br />
with a cell line (rat 9G) which has<br />
integrated in<strong>to</strong> its genome the major<br />
immediate early transcription unit 1 of<br />
human cy<strong>to</strong>megalovirus (Boom et al., 1986).<br />
The pro<strong>to</strong>col is written in general terms and<br />
is applicable <strong>to</strong> abundantly expressed<br />
mRNA species. More information concerning<br />
this specific in situ hybridization<br />
application can be found in Raap et al.<br />
(1991).<br />
I. Cell preparation, fixation and<br />
permeabilization<br />
Note: All solutions must be treated with<br />
RNase inhibi<strong>to</strong>rs.<br />
1 Culture cells at 37° C in a 5% CO2<br />
atmosphere on poly-L-lysine coated<br />
microscopic slides. As culture medium,<br />
use Dulbecco’s minimal essential medium<br />
without phenol red.<br />
2 Wash the cells with PBS at 37°C, then<br />
fix at room temperature for 30 min in a<br />
solution of 4% (w/v) formaldehyde, 5%<br />
(v/v) acetic acid, and 0.9% (w/v) NaCl.<br />
3 Wash the fixed cells with PBS at room<br />
temperature and s<strong>to</strong>re them in 70%<br />
ethanol at 4°C.<br />
4 Before in situ hybridization, treat the<br />
fixed cells as follows:<br />
Dehydrate by incubating successively<br />
in 70%, 90%, and 100% ethanol.<br />
Wash in 100% xylene <strong>to</strong> remove<br />
residual lipids.<br />
Rehydrate by incubating successively<br />
in 100%, 90%, and 70% ethanol.<br />
Finally, incubate in PBS.<br />
5 Treat the fixed cells at 37°C with 0.1%<br />
(w/v) pepsin in 0.1 N HCl, <strong>to</strong> increase<br />
permeability <strong>to</strong> macromolecular reagents.<br />
6 Finally, treat the fixed cells as follows:<br />
Wash with PBS for 5 min.<br />
Post-fix with 1% formaldehyde for<br />
10 min.<br />
Wash again with PBS.<br />
II. <strong>In</strong> situ hybridization<br />
1 Label a suitable probe DNA with digoxigenin<br />
(DIG), using any of the pro<strong>to</strong>cols<br />
given elsewhere in this manual.<br />
2 Prepare hybridization solution which<br />
contains 60% deionized formamide,<br />
300 mM NaCl, 30 mM sodium citrate,<br />
10 mM EDTA, 25 mM NaH2PO4 (pH<br />
7.4), 5% dextran sulfate, and 250 ng/µl<br />
sheared salmon sperm DNA.<br />
3 Denature the DIG-labeled probe DNA<br />
at 80°C shortly before use and add it <strong>to</strong><br />
the hybridization solution at a concentration<br />
of 5 ng/µl.<br />
4 Add 10 µl of the hybridization mixture<br />
(hybridization solution plus denatured<br />
probe) <strong>to</strong> the fixed, permeabilized cells<br />
and cover with an 18 x 18 mm coverslip.<br />
Note: An in situ denaturation step is<br />
optional. <strong>In</strong>clusion of such a step may<br />
intensify the RNA signal since it makes<br />
the sample more accessible <strong>to</strong> the probe.<br />
5 Hybridize at 37°C for 16 h.<br />
III. Washes<br />
1 After hybridization, remove coverslips<br />
by shaking the slides at room temperature<br />
in a solution of 60% formamide,<br />
300 mM NaCl, and 30 mM sodium<br />
citrate .<br />
2 Using the same formamide-salt solution<br />
as in Step 1, wash the slides as follows:<br />
Wash 3 x at room temperature.<br />
Wash 1x at 37°C.<br />
3 Finally, wash the slides 1 x 5 min in PBS.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
IV. Immunofluorescent detection<br />
Note: Other pro<strong>to</strong>cols for amplifying the<br />
signal may also be used. See the pro<strong>to</strong>cols<br />
under “Single color fluorescent detection<br />
with immunological amplification” on<br />
page 62.<br />
1 Block non-specific binding by the<br />
following steps:<br />
Add 100 µl blocking solution<br />
[100 mM Tris-HCl; pH 7.5, 150 mM<br />
NaCl, 0.5% (w/v) blocking reagent]<br />
<strong>to</strong> each slide.<br />
Cover with a 24 x 50 mm coverslip.<br />
Place slide in a moist chamber.<br />
2 To loosen the coverslips, wash the slides<br />
briefly with the buffer used for immunological<br />
detection.<br />
3 Detect the hybridized DIG-labeled<br />
probe by incubating the slides in a moist<br />
chamber for 45 min with a 1:500 dilution<br />
of anti-DIG-fluorescein in blocking<br />
solution (from Step 1) .<br />
4 Wash slides with a solution of 100 mM<br />
Tris-HCl, pH 7.5; 150 mM NaCl;<br />
0.05% Tween ® 20.<br />
5 To dehydrate the cell samples, incubate<br />
the slides for 5 min in each of a series<br />
of ethanol solutions: 70%, 90%, then<br />
100% ethanol.<br />
6 Air dry the slides.<br />
Figure 1: Nuclear staining of integrated IE viral<br />
DNA after induction with cycloheximide. The<br />
signal throughout the cy<strong>to</strong>plasm represents viral<br />
mRNA. The two panels show the same signal with<br />
different counterstains.<br />
CONTENTS<br />
INDEX<br />
<br />
7 Embed the cell samples in an anti-fading<br />
solution which contains:<br />
9 parts glycerol<br />
plus<br />
1 part staining mixture: 1 M Tris-<br />
HCl (pH 7.5), 2% 1,4-diaza-bicyclo-<br />
[2,2,2]-octane (DABCO), and a DNA<br />
counterstain [either propidium iodide<br />
(500 ng/ml) or DAPI (75 ng/µl)].<br />
Results<br />
Panel a: PI counterstain.<br />
Panel b: DAPI counterstain.<br />
References<br />
Boom, R.; Geelen, J. L.; Sol, C. J.; Raap, A. K.;<br />
Minnaar, R. P.; Klaver, B. P.; Noordaa, J. v. d. (1986)<br />
Establishment of a rat cell line inducible for the<br />
expression of human cy<strong>to</strong>megalovirus immediate –<br />
early gene products by protein synthesis inhibition.<br />
J. Virol. 58, 851–859.<br />
Raap, A. K.; Van de Rijke, F .M.; Dirks, R. W.; Sol, C. J.;<br />
Boom, R.; Van der Ploeg, M. (1991) Bicolor fluorescence<br />
in situ hybridization <strong>to</strong> intron- and exon<br />
mRNA sequences. Exp. Cell Res. 197, 319–322.<br />
117<br />
5
5<br />
118<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
Pepsin Aspartic endopeptidase with broad 108 057 1 g<br />
specificity 1 693 387 5 g<br />
Tween ® 20 1 332 465 5 x10 ml<br />
Blocking Reagent Powder 1 096 176 50 g<br />
Anti-Digoxigenin Fab Fragments from sheep 1 207 741 200 µg<br />
Fluorescein<br />
DAPI Fluorescence dye for staining of 236 276 10 mg<br />
chromosomes<br />
Digoxigenin-11-dUTP, Tetralithium salt, 1 mM solution 1 093 088 25 nmol<br />
alkali-stable (25 µl)<br />
1 558 706 125 nmol<br />
(125 µl)<br />
1 570 013 5 x125 nmol<br />
(5 x125 µl)<br />
Fluorescein-12-dUTP Tetralithium salt, 1 mM solution 1 373 242 25 nmol<br />
(25 µl)<br />
Tetramethyl- Tetralithium salt, 1 mM solution 1 534 378 25 nmol<br />
rhodamine-6-dUTP (25 µl)<br />
AMCA-6-dUTP Tetralithium salt, 1 mM solution 1 534 386 25 nmol<br />
(25 µl)<br />
Biotin-16-dUTP Tetralithium salt, 1 mM solution 1 093 070 50 nmol<br />
(50 µl)<br />
DNase I Lyophilizate 104 159 100 mg<br />
DNA Polymerase I Nick Translation Grade 104 485 500 units<br />
104 493 1000 units<br />
EDTA 808 261 250 g<br />
808 270 500 g<br />
808 288 1 kg<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
Identification of single bacterial cells using<br />
DIG-labeled oligonucleotides<br />
B. Zarda, Dr. R. Amann, and Prof. Dr. K.-H. Schleifer, <strong>In</strong>stitute for Microbiology,<br />
Technical University of Munich, Germany.<br />
Note: An earlier version of this procedure<br />
has been published (Zarda et al., 1991).<br />
I. Organisms and growth conditions<br />
1 To prepare cells needed for this experiment,<br />
do the following:<br />
Allow Escherichia coli (Deutsche<br />
Sammlung von Mikroorganismen und<br />
Zellkulturen GmbH, DSM 30083) <strong>to</strong><br />
grow aerobically in YT broth (tryp<strong>to</strong>ne,<br />
10 g/L; yeast extract, 5 g/L; glucose,<br />
5 g/L; sodium chloride, 8 g/L; pH 7.2)<br />
at 37°C.<br />
Cultivate Pseudomonas cepacia (DSM<br />
50181) aerobically in M1 broth<br />
(pep<strong>to</strong>ne, 5 g/L; malt extract, 3 g/L;<br />
pH 7.0) at 30°C.<br />
Note: Cells from Methanococcus vannielii<br />
(DSM1224) were a generous gift of<br />
Dr. R. Huber (Dept. of Microbiology,<br />
University of Regensburg, FRG).<br />
2 To guarantee a high cellular rRNA<br />
content, harvest all cells at midlogarithmic<br />
phase by centrifugation in a<br />
microcentrifuge (5000 x g, 1 min).<br />
3 Discard the growth medium from the<br />
cell pellet and resuspend cells thoroughly<br />
in phosphate buffered saline (130 mM<br />
sodium chloride, 10 mM sodium phosphate;<br />
pH 7.2).<br />
CONTENTS<br />
INDEX<br />
II. Cell fixation and preparation<br />
of cell smears<br />
Note: This procedure was adapted from<br />
Amann et al., 1990.<br />
1 Fix the cells by adding 3 volumes of paraformaldehyde<br />
solution (4% paraformaldehyde<br />
in PBS) <strong>to</strong>1volume of suspended<br />
cells.<br />
2 After 3 h incubation, do the following:<br />
Pellet cells by centrifugation.<br />
Remove the supernatant.<br />
Wash the cell pellet with PBS.<br />
Resuspending the cells in an aliquot<br />
of PBS.<br />
Note: After adding 1 volume ethanol <strong>to</strong><br />
the resuspended cells, you may s<strong>to</strong>re the<br />
cell suspension at –20°C for up <strong>to</strong> 3<br />
months without apparent influence on<br />
the hybridization results.<br />
3 Spot these fixed cell suspensions on<strong>to</strong><br />
thoroughly cleaned glass slides and<br />
allow <strong>to</strong> air dry for at least 2 h.<br />
4 Dehydrate the cell samples by immersing<br />
the slides successively in solutions of<br />
50% ethanol, then 80% ethanol, then<br />
98% ethanol (3 min for each solution).<br />
III. DIG labeling of oligonucleotides<br />
with DIG-ddUTP<br />
Label oligonucleotides either according <strong>to</strong><br />
the pro<strong>to</strong>cols in Chapter 4 of this manual<br />
or at the 5' end according <strong>to</strong> the pro<strong>to</strong>col<br />
of the DIG Oligonucleotide 5'-End Labeling<br />
Set*.<br />
*Sold under the tradename of Genius in the US.<br />
119<br />
5
5<br />
120<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
IV. <strong>In</strong> situ hybridization using<br />
digoxigenin-labeled oligonucleotides<br />
1 Prepare hybridization solution (900 mM<br />
sodium chloride, 20 mM Tris-HCl,<br />
0.01% sodium dodecyl sulfate; pH 7.2).<br />
2 Depending on the method of analysis,<br />
do either of the following:<br />
If you will use fluorescently-labeled<br />
antibodies (Procedure Va below),<br />
proceed directly <strong>to</strong> Step 3.<br />
If you will use peroxidase-conjugated<br />
antibodies (Procedure Vb below), then:<br />
Prior <strong>to</strong> hybridization, incubate fixed<br />
cells for 10 min at 0°C with 1 mg/ml<br />
of lysozyme in TE (100 mM Tris-<br />
HCl, 50 mM EDTA; pH 8.0).<br />
Remove lysozyme by thoroughly<br />
rinsing the slide with sterile H2O.<br />
Air dry the slide.<br />
Proceed <strong>to</strong> Step 3.<br />
3 Add 8 µl hybridization solution containing<br />
50 ng of labeled oligonucleotide<br />
probe <strong>to</strong> the prepared slide (from<br />
Procedure II).<br />
4 <strong>In</strong>cubate the slide for 2 h at 45°C in an<br />
iso<strong>to</strong>nically equilibrated humid chamber.<br />
Va. Detection of DIG-labeled<br />
oligonucleotides with fluorescently<br />
labeled anti-DIG Fab fragments<br />
1 Dilute fluorescein- or rhodamine-labeled<br />
anti-DIG Fab fragments 1:4 in blocking<br />
solution (150 mM sodium chloride;<br />
100 mM Tris-HCl, pH 7.5; 0.5% bovine<br />
serum albumin; and 0.5% blocking<br />
reagent).<br />
2 Add 10 µl of the diluted antibody <strong>to</strong> the<br />
slide and incubate the slide for another<br />
hour at 27°C in the humid chamber.<br />
3 Remove the slide from the humid chamber<br />
and immerse in 40 ml of a washing<br />
solution (150 mM sodium chloride,<br />
100 mM Tris-HCl, 0.01% SDS; pH 7.4)<br />
at 29°C for 10 min.<br />
4 Prepare the slides for viewing by doing<br />
the following:<br />
Rinse the slides briefly with sterile<br />
water (which has been filtered through<br />
a 0.2 µm filter).<br />
Air dry.<br />
Mount in Citifluor (Citifluor Ltd.,<br />
London, U.K.).<br />
5 View the cell smears with a Plan-<br />
Neofluar 100 x objective (oil immersion)<br />
on the following setup: a Zeiss Axioplan<br />
microscope fitted for epifluorescence<br />
microscopy with a 50 W mercury high<br />
pressure bulb and Zeiss filter sets 09 and<br />
15 (Zeiss, Oberkochen, FRG).<br />
6 For pho<strong>to</strong>micrographs, use Kodak Ektachrome<br />
P1600 color reversal film and<br />
an exposure time of 15 s for epifluorescence<br />
or 0.01 s for phase contrast<br />
micrographs.<br />
Vb. Detection of DIG-labeled<br />
oligonucleotides with peroxidaseconjugated<br />
anti-DIG Fab fragments<br />
1 Use the same conditions for hybridization<br />
and antibody binding as for fluorescent<br />
antibodies (Procedures IV and Va),<br />
except include a lysozyme pretreatment<br />
of the cell smears prior <strong>to</strong> hybridization.<br />
For details, see Procedure IV above.<br />
2 Visualize the bound antibody as follows:<br />
Prepare peroxidase substrate-nickle<br />
chloride solution [1.3 mM diaminobenzidine,<br />
0.02% (v/v) H2O2, 0.03%<br />
(w/v) nickel chloride, 5 mM Tris-HCl<br />
(pH 7.4)].<br />
<strong>In</strong>cubate slide with peroxidase substrate-nickle<br />
chloride solution until a<br />
purplish-blue precipitate forms.<br />
3 View slides under a light microscope and<br />
pho<strong>to</strong>graph with Kodak Ektachrome<br />
P1600 color reversal film.<br />
Results<br />
Using the techniques in this article, we<br />
could detect P. cepacia cells in a mixed<br />
sample of three bacteria (Figure 1). Additional<br />
experiments with a DIG-labeled<br />
oligonucleotide not complementary <strong>to</strong><br />
rRNA show no significant levels of nonspecifically<br />
bound DIG-labeled nucleic acid<br />
probes and anti-DIG antibodies.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> cells<br />
a b<br />
c d<br />
References<br />
Amann, R. I.; Binder, B. J.; Olson, R. J.; Chisholm,<br />
S. W.; Devereux, R.; Stahl, D. A. (1990) Combination<br />
of 16 S rRNA-targeted oligonucleotide probes with<br />
flow cy<strong>to</strong>metry for analyzing mixed microbial populations.<br />
Appl. Environ. Microbiol. 56, 1919–1925.<br />
Mühlegger, K.; Huber, E.; von der Eltz, H.; Rüger, R.;<br />
Kessler, C. (1990) Nonradioactive labeling and<br />
detection of nucleic acids. Biol. Chem. Hoppe-Seyler<br />
371, 953–965.<br />
CONTENTS<br />
INDEX<br />
Zarda, B.; Amann, R.; Wallner, G.; Schleifer, K. H.<br />
(1991) Identification of single bacterial cells using<br />
digoxigenin-labeled rRNA-targeted oligonucleotides.<br />
J. Gen. Microbiol. 137, 2823–2830.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG-Oligonucleotide 3'-end labeling of oligonucleotides from 1 362 372 1 Kit<br />
3'-End Labeling Kit* 14 <strong>to</strong> 100 nucleotides in length with (25 labeling<br />
DIG-11-ddUTP and terminal transferase reactions)<br />
DIG-Oligonucleotide With the DIG Oligonucleotide 5'-End Labeling 1 480 863 1 Set<br />
5'-End Labeling Set* Set, oligonucleotides can be labeled with (10 labeling<br />
digoxigenin at the 5’-end after synthesis that reactions)<br />
includes the addition of a phosphoramidite<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 741 200 µg<br />
Fluorescein<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 750 200 µg<br />
Rhodamine<br />
Anti-Digoxigenin-POD Fab Fragments from sheep 1 207 733 150 U<br />
Tris Powder 127 434 100 g<br />
708 968 500 g<br />
708 976 1 kg<br />
EDTA Powder 808 261 250 g<br />
808 270 500 g<br />
808 288 1 kg<br />
Blocking Reagent Powder 1 096 176 50 g<br />
BSA Highest quality lyophilizate 238 031 1 g<br />
238 040 10 g<br />
SDS Purify 99% 1 028 685 100 g<br />
1 028 693 500 g<br />
<br />
Figure 1: Specific identification<br />
of whole fixed cells of P. cepacia<br />
in a mixture of P. cepacia (chains<br />
of rods), E. coli (rods) and M.<br />
van-nielii (cocci) with a DIGlabeled<br />
oligonucleotide probe.<br />
Phase contrast (panel a) and<br />
epifluorescence (panel b) pho<strong>to</strong>s<br />
show detection with fluorescently<br />
labeled anti-DIG Fab fragments<br />
(Zarda et al., 1991). Phase contrast<br />
(panel c) and brightfield (panel d)<br />
pho<strong>to</strong>s show detection with<br />
peroxidase-conjugated anti-DIG Fab<br />
fragments<br />
Reprinted from Zarda, B.; Amann, R.;<br />
Wallner, G.; Schleifer, K. H. (1991) Identification<br />
of single bacterial cells using<br />
digoxigenin-labeled rRNA-targeted<br />
oligonucleotides. J. Gen. Microbiol. 137,<br />
2823–2830 with permission of the<br />
society for general microbiology.<br />
*Sold under the tradename of Genius<br />
in the US.<br />
121<br />
5
5<br />
*Sold under the tradename of Genius<br />
in the US.<br />
122<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Detection of HPV 11 DNA in paraffin-embedded<br />
laryngeal tissue with a DIG-labeled DNA probe<br />
Dr. J. Rolighed and Dr. H. Lindeberg, ENT-department and <strong>In</strong>stitute for Pathology,<br />
Aarhus University Hospital, Denmark.<br />
The technique of tissue in situ hybridization<br />
has become a powerful <strong>to</strong>ol in pathology,<br />
although it is still mainly used for research<br />
purposes. The most important application at<br />
the moment is probably the demonstration<br />
of viral DNA (or RNA) in biopsies. This<br />
technique has made it possible <strong>to</strong><br />
demonstrate infection with CMV (Grody et<br />
al., 1987; Unger et al., 1988), HBV (Blum et<br />
al., 1983; Negro et al., 1985), parvovirus<br />
(Proter et al., 1988), coxsackie B (Archard et<br />
al., 1987) EBV and HIV (Pezzella et al.,<br />
1989). <strong>In</strong> situ hybridization has been widely<br />
used <strong>to</strong> demonstrate HPV sequences in<br />
biopsies from the uterine cervix as well as<br />
from the head and neck (Lindeberg et al.,<br />
1990; Lindeberg et al., 1989; Shah et al.,<br />
1988). Although some of these viruses can be<br />
demonstrated by other methods, in situ<br />
hybridization is much faster than methods<br />
using infection of tissue cultures; for HPV<br />
tissue culture methods do not exist.<br />
Radioactively labeled probes were used<br />
originally, but in recent years nonradioactive<br />
probes have become increasingly<br />
popular for obvious reasons.<br />
<strong>In</strong> general, the use of radioactively labeled<br />
probes is considered superior <strong>to</strong> other<br />
methods. However, this is probably not<br />
correct (Nuevo and Richart, 1989). For<br />
instance, HPV type 16 was demonstrated in<br />
SiHa cells by in situ hybridization with<br />
digoxigenin-labeled probes (Heiles et al.,<br />
1988). As SiHa-cells contain only 1–2 HPV<br />
copies per cell, one can hardly ask for a<br />
further improvement in sensitivity.<br />
There is an increasing demand from his<strong>to</strong>pathologists<br />
for simple in situ hybridization<br />
methods, so that labora<strong>to</strong>ry technicians can<br />
perform, for example, typing of HPV as a<br />
daily routine. To answer this demand, we<br />
present here a pro<strong>to</strong>col for the detection of<br />
HPV DNA type 11 in laryngeal papillomas<br />
as well as in genital condyloma<strong>to</strong>us lesions.<br />
The method is used on routine material<br />
which has been fixed in formalin and<br />
embedded in paraffin. The method described<br />
has the following advantages:<br />
The method is fast; results are obtained in<br />
about 5–6 h, and the hands-on time is<br />
about 2 h.<br />
The method is economical; the DIG<br />
Labeling and Detection Kit* is sufficient<br />
for preparing 10 ml of DIG-labeled probe<br />
cocktail (1 µl labeled DNA/ml). This is<br />
enough for hybridizing 1000 sections.<br />
Problems linked <strong>to</strong> endogenous biotin are<br />
avoided, since endogenous digoxigenin<br />
apparently does not exist.<br />
The main steps in performing in situ hybridization<br />
on formalin-fixed, paraffinembedded<br />
specimens are:<br />
1 Exposure of target DNA. This is done<br />
with a carefully controlled proteolytic<br />
digestion step.<br />
2 Denaturation of ds DNA, followed by<br />
hybridization.<br />
3 Washing and detection of DNA hybrids.<br />
<strong>In</strong> our experience the most difficult step is<br />
optimization of the proteolytic digestion.<br />
I. Probe preparation<br />
1 Using standard methods, remove the viral<br />
insert from its vec<strong>to</strong>r by restriction<br />
enzyme cleavage and separate it on a<br />
submerged agarose gel.<br />
2 Recover the insert from the gel by<br />
electroelution or other methods.<br />
3 Label the 8 kb viral insert nonradioactively<br />
with digoxigenin acccording <strong>to</strong> the<br />
procedures given in Chapter 4 of this<br />
manual.<br />
4 To a tube, add the following ingredients<br />
of the probe cocktail:<br />
10 µl 50 x Denhart’s solution.<br />
50 µl dextran sulfate 50% (w/v).<br />
10 µl sonicated salmon sperm DNA<br />
(10 mg/µl).<br />
100 µl 20 x SSC.<br />
500 ng digoxigenin-labeled probe in<br />
50 µl TE.<br />
Enough distilled water <strong>to</strong> make a <strong>to</strong>tal<br />
volume of 250 µl.<br />
5 To complete the probe cocktail, add<br />
250 µl formamide <strong>to</strong> the tube.<br />
Tip: Use gloves when handling solutions<br />
containing formamide. Formamide<br />
should be handled in a fume hood.<br />
6 Mix the probe cocktail (by vortexing) and<br />
s<strong>to</strong>re it at –20°C.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
II. Pretreatment of slides<br />
1 Wash slides overnight in a detergent, followed<br />
by an intensive wash in tap water,<br />
and finally, a wash in demineralized water.<br />
2 After drying the slides, wash them for<br />
3 min in ace<strong>to</strong>ne.<br />
3 Transfer the washed slides <strong>to</strong> a 2%<br />
solution of 3-aminopropyltrithoxysilane<br />
in ace<strong>to</strong>ne and incubate for 5 min.<br />
4 Wash the slides briefly in distilled water<br />
and allow <strong>to</strong> dry.<br />
Note: The coated slides can be s<strong>to</strong>red dry<br />
under dust-free conditions for several<br />
months.<br />
III. Preparation of tissue sections<br />
1 Fix biopsies from condyloma<strong>to</strong>us lesions<br />
and from laryngeal papillomas in 4%<br />
phosphate-buffered formaldehyde and<br />
embed them in paraffin.<br />
2 Cut routine sections, float them on<br />
demineralized water and place them on<br />
the pretreated slides.<br />
3 Treat the sections on the slides as follows:<br />
Bake the sections for 30 min at 60°C.<br />
Dewax in xylene.<br />
Rehydrate them by dipping them in<br />
a graded ethanol series (2 x in 99%<br />
ethanol, 2 x in 96% ethanol, 1x in 70%<br />
ethanol, 1x in H2O).<br />
4 Immediately before use, prepare a working<br />
Proteinase K solution as follows:<br />
Thaw an aliquoted frozen s<strong>to</strong>ck<br />
solution of Proteinase K, 10 mg/ml, in<br />
H2O.<br />
Dilute the s<strong>to</strong>ck Proteinase K <strong>to</strong> the<br />
working concentration of 100 µg/ml in<br />
TES [50 mM Tris-HCl (pH 7.4),<br />
10 mM EDTA, 10 mM NaCl].<br />
5 Treat each section with 20–30 µl of the<br />
working solution of Proteinase K for<br />
15 min at 37°C. During the proteolytic<br />
digestion cover the sections with coverslips<br />
and place them in a humid chamber.<br />
Tip: We use only siliconized coverslips.<br />
Note: The proteolytic treatment is<br />
crucial and may need <strong>to</strong> be varied with<br />
different tissues.When <strong>to</strong>o much<br />
Proteinase K is used, the tissue <strong>to</strong>tally<br />
disintegrates, and if <strong>to</strong>o little is used<br />
positive signals may be <strong>to</strong>tally absent.<br />
CONTENTS<br />
INDEX<br />
IV. <strong>Hybridization</strong><br />
1 After the treatment with Proteinase K,<br />
remove the coverslips and fix the sections<br />
in 0.4% formaldehyde for 5 min at 4°C.<br />
2 Immerse the sections in distilled water for<br />
5 min.<br />
3 Allow the sections <strong>to</strong> drip and air dry for<br />
5 min.<br />
4 Distribute about 5–10 µl of the probe<br />
cocktail over each section.<br />
Note: Large biopsies may require larger<br />
volumes of probe cocktail.<br />
5 Prepare a negative control by covering<br />
one section from each block with a<br />
“blind” probe cocktail, i.e. a probe<br />
cocktail containing all the ingredients in<br />
Procedure I, except the labeled HPV<br />
DNA.<br />
6 Place coverslips over each section and<br />
denature the DNA by placing the slides<br />
on a heating plate at 95°C for 6 min.<br />
Tip: We use only siliconized coverslips.<br />
7 Cool the slides for 1 min on ice.<br />
8 Place the slides in a humid chamber and<br />
incubate for 3 h at 42°C in an oven.<br />
Tip: The hybridization time may be<br />
prolonged overnight when convenient.<br />
V. Washes<br />
Remove the coverslips and wash the sections<br />
as follows:<br />
2 x 5 min in 2 x SSC at 20°C.<br />
1 x 10 min in 0.1 x SSC at 42°C.<br />
123<br />
5
5<br />
124<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
VI. Detection of hybrids<br />
1 Dip each section in<strong>to</strong> buffer 1 [100 mM<br />
Tris-HCl,150mMNaCl;pH7.5 (20°C)].<br />
2 Cover each section with 20–40 µl buffer 2<br />
[0.5% (w/v) blocking reagent in buffer 1],<br />
then add a coverslip.<br />
3 <strong>In</strong>cubate sections at 20°C for 15 min.<br />
4 Remove the coverslips and dip the<br />
sections in buffer 1.<br />
5 Dilute the antibody conjugate 1:500 in<br />
buffer 2.<br />
6 Distribute 10–20 µl of the diluted conjugate<br />
over each section, including the<br />
negative controls.<br />
7 Place a coverslip over each section and<br />
place all sections in a humid chamber at<br />
room temperature for 1 h.<br />
8 Remove the coverslips, wash the sections<br />
2 x10 min in buffer 1, then equilibrate for<br />
5 min in buffer 3.<br />
9 Distribute approx. 20 µl color-solution<br />
(NBT/BCIP) on<strong>to</strong> each section, cover<br />
with a coverslip and leave in the dark<br />
overnight.<br />
Note: You may shorten the colorreaction<br />
<strong>to</strong> 30–60 min if you wish. <strong>In</strong><br />
fact, a positive reaction may be seen<br />
after a few minutes in the dark when<br />
HPV is present in a high copy-number.<br />
Hint: Use gloves when handling the<br />
color solution.<br />
a b<br />
10 After the incubation, do the following:<br />
Remove the coverslips.<br />
Wash the sections gently.<br />
Stain a few seconds with neutral red.<br />
Mount.<br />
Caution: Avoid dehydrating procedures<br />
since ethanol may remove or<br />
weaken the signal.<br />
Results<br />
The described method is applied <strong>to</strong> biopsies<br />
of multiple and solitary laryngeal papillomas<br />
and on a flat condyloma<strong>to</strong>us lesion of the<br />
uterine cervix (Figure 1). The positive results<br />
are obvious, and little background is<br />
observed in these examples. The procedure<br />
is extremely straightforward and can be<br />
performed in 5–6 h, including the 3 h<br />
hybridization. Consequently, the whole<br />
procedure can be performed in 1 day and<br />
the results recorded the next morning. If<br />
needed, the hybridization can be shortened;<br />
in our initial experiments, we were able <strong>to</strong><br />
detect HPV type 11 after only 1 h of<br />
hybridization.<br />
Acknowledgment<br />
Plasmids with HPV type 11 were kindly<br />
supplied by Prof. zur Hausen and co-workers,<br />
DKFZ, Heidelberg, Germany.<br />
c d<br />
<br />
Figure 1: Detection of HPV 11 DNA in biopsies of multiple and solitary laryngeal papillomas and<br />
on a flat condyloma<strong>to</strong>us lesion of the uterine cervix. Positive results are shown in Panels a and c.<br />
The negative controls (Panels b and d) show no signal.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG DNA Labeling and Random primed labeling of DNA probes 1 093 657 1 Kit (25 labeling<br />
Detection Kit* , ** , *** with DIG-11-dUTP, alkali-labile and color reactions and<br />
detection of DIG-labeled hybrids. detection of 50<br />
blots of 100 cm2 )<br />
Proteinase K Lyophilizate 161 519 25 mg<br />
745 723 100 mg<br />
1 000 144 500 mg<br />
1 092 766 1 g<br />
Tris Powder 127 434 100 g<br />
708 968 500 g<br />
708 976 1 kg<br />
EDTA Powder 808 261 250 g<br />
808 270 500 g<br />
808 288 1 kg<br />
Blocking Reagent Powder 1 096 176 50 g<br />
Anti-DIG-AP Fab Fragments from sheep 1 093 274 150 U (200 µl)<br />
NBT/BCIP S<strong>to</strong>ck solution 1 681 451 8 ml<br />
References<br />
Archard, L. C.; Bowles, N. E.; Olsen, E. G. J.;<br />
Richardson, P. J. (1987) Detection of persistent<br />
coxsachie B virus RNA in dilated cardiomyopathy<br />
and myocarditis. Eur. Heart J. (Suppl.) 8, 437–440.<br />
Blum, H. E.; S<strong>to</strong>wringer, L.; Figue, A. et al. (1983)<br />
Detection of Hepatitis B virus DNA in hepa<strong>to</strong>cytes,<br />
bile duct epithelium, and vascular elements by<br />
in situ hybridization. Proc. Natl. Acad. Sci. (USA)<br />
80, 6685–6688.<br />
Grody, W. W.; Cheng, L.; Lewin, K. J. (1987) <strong>In</strong> situ<br />
viral DNA hybridization in diagnostic surgical<br />
pathology. Hum. Pathol. 18, 535–543.<br />
Heiles, H. B. J.; Genersch, E.; Kessler, C.; Neumann,<br />
R.; Eggers, H. J. (1988) <strong>In</strong> situ hybridization with<br />
digoxigenin-labeled DNA of human papillomaviruses<br />
(HPV 16/18) in HeLa and SiHa cells. BioTechniques<br />
6 (10), 978–981.<br />
Lindeberg, H.; Johansen, L. (1990) The presence<br />
of human papillomavirus (HPV) in solitary adult<br />
laryngeal papillomas demonstrated by in situ<br />
DNA hybridization with sulphonated probes. Clin.<br />
O<strong>to</strong>laryngol. 15, 367–371.<br />
Lindeberg, J.; Syrjänen, S.; Karja, J.; Syrjänen, K.<br />
(1989) Human papillomavirus type 11 DNA in<br />
squamous cell carcinomas and preexisting multiple<br />
laryngeal papillomas. Acta O<strong>to</strong>-Laryngol. 107,<br />
141–149.<br />
Negro, F.; Berninger, M.; Chaiberge, E. et al. (1985)<br />
Detection of HBV-DNA by in situ hybridization using<br />
a biotin-labeled probe. J. Med. Virol. 15, 373–382.<br />
CONTENTS<br />
INDEX<br />
Nuevo, G. J.; Richart, R. M. (1989) A comparison of<br />
Biotin and 35S-based in situ hybridization methodologies<br />
for detection of human papillomavirus<br />
DNA. Lab. <strong>In</strong>vest. 61, 471–475.<br />
Pezzella, M.; Pezzella, F.; Rapicetta, M. et al. (1989)<br />
HBV and HIV expression in lymph nodes of HIV<br />
positive LAS patients: his<strong>to</strong>logy and in situ hybridization.<br />
Mol. Cell Probes 3, 125–132.<br />
Proter, H. J.; Quantrill, A. M.; Fleming, K. A. (1988)<br />
B19 parvovirus infection of myocardial cells.<br />
Lancet 1, 535–536.<br />
Shah, K. V.; Gupta, J. W.; S<strong>to</strong>ler, M. H. (1988)<br />
The in situ hybridization test in the diagnosis of<br />
human papillomaviruses. <strong>In</strong>: De Palo, G.; Rilke, F.;<br />
zur Hausen, H. (Eds.) Serono Symposia 46: Herpes<br />
and Papillomaviruses. New York: Raven Press,<br />
151–159.<br />
Unger, E. R.; Budgeon, L. R.; Myorson, B.; Brigati, D.<br />
J. (1988) Viral diagnosis by in situ hybridization.<br />
Description of a rapid simplified colorimetric<br />
method. Am J. Surg. Pathol. 18, 1–8.<br />
***Sold under the tradename of<br />
Genius in the US.<br />
***EP Patent 0 324 474 granted <strong>to</strong><br />
Boehringer Mannheim GmbH.<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
125<br />
5
5<br />
126<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Detection of mRNA in tissue sections using<br />
DIG-labeled RNA and oligonucleotide probes<br />
P. Komminoth, Division of Cell and Molecular Pathology, Department of Pathology,<br />
University of Zürich, Switzerland.<br />
The pro<strong>to</strong>cols given below are modifications<br />
of recently published methods for noniso<strong>to</strong>pic<br />
in situ hybridization with digoxigenin-labeled<br />
probes (Komminoth, 1992;<br />
Komminoth et al., 1992). <strong>In</strong> those reports we<br />
demonstrated:<br />
Digoxigenin-labeled probes are as sensitive<br />
as 35S-labeled probes.<br />
Pro<strong>to</strong>cols with digoxigenin-labeled probes<br />
may also be applied <strong>to</strong> diagnostic in situ<br />
hybridization procedures.<br />
The following pro<strong>to</strong>cols have been successfully<br />
used in our labora<strong>to</strong>ries <strong>to</strong> detect<br />
mRNA in frozen and paraffin-embedded<br />
tissue sections with either RNA or oligonucleotide<br />
probes.<br />
RNA probes are best for high sensitivity<br />
detection procedures because:<br />
RNA probes are easily generated and<br />
labeled by in vitro transcription procedures.<br />
Hybrids between mRNA and RNA<br />
probes are highly stable.<br />
Pro<strong>to</strong>cols using stringent washing<br />
conditions and RNase digestion steps<br />
yield highly specific signals with low<br />
background.<br />
Synthetic oligonucleotide probes are an<br />
attractive alternative <strong>to</strong> RNA probes for the<br />
detection of abundant mRNA sequences in<br />
tissue sections, because:<br />
Any known nucleic acid sequence can<br />
rapidly be made by au<strong>to</strong>mated chemical<br />
synthesis.<br />
Such probes are more stable than RNA<br />
probes.<br />
Oligonucleotide probes are labeled during<br />
synthesis or by addition of reporter<br />
molecules at the 5' or 3' end after synthesis.<br />
The most efficient labeling method is<br />
addition of a “tail” of labeled nucleotides <strong>to</strong><br />
the 3' end. Oligonucleotide probes are<br />
generally less sensitive than RNA probes<br />
since fewer labeled nucleotides can be<br />
incorporated per molecule of probe.<br />
The pro<strong>to</strong>cols below are written in general<br />
terms. Additional information concerning<br />
the in situ hybridization methods and<br />
important technical details are provided in<br />
Komminoth (1992), Komminoth et al. (1992),<br />
Komminoth et al. (1995), Sambrook et al.<br />
(1989), and the Boehringer Mannheim<br />
DIG/Genius System User’s Guide for<br />
Membrane <strong>Hybridization</strong>.<br />
I. Preparation of slides<br />
Note: Gelatin-coated slides are excellent for<br />
large tissue sections obtained from frozen<br />
or paraffin-embedded specimens. Alternatively,<br />
silane-coated slides can be used, but<br />
are better suited for small tissue samples or<br />
cell preparations.<br />
IA. Gelatin-coated slides<br />
1 Clean slides by soaking for 10 min in<br />
Chromerge ® solution (Merck).<br />
2 Wash slides in running hot water.<br />
3 Rinse slides in distilled water.<br />
4 Prepare gelatin solution as follows:<br />
Dissolve 10 g gelatin (Merck) in 1 liter<br />
of distilled water which has been<br />
heated <strong>to</strong> 40°–50°C.<br />
Add 4 ml 25% chromium potassium<br />
sulfate (CPS) solution (Merck) <strong>to</strong> the<br />
gelatin <strong>to</strong> make a final concentration of<br />
0.1% CPS.<br />
5 Dip slides in gelatin solution for 10 min.<br />
6 Let the slides air dry.<br />
7 Soak slides for 10 min in PBS (pH 7.4)<br />
containing 1% paraformaldehyde.<br />
8 Let the slides air dry.<br />
9 Bake slides at 60°C overnight.<br />
IB. Silane-coated slides<br />
1 Soak clean glass slides for 60 min in silane<br />
solution [5 ml of 3-aminopropyltriethoxysilane<br />
(Sigma) in 250 ml of ace<strong>to</strong>ne].<br />
2 Wash the slides 2 x 10 min in distilled<br />
water.<br />
3 Dry slides overnight at 60°C.<br />
Note: Both gelatin- and silane-coated slides<br />
can be s<strong>to</strong>red for several months under dry<br />
and dust free conditions.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
II. Tissue preparation<br />
<strong>General</strong> guidelines: Fix or freeze tissue as<br />
soon as possible after surgical excision <strong>to</strong><br />
prevent degradation of mRNA.<br />
If possible, use cryostat sections of paraformaldehyde-fixed<br />
tissues which have been<br />
immersed in sucrose (as in Procedure IIA).<br />
These provide excellent conditions for<br />
mRNA localization and preservation of<br />
sample morphology.<br />
However, in surgical pathology, most tissues<br />
are routinely fixed in formalin. For mRNA<br />
localization, do not fix in formalin for more<br />
than 24 h. Prolonged s<strong>to</strong>rage of samples in<br />
formalin will cause covalent linkages<br />
between mRNA and proteins, making target<br />
sequences less accessible.<br />
Caution: Prepare all solutions for procedures<br />
IIA and IIB with distilled, deionized<br />
water (ddH2O) that has been treated<br />
with 0.1% diethylpyrocarbonate (DEPC)<br />
(Sambrook et al., 1989).<br />
IIA. Frozen sections<br />
1 Cut tissues in<strong>to</strong> 2 mm thick slices.<br />
2 <strong>In</strong>cubate cut tissues at 4°C for 2–4 h with<br />
freshly made, filtered fixative (DEPCtreated<br />
PBS containing 4% paraformaldehyde;<br />
pH 7.5).<br />
3 Decant fixative and soak tissues at 4°C<br />
overnight in sucrose solution [DEPCtreated<br />
PBS containing 30% sucrose<br />
(RNase-free)].<br />
Note: During this step, the tissues should<br />
sink <strong>to</strong> the bot<strong>to</strong>m of the container.<br />
4 S<strong>to</strong>re tissue samples in a freezing compound<br />
at –80°C, or, for long time s<strong>to</strong>rage,<br />
at –140°C (Naber et al., 1992).<br />
5 For sectioning, warm the samples <strong>to</strong><br />
–20°C and cut 10 µm sections in a cryostat.<br />
6 Place the sections on pretreated glass<br />
slides (from Procedure I).<br />
7 Dry slides in an oven at 40°C overnight.<br />
8 Do either of the following:<br />
Use the prepared slides immediately.<br />
or<br />
S<strong>to</strong>re the slides in a box at –80°C.<br />
Before processing, warm the s<strong>to</strong>red<br />
slides <strong>to</strong> room temperature and dry<br />
them in an oven at 40°C for a<br />
minimum of 2 h.<br />
Note: Slides with cryostat sections may<br />
be s<strong>to</strong>red at –80°C for several weeks.<br />
CONTENTS<br />
INDEX<br />
IIB. Paraffin sections<br />
1 Prepare formaldehyde-fixed and paraffinembedded<br />
material according <strong>to</strong> standard<br />
procedures.<br />
2 Cut 7 µm sections from the paraffinembedded<br />
material and place the sections<br />
on<strong>to</strong> coated glass slides (from Procedure I).<br />
3 Dry slides in an oven at 40°C overnight.<br />
4 Dewax sections 2 x 10 min with fresh<br />
xylene.<br />
5 Rehydrate sections in the following<br />
solutions:<br />
1 x 5 min in 100% ethanol.<br />
1 x 5 min in 95% ethanol.<br />
1 x 5 min in 70% ethanol.<br />
2 x in DEPC-treated ddH2O.<br />
IIIA. ISH pro<strong>to</strong>col for detection of mRNA<br />
with DIG-labeled RNA probes<br />
Caution: Prepare all solutions for procedures<br />
below (probe labeling through<br />
posthybridization) with distilled, deionized<br />
water (ddH2O) that has been treated<br />
with 0.1% diethylpyrocarbonate (DEPC)<br />
(Sambrook et al., 1989). To avoid RNase<br />
contamination, wear gloves throughout<br />
the procedures and use different glassware<br />
for pre- and posthybridization steps.<br />
Note: Perform all procedures below at<br />
room temperature unless a different<br />
temperature is stated.<br />
Probe labeling<br />
Note: To ensure tissue penetration, we<br />
prefer <strong>to</strong> work with RNA probes that are<br />
≤ 500 bases long.<br />
1 Clone a cDNA insert in<strong>to</strong> an RNA<br />
expression vec<strong>to</strong>r (plasmid) according <strong>to</strong><br />
standard procedures (Sambrook et al.,<br />
1989).<br />
2 Linearize the RNA expression vec<strong>to</strong>r<br />
with appropriate restriction enzymes <strong>to</strong><br />
allow in vitro run-off synthesis of both<br />
sense- and antisense-oriented RNA probes<br />
(Valentino et al., 1987).<br />
Note: As an alternative <strong>to</strong> linearized<br />
plasmids, use PCR-generated templates<br />
containing RNA polymerase promoter<br />
sequences for in vitro transcription<br />
(Young et al., 1991).<br />
127<br />
5
5<br />
*Sold under the tradename of Genius<br />
in the US.<br />
128<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
3 Purify linearized plasmid by phenolchloroform<br />
extraction and ethanol<br />
precipitation.<br />
Caution: Some plasmid purification kits<br />
contain RNase digestion steps for removing<br />
bacterial RNA. Traces of RNase may<br />
destroy transcribed probes. To ensure<br />
removal of residual RNase, perform<br />
multiple phenol-chloroform extractions of<br />
the linearized plasmid.<br />
4 To avoid RNA polymerase inhibition,<br />
resuspend the plasmid in EDTA-free<br />
buffer or DEPC-treated ddH2O.<br />
5 Generate digoxigenin-labeled RNA<br />
probes in both the sense and antisense<br />
direction by in vitro transcription with<br />
the DIG RNA Labeling Kit* or according<br />
<strong>to</strong> procedures in Chapter 4 of this<br />
manual.<br />
6 Purify labeled probes according <strong>to</strong><br />
procedures in the DIG/Genius System<br />
User’s Guide for Membrane <strong>Hybridization</strong><br />
or in Chapter 4 of this manual.<br />
Caution: Probes longer than 500 bases<br />
may not penetrate tissue. If probes are<br />
longer than 500 bases, shorten them<br />
by alkaline hydrolysis according <strong>to</strong><br />
procedures in the DIG/Genius System<br />
User’s Guide for Membrane <strong>Hybridization</strong>.<br />
7 Estimate the yield of labeled probes by<br />
direct blotting procedures as described in<br />
Chapter 4 of this manual.<br />
8 Aliquot labeled probes and s<strong>to</strong>re them at<br />
–80°C.<br />
Note: Probes are stable for up <strong>to</strong> one<br />
year.<br />
Prehybridization<br />
1 <strong>In</strong>cubate sections as follows:<br />
2 x 5 min with DEPC-treated PBS (pH<br />
7.4) (Sambrook et al., 1989).<br />
Note: PBS contains 140 mM NaCl,<br />
2.7 mM KCl, 10 mM Na2HPO4,<br />
1.8 mM KH2PO4.<br />
2 x 5 min with DEPC-treated PBS<br />
containing 100 mM glycine.<br />
2 Treat sections for 15 min with DEPCtreated<br />
PBS containing 0.3% Tri<strong>to</strong>n ®<br />
X-100.<br />
3 Wash 2 x 5 min with DEPC-treated PBS.<br />
4 Permeabilize sections for 30 min at 37°C<br />
with TE buffer (100 mM Tris-HCl,<br />
50 mM EDTA, pH 8.0) containing either<br />
1 µg/ml RNase-free Proteinase K (for<br />
frozen sections) or 5–20 µg/ml RNasefree<br />
Proteinase K (for paraffin sections).<br />
Caution: Permeabilization is the most<br />
critical step of the entire in situ hybridization<br />
procedure. <strong>In</strong> paraffin-embedded<br />
archival materials, optimal tissue permeabilization<br />
differs for each case,<br />
depending upon duration and type of<br />
fixation. We recommend titration of the<br />
Proteinase K concentration. Alternative<br />
permeabilization pro<strong>to</strong>cols for improved<br />
efficiency of digestion include incubation<br />
of slides for 20–30 min at 37°C with<br />
0.1% pepsin in 0.2 M HCl.<br />
5 Post-fix sections for 5 min at 4°C with<br />
DEPC-treated PBS containing 4% paraformaldehyde.<br />
6 Wash sections 2 x 5 min with DEPCtreated<br />
PBS.<br />
7 To acetylate sections, place slide containers<br />
on a rocking platform and incubate<br />
slides 2 x 5 min with 0.1 M triethanolamine<br />
(TEA) buffer, pH 8.0, containing<br />
0.25% (v/v) acetic anhydride (Sigma).<br />
Caution: Acetic anhydride is highly<br />
unstable. Add acetic anhydride <strong>to</strong> each<br />
change of TEA-acetic anhydride solution<br />
immediately before incubation.<br />
8 <strong>In</strong>cubate sections at 37°C for at least<br />
10 min with prehybridization buffer<br />
[4 x SSC containing 50% (v/v) deionized<br />
formamide].<br />
Note: Deionize formamide with<br />
Dowex ® MR 3 (Sigma) according <strong>to</strong><br />
pro<strong>to</strong>cols described in Sambrook et al.<br />
(1989).<br />
Note: 1 x SSC = 150 mM NaCl, 15 mM<br />
sodium citrate, pH 7.2.<br />
<strong>In</strong> situ hybridization<br />
1 Prepare hybridization buffer containing:<br />
40% deionized formamide.<br />
10% dextran sulfate.<br />
1 x Denhardt’s solution [0.02% Ficoll ® ,<br />
0.02% polyvinylpyrrolidone, 10 mg/ml<br />
RNase-free bovine serum albumin].<br />
4 x SSC.<br />
10 mM DTT.<br />
1 mg/ml yeast t-RNA.<br />
1 mg/ml denatured and sheared<br />
salmon sperm DNA.<br />
Caution: Denature and add salmon<br />
sperm DNA <strong>to</strong> buffer shortly before<br />
hybridization.<br />
Note: <strong>Hybridization</strong> buffer (minus<br />
salmon sperm DNA) can be s<strong>to</strong>red at<br />
–20°C for several months.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
2 Drain prehybridization buffer from the<br />
slides and overlay each section with<br />
30 µl of hybridization buffer containing<br />
5–10 ng of digoxigenin-labeled RNA<br />
probe.<br />
3 Cover samples with a 24 x 30 mm<br />
hydrophobic plastic coverslip (e.g. cut<br />
from Gel Bond Film, FMC BioProducts,<br />
Rockland, ME, USA).<br />
4 <strong>In</strong>cubate sections at 42°C overnight in a<br />
humid chamber.<br />
Posthybridization<br />
Caution: Use a separate set of glassware<br />
for posthybridization and prehybridization<br />
procedures <strong>to</strong> avoid RNase contamination<br />
in prehybridization steps.<br />
1 Remove coverslips from sections by<br />
immersing slides for 5–10 min in 2 x SSC.<br />
Caution: Do not place samples which<br />
are hybridized with different probes in<br />
the same container.<br />
2 <strong>In</strong> a shaking water bath at 37°C, wash<br />
sections as follows:<br />
2 x15 min with 2 x SSC.<br />
2 x15 min with 1x SSC.<br />
3 To digest any single-stranded (unbound)<br />
RNA probe, incubate sections for 30 min<br />
at 37°C in NTE buffer [500 mM NaCl,<br />
10 mM Tris, 1 mM EDTA, pH 8.0]<br />
containing 20 µg/ml RNase A.<br />
Caution: Be particularly careful with<br />
RNase. This enzyme is extremely stable<br />
and difficult <strong>to</strong> inactivate. Avoid<br />
contamination of any equipment or<br />
glassware which might be used for<br />
probe preparation or prehybridization<br />
procedures. Use separate glassware for<br />
RNase-contaminated solutions.<br />
4 <strong>In</strong> a shaking water bath at 37°C, wash<br />
sections 2 x 30 min with 0.1 x SSC.<br />
Note: If this procedure gives high background<br />
or nonspecific signals, try posthybridization<br />
washings at 52°C with<br />
2 x SSC containing 50% formamide.<br />
Immunological detection<br />
Note: This detection procedure uses components<br />
of the DIG Nucleic Acid Detection<br />
Kit*. Alternative detection procedures<br />
include the immunogold method with silver<br />
enhancement for enzyme-independent<br />
probe detection (Komminoth et al. 1992;<br />
Komminoth et al., 1995) and other detection<br />
procedures described in Chapter 5 of<br />
this manual.<br />
CONTENTS<br />
INDEX<br />
1 Using a shaking platform, wash sections<br />
2 x 10 min with buffer 1 [100 mM Tris-<br />
HCl (pH 7.5), 150 mM NaCl].<br />
2 Cover sections for 30 min with blocking<br />
solution [buffer 1 containing 0.1%<br />
Tri<strong>to</strong>n ® X-100 and 2% normal sheep<br />
serum (Sigma)].<br />
3 Decant blocking solution and incubate<br />
sections for 2 h in a humid chamber with<br />
buffer 1 containing 0.1% Tri<strong>to</strong>n ® X-100,<br />
1% normal sheep serum, and a suitable<br />
dilution of sheep anti-DIG-alkaline<br />
phosphatase [Fab fragments].<br />
Note: For optimal detection, incubate<br />
several sections (from the same sample)<br />
with different dilutions of the antibody<br />
(1:100; 1:500, and 1:1000).<br />
4 Using a shaking platform, wash sections<br />
2 x10 min with buffer 1.<br />
5 <strong>In</strong>cubate sections for 10 min with buffer 2<br />
[100 mM Tris-HCl (pH 9.5), 100 mM<br />
NaCl, 50 mM MgCl2].<br />
6 Prepare a color solution containing:<br />
10 ml of buffer 2.<br />
45 µl nitroblue tetrazolium (NBT)<br />
solution (75 mg NBT/ml in 70%<br />
dimethylformamide).<br />
35 µl 5-bromo-4-chloro-3-indolylphosphate<br />
(BCIP or X-phosphate)<br />
solution (50 mg X-phosphate/ml in<br />
100% dimethylformamide).<br />
1 mM (2.4 mg/10 ml) levamisole (Sigma).<br />
Note: For convenience, prepare a 1 M<br />
s<strong>to</strong>ck solution of levamisole in ddH2O<br />
(stable for several weeks, when s<strong>to</strong>red<br />
at 4°C) and add 10 µl of the s<strong>to</strong>ck <strong>to</strong><br />
10 ml of the color solution. If endogenous<br />
phosphatase activity is high,<br />
increase the concentration of<br />
levamisole <strong>to</strong> 5 mM (50 µl 1 M<br />
s<strong>to</strong>ck/10 ml solution) in the color<br />
solution.<br />
Note: NBT/BCIP produces a blue precipitating<br />
product. For other colors, use<br />
other alkaline phosphatase substrates.<br />
For example, use either Fast Red or<br />
INT/BCIP for red/brown precipitates.<br />
7 Cover each section with approximately<br />
200 µl color solution and incubate slides<br />
in a humid chamber for 2–24 h in the<br />
dark.<br />
8 When color development is optimal, s<strong>to</strong>p<br />
the color reaction by incubating the slides<br />
in buffer 3 [10 mM Tris-HCl (pH 8.1), 1<br />
mM EDTA].<br />
9 Dip slides briefly in distilled water.<br />
*Sold under the tradename of Genius<br />
in the US.<br />
129<br />
5
5<br />
*Sold under the tradename of Genius<br />
in the US.<br />
130<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
10 Counterstain sections for 1–2 min with<br />
0.02% fast green FCF or 0.1% nuclear<br />
Fast Red (Aldrich Chemical Corp.,<br />
Milwaukee, WI, USA) in distilled H2O.<br />
11 Wash sections 2 x 10 min in tap water.<br />
12 Mount sections using an aqueous mounting<br />
solution (e.g. Aqua-Mount from Lerner<br />
Labora<strong>to</strong>ries, Pittsburgh, PA, USA).<br />
Caution: Do not use xylene-based<br />
mounting solutions. These lead <strong>to</strong> crystal<br />
formation of color precipitates.<br />
IIIB. ISH pro<strong>to</strong>col for detecting mRNA<br />
with DIG-labeled oligonucleotide probes<br />
Probe labeling<br />
1 Label 100 pmol of oligonucleotide probe<br />
(20–30 mer) by tailing with the DIG<br />
Oligonucleotide Tailing Kit* according<br />
<strong>to</strong> the pro<strong>to</strong>col described in Chapter 4 of<br />
this manual.<br />
2 Purify labeled probes according <strong>to</strong> procedures<br />
in the DIG/Genius System<br />
User’s Guide for Membrane <strong>Hybridization</strong><br />
or in Chapter 4 of this manual.<br />
3 Estimate the yield of labeled probes by<br />
direct blotting procedures as described in<br />
Chapter 4 of this manual.<br />
4 Aliquot the labeled probes and s<strong>to</strong>re<br />
them at –20°C.<br />
Note: Probes are stable for up <strong>to</strong> one<br />
year.<br />
Note: To increase the sensitivity of in situ<br />
hybridization procedures, prepare several<br />
labeled probes that are complementary <strong>to</strong><br />
different regions of the target RNA, then<br />
use mixtures of the probes for the hybridization<br />
step below.<br />
Prehybridization<br />
1 Follow Steps 1–7 from the prehybridization<br />
section of Procedure IIIA (for<br />
RNA probes).<br />
2 Overlay each section with 40 µl<br />
prehybridization buffer (identical <strong>to</strong> the<br />
hybridization buffer <strong>to</strong> be used for in situ<br />
hybridization below, but containing no<br />
labeled probe).<br />
3 Add a 24 x 30 mm coverslip <strong>to</strong> each<br />
section and incubate slides in a humid<br />
chamber at 37°C for 2 h.<br />
4 Remove coverslips by immersing slides<br />
for 5 min in 2xSSC.<br />
<strong>In</strong> situ hybridization<br />
Note: To increase the sensitivity of in situ<br />
hybridization procedures, use mixtures of<br />
oligonucleotide probes that are complementary<br />
<strong>to</strong> different regions of the target<br />
RNA.<br />
1 Prepare hybridization buffer containing:<br />
2 x SSC.<br />
1 x Denhardt’s solution [0.02% Ficoll ® ,<br />
0.02% polyvinylpyrrolidone, 10 mg/ml<br />
RNase-free bovine serum albumin].<br />
10% dextran sulfate.<br />
50 mM phosphate buffer (pH 7.0).<br />
50 mM DTT.<br />
250 µg/ml yeast t-RNA.<br />
5 µg/ml polydeoxyadenylic acid.<br />
100 µg/ml polyadenylic acid.<br />
0.05 pM/ml Randomer Oligonucleotide<br />
<strong>Hybridization</strong> Probe (DuPont).<br />
500 µg/ml denatured and sheared<br />
salmon sperm DNA.<br />
Caution: Denature and add salmon<br />
sperm DNA <strong>to</strong> buffer shortly before<br />
hybridization.<br />
Enough deionized formamide (%dF,<br />
as calculated by the formula below) <strong>to</strong><br />
produce stringent hybridization conditions<br />
at 37°C [that is, <strong>to</strong> make 37°C<br />
= Tm (oligonucleotide probe) – 10°C]<br />
(Long et al., 1992).<br />
Caution: %dF should not exceed<br />
47% of the <strong>to</strong>tal volume of the<br />
hybridization buffer. If dF is less than<br />
47%, add ddH2O so that ddH2O plus<br />
dF equals 47% of the volume.<br />
Note: Use the following formula <strong>to</strong><br />
calculate the formamide concentration<br />
(%dF) in the hybridization buffer for<br />
each oligonucleotide probe:<br />
(–7.9) + 81.5 + 0.41 (%GC) – 675/L – % mismatch – (47)<br />
% dF = _______________________________________________<br />
0.65<br />
where, in this case:<br />
–7.9 = 16.6 log10 [Na+] (for 2 x SSC)<br />
%GC = %[G + C] base content of the oligonucleotide<br />
L = oligonucleotide length (in bases)<br />
% mismatch = %(bases in oligonucleotide not complementary <strong>to</strong><br />
target)<br />
47 = hybridization temperature + 10°C (for 37°C)<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Note: <strong>Hybridization</strong> buffer (minus dF,<br />
ddH2O, and salmon sperm DNA) can<br />
be s<strong>to</strong>red at –20° C for several months.<br />
2 Drain 2 x SSC (Step 4, Prehybridization)<br />
from the slides and overlay each section<br />
with 30 µl of hybridization buffer<br />
containing 10–30 ng of digoxigeninlabeled<br />
oligonucleotide probe.<br />
3 Cover sections with a 24 x 30 mm hydrophobic<br />
plastic coverslip (e.g. cut from Gel<br />
Bond Film, FMC BioProducts, Rockland,<br />
ME, USA).<br />
4 <strong>In</strong>cubate samples at 37°C overnight in a<br />
humid chamber.<br />
Posthybridization<br />
1 Remove coverslips from sections by<br />
immersing slides for 5–10 min in 2 x SSC.<br />
2 <strong>In</strong> a shaking water bath at 37°C, wash<br />
sections as follows:<br />
2 x 15 min with 2 x SSC.<br />
2 x 15 min with 1x SSC.<br />
2 x 15 min with 0.25 x SSC.<br />
Immunological detection<br />
Use the same immunological detection<br />
pro<strong>to</strong>col as in Procedure IIIA (for RNA<br />
probes) above.<br />
Controls for in situ hybridizations<br />
Adequate controls must always be included<br />
<strong>to</strong> ensure the specificity of detection signals.<br />
Controls should include positive and<br />
negative samples as well as technical controls<br />
<strong>to</strong> detect false positive and negative results<br />
(Herring<strong>to</strong>n and McGee, 1992).<br />
Positive controls<br />
1 Positive sample: Tissue or cell line known<br />
<strong>to</strong> contain mRNA of interest.<br />
2 Technical control <strong>to</strong> test quality of tissue<br />
mRNA and the procedure reagents:<br />
Labeled poly(dT) probe (for oligonucleotide<br />
in situ hybridization only); labeled<br />
RNA or oligonucleotide probes complementary<br />
<strong>to</strong> abundant “housekeeping<br />
genes” (such as -tubulin) <strong>to</strong> test quality<br />
of tissue mRNA and the procedure<br />
reagents (should give positive results).<br />
CONTENTS<br />
INDEX<br />
Negative controls<br />
1 Negative sample: Tissue or cell line<br />
known <strong>to</strong> lack the sequence of interest.<br />
2 Technical controls:<br />
Target: Digestion of mRNA with<br />
RNase prior <strong>to</strong> in situ hybridization<br />
(should give negative results).<br />
<strong>Hybridization</strong>:<br />
– <strong>Hybridization</strong> with sense probe<br />
– <strong>Hybridization</strong> with irrelevant probe<br />
(e.g. probe for viral sequences)<br />
– <strong>Hybridization</strong> in the presence of excess<br />
unlabeled antisense probe<br />
(all should give negative results).<br />
Detection:<br />
– <strong>Hybridization</strong> without probe<br />
– Omission of anti-DIG antibody<br />
(both should give negative results).<br />
Results<br />
A B<br />
Figure 1: Comparison of 35 <br />
S- and digoxigenin-labeled cRNA probes for the detection<br />
of seminal vesicle secretion protein II (SVS II) mRNA in cryostat sections of the<br />
dorsolateral rat prostate. Note the equal intensity of signals in acini of the lateral lobe<br />
obtained with iso<strong>to</strong>pic (Panel A) and non-iso<strong>to</strong>pic (Panel B) in situ hybridization procedures.<br />
Also note the absence of signal in the coagulating glands (arrows in Panel B) which serves as<br />
an internal negative control.<br />
131<br />
5
5<br />
Figure 2: SVS II mRNA detection<br />
in contiguous glands of the rat<br />
prostate with a digoxigeninlabeled<br />
antisense RNA probe.<br />
Panel A: Strong signals are present<br />
in epithelia of the ampullary gland<br />
and no signals are encountered<br />
in adjacent duct epithelia of the<br />
coagulating gland (arrow).<br />
Panel B: A higher magnification<br />
shows that the hybridization signal<br />
is restricted <strong>to</strong> the cy<strong>to</strong>plasmic<br />
portion of the glandular epithelial<br />
cells (cryostat sections).<br />
132<br />
<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
A<br />
B<br />
<br />
Figure 3: SVS II mRNA detection in contiguous<br />
glands of the rat prostate with a digoxigeninlabeled<br />
oligonucleotide antisense probe.<br />
<strong>Hybridization</strong> signals appear <strong>to</strong> be slightly less<br />
strong than with the SVS II RNA probe (Figure 2).<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Figure 4: Detection of parathyroid hormone<br />
(PTH) mRNA in formaldehyde-fixed, paraffinembedded<br />
tissue of a parathyroid gland with<br />
a digoxigenin-labeled antisense RNA probe.<br />
Panel A: Note the weaker signal in cells of an<br />
adenoma<strong>to</strong>us lesion (upper right part) compared<br />
with the normal parathyroid tissue. Panel B: Higher<br />
magnification shows the excellent resolution of<br />
hybridization signals, which are confined <strong>to</strong> the<br />
cy<strong>to</strong>plasmic portion of cells.<br />
Figure 5: Use of a digoxigenin-labeled antisense<br />
RNA probe and Fast Red chromogen <strong>to</strong> detect<br />
PTH mRNA in formaldehyde-fixed, paraffinembedded<br />
tissue of a parathyroid gland with<br />
chief cell hyperplasia.<br />
Panel A: PTH mRNA is marked by red precipitates.<br />
Panel B: Only weak signals are present when a<br />
sense PTH probe is used as a control.<br />
Figure 6: Detection of synap<strong>to</strong>physin mRNA in<br />
formaldehyde-fixed, paraffin-embedded tissue<br />
of a neuroendocrine carcinoma of the gut with<br />
digoxigenin-labeled oligonucleotide probes and<br />
immunogold-silver enhancement method for<br />
visualization.<br />
Note the strong hybridization signals (consisting of<br />
silver precipitates) over tumor cells in Panel A<br />
(where an antisense probe was used) and the much<br />
weaker signal in Panel B (where the appropriate<br />
sense probe was used as a control).<br />
CONTENTS<br />
INDEX<br />
<br />
<br />
<br />
A<br />
A B<br />
A B<br />
B<br />
133<br />
5
5<br />
134<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG RNA Labeling For RNA labeling with digoxigenin-UTP 1175 025 1 Kit (2 x10<br />
Kit* , ** , *** by in vitro transcription with SP6 and labeling<br />
T7 RNA polymerase. reactions)<br />
DIG Oligonucleotide For tailing oligonucleotides with 1 417 231 1 Kit (25 tailing<br />
Tailing Kit* , *** , **** digoxigenin-dUTP. reactions)<br />
DIG Nucleic Acid For detection of digoxigenin-labeled 1175 041 1 Kit<br />
Detection Kit* nucleic acids by an enzyme-linked<br />
immunoassay with a highly specific anti-<br />
DIG-AP antibody conjugate and the color<br />
substrate NBT and BCIP.<br />
Tri<strong>to</strong>n ® X-100 Vicous, liquid 789 704 100 ml<br />
EDTA Powder 808 261 250 g<br />
808 270 500 g<br />
808 288 1 kg<br />
Proteinase K Solution 1 413 783 1.25 ml<br />
1 373 196 5 ml<br />
1 373 200 25 ml<br />
Pepsin Lyophilizate 108 057 1 g<br />
1 693 387 5 g<br />
BSA Highest quality, lyophilizate 238 031 1 g<br />
238 040 10 g<br />
DTT Purity: > 97% 197 777 2 g<br />
708 984 10 g<br />
1 583 786 25 g<br />
708 992 50 g<br />
709 000 100 g<br />
Tris Powder 127 434 100 g<br />
708 968 500 g<br />
708 976 1 kg<br />
RNase A From bovine pancreas, dry powder 109 142 25 mg<br />
109 169 100 mg<br />
tRNA From baker’s yeast, lyophilizate 109 495 100 mg<br />
109 509 500 mg<br />
Poly(A) Polyadenylic acid 108 626 100 mg<br />
Poly(dA) Poly-deoxy-adenylic acid 223 581 5 A260 units<br />
****Sold under the tradename of Genius in the US.<br />
****EP Patent 0 324 474 granted <strong>to</strong> Boehringer Mannheim GmbH.<br />
****Licensed by <strong>In</strong>stitute Pasteur.<br />
****EP Patents 0 124 657/0 324 474 granted <strong>to</strong> Boehringer Mannheim GmbH.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Acknowledgments<br />
I am grateful <strong>to</strong> Ph. U. Heitz and J. Roth for<br />
general support; <strong>to</strong> A. A. Long, H. J. Wolfe,<br />
S. P. Naber, and W. Membrino for technical<br />
advice; <strong>to</strong> M. Machado, X. Matias-Guiu, F.<br />
B. Merck, I. Leav, and P. Saremaslani for<br />
technical support; and <strong>to</strong> N. Wey and H.<br />
Nef for pho<strong>to</strong>graphic reproductions. The<br />
projects – during which the pro<strong>to</strong>cols have<br />
been established – were supported in part by<br />
the Julius Müller-Grocholski Cancer<br />
Research Foundation, Zürich Switzerland.<br />
CONTENTS<br />
INDEX<br />
References<br />
Herring<strong>to</strong>n, C. S.; McGee, J. O. (1992) Principles<br />
and basic methodology of DNA/RNA detection by<br />
in situ hybridization. <strong>In</strong>: Herring<strong>to</strong>n, C. S.; McGee,<br />
J. O. (Eds.) Diagnostic molecular pathology:<br />
A practical approach. New York: IRL Press, Vol. 1,<br />
pp. 69–102.<br />
Komminoth, P. (1992) Digoxigenin as an alternative<br />
probe labeling for in situ hybridization. Diagn. Mol.<br />
Pathol. 1, 142–150.<br />
Komminoth, P.; Merk, F. B.; Leav, I.; Wolfe, H. J.;<br />
Roth, J. (1992) Comparison of 35S- and digoxigeninlabeled<br />
RNA and oligonucleotide probes for in situ<br />
hybridization. Expression of mRNA of the seminal<br />
vesicle secretion protein II and androgen recep<strong>to</strong>r<br />
genes in the rat prostate. His<strong>to</strong>chemistry 98,<br />
217–228.<br />
Komminoth, P.; Roth, J.; Saremaslani, P.; Schrödel,<br />
S., Heitz, P. U. (1995) Overlapping expression of<br />
immunohis<strong>to</strong>chemical markers and synap<strong>to</strong>physin<br />
mRNA in pheochromocy<strong>to</strong>mas and adrenocortical<br />
carcinomas. Implications for the differential<br />
diagnosis of adrenal gland tumors. Lab. <strong>In</strong>vest. 72,<br />
424–431.<br />
Long, A. A.; Mueller, J.; Andre-Schwartz, J.; Barrett,<br />
K.; Schwartz, R., Wolfe, H. J. (1992) High-specificity<br />
in situ hybridization: Methods and application.<br />
Diagn. Mol. Pathol. 1, 45–57.<br />
Naber, S.; Smith, L.; Wolfe, H. J. (1992) Role of the<br />
frozen tissue bank in molecular pathology. Diagn.<br />
Mol. Pathol. 1, 73–79.<br />
Sambrook, J.; Fritsch, E.; Maniatis, T. (1989)<br />
Molecular Cloning: A Labora<strong>to</strong>ry Manual. Cold<br />
Spring Harbor, NY: Cold Spring Harbor Labora<strong>to</strong>ry<br />
Press.<br />
Valentino, K. L.; Eberwine, J. H.; Barchas, J. D.<br />
(1987) <strong>In</strong> situ <strong>Hybridization</strong>: Applications To<br />
Neurobiology. Oxford, England: Oxford University<br />
Press.<br />
Young, I. D.; Ailles, L.; Deugau, K.; Kisilevsky, R.<br />
(1991) Transcription of cRNA for in situ hybridization<br />
from Polymerase Chain Reaction-amplified DNA.<br />
Lab. <strong>In</strong>vest. 64, 709–712.<br />
135<br />
5
5<br />
*Sold under the tradename of Genius<br />
in the US.<br />
136<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Detection of mRNA on paraffin embedded material<br />
of the central nervous system with DIG-labeled<br />
RNA probes<br />
H. Breitschopf and G. Suchanek, Research Unit for Experimental Neuropathology,<br />
Austrian Academy of Sciences, Vienna, Austria.<br />
The following pro<strong>to</strong>col was developed <strong>to</strong><br />
show mRNA in paraffin embedded material<br />
of the central nervous system. It also allows<br />
double staining of protein and mRNA. This<br />
method is sensitive enough <strong>to</strong> show mRNA<br />
expressed at very low levels (Breitschopf et<br />
al., 1992).<br />
I. Probe preparation<br />
1 Prepare plasmids by standard methods<br />
(Sambrook et al., 1989).<br />
2 Prepare RNA probes from the plasmids<br />
and label them with digoxigenin (DIG)<br />
either according <strong>to</strong> the methods in<br />
Chapter 4 of this manual or according <strong>to</strong><br />
the instructions in the DIG RNA<br />
Labeling Kit*.<br />
3 Remove unincorporated nucleotides<br />
from the labeled probes by passing the<br />
labeling mixture over a Quick Spin<br />
column for radiolabeled RNA preparation<br />
(Sephadex ® G-50).<br />
Caution: Omission of this column step<br />
may lead <strong>to</strong> background problems.<br />
4 Determine the amount of DIG-labeling<br />
with a dot blot according <strong>to</strong> the method<br />
in Chapter 4 of this manual.<br />
II. Tissue preparation<br />
1 Use samples fixed by standardized<br />
methods, such as:<br />
Perfusion-fixed samples.<br />
Caution: Before using perfusion-fixed<br />
samples, treat them further by immersion-fixing<br />
for 3–4 h at room temperature<br />
in 100 mM phosphate buffer<br />
containing 4% paraformaldehyde.<br />
Note: Samples fixed with 4% paraformaldehyde<br />
give the best results in<br />
this procedure.<br />
Routinely fixed au<strong>to</strong>psy samples.<br />
Samples fixed with 2.5% glutaraldehyde.<br />
2 After fixation, wash the samples in<br />
phosphate buffered saline (PBS).<br />
3 Embed the fixed samples in paraffin.<br />
4 Coat slides with a 2% solution of<br />
3-aminopropyltriethoxy-silane (Sigma) in<br />
ace<strong>to</strong>ne, then air dry them.<br />
Caution: Perform Step 4 under RNasefree<br />
conditions.<br />
5 Cut 4 µm thick sections from the fixed<br />
samples with disposable knifes and attach<br />
them <strong>to</strong> the prepared slides.<br />
Caution: Perform Step 5 under RNasefree<br />
conditions.<br />
6 Dry the sections overnight at 55°C.<br />
7 S<strong>to</strong>re the sample slides at room temperature<br />
until they are used.<br />
III. Pretreatment of sections<br />
Caution: Perform pretreatment and<br />
hybridization steps under RNase-free<br />
conditions. Prepare all solutions and<br />
buffers for these steps with DEPC-treated<br />
water (Sambrook et al., 1989). Bake all<br />
glassware for 4 h at 180°C. Assume that<br />
disposable plasticware is RNase-free.<br />
1 Dewax slides extensively by treating with<br />
xylene (preferably overnight) and a<br />
graded series of ethanol solutions.<br />
2 To preserve the mRNA during the<br />
following procedure, fix the sections once<br />
again with 4% paraformaldehyde (in<br />
100 mM phosphate buffer) for 20 min.<br />
3 Rinse the sections 3–5 times with TBS<br />
buffer [50 mM Tris-HCl (pH 7.5);<br />
150 mM NaCl].<br />
4 Treat the sections for 10 min with<br />
200 mM HCl <strong>to</strong> denature proteins.<br />
5 Rinse the sections 3–5 times with TBS.<br />
6 To reduce nonspecific background (Hayashi<br />
et al., 1978), incubate the sections<br />
for 10 min on a magnetic stirrer with a<br />
freshly mixed solution of 0.5% acetic<br />
anhydride in 100 mM Tris (pH 8.0).<br />
7 Rinse the sections 3–5 times with TBS.<br />
8 Treat the sections for 20 min at 37°C with<br />
Proteinase K (10–500 µg per ml in TBS<br />
which contains 2 mM CaCl2).<br />
The concentration of Proteinase K<br />
depends upon the degree of fixation. <strong>General</strong>ly,<br />
start with 20 µg/ml Proteinase K<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
for paraformaldehyde-fixed tissue. The<br />
concentration needed for glutaraldehydefixed<br />
or overfixed tissue is generally<br />
higher than for paraformaldehyde-fixed<br />
tissue.<br />
Caution: Determine the optimal concentration<br />
of Proteinase K empirically<br />
for each type of fixation. One of the<br />
most critical steps in the whole procedure<br />
is finding the balance between<br />
prior fixation and the proper concentration<br />
of Proteinase K. Proteinase K<br />
concentrations which are <strong>to</strong>o low or <strong>to</strong>o<br />
high may lead <strong>to</strong> false negative results.<br />
(See Figure 3 under “Results”.) Our<br />
experience shows that au<strong>to</strong>lysis causes<br />
fewer problems than overfixation does.<br />
Even after 30 hours au<strong>to</strong>lysis, we could<br />
demonstrate mRNA. (See Figure 4 under<br />
“Results”.) <strong>In</strong> overfixed material, we<br />
were not always successful in demonstrating<br />
mRNA, even when we increased<br />
Proteinase K <strong>to</strong> very high concentrations<br />
(up <strong>to</strong> 500 mg/ml).<br />
9 Rinse the sections 3–5 times with TBS.<br />
10 <strong>In</strong>cubate the sections at 4°C for 5 min<br />
with TBS (pH 7.5) <strong>to</strong> s<strong>to</strong>p the Proteinase<br />
K digestion.<br />
Caution: Do not postfix the sections<br />
with paraformaldehyde after protease<br />
digestion, since this reduces signal<br />
intensity.<br />
11 Dehydrate the sections in a graded series<br />
of ethanol solutions (increasing concentrations<br />
of ethanol).<br />
12 Rinse the sections briefly with<br />
chloroform.<br />
Note: At this point, you may, if necessary,<br />
s<strong>to</strong>re the sections under dust- and<br />
RNase-free conditions for several days.<br />
IV. <strong>Hybridization</strong><br />
Caution: Perform the hybridization step<br />
under RNase-free conditions. Prepare all<br />
solutions and buffers for this step with<br />
DEPC-treated water (Sambrook et al.,<br />
1989). Bake all glassware for 4 h at 180°C.<br />
Assume that disposable plasticware is<br />
RNase-free.<br />
1 Place the sections in a humid chamber at<br />
55°C for 30 min.<br />
2 Prepare a hybridization buffer by mixing<br />
the following components, then vortexing<br />
vigorously:<br />
2 x SSC (Sambrook et al., 1989).<br />
10% dextran sulfate.<br />
CONTENTS<br />
INDEX<br />
0.01% sheared salmon sperm DNA<br />
(Sambrook et al., 1989).<br />
0.02% SDS.<br />
50% formamide.<br />
Caution: The concentration of dextran<br />
sulfate is critical. Without appropriate<br />
amounts of dextran sulfate, the method<br />
loses sensitivity. However, excessive<br />
concentrations of dextran sulfate causes<br />
higher viscosity of the hybridization<br />
buffer. To prevent uneven distribution of<br />
the probe and uneven signals, always vortex<br />
the hybridization buffer extensively.<br />
3 Dilute the labeled antisense RNA probe<br />
<strong>to</strong> an appropriate degree in hybridization<br />
buffer. The diluted probe solution may<br />
contain as much as 1 part labeled probe <strong>to</strong><br />
4 parts hybridization buffer.<br />
Note: The amount of probe needed<br />
depends upon the degree of probe<br />
labeling (as determined in Procedure I,<br />
Step 4 above). <strong>General</strong>ly, use the lowest<br />
probe concentration that gives optimal<br />
response in that dot blot procedure.<br />
Example: <strong>In</strong> a serial dilution of the<br />
probe on a dot blot , if a 1:160 dilution<br />
gives a significantly stronger response<br />
than a 1:320 dilution, perform the initial<br />
hybridization experiments with both a<br />
1:200 and a 1:300 dilution of the probe.<br />
4 Pipette the diluted antisense probe<br />
solution on<strong>to</strong> each section at a volume of<br />
10 µl/cm 2 . Cover with a coverslip.<br />
Note: <strong>In</strong> our experience, a prehybridization<br />
step (with hybridization buffer<br />
alone) did not improve results.<br />
5 As a control serve sections treated in the<br />
same way whereby in steps 3 and 4 a<br />
labeled sense RNA probe is used.<br />
Caution: Control hybridization with<br />
sense probes is necessary <strong>to</strong> prove the<br />
specificity of the reaction. However,<br />
hybridization with sense probes sometimes<br />
gives unexpected hybridization<br />
signals or background staining.<br />
6 Place the slides on a hot plate at 95°C for<br />
4 min.<br />
Note: This step increases the signal from<br />
RNA/RNA hybrids.<br />
7 <strong>In</strong>cubate the slides in a humid chamber<br />
for 4–6 h at 55°–75°C.<br />
Note: <strong>Hybridization</strong> specificity can be<br />
increased by increasing the temperature<br />
of hybridization, if necessary, as high as<br />
75°C. <strong>In</strong>creasing the temperature can<br />
help <strong>to</strong> differentiate mRNAs of highly<br />
homologous proteins (Taylor et al.,<br />
1994).<br />
137<br />
5
5<br />
138<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
V. Washes and detection of mRNA<br />
Note: Stringency washings, often described<br />
as a method <strong>to</strong> remove nonspecifically<br />
bound probes, are helpful in reducing<br />
diffuse background staining, but do not<br />
significantly improve the specificity of the<br />
hybridization.<br />
1 <strong>In</strong>cubate the slides in 2 x SSC overnight.<br />
Note: The coverslips will float off during<br />
this incubation.<br />
2 Wash the slides as follows:<br />
3 x 20 min at 55°C with 50% deionized<br />
formamide in 1x SSC.<br />
2 x15 min at room temperature with<br />
1x SSC .<br />
3 Rinse the sections 3–5 times with TBS.<br />
4 <strong>In</strong>cubate the slides for 15 min with<br />
blocking mixture (blocking reagent<br />
containing 10% fetal calf serum).<br />
5 <strong>In</strong>cubate the slides for 60 min with<br />
alkaline-phosphatase-conjugated anti-<br />
DIG antibody [diluted 1: 500 in blocking<br />
mixture (from Step 4 above)].<br />
6 Rinse the sections 3–5 times with TBS.<br />
7 Prepare NBT/BCIP color reagent as recommended<br />
by the manufacturer.<br />
8 <strong>In</strong> a Coplin jar in the refrigera<strong>to</strong>r,<br />
incubate the sections with color reagent<br />
until sufficient color develops.<br />
Note: <strong>In</strong>cubation can be extended up <strong>to</strong><br />
120 h if the color reagent is replaced<br />
every time it precipitates or changes color.<br />
9 S<strong>to</strong>p the color reaction by rinsing the<br />
slides several times with tap water.<br />
10 Finally, rinse the slides with distilled<br />
water.<br />
11 Mount the slides directly with any watersoluble<br />
mounting medium.<br />
Note: Optionally, counterstain the slides<br />
or use immunocy<strong>to</strong>chemistry (as in Procedure<br />
VI below) <strong>to</strong> visualize proteins<br />
on the slides.<br />
VI. Detection of proteins by<br />
immunocy<strong>to</strong>chemistry<br />
Note: This pro<strong>to</strong>col describes a triple<br />
APAAP (alkaline phosphatase anti-alkaline<br />
phosphatase) reaction (Vass et al.,<br />
1989), which allows visualization of<br />
proteins on the same slide with the mRNA.<br />
See Figure 1 under “Results” for an<br />
example of double staining obtained with<br />
this technique.<br />
1 <strong>In</strong>cubate slide overnight at 4°C with<br />
primary antibody (either polyclonal or<br />
mouse monoclonal), diluted as necessary<br />
in TBS containing 10% fetal calf serum<br />
(TBS-FCS).<br />
Example: The polyclonal antibody for<br />
proteolipid protein used in Figure 1 was<br />
diluted 1:1000.<br />
2 Rinse the slide 3–5 times with TBS at<br />
room temperature.<br />
Note: Perform Step 2 as well as all the<br />
remaining incubation and wash steps of<br />
Procedure VI at room temperature.<br />
3 Depending upon the type of primary<br />
antibody used in Step 1, do one of the<br />
following:<br />
If the primary antibody was a polyclonal<br />
antibody from rabbit, incubate<br />
the slide for 60 min with anti-rabbit<br />
serum from mouse [Dakopatts], diluted<br />
1:100 in TBS-FCS, then rinse the<br />
slide 3–5 times with TBS. Go <strong>to</strong> Step 4.<br />
If the primary antibody was a mouse<br />
monoclonal antibody, skip this step<br />
and go <strong>to</strong> Step 4.<br />
4 <strong>In</strong>cubate slide for 60 min with anti-mouse<br />
serum (from rabbit [Dakopatts], diluted<br />
1:100 in TBS-FCS), then rinse the slide<br />
3–5 times with TBS.<br />
5 <strong>In</strong>cubate slide for 60 min with APAAP<br />
complex (mouse) (diluted 1:100 in TBS-<br />
FCS), then rinse the slide 3–5 times with<br />
TBS.<br />
6 <strong>In</strong>cubate slide for 30 min with anti-mouse<br />
serum (from rabbit) (diluted 1:100 in<br />
TBS-FCS), then rinse the slide 3–5 times<br />
with TBS.<br />
7 <strong>In</strong>cubate slide for 30 min with APAAP<br />
complex (mouse) (diluted 1:100 in TBS-<br />
FCS), then rinse the slide 3–5 times with<br />
TBS.<br />
8 Repeat Steps 6 and 7.<br />
Note: Repeating the APAAP steps will<br />
enhance the signal.<br />
9 Prepare APAAP substrate by dissolving<br />
200 mg naphthol-ASMX-phosphate,<br />
20 ml dimethylformamide, and 1 ml of<br />
1 M levamisole (all from Sigma) in 980 ml<br />
Tris-HCl (pH 8.2).<br />
10 Dissolve 50 mg Fast Red TR Salt in 50 ml<br />
of APAAP substrate, then filter the<br />
solution.<br />
11 <strong>In</strong> a Coplin jar at room temperature,<br />
incubate the slides with the Fast Red-<br />
APAAP substrate solution until the color<br />
develops.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Note: If you substitute PAP complex for<br />
APAAP complex, modify the above<br />
procedure as follows:<br />
Perform all rinses and all dilutions with<br />
PBS rather than TBS.<br />
For the color reaction, use filtered diaminobenzidine<br />
reagent (50 mg diaminobenzidine<br />
dissolved in 100 ml PBS<br />
which contains 0.01% H2O2)<br />
For an example of immunostaining with<br />
PAP complex, see Figure 2 under “Results”.<br />
Results<br />
<br />
Figure 1: Double staining of mRNA and protein<br />
(APAAP method) in a normal rat brain. The<br />
mRNA (black-blue) for proteolipid protein (PLP) was<br />
detected by the procedure described in the text and<br />
stained with NBT/BCIP color reagent. Proteolipid<br />
protein (red) was detected with a 1:1000-diluted<br />
rabbit polyclonal antibody and visualized with<br />
APAAP and Fast Red TR Salt.<br />
<br />
Figure 2: Double staining of mRNA and<br />
protein (PAP method) in a normal rat brain.<br />
The experiment is identical <strong>to</strong> that in Figure 1,<br />
except PLP (brown) was visualized with PAP and<br />
diaminobenzidine reagent.<br />
CONTENTS<br />
INDEX<br />
PFA GA<br />
0.002%<br />
0.005%<br />
0.02%<br />
0.05%<br />
a b<br />
<br />
Figure 3: Effect of paraformaldehyde and glutaraldehyde<br />
fixation on in situ hybridization of mRNA. PLP mRNA<br />
was detected in sections of rat spinal cord which had been fixed<br />
by different methods. Panel a: Sections were fixed with 4% paraformaldehyde<br />
and then treated with different concentrations of<br />
Proteinase K. From <strong>to</strong>p <strong>to</strong> bot<strong>to</strong>m the Proteinase K concentrations<br />
were: 0.002%, 0.005%, 0.02%, 0.05%. Panel b: Sections were<br />
fixed in 2.5% glutaraldehyde, then treated with the same<br />
concentrations of Proteinase K as in Panel a.<br />
139<br />
5
5<br />
Figure 4: Effect of au<strong>to</strong>lysis and<br />
overfixation on in situ hybridization<br />
of mRNA and immunocy<strong>to</strong>chemical<br />
staining. <strong>In</strong> spite of<br />
pronounced au<strong>to</strong>lytic changes that<br />
occur postmortem, a good PLP<br />
mRNA signal can be seen in human<br />
brain au<strong>to</strong>psy samples (Panel a).<br />
Although in well preserved and fixed<br />
experimental tissue (Panel b) both,<br />
the signal for in situ hybridization as<br />
well as the signal for immunocy<strong>to</strong>chemistry<br />
is much more distinct.<br />
Protein (red) and mRNA (blue-black)<br />
were stained as in Figure 1.<br />
140<br />
<br />
a<br />
b<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Acknowledgments<br />
The rabbit polyclonal antibody against<br />
proteolipid protein (PLP) was a gift from<br />
Dr. S. Piddlesden, University of Cardiff, UK.<br />
References<br />
Breitschopf, H; Suchanek, G; Gould, R. M.;<br />
Colman, D. R.; Lassmann, H. (1992) <strong>In</strong> situ<br />
hybridization with digoxigenin-labeled probes:<br />
Sensitive and reliable detection method applied<br />
<strong>to</strong> myelinating rat brain. Acta Neuropathol. 84,<br />
581–587.<br />
Hayashi, S; Gillam, I. C.; Delaney, A. D.;<br />
Tener, G. M. (1978) Acetylation of chromosome<br />
squashes of Drosophila melanogaster decreases<br />
the background in au<strong>to</strong>radiographs from<br />
hybridization with 125I-labeled RNA. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 26, 677–679.<br />
Sambrook, J; Fritsch, E. F.; Maniatis, T. (1989)<br />
Molecular cloning: A Labora<strong>to</strong>ry Manual, 2nd ed.<br />
Cold Spring Harbor, N.Y.: Cold Spring Harbor<br />
Labora<strong>to</strong>ry Press.<br />
Taylor, V.; Miescher, G. C.; Pfarr, S.; Honegger, P.;<br />
Breitschopf, H.; Lassmann, H.; Steck, A. J. (1994)<br />
Expression and developmental regulation of Ehk-1,<br />
a neuronal Elk-like recep<strong>to</strong>r tyrosine kinase in brain.<br />
Neuroscience 63, 163–178.<br />
Vass, K.; Berger, M. L.; Nowak, T. S. Jr.; Welch,<br />
W. J.; Lassmann, H. (1989) <strong>In</strong>duction of stress<br />
protein HSP 70 in nerve cells after status<br />
epilepticus in the rat. Neurosci. Lett. 100, 259–264.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG RNA Labeling For RNA labeling with digoxigenin-UTP 1175 025 1 Kit (2 x10<br />
Kit* , ** , *** by in vitro transcription with SP6 and labeling<br />
T7 RNA polymerase. reactions)<br />
Proteinase K Lyophilizate 161 519 25 mg<br />
745 723 100 mg<br />
1 000 144 500 mg<br />
1 092 766 1 g<br />
Tris Powder 127 434 100 g<br />
708 968 500 g<br />
708 976 1 kg<br />
Blocking Reagent Powder 1 096 176 50 g<br />
Anti-DIG-AP Fab Fragments from sheep 1 093 274 150 U (200 µl)<br />
NBT/BCIP S<strong>to</strong>ck solution 1 681 451 8 ml<br />
***Sold under the tradename of Genius in the US.<br />
***EP Patent 0 324 474 granted <strong>to</strong> Boehringer Mannheim GmbH.<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
RNA-RNA in situ hybridization using DIG-labeled<br />
probes: the effect of high molecular weight<br />
polyvinyl alcohol on the alkaline phosphatase<br />
indoxyl-nitroblue tetrazolium reaction<br />
Marc DeBlock and Dirk Debrouwer, Plant Genetic Systems N.V., Gent, Belgium.<br />
Note: The following article is reprinted<br />
with the permission of Academic Press<br />
(Copyright ® 1993 by Academic Press, <strong>In</strong>c.)<br />
and Harcourt Brace & Company and is<br />
based on the original article: DeBlock, M.,<br />
Debrouwer, D. (1993) RNA-RNA in situ<br />
hybridization using digoxigenin-labeled<br />
probes: the use of high molecular weight<br />
polyvinyl alcohol in the alkaline phosphatase<br />
indoxyl-nitroblue tetrazolium. Analytical<br />
Biochemistry 216; 88–89.<br />
The indoxyl-nitroblue tetrazolium (BCIP-<br />
NBT) reaction is relatively slow. During the<br />
reaction, intermediates (indoxyls) diffuse<br />
away in<strong>to</strong> the medium, making it difficult <strong>to</strong><br />
localize the site of hybridization (Van<br />
Noorden and Jonges, 1987) and reducing the<br />
hybridization signal.<br />
<strong>In</strong> this paper, an improved nonradioactive<br />
RNA-RNA in situ hybridization pro<strong>to</strong>col<br />
using alkaline phosphatase-conjugated digoxigenin-<br />
(DIG-) labeled probes is presented.<br />
The addition of polyvinyl alcohol (PVA) of<br />
high molecular weight (40–100 kD) <strong>to</strong> the<br />
BCIP-NBT detection system enhances the<br />
alkaline phosphatase reaction and prevents<br />
diffusion of reaction intermediates, resulting<br />
in a twentyfold increase in sensitivity without<br />
increasing the background. Due <strong>to</strong> the more<br />
localized precipitation of the formazan, the<br />
site of hybridization can be determined more<br />
precisely.<br />
CONTENTS<br />
INDEX<br />
I. Fixation, dehydration,<br />
and embedding<br />
Follow the pro<strong>to</strong>col described by Jackson<br />
(1992) <strong>to</strong> fix, dehydrate, and embed the<br />
tissue in paraffin, with the following<br />
modifications:<br />
1 For fixation, prepare either of the following<br />
solutions:<br />
100 mM phosphate buffer, pH 7,<br />
containing 0.25% gluteraldehyde and<br />
4% freshly depolymerized paraformaldehyde.<br />
Formalin-acetic acid (50% ethanol;<br />
10% formalin, containing 37% formaldehyde;<br />
5% acetic acid).<br />
2 Using either of the solutions from<br />
Step 1, fix the tissue for 4 h at room<br />
temperature. During the fixation:<br />
Vacuum infiltrate the tissue (with a<br />
water aspira<strong>to</strong>r) for 10 min once an<br />
hour.<br />
After each vacuum infiltration, renew<br />
the fixative solution.<br />
3 Depending on the fixative used in<br />
Step 2, wash the fixed tissue as follows:<br />
If gluteraldehyde-paraformaldehyde<br />
was the fixative, wash the fixed tissue<br />
2 x 30 min with 100 mM phosphate<br />
buffer, pH 7.<br />
If formalin-acetic acid was the fixative,<br />
wash the fixed tissue 2 x 30 min with<br />
50% ethanol.<br />
4 Dehydrate the tissue by incubating in the<br />
following series of ethanol solutions:<br />
Either 90 min (after gluteraldehydeparaformaldehyde<br />
fixation) or 30 min<br />
(after formalin-acetic acid fixation) at<br />
room temperature in 50% ethanol.<br />
90 min at room temperature in 70%<br />
ethanol.<br />
Overnight at 4°C in 85% ethanol.<br />
3 x 90 min at room temperature in<br />
100% ethanol.<br />
141<br />
5
5<br />
142<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
II. Sectioning<br />
1 Cut the paraffin-embedded tissues in<br />
10 µm sections.<br />
2 Attach the sections at 75°C for 1 h <strong>to</strong><br />
slides that have been treated with Vectabond<br />
(Vec<strong>to</strong>r Labora<strong>to</strong>ries, Burlingame,<br />
CA, U.S.A.).<br />
III. Prehybridization treatments<br />
1 Dewax and hydrate the sections as<br />
previously described (Jackson, 1992).<br />
2 <strong>In</strong>cubate the sections with a Proteinase K<br />
solution (100 mM Tris, pH 7.5;<br />
50 mM EDTA; 2 µg/ml Proteinase K) for<br />
30 min at 37°C.<br />
3 After the Proteinase K treatment, wash<br />
the slides 2 x in phosphate buffered saline<br />
(PBS).<br />
4 Dehydrate the sections in ascending<br />
concentrations of ethanol as previously<br />
described (Jackson, 1991).<br />
IV. <strong>Hybridization</strong><br />
1 Label the probe RNA with DIG-UTP<br />
according <strong>to</strong> the procedures given in<br />
Chapter 4 of this manual.<br />
2 Reduce the length of the probe <strong>to</strong><br />
approximately 200 bases as follows:<br />
To 50 µl of labeled probe RNA in<br />
a microcentrifuge tube, add 30 µl<br />
200 mM Na2CO3 and 20 µl 200 mM<br />
NaHCO3.<br />
Hydrolyze the probe at 60°C for t<br />
min, where:<br />
t = (L0 – Lf) / (K · L0 · Lf)<br />
L0 = starting length of probe RNA<br />
(in kb)<br />
Lf = length of probe RNA<br />
(in kb) (<strong>In</strong> this case, Lf = 0.2 kb.)<br />
K = rate constant<br />
(<strong>In</strong> this case, K = 0.11 kb/min.)<br />
t = hydrolysis time in min<br />
3 After hydrolysis, purify the probe RNA<br />
as follows:<br />
Add the following <strong>to</strong> the hydrolyzed<br />
probe solution:<br />
– 5 µl 10% acetic acid<br />
– 11 µl 3 M sodium acetate (pH 6.0)<br />
– 1 µl of a 10 mg/ml tRNA s<strong>to</strong>ck<br />
– 1.2 µl 1 M MgCl2<br />
– 300 µl (about 2.5 volumes) cold<br />
ethanol<br />
<strong>In</strong>cubate 4–16 h at –20°C.<br />
Centrifuge in a microcentrifuge for 15<br />
min at 4°C <strong>to</strong> pellet the RNA.<br />
Discard the supernatant and dry the<br />
RNA pellet in a vacuum desicca<strong>to</strong>r.<br />
Resuspend labeled probe RNA in<br />
DEPC-treated water at 10–50 µg/ml.<br />
4 Prepare a hybridization mixture containing<br />
the following:<br />
50% deionized formamide.<br />
2.25 x SSPE (300 mM NaCl; 20 mM<br />
NaH2PO4; 2 mM EDTA; pH 7.4).<br />
10% dextran sulfate.<br />
2.5 x Denhardt’s solution.<br />
100 µg/ml sheared and denatured<br />
herring sperm DNA.<br />
100 µg/ml tRNA.<br />
5 mM DTT.<br />
40 units/ml RNase inhibi<strong>to</strong>r.<br />
0.2–1.0 µg/ml hydrolyzed and denatured<br />
probe (200 bases long).<br />
5 Cover each section with 250–500 µl of<br />
hybridization mixture (depending on the<br />
size of the section) and incubate in a<br />
humidified box at 42°C overnight.<br />
Note: Do not use a coverslip during the<br />
hybridization incubation.<br />
6 After hybridization, wash the slides as<br />
follows:<br />
5 min at room temperature with<br />
3 x SSC.<br />
Note: 1x SSC contains 150 mM NaCl,<br />
15 mM Na-citrate; pH 7.<br />
5 min at room temperature with NTE<br />
(500 mM NaCl, 10 mM Tris-HCl,<br />
1 mM EDTA; pH 7.5).<br />
7 To remove unhybridized single-stranded<br />
RNA probe, put slides in<strong>to</strong> a humidified<br />
box and cover each section with<br />
500 µl of NTE buffer containing 50 µg/<br />
ml RNase A. <strong>In</strong>cubate for 30 min at<br />
37°C.<br />
8 After RNase treatment, wash the slides<br />
3 x 5 min at room temperature with NTE.<br />
9 To remove nonspecifically hybridized<br />
probe, wash the slides as follows:<br />
30 min at room temperature with<br />
2 x SSC.<br />
1 h at 57°C with 0.1 x SSC.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
V. Detection of DIG-labeled hybrids<br />
1 <strong>In</strong>cubate the slides first with blocking<br />
solution, then with blocking solution<br />
containing 1.25 units/ml of alkaline<br />
phosphatase-conjugated anti-DIG Fab<br />
fragments as recommended in the pack<br />
insert of the DIG Nucleic Acid Detection<br />
Kit*.<br />
2 After the antibody incubation, wash the<br />
slides <strong>to</strong> remove unbound antibody as<br />
recommended in the Boehringer<br />
Mannheim DIG/Genius System User’s<br />
Guide for Membrane <strong>Hybridization</strong>.<br />
3 Prepare the BCIP-NBT-PVA color development<br />
solution as follows:<br />
Prepare a Tris-NaCl-PVA s<strong>to</strong>ck solution<br />
by dissolving 10% (w/v) polyvinyl<br />
alcohol [PVA, either 40 kD<br />
or 70–100 kD (Sigma)] at 90°C in<br />
100 mM Tris-HCl (pH 9) containing<br />
100 mM NaCl.<br />
Cool the Tris-NaCl-PVA s<strong>to</strong>ck solution<br />
<strong>to</strong> room temperature.<br />
Add MgCl2, BCIP, and NBT <strong>to</strong> the<br />
Tris-NaCl-PVA s<strong>to</strong>ck <strong>to</strong> produce a<br />
final color development solution that<br />
contains:<br />
– 5 mM MgCl<br />
– 0.2 mM 5-bromo-4-chloro-3-indolyl<br />
phosphate (BCIP)<br />
– 0.2 mM nitroblue tetrazolium salt<br />
(NBT).<br />
4 After the washes in Step 2, perform the<br />
visualization step as follows:<br />
Place the slides in 30 ml of BCIP-<br />
NBT-PVA color development solution<br />
in a vertical staining dish suited for<br />
eight slides.<br />
<strong>In</strong>cubate the slides in the color development<br />
solution for 2–16 h at 30°C.<br />
Moni<strong>to</strong>r color formation visually.<br />
5 When the color on each slide is optimal,<br />
s<strong>to</strong>p the color reaction by washing the<br />
slide 3 x 5 min in distilled water.<br />
*Sold under the tradename of Genius in the US.<br />
CONTENTS<br />
INDEX<br />
6 Dehydrate the sections by incubating the<br />
slides without shaking in the following<br />
ethanol solutions:<br />
15 s in 70% ethanol.<br />
2 x15 s in 100% ethanol.<br />
7 Air dry the slides and mount them with<br />
Eukitt (O. Kindler GmbH, FRG).<br />
8 Examine the sections with a Dialux<br />
22 microscope (Leitz, Wetzlar, FRG)<br />
equipped with Normaski differential<br />
interference contrast.<br />
Results and discussion<br />
The direct influence of the polymers on the<br />
BCIP-NBT alkaline phosphatase reaction in<br />
a test tube is shown in Table 1. From these<br />
results it is clear that polyvinyl alcohol was<br />
the only polymer that enhanced formazan<br />
formation in the alkaline phosphatase<br />
reaction.<br />
This enhancement was even more pronounced<br />
in in situ hybridization experiments.<br />
Figure 1 shows the results of an<br />
in situ hybridization in which sections of<br />
<strong>to</strong>bacco pistils were hybridized with an<br />
antisense RNA probe from a pistil-specific<br />
cDNA clone (de S. Goldman et al., 1992).<br />
After three hours development no hybridization<br />
could be detected if no PVA had been<br />
added <strong>to</strong> the reaction buffer. A clear but still<br />
weak signal was visible after three h if 20%<br />
PVA (molecular weight, 10 kD) was used<br />
(Figure 1a). However, with 10% PVA<br />
(molecular weight, 70–100 kD), a strong<br />
hybridization signal appeared in the<br />
transmitting tissue of the pistil after a few h<br />
(Figure 1b). <strong>In</strong> the control with the sense<br />
RNA probe no signal could be detected,<br />
even after 24 h of development (Figure 1c).<br />
143<br />
5
5<br />
144<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Polymer Molecular Concentration b Effect on the alkaline<br />
weight phosphatase BCIP-NBT reaction e<br />
PVP 15 kD 10, 20, 30% Au<strong>to</strong>reduction of NBT<br />
25 kD 10, 20, 30%<br />
44 kD 10, 20, 30%<br />
PEG 6 kD 10, 20, 30% No enhancement<br />
20 kD 10, 20, 30% (0.01 mM formazan)<br />
PVA 10 kD 10, 20% c Approx. 4-fold enhancement<br />
(0.04 mM formazan)<br />
40 kD 10% d Approximately 6- <strong>to</strong> 8-fold enhance-<br />
70–100 kD 10% d ment (0.06 <strong>to</strong> 0.08 mM formazan)<br />
Table 1: <strong>In</strong>fluence of polymers on the alkaline phosphatase BCIP-NBT reactiona .<br />
a Each reaction was done with a <strong>to</strong>tal volume of 2 ml BCIP-NBT reaction mixture in a test tube.<br />
The BCIP-NBT reaction mixture was as described in the text, except that it contained 7.5 X 10 –3 <br />
units<br />
alkaline phosphatase/ml and the polymer indicated in the table. <strong>In</strong>cubation was for 30 min at 24°C.<br />
b The polymers were dissolved in the alkaline phosphatase reaction buffer in concentrations between 10%<br />
and 30%. The concentrations are given as a percentage of weight <strong>to</strong> volume.<br />
c A solution of 30% 10 kD PVA was <strong>to</strong>o viscous.<br />
d Solutions of 20 or 30% 40 kD PVA and 20 or 30% 70–100 kD PVA were <strong>to</strong>o viscous.<br />
e The amount of formazan formed was measured at 605 nm (Eadie et al., 1970). The enhancement fac<strong>to</strong>r<br />
is expressed with respect <strong>to</strong> the controls (no polymer added). If no polymer was added, about 0.01 mM<br />
formazan was formed.<br />
a b c<br />
<br />
Figure 1: The influence of PVA on the alkaline phosphatase BCIP-NBT reaction in in situ<br />
hybridizations. The hybridizations were carried out on 10 µm paraffin sections of stigmas and styles of<br />
<strong>to</strong>bacco with antisense and sense DIG-labeled RNA probes of pMG07 (de S. Goldman et al., 1992).<br />
C, cortex tissue; TT, transmitting tissue;<br />
V, vascular tissue. Bars = 200 µm.<br />
Panel a: <strong>Hybridization</strong> with antisense probe.<br />
Twenty percent 10 kD PVA was added <strong>to</strong> the alkaline phosphatase reaction buffer. Development was done for 4 h.<br />
Panel b: <strong>Hybridization</strong> with antisense probe. Ten percent 70–100 kD PVA was added <strong>to</strong> the alkaline<br />
phosphatase reaction buffer. Development was done for 2 h.<br />
Panel c: <strong>Hybridization</strong> with sense RNA probe. Ten percent 70–100 kD PVA was added <strong>to</strong> the alkaline<br />
phosphatase reaction buffer. Development was done for 20 h.<br />
CONTENTS<br />
INDEX
References<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
DeBlock, M.; Debrouwer, D. (1993) RNA-RNA in situ<br />
hybridization using digoxigenin-labeled probes:<br />
the use of high molecular weight polyvinyl alcohol<br />
in the alkaline phosphatase indoxyl-nitroblue<br />
tetrazolium reaction. Anal. Biochem. 215, 86–89.<br />
de S. Goldman, M. H.; Pezzotti, M.; Seurinck, J.;<br />
Mariani, C. (1992) Developmental expression of<br />
<strong>to</strong>bacco pistil-specific genes encoding novel<br />
extensin-like proteins. Plant Cell 4, 1041–1051.<br />
Eadie, M. J.; Tyrer, J. H.; Kukums, J. R.; Hooper,<br />
W. D. (1970) His<strong>to</strong>chemie 21, 170–180.<br />
Jackson, D. (1991) <strong>In</strong> situ hybridization in plants.<br />
<strong>In</strong>: Gurr, S. J.; McPherson; Bowles, D. J. (Eds.)<br />
Molecular Plant Pathology, A Practical Approach.<br />
Oxford, England: Oxford University Press, Vol. 1,<br />
pp. 163–174.<br />
Van Noorden, C. J. F.; Jonges, G. N. (1987)<br />
Quantification of the his<strong>to</strong>chemical reaction for<br />
alkaline phosphatase activity using the indoxyltetranitro<br />
BT method. His<strong>to</strong>chem. J. 19, 94–102.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG RNA Labeling For RNA labeling with digoxigenin-UTP 1175 025 1 Kit (2 x10<br />
Kit* , ** , *** by in vitro transcription with SP6 and labeling<br />
T7 RNA polymerase. reactions)<br />
Proteinase K Lyophilizate 161 519 25 mg<br />
745 723 100 mg<br />
1 000 144 500 mg<br />
1 092 766 1 g<br />
tRNA From baker’s yeast, lyophilizate 109 495 100 mg<br />
109 509 500 mg<br />
DNA from herring Lyophilized, sodium salt 223 646 1 g<br />
sperm<br />
DTT Purity: > 97% 197 777 2 g<br />
708 984 10 g<br />
1 583 786 25 g<br />
708 992 50 g<br />
709 000 100 g<br />
RNase A Powder 109 142 25 mg<br />
109 169 100 mg<br />
RNase <strong>In</strong>hibi<strong>to</strong>r From human placenta 799 017 2,000 units<br />
799 025 10,000 units<br />
DIG Nucleic Acid For detection of digoxigenin-labeled 1175 041 1 Kit<br />
Detection Kit* nucleic acids by an enzyme-linked<br />
immunoassay with a highly specific anti-<br />
DIG-AP antibody conjugate and the color<br />
substrates NBT and BCIP.<br />
***Sold under the tradename of Genius in the US.<br />
***EP Patent 0 324 474 granted <strong>to</strong> Boehringer Mannheim GmbH.<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
CONTENTS<br />
INDEX<br />
145<br />
5
5<br />
146<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Detection of neuropeptide mRNAs<br />
in tissue sections using oligonucleotides tailed<br />
with fluorescein-12-dUTP or DIG-dUTP<br />
Department of Cy<strong>to</strong>chemistry and Cy<strong>to</strong>metry, University of Leiden, The Netherlands.<br />
The pro<strong>to</strong>col given below has been developed<br />
with the neuropeptidergic system of<br />
the pond snail Lymnaea stagnalis. More<br />
information concerning the application and<br />
in situ hybridization methodology can be<br />
found in Van Minnen et al. (1989), Dirks et<br />
al. (1988), Dirks et al. (1990), and Dirks et al.<br />
(1991).<br />
I. Tissue preparation<br />
1 Dissect the tissue, embed in O.C.T.<br />
compound (Miles Scientific, USA), and<br />
freeze in liquid nitrogen.<br />
2 Prepare sections as follows:<br />
Cut cryostat sections of 8 µm.<br />
Mount on poly-L-lysine-coated slides.<br />
Air dry.<br />
3 After mounting, do the following:<br />
Fix the sections for 30 min at 4°C with<br />
modified Carnoy’s [2% formalin,<br />
(from 37% s<strong>to</strong>ck), 75% ethanol, 23%<br />
acetic acid].<br />
Rinse the slides with water.<br />
Dehydrate the sections.<br />
II. Probe preparation<br />
Synthesize and purify the oligonucleotides<br />
according <strong>to</strong> routine procedures. Tail the<br />
oligonucleotide with DIG-dUTP or fluorescein-dUTP<br />
according <strong>to</strong> the procedures<br />
given in Chapter 4, but without using dATP.<br />
Note: If you use fluorescein-dUTP, add <strong>to</strong><br />
the labeling mixture equal amounts of<br />
unmodified dTTP and fluorescein-dUTP,<br />
then carry out the labeling procedure in<br />
the dark.<br />
III. <strong>In</strong> situ hybridization<br />
Note: 18-mers are used in this study. For<br />
oligonucleotides with other lengths and/<br />
or composition, you may have <strong>to</strong> alter the<br />
stringency of hybridization by changing<br />
the formamide concentration or the hybridization<br />
temperature listed below.<br />
1 Perform the hybridization as follows:<br />
Prepare hybridization mixture [25%<br />
formamide; 3 x SSC; 0.1% polyvinylpyrrolidone;<br />
0.1% ficoll, 1% bovine<br />
serum albumin; 500 µg/ml sheared<br />
salmon sperm DNA; 500 µg/ml yeast<br />
RNA].<br />
Note: 1x SSC contains 150 mM sodium<br />
chloride, 15 mM sodium citrate; pH 7.0.<br />
To the cryostat sections, add hybridization<br />
mixture containing 1 ng/µl<br />
labeled probe.<br />
<strong>In</strong>cubate for 2 h at room temperature.<br />
Note: If the probe contains a fluorochrome<br />
label, perform the hybridization<br />
incubation in the dark.<br />
2 After hybridization, do the following:<br />
Rinse the section 3 times in 4 x SSC at<br />
room temperature.<br />
Dehydrate the sections.<br />
Note: If the probe contains a fluorochrome<br />
label, perform the washes in<br />
the dark.<br />
IV. Hybrid detection<br />
Depending on the label used on the probe,<br />
follow one of these procedures:<br />
If sections are hybridized with fluoresceinlabeled<br />
oligonucleotides:<br />
Mount sections in PBS/glycerol (1:9;<br />
v/v) containing 2.3% 1,4-diazabicyclo-<br />
(2,2,2)-octane (DABCO, from Sigma)<br />
and 0.1 µg/µl 4',6'-diamidino-2phenylindole<br />
(DAPI).<br />
Evaluate under a fluorescence microscope.<br />
If sections are hybridized with DIGlabeled<br />
oligonucleotides:<br />
Make a 1:250 dilution of fluoresceinconjugated<br />
anti-DIG antibody (from<br />
sheep) in incubation buffer [100 mM<br />
Tris-HCl, pH 7.4; 150 mM NaCl; 1%<br />
blocking reagent].<br />
Overlay the sections with the diluted<br />
antibody in incubation buffer.<br />
<strong>In</strong>cubate sections at room temperature<br />
for 30 min.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Rinse sections 3 x 5 min in Tris-NaCl<br />
[100 mM Tris, pH 7.4; 150 mM NaCl].<br />
Mount and evaluate as for fluoresceinlabeled<br />
oligonucleotides.<br />
Results<br />
<br />
Figure 1: Direct detection of caudodorsal cells<br />
with fluorescein-labeled CDCH-I.<br />
References<br />
Dirks, R. W.; van Gijlswijk, R. P. M.; Vooijs, M. A.;<br />
Smit, A. B.; Bogerd, J.; Van Minnen, J.; Raap, A. K.;<br />
Van der Ploeg, M. (1991) 3'-end fluorochromized<br />
and haptenized oligonucleotides as in situ hybridization<br />
probes for multiple, simultaneous RNA<br />
detection. Exp. Cell Res. 194, 310–315.<br />
Dirks, R. W.; van Gijlswijk, R. P. M.; Tullis, R. H.;<br />
Smit, A. B.; Van Minnen, J.; Van der Ploeg, M.;<br />
Raap, A. K. (1990) Simultaneous detection of<br />
different mRNA sequences coding for neuropeptide<br />
hormones by double in situ hybridization using FITCand<br />
biotin-labeled oligonucleotides. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 38, 467–473.<br />
CONTENTS<br />
INDEX<br />
Dirks, R. W.; Raap, A. K.; Van Minnen, J.;<br />
Vreugdenhil, E.; Smit, A. B.; Van der Ploeg, M.<br />
(1989) Detection of mRNA molecules coding for<br />
neuropeptide hormones of the pond snail Lymnaeae<br />
stagnalis by radioactive and nonradioactive in situ<br />
hybridization: a model study for mRNA detection.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 37, 7–14.<br />
Van Minnen, J.; Van de Haar, Ch.; Raap, A. K.;<br />
Vreugdenhil, E. (1988) Localization of ovulation<br />
hormone-like neuropeptide in the central nervous<br />
system of the snail Lymnaeae stagnalis by means of<br />
immunocy<strong>to</strong>chemistry and in situ hybridization.<br />
Cell Tissue Res. 251, 477–484.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG Oligonucleotide For tailing oligonucleotides with 1 417 231 1 Kit (25 tailing<br />
Tailing Kit* , ** , *** digoxigenin-dUTP. reactions)<br />
Fluorescein-12-dUTP Tetralithium salt, solution 1 373 242 25 nmol (25 µl)<br />
tRNA From baker’s yeast, lyophilizate 109 495 100 mg<br />
109 509 500 mg<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 741 200 µg<br />
Fluorescein<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 750 200 µg<br />
Rhodamine<br />
DAPI Fluorescence dye for staining of 236 276 10 mg<br />
chromosomes<br />
Blocking Reagent Blocking reagent for nucleic acid 1 096 176 50 g<br />
hybridization<br />
BSA Highest quality, lyophilizate 238 031 1 g<br />
238 040 10 g<br />
<br />
Figure 2: <strong>In</strong>direct detection of<br />
caudodorsal cells with DIG-labeled<br />
CDCH-I and sheep anti-DIG-fluorescein<br />
conjugate. The same cells<br />
are positive, but the hybridization<br />
signal is clearly more intense than<br />
that obtained with the direct technique<br />
(Figure 1).<br />
***Sold under the tradename of<br />
Genius in the US.<br />
***EP Patents 0 124 657/0 324 474<br />
granted <strong>to</strong> Boehringer Mannheim<br />
GmbH.<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
147<br />
5
5<br />
148<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
<strong>In</strong> situ hybridization of DIG-labeled rRNA probes<br />
<strong>to</strong> mouse liver ultrathin sections<br />
Dr. D. Fischer, D. Weisenberger, and Prof. Dr. U. Scheer, <strong>In</strong>stitute for Zoology I,<br />
University of Würzburg, Germany.<br />
Thin section electron microscopy of nucleoli<br />
from mammalian cells reveals three<br />
nucleolar substructures. These are the<br />
fibrillar centers (FC), the dense fibrillar<br />
component, which forms a closely apposed<br />
layer upon the FCs, and the granular<br />
component, which constitutes the bulk of<br />
the nucleolar mass. Although there is no<br />
doubt that this ultrastructural organization<br />
somehow reflects the vec<strong>to</strong>rial process of<br />
ribosome formation, the exact structurefunction<br />
relationships have been a matter of<br />
much discussion and are still largely unclear.<br />
(For a review, see Scheer and Benavente,<br />
1990.)<br />
Here we describe an approach <strong>to</strong> localize<br />
specific intermediates for the pre-rRNA<br />
maturation process using in situ hybridization<br />
at the ultrastructural level. This<br />
approach will allow the correlation of each<br />
pre-rRNA processing step with the defined<br />
nucleolar substructures. The procedure<br />
described can also be applied <strong>to</strong> the<br />
localization of other RNA species involved<br />
in ribosome biogenesis, such as 5S rRNA or<br />
U3 snRNA (Fischer et al., 1991).<br />
I. Embedding in Lowicryl K4M<br />
(according <strong>to</strong> Carlemalm and Villiger,<br />
1989, with alterations)<br />
IA. Fixation of material<br />
1 Prepare the following fixation solutions<br />
and keep them on ice:<br />
4% paraformaldehyde (PFA) in PBS<br />
(137 mM NaCl, 2.7 mM KCl, 7 mM<br />
Na2HPO4, 1.5 mM KH2PO4).<br />
0.5% glutaraldehyde (GA) plus 4%<br />
PFA in PBS.<br />
2 Take a piece of freshly prepared mouse<br />
liver and submerge it in a petri dish filled<br />
with 4% PFA in PBS on ice.<br />
3 Cut the liver in<strong>to</strong> small cubes with a<br />
maximal side length of 1 mm.<br />
Note: The smaller the pieces, the better<br />
reagent penetrates them in the procedure<br />
below.<br />
4 Transfer the liver cubes <strong>to</strong> other petri<br />
dishes on ice, containing the fixatives (i)<br />
4% PFA and (ii) 0.5% GA plus 4% PFA.<br />
5 <strong>In</strong>cubate the cubes in the fixatives for<br />
about 2 h.<br />
6 To remove the fixative, wash the cubes<br />
3 x 5 min with ice cold PBS.<br />
IB. Dehydration of material<br />
Transfer the object cubes <strong>to</strong> preparative<br />
glasses and dehydrate them in a series of<br />
ethanol solutions according <strong>to</strong> the following<br />
scheme:<br />
2 x15 min in 30% ethanol at 4°C.<br />
1x 30 min in 50% ethanol at 4°C.<br />
1x 30 min in 50% ethanol at –20°C.<br />
2 x 30 min in 70% ethanol at –20°C.<br />
2 x 30 min in 90% ethanol at –20°C.<br />
2 x 30 min in 96% ethanol at –20°C.<br />
2 x 30 min in 100% ethanol at –20°C.<br />
Caution: Leave the objects in a small<br />
amount of liquid during changes from one<br />
ethanol solution <strong>to</strong> another. This prevents<br />
them from drying out, especially at higher<br />
ethanol concentrations.<br />
IC. <strong>In</strong>filtration<br />
After dehydration, ethanol must be infiltrated<br />
with the embedding medium Lowicryl K4M<br />
(Chemische Werke Lowi, Waldkraiburg,<br />
FRG). This resin <strong>to</strong>lerates a little residual water<br />
in the object and produces good results in<br />
immunocy<strong>to</strong>chemistry.<br />
Caution: When working with Lowicryl<br />
K4M, perform all steps:<br />
– At low temperatures<br />
– Under the fume hood<br />
– While wearing gloves<br />
– While excluding air (oxygen) from K4M as<br />
much as possible.<br />
To exclude air from the embedding medium,<br />
do one of the following:<br />
Fill all vessels which contain K4M with<br />
nitrogen.<br />
Perform all steps in a closed chamber<br />
cooled <strong>to</strong> constant temperature by liquid<br />
nitrogen, thus providing a nitrogen-saturated<br />
atmosphere in the closed preparation<br />
chamber (e.g., “CS-au<strong>to</strong>”, Reichert<br />
& Jung, Cambridge <strong>In</strong>str.).<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
1 Prepare Lowicryl K4M as follows (<strong>to</strong><br />
produce a medium hard plastic):<br />
Mix 2 g Crosslinker A, 13 g Monomer<br />
B, and 0.075 g <strong>In</strong>itia<strong>to</strong>r C.<br />
Dissolve <strong>In</strong>itia<strong>to</strong>r C by gentle stirring<br />
or by bubbling dry nitrogen through<br />
the mixture.<br />
Cool the mixture <strong>to</strong> –20°C in the<br />
freezer.<br />
2 Perform infiltration at about –20°C with<br />
suitably precooled material according <strong>to</strong><br />
the following scheme:<br />
1hwith100% ethanol:K4M (1:1, v/v).<br />
2 x1 h with K4M.<br />
Overnight with K4M.<br />
2 x 3 h with K4M.<br />
ID. Embedding<br />
Gelatin capsules (e.g. Capsulae Operculatae<br />
No. 2) are very suitable as molds for<br />
embedding because they are transparent <strong>to</strong><br />
UV-light and can afterwards easily be cut<br />
away.<br />
1 Cool the gelatin capsules <strong>to</strong> the<br />
appropriate temperature.<br />
2 Add a few drops of Lowicryl K4M <strong>to</strong><br />
each capsule.<br />
3 Drop one object cube in<strong>to</strong> each capsule.<br />
Caution: Do this transfer very carefully.<br />
Do not mechanically damage the cube,<br />
allow it <strong>to</strong> dry out, or allow it <strong>to</strong> warm up.<br />
4 Fill the capsules with the embedding<br />
medium.<br />
5 Let the capsules stand for about half an<br />
hour <strong>to</strong> allow the air bubbles <strong>to</strong> leave.<br />
IE. Polymerization<br />
1 Before switching on the UV light, turn<br />
the temperature a bit lower <strong>to</strong> compensate<br />
for the heat from the light.<br />
2 <strong>In</strong>duce polymerization of Lowicryl K4M<br />
by 360 nm long-wave UV radiation<br />
(“CS-UV”, Reichert & Jung, Cambridge<br />
<strong>In</strong>str.) over a five day period. During the<br />
polymerization, do the following:<br />
For about three days, keep the<br />
polymerization temperature constant<br />
at any temperature between 0°C and<br />
–40°C.<br />
After three days, allow the temperature<br />
<strong>to</strong> rise <strong>to</strong> room temperature with about<br />
8 K/h.<br />
Note: For troubleshooting, see<br />
Carlemalm and Villiger (1989).<br />
CONTENTS<br />
INDEX<br />
II. Sectioning<br />
The embedded mouse liver cubes can easily<br />
be recognized in the transparent resin<br />
Lowicryl K4M. Carlemalm and Villiger<br />
(1989) recommend trimming with the<br />
ultramicro<strong>to</strong>me and a glass knife <strong>to</strong> get<br />
smooth surfaces.<br />
1 Obtain semithin sections with a glass<br />
knife and ultrathin sections with a<br />
diamond knife, according <strong>to</strong> standard<br />
pro<strong>to</strong>cols.<br />
Caution: Because of the hydrophilicity<br />
of Lowicryl K4M, be careful not <strong>to</strong> wet<br />
the surface of the block.<br />
2 Transfer sections <strong>to</strong> 200 mesh nickel grids<br />
which have been coated with 0.5%<br />
parlodion.<br />
3 Air dry the sections.<br />
Note: Now the sections are ready for<br />
hybridization.<br />
III. Probe preparation<br />
1 Clone restriction fragments from mouse<br />
rDNA.<br />
2 Prepare in vitro transcripts from the<br />
rDNA clones and label them with DIG-<br />
UTP according <strong>to</strong> the pro<strong>to</strong>cols in<br />
Chapter 4 of this manual.<br />
3 Since probe length might influence the<br />
efficiency of in situ hybridization experiments,<br />
moni<strong>to</strong>r transcript length by<br />
electrophoresis (in formaldehyde-containing<br />
gels), blotting on<strong>to</strong> nitrocellulose,<br />
and detection with the anti-DIG-alkaline<br />
phosphatase conjugate.<br />
4 If necessary, reduce probe length <strong>to</strong><br />
approximately 150 nucleotides by limited<br />
alkaline hydrolysis of the transcripts<br />
according <strong>to</strong> Cox et al. (1984). Briefly, the<br />
procedure is:<br />
<strong>In</strong>cubate the transcripts with a solution<br />
of 40 mM NaHCO3 and 60 mM<br />
Na2CO3 at 60°C.<br />
Calculate the <strong>In</strong>cubation time as<br />
follows:<br />
L0 – Lf<br />
t = ________<br />
k · L0 · Lf<br />
L0 = initial length of transcript (in kb)<br />
Lf = desired probe length (in kb)<br />
k = constant = 0.11 kb/min<br />
S<strong>to</strong>p the hydrolysis by adding 3 M<br />
sodium acetate and acetic acid.<br />
Precipitate the hydrolyzate with ethanol.<br />
Dissolve the precipitate in water.<br />
149<br />
5
5<br />
150<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
IV. <strong>Hybridization</strong><br />
Note: Perform all the following steps<br />
(including the hybridization) in a moist<br />
chamber.<br />
1 Prepare hybridization mixture [5 x SSC;<br />
0.1 mg/ml tRNA; DIG-labeled antisense<br />
transcript at a final concentration of<br />
10 ng/µl].<br />
Note: 1 x SSC contains 0.15 M NaCl,<br />
0.015 M sodium citrate.<br />
2 To moni<strong>to</strong>r the specificity of binding,<br />
prepare a “negative” probe by substituting<br />
the sense transcript for the antisense<br />
transcript in the hybridization mixture<br />
above.<br />
3 Place a droplet of the appropriate hybridization<br />
mixture on<strong>to</strong> Parafilm ® .<br />
4 <strong>In</strong>cubate the ultrathin sections by putting<br />
the grid (section-side down) on <strong>to</strong>p of the<br />
droplet.<br />
5 Perform hybridization for at least 3 h at<br />
65°C.<br />
6 Wash the sections as follows, all at room<br />
temperature:<br />
3 x 5 min with 2 x SSC.<br />
2 x10 min with PBST (PBS containing<br />
0.1% Tween ® 20).<br />
V. Detection<br />
1 To block nonspecific sites, incubate each<br />
section for 15 min with PBST plus BG<br />
(PBST containing 1% bovine serum<br />
albumin, 0.1% CWFS-gelatin).<br />
2 Dilute 1 nm gold-conjugated anti-DIG<br />
antibody 1:30 in PBST plus BG.<br />
<br />
Figure 1: <strong>In</strong> situ hybridization of a digoxigeninlabeled<br />
RNA probe complementary <strong>to</strong> most of the<br />
28 S rRNA region <strong>to</strong> an ultrathin section of mouse<br />
liver fixed with 3% formaldehyde and embedded<br />
in Lowicryl K4M. The nucleolus as well as the<br />
cy<strong>to</strong>plasm are clearly marked. Label is essentially<br />
absent from the mi<strong>to</strong>chondria, demonstrating the<br />
specificity of the method. Cy<strong>to</strong>plasmic labeling is<br />
due <strong>to</strong> labeling of the ribosomes, especially the<br />
endoplasmatic reticulum-associated ones<br />
(Magnification: 25,200 x).<br />
3 Apply diluted antibody <strong>to</strong> section and<br />
incubate for 1 h.<br />
4 Wash the sections as follows:<br />
3 x 5 min with PBST.<br />
6 x 5 min with redistilled water.<br />
5 Perform silver enhancement by incubating<br />
sectionswithdeveloperandenhancer (from<br />
the set of silver enhancement reagents) at a<br />
ratio of 1:1 for 4–20 min (depending on the<br />
desired silver grain size).<br />
6 Wash the sections 6 x 5 min with redistilled<br />
water.<br />
7 Stain with 2% aqueous uranyl acetate<br />
(4 min) and Reynolds’ lead citrate for<br />
1 min (Reynolds, 1963) according <strong>to</strong><br />
standard procedures.<br />
8 Evaluate the specimen in the electron<br />
microscope.<br />
Results<br />
<strong>In</strong> Figure 1, the hybridized probe was<br />
detected with monoclonal anti-DIG antibody<br />
coupled <strong>to</strong> 1 nm gold particles. The<br />
signal was enhanced with silver staining for<br />
6 min at room temperature. Silver intensification<br />
facilitates visualization of the bound<br />
hybridization probe at low magnification.<br />
The silver grains scattered throughout the<br />
nucleoplasm might indicate transport of<br />
preribosomal particles from the nucleolus <strong>to</strong><br />
the cy<strong>to</strong>plasm.<br />
<strong>In</strong> Figure 2, a digoxigenin-labeled riboprobe<br />
complementary <strong>to</strong> the first 3 kb of the<br />
5' region of the ETS1 was hybridized <strong>to</strong> a<br />
Lowicryl section of mouse liver and<br />
detected as described in Figure 1.<br />
Figure 2: Localization of pre-rRNA molecules<br />
containing the 5' region of the ETS1. For details of<br />
the probe, see the text. The survey view shows<br />
selective labeling of the fibrillar components of the<br />
nucleolus<br />
(Magnification: 27,000x).<br />
CONTENTS<br />
INDEX
References<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Carlemalm, E.; Villiger, W. (1989) Low temperature<br />
embedding. <strong>In</strong>: Bullock, G. R.; Petrusz, P. (Eds)<br />
Techniques Immunocy<strong>to</strong>chem. 4, 29–44.<br />
Cox, K. H.; DeLeon, D. V.; Angerer, L. M.;<br />
Angerer, R. C. (1984) Detection of mRNAs in sea<br />
urchin embryos by in situ hybridization using<br />
asymmetric RNA probes. Dev. Biol. 101, 485–502.<br />
Fischer, D.; Weisenberger, D.; Scheer, U. (1991)<br />
Assigning functions <strong>to</strong> nucleolar structures.<br />
Chromosoma 101, 133–140.<br />
Reynolds, E. S. (1963) The use of lead citrate at<br />
high pH as an electron-opaque stain in electron<br />
microscopy. J. Cell Biol. 17, 208–212.<br />
Scheer, U.; Benavente, R. (1990) Functional and<br />
dynamic aspects of the mammalian nucleolus.<br />
BioEssays 12, 14–21.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG RNA Labeling For RNA labeling with digoxigenin-UTP 1175 025 1 Kit (2 x10<br />
Kit* , ** , *** by in vitro transcription with SP6 and labeling<br />
T7 RNA polymerase. reactions)<br />
Tween ® 20 1 332 465 5 x10 ml<br />
BSA Highest quality, lyophilizate 238 031 1 g<br />
238 040 10 g<br />
Anti-Digoxigenin- Affinity purified sheep IgG <strong>to</strong> digoxigenin 1 450 590 1 ml<br />
Gold conjugated with ultra small gold particles<br />
(average diameter ≤ 0.8 nm).<br />
Silver Enhancement Detection of colloidal gold particles 1 465 350 1 set<br />
Reagents (anti-DIG-gold) by silver deposition on<br />
the particle surface<br />
***Sold under the tradename of Genius in the US.<br />
***EP Patent 0 324 474 granted <strong>to</strong> Boehringer Mannheim GmbH.<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
CONTENTS<br />
INDEX<br />
151<br />
5
5<br />
152<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
RNA in situ hybridization using DIG-labeled<br />
cRNA probes<br />
H. B. P. M. Dijkman, S. Mentzel, A. S. de Jong, and K. J. M. Assmann<br />
Department of Pathology, Nijmegen University Hospital, Nijmegen, The Netherlands.<br />
<strong>In</strong> recent years, the in situ hybridization<br />
(ISH) technique has found widespread<br />
application in both basic science and diagnostic<br />
clinical research. The ISH technique<br />
has frequently been used <strong>to</strong> localize specific<br />
genes on metaphase chromosomes and<br />
<strong>to</strong> detect viral and bacterial genomes in<br />
infected tissues. The RNA in situ hybridization<br />
(RISH) technique for the examination<br />
of mRNA expression has gained less<br />
attention due <strong>to</strong> the many technical problems<br />
associated with this technique.<br />
<strong>In</strong> this report, we present a step-by-step<br />
pro<strong>to</strong>col for a nonradioactive RISH technique<br />
on frozen sections using digoxigeninlabeled<br />
copy RNA (cRNA) probes. We<br />
demonstrate this technique on frozen<br />
sections of mouse kidney using DIG-labeled<br />
cRNA probes for the ec<strong>to</strong>enzyme aminopeptidase<br />
A, a low-copy RNA (Assmann et<br />
al., 1992). For a high-copy RNA, we studied<br />
human psoriatic epidermis using a DIGlabeled<br />
cRNA probe for elafin/SKALP, an<br />
inhibi<strong>to</strong>r of leukocyte elastase and proteinase<br />
3 (Alkemade et al., 1994). This pro<strong>to</strong>col has<br />
been optimized <strong>to</strong> give strong hybridization<br />
signals, even with low-copy mRNA<br />
molecules.<br />
For a full discussion of each step of this<br />
pro<strong>to</strong>col, along with more hints on enhancing<br />
the result of this often laborious and<br />
troublesome technique, see the previously<br />
published version of this report (Dijkman et<br />
al., 1995a; 1995b).<br />
I. Probe selection<br />
Choosing the type of probe (i.e., DNA,<br />
RNA, or oligonucleotide) is essential for<br />
a good final result. For the optimization of<br />
the probe labeling, we have tested four<br />
methods of incorporating the DIG label:<br />
Direct labeling of cDNA molecules using<br />
the DIG DNA Labeling Kit*.<br />
DIG labeling of oligonucleotides using<br />
the DIG Oligonucleotide Tailing Kit*.<br />
DIG labeling of PCR products according<br />
<strong>to</strong> the method of Hannon et al. (1993).<br />
DIG labeling of cRNA molecules using<br />
the DIG RNA Labeling Kit*.<br />
The RNA labeling method gave by far the<br />
best results. Therefore, we provide some<br />
hints on how <strong>to</strong> transcribe DIG-labeled<br />
cRNA molecules:<br />
For cRNA probe synthesis, subclone a<br />
cDNA molecule in an appropriate vec<strong>to</strong>r.<br />
The vec<strong>to</strong>r should have sequences<br />
flanking the insert that allow the insert <strong>to</strong><br />
be transcribed. Typically, commercially<br />
available vec<strong>to</strong>rs have SP6 and T7 RNA<br />
polymerase sites flanking the multiple<br />
cloning sites.<br />
Regulate the length of the cDNA<br />
molecule since this greatly affects the<br />
hybridization efficiency. Usually, a cDNA<br />
length between 200 and 500 nucleotides<br />
gives the best results, allowing efficient<br />
hybridization and good penetration of the<br />
tissue.<br />
When a molecule of interest is expressed as<br />
a high-copy RNA but the target RNA is<br />
masked by proteins, make probes between<br />
100 and 200 nucleotides long for better<br />
penetration (Figure 1).<br />
*Sold under the tradename of Genius in the US.<br />
CONTENTS<br />
INDEX
a<br />
b<br />
c<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
<br />
Figure 1: RNA in situ hybridization on a frozen<br />
section of human psoriatic epidermis with DIGlabeled<br />
cRNA probes coding for human SKALP.<br />
Panel a: An antisense cRNA probe (150 bp) was<br />
used on a 10 µm thick section (magnification x125).<br />
Panel b: An antisense cRNA probe (150 bp) was<br />
used on a 20 µm thick section (magnification x 500).<br />
Panel c: A sense cRNA probe (150 bp) was used on<br />
a 10 µm thick section (magnification x 270). <strong>In</strong>tense<br />
staining of both the stratum spinosum and stratum<br />
granulosum is observed with the antisense probe.<br />
CONTENTS<br />
INDEX<br />
II. Probe labeling<br />
1 After subcloning the cDNA molecule,<br />
linearize the circular vec<strong>to</strong>r with restriction<br />
enzymes that cut the multiple<br />
cloning site in 2 orientations, allowing<br />
sense and antisense synthesis.<br />
Caution: Control this linearization step<br />
carefully by moni<strong>to</strong>ring the digestion<br />
with agarose gel electrophoresis. Circular<br />
molecules that are left in the digestion<br />
mixture affect the transcription efficiency.<br />
2 Extract the linearized molecules from the<br />
digestion mixture by phenol extraction.<br />
3 Label the transcripts from the linearized<br />
molecules with DIG-labeled nucleotides<br />
and the DIG RNA Labeling Kit*<br />
according <strong>to</strong> the instructions given in the<br />
kit, but with the following modifications:<br />
Perform the SP6 polymerase incubation<br />
at 40°C instead of 37°C.<br />
Precipitate the labeled molecules overnight<br />
at –20°C, rather than 30 min at<br />
–70°C.<br />
Moni<strong>to</strong>r the transcription reaction by<br />
agarose gel electrophoresis <strong>to</strong> check for<br />
correct cRNA probe length.<br />
4 Moni<strong>to</strong>r probe labeling by spotting<br />
diluted aliquots of the labeled cRNA<br />
probes on nylon membranes and analyzing<br />
with the DIG Luminescent Detection<br />
Kit*. See also Chapter 4, page 51.<br />
Note: The sense and antisense cRNA<br />
probes should be labeled equally as<br />
efficiently as the control DNA included<br />
in the DIG RNA Labeling Kit*.<br />
5 If necessary, adjust the concentration of<br />
the labeled sense and antisense cRNA<br />
probes so they contain equal amounts of<br />
label.<br />
6 Aliquot the cRNA probes in polypropylene<br />
tubes at –70°C.<br />
Note: Repeated freezing and thawing<br />
affects the labeled cRNA probe.<br />
*Sold under the tradename of Genius in the US.<br />
153<br />
5
5<br />
154<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
III. Preparation of tissue sections<br />
Note: For detection of low-copy RNA<br />
molecules, always prepare frozen sections,<br />
since paraffin embedding causes a loss of<br />
approximately 30% of the RNA. The<br />
method described here has been optimized<br />
for frozen sections.<br />
1 For the processing of tissue, clean all<br />
knives and other materials with RNase<br />
ZAP (AMBION) and work as aseptically<br />
as possible.<br />
2 Remove the tissue from the animal,<br />
immediately snap-freeze the tissue, and<br />
s<strong>to</strong>re it in liquid nitrogen. Work quickly<br />
<strong>to</strong> avoid degradation of RNA (Bar<strong>to</strong>n et<br />
al., 1993).<br />
3 Cut 10 µm thick frozen sections.<br />
Note: To get a higher signal, cut sections<br />
thicker than 10 µm. For better signal<br />
localization, cut sections thinner than<br />
10 µm.<br />
4 Mount tissue directly on Superfrost Plus<br />
slides (Menzel Gläser, Omnilabo, Breda,<br />
The Netherlands) <strong>to</strong> prevent detachment<br />
of the section during the RISH<br />
procedure.<br />
Figure 2: RNA in situ hybridization on a frozen <br />
kidney section with a DIG-labeled cRNA probe for<br />
mouse aminopeptidase A (without delipidization).<br />
The section was 10 µM thick and was taken from<br />
a male BALB/c mouse. Note the many nonspecific<br />
lipid vesicles in the section. The specific hybridization<br />
signal appears in cells of the glomerulus<br />
(arrows). Magnification, 600 x.<br />
IV. Pretreatment of slides<br />
Caution: Prepare all solutions for<br />
Procedures IV with water that has been<br />
treated with 0.1% DEPC.<br />
1 Directly after mounting, heat the sections<br />
on a s<strong>to</strong>ve for 2 min at 50°C <strong>to</strong> fix the<br />
RNA in the tissue.<br />
Note: Vary the time (from 10–120 s) and<br />
temperature (from 50°–90°C) of the<br />
fixation step <strong>to</strong> accommodate different<br />
types of tissue and RNA.<br />
2 Dry the sections for 30 min.<br />
3 Circle the sections with a silicone pen<br />
(DAKO A/S, Glostrup, Denmark) <strong>to</strong><br />
prevent smudging of the substrate.<br />
4 Use the following criteria <strong>to</strong> decide the<br />
next step of the procedure:<br />
If the target tissue has lipid vesicles<br />
(Figure 2) that interfere with the RISH<br />
detection, go <strong>to</strong> Step 5.<br />
If the target tissue does not have lipid<br />
vesicles that interfere with the RISH<br />
detection, go <strong>to</strong> Step 6.<br />
➞<br />
5 (Optional) To minimize nonspecific<br />
background caused by lipid vesicles, do<br />
the following (all at room temperature):<br />
Delipidize the sections by extracting<br />
them for 5 min in chloroform.<br />
Dry the section <strong>to</strong> evaporate the<br />
chloroform.<br />
Note: This delipidation step may be<br />
omitted in pilot studies on a new tissue.<br />
6 Fix the tissue sections as follows (all at<br />
room temperature):<br />
<strong>In</strong>cubate tissue in PBS containing 4%<br />
paraformaldehyde for 7 min.<br />
Wash 1 x 3 min with PBS.<br />
Wash 2 x 5 min with 2 x SSC.<br />
Note: 1 x SSC contains 150 mM NaCl,<br />
15 mM sodium citrate; pH 7.2.<br />
CONTENTS<br />
➞<br />
➞<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
V. Prehybridization, hybridization,<br />
and posthybridization<br />
Caution: Prepare all solutions for<br />
Procedures V with water that has been<br />
treated with 0.1% DEPC.<br />
1 Prehybridize each section for 60 min at<br />
37°C in 100 µl hybridization buffer<br />
[4 x SSC; 10% dextran sulfate; 1 x<br />
Denhardt’s solution (0.02% Ficoll ® 400,<br />
0.02% polyvinyl pyrolidone, 0.02%<br />
bovine serum albumin); 2 mM EDTA;<br />
50% deionized formamide; 500 µg/ml<br />
herring sperm DNA].<br />
Note: You may vary the temperature of<br />
the prehybridization and hybridization<br />
steps between 37°C and 50°C.<br />
2 Perform hybridization as follows:<br />
Remove and discard the buffer from<br />
the prehybridization step.<br />
Cover each section with 100 µl hybridization<br />
buffer containing 200 ng/ml of<br />
DIG-labeled cRNA probe.<br />
Caution: Do not use coverslips, since<br />
they decrease the signal up <strong>to</strong> fourfold.<br />
Caution: A probe concentration of<br />
200 ng/ml holds only if the cRNA was<br />
labeled efficiently. If, in Procedure II,<br />
the cRNA probe was not labeled as<br />
efficiently as the controls from the<br />
DIG RNA Labeling Kit*, adjust the<br />
concentration of the cRNA probe in<br />
the hybridization mixture.<br />
<strong>In</strong>cubate for 16 h at 37°C.<br />
Note: You may vary the temperature<br />
of the prehybridization and hybridization<br />
steps between 37°C and 50°C.<br />
3 After the hybridization, wash unbound<br />
cRNA probe from the section as follows:<br />
1 x 5 min with 2 x SSC at 37°C.<br />
Note: To make the wash more<br />
stringent and wash away nonspecifically<br />
bound cRNA probe, lower the<br />
salt concentration or increase the<br />
formamide concentration in the<br />
washing buffer and perform the<br />
washing step at a temperature 5°C<br />
beneath the melting temperature of<br />
the probe.<br />
3 x 5 min with 60% formamide in<br />
0.2 x SSC at 37°C.<br />
2 x 5 min with 2 x SSC at room temperature.<br />
*Sold under the tradename of Genius in the US.<br />
CONTENTS<br />
INDEX<br />
VI. Immunological detection<br />
1 Wash the sections for 5 min at room<br />
temperature with 100 mM Tris-HCl (pH<br />
7.5), 150 mM NaCl.<br />
2 <strong>In</strong>cubate the sections for 30 min at room<br />
temperature with blocking buffer<br />
[100 mM Tris-HCl (pH 7.5), 150 mM<br />
NaCl; saturated with blocking reagent].<br />
3 Prepare a 1:200 dilution of alkaline phosphatase-conjugated<br />
anti-DIG antibody<br />
(polyclonal, Fab fragments, from sheep)<br />
in blocking buffer (from Step 2).<br />
4 <strong>In</strong>cubate the sections for 120 min at room<br />
temperature with the diluted anti-DIG<br />
antibody conjugate prepared in Step 3.<br />
5 Wash the sections as follows:<br />
2 x 5 min at room temperature with<br />
100 mM Tris-HCl (pH 7.5), 150 mM<br />
NaCl.<br />
1x10 min at room temperature with<br />
100 mM detection buffer [Tris-HCl<br />
(pH 9.5), 100 mM NaCl, 50 mM<br />
MgCl2].<br />
6 Cover the sections with detection buffer<br />
containing 0.18 mg/ml BCIP, 0.34 mg/ml<br />
NBT, and 240 µg/ml levamisole. <strong>In</strong>cubate<br />
for 16 h at room temperature (for<br />
detection of low abundance RNA).<br />
Note: This development should be<br />
carried out with the slides standing up<br />
in a small container <strong>to</strong> prevent nonspecifically<br />
converted substrate from<br />
falling on<strong>to</strong> the section.<br />
7 S<strong>to</strong>p the color reaction by washing the<br />
sections for 5 min in 10 mM Tris (pH 8),<br />
1 mM EDTA.<br />
VII. Counterstain<br />
1 Wash the sections for 5 min with distilled<br />
H2O at room temperature.<br />
2 Counterstain the sections for 5–10 min<br />
with 1% methylene green at 37°C.<br />
3 Repeat wash (from Step 1).<br />
4 Mount coverslips in Kaiser’s solution<br />
(available from Merck).<br />
155<br />
5
5<br />
156<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Results and discussion<br />
Figure 3 shows a typical RISH signal<br />
obtained with this pro<strong>to</strong>col and a labeled<br />
antisense cRNA probe coding for mouse<br />
aminopeptidase A. The pro<strong>to</strong>col included<br />
the optional delipidation step with chloroform<br />
(Procedure IV, Step 5). Figure 4 shows<br />
the control reaction with the labeled sense<br />
cRNA probe.<br />
We have provided a standard pro<strong>to</strong>col for<br />
RISH on low- and high-copy RNA<br />
molecules. Using this pro<strong>to</strong>col, one should<br />
be able <strong>to</strong> perform RISH on each RNA<br />
molecule of interest, with only minor<br />
modifications depending on the abundance<br />
of the RNA of interest.<br />
➞<br />
➞<br />
<br />
Figure 3: RNA in situ hybridization on a frozen<br />
kidney section with a DIG-labeled antisense<br />
cRNA probe for mouse aminopeptidase A (after<br />
delipidization). The section was 10 µm thick<br />
and was taken from a male BALB/c mouse.<br />
Pretreatment of the section with chloroform prior <strong>to</strong><br />
the hybridization delipidized the section and<br />
reduced<br />
a nonspecific signal previously observed in lipid<br />
vesicles (Figure 2). The specific hybridization signal<br />
(arrows) was undiminished by the chloroform<br />
➞<br />
Acknowledgments<br />
The cDNA clone coding for the mouse aminopeptidase<br />
A cDNA sequence was kindly<br />
provided by Dr. Max D. Cooper from the<br />
University of Alabama at Birmingham, USA<br />
(Wu et al., 1990). The cRNA probe for<br />
elafin/SKALP was kindly provided by Dr. J.<br />
Schalkwijk, department of Derma<strong>to</strong>logy,<br />
University Hospital Nijmegen, The<br />
Netherlands.<br />
Figure 4: RNA in situ hybridization on a frozen<br />
kidney section from the same mouse used in<br />
Figure 3 with a DIG-labeled sense cRNA probe<br />
for mouse aminopeptidase A. As in Figure 3,<br />
the section was 10 µm thick and was taken from a<br />
male BALB/c mouse. The section was pretreated<br />
with chloroform prior <strong>to</strong> the hybridization. No signal<br />
could be seen, indicating the specificity of the<br />
antisense hybridization signal seen in Figure 3.<br />
(magnification, 600 x).<br />
CONTENTS<br />
INDEX
References<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
Alkemade, J. A. C.; Molhuizen, H. O. F.; Ponec, M.;<br />
Kempenaar, J. A.; Zeeuwen, P. L. J. M.; de Jongh,<br />
G. J.; van Vlijmen-Willems, I. M. J. J.; van Erp, P. E. J.;<br />
van de Kerkhof, P. C. M.; Schalkwijk, J. (1994)<br />
SKALP/elafin is an inducible proteinase inhibi<strong>to</strong>r in<br />
human epidermal keratinocytes.<br />
J. Cell Sci. 107, 2335–2342.<br />
Assmann, K. J. M.; van Son, J. P. H. F.; Dijkman,<br />
H. B. P. M.; Koene, R. A. P. (1992) A nephri<strong>to</strong>genic<br />
rat monoclonal antibody <strong>to</strong> mouse aminopeptidase<br />
A. <strong>In</strong>duction of massive albuminuria after a single<br />
intravenous injection. J. Exp. Med. 175, 623–636.<br />
Dijkman, H. B. P. M.; Mentzel, S.; de Jong, A. S.;<br />
Assmann; K. J. M. (1995a) RNA <strong>In</strong> <strong>Situ</strong> hybridization<br />
using digoxigenin-labeled cRNA probes. Biochemica<br />
(U.S. version) No. 2 [1995], 23–27.<br />
CONTENTS<br />
INDEX<br />
Dijkman, H. B. P. M.; Mentzel, S.; de Jong, A. S.;<br />
Assmann; K. J. M. (1995b) RNA <strong>In</strong> <strong>Situ</strong> hybridization<br />
using digoxigenin-labeled cRNA probes. Biochemica<br />
(worldwide version) No. 2 [1995], 21–25.<br />
Bar<strong>to</strong>n, A. J. L.; Pearson, R. C. A.; Najlerahim, A.;<br />
Harrison, P. J. (1993) Pre- and postmortem<br />
influences on brain RNA. J. Neurochem. 61, 1–11.<br />
Hannon, K.; Johns<strong>to</strong>ne, E.; Craft, L. S.; Little, S. P.;<br />
Smith, C. K.; Heiman, M. L.; Santerre, R. F. (1993)<br />
Synthesis of PCR-derived, single-stranded DNA<br />
probes suitable for in situ hybridization.<br />
Anal. Biochem. 212, 421–427.<br />
Wu, Q.; Lahti, J. M.; Air, G. M.; Burrows, P. D.;<br />
Cooper, M. D. (1990) Molecular cloning of the murine<br />
BP-1/6C3 antigen: a member of the zinc-dependent<br />
metallopeptidase family. Proc. Natl. Acad. Sci. USA<br />
87, 993–997.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG RNA Labeling For RNA labeling with digoxigenin-UTP 1175 025 1 Kit (2 x10<br />
Kit* , ** , *** by in vitro transcription with SP6 and labeling<br />
T7 RNA polymerases. reactions)<br />
EDTA Powder 808 261 250 g<br />
808 270 500 g<br />
808 288 1 kg<br />
DNA, from herring lyophilized sodium salt 223 646 1 g<br />
sperm<br />
Blocking Reagent For nucleic acid hybridization 1 096 176 50 g<br />
Anti-Digoxigenin-AP Anti-Digoxigenin, Fab fragments 1 093 274 150 U<br />
conjugated with alkaline phosphatase (200 µl)<br />
Tris For preparation of buffer solutions 127 434 100 g<br />
708 968 500 g<br />
708 976 1 kg<br />
NBT solution 100 mg/ml nitroblue tetrazolium salt in 1 383 213 3 ml (300 mg)<br />
70% (v/v) dimethylformamide (dilute prior<br />
<strong>to</strong> use)<br />
BCIP solution 50 mg/ml 5-bromo-4-chloro-3-indolyl 1 383 221 3 ml (150 mg)<br />
phosphate (BCIP), <strong>to</strong>luidinium salt in<br />
100% dimethylformamide<br />
***Sold under the tradename of Genius in the US.<br />
***EP Patent 0 324 474 granted <strong>to</strong> Boehringer Mannheim GmbH.<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
157<br />
5
5<br />
158<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
Localization of the expression of the segmentation<br />
gene hunchback in Drosophila embryos with<br />
DIG-labeled DNA probes<br />
Dr. D. Tautz, <strong>In</strong>stitute for Genetics and Microbiology, University of Munich, Germany.<br />
<strong>In</strong> situ hybridization <strong>to</strong> RNA on sections<br />
of early embryos provided one of the most<br />
significant advances for the analysis of<br />
spatially regulated transcripts of segmentation<br />
genes in Drosophila. It was therefore<br />
soon adapted <strong>to</strong> other systems. The<br />
procedure is, however, rather tedious and<br />
time-consuming. It depends on the quality<br />
of the sections and particularly on the<br />
quality of the probe.<br />
<strong>In</strong> contrast, antibody staining of the protein<br />
products from these genes in whole embryos<br />
simplified the procedure and allowed a much<br />
higher resolution. However, certain regula<strong>to</strong>ry<br />
events have <strong>to</strong> be analyzed at the RNA<br />
level. Also antibody production itself is<br />
somewhat time consuming. We have therefore<br />
sought <strong>to</strong> develop an in situ hybridization<br />
technique which offers the same advantages as<br />
antibody staining. We found the use of<br />
digoxigenin-labeled probes <strong>to</strong> be highly<br />
successful for this purpose. These probes<br />
allow a resolution which is directly comparable<br />
<strong>to</strong> antibody staining in embryos, and<br />
both the sensitivity and the speed is superior<br />
<strong>to</strong> conventional radioactive methods.<br />
The method is not limited <strong>to</strong> applications in<br />
Drosophila, but is apparently suitable for all<br />
kinds of tissues, at least for those in which<br />
antibody staining has been successful. We<br />
have already developed a pro<strong>to</strong>col for the<br />
staining of specific cells in whole Hydra<br />
animals, which required only minor<br />
modifications (E. Kurz and C. David,<br />
University of Munich, Dept. of Zoology).<br />
The procedure given below has been published<br />
(Tautz and Pfeiffle, 1989).<br />
I. Preparation of embryos<br />
Note: All embryos in this study came from<br />
wild-type Drosophila flies and were collected<br />
on apple juice agar plates at<br />
intervals of 0–4 h at 25°C (Wieschaus and<br />
Nüsslein-Volhard, 1986)<br />
1 Collect the embryos in small baskets.<br />
2 Wash embryos with water.<br />
3 Dechorionate embryos for about 2–3 min<br />
in a solution of 50% commercial bleach<br />
(about 5% sodium hypochlorite) in water.<br />
4 Wash the embryos with 0.1% Tri<strong>to</strong>n ® X-<br />
100.<br />
5 Fix the embryos either with formaldehyde<br />
(Procedure IIA) or paraformaldehyde<br />
(Procedure IIB).<br />
IIA. Formaldehyde fixation<br />
1 Transfer each embryo in<strong>to</strong> a glass<br />
scintillation vial containing 4 ml of<br />
fixation buffer [0.1 M Hepes, pH 6.9;<br />
2 mM magnesium sulfate, 1 mM EGTA<br />
(from a 0.5 M s<strong>to</strong>ck EGTA solution that<br />
has been adjusted <strong>to</strong> pH 8 with NaOH)].<br />
2 Add <strong>to</strong> the scintillation vial 0.5 ml 37%<br />
formaldehyde solution and 5 ml heptane.<br />
3 Shake the vial vigorously for 15–20 min<br />
<strong>to</strong> maintain an effective emulsion of the<br />
organic and the water phase.<br />
4 Remove the lower phase and add 10 ml<br />
methanol.<br />
If the embryos sink <strong>to</strong> the bot<strong>to</strong>m at<br />
this stage, proceed <strong>to</strong> Step 5.<br />
If the embryos do not sink <strong>to</strong> the<br />
bot<strong>to</strong>m at this stage, remove the upper<br />
phase (heptane) and add more methanol.<br />
5 S<strong>to</strong>re the fixed embryos in methanol (up<br />
<strong>to</strong> several weeks) in the refrigera<strong>to</strong>r.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
IIB. Paraformaldehyde fixation<br />
Note: This pro<strong>to</strong>col is more laborious, but<br />
leads, in some cases, <strong>to</strong> a lower background<br />
and <strong>to</strong> better preservation of the morphology.<br />
1 Transfer the embryos in<strong>to</strong> a glass<br />
scintillation vial containing 1.6 ml of<br />
fixation buffer [100 mM Hepes, pH 6.9;<br />
2 mM magnesium sulfate, 1 mM EGTA<br />
(from a 500 mM s<strong>to</strong>ck EGTA solution<br />
that has been adjusted <strong>to</strong> pH 8 with<br />
NaOH)].<br />
2 Liquify a 20% s<strong>to</strong>ck solution of paraformaldehyde<br />
in water as follows:<br />
Remove the s<strong>to</strong>ck 20% paraformaldehyde<br />
from its s<strong>to</strong>rage at –20°C.<br />
Heat the s<strong>to</strong>ck <strong>to</strong> 65°C.<br />
Neutralize with a little NaOH.<br />
3 From the liquified s<strong>to</strong>ck 20% solution of<br />
paraformaldehyde, remove 0.4 ml and<br />
add it <strong>to</strong> the scintillation vial.<br />
4 Also add 8 ml heptane <strong>to</strong> the vial.<br />
5 Shake the vial and treat with methanol as<br />
in Steps 3 and 4 in Procedure IIA above.<br />
6 Transfer each embryo <strong>to</strong> a 1.5 ml microcentrifuge<br />
tube containing ME [90%<br />
methanol, 10% 0.5 M EGTA] .<br />
7 Prepare PP solution (4% paraformaldehyde<br />
in PBS).<br />
Note: PBS contains 130 mM NaCl and<br />
10 mM sodium phosphate; pH 7.2.<br />
8 Refix the embryos and dehydrate by<br />
passage through the following series of<br />
solutions containing ME and PP:<br />
5 min in ME:PP (7:3).<br />
5 min in ME:PP (1:1).<br />
5 min in ME:PP (3:7).<br />
20 min in PP alone.<br />
9 Wash the embryos in PBS for 10 min and<br />
do either of the following:<br />
Use the fixed embryos in Procedure<br />
III.<br />
or<br />
If the fixed embryos are not <strong>to</strong> be used<br />
immediately, dehydrate them in a<br />
series of ethanol solutions (30%, 50%,<br />
then 70% ethanol) and s<strong>to</strong>re them at<br />
–20°C.<br />
Caution: Dehydrated, s<strong>to</strong>red embryos<br />
must be rehydrated before they can<br />
be used in Procedure III.<br />
CONTENTS<br />
INDEX<br />
III. Pretreatment<br />
Caution: <strong>In</strong> the steps below, use the<br />
normal precautions for avoiding potential<br />
RNase contamination.<br />
1 Treat the PBS for the following steps with<br />
diethylpyrocarbonate (20 µl per 500 ml<br />
PBS), then au<strong>to</strong>clave the treated PBS.<br />
2 Place each fixed embryo in a 1.5 ml<br />
microcentrifuge tube. Perform the incubations<br />
in Steps 3–8 below at room<br />
temperature on a revolving wheel.<br />
3 Wash each embryo 3 x 5 min in 1 ml PBT<br />
(PBS plus 0.1% Tween ® 20).<br />
Note: Tween reduces non-specific adhesion<br />
of the embryos <strong>to</strong> the plastic surfaces.<br />
4 <strong>In</strong>cubate the embryo for 3–5 min in 1 ml of<br />
PBS containing 50 µg/ml Proteinase K.<br />
5 S<strong>to</strong>p the digestion by removing the<br />
Proteinase K solution, adding 1 ml PBT<br />
containing 2 mg/ml glycine <strong>to</strong> the<br />
embryo. <strong>In</strong>cubate for 2 min.<br />
Caution: The proteinase digestion time<br />
is critical. If it is <strong>to</strong>o short, the background<br />
increases and sensitivity is lost.<br />
If it is <strong>to</strong>o long, the embryos burst<br />
during the subsequent steps.<br />
6 After the Proteinase K digestion, wash<br />
the embryo 2 x 5 min in 1 ml PBT.<br />
7 Refix for 20 min in 1 ml PP (4%<br />
paraformaldehyde in PBS).<br />
8 Wash 3 x 10 min in 1 ml PBT.<br />
IV. Probe labeling<br />
The probes are DNA restriction fragments<br />
isolated from agarose gels. Label them<br />
according <strong>to</strong> the random priming method<br />
described in Chapter 4 of this manual.<br />
159<br />
5
5<br />
160<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
V. <strong>Hybridization</strong><br />
1 Prepare the hybridization solution (HS)<br />
[50% formamide; 5 x SSC (where 1 x SSC<br />
contains 150 mM NaCl, 15 mM sodium<br />
citrate); 50 µg/ml heparin, 0.1% Tween ®<br />
20; and 100 µg/ml sonicated and denatured<br />
salmon sperm DNA].<br />
Note: HS may be s<strong>to</strong>red at –20°C.<br />
2 Wash the embryos as follows:<br />
20 min in 1:1 HS:PBT.<br />
20–60 min in HS.<br />
3 Prehybridize for 20–60 min in HS at<br />
45°C in a water bath.<br />
4 Heat denature the probe in the presence<br />
of 10 µg sonicated salmon sperm DNA.<br />
Note: The salmon sperm DNA should<br />
effectively compete out simple sequences<br />
and thus reduce the background.<br />
5 Dilute the probe <strong>to</strong> approximately 0.5 µg<br />
labeled probe per ml in HS.<br />
6 Remove most of the prehybridization<br />
supernatant from the embryo, then add<br />
the heat-denatured probe and thoroughly<br />
mix.<br />
7 Hybridize overnight at 45°C in a water<br />
bath without shaking.<br />
8 Wash the embryos at room temperature<br />
in each of the following solutions:<br />
20 min in HS.<br />
20 min in 4:1 HS:PBT.<br />
20 min in 3:2 HS:PBT.<br />
20 min in 2:3 HS:PBT.<br />
20 min in 1:4 HS:PBT.<br />
2 x 20 min in PBT.<br />
Note: Use a less extensive washing<br />
pro<strong>to</strong>col if probe produces a low background.<br />
VI. Detection<br />
1 Prepare a fresh dilution (1:2000 <strong>to</strong><br />
1:5000) of alkaline phosphataseconjugated<br />
anti-DIG-antibody in PBT.<br />
Note: The antibody may be preabsorbed<br />
for 1 h with fixed embryos <strong>to</strong><br />
reduce the background.<br />
2 <strong>In</strong>cubate each embryo with 500 µl freshly<br />
diluted antibody conjugate for 1 h at<br />
room temperature on a revolving wheel.<br />
3 Wash the embryo as follows:<br />
4x20 min in PBT.<br />
3x5 min in color buffer [100 mM<br />
NaCl, 50 mM MgCl2, 100 mM Tris<br />
(pH 9.5), 1 mM levamisole, 0.1%<br />
Tween ® 20].<br />
Note: Levamisole is a potent<br />
inhibi<strong>to</strong>r of lysosomal phosphatases.<br />
4 Bring the embryos in<strong>to</strong> a small dish with<br />
1 ml of color buffer. Add <strong>to</strong> this<br />
4.5 µl NBT and 3.5 µl BCIP with thorough<br />
mixing.<br />
4 Develop the color for 10–60 min in the<br />
dark.<br />
Note: Color development may<br />
occasionally be controlled under the<br />
binocular microscope and s<strong>to</strong>pped in<br />
PBT before background develops.<br />
6 Dehydrate the embryos in a series of<br />
ethanol solutions and mount in GMM<br />
(Lawrence et al., 1986).<br />
Results<br />
Figure 1 shows typical results obtained with<br />
the above pro<strong>to</strong>col. Panel a shows three<br />
embryos at different developmental stages<br />
which represent the dynamic expression<br />
pattern of hunchback. The embryo on the<br />
<strong>to</strong>p right in Panel a shows the maternal<br />
gradient of hunchback RNA distribution;<br />
the embryo at the left the primary zygotic<br />
expression in two domains; and the middle<br />
embryo, the late zygotic expression.<br />
<strong>In</strong> Panel b, an enlarged section of an embryo<br />
shows the predominant cy<strong>to</strong>plasmic location<br />
of the hybridization signal. The section<br />
of the embryo corresponds <strong>to</strong> the frame<br />
depicted in Panel a although the pho<strong>to</strong> was<br />
taken of a different embryo.<br />
Panel c shows an embryo after gastrulation,<br />
where individual cells of the developing<br />
nervous system express hunchback.<br />
CONTENTS<br />
INDEX
References<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
ISH <strong>to</strong> Tissues<br />
a c<br />
Lawrence, P. A.; Johns<strong>to</strong>n, P.; Morata, G. (1986)<br />
Methods of marking cells. <strong>In</strong>: Roberts, D. B. (ed.)<br />
Drosophila, A Practical Approach. Oxford: IRL Press,<br />
pp. 229–242.<br />
Tautz, D.; Pfeiffle, C. (1989) A nonradioactive in situ<br />
hybridization method for the localization of specific<br />
RNAs in Drosophila embryos reveals a translational<br />
control of the segmentation gene hunchback.<br />
Chromosoma (Berl.) 98, 81–85.<br />
CONTENTS<br />
INDEX<br />
Wieschaus, E.; Nüsslein-Vollhard, C. (1986)<br />
Looking at embryos. <strong>In</strong>: Roberts, D. B. (ed.)<br />
Drosophila, A Practical Approach. Oxford: IRL<br />
Press, pp. 199–228.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
Tri<strong>to</strong>n ® X-100 Vicous, liquid 789 704 100 ml<br />
Hepes Purity: 98% (from N) 223 778 100 g<br />
737 151 500 g<br />
242 608 1 kg<br />
EGTA Purity: > 98% 1 093 053 50 g<br />
Tween ® 20 1 332 465 5 x10 ml<br />
Proteinase K Lyophilizate 161 519 25 mg<br />
745 723 100 mg<br />
1 000 144 500 mg<br />
1 092 766 1 g<br />
DIG-High Prime* , ** , *** Premixed solution for 40 random-primed 1 585 606 160 µl<br />
DNA labeling reactions with DIG-11-dUTP, (40 labeling<br />
alkali-labile reactions)<br />
Anti-Digoxigenin-AP 750 units/ml Anti-Digoxigenin, Fab 1 093 274 150 U<br />
fragments conjugated <strong>to</strong> alkaline (200 µl)<br />
phosphatase<br />
NBT solution 100 mg/ml nitroblue tetrazolium salt in 1 383 213 3 ml (300 mg)<br />
70% (v/v) dimethylformamide (dilute prior<br />
<strong>to</strong> use)<br />
BCIP solution 50 mg/ml 5-bromo-4-chloro-3-indolyl 1 383 221 3 ml (150 mg)<br />
phosphate (BCIP), <strong>to</strong>luidinium salt in<br />
100% dimethylformamide<br />
b<br />
nuclei<br />
cy<strong>to</strong>plasm<br />
yolk<br />
<br />
Figure 1: <strong>In</strong> situ hybridization on<br />
whole Drosophila embryos using<br />
a probe for the segmentation gene<br />
hunchback. Optical sections were<br />
obtained by appropriate focusing.<br />
For details of the panels, see text.<br />
Panel a (The bar at the <strong>to</strong>p<br />
represents approx. 100 µm.)<br />
Panel b (The bar at the <strong>to</strong>p<br />
represents approx. 5 µm.)<br />
***EP Patent 0 324 474 granted <strong>to</strong><br />
and EP Patent application<br />
0 371 262 pending for Boehringer<br />
Mannheim GmbH.<br />
***This product or the use of this<br />
product may be covered by one<br />
or more patents of Boehringer<br />
Mannheim GmbH, including the<br />
following: EP patent 0 649 909<br />
(application pending).<br />
***Licensed by <strong>In</strong>stitute Pasteur.<br />
161<br />
5
5<br />
162<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
Detection of even-skipped transcripts in Drosophila<br />
embryos with PCR/DIG-labeled DNA probes<br />
Dr. N. Patel and Dr. C. Goodman, Carnegie <strong>In</strong>stitute of Washing<strong>to</strong>n,<br />
Embryology Department, Baltimore, Maryland, USA.<br />
This pro<strong>to</strong>col has been used <strong>to</strong> detect the<br />
transcript distribution of a number of genes<br />
by in situ hybridization, including evenskipped<br />
and seven-up, in whole mount<br />
Drosophila embryos, and engrailed<br />
Antennapedia in whole mount grasshopper<br />
embryos. The in situ hybridization and<br />
detection was performed essentially<br />
according <strong>to</strong> the pro<strong>to</strong>col of Tautz and<br />
Pfeiffle (1989).<br />
This labora<strong>to</strong>ry uses PCR rather than<br />
random primed labeling <strong>to</strong> prepare DIGlabeled<br />
probes because:<br />
A much larger quantity of probe can be<br />
made with the same amount of starting<br />
nucleotide.<br />
The ratio of labeled DNA <strong>to</strong> unlabeled<br />
starting material is much higher<br />
(especially important when transcripts <strong>to</strong><br />
be detected are not very abundant).<br />
PCR can produce strand-specific copies.<br />
Disadvantage:<br />
It is more difficult <strong>to</strong> control the probe<br />
size.<br />
This labora<strong>to</strong>ry has also found that biotin-<br />
16-dUTP incorporated in the same way and<br />
detected with streptavidin-alkaline phosphatase<br />
is about three- <strong>to</strong> fivefold less<br />
sensitive than DIG-labeled probes in in situ<br />
hybridization experiments.<br />
I. Probe labeling<br />
1 Prepare the following s<strong>to</strong>ck solutions:<br />
10 x concentrated reaction mix: 500 mM<br />
KCl; 100 mM Tris-HCl, pH 8.3;<br />
15 mM MgCl2; 0.01% (w/v) gelatin.<br />
5 x concentrated dNTP mix: 1 mM<br />
dATP, 1 mM dCTP, 1 mM dGTP,<br />
0.65 mM dTTP, 0.35 mM digoxigenin-<br />
11-dUTP.<br />
A primer s<strong>to</strong>ck solution containing<br />
either 30 ng/µl (approx. 5.3 mmol)<br />
primer 1 (e.g. generated by SP6 RNA<br />
polymerase) or 30 ng/µl (approx.<br />
5.3 mmol) primer 2 (e.g. generated by<br />
T7 RNA polymerase).<br />
2 With a restriction enzyme, linearize “dual<br />
promo<strong>to</strong>r vec<strong>to</strong>r DNA” containing the<br />
insert, as one would <strong>to</strong> make run-off<br />
RNA transcripts.<br />
Note: The two different primers can be<br />
used <strong>to</strong> create an antisense strand and a<br />
sense strand (as control).<br />
3 Heat inactivates the restriction enzyme.<br />
4 Dilute the linearized DNA with water <strong>to</strong><br />
a final concentration of about 100–<br />
200 ng/µl.<br />
Note: If the insert is much over 3 kb,<br />
the probe produced will probably not<br />
represent the entire insert.<br />
5 Set up the following reaction mix:<br />
9.25 µl water.<br />
2.5 µl 10 x concentrated reaction<br />
mixture.<br />
5.0 µl 5 x concentrated dNTP mix.<br />
5.0 µl primer 1 or 2 (from 30 ng/µl<br />
s<strong>to</strong>ck).<br />
2.0 µl linearized DNA (100–200 ng/µl).<br />
6 Add 40 µl mineral oil, centrifuge, then<br />
boil the mix for 5 min.<br />
7 To the mix, add 1.25 µl of 1 unit/µl Taq<br />
DNA Polymerase (1.25 units of Taq<br />
Polymerase). [Final volume of reaction<br />
mix with Taq is 25 ml.]<br />
8 Mix the contents of the reaction tube and<br />
then centrifuge for 2 min.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
9 <strong>In</strong>cubate for 30 cycles in the PCR thermal<br />
cycler under the following conditions:<br />
Denaturation at 95°C for 45 s.<br />
Annealing at 50°–55°C for 30 s.<br />
Note: Annealing temperature depends<br />
on length of primer. Use 55°C for a<br />
21-mer.<br />
Elongation at 72°C for 1.0–1.5 min.<br />
Note: Elongation time depends on<br />
length of insert. Use 1 min for 1.0 kb<br />
or less, 1.5 min for 2.5 kb or more.<br />
10 After the PCR run, add 75 µl distilled H2O<br />
<strong>to</strong> the reaction tube, then centrifuge it.<br />
11 Remove 90–95 µl of the reaction mix<br />
from beneath the oil.<br />
12 To recover the DNA, do an ethanol<br />
precipitation as follows:<br />
Add NaCl <strong>to</strong> a final concentration of<br />
0.1 M.<br />
Add 10 µg of glycogen or tRNA as a<br />
carrier (0.5 µl of a 20 mg/ml s<strong>to</strong>ck).<br />
Add 3 volumes of 100% EtOH.<br />
Mix well and leave at –70°C for<br />
30 min.<br />
Centrifuge.<br />
Wash pellet with 70% ethanol.<br />
Dry under vacuum.<br />
Optional: Perform a second ethanol<br />
precipitation as above.<br />
13 Resuspend DNA pellet in 300 µl of<br />
hybridization buffer [50% formamide;<br />
5 x SSC (where 1 x SSC contains 150 mM<br />
NaCl, 15 mM sodium citrate); 50 µg/ml<br />
heparin, 0.1% Tween ® 20; and 100 µg/<br />
ml sonicated and denatured salmon<br />
sperm DNA] (according <strong>to</strong> Tautz and<br />
Pfeifle, 1989).<br />
14 To reduce the size of the single-stranded<br />
DNA, boil the probe for 40–60 min.<br />
Note: For efficient penetration of and<br />
hybridization <strong>to</strong> the embryos, the<br />
average probe length should be about<br />
50–200 bp.<br />
15 Dilute the probe as much as tenfold<br />
before use.<br />
Note: Optimal dilution varies depending<br />
on the abundance of the transcript<br />
and background staining. We recommend<br />
using the probe either undiluted<br />
(original 300 µl) or diluted up <strong>to</strong> threefold<br />
for the initial experiment.<br />
CONTENTS<br />
INDEX<br />
II. Evaluation of labeling reaction<br />
1 Prepare an aliquot of the probe as follows:<br />
Remove 1 µl of probe from the<br />
reaction mix.<br />
Add 5 µl of 5 x SSC.<br />
Boil 5 min.<br />
Quick cool on ice.<br />
Centrifuge.<br />
2 Spot 1–2 µl of the probe aliquot on<strong>to</strong> a<br />
small nitrocellulose strip cut <strong>to</strong> fit in<strong>to</strong> a<br />
1.5 ml microcentrifuge tube or a 5 ml<br />
snap cap tube.<br />
3 Bake the filter between two sheets of<br />
filter paper in an 80°C vacuum oven for<br />
30 min.<br />
Caution: The residual formamide may<br />
cause the nitrocellulose <strong>to</strong> warp. If this<br />
is a problem, reduce the time in the<br />
baking oven or do this spot test before<br />
the second precipitation (Procedure I,<br />
Step 12).<br />
Note: Unincorporated nucleotide binds<br />
only slightly <strong>to</strong> the nitrocellulose.<br />
4 Treat the baked filter as follows:<br />
Wet the filter with 2 x SSC.<br />
Wash filter 2 x 5 min in PBT (1 x PBS,<br />
0.2% BSA, 0.1% Tri<strong>to</strong>n ® X-100).<br />
Place filter in<strong>to</strong> a 1.5 ml microcentrifuge<br />
tube or 5 ml snap cap tube.<br />
5 Detect the labeled probe as follows:<br />
Block the filter by incubating it<br />
30 min in PBT.<br />
<strong>In</strong>cubate in PBT for 30–60 min with a<br />
1:2000 dilution (in PBT) of alkaline<br />
phosphatase-conjugated anti-DIG antibody.<br />
Wash 4 x 15 min in PBT.<br />
Wash 2 x 5 min in a solution containing<br />
100 mM NaCl; 50 mM MgCl2;<br />
100 mM Tris, pH 9.5; 0.1% Tween ® 20.<br />
Note: Levamisole is not needed.<br />
6 Develop color with NBT and BCIP as<br />
described in the appropriate Boehringer<br />
Mannheim pack insert.<br />
7 S<strong>to</strong>p the reaction when the spots are<br />
visible.<br />
Note: Spots should be visible within a<br />
few minutes and dark after 10–15 min.<br />
163<br />
5
5<br />
*This product is sold under licensing<br />
arrangements with Roche<br />
Molecular Systems and The Perkin-<br />
Elmer Corporation. Purchase of this<br />
product is accompanied by a<br />
license <strong>to</strong> use it in the Polymerase<br />
Chain Reaction (PCR) process in<br />
conjunction with an Authorized<br />
Thermal Cycler. For complete<br />
license disclaimer, see inside back<br />
164<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
III. Preparation of embryos,<br />
hybridization and detection<br />
Perform the preparation of the embryos,<br />
subsequent hybridization of the DIG-PCR<br />
probe, and immunological detection as<br />
described in the Tautz article, “Localization<br />
of the expression of the segmentation gene<br />
hunchback in Drosophila embryos with<br />
digoxigenin-labeled DNA probes,” page<br />
158 in this manual.<br />
Results<br />
a b<br />
Reference<br />
Tautz, D.; Pfeiffle, C. (1989) A nonradioactive in situ<br />
hybridization method for the localization of specific<br />
RNAs in Drosophila embryos reveals a translational<br />
control of the segmentation gene hunchback.<br />
Chromosoma (Berl.) 98, 81–85.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
<br />
Figure 1: Detection of the even-skipped<br />
phenotype on blas<strong>to</strong>derm stage Drosophila<br />
embryos. Panel a shows an in situ hybridization<br />
using the Drosophila even-skipped gene as probe.<br />
Panel b demonstrates the even-skipped product<br />
using the specific antibody as probe. The seven<br />
stripe pattern is associated with the even-skipped<br />
phenotype.<br />
Reagent Description Cat. No. Pack size<br />
PCR DIG Probe For generating highly sensitive probes 1 636 090 1 Kit<br />
Synthesis Kit* labeled with DIG-dUTP (alkali-labile) in<br />
the polymerase chain reaction (PCR)<br />
using a ratio of 1+2 (DIG-dUTP:dTTP)<br />
(25 reactions)<br />
Tween ® 20 1 332 465 5 x10 ml<br />
Glycogen From rabbit liver 106 089 500 mg<br />
BSA Highest quality, lyophilizate 238 031 1 g<br />
238 040 10 g<br />
Tri<strong>to</strong>n ® X-100 Vicous, liquid 789 704 100 ml<br />
Anti-Digoxigenin-AP 750 units/ml Anti-Digoxigenin, Fab 1 093 274 150 U<br />
fragments conjugated <strong>to</strong> alkaline (200 µl)<br />
phosphatase<br />
NBT solution 100 mg/ml nitroblue tetrazolium salt in 1 383 213 3 ml (300 mg)<br />
70% (v/v) dimethylformamide (dilute prior<br />
<strong>to</strong> use)<br />
BCIP solution 50 mg/ml 5-bromo-4-chloro-3-indolyl 1 383 221 3 ml (150 mg)<br />
phosphate (BCIP), <strong>to</strong>luidinium salt in<br />
100% dimethylformamide<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
Whole mount fluorescence in situ hybridization (FISH)<br />
of repetitive DNA sequences on interphase nuclei of<br />
the small cruciferous plant Arabidopsis thaliana<br />
Serge Bauwens 1 and Patrick Van Oostveldt 2<br />
1 Labora<strong>to</strong>ry for Genetics, Gent University, Gent, Belgium<br />
2 Labora<strong>to</strong>ry for Biochemistry and Molecular Cy<strong>to</strong>logy, Gent University, Gent, Belgium<br />
Hybridizing fluorescently labeled DNA<br />
probes in situ <strong>to</strong> the chromatin of interphase<br />
nuclei in whole mounts allows the study of<br />
nuclear architecture in morphologically well<br />
preserved specimens. Fluorescent labeling of<br />
the DNA probes (either directly or<br />
indirectly) allows the simultaneous, but<br />
differential, detection of several sequences<br />
(e.g. Lengauer et al., 1993; Nederlof et al.,<br />
1990). Also, fluorescent signals can be<br />
imaged by confocal microscopy so that<br />
stacks of optical section images can be<br />
recorded through the whole mounts.<br />
Multiple labeling FISH on whole mounts<br />
therefore allows the study of the relative<br />
positions of different chromosomes or<br />
chromosome segments in individual<br />
interphase nuclei as well as between nuclei of<br />
related cells.<br />
<strong>In</strong> the experiments presented here, two<br />
tandemly repeated sequences, rDNA and a<br />
500 bp repeat sequence, were hybridized <strong>to</strong><br />
interphase nuclei of seedlings and flowers<br />
(inflorescences) of the small cruciferous<br />
plant Arabidopsis thaliana. The procedure<br />
used in the experiments, based on the<br />
pro<strong>to</strong>cols published by Ludevid et al. (1992)<br />
and Tautz and Pfeifle (1989), was described<br />
earlier by Bauwens et al. (1994).<br />
I. Seed sterilization and germination<br />
Note: Procedure I is based on the pro<strong>to</strong>col<br />
of Valvekens et al. (1988).<br />
1 Surface sterilize seeds of Arabidopsis<br />
thaliana (C24) by immersing them as<br />
follows:<br />
2 min in 70% (v/v) ethanol.<br />
15 min in a solution of 5% (v/v)<br />
NaOCl and 0.05% (v/v) Tween ® 20.<br />
2 Wash seeds 5 times in sterile, distilled<br />
water.<br />
CONTENTS<br />
INDEX<br />
3 Pipette on<strong>to</strong> germination medium (1x<br />
Murashige and Skoog salt mixture (Flow<br />
Labora<strong>to</strong>ries, USA); 0.5 g/L 2-(Nmorpholino)ethane<br />
sulphonic acid<br />
(MES), pH 5.7 (adjusted with 1 M<br />
KOH); 0.8% (w/v) Bac<strong>to</strong>-agar (Difco<br />
Labora<strong>to</strong>ries, USA).<br />
4 Allow the seeds <strong>to</strong> germinate at room<br />
conditions for 4 days.<br />
5 Transfer part of the seedlings <strong>to</strong> soil.<br />
6 Grow plants under continuous light<br />
conditions at desk temperature.<br />
7 Harvest flowers and inflorescences after<br />
3–4 weeks.<br />
II. Tissue fixation<br />
1 Place approximately 30–40 seedlings or a<br />
few flowers or inflorescences in a glass<br />
vial containing:<br />
4.365 ml fixation buffer [1.1 x PBS;<br />
0.067 M EGTA, pH 7.5 (adjusted with<br />
NaOH)].<br />
Note: 10 x PBS contains 1.3 M NaCl,<br />
0.0027 M KCl, 0.07 M Na2HPO4, 0.03 M<br />
NaH2PO4; pH 7.2.<br />
0.135 ml 37% formaldehyde (Sigma,<br />
USA).<br />
0.5 ml DMSO.<br />
Note: Final concentrations in vial are<br />
1% formaldehyde and 10% DMSO.<br />
2 Rock the glass vial for 25 min at room<br />
temperature.<br />
3 Remove the fixative and rinse as follows:<br />
2 x with 5 ml methanol.<br />
4 x with 5 ml ethanol.<br />
4 Discard the last ethanol wash, then cover<br />
sample with a final 5 ml ethanol.<br />
5 Leave sample at –20°C for 2–4 days.<br />
Caution: Keeping the material for<br />
longer periods of time in ethanol makes<br />
it brittle.<br />
165<br />
5
5<br />
166<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
III. Labeling of the probe DNA<br />
1 Use the following as hybridization<br />
probes:<br />
A mixture of three ribosomal DNA<br />
(rDNA) inserts, each cloned in<strong>to</strong> pBS<br />
(I)KS + (Stratagene, USA) from A.<br />
thaliana. The inserts contain the 5.8S,<br />
18S and 25S rRNA genes, as well as the<br />
intergenic region (IGR) (Unfried and<br />
Gruendler, 1990; Unfried et al., 1989).<br />
A 500 bp repeat DNA sequence,<br />
cloned in<strong>to</strong> pGem-2 (Promega, USA).<br />
The repeat is one of three classes of<br />
highly repetitive, tandemly arranged<br />
DNA sequences in A. thaliana<br />
(Simoens et al., 1988).<br />
2 Label undigested samples of both probes<br />
according <strong>to</strong> the nick translation procedures<br />
in Chapter IV of this manual. Use<br />
the following labels:<br />
Label the rDNA with either DIGdUTP<br />
or fluorescein-dUTP.<br />
Note: The concentration of substituted<br />
nucleotide in the nick translation<br />
labeling mixture should be the<br />
same for either fluorescein-dUTP or<br />
DIG-dUTP.<br />
Label the 500 bp repeat DNA with<br />
DIG-dUTP.<br />
3 After nick translation, treat each labeled<br />
probe as follows:<br />
Co-precipitate 1 µg of labeled DNA<br />
with 55 µg of sonicated salmon sperm<br />
DNA (Sigma, USA).<br />
Redissolve probe in 25 µl H2O <strong>to</strong> a<br />
concentration of 40 ng labeled DNA<br />
per µl.<br />
IV. Pretreatment<br />
1 Remove ethanol from seedlings or flowers<br />
(or inflorescences) and transfer<br />
material <strong>to</strong> microcentrifuge tubes.<br />
2 Fix each sample as follows:<br />
Rinse 2 x with 1 ml ethanol.<br />
Replace ethanol with 1 ml ethanol/<br />
xylene (1:1) and incubate for 30 min.<br />
Rinse 2 x with 1 ml ethanol.<br />
Rinse 2 x with 1 ml methanol.<br />
Replace methanol with 1 ml of a 1:1<br />
mixture of methanol and [PBT<br />
containing 1% (v/v) formaldehyde].<br />
Rock for 5 min.<br />
Note: PBT contains 1 x PBS and<br />
0.1% (v/v) Tween ® 20.<br />
3 Post-fix sample for 25 min in 1 ml PBT<br />
containing 1% formaldehyde.<br />
4 Remove fixative and rinse sample with<br />
5 x1 ml PBT.<br />
5 Wash sample 3 x 1 ml of 2 x SSC (each<br />
wash, 5 min).<br />
Note: 1 x SSC contains 150 mM NaCl<br />
and 15 mM sodium citrate, pH 7.0.<br />
6 Digest with RNase A (100 µg/ml in<br />
2 x SSC) for 1 h at 37°C.<br />
7 Wash 3 x 5 min with 1 ml PBT.<br />
8 Digest with Proteinase K (40 µg/ml in<br />
PBT) for 8 min at 37°C.<br />
9 After the Proteinase K digestion, do the<br />
following:<br />
Rinse 2 x with 1 ml PBT.<br />
Wash 2 x 2 min with 1 ml PBT.<br />
Rinse 2 x with 1 ml PBT.<br />
10 Postfix a second time for 25 min with<br />
1 ml PBT containing 1% formaldehyde.<br />
11 Remove fixative and rinse 5 x with 1 ml<br />
PBT.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
V. <strong>In</strong> situ hybridization<br />
1 Wash each sample 10 min with 1 ml of a<br />
1:1 mixture of PBT and hybridization<br />
solution [hybridization solution contains<br />
50% formamide (Ultra Pure from USB,<br />
USA) in 2 x SSC].<br />
2 Rinse sample with 2 x1 ml hybridization<br />
solution.<br />
3 Remove the hybridization solution and<br />
add the following <strong>to</strong> each sample (<strong>to</strong><br />
produce a final volume of 500 µl of<br />
hybridization solution):<br />
250 µl formamide.<br />
50 µl 20 x SSC.<br />
Enough H2O <strong>to</strong> make a <strong>to</strong>tal volume,<br />
including probes, of 500 µl.<br />
25 µl of each labeled rDNA probe (for<br />
single or double labeling experiments).<br />
25 µl labeled 500 bp repeat probe (for<br />
double labeling experiments only).<br />
Note: Each labeled probe has a final<br />
concentration of 2 ng/µl.<br />
Note: This incubation mixture can be<br />
used for either a single label hybridization<br />
(fluorescein-labeled probe) with<br />
direct detection; a single label hybridization<br />
(DIG-labeled probe) with indirect<br />
detection; or a double label hybridization<br />
(both fluorescein- and digoxigeninlabeled<br />
probes). See Procedure VIII below<br />
for details on these different types of<br />
experiments.<br />
4 Treat the sample as follows:<br />
Denature target and probe in hybridization<br />
solution for 4 min at 100°C.<br />
Place immediately on ice for 3 min.<br />
Centrifuge very briefly.<br />
<strong>In</strong>cubate overnight at 37°C <strong>to</strong> hybridize<br />
probe and target.<br />
Caution: If using a directly labeled<br />
(i.e., fluorescent) probe, perform the<br />
hybridization incubation and the rest<br />
of the procedure in the dark.<br />
CONTENTS<br />
INDEX<br />
VI. Pre-absorption of antibodies<br />
(for indirect detection only)<br />
1 Prepare powdered A. thaliana root or<br />
seedling extract as follows:<br />
Grind the root or seedling under liquid<br />
nitrogen.<br />
Extract the ground powder with<br />
ace<strong>to</strong>ne under liquid nitrogen.<br />
Decant the ace<strong>to</strong>ne supernatant.<br />
Let the residual ace<strong>to</strong>ne evaporate<br />
from the precipitate.<br />
Use the dry, powdered precipitate in<br />
the pre-absorption procedure below.<br />
2 Dilute each detection antibody, in 4 x SSC<br />
containing 1% (w/v) BSA, <strong>to</strong> the<br />
working dilution suggested by the manufacturers<br />
and a final volume of 500 µl.<br />
3 Add approximately 2 mg of powdered<br />
A. thaliana root or seedling extract (from<br />
Step 1 above) <strong>to</strong> the diluted antibody.<br />
4 Pre-absorb the antibodies overnight at<br />
15°C, in the dark.<br />
5 Centrifuge the pre-absorption mixture.<br />
6 Use the supernatant in the immunocy<strong>to</strong>chemical<br />
detection reaction.<br />
VII. Posthybridization washes<br />
1 After overnight hybridization at 37°C<br />
(Procedure V, Step 4), treat the hybridization<br />
sample as follows:<br />
Remove the hybridization solution.<br />
Wash the sample for 1 h in fresh<br />
hybridization solution at 37°C.<br />
Wash the sample 4 x 30 min in hybridization<br />
solution at 37°C.<br />
If performing an in situ hybridization<br />
experiment with directly labeled probe<br />
DNA (rDNA) in a single labeling experiment,<br />
proceed <strong>to</strong> procedure VIII a.<br />
If performing an in situ hybridization<br />
experiment requiring indirect detection<br />
with antibodies, proceed <strong>to</strong> step 2.<br />
2 Bring the seedlings or flowers (or inflorescences)<br />
gradually <strong>to</strong> 4 x SSC through<br />
the following washes (all at room<br />
temperature):<br />
20 min with a 3:1 mix of hybridization<br />
solution and 4 x SSC.<br />
20 min with a 1:1 mix of hybridization<br />
solution and 4 x SSC.<br />
20 min with a 1:3 mix of hybridization<br />
solution and 4 x SSC.<br />
4 x 5 min with 4 x SSC.<br />
167<br />
5
5<br />
<br />
Table 1: Immunocy<strong>to</strong>chemical<br />
detection schemes for single and<br />
double labeling experiments<br />
a All antibodies should be preabsorbed,<br />
according <strong>to</strong> Procedure<br />
VI above.<br />
b Fab fragments.<br />
c Fab fragments, from Sigma, USA.<br />
d Fab fragments.<br />
e Whole molecule, from Chemicon,<br />
USA.<br />
168<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
VIII. Immunocy<strong>to</strong>chemical detection<br />
Use the immunocy<strong>to</strong>chemical detection<br />
schemes detailed in Table 1 <strong>to</strong> analyze the<br />
single and double labeling in situ hybridization<br />
experiments.<br />
Antibodya Type of Experiment Probe Label 1st (detecting) 2nd (amplifying) Procedure <strong>to</strong> Follow<br />
Single label, rDNA Fluorescein- – – VIIIa<br />
direct detection dUTP<br />
Single label, rDNA DIG-dUTP Fluorescein-conju- Fluorescein-conju- VIIIb<br />
indirect detection gated anti-DIG anti- gated anti-sheep antibody<br />
(from sheep) b body (from donkey) c<br />
Double label rDNA Fluorescein- – – VIIIb<br />
dUTP<br />
500 bp DIG-dUTP Tetramethylrhoda- Tetramethylrhodamine-conjugated<br />
mine-conjugated<br />
anti-DIG antibody anti-sheep antibody<br />
(from sheep) d body (from rabbit) e<br />
VIIIa. Direct detection<br />
1 Bring the samples <strong>to</strong> 1 x PBS gradually<br />
through the following washes (all at room<br />
temperature):<br />
20 min with a 3:1 mix of hybridization<br />
solution and 1 x PBS.<br />
20 min with a 1:1 mix of hybridization<br />
solution and 1 x PBS.<br />
20 min with a 1:3 mix of hybridization<br />
solution and 1 x PBS.<br />
4 x 15 min in 1 ml 1 x PBS.<br />
2 Proceed <strong>to</strong> the staining and mounting<br />
procedure (Procedure IX).<br />
VIIIb. <strong>In</strong>direct detection<br />
1 After the posthybridizationwashes (Procedure<br />
VII), remove the 4 x SSC solution<br />
from the samples.<br />
2 Add the first pre-absorbed antibody<br />
(from Table 1) <strong>to</strong> the sample and incubate<br />
overnight at 15°C in the dark.<br />
3 Remove the first antibody and wash the<br />
material 4 x15 min in 1 ml 4 x SSC<br />
containing 0.05% (v/v) Tween ® 20.<br />
4 Depending on whether you are using an<br />
amplifying (second antibody), do either<br />
of the following:<br />
If you use an amplifying antibody,<br />
proceed <strong>to</strong> Step 5.<br />
If you do not use an amplifying<br />
antibody, proceed <strong>to</strong> Step 7.<br />
5 If amplifying the signal, wash the sample<br />
4 x 15 min with 4 x SSC containing 1%<br />
bovine serum albumin.<br />
6 Remove the wash solution; add the<br />
second pre-absorbed antibody (from<br />
Table 1) <strong>to</strong> the sample, and incubate<br />
overnight at 15°C in the dark.<br />
7 After the last (first or second) antibody<br />
incubation, remove the antibody and<br />
wash the sample 4 x 15 min in 1 ml 1 x<br />
PBS.<br />
8 Proceed <strong>to</strong> the staining and mounting<br />
procedure (Procedure IX).<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
IX. Staining and mounting<br />
1 Counterstain the sample as follows:<br />
For single labeling experiments with<br />
fluorescein-conjugated antibodies or<br />
nucleotides: Counterstain the chromatin<br />
of the interphase nuclei with 0.5 µg/ml<br />
propidium iodide (in 1 x PBS) for 1 h in<br />
the dark.<br />
For double labeling experiments with<br />
fluorescein- and tetramethylrhodamineconjugated<br />
nucleotides and antibodies:<br />
Counterstain the chromatin of the<br />
interphase nuclei with 0.2 µg/ml DAPI<br />
(in 1 x PBS) for 1 h in the dark.<br />
Note: DAPI is 4,6'-diamidino-2phenylindole.<br />
2 Place a few seedlings or flowers (or part<br />
of an inflorescence) on a slide.<br />
3 Apply some tape <strong>to</strong> the slides <strong>to</strong> create a<br />
support for the cover slip, so as not <strong>to</strong><br />
crush the seedlings or flowers.<br />
4 Apply a drop of antifade reagent<br />
(Vectashield, Vec<strong>to</strong>r Labora<strong>to</strong>ries, USA)<br />
and cover with a cover slip.<br />
X. Fluorescence microscopy<br />
Xa. Conventional fluorescence microscopy<br />
1 Visually inspect the slides on a<br />
DIAPHOT 300 inverted microscope<br />
(Nikon, Japan), fitted with either a 60 x,<br />
NA 1.40 oil immersion lens (Olympus,<br />
Japan) or an NPL FLUOTAR, 40 x, NA<br />
1.30 oil immersion lens (Leitz, FRG).<br />
2 Use the following filter combinations<br />
(Chroma Technology Corp., USA):<br />
To localize propidium iodide-stained<br />
nuclei and tetramethylrhodaminelabeled<br />
hybrids: filter block 31014 404.<br />
To localize DAPI-stained nuclei: filter<br />
block 31000 404.<br />
To localize fluorescein-labeled hybrids:<br />
filter block 31 001 404.<br />
3 As light source, use a mercury arc lamp<br />
(100 W).<br />
CONTENTS<br />
INDEX<br />
Xb. Confocal fluorescence microscopy<br />
1 Record images with the MRC-600<br />
Confocal Scanning Laser Microscope<br />
(CSLM) System (Bio-Rad, USA). Attach<br />
the CSLM <strong>to</strong> the DIAPHOT 300<br />
inverted microscope fitted with appropriate<br />
lenses (same microscope and lenses<br />
as described in Procedure Xa, Step 1<br />
above).<br />
2 Use the K1/K2 filter block combinations<br />
(Bio-Rad, USA) and either:<br />
The 568 nm line from a Kryp<strong>to</strong>n-<br />
Argon laser (Ion Laser Technology,<br />
Utah, USA), <strong>to</strong> image the propidium<br />
iodide-stained interphase nuclei and<br />
the tetramethylrhodamine-labeled<br />
hybrids.<br />
The 488 nm line from the same<br />
Kryp<strong>to</strong>n-Argon laser, <strong>to</strong> image the<br />
fluorescein-labeled hybrids.<br />
Results and discussion<br />
Figures 1 and 2 show some of the results<br />
obtained by FISH of rDNA and the 500 bp<br />
repeat on whole mounts of flowers and<br />
seedlings from A. thaliana.<br />
The rDNA from A. thaliana covers about<br />
5.7 Mbp per haploid genome (Meyerowitz<br />
and Pruitt, 1985), and is distributed over two<br />
large tandem repeats on chromosomes 2 and<br />
4 (Maluszynska and Heslop-Harrison, 1991;<br />
Murata et al. 1990). Diploid interphase<br />
nuclei from A. thaliana exhibit, however, a<br />
number of rDNA-loci ranging from two <strong>to</strong><br />
more than four (Bauwens et al. 1991) as can<br />
clearly be seen from the merged image in<br />
Figure 1.<br />
The 500 bp repeat sequence covers about<br />
0.3–0.6 Mbp per haploid genome (Bauwens<br />
et al., 1991; Simoens et al., 1988) and exhibits a<br />
chromosome-specific large cluster (Bauwens<br />
and Van Oostveldt, 1991; Bauwens et al.,<br />
1991), resulting in two distinct signals in<br />
diploid interphase nuclei as can be seen from<br />
the merged image in Figure 2.<br />
Some helpful remarks should be made about<br />
confocal observation of fluorescent signals<br />
in whole mounts.<br />
169<br />
5
5<br />
170<br />
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
Figure 1: Whole mount FISH with rDNA on a<br />
developing flower from A. thaliana. The image is<br />
a merged image representing part of the pistil of a<br />
developing flower, showing fluorescein-labeled<br />
rDNA loci (yellow-green) and propidium iodidestained<br />
interphase nuclei (red). An extended focus<br />
image of 15 optical sections through the pistil<br />
was created by maximum brightness projection<br />
before merging the ‘green’ (rDNA) and ‘red’ (nuclei)<br />
images. Bar 25 µm ^=<br />
<br />
17 mm.<br />
Figure 2: Whole mount double labeling FISH with<br />
rDNA and the 500 bp repeat on a seedling from<br />
A. thaliana. This merged image represents part of<br />
the meristematic zone of a seedling roottip. It shows<br />
fluorescein-labeled rDNA loci (green) and tetramethylrhodamine-labeled<br />
500 bp repeat loci (red).<br />
An extended focus image of 20 optical sections<br />
through the meristematic zone of the roottip was<br />
created by maximum brightness projection before<br />
merging the ‘green’ (rDNA) and ‘red’ (500 bp repeat)<br />
images. Bar 25 µm ^=<br />
<br />
15 mm.<br />
Sequential excitation with the 568 nm and<br />
the 488 nm lines of the Kr-Ar-laser and the<br />
K1/K2 filter combinations from the Bio-<br />
Rad MRC-600 CSLM, allowed a clear<br />
separation of the red (tetramethylrhodamine)<br />
and the green (fluorescein) signal. [See<br />
the signals from the 500 bp repeat (red) and<br />
the rDNA (green) probes in Figure 2.].<br />
Especially, the yellow 568 nm line allows<br />
specific excitation of the red fluorescing dyes<br />
such as tetramethylrhodamine or, preferably,<br />
Texas Red with almost no excitation of<br />
fluorescein.<br />
Confocal observation of the preparations<br />
appeared <strong>to</strong> be absolutely necessary <strong>to</strong><br />
obtain clear images of the signals, especially<br />
in the very dense meristematic tissues of the<br />
seedling roottips and the developing flowers<br />
in the inflorescences. This was especially<br />
true for the weaker signal of the 500 bp<br />
repeat that, in many cases, could not be<br />
observed through the au<strong>to</strong>fluorescence haze<br />
by conventional fluorescence microscopy.<br />
Acquiring digital images through confocal<br />
microscopy has the added advantage that<br />
images recorded at different wavelengths can<br />
be easily and accurately merged and<br />
compared.<br />
Finally, the development of FISH pro<strong>to</strong>cols<br />
on whole mounts for localizing mRNA<br />
sequences, as already suggested by de<br />
Almeida Engler et al. (1994), will make it<br />
possible <strong>to</strong> follow the expression of different<br />
genes simultaneously at the cellular level, in<br />
three dimensions, through confocal<br />
observation.<br />
References<br />
Bauwens, S.; Katsanis, K.; Van Montagu, M.;<br />
Van Oostveldt, P.; Engler, G. (1994) Procedure for<br />
whole mount fluorescence in situ hybridization<br />
of interphase nuclei on Arabidopsis thaliana.<br />
Plant J. 6, 123–131.<br />
Bauwens, S.; Van Oostveldt, P. (1991) Cy<strong>to</strong>genetic<br />
analysis on interphase nuclei with non-iso<strong>to</strong>pic<br />
in situ hybridization and confocal microscopy.<br />
Med. Fac. Landbouww. Rijksuniv. Gent. 56/3a,<br />
753–758.<br />
Bauwens, S.; Van Oostveldt, P.; Engler, G.;<br />
Van Montagu, M. (1991) Distribution of the rDNA<br />
and three classes of highly repetitive DNA in the<br />
chromatin of interphase nuclei of Arabidopsis<br />
thaliana. Chromosoma 101, 41–48.<br />
de Almeida Engler, J.; Van Montagu, M.; Engler, G.<br />
(1994) <strong>Hybridization</strong> in situ of whole-mount<br />
messenger RNA in plants. Plant Mol. Biol. Reporter<br />
12, 321–331.<br />
CONTENTS<br />
INDEX
Procedures for <strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> <strong>to</strong> Chromosomes, Cells, and Tissue Sections<br />
Whole mount ISH<br />
Lengauer, C.; Speicher, M. R.; Popp, S.; Jauch, A.;<br />
Taniwaki, M.; Nagaraja, R.; Riethman, H. C.;<br />
Donis-Keller, H.; D’Urso, M.; Schlessinger, D.;<br />
Cremer, T. (1993) Chromosomal bar codes produced<br />
by multicolor fluorescence in situ hybridization with<br />
multiple YAC clones and whole chromosome<br />
painting probes. Hum. Mol. Gen. 2, 505–512.<br />
Ludevid, D.; Höfte, H.; Himelblau, E.; Chrispeels,<br />
M. J. (1992) The expression pattern of the <strong>to</strong>noplast<br />
intrinsic protein -TIP in Arabidopsis thaliana is<br />
correlated with cell enlargement. Plant Physiol.<br />
100, 1633–1639.<br />
Maluszynska, J.; Heslop-Harrison, J. S. (1991)<br />
Localization of tandemly repeated DNA sequences<br />
in Arabidopsis thaliana. Plant J. 1, 159–166.<br />
Meyerowitz, E. M.; Pruitt, R. E. (1985) Arabidopsis<br />
thaliana and plant molecular genetics. Science 229,<br />
1214–1218.<br />
Murata, M.; Varga, F.; Maluszynska, J.;<br />
Gruendler, P.; Schweitzer, D. (1990) Chromosomal<br />
localization of the ribosomal RNA genes in<br />
Arabidopsis thaliana by in situ hybridization.<br />
<strong>In</strong>: Schweitzer, D.; Peuker, K.; Loidl, J. (Eds) Fourth<br />
<strong>In</strong>ternational Conference on Arabidopsis Research,<br />
Vienna, Abstracts, 5.<br />
Nederlof, P. M.; van der Ploeg, S.; Wiegant, J.;<br />
Raap, A. K.; Tanke, H. J.; Ploem, J. S.; van der<br />
Ploeg, M. (1990) Multiple fluorescence in situ<br />
hybridization. Cy<strong>to</strong>metry 11, 126–131.<br />
Simoens, C. R.; Gielen, J.; Van Montagu, M.;<br />
<strong>In</strong>zé, D. (1988) Characterization of highly repetitive<br />
sequences of Arabidopsis thaliana. Nucleic Acids<br />
Res. 16, 6753–6766.<br />
Tautz, D.; Pfeifle, C. (1989) A nonradioactive in situ<br />
hybridization method for the localization of specific<br />
RNAs in Drosophila embryos reveals translational<br />
control of the segmentation gene hunchback.<br />
Chromosoma 98, 81–85.<br />
Unfried, I.; Gruendler, P. (1990) Nucleotide sequence<br />
of the 5.8S and 25S rRNA genes and of the internal<br />
transcribed spacers from Arabidopsis thaliana.<br />
Nucleic Acids Res. 18, 4011.<br />
Unfried, I.; S<strong>to</strong>cker, U.; Gruendler, P. (1989)<br />
Nucleotide sequence of the 18S rRNA gene from<br />
Arabidopsis thaliana Co 10. Nucleic Acids Res 7,<br />
7513.<br />
Valvekens, D.; Van Lijsebettens, M.; Van Montagu,<br />
M. (1988) Agrobacterium tumefaciens-mediated<br />
transformation of Arabidopsis thaliana root explants<br />
by using kanamycin selection. Proc. Natl. Acad. Sci.<br />
USA 85, 5536–5540.<br />
Reagents available from Boehringer<br />
Mannheim for this procedure<br />
Reagent Description Cat. No. Pack size<br />
DIG-Nick Translation For generation of highly sensitive probes for 1745 816 160 µl<br />
Mix* in situ hybridization with digoxigenin-11-dUTP.<br />
Premixed solution for 40 labeling reactions<br />
Nick Translation Mix* For generation of highly sensitive probes for 1745 808 200 µl<br />
fluorescence in situ hybridization. The Nick<br />
Translation Mix for in situ probes is designed<br />
for direct fluorophore-labeling of in situ probes.<br />
Fluorescein-12-dUTP Tetralithium salt, solution, 1 mmol/l 1 373 242 25 nmol (25 µl)<br />
dNTP Set Set of dATP, dCTP, dGTP, dTTP, lithium salts, 1 277 049 1 set,<br />
solutions 4 x10 µmol<br />
(100 µl)<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 750 200 µg<br />
Rhodamine<br />
Anti-Digoxigenin- Fab Fragments from sheep 1 207 741 200 µg<br />
Fluorescein<br />
Tween ® 20 1 332 465 5 x10 ml<br />
EGTA Purity: > 98% 1 093 053 50 g<br />
Proteinase K Lyophilizate 161 519 25 mg<br />
745 723 100 mg<br />
1 000 144 500 mg<br />
1 092 766 1 g<br />
RNase A Dry powder 109 142 25 mg<br />
109 169 100 mg<br />
*This product or the use of this product may be covered by one or more patents of Boehringer Mannheim<br />
GmbH, including the following: EP patent 0 649 909 (application pending).<br />
CONTENTS<br />
INDEX<br />
171<br />
5
CONTENTS<br />
INDEX<br />
References
6<br />
174<br />
References<br />
<strong>In</strong> this chapter general references of<br />
publications on the use of digoxigenin in in<br />
situ hybridization experiments are listed<br />
alphabetically <strong>to</strong> give <strong>to</strong> the reader an<br />
overview on the wide range of applications<br />
presently available.<br />
1. mRNA target<br />
A. DNA probe<br />
a. RPL<br />
Aida, T.; Yamada, H.; Asano, G. (1990) Expression<br />
of type VI procollagen and prolyl-4-hydroxylase<br />
mRNA in carbon tetra-chloride induced liver fibrosis<br />
studied by in situ hybridization. Acta His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 23 (6), 817–824.<br />
Ayoubi, T. A. Y.; van Duijnhoven, H. L. P.; Coenen, A.<br />
J. M.; Jenks, B. G.; Roubos, E. W.; Martens, G. J. M.<br />
(1991) Coordinated expression of 7B2 and MSH in<br />
the melanotrope cells of Xenopus laevis. Cell Tissue<br />
Res. 264, 329–334.<br />
Bier, E.; Jan, L. Y.; Nung Jan, Y. (1990) Rhomboid,<br />
a gene required for dorsoventral axis establishment<br />
and peripheral nervous system development in<br />
Drosophila melanogaster. Genes & Development 4,<br />
190–203.<br />
Bland, Y. S.; Critchlow, M. A.; Ashhurst, D. E. (1991)<br />
Digoxigenin as a probe label for in situ hybridization<br />
on skeletal tissue. His<strong>to</strong>chem. J. 23, 415–418.<br />
Blochlinger, K.; Bodmer, R.; Jan, L. Y.; Jan, Y. N.<br />
(1990) Patterns of expression of cut, a protein<br />
required for external sensory organ development<br />
in wild-type and cut mutant Drosophila embryos.<br />
Genes & Development 8, 1322–1331.<br />
Bochenek, B.; Hirsch, A. (1990) <strong>In</strong> situ hybridization<br />
of nodulin mRNAs in root nodules using nonradioactive<br />
probes. Plant Mol. Biol. Reporter 8 (4),<br />
237–248.<br />
Breitschopf, H.; Suchanek, G.; Gould, R. M.; Colman,<br />
D. R.; Lassmann, H. (1992) <strong>In</strong> situ hybridization with<br />
digoxigenin-labeled probes: sensitive and reliable<br />
detection method applied <strong>to</strong> myelinating rat brain.<br />
Acta Neuropathol. 84, 581–587.<br />
Brown, D. W.; Welsh, R. M.; Like, A. A. (1993)<br />
<strong>In</strong>fection of peripancreatic lymph nodes but not<br />
islets precedes kilham rat virus-induced diabetes<br />
in BB/Wor rats. J. Virol. 67 (10), 5873–5878.<br />
Casanova, J.; Struhl, G. (1993) The <strong>to</strong>rso recep<strong>to</strong>r<br />
localizes as well as transduces the spatial signal<br />
specifying terminal body pattern in Drosophila.<br />
Nature 362, 152–155.<br />
Cohen, B.; Wimmer, E. A.; Cohen, S. M. (1991)<br />
Early development of leg and wing primordia in<br />
the Drosophila embryo. Mechan. Develop. 33,<br />
229–240.<br />
Cohen, S. M. (1990) Specification of limb development<br />
in the drosophila embryo by positional cues<br />
from segmentation genes. Nature 343, 173–177.<br />
Corbin, V.; Michelson, A. M.; Abmayr, S. M.; Neel, V.;<br />
Alcamo, E.; Maniatis, T.; Young, M. W. (1991)<br />
A role for the drosophila neurogenic genes in<br />
mesoderm differentiation. Cell Vol. 67, 311–323.<br />
Crespo, P.; Angeles-Ros, M.; Ordovas, J. M.;<br />
Rodriguez, J. C.; Ortiz, J. M.; Leon, J. (1992) Foam<br />
cells from aorta and spleen overexpress apolipoprotein<br />
E in the absence of hypercholesterolemia.<br />
Biochem. & Biophys. Res. Communications 183 (2),<br />
514–523.<br />
Crowley, T. E.; Hoey, T.; Liu, J.-K.; Jan, Y. N.;<br />
Jan, L. Y.; Tjian, R. (1993) A new fac<strong>to</strong>r related<br />
<strong>to</strong> TATA-binding protein has highly restricted<br />
expression patterns in Drosophila. Nature 361,<br />
557–561.<br />
Donly, B. C.; Ding, Q.; Tobe, S. S.; Bendena, W. G.<br />
(1993) Molecular cloning of the gene for the alla<strong>to</strong>statin<br />
family of neuropeptides from the cockroach<br />
Diploptera punctata. Proc. Natl. Acad. Sci. USA 90,<br />
8807–8811.<br />
Doria-Medina, C. L.; Lund, D. D.; Pasley, A.;<br />
Sandra, A.; Sivitz, W .I. (1993) Immunolocalization<br />
of GLUT-1 glucose transporter in rat skeletalmuscle<br />
and in normal and hypoxic cardia tissue. Am. J.<br />
Physiol. 265, E454–E464.<br />
Durham, S. K.; Goller, N. L.; Lynch, J. S.; Fisher,<br />
S. M.; Rose, P. M. (1993) Endothelin recep<strong>to</strong>r B<br />
expression in the rat and rabbit lung as determined<br />
by in situ hybridization using noniso<strong>to</strong>pic probes.<br />
J. Cardiovas. Pharm. 22 (Suppl. 8), S1–S3.<br />
Fasano, L.; Röder, L.; Coré, N.; Alexandre, E.; Vola,<br />
C.; Jacq, B.; Kerridge, S. (1991) The gene teashirt<br />
is required for the development of Drosophila<br />
embryonic trunk segments and encodes a protein<br />
with widely spaced zinc finger motifs. Cell 64,<br />
63–79.<br />
Frasch, M. (1991) The maternally expressed<br />
Drosophila gene encoding the chromatin-binding<br />
protein BJ1 is a homolog of the vertebrate gene<br />
regula<strong>to</strong>r of chromatin condensation, RCC1.<br />
EMBO J. 10 (5), 1225–1236.<br />
CONTENTS<br />
INDEX
Fukuda, T.; Nakajima, H.; Fukushima, Y.; Akutsu, I.;<br />
Numao, T.; Majima, K.; Mo<strong>to</strong>jima, S.; Sa<strong>to</strong>, Y.;<br />
Takatsu, K.; Makino, S. (1994) Detection of<br />
interleukin-5 messenger RNA and interleukin-5<br />
protein in bronchial biopsies from asthma by<br />
nonradioactive in situ hybridization and<br />
immunohis<strong>to</strong>chemistry. J. Allergy Clin. Immunol.<br />
94, 584–593.<br />
Grabner, M.; Bachmann, A.; Rosenthal, F.;<br />
Striessnig, J.; Schulz, C.; Tautz, D.; Glossmann, H.<br />
(1994) <strong>In</strong>sect calcium channels. Molecular cloning<br />
of an 1-subunit from housefly (Musca domestica)<br />
muscle. FEBS Letters 339, 189–194.<br />
Haenlin, M.; Kramatschek, B.; Campos-Ortega,<br />
J. A. (1990) The pattern of transcription of the<br />
neurogenic gene delta of Drosophila melanogaster.<br />
Develop. 110, 905–914.<br />
Heemskerk, J.; DiNardo, S.; Kostriken, R.; O’Farell,<br />
P. H. (1991) Multiple modes of engrailed regulation<br />
in the progression <strong>to</strong>wards cell fate determination.<br />
Nature 352, 404–410.<br />
Hülskamp, M.; Pfeifle, C.; Tautz, D. (1990)<br />
A morphogenetic gradient of hunchback protein<br />
organizes the expression of the gap genes krüppel<br />
and knirps in the early Drosophila embryo.<br />
Nature 346, 577–580.<br />
Hukkanen, V.; Heino, P.; Sears, A. E.; Roizman, B.<br />
(1990) Detection of Herpes Simplex Virus latencyassociated<br />
RNA in mouse trigeminal ganglia by in<br />
situ hybridization using nonradioactive digoxigeninlabeled<br />
DNA and RNA probes. Methods Mol.<br />
Cell. Biol. 2, 70–81.<br />
Kellerman, K. A.; Mattson, D. M.; Duncan, I. (1990)<br />
Mutations affecting the stability of the fushi tarazu<br />
protein of Drosophila. Genes & Development 4,<br />
1936–1950.<br />
Krauss, S.; Johansen, T.; Korzh, V.; Fjose, A. (1991)<br />
Expression pattern of zebrafish pax genes suggest<br />
a role in early brain regionalization. Nature 353,<br />
267–270.<br />
Kumar, G.; Patel, D.; Naz, R. K. (1993) c-MYC mRNA<br />
is present in human sperm cells. Cell. & Mol. Biol.<br />
Res. 39, 111–117.<br />
Levine, P. H.; Jahan, N.; Murari, P.; Manak, M.;<br />
Jaffe, E. S. (1992) Detection of human herpesvirus<br />
6 in tissues involved by sinus histiocy<strong>to</strong>sis with<br />
massive lymphadenopathy (Rosai-Dorfman<br />
Disease). J. <strong>In</strong>fect. Dis. 166, 291–295.<br />
Maggiano, N.; Larocca, L. M.; Piantelli, M.;<br />
Ranelletti, F. O.; Lauriola, L.; Ricci, R.; Capelli, A.<br />
(1991) Detection of mRNA and hnRNA using a<br />
digoxigenin labeled cDNA probe by in situ<br />
hybridization on frozen tissue sections. His<strong>to</strong>chem.<br />
J. 23, 69–74.<br />
Masucci, J. D.; Miltenberger, R. J.; Hoffman, F. M.<br />
(1990) Pattern-specific expression of the Drosophila<br />
decapentaplegic gene in imaginal disks is regulated<br />
by 3’cisregula<strong>to</strong>ry elements. Genes & Development<br />
4, 2011–2023.<br />
CONTENTS<br />
INDEX<br />
References<br />
Mlodzik, M.; Baker, N. E.; Rubin, G. M. (1990)<br />
Isolation and expression of scabrous, a gene<br />
regulating neurogenesis in Drosophila. Genes &<br />
Development 4, 1848–1861.<br />
Nakano, Y.; Guerrero, I.; Hidalgo, A.; Taylor, A.;<br />
Whittle, J. R. S.; <strong>In</strong>gham, P. W. (1989) A protein<br />
with several possible membrane-spanning domains<br />
encoded by the Drosophila segment polarity gene<br />
patched. Nature 341, 508–513.<br />
Noiri, E.; Kuwata, S.; Nosaka, K.; Tokunaga, K.;<br />
Juji, T.; Shibata, Y.; Kurokawa, K. (1994) Tumor<br />
necrosis fac<strong>to</strong>r- mRNA Expression in lipopolysaccharide-stimulated<br />
rat kidney. Am. J. Path.<br />
144 (6), 1159–1166.<br />
Ono, J. K.; McCaman, R. E. (1992) <strong>In</strong> situ<br />
hybridization of whole-mounts of Aplysia ganglia<br />
using non-radioactive probes. J. Neurosci. Meth.<br />
44, 71–79.<br />
Radema, S. A.; van Deventer, S. J. H.; Cerami, A.<br />
(1991) <strong>In</strong>terleukin 1 Is expressed predominantly<br />
by enterocytes in experimental colitis.<br />
Gastroenterol. 100, 1180–1186.<br />
Rao, Yi; Jan, L-Y; Jan, Y. N. (1990) Similarity of the<br />
product of the Drosophila neurogenic gene big brain<br />
<strong>to</strong> transmembrane channel proteins. Nature 345,<br />
163 –157.<br />
Reuter, R.; Leptin, M. (1994) <strong>In</strong>teracting functions<br />
of snail, twist and huckebein during the early development<br />
of germ layers in Drosophila. Develop. 120,<br />
1137–1150.<br />
Rothe, M.; Pehl, M.; Taubert, H.; Jäckle, H. (1992)<br />
Loss of gene function through rapid mi<strong>to</strong>tic cycles<br />
in the Drosophila embryo. Nature 359, 156–159.<br />
Sampedro, J.; Guerrero, I. (1991) Unrestricted<br />
expression of the Drosophila gene patched allows<br />
a normal segment polarity. Nature 353, 187–190.<br />
Sano, J.; Miki, K.; Ichinose, M.; Kimura, M.;<br />
Kurokawa, K.; Aida, T.; Ishizaki, M.; Asano, G.;<br />
Masugi, Y.; Wong, R. N. S.; Takahashi, K. (1989)<br />
<strong>In</strong> situ localization of pepsinogens I and II mRNA in<br />
human gastric mucosa. Acta Pathol. Japonica. 39<br />
(12), 765–771.<br />
Schlinger, B. A.; Amur-Umarjee, S.; Shen, P.;<br />
Campagnoni, A. T.; Arnold, A. P. (1994) Neuronal<br />
and non-neuronal aromatase in primary cultures<br />
of developing zebra finch telencephalon.<br />
J. Neurosci. 14 (12), 7541–7552.<br />
Shermoen, A. W.; O’Farrell, P. H. (1991) Progression<br />
of the cell cycle through mi<strong>to</strong>sis leads <strong>to</strong> abortion of<br />
nascent transcripts. Cell 67, 303–310.<br />
Shin, D. M.; Chiao, P. J.; Sacks, P. G.; Shin, H. J.;<br />
Hong, W. K.; Hittelman, W. N.; Tainsky, M. A. (1993)<br />
Activation of ribosomal protein S2 gene expression<br />
in a hamster model of chemically induced oral<br />
carcinogenesis. Carcinogenesis 14 (1), 163–166.<br />
Sibon, O. C. M.; Cremers, F. F. M.; Boonstra, J.;<br />
Humbel, B. M.; Verkleij, A. J. (1993) Localisation of<br />
EGF-recep<strong>to</strong>r mRNA in the nucleus of A431 cells by<br />
light microscopy. Cell Biol. <strong>In</strong>tern. 17 (1), 1–11.<br />
175<br />
6
6<br />
176<br />
References<br />
Sommer, R.; Tautz, D. (1991) Nonradioactive in situ<br />
hybridization <strong>to</strong> sectioned tissues. Trends Genet. 7<br />
(4), 110.<br />
Steinmetz, R. W.; Grant, A. L.; Malven, P. V. (1993)<br />
Transcription of prolactin gene in milk secre<strong>to</strong>ry<br />
cells of the rat mammary gland. J. Endocrinol. 136,<br />
271–276.<br />
Tautz, D.; Pfeifle, C. (1989) A non-radioactive in situ<br />
hybridization method for the localization of specific<br />
RNAs in Drosophila embryos reveals translational<br />
control of the segmentation gene hunchback.<br />
Chromosoma (Berl.) 98, 81–85.<br />
Treacy, M. N.; He, X.; Rosenfeld, M. G. (1991) I-POU:<br />
a POU-domain protein that inhibits neuron-specific<br />
gene activation. Nature 350, 577–584.<br />
Vassias, I.; Perol, S.; Coulombel, L.; Thebault,<br />
M.-C.; Lagrange, P. H.; Morinet, F. (1993) An in situ<br />
hybridization technique for the study of B19 human<br />
parvovirus replication in bone marrow cell cultures.<br />
J. Virol. Meth. 44, 329–338.<br />
Wiethege, Th.; Voss, B.; Pohle, Th.; Fisseler-Eckhoff,<br />
A.; Müller, K. M. (1991) Localization of elastase and<br />
tumor necrosis fac<strong>to</strong>r- mRNA by non-radioactive<br />
in situ hybridization in cultures of alveolar<br />
macrophages. Path. Res. Pract. 187, 912–915.<br />
Wu, T.-C.; Mann, R. B.; Epstein, J. I.; MacMahon, E.;<br />
Lee, W. A.; Charache, P.; Hayward, S. D.; Kurman,<br />
R. J.; Hayward, G. S.; Ambinder, R. F. (1991)<br />
Abundant expression of EBER 1 small nuclear RNA<br />
in nasopharyngeal carcinoma. A morphologically<br />
distinctive target for detection of Epstein-Barr virus<br />
in formalin-fixed paraffin-embedded carcinoma<br />
specimens. Am. J. Pathol. 128 (6), 1461–1469.<br />
Wulf, M.; Bosse, A.; Wiethege, T.; Voss, B.; Müller,<br />
K. M. (1994) Localization of collagen types I, II and<br />
III mRNAs in human hetero<strong>to</strong>pic ossification by<br />
non-radioactive in situ hybridization. Path. Res.<br />
Pract. 190, 25–32.<br />
Xing, Y.; Johnson, C. V.; Dobner, P. R.; Lawrence,<br />
J. B. (1993) Higher level organization of individual<br />
gene transcription and RNA splicing. Science 259,<br />
1326–1330.<br />
Yamada, H.; Aida, T.; Taguchi, K.; Asona, G. (1989)<br />
Localization of type III procollagen mRNA in areas<br />
of liver fibrosis by in situ hybridization. Acta Pathol.<br />
Japonica. 39 (11), 719–724.<br />
Zhang, P.; Knowles, B. A.; Goldstein, L. S. B.;<br />
Hawley, R. S. (1990) A kinesin-like protein required<br />
for distributive chromosome segregation in<br />
Drosophila. Cell 62, 1053–1062.<br />
Zhao, T.-J.; Chiu, T. H.; Rosenberg, H. C. (1994)<br />
Reduced expression of -Aminobutyric acid type<br />
A/benzodiazepine recep<strong>to</strong>r 2 and 5 subunit<br />
mRNAs in brain regions of flurazepam-treated rats.<br />
Mol. Pharmacol. 45, 657–663.<br />
Zheng, M. H.; Fan, Y.; Wysocki, S.; Wood, D. J.;<br />
Papadimitriou, J. M. (1993) Detection of mRNA for<br />
carbonic anhydrase II in human oesteoclast-like<br />
cells by in situ hybridization. J. Bone Mineral Res. 8<br />
(1), 113–118.<br />
b. Nick translation<br />
Coates, P. J.; Mak, W. P.; Slavin, G.; d’Ardenne, A. J.<br />
(1991) Detection of single copies of Epstein-Barr<br />
virus in paraffin wax sections by non-radioactive<br />
in situ hybridization. J. Clin. Pathol. 44, 487–491.<br />
Dirks, R. W.; Van Dorp, A. G. M.; Van Minnen, J.;<br />
Fransen, J. A. M; Van Der Ploeg, M.; Raap, A. K.<br />
(1992) Electron microscopic detection of RNA<br />
sequences by non-radioactive in situ hybridization<br />
in the mollusk lymnaea stagnalis. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 40 (11), 1647–1657.<br />
Dirks, R. W.; Van de Rijke, F. M.; Fujishita, S.; Van<br />
Der Ploeg, M.; Raap, A. K. (1993) Methodologies for<br />
specific intron and exon RNA localization in cultured<br />
cells by haptenized and fluorochromized probes.<br />
J. Cell Sci. 104, 1187–1197.<br />
Flemming, K. A.; Evans, M.; Ryley, K. C.; Franklin,<br />
D.; Lovell-Badge, R. H.; Morey, A. L. (1992)<br />
Optimization of non-iso<strong>to</strong>pic in situ hybridization on<br />
formalin-fixed, paraffin-embedded material using<br />
digoxigenin-labeled probes and transgenic tissues.<br />
J. Pathol. 167, 9–17.<br />
Whawell, S. A.; Wang, Y.; Fleming, K. A.; Thompson,<br />
E. M.; Thompson, J. N. (1993) Localization of<br />
plasminogen activa<strong>to</strong>r inhibi<strong>to</strong>r-1 production in<br />
inflamed appendix by in situ mRNA hybridization.<br />
J. Pathol. 169, 67–71.<br />
c. cDNA synthesis<br />
Ultsch, A.; Schuster, C. M.; Laube, B.; Schloss, P.;<br />
Schmitt, B.; Betz, H. (1992) Glutamate recep<strong>to</strong>rs<br />
of Drosophila melanogaster: Cloning of a kainateselective<br />
subunit expressed in the central nervous<br />
system. Proc. Natl. Acad. Sci. USA 89, 10484–10488.<br />
d. PCR<br />
Barka, T.; van der Noen, H. (1993) Expression of the<br />
cysteine proteinase inhibi<strong>to</strong>r cystatin C gene in rat<br />
heart: Use of digoxigenin-labeled probes generated<br />
by polymerase chain reaction directly for in situ<br />
and northern blot hybridizations. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 41 (12) 1863–1867.<br />
Barka, T.; van der Noen, H. (1994) Expressions of<br />
the genes for cysteine proteinase inhibi<strong>to</strong>rs cystatin<br />
C and cystatin S in rat submandibular salivary<br />
gland. Archs oral Biol. 39 (4), 307–314.<br />
Barka, T.; van der Noen, H. (1994) Expression of the<br />
cysteine proteinase inhibi<strong>to</strong>r cystatin C mRNA in rat<br />
eye. Ana<strong>to</strong>m. Rec. 239, 343–348.<br />
Cripe, L.; Morris, E.; Ful<strong>to</strong>n, A. B. (1993) Vimentin<br />
mRNA location changes during muscle development.<br />
Proc. Natl. Acad. Sci. USA 90, 2724–2728.<br />
Dirks, R. W.; van de Rijke, F. M.; Fujishita, S.; van<br />
der Ploeg, M.; Raap, A. K. (1993) Methodologies for<br />
specific intron and exon RNA localization in cultured<br />
cells by haptenized and fluorochromized probes.<br />
J. Cell Sci. 104, 1187–1197.<br />
CONTENTS<br />
INDEX
Hannon, K.; Johns<strong>to</strong>ne, E.; Craft, L. S.; Little, S. P.;<br />
Smith, C. K.; Heiman, M. L.; Santerre, R. F. (1993)<br />
Synthesis of PCR-derived, single-stranded DNA<br />
probes suitable for in situ hybridization. Anal.<br />
Biochem. 212, 421–427.<br />
Iwamura, M.; Wu, G.; Abrahamsson, P.-A.; Di<br />
Sant’Agnese, P. A.; Cockett, A. T. K.; Def<strong>to</strong>s, L. J.<br />
(1994) Parathyroid hormone-related protein is<br />
expressed by prostatic neuroendocrine cells.<br />
Urology 43 (5), 667–674.<br />
Räsänen, L. A.; Karvonen, U.; Pösö, A. R. (1993)<br />
Localization of xanthine dehydrogenase mRNA in<br />
horse skeletal muscle by in situ hybridization with<br />
digoxigenin-labeled probe. Biochem. J. 292,<br />
639–641.<br />
Sommer, R. J.; Tautz, D. (1993) <strong>In</strong>volvement of an<br />
orthologue of the Drosophila pair-rule gene hairy in<br />
segment formation of the short germ-band embryo<br />
of Tribolium (Coleoptera). Nature 361, 448–450.<br />
Yang, X.; Stedra, J.; Cerny, J. (1994) Reper<strong>to</strong>ire<br />
diversity of antibody response <strong>to</strong> bacterial antigens<br />
in aged mice. IV. Study of VH and VL gene utilization<br />
in splenic antibody foci by in situ hybridization.<br />
J. Immunol. 152, 2214–2220.<br />
B. RNA probes<br />
Adham, I. M.; Burkhardt, E.; Benahmed, M.; Engel,<br />
W. (1993) Cloning of a cDNA for a novel insulin-like<br />
peptide of the testicular leydig cells. J. Biol. Chem.<br />
268 (35), 26668–26672.<br />
Ahn, K. Y.; Madsen, K. M.; Tisher, C. C.; Kone, B. C.<br />
(1993) Differential expression and cellular<br />
distribution of mRNAs encoding - and -isoforms<br />
of Na + -K + -ATPase in rat kidney. Am. J. Physiol. 265,<br />
792–801.<br />
Bachmann, S.; Le Hir, M.; Eckardt, K.-U. (1993)<br />
Co-localization of erythropoietin mRNA and ec<strong>to</strong>-5’nucleotidase<br />
immunoreactivity in peritubular cells<br />
of rat renal cortex indicates that fibroblasts produce<br />
erythropoietin. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 41,<br />
335–341.<br />
Baldino, F.; Robbins, E.; Grega D.; Meyers, S. L.;<br />
Springer, J. E.; Lewis, M. E. (1989) Non-radioactive<br />
detection of NGF-recep<strong>to</strong>r messenger RNA with<br />
digoxigenin-UTP labeled RNA probes. 19th Annual<br />
Meeting Soc. Neuroscience, Phoenix, Arizona, USA,<br />
Oct. 29–Nov. 3, 1989. Soc. Neurosci. Abst.<br />
15 (1), 864.<br />
Barthel, L. K.; Raymond, P. A. (1993) Subcellular<br />
localization of -tubulin and opsin mRNA in the<br />
goldfish retina using digoxigenin-labeled cRNA<br />
probes detected by alkaline phosphatase and HRP<br />
his<strong>to</strong>chemistry. J. Neurosci. Meth. 50, 145–152.<br />
Biffo, S.; Verdun di Can<strong>to</strong>gno, L.; Fasolo, A. (1992)<br />
Double labeling with non-iso<strong>to</strong>pic in situ hybridization<br />
and BrdU immunohis<strong>to</strong>chemistry:<br />
Calmodulin (CaM) mRNA expression in post-mi<strong>to</strong>tic<br />
neurons of the olfac<strong>to</strong>ry system. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 40 (4), 535–540.<br />
CONTENTS<br />
INDEX<br />
References<br />
Birk, P. E.; Grimm, P. C. (1994) Rapid nonradioactive<br />
in situ hybridization for interleukin-2 mRNA with<br />
riboprobes generated using the polymerase chain<br />
reaction. J. Immunol. Meth. 167, 83–89.<br />
Bochenek, B.; Hirsch, A. (1990) <strong>In</strong> situ hybridization<br />
of nodulin mRNAs in root nudules using nonradioactive<br />
probes. Plant Mol. Biol. Reporter 8 (4),<br />
237–248.<br />
Brewer, L. M.; Sheardown, S. A.; Brown, N. A.<br />
(1993) HMG-CoA reductase mRNA in the postimplantation<br />
rat embryo studied by in situ<br />
hybridization. Tetra<strong>to</strong>l. 47, 137–146.<br />
Broide, D. H.; Paine, M. M.; Firestein, G. S. (1992)<br />
Eosinophils express interleukin 5 and granulocyte<br />
macrophage-colony-stimulating fac<strong>to</strong>r mRNA at<br />
sites of allergic inflammation in asthmatics.<br />
J. Clin. <strong>In</strong>vest. 90, 1414–1424.<br />
Bromley, L.; McCarthy, S. P.; Stickland, J. E.;<br />
Lewis, C. E.; McGee, J. (1994) Non-iso<strong>to</strong>pic in situ<br />
detection of mRNA for interleukin-4 in archival<br />
human tissue. J. Immunol. Meth. 167, 47–54.<br />
Brown, P. A. J.; Wilson, H. M.; Reid, F. J.; Booth, N.<br />
A.; Simpson, J. G.; Morrison, L.; Power, D. A.;<br />
Haites, N. E. (1994) Urokinase-plasminogen<br />
activa<strong>to</strong>r is synthesized in vitro by human<br />
glomerular epithelial cells but not by mesangial<br />
cells. Kidney <strong>In</strong>t. 45, 43–47.<br />
Bu, G.; Maksymovitch, E. A.; Nerbonne, J. M.;<br />
Schwartz, A. L. (1994) Expression and function of<br />
the low density lipoprotein recep<strong>to</strong>r-related protein<br />
(LRP) in mammalian central neurons. J. Biol. Chem.<br />
269 (28), 18521–18528.<br />
Butcher, L. L.; Oh, J. D.; Woole, N. J.; Edwards,<br />
R. H.; Roghani, A. (1992) Organization of central<br />
cholinergic neurons revealed by combined in situ<br />
hybridization his<strong>to</strong>chemistry and choline-Oacetyltransferase<br />
immunocy<strong>to</strong>chemistry.<br />
Neurochem. <strong>In</strong>t. 21 (3), 429–445.<br />
Cai, W. Q.; Terenghi, G.; Bodin, P.; Burns<strong>to</strong>ck, G.;<br />
Polak, J. M. (1993) <strong>In</strong> situ hybridization of atrial<br />
natriuretic peptide mRNA in the endothelial cells<br />
of human umbilical vessels. His<strong>to</strong>chem. 100,<br />
277–283.<br />
Campbell, A. M.; Wuytack, F.; Fambrough, D. M.<br />
(1993) Differential distribution of the alternative<br />
forms of the sarcoplasmic/endoplasmic reticulum<br />
Ca2+ -ATPase, SERCA2b and SERCA2a, in the avian<br />
brain. Brain Res. 605, 67–76.<br />
Canas, L. A.; Busscher, M.; Angenent, G. C.;<br />
Beltran, J.-P.; van Tunen, A. J. (1994) Nuclear<br />
localization of the petunia MADS box protein FBP1.<br />
Plant J. 6 (4), 597–604.<br />
Caroni, P.; Schneider, C. (1994) Signaling by insulinlike<br />
growth fac<strong>to</strong>rs in paralyzed skeletal muscle:<br />
rapid induction of IGF-1 expression in muscle fibers<br />
and prevention of interstitial cell proliferation by<br />
IGF-BP5 and IGF-BP4. J. Neurosci. 14 (5),<br />
3378–3388.<br />
177<br />
6
6<br />
178<br />
References<br />
Coutinho, L. L.; Morris, J.; Ivarie, R. (1992)<br />
Whole mount in situ detection of low abundance<br />
transcripts of the myogenic fac<strong>to</strong>r qmf1 and myosin<br />
heavy chain protein in quail embryos. BioTechn. 13<br />
(5), 722–724.<br />
De, S. K.; Chen, H.-L., Pace, J. L.; Hunt, J. S.;<br />
Terranova, P. F.; Enders, G. C. (1993) Expression<br />
of tumor necrosis fac<strong>to</strong>r- in mouse sperma<strong>to</strong>genic<br />
cells. Endocrinol. 133 (1), 389–396.<br />
De Block, M.; Debrouwer, D. (1993) RNA-RNA in situ<br />
hybridization using digoxigenin-labeled probes:<br />
The use of high-molecular-weight polyvinyl alcohol<br />
in the alkaline phosphatase indoxyl-nitroblue<br />
tetrazolium reaction. Anal. Biochem. 215, 86–89.<br />
Dekker, E.-J.; Pannese, M.; Houtzager, E.;<br />
Timmermans, A.; Boncinelli, E.; Durs<strong>to</strong>n, A. (1992)<br />
Xenopus Hox-2 genes are expressed sequentially<br />
after the onset of gastrulation and are differentially<br />
inducible by retionic acid. Development, 195–202.<br />
Dekker, E.-J.; Vaessen, M.-J.; van den Berg, C.;<br />
Timmermans, A.; Godsave, S.; Holling, T.;<br />
Nieuwkoop, P.; Geurts van Kessel, A.; Durs<strong>to</strong>n, A.<br />
(1993) Overexpression of a novel gastrula specific<br />
cellular retinoic acid binding protein (xCRABP)<br />
causes anteroposterior defects in developing<br />
Xenopus embryos. Submitted.<br />
Dirks, R. W.; van de Rijke, F. M.; Fujishita, S.; van<br />
der Ploeg, M.; Raap, A. K. (1993) Methodologies for<br />
specific intron and exon RNA localization in cultured<br />
cells by haptenized and fluorochromized probes.<br />
J. Cell Sci. 104, 1187–1197.<br />
Dörries, U.; Bartsch, U.; Nolte, Ch.; Roth, J.;<br />
Schachner, M. (1993) Adaptation of a non-radioactive<br />
in situ hybridization method <strong>to</strong> electron<br />
microscopy: detection of tenascin mRNAs in mouse<br />
cerebellum with digoxigenin-labeled probes and<br />
gold-labeled antibodies. His<strong>to</strong>chem. 99, 251–262.<br />
Egger, D.; Troxler, M.; Bienz, K. (1994) Light and<br />
electron microscopic in situ hybridization: nonradioactive<br />
labeling and detection, double<br />
hybridization, and combined hybridization-immunocy<strong>to</strong>chemistry.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 42 (6),<br />
815–822.<br />
Eilers, F.; Bartles, H.; Jungermann, K. (1993) Zonal<br />
expression of the glucokinase gene in rat liver.<br />
Dynamics during the daily feeding rhythm and<br />
starvation-refeeding cycle demonstrated by in situ<br />
hybridization. His<strong>to</strong>chem. 99, 133–140.<br />
Ephrussi, A.; Lehman, R. (1992) <strong>In</strong>duction of germ<br />
cell formation by oskar. Nature 358, 387–392.<br />
Esclapez, M.; Tillakaratne, N. J. K.; Kaufman, D. L.;<br />
Tobin, A. J.; Houser, C. R. (1994) Comparative localization<br />
of two forms of glutamic acid decarboxylase<br />
and their mRNAs in rat brain supports the concept<br />
of functional differences between the forms.<br />
J. Neurosci. 14 (3), 1834–1855.<br />
Fisher, C.; Angus, B.; Rees, J. (1991) in situ<br />
hybridization using digoxigenin-labeled probes in<br />
human skin. Brit. J. Derma<strong>to</strong>l. 125, 516–520.<br />
Foss, H.-D.; Herbst, H.; Hummel, M.; Araujo, I.;<br />
Latza, U.; Rancso, C.; Dallenbach, F.; Stein, H.<br />
(1994) Patterns of cy<strong>to</strong>kine gene expression in<br />
infectious mononucleosis. Blood 83 (3), 707–712.<br />
Furuta, H.; Mori, N.; Sa<strong>to</strong>, C.; Hoshikawa, H.; Sakai,<br />
S.-I.; Iwkura, S.; Doi, K. (1994) Mineralocorticoid<br />
type I recep<strong>to</strong>r in the rat cochlea: mRNA identification<br />
by polymerase chain reaction (PCR) and in situ<br />
hybridization. Hearing Res. 78, 175–180.<br />
Grefte, A.; Harmsen, M. C.; van der Giessen, M.;<br />
Knollema, S.; van Son, W. J.; The, T. H. (1994)<br />
Presence of human cy<strong>to</strong>megalovirus (HCMV)<br />
immediate early mRNA but not ppUL83 (lower<br />
matrix protein pp65) mRNA in polymorphonuclear<br />
and mononuclear leukocytes during active HCMV<br />
infection. J. Gen. Virol. 75, 1989–1998.<br />
Grossman, A. B.; Rossmanith, W. G.; Kabigting,<br />
E. B.; Cadd, G.; Clif<strong>to</strong>n, D.; Steiner, R. A. (1994) The<br />
distribution of hypothalamic nitric oxide synthase<br />
mRNA in relation <strong>to</strong> gonadotrophin-releasing<br />
hormone neurons. J. Endocrinol. 140, R5–R8.<br />
Hanh, D.; Amann, R. I.; Zeyer, J. (1993) Detection of<br />
mRNA in Strep<strong>to</strong>myces by whole-cell hybridization<br />
with digoxigenin-labeled probes. Appl. Environm.<br />
Microbiol. 59 (8), 2753–2757.<br />
Hamil<strong>to</strong>n-Du<strong>to</strong>it, S. J.; Raphael, M.; Audouin, J.;<br />
Diebold, J.; Lisse, I.; Pedersen, C.; Oksenhendler, E.;<br />
Marelle, L.; Pallesen, G. (1993) <strong>In</strong> situ demonstration<br />
of Epstein-Barr virus small RNAs (EBER 1) in<br />
acquired immunodeficiency syndrome-related<br />
lymphomas: correlation with tumor morphology<br />
and primary site. Blood 82 (2), 619–624.<br />
Hasegawa, K.; Fujiwara, H.; Doyama, K.; <strong>In</strong>ada, T.;<br />
Ohtani, S.; Fujiwaara, T.; Hosoda, K.; Nakao, K.;<br />
Sasayama, S. (1994) Endothelin-1-selective<br />
recep<strong>to</strong>r in the arterial intima of patients with<br />
hypertension. Hypertension 23, 288–293.<br />
Hauptmann, G.; Gerster, T. (1994) Two-color<br />
whole-mount in situ hybridization <strong>to</strong> vertebrate and<br />
Drosophila embryos. TIG 10 (8), 266.<br />
Hemmati-Brivanlou, A.; Frank, D.; Bolce, M. E.;<br />
Brown, B. D.; Sive, H. L.; Harland, R. M. (1990)<br />
Localization of specific mRNAs in xenopus embryos<br />
by whole-mount in situ hybridization. Development<br />
110, 325–330.<br />
Hemmati-Brivanlou, A.; Mel<strong>to</strong>n, D. A. (1992)<br />
A truncated activin recep<strong>to</strong>r inhibits mesoderm<br />
induction and formation of axial structures in<br />
Xenopus embryos. Nature 359, 609–614.<br />
Hendrickson, A. E.; Tillakaratne, N. J. K.; Mehra,<br />
R. D.; Esclapez, M.; Erickson, A.; Vician, L.; Tobin,<br />
A. J. (1994) Differential localization of two glutamic<br />
acid decarboxylases (GAD65 and GAD67) in adult<br />
monkey visual cortex. J. Comparative Neurol. 343,<br />
566–581.<br />
Hill, W. D.; Arai, M.; Cohen, J. A.; Trojanowoski,<br />
J. Q. (1993) Neurofilament mRNA is reduced in<br />
Parkinson’s disease substantia nigra pars compacta<br />
neurons. J. Comparative Neurol. 329, 328–336.<br />
CONTENTS<br />
INDEX
Hillan, K. J.; Farquharson, M.; Harvie, R.; McKee,<br />
T. A.; MacSween, R. N. M.; McNicol, A. M. (1990)<br />
Detection of messenger RNA in formalin fixed rat<br />
tissues using RNA probes labeled with a new<br />
nucleotide analogue digoxigenin-11-UTP. 160th<br />
Meeting Pathol. Soc. GB and Ireland, London,<br />
England, UK, Jan. 3–5, 1990. J. Pathol. 160 (2)<br />
164A.<br />
Hirota, S.; I<strong>to</strong>, A.; Morii, E.; Wanaka, A.; Tohyama,<br />
M.; Kitamura, Y.; Nomura, S. (1992) Localization of<br />
mRNA for c-kit recep<strong>to</strong>r and its ligand in the brain<br />
of adult rats: an analysis using in situ hybridization<br />
his<strong>to</strong>chemistry. Mol. Brain Res. (in press)<br />
Houtani, T.; Ueyama, T.; Takeshima, H.; Ka<strong>to</strong>, S.;<br />
Fukuda, K.; Mori, K.; Sugimo<strong>to</strong>, T. (1994) µ Opioid<br />
recep<strong>to</strong>r: expression and vago<strong>to</strong>my-induced<br />
depletion of the mRNA in medullary preganglionic<br />
neurons. Mol. Brain Res. 24, 347–352.<br />
Hukkanen, V.; Heino, P.; Sears, A. E.; Roizman, B.<br />
(1990) Detection of Herpes Simplex Virus latencyassociated<br />
RNA in mouse trigeminal ganglia by in<br />
situ hybridization using nonradioactive digoxigeninlabeled<br />
DNA and RNA probes. Methods Mol. Cell.<br />
Biol. 2, 70–81.<br />
Hummel, M. (1992) The Polymerase Chain Reaction<br />
in modern diagnosis – Possibilities and Limitations<br />
– BIOforum 11, 395–400.<br />
Humpel, C.; Chadi, G.; Lippoldt, A.; Ganten, D.;<br />
Fuxe, K.; Olson, L. (1994) <strong>In</strong>crease of basic fibroblast<br />
growth fac<strong>to</strong>r (bFGF, FGF-2) messenger RNA<br />
and protein following implantation of a<br />
microdialysis probe in<strong>to</strong> rat hippocampus. Exp.<br />
Brain Res. 98, 229–237.<br />
Humpel, C.; Lippoldt, A.; Strömberg, I.; Bygdeman,<br />
M.; Wagner, J.; Hilgenfeldt, U.; Ganten, D.; Fuxe, K.;<br />
Olson, L. (1994) Human angiotensinogen is highly<br />
expressed in astrocytes in human cortical grafts.<br />
GLIA 10, 186–192.<br />
Humpel, C.; Lippoldt, A.; Chadi, G.; Ganten, D.;<br />
Olson, L.; Fuxe, K. (1993) Fast and widespread<br />
increase of basic fibroblast growth fac<strong>to</strong>rs messenger<br />
RNA and protein in the forebrain after<br />
kainate-induced seizures. Neurosci. 57 (4),<br />
913–922.<br />
Ikeshima, H.; Yuasa, S.; Matsuo, K.; Kawamura, K.;<br />
Hata, J.; Takano, T. (1993) Expression of three<br />
nonallelic genes coding calmodulin exhibits similar<br />
localization on the central nervous system of adult<br />
rats. J. Neurosci. Res. 36, 111–119.<br />
<strong>In</strong>gham, P. W.; Taylor, A. M.; Nakano, Y. (1991)<br />
Role of the Drosophila patched gene in positional<br />
signaling. Nature 353, 184–186.<br />
<strong>In</strong>oue, S.; Orimo, A.; Hosoi, T.; Ikegami, A.; Kozaki,<br />
K.; Ouchi, Y.; Nomura, S.; Muramatsu, M.; Orimo, H.<br />
(1994) Demonstration of activin-a in arteriosclerotic<br />
lesions. Biochem. Biophys. Res. Com. 205 (1),<br />
441–448.<br />
Ishida, N.; Matsui, M.; Mitsui, Y.; Mishina, M. (1994)<br />
Circadian expression of NMDA recep<strong>to</strong>r mRNAs,<br />
3 and 1, in the suprachiasmatic nucleus of rat<br />
brain. Neurosci. Letters 166, 211–215.<br />
CONTENTS<br />
INDEX<br />
References<br />
Jackson, A. C.(1992) Detection of rabies virus<br />
mRNA in mouse brain by using in situ hybridization<br />
with digoxigenin-labeled RNA probes. Mol. Cell.<br />
Probes 6, 131–136.<br />
Jacque, C.; Tchélingérian, J.-L. (1993) Synthèse<br />
de cy<strong>to</strong>kines: une nouvelle forme de réponse des<br />
neurones centraux. C. R. Soc. Biol. 188, 47–57.<br />
Jennische, E.; Andersson, G. L. (1991) Expression of<br />
GH recep<strong>to</strong>r mRNA in regenerating skeletal muscle<br />
of normal and hypophysec<strong>to</strong>mized rats. An in situ<br />
hybridization study. Acta Endocrinol. 125, 595–602.<br />
Jowett, T.; Lettice, L. (1994) Whole-mount in situ<br />
hybridizations on zebrafisch embryos using a<br />
mixture of digoxigenin- and fluorescein-labeled<br />
probes. TIG 10 (3), 73–74.<br />
Karr, L. J.; Panoskaltsis-Mortari, A.; Li, J.; Devore-<br />
Carter, D.; Weaver, C. T.; Bucy, R. P. (1995) <strong>In</strong> situ<br />
hybridization for cy<strong>to</strong>kine mRNA with digoxigeninlabeled<br />
riboprobes. Sensitivity of detection and<br />
double label applications. J. Immunol. Meth. 182,<br />
93–106.<br />
Kaneko, Y.; Takano, S.; Okumura, K.; Takenawa, J.;<br />
Higashituji, H.; Fukumo<strong>to</strong>, M.; Nakayama, H.;<br />
Fujita, J. (1993) Identification of protein tyrosine<br />
phosphatase expressed in murine male germ cells.<br />
Biochem. Biophys. Res. Commun. 197 (2),<br />
625–631.<br />
Kieft, H.; Brady, J.; Brady, T. E.; de Ruijter, N. C. A.;<br />
Schel, J. H. N. Detection of phaseolin m-RNA using<br />
silver enhanced anti-digoxigenin/ultra small gold<br />
probes.<br />
Kishimo<strong>to</strong>, J.; Cox, H.; Keverne, E. B.; Emson, P. C.<br />
(1994) Cellular localization of putative odorant<br />
recep<strong>to</strong>r mRNAs in olfac<strong>to</strong>ry and chemosensory<br />
neurons: a non radioactive in situ hybridization<br />
study. Mol. Brain Res. 23, 33–39.<br />
Komminoth, P. (1992) Digoxigenin as an alternative<br />
probe labeling for in situ hybridization. Diagn. Mol.<br />
Pathol. 1 (2), 142–150.<br />
Komminoth, P.; Merk, F. B.; Leav, I.; Wolfe, H. J.;<br />
Roth, J. (1992) Comparison of 35S- and digoxigeninlabeled<br />
RNA and oligonucleotide probes for in situ<br />
hybridization. His<strong>to</strong>chem. 98, 217–228.<br />
Kon, Y.; Endoh, D.; Fukamizu, A.; Murakami, K.;<br />
Hashimo<strong>to</strong>, Y.; Sugimura, M. (1993) A simple<br />
method of hybridohis<strong>to</strong>chemistry for detection of<br />
renin mRNA in the mouse kidney. J. Vet. Med. Sci.<br />
55 (3), 461–463.<br />
Kriegsmann, J.; Keyszer, G.; Geiler, T.; Gay, R. E.;<br />
Gay, S. (1994) A new double labeling technique for<br />
combined in situ hybridization and<br />
immunohis<strong>to</strong>chemical analysis. Lab. <strong>In</strong>vest. 71 (6),<br />
911–917.<br />
Kronenberger, J.; Desprez, T.; Höfte, H.; Caboche,<br />
M.; Traas, J. (1993) A methacrylate embedding<br />
procedure developed for immunolocalization on<br />
plant tissues is also compatible with in situ<br />
hybridization. Cell Biol. <strong>In</strong>t. 17 (11), 1013–1021.<br />
179<br />
6
6<br />
180<br />
References<br />
Labrecque, L. G.; Lampert, I.; Kazembe, P.; Philips,<br />
J.; Griffin, B. E. (1994) Correlation between cy<strong>to</strong>pathological<br />
results and in situ hybridization on needle<br />
aspiration biopsies of suspected african burkitt’s<br />
lymphomas. <strong>In</strong>t. J. Canc. 59, 591–596.<br />
Lauterborn, J. C.; Tran, T. M. D.; Isackson, P. J.; Gall,<br />
C. M. (1993) Nerve growth fac<strong>to</strong>r mRNA is expressed<br />
by GABAergic neurons in rat hippocampus.<br />
NeuroReport 5, 273–276.<br />
Lepage, T.; Ghiglione, C.; Gache, C. (1992) Spatial<br />
and temporal expression pattern during sea urchin<br />
embryogenesis of a gene coding for a protease<br />
homologous <strong>to</strong> the human protein BMP-1 and <strong>to</strong> the<br />
product of the Drosophila dorsal-ventral patterning<br />
gene <strong>to</strong>lloid. Development 114.<br />
Lepage, T.; Sardet, C.; Gache, C. (1992) Spatial<br />
expression of the hatching enzyme gene in the sea<br />
urchin embryo. Development Biol. 150.<br />
Lin, N.-S.; Chen, C.-C.; Hsu, Y.-H. (1993) Postembedding<br />
in situ hybridization for localization<br />
of viral nucleic acid in ultra-thin sections.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 41 (10), 1513–1519.<br />
Linares-Cruz, G.; Rigaut, J. P.; Vassy, J.; De Oliveira,<br />
T. C.; De Cremoux, P.; Olofsson, B.; Calvo, F. (1994)<br />
Reflectance in situ hybridization (RISH): detection,<br />
by confocal reflectance laser microscopy, of goldlabeled<br />
riboprobes in breast cancer cell lines and<br />
his<strong>to</strong>logical specimens. J. Microsc. 173 (1), 27–38.<br />
Maguire, S. M.; Millar, M. R.; Sharpe, R. M.;<br />
Saunders, P. T. K. (1993) Stage-dependent<br />
expression of mRNA for cyclic protein 2 during<br />
sperma<strong>to</strong>genesis is modulated by elongate<br />
spermatids. Mol. Cel. Endocrinol. 94, 79–88.<br />
Manoukian, A. S.; Krause, H. M. (1992)<br />
Concentration-dependent activities of the evenskipped<br />
protein in drosophila embryos. Genes &<br />
Development 6, 1740–1751.<br />
Marks, D. L.; Smith, M. S.; Clif<strong>to</strong>n, D. K.; Steiner, R.<br />
A. (1993) Regulation of gonadotropin-releasing<br />
hormone (GnRH) and galanin gene expression in<br />
GnRH neurons during lactation in the rat.<br />
Endocrinol. 133 (3), 1450–1458.<br />
Marks, D. L.; Smith, M. S.; Vrontakis, M.; Clif<strong>to</strong>n,<br />
D. K.; Steiner, R. A. (1993) Regulation of galanin<br />
gene expression in gonadotropin-releasing hormone<br />
neurons during the estrous cycle of the rat.<br />
Endocrinol. 132 (4), 1836–1844.<br />
Martinez-Montero, J. C.; Herring<strong>to</strong>n, C. S.;<br />
Stickland, J.; Sawyer, H.; Evans, M.; Flannery, D. M.<br />
J.; McGee, J. O’D. (1991) Model system for<br />
optimising mRNA non-iso<strong>to</strong>pic in situ hybridization:<br />
Riboprobe detection of lysozyme mRNA in archival<br />
gut biopsy specimens. J. Clin. Pathol. 44, 835–839.<br />
Matejka, G. L.; Eriksson, P. S.; Carlsson, B.;<br />
Jennische, E. (1992) Distribution of IGF-I mRNA and<br />
IGF-I binding sites in the rat kidney. His<strong>to</strong>chem. 97<br />
(2), 173–180.<br />
Matsui, M.; Mitsui, Y.; Ishida, N. (1993) Circadian<br />
regulation of per repeat mRNA in the suprachiasmatic<br />
nucleus of rat brain. Neurosci. Letters 163,<br />
189–192.<br />
McFadden, G.; Bönig, I.; Clarke, A. Double label<br />
in situ hybridization for electron microscopy.<br />
Merchant, K. M.; Miller, M. A. (1994) Coexpression<br />
of neurotensin and c-fos mRNAs in rat neostriatal<br />
neurons following acute haloperidol. Mol. Brain<br />
Res. 23, 271–277.<br />
Millar, M. R.; Sharpe, R. M.; Maguire, S. M.;<br />
Saunders, P. T. K. (1993) Cellular localisation of<br />
messenger RNAs in rat testis: application of<br />
digoxigenin-labeled ribonucleotide probes <strong>to</strong><br />
embedded tissue. Cell Tissue Res. 273, 269–277.<br />
Millar, M. R.; Sharpe, R. M.; Maguire, S. M.;<br />
Gaughan, J.; West, A. P.; Saunders, P. T. K. (1994)<br />
Localization of mRNAs by in situ hybridization <strong>to</strong> the<br />
residual body at stages IX-X of the cycle of the rat<br />
seminiferous epithelium: fact or artefact?<br />
<strong>In</strong>t. J. Androl. 17, 149–160.<br />
Miller, M. A.; Kolb, P. E.; Raskind, M. A. (1993)<br />
Extra-hypothalamic vasopressin neurons coexpress<br />
galanin messenger RNA as shwon by double in situ<br />
hybridization his<strong>to</strong>chemistry. J. Comparative<br />
Neurol. 329, 378–384.<br />
Miller, M. A.; Kolb, P. E.; Raskind, M. A. (1993)<br />
A method for simultaneous detection of multiple<br />
mRNAs using digoxigenin and radioiso<strong>to</strong>pic cRNA<br />
probes. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 41 (12),<br />
1741–1750.<br />
Mitani, K.; Fujita, H.; Hayashi, N.; Yamamo<strong>to</strong>, M.;<br />
Sassa, S. (1992) Differential induction responses<br />
of -aminolevulinate synthase mRNAs during<br />
erythroid differentiation: Use of nonradioactive<br />
in situ hybridization. Am. J. Hema<strong>to</strong>l. 39, 63–64.<br />
Mizuno, K.; Hasegawa, K.; Ogimo<strong>to</strong>, M.; Katagiri, T.;<br />
Yakura, H. (1994) Developmental regulation of gene<br />
expression for the MPTP isoforms in the central<br />
nervous system and the immune system. FEBS<br />
Letters 355, 223–228.<br />
Morvan, P.-Y.; Picot, C.; Dejour, R.; Gillot, E.;<br />
Genetet, B.; Genetet, N. (1994) <strong>In</strong> situ hybridization<br />
and cy<strong>to</strong>fluorometric analysis of cy<strong>to</strong>kine mRNA<br />
during in vitro activation of human T cells. Eur.<br />
Cy<strong>to</strong>kine Netw. 5 (5), 469–480.<br />
Nagamatsu, S.; Sawa, H.; Kamada, K.; Nakamichi, Y.;<br />
Yoshimo<strong>to</strong>, K.; Hoshino, T. (1993) Neuron-specific<br />
glucose transporter (NSGT): CNS distribution of<br />
GLUT3 rat glucose transporter (RGT3) in rat central<br />
neurons. FEBS 334 (3), 289–295.<br />
Nakase, T.; Nomura, S.; Yoshikawa, H.; Hashimo<strong>to</strong>,<br />
J.; Hirota, S.; Kitamura, Y.; Oikawa, S.; Ono, K.;<br />
Takaoka, K. (1994) Transient and localized expression<br />
of bone morphogenetic protein 4 messenger<br />
RNA during fracture healing. J. Bone Mineral Res.<br />
9 (5), 651–659.<br />
Nojima, T.; Abe, S.; Furuta, Y.; Nagashima, K.;<br />
Alam, S.; Takada, N.; Sasaki, F.; Hata, Y. (1991)<br />
Morphological and cy<strong>to</strong>genetic characterization and<br />
N-myc oncogene analysis of a newly established<br />
neuroblas<strong>to</strong>ma cell line. Acta Pathol. Japonica. 41,<br />
507–515.<br />
CONTENTS<br />
INDEX
Nonomura, K.; Yamanishi, K.; Hosokawa, Y.; Doi,<br />
H.; Hirano, J.; Fukushima, S.; Yasuno, H. (1993)<br />
Localization of transglutaminase 1 mRNA in normal<br />
and psoriatic epidermis by non-radioactive in situ<br />
hybridization. Brit. J. Dema<strong>to</strong>l. 128, 23–28.<br />
Obenaus, A.; Esclapez, M.; Houser, C.R. (1993) Loss<br />
of glutamate decarboxylase mRNA-containing<br />
neurons in the rat dentate gyrus following<br />
pilocarpine-induced seizures. J. Neurosci. 13 (10),<br />
4470–4485.<br />
Oh, J. D.; Woolf, N. J.; Roghani, A.; Edwards, R. H.;<br />
Butcher. L. L. (1992) Cholinergic neurons in the rat<br />
central nervous system demonstrated by in situ<br />
hybridization of choline acetyltransferase mRNA.<br />
Neurosci. 47 (4), 807–822.<br />
Ohtani, H.; Kuroiwa, A.; Obinata, M.; Ooshima, A.;<br />
Nagura, H. (1992) Identification of type I collagenproducing<br />
cells in human gastrointestinal<br />
carcinomas by non-radioactive in situ hybridization<br />
and immunoelectron microscopy. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 40 (8), 1139–1146.<br />
Okada, K.; Matsuda, S.; Li, Y.; Okumura, N.; Uryu,<br />
K.; Fujita, H.; Sakanaka, M. (1993) Basic fibroblast<br />
growth fac<strong>to</strong>r-like immunoreactivity in the rat<br />
trigeminal sensory system and peri-oral skin with<br />
vibrissae. Cell Tissue Res. 272, 417– 427.<br />
Okamura, T.; Shimokawa, H.; Takagi, Y.; Ono, H.;<br />
Sasaki, S. (1993) Detection of collagenase mRNA in<br />
odon<strong>to</strong>clasts of bovine root-resorbing tissue by<br />
in situ hybridization. Calcif Tissue <strong>In</strong>t. 52, 325–330.<br />
O’Neill, J. W.; Bier, E. (1994) Double-label in situ<br />
hybridization using biotin and digoxigenin-tagged<br />
RNA probes. BioTechn. 17 (5), 870–875.<br />
Oschwald, R.; Richter, K.; Grunz, H. (1991)<br />
Localization of a nervous system-specific class II<br />
-tubulin gene in Xenopus laevis embryos by<br />
whole-mount in situ hybridization. <strong>In</strong>t. J. Dev. Biol.<br />
35, 399–405.<br />
Pan, L.; Happerfield, L. C.; Bobrow, L. G.; Isaacson,<br />
P. G. (1993) <strong>In</strong> situ detection of human Ig ligh-chain<br />
mRNA on formalin-fixed and paraffin-embedded<br />
tissue sections using digoxigenin-labeled RNA<br />
probes. His<strong>to</strong>chem. J. 25, 57–63.<br />
Pang, M.; Baum, L. G. (1993) Application of<br />
noniso<strong>to</strong>pic RNA in situ hybridization <strong>to</strong> detect<br />
endogenous gene expression in pathologic<br />
specimens. Diagn. Mol. Pathol. 2 (4), 277–282.<br />
Panoskaltsis-Mortari, A.; Bucy, R. P. (1995) <strong>In</strong> situ<br />
hybridization with digoxigenin-labeled RNA probes:<br />
facts and artifacts. BioTechn. 18 (2), 300–307.<br />
Peng, C.; Gallin, W.; Peter, R. E.; Blomqvist, A. G.;<br />
Larhammar, D. (1994) Neuropeptide-Y gene<br />
expression in the goldfish brain: Distribution and<br />
regulation by ovarian steroids. Endocrinol. 134 (3),<br />
1095–1103.<br />
Qian, Z.; Gilbert, M. E.; Colicos, M. A.; Kandel, E. R.;<br />
Kuhl, D. (1993) Tissue-plasminogen activa<strong>to</strong>r is<br />
induced as an immediate-early gene during seizure,<br />
kindling and long-term potentiation. Nature 361,<br />
453–457.<br />
CONTENTS<br />
INDEX<br />
References<br />
Redies, C.; Takeichi, M. (1993) Expression of<br />
N-Cadherin mRNA during development of the<br />
mouse brain. Developm. Dynam. 197, 26–39.<br />
Rees, J. L.; Fisher, C. (1992) Nonradioactive in situ<br />
hybridization with digoxigenin. Trends Genet. 8 (1), 8.<br />
Robbins, E.; Baldino, F.; Roberts-Lewis, J. M.;<br />
Meyer, S. L.; Grega, D.; Lewis, M. E. (1991)<br />
Quantitative non-radioactive in situ hybridization of<br />
preproenkephalin mRNA with digoxigenin-labeled<br />
cRNA probes. Ana<strong>to</strong>m. Rec. 231, 559–562.<br />
Rosen, B.; Bedding<strong>to</strong>n, R. S. P. (1993) Whole-mount<br />
in situ hybridization in the mouse embryo: gene<br />
expression in three dimensions. TIG 9 (5), 162–167.<br />
Rosinski-Chupin, I.; Rougeot, C.; Courty, Y.;<br />
Rougeon, F. (1993) Localization of mRNAs of two<br />
androgen-dependent proteins, SMR1 and SMR2, by<br />
in situ hybridization reveals sexual differences in<br />
acinar cells of rat submandibular gland. J.<br />
His<strong>to</strong>chem. Cy<strong>to</strong>chem. 41 (11), 1645–1649.<br />
Sakamo<strong>to</strong>, K.; Ezashi, T.; Miwa, K.; Okuda-Ashitaka,<br />
E.; Houtani, T.; Sugimo<strong>to</strong>, T.; I<strong>to</strong>, S.; Hayaishi, O.<br />
(1994) Molecular cloning and expression of a cDNA<br />
of the bovine prostaglandin F2 Recep<strong>to</strong>r. J. Biolog.<br />
Chem. 269 (5), 3881–3886.<br />
Sasaki, J.; Nomura, T.; Watanabe, S.; Kanda, S.;<br />
Kouno, T.; Okada, T.; Noji, S.; Watanabe, H. (1991)<br />
The localization of actin mRNA in megakaryocytes<br />
demonstrated by in situ hybridization using<br />
digoxigenin-labeled riboprobes. Acta His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 24 (3), 335–339.<br />
Saunders, P. T. K.; Millar, M. R.; Maguire, S. M.;<br />
Sharpe, R. M. (1992) Stage-specific expression<br />
of rat transition protein 2 mRNA and possible localization<br />
<strong>to</strong> the chroma<strong>to</strong>id body of step 7 spermatids<br />
by in situ hybridization using a nonradiaoctive<br />
riboprobe. Mol. Reprod. Develop. 33, 385–391.<br />
Saunders, P. T. K.; Millar, M. R.; West, A. P.; Sharpe,<br />
R. M. (1993) Mi<strong>to</strong>chondrial cy<strong>to</strong>chrome C oxidase II<br />
messenger ribonucleic acid is expressed in<br />
pachytene sperma<strong>to</strong>cytes at high levels and in a<br />
stage-dependent manner during sperma<strong>to</strong>genesis<br />
in the rat. Biol. Reprod. 48, 57–67.<br />
Schaeren-Wiemers, N.; Gerfin-Moser, A. <strong>In</strong> situ<br />
hybridization using digoxigenin labeled cRNA<br />
probes; A standardized pro<strong>to</strong>col <strong>to</strong> detect low<br />
abundant mRNA transcripts in tissue sections and<br />
cell cultures. Abstract.<br />
Schaeren-Wiemers, N.; Gerfin-Moser, A. (1993) A<br />
single pro<strong>to</strong>col <strong>to</strong> detect transcripts of various types<br />
and expression levels in neural tissue and cultured<br />
cells: in situ hybridization using digoxigenin-labeled<br />
cRNA probes. His<strong>to</strong>chem. 100, 431–440.<br />
Schröder, H.; Giacobini, E.; Wevers, A.; Birtsch, C.;<br />
Schütz, U. (1995) Nicotinic recep<strong>to</strong>rs in Alzheimer’s<br />
disease.<br />
Spreyer, P.; Kuhn, G.; Hanemann, C. O.; Gillen, C.;<br />
Schaal, H.; Kuhn, R.; Lemke, G.; Müller, H. W.<br />
(1991) Axon-regulated expression of a Schwann cell<br />
transcript that is homologous <strong>to</strong> a “growth arrestspecific”<br />
gene. EMBO J. 10 (12), 3661–3668.<br />
181<br />
6
6<br />
182<br />
References<br />
Springer, J. E.; Gwag, B. J.; Lewis, M. E.; Baldino, F.<br />
(1991) Non-radioactive detection of nerve growth<br />
fac<strong>to</strong>r recep<strong>to</strong>r (NGFR) mRNA in rat brain using<br />
in situ hybridization his<strong>to</strong>chemistry. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 39 (2), 231–234.<br />
Steel, J. H.; Martinez, A.; Springall, D. R.; Tres<strong>to</strong>n,<br />
A. M.; Cuttitta, F.; Polak, J. M. (1994) Peptidylglycine<br />
-amidating monooxygenase (PAM) immunoreactivity<br />
and messenger RNA in human pituitary<br />
and increased expression in pituitary tumours.<br />
Cell Tissue Res. 276, 197–207.<br />
Strähle, U.; Blader, P.; Adam, J.; <strong>In</strong>gham, P. W.<br />
(1994) A simple and efficient procedure for noniso<strong>to</strong>pic<br />
in situ hybridization <strong>to</strong> sectioned material.<br />
TIG 10 (3), 75–76.<br />
Swain, G. P.; Jacobs, A. J.; Frei, E.; Selzer, M. E.<br />
(1994) A method for in situ hybridization in<br />
wholemounted lamprey brain: neurofilament<br />
expression in larvae and adults. Experim. Neurol.<br />
125, 256–269.<br />
Tensen, C. P.; Coenen, T.; van Herp, F. (1991)<br />
Detection of mRNA encoding Crustacean<br />
hyperglycemic hormone (CHH) in the eyestalk of the<br />
crayfish orconectes limosus using non-radioactive<br />
in situ hybridization. Neurosci. Letter 124,<br />
178–182.<br />
Tensen, C. P.; van Kesteren, E. R.; Planta, R. J.;<br />
Cox, K. J. A.; Burke, J. F.; van Heerikhuizen, H.;<br />
Vreugdenhil, E. (1994) A G protein-coupled recep<strong>to</strong>r<br />
with low density lipoprotein-binding motifs suggests<br />
a role for lipoproteins in G-linked signal transduction.<br />
Proc. Natl. Acad. Sci. USA 91, 4816–4820.<br />
Tezuka, K.-I.; Tezuka, Y.; Maejima, A.; Sa<strong>to</strong>, T.;<br />
Nemo<strong>to</strong>, K.; Kamioka, H.; Hakeda, Y.; Kumegawa,<br />
M. (1994) Molecular cloning of a possible cysteine<br />
proteinase predominantly expressed in osteoclasts.<br />
J. Biolog. Chem. 269 (2), 1106–1109.<br />
Tiret, L.; Le Mouellic, H.; Lallemand, Y.; Maury, M.;<br />
Brulet, P. (1993) Altering the spatial determinations<br />
in the mouse embryos by manipulating the Hox<br />
genes. C.R. Acad. Sci. 316, 1017–1024.<br />
Tohyama, C.; Nishimura, N.; Suzuki, J. S. (1994)<br />
Metallothionein mRNA in the testis and prostate of<br />
the rat detected by digoxigenin-labeled riboprobe.<br />
His<strong>to</strong>chem. 101, 341–346.<br />
Torii, S.; Yamagishi, T.; Murakami, K.; Nakayama,<br />
K. (1993) Localization of Kex2-like processing<br />
endoproteases, furin and PC4, within mouse testis<br />
by in situ hybridization. FEBS 316 (1), 12–16.<br />
Tsukamo<strong>to</strong>, T.; Kusakabe, M.; Saga, Y. (1991) <strong>In</strong> situ<br />
hybridization with non-radiactive digoxigenin-11-<br />
UTP-labeled cRNA probes: localization of<br />
developmentally regulated mouse tenascin mRNAs.<br />
<strong>In</strong>t. J. Dev. Biol. 35, 25–32.<br />
Uehara, F.; Ohba, N.; Nakashima, Y.; Yanagita, T.;<br />
Ozawa, M.; Muramatsu, T. (1993) Developmental<br />
change of distribution of -galac<strong>to</strong>side 2,6sialyltransferase<br />
mRNA in rat retina. Exp. Eye Res.<br />
56, 89–93.<br />
Uryu, K.; Iwata, H.; Yoshida, S.; Shiosaka, S.;<br />
Matsuda, S.; Sakanaka, M. (1993) Localization with<br />
a digoxigenin-labeled cRNA probe of basic<br />
fibroblast growth fac<strong>to</strong>r mRNA in dystrophic (MDX)<br />
mouse masseter muscle and rat hair follicles. Acta<br />
His<strong>to</strong>chem. Cy<strong>to</strong>chem. 26 (5), 381–389.<br />
Van Bael, A.; Huygen, R.; Himpens, B.; Denef, C.<br />
(1994) <strong>In</strong> vitro evidence that LHRH stimulates the<br />
recruitment of prolactin mRNA-expressing cells<br />
during the postnatal period in the rat. J. Mol.<br />
Endocrinol. 12, 107–118.<br />
Viaene, A. I.; Baert, J. H. (1994) Localization<br />
of cy<strong>to</strong>keratin 4 mRNA in human oesophageal<br />
epithelium by non-radioactive in situ hybridization.<br />
His<strong>to</strong>chem. J. 26, 50–58.<br />
Wahle, P.; Beckh, S. (1992) A method of in situ<br />
hybridization combined with immunocy<strong>to</strong>chemistry,<br />
his<strong>to</strong>chemistry, and tract tracing <strong>to</strong> characterize the<br />
mRNA expressing cell types in heterogeneous<br />
neuronal populations. J. Neurosci. Meth. 41,<br />
153–166.<br />
Wang, D.; Cutz, E. (1994) Methods in labora<strong>to</strong>ry<br />
investigation. Simultaneous detection of messenger<br />
ribonucleic acids for bombesin/gastrin-releasing<br />
peptide in its recep<strong>to</strong>r in rat brain by nonradiolabeled<br />
double in situ hybridization. Lab. <strong>In</strong>vest. 70 (5),<br />
775–780.<br />
West, A. P.; Sharpe, R. M.; Saunders, P. T. K.<br />
(1994) Differential regulation of cyclic adenosine<br />
3’,5’-monophosphate (cAMP) response elementbinding<br />
protein and cAMP response element<br />
modula<strong>to</strong>r messenger ribonucleic acid transcripts<br />
by follicle-stimulating hormone and androgen in<br />
the adult rat testis. Biol. Reprod. 50, 869–881.<br />
Wevers, A.; Jeske, A.; Lobron, Ch.; Birtsch, Ch.;<br />
Heinemann, S.; Maelicke, A.; Schröder, R.;<br />
Schröder, H. (1994) Cellular distribution of nicotinic<br />
acetylcholine recep<strong>to</strong>r subunit mRNAs in the human<br />
cerebral cortex as revealed by non-iso<strong>to</strong>pic in situ<br />
hybridization. Mol. Brain Res. 25, 122–128.<br />
Wiel, van de, C.; Norris, J. H.; Bochenek, B.;<br />
Dickstein, R.; Bisseling, T.; Hirsch, A. M. (1990)<br />
Nodulin gene expression and ENOD2 localization<br />
in effective, nitrogen-fixing and ineffective,<br />
bacteria-free modules of alfalfa. Plant Cell 2,<br />
1009–1017.<br />
Wright, D. E.; Jennes, L. (1993) Lack of expression of<br />
sero<strong>to</strong>nin recep<strong>to</strong>r subtype -1a, 1c, and -2 mRNAs in<br />
gonadotropin-releasing hormone producing neurons<br />
of the rat. Neurosci. Letters 163, 1–4.<br />
Wu, T.-C.; Kanayama, M. D.; Hruban, R. H.;<br />
Au, W.-C.; Askin, F. B.; Hutchins, G. M. (1992) Virusassociated<br />
RNAs (VA-I and VA-II). An efficient target<br />
for the detection of adenovirus infections by in situ<br />
hybridization. Am. J. Pathol. 140 (4), 991–998.<br />
Wu, T.-C.; Kanayama, M. D.; Hruban, R. H.;<br />
Whitehead, W.; Raj, N. B. K. (1993) Detection of a<br />
neuron-specific 9.0-kb transcript which shares<br />
homology with antisense transcripts of HIV-1 gag<br />
Gene in patients with and without HIV-1 infection.<br />
Am. J. Pathol. 142, 25–31.<br />
CONTENTS<br />
INDEX
Wu, T.-C.; Lee, W. A.; Pizzorno, M. C.; Au, W.-C.;<br />
Chan, Y.-J.; Hruban, R. H.; Hutchins, G. M.;<br />
Hayward, G. S. (1992) Localization of the human<br />
cy<strong>to</strong>megalovirus 2.7-kb major early -gene<br />
transcripts by RNA in situ hybridization in<br />
permissive and nonpermissive infections. Am. J.<br />
Pathol. 141, 1247–1254.<br />
Wu, T.-C.; Pizzorno, M. C.; Hayward, G. S.;<br />
Willoughby, S.; Neumann, D. A.; Rose, N. R.;<br />
Ansari, A. A.; Beschorner, W. E.; Baughman, K. L.;<br />
Herskowitz, A. (1992) <strong>In</strong> situ detection of human<br />
cy<strong>to</strong>megalovirus immediate-early gene transcripts<br />
within cardiac myocytes of patients with HIVassociated<br />
cardiomyopathy. AIDS 6, 777–785.<br />
Wu, T.-C.; Kuo, T.-T. (1993) Study of epstein-barr<br />
virus early RNA 1 (EBER 1) expression by in situ<br />
hybridization in thymic epithelial tumors of chinese<br />
patients in Taiwan. Hum. Pathol. 24, 235–238.<br />
Xu, X.-C.; Ro, J. Y.; Lee, J. S.; Shin, D. M.; Hong,<br />
W. K.; Lotan, R. (1994) Differential expression of<br />
nuclear retinoid recep<strong>to</strong>rs in normal, premalignant,<br />
and malignant head and neck tissues. Cancer Res.<br />
54, 3580–3587.<br />
Xu, X.-C.; Clifford, J. L.; Hong, W. K.; Lotan, R.<br />
(1994) Detection of nuclear retinoic acid recep<strong>to</strong>r<br />
mRNA in his<strong>to</strong>logical tissue sections using nonradioactive<br />
in situ hybridization his<strong>to</strong>chemistry.<br />
Diagn. Mol. Pathol. 3 (2), 122–131.<br />
Yan, Y.; Lagenaur, C.; Narayanan, V. (1993) Molecular<br />
cloning of M6: identification of a PLP/DM20 gene<br />
family. Neuron 11, 423–431.<br />
Ying, S.; Durham, S. R.; Barkans, J.; Masuyama, K.;<br />
Jacobson, M.; Rak, S.; Löwhagen, O.; Moqbel, R.;<br />
Kay, A. B.; Hamid, Q. A. (1993) T cells are the<br />
principal source of <strong>In</strong>terleukin-5 mRNA in allergeninduced<br />
rhinitis. Am. J. Respir. Cell Mol. Biol. 9,<br />
356–360.<br />
Yokouchi, Y.; Sasaki, H.; Kuroiwa, A. (1991)<br />
Homeobox gene expression correlated with the<br />
bifurcation process of limb cartilage development.<br />
Nature 353, 443–445.<br />
Yoshimura, A.; Gordon, K.; Alpers, C. E.; Floege, J.;<br />
Pritzl, P.; Ross, R.; Couser, W. G.; Bowen-Pope,<br />
D. F.; Johnson, R. J. (1991) Demonstration of PDGF<br />
B-chain mRNA in glomeruli in mesangial proliferative<br />
nephritis by in situ hybridization. Kidney <strong>In</strong>ternat.<br />
40, 470–476.<br />
Young, I. D.; Stewart, R. J.; Ailles, L.; Mackie, A.;<br />
Gore, J. (1993) Synthesis of digoxigenin-labeled<br />
cRNA probes for noniso<strong>to</strong>pic in situ hybridization<br />
using reverse transcription polymerase chain<br />
reaction. Biotechn. His<strong>to</strong>chem. 68 (3), 153–158.<br />
Zhou, X.; Sasaki, H.; Lowe, L.; Hogan, B. L. M.;<br />
Kuehn, M. R. (1993) Nodal is a novel TGF--like<br />
gene expressed in the mouse node during<br />
gastrulation. Nature 361, 543–547.<br />
Zurbriggen, A.; Müller, C.; Vandevelde, M. (1993)<br />
<strong>In</strong> situ hybridization of virulent canine distemper<br />
virus in brain tissue, using digoxigenin-labeled<br />
probes. Am. J. Vet. Res. 54 (9), 1457–1461.<br />
CONTENTS<br />
INDEX<br />
C. Oligonucleotide probes<br />
a. 3'-Endlabeling<br />
References<br />
Campbell, A. M.; Wuytack, F.; Fambrough, D. M.<br />
(1993) Differential distribution of the alternative<br />
forms of the sarcoplasmic/endoplasmic reticulum<br />
Ca2+ -ATPase, SERCA2b and SERCA2a, in the avian<br />
brain. Brain Res. 605, 67–76.<br />
Hodges, E.; Howell, W. M.; Tyacke, S. R.; Wong, R.;<br />
Cawley, M. I. D. (1994) Detection of T-Cell recep<strong>to</strong>r<br />
chain mRNA in frozen and paraffin-embedded<br />
biopsy tissue using digoxigenin-labeled oligonucleotide<br />
probes in situ. J. Pathol. 174, 151–158.<br />
McNicol, A. M.; Farquharson, M. A.; Walker, E.<br />
(1991) Non-Iso<strong>to</strong>pic in situ hybridization with<br />
digoxigenin and alkaline phosphatase labeled<br />
oligodeoxynucleotide probes. Path. Res. Pract. 187,<br />
556–558.<br />
Roncaroli, F.; Dina, R.; Geuna, M.; Rea<strong>to</strong>, G.;<br />
Ponti, R.; Palestro, G. (1994) Identification of<br />
granulocyte-macrophage colony stimulating fac<strong>to</strong>r<br />
recep<strong>to</strong>r mRNA by non-iso<strong>to</strong>pic in situ hybridization<br />
in bone marrow biopsies. Haemo<strong>to</strong>l. 79, 322–327.<br />
Thomas, G. A.; Davies, H. G.; Williams, E. D. (1993)<br />
Demonstration of mRNA using digoxigenin labeled<br />
oligonucleotide probes for in situ hybridzation in<br />
formamide free conditions. J. Clin. Pathol. 46,<br />
171–174.<br />
b. 3'-Tailing<br />
Artero, R. D.; Akam, M.; Pérez-Alonso, M. (1992)<br />
Oligonucleotide probes detect splicing variants<br />
in situ in Drosophila embryos. Nucl. Acids Res. 20<br />
(21), 5687–5690.<br />
Amberg, D. C.; Goldstein, A. L.; Cole, C. N. (1992)<br />
Isolation and characterization of RAT1: an essential<br />
gene of Saccharomyces cerevisiae required for the<br />
efficient nucleocy<strong>to</strong>plasmic trafficking of mRNA.<br />
Genes Develop. 6, 1173–1189.<br />
Baldino, F.; Lewis, M. E. (1989) Non-radioactive in<br />
situ hybridization his<strong>to</strong>chemistry with digoxigenindUTP<br />
labeled oligonucleotides. Methods in Neuroscience<br />
Vol. 1 (Conn, P. M., ed.) Acadmic Press,<br />
New York, 282–292.<br />
Black, M.; Carey, F. A.; Farquharson, M. A.; Murray,<br />
G. D.; McNicol, A. M. (1993) Expression of the proopiomelanocortin<br />
gene in lung neuroendocrine<br />
tumours: in situ hybridization and immunohis<strong>to</strong>chemical<br />
studies. J. Pathol. 169, 329–334.<br />
Brouwer, N.; Van Dijken, H.; Ruiters, M. H. J.; Van<br />
Willigen, J.-D.; Ter Horst, G. J. (1992) Localization<br />
of dopamine D2 recep<strong>to</strong>r mRNA with non-radioactive<br />
in situ hybridization his<strong>to</strong>chemistry.<br />
Neurosci. Letters 142, 223–227.<br />
Dechesne, C. J.; Winsky, L.; Moniot, B.; Raymond,<br />
J. (1993) Localization of calretinin mRNA in rat<br />
and guinea pig inner ear by in situ hybridization<br />
using radioactive and non-radioactive probes.<br />
Hear. Res. 69, 91–97.<br />
183<br />
6
6<br />
184<br />
References<br />
Dickerson, D. S.; Huerter, B. S.; Morris, S. J.;<br />
Chronwall, B. M. (1994) POMC mRNA levels in<br />
individual melanotropes and GFAP in glial-like cells<br />
in rat pituitary. Peptides 15 (2), 247–256.<br />
Dirks, R. W.; Van Dorp, A. G. M.; Van Minnen, J.;<br />
Fransen, J. A. M.; Van der Ploeg, M.; Raap, A. K.<br />
(1992) Electron microscopic detection or RNA<br />
sequences by non-radioactive in situ hybridization<br />
in the mollusk lymnaea stagnalis. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 40, 1647–1657.<br />
Dirks, R. W.; Van Gijlswijk, R. P. M.; Vooljs, M. A.;<br />
Smit, A. B.; Bogerd, J.; Van Minnen, J.; Raap, A. K.;<br />
Van der Ploeg, M. (1991) 3’End fluorochromized and<br />
haptenized oligonucleotides as in situ hybridization<br />
probes for multiple, simultaneous RNA detection.<br />
Experim. Cell Res. 194, 310–315.<br />
Dirks, R. W.; Van der Rijke, F. M.; Fujishita, S.;<br />
Van der Ploeg, M.; Raap, A. K. (1993) Methodologies<br />
for specific intron and exon RNA localization in<br />
cultured cells by haptenized and fluorochromized<br />
probes. J. Cell Sci. 104, 1187–1197.<br />
Dumas, S.; Horellou, P.; Helin, C.; Mallet, J. (1992)<br />
Co-expression of tyrosine hydroxylase messenger<br />
RNA1 and 2 in human ventral mesencephalon<br />
revealed by digoxigenin- and biotin-labeled oligodeoxyribonucleotides.<br />
J. Chem. Neuroana<strong>to</strong>my 5,<br />
11–18.<br />
Crabb, I. D.; Hughes, S. S.; Hicks, D. G.; Puzas, J. E.;<br />
Tsao, G. J. Y.; Rosier, R. N. (1992) Nonradioactive<br />
in situ hybridization using digoxigenin-labeled oligonucleotides.<br />
Am. J. Pathol. 141 (3), 579–589.<br />
Farquharson, M.; Harvie, R.; McNicol, A. M. (1990)<br />
Detection of messenger RNA using a digoxigenin<br />
end labeled oligonucleotide probe. J. Clin Pathol.<br />
43, 424–428.<br />
Farquharson, M.; Harvie, R.; McNicol, A. M. (1990)<br />
Detection of pro-opiomelanocortin messenger RNA<br />
using a digoxigenin end labeled oligodeoxynucleotide<br />
probe. J. Endocrinol. 124 (Supplement).<br />
Fevre-Montange, M.; Trembleau, A.; Landry, M.;<br />
Calas, A. (1992) Hybridation in situ avec des sondes<br />
oligonucléotidiques marquées à la digoxigénine:<br />
application à la détection des ARNm de la vasopressine<br />
et de l’ocy<strong>to</strong>cine. Techniques, 479–486.<br />
Grega, D.; Cavanaugh, T.; Martin, R.; Lewis, M.;<br />
Baldino, F. (1989) <strong>In</strong> situ hybridization his<strong>to</strong>chemistry<br />
using a new non-radioactive detection method. ICSU<br />
Short Reports, Advances in Gene Technology: Molecular<br />
Neurobiology and Neuropharmacology, Proceedings<br />
of the 1989 Miami Bio/Technology Winter<br />
Symposium, Vol. 9, p. 69, IRL Press, McLean, Virginia.<br />
Guellec Le, P.; Dumas, S.; Volle, G. E.; Pidoux, E.;<br />
Moukhtar, M. S.; Treilhou-Lahille, F. (1993) An<br />
efficient method <strong>to</strong> detect calci<strong>to</strong>nin mRNA in normal<br />
and neoplastic rat c-cells (Medullary Thyroid<br />
Carcinoma) by in situ hybridization using a<br />
digoxigenin-labeled synthetic<br />
oligodeoxyribonucleotide probe.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 41, 389–395.<br />
Hamada, K.; Okawara, Y.; Fryer, J. N.; Tomonaga,<br />
A.; Fukuda, H. (1994) Localization of mRNA of<br />
procollagen 1 type I in <strong>to</strong>rn supraspinatus tendons.<br />
Clin. Orthopaed. Related Res. 304, 18–21.<br />
Harper, S. J.; Pringle, J. H.; Gillies, A.; Allen, A. C.;<br />
Layward, L.; Feehally, J.; Lauder, I. (1992) Simultaneous<br />
in situ hybridization of native mRNA and<br />
immunoglobulin detection by conventional<br />
immunofluorescence in paraffin way embedded<br />
sections. J. Clin. Pathol. 45, 114–119.<br />
Harvie, R.; Elvin, P.; McArdle, C.; Morten, J. E. N.;<br />
McNicol, A. M. (1991) Detection of mRNA for ribosomal<br />
phosphoprotein P2 in normal colon and colonic<br />
tumours by in situ hybridization. J. Pathol. 164,<br />
67–73.<br />
Hil<strong>to</strong>n, D. A.; Day; C.; Pringle, J. H.; Fletcher, A.; Chambers,<br />
S. (1992) Demonstration of the distribution of<br />
Coxsackie virus RNA in neonatal mice by non-iso<strong>to</strong>pic<br />
in situ hybridization. J. Virol. Meth. 40, 155–162.<br />
Hil<strong>to</strong>n, D. A.; Fletcher, A.; Pringle, J. H. (1994)<br />
Absence of coxsacki viruses in idiopathic<br />
inflamma<strong>to</strong>ry muscle disease by in situ hybridization.<br />
Neuropathol. Appl. Neurobiol. 20, 238–242.<br />
Humpel, C.; Lindqvist, E.; Olson, L. (1993) Detection<br />
of nerve growth fac<strong>to</strong>r mRNA in rodent salivary<br />
glands with digoxigenin- and 33P-labeled oligonucleotides:<br />
effects of castration and sympathec<strong>to</strong>my.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 41 (5), 703–708.<br />
Kendall, C. H.; Roberts, P. A.; Pringle, J. H.;<br />
Lauder, I. (1991) The expression of parathyroid<br />
hormone messenger RNA in normal and abnormal<br />
parathyroid tissue. J. Pathol. 165, 111–118.<br />
Kennedy, R. E.; Hutchins, J. B. (1992) Choline acetyltransferase<br />
expression studied with an oligonucleotide<br />
probe. Cell. Mol. Neurobiol. 12 (4), 309–315.<br />
Khan, G.; Coates, P .J.; Kangro, H. O.; Slavin, G.<br />
(1992) Epstein Barr virus (EBV) encoded small RNAs:<br />
Targets for detection by in situ hybridization with<br />
oligonucleotide probes. J. Clin. Pathol. 45, 616–620.<br />
Khan, G.; Nor<strong>to</strong>n, A. J.; Slavin, G. (1993) Epstein-<br />
Barr virus in angioimmunoblastic T-cell lymphomas.<br />
His<strong>to</strong>pha<strong>to</strong>l. 22, 145–149.<br />
Kirchgessner, A. L.; Liu, M.-T.; Howard, M. J.;<br />
Gershon, M. D. (1993) Detection of the 5-HT1A<br />
Recep<strong>to</strong>r and 5-HT1A Recep<strong>to</strong>r mRNA in the rat<br />
bowel and pancreas: comparison with 5-HT1P<br />
Recep<strong>to</strong>rs. J. Comparative Neurol. 327, 233–250.<br />
Koji, T.; Brenner, R. M. (1993) Localization of<br />
estrogen recep<strong>to</strong>r messenger ribonucleic acid in<br />
rhesus monkey uterus by nonradioactive in situ<br />
hybridization with digoxigenin-labeled oligodeoxynucleotides.<br />
Endocrinol. 132, 382–392.<br />
Komminoth, P. (1992) Digoxigenin as an alternative<br />
probe labeling for in situ hybridization. Diagn. Mol.<br />
Pathol. 1 (2), 142–150.<br />
Komminoth, P.; Merk, F. B.; Leav, I.; Wolfe, H. J.;<br />
Roth, J. (1992) Comparison of 35S- and digoxigeninlabeled<br />
RNA and oligonucleotide probes for in situ<br />
hybridization. His<strong>to</strong>chem. 98, 217–228.<br />
Krizbai, I.; Deli, M.; Lengyel, I.; Maderspach, K.;<br />
Pákáski, M.; Joó, F.; Wolff, J. R. (1993) <strong>In</strong> situ<br />
hybridization with digoxigenin labeled oligonucleotide<br />
probes: detection of CAMK-II gene expression<br />
in primary cultures of cerebral endothelial cells.<br />
Neurobiol. 1 (3), 235–240.<br />
CONTENTS<br />
INDEX
Krusche, C.; Beier, H. M. (1994) Localization of<br />
uteroglobin mRNA by nonradioactive in situ<br />
hybridization in the pregnant rabbit endometrium.<br />
Ann. Anat. 176, 23–31.<br />
Laverdure, A.-M.; Carette-Desmoucelles, C.;<br />
Breuzet, M.; Descamps, M. (1994) Neuropeptides<br />
and related nucleic acid sequences detected in<br />
peneid shrimps by immunohis<strong>to</strong>chemistry and<br />
molecular hybridizations. Neurosci. 60 (2), 569–579.<br />
Laverdure, A.-M.; Breuzet, M.; Soyez, D.; Becker, J.<br />
(1992) Detection of the mRNA encoding vitellogenesis<br />
inhibiting hormone in neurosecre<strong>to</strong>ry cells of the<br />
X-organ in homarus americanus by in situ hybridization.<br />
Gen. Compar. Endocrinol. 87, 443–450.<br />
Lee, D.; Huang, W.; Yang, Z.; Copolov, D. L.;<br />
Lim, A. T. (1992) <strong>In</strong> vitro evidence for modulation of<br />
morphological and functional development of<br />
hypothalamic immunoreactive atrial natriuretic<br />
peptide neurons by cyclic 3', 5'-adenosine<br />
monophosphate. Endocrinol. 131, 911–918.<br />
Lewis, M. E.; Robbins, E.; Grega, D.; Baldino, F.<br />
(1989) Nonradioactive detection of vasopression<br />
and soma<strong>to</strong>statin mRNA with Digoxigenin-labeled<br />
oligonucleotide probes. Ann. NY Acad. Sci. V:<br />
Molecular Biology: The Future of Neuropeptide<br />
Research, pp 246–253.<br />
Matute, C.; Wahle, P.; Gutiérrez-Igarza, K.; Albus, K.<br />
(1993) Distribution of neurons expression substance<br />
P recep<strong>to</strong>r messenger RNA in immature and adult<br />
cat visual cortex. Exp. Brain Res. 97, 295–300.<br />
Mertani, H. C.; Waters, M. J.; Jambou, R.; Gossard, F.;<br />
Morel, G. (1994) Growth hormone recep<strong>to</strong>r inding<br />
protein in rat anterior pituitary. Neuroendocrinol. 59,<br />
483–494.<br />
Miranda, R. C.; Toran-Allerand, C. D. (1992)<br />
Developmental expression of estrogen recep<strong>to</strong>r<br />
mRNA in the rat cerebral cortex: A noniso<strong>to</strong>pic in<br />
situ hybridization his<strong>to</strong>chemistry study. Cerebral<br />
Cortex Jan/Feb 2, 1–15.<br />
Mitchel, V.; Gambiez, A.; Beauvillain, J. C. (1993)<br />
Fine-structural localization of proenkephalin mRNAs<br />
in the hypothalamic magnocellular dorsal nucleus<br />
of the guinea pig: a comparison of radioiso<strong>to</strong>pic and<br />
enzymatic in situ hybridization methods at the lightand<br />
electron-microscopic levels. Cell Tissue Res.<br />
274, 219–228.<br />
Millar, M. R.; Sharpe, R. M.; Maguire, S. M.;<br />
Saunders, P. T. K. (1993) Cellular localisation of<br />
messenger RNAs in rat testis: application of<br />
digoxigenin-labeled ribonucleotide probes <strong>to</strong><br />
embedded tissue. Cell Tissue Res. 273, 269–277.<br />
Miyazaki, M.; Nikolic-Paterson, D. J.; Masayuki, E.;<br />
Nomo<strong>to</strong>, Y.; Sakai, H.; Atkins, R. C.; Koji, T. (1994)<br />
A sensitive method of non-radioactive in situ<br />
hybridization for mRNA localization within human<br />
renal biopsy specimens: use of digoxigenin labeled<br />
oligonucleotides. <strong>In</strong>t. Med. 33, 87–91.<br />
Murray, G. I.; Paterson, P. J.; Ewen, S. W. B.; Melvin,<br />
W. T. (1992) <strong>In</strong> situ hybridization of albumin mRNA<br />
in normal liver and hepa<strong>to</strong>cellular carcinoma with a<br />
digoxigenin labeled oligonucleotide probe. J. Clin.<br />
Pathol. 45, 21–24.<br />
CONTENTS<br />
INDEX<br />
References<br />
Myatt, N.; Coghill, G.; Morrison, K.; Jones, D.;<br />
Cree, I. A. (1994) Detection of tumour necrosis<br />
fac<strong>to</strong>r- in sarcoidosis and tuberculosis<br />
granulomas using in situ hybridization. J. Clin.<br />
Pathol. 47, 423–426.<br />
Nakagawa, M.; Kukita, T.; Nakasima, A.; Kurisu, K.<br />
(1994) Expression of the type I collagen gene in rat<br />
periodontal ligament during <strong>to</strong>oth movement as<br />
revealed by in situ hybridization. Archs oral Biol. 39<br />
(4), 289–294.<br />
Negro, F.; Papotti, M.; Pacchioni, D.; Galimi, F.;<br />
Bonino, F.; Bussolati, G. (1994) Detection of human<br />
androgen recep<strong>to</strong>r mRNA in hepa<strong>to</strong>cellular<br />
carcinoma by in situ hybridization. Liver 14,<br />
213–219.<br />
Nicoloso, M.; Caizergues-Ferrer, M.; Michot, B.;<br />
Azum, M.-C.; Bachellerie, J.-P. (1994) U20, a novel<br />
small nucleolar RNA, is encoded in an intron of the<br />
nucleolin gene in mammals. Mol. Cell. Biol. 14 (9),<br />
5766–5776.<br />
O’Keefe, R. J.; Puzas, J. E.; Loveys, L.; Hicks, D. G.;<br />
Rosier, R. N. (1994) Analysis of type II and type X<br />
collagen synthesis in cultured growth plate chondrocytes<br />
by in situ hybridization: rapid induction of<br />
type X collagen in culture. J. Bone Mineral Res. 9<br />
(11), 1713–1722.<br />
Ong, W. Y.; Garey, L. J.; Sumi, Y. (1994) Distribution<br />
of preprosoma<strong>to</strong>statin mRNA in the rat parietal and<br />
temporal cortex. Mol. Brain Res. 23, 151–156.<br />
Pacchioni, D.; Papotti, M.; Andorno, E.; Bonino, F.;<br />
Mondardini, A.; Oliveri, F.; Brunet<strong>to</strong>, M.; Ussolati,<br />
G.; Negro, F. (1993) Expression of estrogen recep<strong>to</strong>r<br />
mRNA in tumorous and non-tumorous liver tissue as<br />
detected by in situ hybridization. J. Surgical Oncol.<br />
Suppl. 3, 14–17.<br />
Papotti, M.; Pacchioni, D.; Negro, F.; Bonino, F.;<br />
Bussolati, G. (1994) Albumin gene expression in<br />
liver tumors: diagnostic interest in fine needle<br />
aspiration biopsies. Modern Pathol. 7 (3), 271–275.<br />
Paulmyer-Lacroix, O.; Anglade, G.; Grino, M. (1994)<br />
<strong>In</strong>sulin-induced hypoglycaemia increase colocalization<br />
of corticotrophin-releasing fac<strong>to</strong>r and arginine<br />
vasopressin mRNAs in the rat hypothalamic<br />
paraventricular nucleus. J. Mol. Endocrinol. 13,<br />
313–320.<br />
Samoszuk, M.; Nansen, L. (1990) Detection of<br />
<strong>In</strong>terleukin-5 messenger RNA in Reed-Sternberg<br />
cells of Hodgkin’s desease with eosinophilia.<br />
Blood 75 (1), 13–16.<br />
Sharara, F. I.; Nieman, L. K. (1994) Identification<br />
and cellular localization of growth hormone recep<strong>to</strong>r<br />
gene expression in the human ovary. J. Clin.<br />
Endocrinol. Metabolism 79 (2), 670–672.<br />
Shorrock, K.; Roberts, P.; Pringle, J. H.; Lauder, I.<br />
(1991) Demonstration of insulin and glucagon mRNA<br />
in routinely fixed and processed pancreatic tissue<br />
by in situ hybridization.J. Pathol. 165, 105–110.<br />
Thomas, G. A.; Davies, H. G.; Williams, E. D. (1994)<br />
Site of production of IGF1 in the normal and<br />
stimulated mouse thyroid. J. Pathol. 173, 355–360.<br />
185<br />
6
6<br />
186<br />
References<br />
Throsby, M.; Lee, D.; Huang, W.; Yang, Z.; Copolov,<br />
D. L.; Lim, A. T. (1991) Evidence for atrial natriuretic<br />
peptide-(5-28) production by macrophages of the<br />
rat spleen: An immunochemical and nonradioactive<br />
in situ hybridization approach. Endo. 129, 991–1000.<br />
Throsby, M.; Yang, Z.; Lee, D.; Huang, W.; Copolov,<br />
D. L.; Lim, A. T. (1993) <strong>In</strong> vitro evidence for atrial<br />
natriuretic fac<strong>to</strong>r-(5-28) production by macrophages<br />
of adult rat thymi. Endocrinol. 132 (5), 2184–2190.<br />
Tokushige, E.; I<strong>to</strong>, K.; Ushikai, M.; Katahira, S.;<br />
Fukuda, K. (1994) Localization of IL-1 mRNA<br />
and cell adhesion molecules in the maxillary sinus<br />
mucosa of patients with chronic sinusitis.<br />
Laryngoscope 104, 1245–1250.<br />
Toran-Allerand, C. D.; Miranda, R. C.; Hochberg,<br />
R. B.; MacLusky, N. J. (1992) Cellular variations in<br />
estrogen recep<strong>to</strong>r mRNA translation in the developing<br />
brain: evidence from combined [ 125I] estrogen<br />
au<strong>to</strong>radiography and non-iso<strong>to</strong>pic in situ hybridization<br />
his<strong>to</strong>chemistry. Brain Res. 576, 25–41.<br />
Trembleau, A.; Roche, D.; Calas, A. (1993)<br />
Combination of non-radioactive and radioactive in<br />
situ hybridization with immunohis<strong>to</strong>chemistry: a new<br />
method allowing the simultaneous detection of two<br />
mRNAs and one antigen in the same brain tissue<br />
section. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 41, 489–498.<br />
Trembleau, A.; Morales, M.; Bloom, F. E. (1994)<br />
Aggregation of vasopressin mRNA in a subset of<br />
axonal swellings of the median eminence and<br />
posterior pituitary: Light and electron microscopic<br />
evidence. J. Neurosci. 14 (1), 39–53.<br />
Ueyama, T.; Houtani, T.; Nakagawa, H.; Baba, K.;<br />
Ikeda, M.; Yamashita, T.; Sugimo<strong>to</strong>, T. (1994) A<br />
subpopulation of olivocerebellar projection neurons<br />
express neuropeptide Y. Brain Res. 634, 353–357.<br />
Wani, G.; Wani, A. A.; Ambrosio, S. (1992) <strong>In</strong> situ<br />
hybridization of human kidney tissue reveals celltype-specific<br />
expression of the O6-methylguanine- DNA methyltransferase gene. Carcinogenesis 13<br />
(3), 463–468.<br />
Wani, G.; Wani, A. A.; Ambrosio, S. (1993) Cell typespecific<br />
expression of the O6-alkylguanine-DNA alkyltransferase gene in normal human liver tissues<br />
as revealed by in situ hybridization. Carcinogenesis<br />
14 (4), 737–741.<br />
Whitman, G. F.; Pantazis, C. G. (1991) Cellular localization<br />
of müllerian inhibiting substance messenger<br />
ribonucleic acid during human ovarian follicular<br />
development. Am. J. Obstet. Gynecol. 165,<br />
1881–1886.<br />
Woodroofe, M. N.; Cuzner, M. L. (1993) Cy<strong>to</strong>kine<br />
mRNA expression in inflamma<strong>to</strong>ry multiple sclerosis<br />
lesions: detection by non-radioactive in situ<br />
hybridization. Cy<strong>to</strong>kine 5 (6), 583–588.<br />
Xerri, L.; Monges, G.; Guigou, V.; Parc, P.; Hassoun,<br />
J. (1992) Detection of gastrin mRNA by in situ<br />
hybridization using radioactive- and digoxigeninlabeled<br />
probes: a comparative study. APMIS 100,<br />
949–953.<br />
Yamada, S.; Takahashi, M.; Hara, M.; Sano, T.; Aiba,<br />
T.; Shishiba, Y.; Suzuki, T.; Asa, S. L. (1994) Growth<br />
hormone and prolactin gene expression in human<br />
densely and sparsely granulated soma<strong>to</strong>troph<br />
adenomas by in situ hybridization with digoxigeninlabeled<br />
probes. Diagn. Mol. Pathol. 3 (1), 46–52.<br />
Young, W. S. III (1989) Simultaneous use of<br />
digoxigenin- and radiolabeled oligodeoxyribonucleotide<br />
probes for hybridization his<strong>to</strong>chemistry.<br />
Neuropeptides (Edinburgh) 18, 271–275.<br />
Young, W. S. III; Horvath, S.; Palkovits, M. (1990)<br />
The influence of hyperosmolality and synaptic<br />
inputs on galanin and vasopressin expression in the<br />
hypothalamus. Neurosci. 39 (1), 115–125.<br />
Young, W. S. III; Reynolds, K.; Shepard, E. A.;<br />
Gainer, H.; Castel, M. (1990) Cell-specific expression<br />
of the rat oxy<strong>to</strong>cin gene in transgenic mice.<br />
J. Neuroendocrinol. 2 (6), 917–925.<br />
Zupanc, G. K. H.; Okawara, Y.; Zupanc, M. M.;<br />
Fryer, J. N.; Maler, L. (1991) <strong>In</strong> situ hybridization of<br />
putative soma<strong>to</strong>statin mRNA in the brain of electric<br />
gymnotiform fish. Neuro Report 2, 707–710.<br />
c. Chemical synthesis<br />
Hassall, C. J. S.; Stanford, S. C.; Burns<strong>to</strong>ck, G.;<br />
Buckley, N. J. (1993) Co-expression of four<br />
muscarinic recep<strong>to</strong>r genes by the intrinsic neurons<br />
of the rat and guinea-pig heart. Neurosci. 56 (4),<br />
1041–1048.<br />
Hell, K.; Pringle, J. H.; Hansmann, M.-L.; Lorenzen,<br />
J.; Colloby, P.; Lauder, I.; Fischer, R. (1993)<br />
Demonstration of light chain mRNA in hodgkin’s<br />
disease.J. Pathol. 171, 137–143.<br />
Hodges, E.; Howell, W. M.; Tyacke, S. R.; Wong, R.;<br />
Cawley, M. I. D.; Smith, J. L. (1994) Detection of<br />
T-cell recep<strong>to</strong>r chain mRNA in frozen and paraffinembedded<br />
biopsy tissue using digoxigenin-labeled<br />
oligonucleotide probes in situ. J. Pathol. 174,<br />
151–158.<br />
Li, D.; Bell, J.; Brown, A.; Berry, C. L. (1994) The<br />
observation of angiogenin and basic fibroblast<br />
growth fac<strong>to</strong>r gene expression in human colonic<br />
adenocarcinomas, gastric adenocarcinomas, and<br />
hepa<strong>to</strong>cellular carcinomas. J. Pathol. 172, 171–175.<br />
Shanks, J. H.; Lappin, T. R. J.; Hill, C. M. <strong>In</strong> situ<br />
hybridization for erythropoietin messenger RNA<br />
using digoxigenin-labeled oligonucleotides. Annals<br />
New York Academy of Sciences.<br />
Thomas, G. A.; Neonakis, E.; Davies, H. G.; Wheeler,<br />
M. H.; Williams, E. D. (1994) Synthesis and s<strong>to</strong>rage<br />
in rat thyroid C-cells. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 42<br />
(8), 1055–1060.<br />
CONTENTS<br />
INDEX
1.2 rRNA target<br />
A. RNA probe<br />
Cary, S. C.; Warren, W.; Anderson, E.; Giovannoni,<br />
S. J. (1993) Identification and localization of<br />
bacterial endosymbionts in hydrothermal vent taxa<br />
with symbiont-specific polymerase chain reaction<br />
amplification and in situ hybridization techniques.<br />
Mol. Marine Biol. Biotechn. 2 (1), 51–62.<br />
Fischer, D.; Weisenberger, D.; Scheer, U.: Assigning<br />
functions <strong>to</strong> nucleolar structures. Chomosoma<br />
Focus.<br />
B. Oligonucleotide probes<br />
a. 3'-Endlabeling<br />
Dixon, B. (1992) Targeting ribosomal RNA:<br />
Identifying microbes. BioTechn. 10, 124.<br />
Zarda, B.; Amann, R.; Wallner, G.; Schleifer, K.-H.<br />
(1991) Identification of single bacterial cells using<br />
digoxigenin-labeled rRNA-targeted oligonucleotides.<br />
J. Gen. Microbiol. 137, 2823–2830.<br />
b. 3'-Tailing<br />
Azum-Gélade, M.-C.; Noaillac-Depeyre, J.;<br />
Caizergues-Ferrer, M.; Gas, N. (1994) Cell cycle<br />
redistribution of U3 snRNA and fibrillarin. Presence<br />
in the cy<strong>to</strong>plasmic nucleolus remnant and in the<br />
prenucleolar bodies at telophase. J. Cell Sci. 107,<br />
463–475.<br />
Concha, I. I.; Urzua, U.; Yanez, A.; Schroeder, R.;<br />
Pessot, C.; Burzio, L. O. (1993) U1 and U2 snRNA<br />
are localized in the sperm nucleus. Experiment. Cell<br />
Res. 204, 378–381.<br />
c. Chemical synthesis<br />
Gersdorf, H.; Pelz, K.; Göbel, U. B. (1993)<br />
Fluorescence in situ hybridization for direct<br />
visualization of Gram-negative anaerobes in<br />
subgingival plaque samples. FEMS Immunol. &<br />
Medical Microbiol. 6, 109–114.<br />
Roller, C.; Wagner, M.; Amann, R.; Ludwig, W.;<br />
Schleifer, K.-H. (1994) <strong>In</strong> situ probing of Grampositive<br />
bacteria with high DNA G+C content using<br />
23S rRNA-targeted oligonucleotides. Microbiol. 140,<br />
2849–2858.<br />
Wallner, G.; Amann, R.; Beisker, W. (1993)<br />
Optimizing fluorescent in situ hybridization with<br />
rRNA-targeted oligonucleotide probes for flow<br />
cy<strong>to</strong>metric identification of microorganisms.<br />
Cy<strong>to</strong>m. 14, 136–143.<br />
Zarda, B.; Amann, R.; Wallner, G.; Schleifer, K.-H.<br />
(1991) Identification of single bacterial cells using<br />
digoxigenin-labeled rRNA-targeted oligonucleotides.<br />
J. Gen. Microbiol. 137, 2823–2830.<br />
CONTENTS<br />
INDEX<br />
1.3 RNA target<br />
A. Oligonucleotide Probes<br />
b. 3'-Tailing<br />
Negro, F.; Pacchioni, D.; Shimizu, Y.; Miller, R. H.;<br />
Bussolati, G.; Purcell, R. H.; Bonino, F. (1992)<br />
Detection of intrahepatic replication of hepatitis C<br />
virus RNA by in situ hybridization and comparison<br />
with his<strong>to</strong>pathology. Proc. Natl. Acad. Sci. USA 89,<br />
2247–2251.<br />
Azum-Gelade, M.-C.; Noaillac-Depeyre, J.;<br />
Caizergues-Ferrer, M.; Gas, N. (1994) Cell cycle<br />
redistribution of U3 snRNA and fibrillarin. J. Cell<br />
Sci. 107, 463–475.<br />
B. RNA probes<br />
Bashir, R.; McManus, B.; Cunningham, C.;<br />
Weisenburger, D.; Hochberg, F. (1994) Detection<br />
of Eber-1 RNA in primary brain lymphomas in<br />
immunocompetent and immunocompromised<br />
patients. J. Neuro-Oncol. 20, 47–53.<br />
Di Giuseppe, J. A.; Wu, T.-C.; Corio, R. L. (1994)<br />
Analysis of epstein-barr virus-encoded small RNA 1<br />
expression in benign lymphoepithelial salivary<br />
gland lesions. Mod. Pathol. 7 (5), 555–559.<br />
Lima, M. I.; Fonseca, M. E. N.; Flores, R.; Kitajima,<br />
E. W. (1994) Detection of avocado sunblotch viroid<br />
in chloroplasts of avocado leaves by in situ<br />
hybridization. Arch. Virol. 138, 385–390.<br />
Lin, N.-S.; Chen, C.-C.; Hsu, Y.-H. (1993) Postembedding<br />
in situ hybridization for localization<br />
of viral nucleic acid in ultra-thin sections. J.<br />
His<strong>to</strong>chem. Cy<strong>to</strong>chem. 41 (10), 1513–1519.<br />
C. DNA probes<br />
d. PCR<br />
References<br />
Tanaka, Y.; Enomo<strong>to</strong>, N.; Kojima, S.; Tang, L.;<br />
Go<strong>to</strong>, M.; Marumo, F.; Sa<strong>to</strong>, C. (1993) Detection<br />
of hepatitis C virus RNA in the liver by in situ<br />
hybridization. Liver 13, 203–208.<br />
187<br />
6
6<br />
188<br />
References<br />
2. DNA target<br />
A. DNA probes<br />
a. RPL<br />
Boland, N. I.; Gosden, R. G. (1994) Clonal analysis<br />
of chimaeric mouse ovaries using DNA in situ<br />
hybridization. J. Reprod. Fertility 100, 203–210.<br />
Brown, D. W.; Welsh, R. M.; Like, A. A. (1993)<br />
<strong>In</strong>fection of peripancreatic lymph nodes but not<br />
islets precedes kilham rat virus-induced diabetes in<br />
BB/Wor rats. J. Virol. 67 (10), 5873–5878.<br />
Burnett, S.; Kiessling, U.; Pettersson, U. (1989) Loss<br />
of bovine papillomavirus DNA replication control in<br />
growth-arrested transformed cells. J. Virol. 63 (5),<br />
2215–2225.<br />
Cenacchi, G.; Musiani, M.; Gentilomi, G.; Righi, S.;<br />
Zerbini, M.; Chandler, J. G.; Scala, C.; La Plaga, M.;<br />
Martinelli, G. N. (1993) <strong>In</strong> situ hybridization at the<br />
ultrastructural level: localization of cy<strong>to</strong>megalovirus<br />
DNA using digoxigenin labeled probes.<br />
J. Submicrosc. Cy<strong>to</strong>l. Pathol. 25 (3), 341–345.<br />
Clark, J.; Moore, L.; Krasinskas, A.; Way, J.;<br />
Battey, J.; Tamkun, J.; Kahn, R. A. (1993) Selective<br />
amplification of additional members of the ADPribosylation<br />
fac<strong>to</strong>r (ARF) family: Cloning of additional<br />
human and drosophila ARF-like genes. Proc. Natl.<br />
Acad. Sci. USA 90, 8952–8956.<br />
Coates, P. J.; D’Ardenne, A. J.; Slavin, G.; Kings<strong>to</strong>n,<br />
J. E.; Malpas, J. S. (1993) Detection of Epstein-Barr<br />
virus in reed-sternberg cells of hodgkin’s disease<br />
arising in children. Med. Pediatric Oncol. 21, 19–23.<br />
Delvenne, P.; Fontaine, M.-A.; Delvenne, C.;<br />
Nikkels, A.; Boniver, J. (1994) Detection of human<br />
papillomaviruses in paraffin-embedded biopsies<br />
of cervical intraepithelial lesions: analysis by<br />
immunohis<strong>to</strong>chemistry, in situ hybridization, and<br />
the polymerase chain reaction. Modern Pathol. 7<br />
(1), 113–119.<br />
Delvenne, P.; Kaschten, B.; Deneufbourg, J. M.;<br />
Demanez, L.; Stevenaert, A.; Reznik, M.; Boniver, J.<br />
(1993) Detection of Epstein-Barr virus in a case of<br />
undifferentiated nasopharyngeal carcinoma by<br />
in situ hybridization with digoxigenin-labeled PCRgenerated<br />
probes. Virchows Archiv A. Pathol. Anat.<br />
423, 145–150.<br />
Fletcher, S.; Darragh, D.; Fan, Y.; Grounds, M. D.;<br />
Fischer, C. J.; Beilharz, M. W. (1993) Specific<br />
cloning of DNA fragments unique <strong>to</strong> the dog<br />
Y chromosome. GATA 10 (3–4), 77–83.<br />
Furuta, Y.; <strong>In</strong>uyama, Y.; Nagashima, K. (1989)<br />
Detection of human papillomavirus genome in<br />
nasolaryngeal papillomas using digoxigenin labeled<br />
DNA probes. J. O<strong>to</strong>laryngol. Japan. 92, 2055–2063.<br />
Furuta, Y.; Shinohara, T.; Sano, K.; Meguro, M.;<br />
Nagashima, K. (1990) <strong>In</strong> situ hybridization with<br />
digoxigenin-labeled DNA probes for detection of<br />
viral genomes. J. Clin. Pathol. 43, 806–809.<br />
Gentilomi, G.; Musiani, M.; Zerbini, M.; Gallinella, G.;<br />
Gibellini, D.; La Placa, M. (1989) A hybrido-immunocy<strong>to</strong>chemical<br />
assay for the in situ detection of<br />
cy<strong>to</strong>megalovirus DNA using digoxigenin-labeled<br />
probes. J. Immunol. Methods 125, 177–183.<br />
Genitilomi, G.; Musiani, M.; Zerbini, M.; Gibellini, D.;<br />
Gallinella, G.; Venturoli, S. (1992) Double in situ<br />
hybridization for detection of herpes simplex virus<br />
and cy<strong>to</strong>megalovirus DNA using non-radioactive<br />
probes. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 40 (3), 421–425.<br />
Gentilomi, G.; Zerbini, M.; Musiani, M.; Gallinella,<br />
G.; Gibellini, D.; Venturoli, S.; Re, M. C.; Pileri, S.;<br />
Finelli, C.; La Placa, M. (1993) <strong>In</strong> situ detection of<br />
B19 DNA in bone marrow of immunodeficient<br />
patients using a digoxigenin-labeled probe. Mol.<br />
Cell. Probes 7, 19–24.<br />
Han, K.-H.; Hollinger, F. B.; Noonan, C. A.; Yoffe, B.<br />
(1992) Simultaneous detection of HBV-specific<br />
antigens and DNA in paraffin-embedded liver tissue<br />
by immunohis<strong>to</strong>-chemistry and in situ hybridization<br />
using a digoxigenin-labeled probe. J. Virol. Meth.<br />
37, 89–98.<br />
Heiles, H. B. J.; Genersch, E.; Kessler, C.; Neumann,<br />
R.; Eggers, H. J. (1988) <strong>In</strong> situ hybridization with<br />
digoxigenin-labeled DNA of human papillomaviruses<br />
(HPV 16/18) in HeLa and SiHa cells. BioTechn. 6,<br />
978–981.<br />
Heino, P.; Hukkanen, V.; Arstila, P. (1989) Detection<br />
of human papilloma virus (HPV) DNA in genital<br />
biopsy specimens by in situ hybridization with<br />
digoxigenin-labeled probes. J. Virol. Methods 26,<br />
331–338.<br />
Holm, R.; Karlsen, F.; Nesland, J. M. (1992)<br />
<strong>In</strong> situ hybridization with noniso<strong>to</strong>pic probes using<br />
different detection systems. Modern Pathol. 5 (3),<br />
315–319.<br />
Han, K. H.; Hollinger, F. B.; Noonan, C. A.; Solomon,<br />
H.; Klintmalm, G. B. G.; Genta, R. M.; Yoffe, B.<br />
(1993) Southern-blot analysis and simultaneous<br />
in situ detection of hepatitis B virus-associated<br />
DNA and antigens in patients with end-stage liver<br />
disease. Hepa<strong>to</strong>l. 18, 1032–1038.<br />
Jackwood, D. J.; Swayne, D. E.; Fisk, R. J. (1992)<br />
Detection of infectious bursal disease viruses<br />
using in situ hybridization and non-radioactive<br />
probes. Avian Diseases 36, 154–157.<br />
Jacob, J.; Kassir, R.; Kelsoe, G. (1991) <strong>In</strong> situ<br />
studies of the primary immune response <strong>to</strong><br />
(4-hydroxy-3-nitrophenyl)acetyl. I. The architecture<br />
and dynamics of responding cell populations.<br />
J. Exp. Med. 173, 1165–1175.<br />
CONTENTS<br />
INDEX
Kawase, M.; Honda, M.; Niimura, M. (1994)<br />
Detection of human papillomavirus type 60 in<br />
plantar cysts and verruca plantaris by the in situ<br />
hybridization method using digoxigenin labeled<br />
probes. J. Derma<strong>to</strong>l. 21, 709–715.<br />
Keighren, M.; West, J. D. (1993) Analysis of cell<br />
ploidy in his<strong>to</strong>logical sections of mouse tissues by<br />
DNA-DNA in situ hybridization with digoxigeninlabeled<br />
probes. His<strong>to</strong>chem. J. 25, 30–44.<br />
Konkle, B. A.; Shapiro, S. S.; Asch, A. S.; Nachman,<br />
R. L. (1990) Cy<strong>to</strong>kine-enhanced expression of<br />
glycoprotein Iba in human endothelium. J. Biol.<br />
Chem. 265 (32), 19833–19838.<br />
Lassus, J.; Niemi, K.-M.; Marjamäki, A.; Syrjänen, S.;<br />
Kartamaa, M.; Lehmus, A.; Krohn, K.; Ranki, A.<br />
(1992) Comparison of four in situ hybridization<br />
methods, based on digoxigenin- and biotin-labeled<br />
probes, in detecting HPV DNA in male condylomata<br />
acuminata. <strong>In</strong>tern. J. STD & AIDS 3, 196–203.<br />
Lau, J. Y. N.; Naoumov, N. V.; Alexander, G. J. M.;<br />
Williams, R. (1991) Rapid detection of hepatitis B<br />
virus DNA in liver tissue by in situ hybridization<br />
and its combination with immunohis<strong>to</strong>chemistry<br />
for simultaneous detection of HBV antigens.<br />
J. Clin. Pathol. 44, 905–908.<br />
Lereuz, M.; Pallier, C.; Vassias, I.; Elouet, J. F.;<br />
Romeo, P.; Morinet, F. (1994) Differential<br />
transcription, without replication, of non-structural<br />
and structural genes of human parvovirus B19 in<br />
the UT7/EPO cell line as demonstrated by in situ<br />
hybridization. J. Gen. Virol. 75, 1475–1478.<br />
Morey, A. L.; Ferguson, D. J. P.; Leslie, K. O.;<br />
Taatjes, D. J.; Fleming, K. A. (1993) <strong>In</strong>tracellular<br />
localization of parvovirus B19 nucleic acid at the<br />
ultrastructural level by in situ hybridization with<br />
digoxigenin-labeled probes. His<strong>to</strong>chem. J. 25,<br />
421–429.<br />
Morris, R. G.; Arends, M. J.; Bishop, P. E.; Sizer, K.;<br />
Duvall, E.; Bird, C. C. (1990) Sensitivity of digoxigenin-<br />
and biotin-labeled probes of detection of<br />
human papillomavirus by in situ hybridization.<br />
J. Clin. Pathol. 43, 800–805.<br />
Musiani, M.; Gentilomi, G.; Zerbini, M.; Gibellini, D.;<br />
Gallinella, G.; Pileri, S.; Baglioni, P.; La Placa, M.<br />
(1990) <strong>In</strong> situ detection of cy<strong>to</strong>megalovirus DNA<br />
in biopsies of AIDS patients using a hybridoimmunocy<strong>to</strong>chemical<br />
assay. His<strong>to</strong>chem. 94, 21–25.<br />
Prelle, A.; Fagiolari, G.; Checcarelli, N.; Moggio, M.;<br />
Battistel, A.; Comi, G. P.; Bazzi, P.; Bordoni, A.;<br />
Zeviani, M.; Scarla<strong>to</strong>, G. (1994) Mi<strong>to</strong>chondrial<br />
myopathy: correlation between oxidative defect<br />
and mi<strong>to</strong>chondrial DNA deletions at single fiber<br />
level. Acta Neuropathol. 87, 371–376.<br />
Permeen, A. M. Y.; Sam, C. K.; Pathmanathan, R.;<br />
Prasad, U.; Wolf, H. (1990) Detection of Epstein Barr<br />
Virus DNA in nasopharyngeal carcinoma using a<br />
non-radioactive digoxigenin-labeled probe. J. Virol.<br />
Meth. 27 (3), 261–268.<br />
CONTENTS<br />
INDEX<br />
Premoli-de-Percoco, G.; Galindo, I.; Ramirez, J. L.<br />
(1992) <strong>In</strong> situ hybridization with digoxigenin-labeled<br />
DNA probes for the detection of human papillomavirus-induced<br />
focal epithelial hyperplasia among<br />
Venezuelans. Virchows Archiv A. Pathol. Anat. 420,<br />
295–300.<br />
Schmidt, P.; Meyer, H.; Hübert, P.; Hafner, A.;<br />
Andiel, E.; Grabner, A.; Dahme, E. (1994) <strong>In</strong> situ<br />
hybridization for demonstration of equine herpesvirus<br />
type 1 DNA in paraffin wax-embedded tissues<br />
and its use in horses with disseminated necrotizing<br />
myeloencephalitis. J. Comp. Path. 110, 215–225.<br />
Schwarz, T. F.; Nerlich, A.; Hottenträger, B.; Jäger,<br />
G.; Wiest, I.; Kantimm, S.; Roggendorf, H.; Schultz,<br />
M.; Gloning, K.-P.; Schramm, T.; Holzgreve, W.;<br />
Roggendorf, M. (1991) Parvovirus B19 infection<br />
of the fetus. His<strong>to</strong>logy and in situ hybridization.<br />
Am. J. Clin. Pathol. 96 (1), 121–126.<br />
Schwarz, T. F.; Nerlich, A.; Hillemanns, P. (1993)<br />
Detection of parvovirus B19 in fetal au<strong>to</strong>psies. Arch.<br />
Gynecol. Obstet. 253, 207–213.<br />
Smith, K. L.; Robbins, P. D.; Dawkins, H. J. S.;<br />
Papadimitriou, J. M.; Redmond, S. L.; Carrello, S.;<br />
Harvey, J. M.; Sterrett, G. F. (1994) c-erbB-2<br />
amplification in breast cancer: Detection in<br />
formalin-fixed, paraffin-embedded tissue by in situ<br />
hybridization. Hum. Pathol. 25, 413–418.<br />
Thompson, C. H.; Biggs, I. M.; De Zwart-Steffe, R. T.<br />
(1990) Detection of molluscum contagiosum virus<br />
DNA by in situ hybridization. Pathol. 22, 181–186.<br />
b. Nick translation<br />
References<br />
Coates, P. J.; Mak, W. P.; Slavin, G.; D’Ardenne, A. J.<br />
(1991) Detection of single copies of Epstein-Barr<br />
virus in paraffin wax sections by non-radioactive<br />
in situ hybridization. J. Clin. Pathol. 44, 487–491.<br />
Coates, P. J.; Slavin, G.; D’Ardenne, A. J. (1991)<br />
Persistence of epstein-barr virus in reed-sternberg<br />
cells throughout the course of hodgkin’s disease.<br />
J. Pathol. 164, 291–297.<br />
Cooper, K.; Herring<strong>to</strong>n, C. S.; Graham, A. K.;<br />
Evans, M. F.; McGee, J. O’D (1991) <strong>In</strong> situ human<br />
papillomavirus (HPV) genotyping of cervical intraepithelial<br />
neoplasia in South African and British<br />
patients: Evidence for putative HPV integration<br />
in vivo. J. Clin. Pathol. 44, 400–405.<br />
Cooper, K.; Herring<strong>to</strong>n, C. S.; Lo, E. S.-F.; Evans,<br />
M. F.; McGee, J. O. (1992) <strong>In</strong>tegration of human<br />
papillomavirus types 16 and 18 in cervical<br />
adenocarcinoma. J. Clin. Pathol. 45, 382–384.<br />
Del Buono, R.; Fleming, K. A.; Morey, A. L.;<br />
Hall, P. A.; Wright, N. A. (1992) A nude mouse<br />
xenograft model of fetal intestine development<br />
and differentiation. Development 114, 67–73.<br />
Egawa, K.; Shibasaki, Y.; De Villiers, E.-M. (1993)<br />
Double infection with human papillomavirus 1 and<br />
human papillomavirus 63 in single cells of a lesion<br />
displaying only an human papillomavirus 63-induced<br />
cy<strong>to</strong>pathogenic effect. Lab. <strong>In</strong>vest. 69 (5), 583–588.<br />
189<br />
6
6<br />
190<br />
References<br />
Hegele, R. G.; Bicknell, S. G.; Bailey, D. J.; Cameron,<br />
R. G. (1994) <strong>In</strong> situ hybridization for the Y chromosome<br />
reveals a donor origin for a posttransplant<br />
lymphoproliferative disorder in a sex-mismatched<br />
hepatic allograft. Arch. Pathol. Lab. Med. 118,<br />
795–796.<br />
Heiskanen, M.; Karhu, R.; Hellsten, E.; Pel<strong>to</strong>nen, L.;<br />
Kallioniemi, O. P.; Palotie, A. (1994) High resolution<br />
mapping using fluorescence in situ hybridization <strong>to</strong><br />
extended DNA fibers prepared from agaroseembedded<br />
cells. BioTechn. 17 (5), 928–933.<br />
Herring<strong>to</strong>n, C. S.; Burns, J.; Graham, A. K.;<br />
Bhatt, B.; McGee, J. O. (1989) <strong>In</strong>terphase cy<strong>to</strong>genetics<br />
using biotin and digoxigenin labeled<br />
probes. II. Simultaneous differential detection of<br />
human and papilloma virus nucleic acids in<br />
individual nuclei. J. Clin. Pathol. (Lond) 42 (6),<br />
601–606.<br />
Herring<strong>to</strong>n, C. S.; Burns, J.; Graham, A. K.; Evans,<br />
M.; McGee, J. O. (1989) <strong>In</strong>terphase cy<strong>to</strong>genetics<br />
using biotin and digoxigenin labeled probes. I.<br />
Relative sensitivity of both reporter molecules for<br />
detection of HPV16 in caski cells. J. Clin. Pathol.<br />
(Lond) 42 (6), 592–600.<br />
Herring<strong>to</strong>n, C. S.; Bhatt, B.; Burns, J.; Graham, A. K.;<br />
McGee, J. O. (1989) Simultaneous non-iso<strong>to</strong>pic in<br />
situ hybridization using biotinylated and digoxigeninlabeled<br />
probes. J. Pathol. (Edin) 157, 163.<br />
Herring<strong>to</strong>n, C. S.; De Angelis, M.; Evans, M. F.;<br />
Troncone, G.; McGee, J. O. (1992) Detection of high<br />
risk human papillomavirus in routine cervical<br />
smears: Strategy for screening. J. Clin. Pathol. 45,<br />
385–390.<br />
Herring<strong>to</strong>n, C. S.; Graham, A. K.; Burns, J.;<br />
McGee, J. O. (1989) Enhancement of sensitivity of<br />
digoxigenin labeled probes: the evaluation of a<br />
biotin independent detection system. J. Pathol.<br />
(Edin) 158, 337.<br />
Herring<strong>to</strong>n, C. S.; Graham, A. K; McGee, J. O.<br />
(1991) <strong>In</strong>terphase cy<strong>to</strong>genetics using biotin and<br />
digoxigenin labeled probes: III. <strong>In</strong>creased sensitivity<br />
and flexibility for detecting HPV in cervical biopsy<br />
specimens and cell lines. J. Clin. Pathol. 44 (1),<br />
33–38.<br />
Kerstens, H. M. J.; Poddighe, P. J.; Hanselaar,<br />
A. G. J. M. (1995) A novel in situ hybridization<br />
signal amplification method based on the deposition<br />
of biotinylated tyramine. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem.<br />
43 (4), 347–352.<br />
Kerstens, H. M. J.; Poddighe, P. J.; Hanselaar, A. G.<br />
J. M. (1994) Double-target in situ hybridization in<br />
brightfield microscopy. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 42<br />
(8), 1071–1077.<br />
Lawrence, J. B.; Marselle, L. M.; Byron, K. S.;<br />
Johnson, C. V.; Sullivan, J. L.; Singer, R. H. (1990)<br />
Subcellular localization of low-abundance human<br />
immunodeficiency virus nucleic acid sequences<br />
visualized by fluorescence in situ hybridization.<br />
Proc. Natl. Acad. Sci. 87, 5420–5424.<br />
Leitch, I. J.; Leitch, A. R.; Heslop-Harrison, J. S.<br />
(1991) Physical mapping of plant DNA sequences<br />
by simultaneous in situ hybridization of two<br />
differently labeled fluorescent probes. Genome 34,<br />
329–333.<br />
Morey, A. L.; Porter, H. J.; Keeling, J. W.; Fleming,<br />
K. A. (1992) Non-iso<strong>to</strong>pic in situ hybridization and<br />
immunophenotyping of infected cells in the<br />
investigation of human fetal parvovirus infection.<br />
J. Clin. Pathol. 45, 673–678.<br />
Scherthan, H. (1991) Characterisation of a tandem<br />
repetitive sequence cloned from the deer capreolus<br />
capreolus and it’s chromosomal localisation in two<br />
muntjac species. Hereditas (in press).<br />
Steilen, H.; Ketter, R.; Romanakis, K.; Zwergel, T.;<br />
Unteregger, G.; Bonkhoff, H.; Seitz, G.; Ziegler, M.;<br />
Zand, K. D.; Wullich, B. (1994) DNA aneuploidy in<br />
prostatic adenocarcinoma: A frequent event as<br />
shown by fluroescence in situ DNA hybridization.<br />
Hum. Pathol. 25, 1306–1313.<br />
Troncone, G.; Herring<strong>to</strong>n, C. S.; Cooper, K.;<br />
De Angelis, M. L.; McGee, J. O. (1992) Detection of<br />
human papillomavirus in matched cervical smears<br />
and biopsy specimens by non-iso<strong>to</strong>pic in situ<br />
hybridization. J. Clin. Pathol. 45, 308–313.<br />
Wachtler, F.; Schöfer, C.; Schedle, A.; Schwarzacher,<br />
H. G.; Hartung, M.; Stahl, A.; Gonzales, I.; Sylvester, J.<br />
(1991) Transcribed and nontranscribed parts of the<br />
human ribosomal gene repeat show a similar<br />
pattern of distribution in nucleoli. Cy<strong>to</strong>genet. Cell<br />
Genet. 57, 175–178.<br />
Wood, N. B.; Sheikholeslami, M.; Pool, M.; Coon, J. S.<br />
(1994) PCR production of a digoxigenin-labeled<br />
probe for the detection of human cy<strong>to</strong>megalovirus<br />
in tissue sections. Diagn. Mol. Pathol. 3 (3),<br />
200–208.<br />
d. PCR<br />
Saeki, K.; Mishima, K.; Horiuchi, K.; Hirota, S.;<br />
Nomura, S.; Kitamura, Y.; Aozasa, K. (1993)<br />
Detection of low copy numbers of epstein-barr<br />
virus by in situ hybridization using nonradioiso<strong>to</strong>pic<br />
probes prepared by the polymerase chain reaction.<br />
Diagn. Mol. Pathol. 2 (2), 108–115.<br />
Varma, V. A.; Cerjan, C. M.; Abbott, K. L.; Hunter, S. B.<br />
(1994) Non-iso<strong>to</strong>pic in situ hybridization method for<br />
mi<strong>to</strong>chondria in oncocytes. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. 42 (2), 273–276.<br />
CONTENTS<br />
INDEX
B. RNA probes<br />
Brown, C. C.; Meyer, R. F.; Grubman, M. J. (1994)<br />
Identification of african horse sickness virus in cell<br />
culture using a digoxigenin-labeled RNA probe.<br />
J. Vet. Diagn. <strong>In</strong>vest. 6, 153–155.<br />
Coen, E. S.; Romero, J. M.; Doyle, S.; Elliott, R.;<br />
Murphy, G.; Carpenter, R. (1990) Floricaula:<br />
A homeotic gene required for flower development<br />
in Antirrhinum majus. Cell 63, 1311–1322.<br />
Marquardt, D. L.; Walker, L. L.; Heinemann, S.<br />
(1994) Cloning of two adenosine recep<strong>to</strong>r subtypes<br />
from mouse bone marrow-derived mast cells.<br />
J. Immunol. 152, 4508–4515.<br />
Su, I.-J.; Chen, R.-L.; Lin, D.-T.; Lin, K.-S.;<br />
Chen, C.-C. (1994) Epstein-Barr virus (EBV) infects<br />
T lymphocytes in childhood EBV-associated<br />
hemophagocytic syndrome in Taiwan. Am. J. Pathol.<br />
144 (6), 1219–1225.<br />
CONTENTS<br />
INDEX<br />
C. Oligonucleotide probe<br />
b. 3'-Tailing<br />
Cubie, H. A.; Felix, D. H.; Southam, J. C.; Wray, D.<br />
(1991) Application of molecular techniques in the<br />
rapid diagnosis of EBV-associated oral hairy<br />
leukoplakia. J. Oral. Pathol. Med. 20, 271–274.<br />
Cubie, H. A.; <strong>In</strong>glis, J. M.; McGowan, A. M. (1991)<br />
Detection of respira<strong>to</strong>ry syncytial virus antigen and<br />
nucleic acid in clinical specimens using synthetic<br />
oligonucleotides. J. Virol. Meth. 34, 27–35.<br />
Oraveerakul, K.; Choi, C. S.; Moli<strong>to</strong>r, T. W. (1993)<br />
Tissue tropisms of porcine parvovirus in swine.<br />
Arch. Virol. 130, 377–389.<br />
Pacchioni, D.; Papotti, M.; Bonio, F.; Bussolati, G.;<br />
Negro, F. (1992) Detection of cy<strong>to</strong>megalovirus by<br />
in situ hybridization using a digoxigenin-tailed oligonucleotide.<br />
Liver 12, 257–261.<br />
c. Chemical synthesis<br />
References<br />
Zischler, H.; Nanda, J.; Schäfer, R.; Schmid, M.;<br />
Epplen, J. (1989) Digoxigenated oligonucleotide<br />
probes specific for simple repeats in DNA<br />
fingerprinting and hybridization in situ. Hum. Genet.<br />
82 (3), 227–233.<br />
191<br />
6
6<br />
192<br />
References<br />
3. Chromosomes/<strong>In</strong>terphase nuclei<br />
An<strong>to</strong>nacci, R.; Marzella, R.; Finelli, P.; Lonoce, A.;<br />
Forabosco, A.; Archidiacono, N.; Rocchi, M. (1995)<br />
A panel of subchromosomal painting libraries<br />
representing over 300 regions of the human<br />
genome. Cy<strong>to</strong>genet. Cell Genet. 68, 25–32.<br />
Arnold, N.; Seibl, R.; Kessler, C.; Wienberg, J.<br />
(1992) Non-radioactive in situ hybridization with<br />
digoxigenin labeled DNA probes. Biotechnic<br />
His<strong>to</strong>chem. 67 (2), 59–67.<br />
Arnoldus, E. P. J.; Wiegant, J.; Noordermeer, I. A.;<br />
Wessels, J. W.; Beers<strong>to</strong>ck, G. C.; Grosveld, G. C.;<br />
van der Ploeg, M.; Raap, A. K. (1990) Detection of<br />
the Philadelphia chromosome in interphase nuclei.<br />
Cy<strong>to</strong>genet. Cell Genet. 54, 108–111.<br />
Ashley, T.; Ried, T.; Ward, D. C. (1994) Detection<br />
of nondisjunction and recombination in meiotic and<br />
postmeiotic cells from XYSxr [XY, Tp(Y)1Ct] mice<br />
using multicolor fluorescence in situ hybridization.<br />
Proc. Natl. Acad. Sci. USA 91, 524–528.<br />
Avarello, R.; Pedicini, A.; Caiulo, A.; Zuffardi, O.;<br />
Fraccaro, M. (1992) Evidence for an ancestral<br />
alphoid domain on the long arm of human<br />
chromosome 2. Hum. Genet 89, 247–249.<br />
Balazs, M.; Mayall, B. H.; Waldmann, F. M. (1991)<br />
Simultaneous analysis of chromosomal aneusomy<br />
and 5-bromodeoxyuridine incorporation in MCF-7<br />
breast tumor cell line. Cancer Genet. Cy<strong>to</strong>genet. 57,<br />
93–102.<br />
Boggs, B. A.; Chinault, C. (1994) Analysis of<br />
replication timing properties of human X-chromosomal<br />
loci by fluorescence in situ hybridization.<br />
Proc. Natl. Acad. Sci. USA 91, 6083–6087.<br />
Boschman, G. A.; Buys, C. H. C. M.; Van der Veen,<br />
A. Y.; Rens, W.; Osinga, J.; Slater, R. M.; Aten, J. A.<br />
(1993) Identification of a tumor marker chromosome<br />
by flow sorting, DNA amplification in vitro,<br />
and in situ hybridization of the amplified product.<br />
Genes Chrom. Cancer 6, 10–16.<br />
Boyle, A. L.; Feltquite, D. M.; Dracopoli, N. C.;<br />
Housman, D. E.; Ward, D. C. (1992) Rapid physical<br />
mapping of cloned DNA on banded mouse chromosomes<br />
by fluorescence in situ hybridization.<br />
Genomics 12, 106–115.<br />
Brandt, C. A.; Hindkjaer, J.; Stromkjaer, H.;<br />
Pedersen, S.; Sunde, L.; Kolvraa, S. (1993)<br />
Molecular cy<strong>to</strong>genetics: Applications in clinical<br />
genetics. Europ. J. Obstetrics & Gynecol. Reprod.<br />
Biol. 50, 235–242.<br />
Brandt, C. A.; Lyngbye, T.; Pedersen, S.; Bolund, L.;<br />
Friedrich, U. (1994) Value of chromosome painting<br />
in determining the chromosomal outcome in<br />
offspring of a 12; 16 translocation carrier. J. Med.<br />
Genet. 31, 234–237.<br />
Celeda, D.; Bettag, U.; Cremer, C. (1992)<br />
PCR Amplification and simultaneous digoxigenin<br />
incorporation of long DNA probes for fluorescence<br />
in situ hybridization. BioTechn. 12 (1), 98–102.<br />
Celeda, D.; Aldinger, K.; Haar, F.-M.; Hausmann, M.;<br />
Durm, M.; Ludwig, H.; Cremer, C. (1994) Rapid<br />
fluorescence in situ hybridization with repetitive<br />
DNA probes: Quantification by digital image<br />
analysis. Cy<strong>to</strong>metry 17, 13–25.<br />
Chevillard, C.; Le Paslier, D.; Passage, E.; Ougen, P.;<br />
Billault, A.; Boyer, S.; Mazan, S.; Bachellerie,<br />
J. P.; Vignal, A.; Cohen, D.; Fontes, M. (1993)<br />
Relationship between Charcot-Marie-Tooth 1A and<br />
Smith-Magenis regions. snU3 may be a candidate<br />
gene for the Smith-Magenis syndrome. Hum. Mol.<br />
Gen. 2 (8), 1235–1243.<br />
Christmann, A.; Lagoda, P. J. L.; Zang, K. D. (1991)<br />
Non-radioactive in situ hybridization pattern of the<br />
M13 minisatellite sequences on human metaphase<br />
chromosomes. Hum. Genet. 86, 487–490.<br />
Couturier, J.; Garau-Sastre, X.; Schneider-<br />
Maunoury, S.; Labib, A.; Orth, G. (1991) <strong>In</strong>tegration<br />
of papillomavirus DNA near myc genes in genital<br />
carcinomas and its consequences for pro<strong>to</strong>oncogene<br />
expression. J. Virol. Vol. 65, No. 8,<br />
4534–4538.<br />
Dal Cin, P.; Aly, M. S.; Delabie, J.; Ceuppens, J. L.;<br />
Van Gool, S.; Van Damme, B.; Baert, L.; Van Poppel,<br />
H.; Van Den Berghe, H. (1992) Trisomy 7 and<br />
trisomy 10 characterize subpopulations of tumorinfiltrating<br />
lymphocytes in kidney tumors and in the<br />
surrounding kidney tissue. Proc. Natl. Acad. Sci.<br />
USA 89, 9744–9748.<br />
Dauwerse, J. G.; Wiegant, J.; Raap, A. K.; Breuning,<br />
M. H.; Ommen, van, G. J. B. (1992) Multiple colors<br />
by fluorescence in situ hybridization using ratiolabeled<br />
DNA probes create a molecular karyotype.<br />
Hum. Mol. Gen. 1 (8), 593–598.<br />
Davies, A. F.; Barber, L.; Murer-Orlando, M.;<br />
Bobrow, M.; Adinolfi, M. (1994) FISH detection of<br />
trisomy 21 in interphase by the simultaneous use<br />
of two differentially labeled cosmid contigs. J. Med.<br />
Genet. 31, 679–685.<br />
De Fru<strong>to</strong>s, R.; Kimura, K.; Peterson, K. R. (1990)<br />
<strong>In</strong> situ hybridization of Drosophila polytene<br />
chromosomes with digoxigenin-dUTP labeled<br />
probes. Methods Mol. Cell. Biol. 2, 32–36.<br />
Delhanty, J. D. A.; Griffin, D. K.; Handyside, A. H.;<br />
Harper, J.; Atkinson, G. H. G.; Pieters, M. H. E. C.;<br />
Wins<strong>to</strong>n, R. M. L. (1993) Detection of aneuploidy<br />
and chromosomal mosaicism in human embryos<br />
during preimplantation sex determination by<br />
fluorescent in situ hybridzation (FISH). Hum. Mol.<br />
Gen. 2 (8), 1183–1185.<br />
De Leeuw, B.; Suijkerbuijk, R. F.; Balemans, M.;<br />
Sinke, R. J.; De Jong, B.; Molenaar, W. M.; Meloni,<br />
A. M.; Sandberg, A. A.; Geraghty, M.; Hofker, M.;<br />
Ropers, H. H.; Geurts van Kessel, A. (1993)<br />
Sublocalization of the synovial sarcoma-associated<br />
t(X;18) chromosomal breakpoint in Xp11.2 using<br />
cosmid cloning and fluorescence in situ<br />
hybridization. Oncogene 8, 1457–1463.<br />
CONTENTS<br />
INDEX
De Leeuw, B.; Berger, W.; Sinke, R. J.; Suijkerbuijk,<br />
R. F.; Gilgenkrantz, S.; Geraghty, M. T.; Valle, D.;<br />
Monaco, A. P.; Lehrach, H.; Ropers, H. H.; Geurts<br />
van Kessel, A. (1993) Identification of a yeast<br />
artificial chromosome (YAC) spanning the synovial<br />
sarcoma-specific t(X;18)(p11.2;q11.2) Breakpoint.<br />
Genes, Chrom. Cancer 6, 182–189.<br />
Desmaze, C.; Zucman, J.; Delattre, O.; Thomas, G.;<br />
Aurias, A. (1992) <strong>In</strong> situ hybridization of PCR<br />
amplified inter-Alu sequences from a hybrid cell<br />
line. Hum. Genet. 88, 541–544.<br />
De Vries, J. E.; Kornips, F. H. A. C.; Wiegant, J.;<br />
Moerkerk, P. M.; Senden, N.; Schutte, B.; Geraedts,<br />
J. P. M.; Bosman, F. T.; ten Kate, J. (1992)<br />
Chromosomal localization of transfected genes by<br />
a combination of hot banding and fluorescence<br />
in situ hybridization.<br />
Döhner, H.; Pohl, S.; Bulgay-Mörschel, M.;<br />
Stilgenbauer, S.; Bentz, M.; Lichter, P. (1993)<br />
Trisomy 12 in Chronic Lymphoid Leukemias – a<br />
Metaphase and <strong>In</strong>terphase Cy<strong>to</strong>genetic Analysis.<br />
Leukemia 7 (4), 516–520.<br />
Dunham, I.; Lengauer, C.; Cremer, T.; Feathers<strong>to</strong>ne,<br />
T. (1992) Rapid generation of chromosome-specific<br />
alphoid DNA probes using the polymerase chain<br />
reaction. Hum. Genet. 88, 457–462.<br />
Fidlerová, H.; Senger, G.; Kost, M.; Sanseau, P.;<br />
Sheer, D (1994) Two simple procedures for<br />
releasing chromatin from routinely fixed cells for<br />
fluorescence in situ hybridization. Cy<strong>to</strong>genet. Cell<br />
Genet. 65, 203–205.<br />
Flejter, W. L.; Barcroft, C. L.; Guo, S.-W.; Lynch, E.<br />
D.; Boehnke, M.; Chandrasekharappa, S.; Hayes, S.;<br />
Collins, F. S.; Weber, B. L.; Glover, T. W. (1993)<br />
Multicolor FISH mapping with Alu-PCR-Amplified<br />
YAC Clone DNA determines the order of markers in<br />
the BRCA1 region on chromosome 17q12-q21.<br />
Genomics 17, 624–631.<br />
Gerdes, M. G.; Carter, K. C.; Moen, P. T.; Lawrence,<br />
J. B. (1994) Dynamic changes in the higher-level<br />
chromatin organization of specific sequences<br />
revealed by in situ hybridization <strong>to</strong> nuclear halos.<br />
J. Cell Biol. 126 (2), 289–304.<br />
Geurts van Kessel, A.; Stellink, F.; van Gaal, J.;<br />
van de Klundert, W.; Siepman, A.; Oosten, H. R.<br />
(1994) Translocation (12;22) (p13;q12) as sole<br />
karyotypic abnormality in a patient with nonlymphocytic<br />
leukemia. Cancer Genet. Cy<strong>to</strong>genet.<br />
72, 105–108.<br />
Gray, J. W.; Pinkel, D.; Brown, J. M. (1994)<br />
Fluorescence in situ hybridization in cancer and<br />
radiation biology. Radiat. Res. 137, 275–289.<br />
Haar, F.-M.; Durm, M.; Aldinger, K.; Celeda, D.;<br />
Hausmann, M.; Ludwig, H.; Cremer, C. (1994)<br />
A rapid FISH technique for quantitative microscopy.<br />
BioTechn. 17 (2), 346–355.<br />
Han, T. L.; Ford, J. H.; Webb, G. C.; Flaherty, S. P.;<br />
Correll, A.; Matthews, C. D. (1993) Simultaneous<br />
detection of X- and Y-bearing human sperm by<br />
double fluorescence in situ hybridization. Mol.<br />
Reprod. Develop. 34, 308–313.<br />
CONTENTS<br />
INDEX<br />
References<br />
Han, T. L.; Ford, J. H.; Flaherty, S. P.; Webb, G. C.;<br />
Matthews, C. D. (1994) A fluorescent in situ<br />
hybridization analysis of the chromosome<br />
constitution of ejaculated sperm in a 47,XYY male.<br />
Clin. Genet. 45, 57–70.<br />
Hausmann, M.; Dudin, G.; Aten, J. A.; Heilig, R.;<br />
Diaz, E.; Cremer, C. (1991) Slit Scan Flow Cy<strong>to</strong>metry<br />
of isolated chromosomes following fluorescence<br />
hybridization: an Approach of online screening for<br />
specific chromosomes and chromosome translocations.<br />
Z. Naturforsch. 46c, 433–441.<br />
Heppell-Par<strong>to</strong>n, A. C.; Albertson, D. G.; Fishpool, R.;<br />
Rabbitts, P. H. (1994) Multicolour fluorescence in<br />
situ hybridization <strong>to</strong> order small, single-copy probes<br />
on metaphase chromosomes. Cy<strong>to</strong>genet. Cell<br />
Genet. 66, 42–47.<br />
Heslop-Harrison, J. S.; Schwarzacher, T.;<br />
Anamthawat-Jonsson, K.; Leitch, A. R.; Shi, M.;<br />
Leitch, I. J. (1991) <strong>In</strong> situ hybridization with<br />
au<strong>to</strong>mated chromosome denaturation. Technique<br />
3 (3), 109–116.<br />
Hyytinen, E.; Visakorpi, T.; Kallioniemi, A.;<br />
Kallioniemi, O.-P.; Isola, J. J. (1994) Improved<br />
technique for analysis of formalin-fixed, paraffinembedded<br />
tumors by fluorescence in situ hybridization.<br />
Cy<strong>to</strong>metry 16, 93–99.<br />
Jansen, G.; Bar<strong>to</strong>lomei, M.; Kalscheuer, V.; Merkx,<br />
G.; Wormskamp, N.; Mariman, E.; Smeets, D.;<br />
Ropers, H.-H.; Wieringa, B. (1993) No imprinting<br />
involved in the expression of DM-kinase mRNAs in<br />
mouse and human tissues. Hum. Mol. Gen. 2 (8),<br />
1221–1227.<br />
Jauch, A.; Wienberg, J.; Stanyon, R.; Arnold, N.;<br />
Tofanelli, S.; Ishida, T.; Cremer, T. (1992)<br />
Reconstruction of genomic rearrangements in great<br />
apes and gibbons by chromosome painting. Proc.<br />
Natl. Acad. Sci. USA 89, 8611–8615.<br />
Jenne, D. E.; Zimmer, M.; Garcia-Sanz, J. A.;<br />
Tschopp, J.; Lichter, P. (1991) Genomic organization<br />
and subchromosomal in situ localization of the<br />
murine granzyme F, a serine protease expressed in<br />
CD8+ T cells. J. Immunol. 147, 1045–1052.<br />
Johnson, C. V.; McNeil, J.; Carter, K. C.; Lawrence,<br />
J. B. (1991) A simple, rapid technique for precise<br />
mapping of multiple sequences in two colors using<br />
a single optical filter set. GATA 8 (2), 75–76.<br />
Joos, S.; Scherthan, H.; Speicher, M. R.; Schlegel,<br />
J.; Cremer, T.; Lichter, P. (1993) Detection of<br />
amplified DNA sequences by reverse chromosome<br />
painting using genomic tumor DNA as probe. Hum.<br />
Genet. 90, 584–589.<br />
Kallioniemi, A.; Kallinoniemi, O.-P.; Piper, J.; Tanner,<br />
M.; S<strong>to</strong>kke, T.; Chen, L.; Smith, H. S.; Pinkel, D.;<br />
Gray, J. W.; Waldman, F. M. (1994) Detection and<br />
mapping of amplified DNA sequences in breast<br />
cancer by comparative genomic hybridization. Proc.<br />
Natl. Acad. Sci. USA 91, 2156–2160.<br />
Kallioniemi, O.-P.; Kallioniemi, A.; Piper, J.; Isola, J.;<br />
Waldman, F. M.; Gray, J. W.; Pinkel, D. (1994)<br />
Optimizing comparative genomic hybridization for<br />
analysis of DNA sequence copy number changes in<br />
solid tumors. Genes, Chrom. Canc. 10, 231–243.<br />
193<br />
6
6<br />
194<br />
References<br />
Kerstens, H. M. J.; Poddighe, P. J.; Hanselaar,<br />
A. G. J. M. (1994) Double-target in situ hybridization<br />
in brightfield microscopy. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem.<br />
42 (8), 1071–1077.<br />
Kerstens, H. M. J.; Poddighe, P. J.; Hanselaar, A. G.<br />
J. M. (1995) A novel in situ hybridization signal<br />
amplifiaction method based on the deposition of<br />
biotinylated tyramine. J. His<strong>to</strong>chem. Cy<strong>to</strong>chem.<br />
43 (4), 347–352.<br />
Khatib, Z. A.; Matsushime, H.; Valentine, M.;<br />
Shapiro, C. N.; Sherr, D. J.; Look, A. T. (1993)<br />
Coamplification of the CDK4 Gene with MDM2 and<br />
GLI in human sarcomas. Canc. Res. 53,<br />
5535–5541.<br />
Kibbelaar, R. E.; Mulder, J.-W. R.; van Kamp, H.;<br />
Dreef, E. J.; Wessels, H. W.; Bevers<strong>to</strong>ck, G. C.;<br />
Haak, H. L.; Raap, A. K.; Kluin, P. M. (1992)<br />
Nonradioactive in situ hybridization of the<br />
translocation t(1;7) in myeloid malignancies.<br />
Genes Chrom. Cancer 4, 128–134.<br />
Kitsberg, D.; Selig, S.; Brandels, M.; Simon, I.;<br />
Keshet, I.; Driscoll, D. J.; Nicholls, R. D.; Cedar, H.<br />
(1993) Allele-specific replication timing of imprinted<br />
gene regions. Nature 364, 459–463.<br />
Kluck, P. M. C.; Wiegant, J.; Raap, A. K.; Vrolijk, H.;<br />
Tanke, H. J.; Willemze, R.; Landegent, J. E. (1993)<br />
Order of human hema<strong>to</strong>poietic growth fac<strong>to</strong>r and<br />
recep<strong>to</strong>r genes on the long arm of chromosome 5,<br />
as determined by fluorescence in situ hybridization.<br />
Ann. Hema<strong>to</strong>l. 66, 15–20.<br />
Knehr, S.; Zitzelsberger, H.; Braselmann, H.;<br />
Bauchinger, M. (1994) Analysis for DNA-proportional<br />
distribution of radiation-induced chromosome<br />
aberrations in various triple combinations of human<br />
chromosomes using fluorescence in situ hybridization.<br />
<strong>In</strong>t. J. Radiat. Biol. 65 (6), 683–690.<br />
Kobayashi, H.; Espinosa III, R.; Thirman, M. J.;<br />
Davis, E. M.; Diaz, M. O.; Le Beau, M. M.; Rowley,<br />
J. D. (1993) Variability of 11q23 rearrangements in<br />
hema<strong>to</strong>poietic cell lines identified with fluorescence<br />
in situ hybridization. Blood 81 (11), 3027–3033.<br />
Lalli, E.; Gibellini, D.; Santi, S.; Facchini, A.<br />
(1992) <strong>In</strong> situ hybridization in suspension and flow<br />
cy<strong>to</strong>metry as a <strong>to</strong>ol for the study of gene<br />
expression. Anal. Biochem. 207, 298–303.<br />
Larin, Z.; Fricker, M. D.; Maher, E.; Ishikawa-Brush,<br />
Y.; Southern, E. M. (1994) Fluorescence in situ<br />
hybridization of multiple probes on a single<br />
microscope slide. Nucl. Acids Res. 22 (18),<br />
3689–3692.<br />
Larramendy, M.; Heiskanen, M.; Wessman, M.;<br />
Ritvanen, A.; Pel<strong>to</strong>mäki, P.; Simola, K.; Kääriäinen,<br />
H.; Von Koskull, H.; Kähkönen, M.; Knuutila, S.<br />
(1993) Molecular cy<strong>to</strong>genetic study of patients<br />
with Pallister-Killian syndrome. Hum. Genet. 91,<br />
121–127.<br />
Larramendy, M.; Nylund, S. J.; Armstrong, E.;<br />
Knuutila, S. (1993) Simultaneous detection of highresolution<br />
R-banding and fluorescence in situ<br />
hybridization signals after fluorouracil-induced<br />
cellular synchronization. Hereditas 119, 89–94.<br />
Lawrence, J. B. (1990) A fluorescence in situ<br />
hybridization approach for gene mapping and the<br />
study of nuclear organization. <strong>In</strong>: Davies, K. E.;<br />
Tilghman, S. M. (eds) Genetic and Physical<br />
Mapping, Cold Spring Harbor Labora<strong>to</strong>ry Press,<br />
page 1–38.<br />
Lawrence, J. B.; Singer, R. H.; McNeil, J. A. (1990)<br />
<strong>In</strong>terphase and metaphase resolution of different<br />
distances within the human dystrophin gene.<br />
Science 249, 928–932.<br />
Lazaridou, A.; Chase, A.; Melo, J.; Garicochea, B.;<br />
Diamond, J.; Goldman, J. (1994) Lack of reciprocal<br />
translocation in BCR-ABL positive Ph-negative<br />
chronic myeloid leukaemia. Leukemia 8 (3),<br />
454–457.<br />
Le Beau, M. M.; Espinosa III, R.; Neuman, W. L.;<br />
S<strong>to</strong>ck, W.; Rouls<strong>to</strong>n, D.; Larson, R. A.; Keinanen, M.;<br />
Westbrook, C. A. (1993) Cy<strong>to</strong>genetic and molecular<br />
delineation of the smallest commonly deleted<br />
region of chromosome 5 in malignant myeloid<br />
diseases. Proc. Natl. Acad. Sci. USA 90,<br />
5484–5488.<br />
Léger, I.; Thomas, M.; Ronot, X.; Brugal, G. (1993)<br />
Detection of chromosomes 1 aberrations by<br />
fluorescent in situ hybridization (FISH) in the human<br />
breast cancer cell line MCF-7. Anal. Cell. Pathol. 5,<br />
299–309.<br />
Léger, I.; Robert-Nicoud, M.; Brugal, G. (1994)<br />
Combination of DNA in situ hybridization and<br />
immunocy<strong>to</strong>chemical detection of nucleolar<br />
proteins: A contribution <strong>to</strong> the functional mapping<br />
of the human genome by fluorescence microscopy.<br />
J. His<strong>to</strong>chem. Cy<strong>to</strong>chem. 42 (2), 149–154.<br />
Léger, I.; Guillaud, M.; Krief, B.; Brugal, G. (1994)<br />
<strong>In</strong>teractive computer-assisted analysis of chromosome<br />
1 colocalization with nucleoli. Cy<strong>to</strong>metry 16,<br />
313–323.<br />
Leitch, A. R.; Mosgöller, W.; Shi, M.; Heslop-<br />
Harrison, J. S. (1992) Different patterns of rDNA<br />
organization at interphase in nuclei of wheat and<br />
rye. J. Cell Sci. 101, 751–757.<br />
Leitch, A.R.; Schwarzacher, T.; Leitch, I. J. (1994)<br />
The use of fluorochromes in the cy<strong>to</strong>genetics of the<br />
small-grained cereals (Triticeae). His<strong>to</strong>chem. J. 26,<br />
471–479.<br />
Lemieux, N.; Malfoy, B.; Fetni, R.; Muleris, M.;<br />
Vogt, N.; Richer, C. L.; Dutrillaux, B. (1994) <strong>In</strong> situ<br />
hybridization approach at infragenic level on<br />
metaphase chromosomes. Cy<strong>to</strong>genet. Cell Genet.<br />
66, 107–112.<br />
Lengauer, C.; Speicher, M. R.; Popp, S.; Jauch, A.;<br />
Taniwaki, M.; Nagaraja, R.; Riethman, H. C.;<br />
Donis-Keller, H.; D’Urso, M.; Schlessinger, D.;<br />
Cremer, T. (1993) Chromosomal bar codes produced<br />
by multicolor fluorescence in situ hybridization with<br />
multiple YAC clones and whole chromosome<br />
painting probes. Hum. Mol. Gen. 2 (5), 505–512.<br />
Lichter, P.; Boyle, A. L.; Cremer, T.; Ward, D. C.<br />
(1991) Analysis of genes and chromosomes by<br />
noniso<strong>to</strong>pic in situ hybridization. GATA 8 (1), 24–35.<br />
CONTENTS<br />
INDEX
Lichter, P.; Chang Tang, C.; Call, K.; Hermanson, G.;<br />
Evans, G. A.; Housman, D.; Ward, D. C. (1990) High<br />
resolution mapping of human chromosome II by in<br />
situ hybridization with cosmid clones. Science 247,<br />
64–69.<br />
Lutz, S.; Welter, C.; Urbschat, K.; Seitz, G.; Blin, N.<br />
(1992) Regional loss of the Y chromosome in<br />
urothelial carcinoma. <strong>In</strong>t. J. Oncol. 1, 115–119.<br />
Makowski, E. R.; Ruzin, S. E. (1994) Fluorescent<br />
<strong>In</strong> <strong>Situ</strong> <strong>Hybridization</strong> of maize meiotic chromosomes<br />
a visualized by confocal microscopy. BioTechn.<br />
16 (2), 256–263.<br />
Maluszynska, J.; Heslop-Harrison, J. S. (1991)<br />
Localization of tandemly repeated DNA sequences<br />
in arabidopsis thaliana. Plant J. 1 (7).<br />
Manoir du, S.; Speicher, M. R.; Joos, S.; Schröck, E.;<br />
Popp, S.; Döhner, H.; Kovacs, G.; Robert-Nicoud, M.;<br />
Lichter, P.; Cremer, T. (1993) Detection of complete<br />
and partial chromosomes gains and losses by<br />
comparative genomic in situ hybridization. Hum.<br />
Genet. 90, 590–610.<br />
McNeil, J. A.; Johnson, C. V.; Carter, K. C.; Singer,<br />
R. H.; Lawrence, J. B. (1991) Localizing DNA and<br />
RNA within nuclei and chromosomes by fluorescence<br />
in situ hybridization. GATA 8 (2), 41–58.<br />
Meloni, A. M.; Peier, A. M.; Haddad, F. S.; Powell,<br />
I. J.; Block, A. W.; Huben, R. P.; Todd, I.; Potter, W.;<br />
Sandberg, A. A. (1993) A new approach in the<br />
diagnosis and follow-up of bladder cancer. Cancer<br />
Genet. Cy<strong>to</strong>genet. 71, 105–118.<br />
Michaelis, K. C.; Helvering, L. M.; Kinding, D. E.;<br />
Garriott, M. L.; Richardson, K. K. (1994) Localization<br />
of the xanthine guanine phosphoribosyl transferase<br />
gene (gpt) of e.coli in AS52 metaphase cells by<br />
fluorescence in situ hybridization. Environm. Mol.<br />
Mutagen. 24, 176–180.<br />
Munné, S.; Lee, A., Rosenwaks, Z.; Grifo, J.;<br />
Cohen, J. (1993) Diagnosis of major chromosome<br />
aneuploidies in human preimplantation embryos.<br />
Human Reprod. 8 (12), 2185–2191.<br />
Nederlof, P. M.; Flier, van der, S.; Raap, A. K.;<br />
Tanke, H. J. (1992) Quantification of inter- and<br />
intra-nuclear variation of fluorescence in situ<br />
hybridization signals. Cy<strong>to</strong>metry 13, 831–838.<br />
Nederlof, P. M.; Flier, van der, S.; Verwoerd, N. P.;<br />
Vrolijk, J.; Raap, A. K.; Tanke, H. J. (1992)<br />
Quantification of fluorescence in situ hybridization<br />
signals by image cy<strong>to</strong>metry. Cy<strong>to</strong>metry 13,<br />
846–852.<br />
Nederlof, P. M.; Flier, van der, S.; Vrolijk, J.; Tanke,<br />
H. J.; Raap, A. K. (1992) Fluorescence ratio<br />
measurements of double-labeled probes for<br />
multiple in situ hybridization by digital imaging<br />
microscopy. Cy<strong>to</strong>metry. 13, 839–845.<br />
Nylund, S. J.; Ruutu, T.; Saarinen, U.; Larramendy,<br />
M. L.; Knuutila, S. (1994) Detection of minimal<br />
residual disease using fluorescence DNA in situ<br />
hybridization: a follow-up study in leukemia and<br />
lymphoma patients. Leukemia 8 (4), 587–594.<br />
CONTENTS<br />
INDEX<br />
References<br />
Pendás, A. M.; Morán, P.; Garcia-Vázquez, E. (1993)<br />
Ribosomal RNA genes are interspersed throughout<br />
a heterochromatic chromosome arm in Atlantic<br />
salmon. Cy<strong>to</strong>genet. Cell Genet. 63, 128–130.<br />
Pendás, A. M.; Morán, P.; Garcia-Vázquez, E. (1993)<br />
Multi-chromosomal location of ribosomal RNA<br />
genes and heterochromatin association in brown<br />
trout. Chrom. Res. 1, 63–67.<br />
Popp, S.; Jauch, A.; Schindler, D.; Speicher, M. R.;<br />
Lengauer, C.; Donis-Keller, H.; Riethman, H. C.;<br />
Cremer, T. (1993) A strategy for the characterization<br />
of minute chromosome rearrangements using<br />
multiple color fluorescence in situ hybridization<br />
with chromosome-specific DNA libraries and YAC<br />
clones. Hum. Genet. 92, 527–532.<br />
Raap, A. K.; Wiegant, J.; Lichter, P. Multiple<br />
fluorescence in situ hybridization for molecular<br />
cy<strong>to</strong>genetics.<br />
Rassool, F. V.; McKeithan, T. W.; Neilly, M. E.; Van<br />
Melle, E.; Espinosa III, R.; Le Beau, M. M. (1991)<br />
Preferential integration of marker DNA in<strong>to</strong> the<br />
chromosomal fragile site at 3p14: an approach <strong>to</strong><br />
cloning fragile sites. Proc. Natl. Acad. Sci. USA 88,<br />
6657–6661.<br />
Richard, F.; Vogt, N.; Muleris, M.; Malfoy, B.;<br />
Dutrillaux, B. (1994) <strong>In</strong>creased FISH efficieny using<br />
APC probes generated by direct incorporation of<br />
labeled nucleotides by PCR. Cy<strong>to</strong>genet. Cell Genet.<br />
65, 169–171.<br />
Ried, T.; Arnold, N.; Ward, D. C.; Wienberg, J. (1993)<br />
Comparative high-resolution mapping of human and<br />
primate chromosomes by fluorescence in situ<br />
hybridization. Genomics 18, 381–386.<br />
Ried, T.; Baldini, A.; Rand, T. C.; Ward, D. C. (1992)<br />
Simultaneous visualization of seven different DNA<br />
probes by in situ hybridization using combina<strong>to</strong>rial<br />
fluorescence and digital imaging microscopy. Proc.<br />
Natl. Acad. Sci. USA 89, 1388–1392.<br />
Ried, T.; Landes, G.; Dackowski, W.; Klinger, K.;<br />
Ward, D. C. (1992) Multicolor fluorescence in situ<br />
hybridization for the simultaneous detection of<br />
probe sets for chromosomes 13, 18, 21, X and Y in<br />
uncultured amniotic fluid cells. Human Mol. Gen. 1<br />
(5), 307–313.<br />
Ried, T.; Lengauer, C.; Cremer, T.; Wiegant, J.;<br />
Raap, A. K.; van der Ploeg, M.; Groitl, P.; Lipp, M.<br />
(1991) Specific metaphase and interphase detection<br />
of the breakpoint region in 8q24 of burkitt<br />
lymphoma cells by triple-color fluorescence in situ<br />
hybridization. Genes, Chromosomes & Cancer 4,<br />
69–74.<br />
Sai<strong>to</strong>h, Y.; Mizuno, S. (1992) Distribution of Xho I<br />
and Eco RI family repetitive DNA sequences in<strong>to</strong><br />
separate domains in the chicken W chromosome.<br />
Chromosoma 101, 474–477.<br />
Scherthan, H.; Köhler, M.; Vogt, P.; Malsch, von,<br />
K.; Schweizer, D. (1992) Chromosomal in situ<br />
hybridization with double-labeled DNA: signal<br />
amplification at the probe level. Cy<strong>to</strong>genet. Cell<br />
Genet. 60, 4–7.<br />
195<br />
6
6<br />
196<br />
References<br />
Scherthan, H.; Loidl, J.; Schuster, T.; Schweizer, D.<br />
(1992) Meiotic chromosome condensation and<br />
pairing in Saccharomyces cerevisiae studied by<br />
chromosome painting. Chromosoma 101, 590–595.<br />
Schmidt, E. R. (1992) Multicolor in situ hybridization<br />
– a helpful technique for precise gene localisation.<br />
Scient. Techn. <strong>In</strong>form. X (3), 80–84.<br />
Schwarzacher, T.; Anamthawat-Jonsson, K.;<br />
Harrison, G. E.; Islam, A. K. M. R.; Jia, J. Z.; King, I.<br />
P.; Leitch, A. R.; Miller, T. E.; Reader, S. M.; Rogers,<br />
W. J.; Shi, M.; Heslop-Harrison, J. S. (1992)<br />
Genomic in situ hybridization <strong>to</strong> identify alien<br />
chromosomes and chromosome segments in wheat.<br />
Theor. Appl. Genet. 84, 778–786.<br />
Schwarzacher, T.; Heslop-Harrison, J. S.;<br />
Anamthawat-Jonsson, K. (1992) Parental genome<br />
separation in reconstructions of somatic and<br />
premeiotic metaphases of Hordeum vulgare x H.<br />
bulbosum. J. Cell Sci. 101, 13–24.<br />
Selig, S.; Okumura, K.; Ward, D. C.; Cedar, H.<br />
(1992) Delineation of DNA replication time zones by<br />
fluorescence in situ hybridization. EMBO J. 11 (3),<br />
1217–1225.<br />
Shi, G.-P.; Webb, A. C.; Foster, K. E.; Knoll, J. H. M.;<br />
Lemere, C. A.; Munger, J. S.; Chapman, H. A. (1994)<br />
Human cathepsin S: Chromosomal localization,<br />
gene structure, and tissue distribution. J. Biol.<br />
Chem. 269 (15), 11530–11536.<br />
Shi, Y.-P.; Huang, T.-T.; Carlson, E. J.; Epstein, C. J.<br />
(1994) The mapping of transgenes by fluorescence<br />
in situ hybridization on G-banded mouse chromosomes.<br />
Mammal. Genome 5, 337–341.<br />
Shibasaki, Y. (1994) High resolution mapping of the<br />
MYCN pro<strong>to</strong>-oncogene at human chromosome<br />
2p24.3 by fluorescence in situ hybridization.<br />
Cy<strong>to</strong>genet. Cell Genet. 66, 75–76.<br />
Speel, E. J. M.; Kamps, M.; Bonnet, J.; Ramaekers,<br />
F. C. S.; Hopman, A. H. N. (1993) Multicolour<br />
preparations for in situ hybridization using<br />
precipitating enzyme cy<strong>to</strong>chemistry in combination<br />
with reflection contrast microscopy. His<strong>to</strong>chem.<br />
100, 357–366.<br />
Speleman, F.; Leroy, J. G.; Roy, van, N.; De Paepe,<br />
A.; Suijkerbuijk, R.; Brunner, H.; Looijenga, L.;<br />
Verschraegen-Spae, M.-R.; Orye, E. (1991)<br />
Pallister-Killian syndrome: Characterization of<br />
the isochromosome 12p by fluorescent in situ<br />
hybridization. Am. J. Med. Gen. 41, 381–387.<br />
Speleman, F.; Van Roy, N.; De Vos, E.; Hilliker, C.;<br />
Suijkerbuijk, R. F. S.; Leroy, J.G. (1993) Molecular<br />
cy<strong>to</strong>genetic analysis of a familial pericentric<br />
inversion of chromosome 12. Clin. Genet. 44,<br />
156–163.<br />
Spriggs, E. L.; Martin, R. H. (1994) Analysis of<br />
segregation in a human male reciprocal translocation<br />
carrier, t (1;11) (p36.3;q13.1), by twocolour<br />
fluorescence in situ hybridization. Mol.<br />
Reprod. Develop. 38, 247–250.<br />
Stanyon, R.; Arnold, N.; Koehler, U.; Bigoni, F.;<br />
Wienberg, J. (1995) Chromosomal painting shows<br />
that “marked chromosomes” in lesser apes and old<br />
world monkey are not homologous and evolved by<br />
convergence. Cy<strong>to</strong>genet. Cell Genet. 68, 74–78.<br />
Steilen, H.; Ketter, R.; Romanakis, K.; Zwergel, T.;<br />
Unteregger, G.; Bonkhoff, H.; Seitz, G.; Ziegler, M.;<br />
Zang, K. D.; Wullich, B. (1994) DNA aneuploidy in<br />
prostatic adenocarcinoma: A frequent event as<br />
shown by fluorescence in situ DNA hybridization.<br />
Hum. Pathol. 25, 1306–1313.<br />
Strehl, S.; Ambros, P. F. (1993) Fluorescence in situ<br />
hybridization combined with immuno-his<strong>to</strong>chemistry<br />
for highly sensitive detection of chromosome 1<br />
aberrations in neuroblas<strong>to</strong>ma. Cy<strong>to</strong>genet. Cell<br />
Genet. 63, 24–28.<br />
Tagarro, I.; Wiegant, J.; Raap, A. K.; Gonzalez-<br />
Aguilera, J. J.; Fernandez-Peralta, A. M. (1994)<br />
Assignment of human satellite 1 DNA as revealed<br />
by fluorescent in situ hybridization with oligonucleotides.<br />
Hum. Genet. 93, 125–128.<br />
Tkachuk, D. C.; Westbrook, C. A.; Andreeff, M.;<br />
Donlon, T. A.; Cleary, M. L.; Suryanarayan, K.;<br />
Homge, M.; Redner, A.; Gray, J.; Pinkel, D. (1990)<br />
Detection of bcr-abl fusion in chronic myelogeneous<br />
leukemia by in situ hybridization. Science 250,<br />
559–561.<br />
Toledo, F.; Buttin, G.; Debatisse, M. (1993) The<br />
origin of chromosome rearrangements at early<br />
stages of AMPD2 gene amplification in Chinese<br />
hamster cells. Current Biol. 3 (5), 255–264.<br />
Trask, B. J.; Massa, H.; Kenwrick, S.; Gitschier, J.<br />
(1991) Mapping of human chromosome Xq28 by<br />
two-color fluorescence in situ hybridization of DNA<br />
sequences <strong>to</strong> interphase cell nuclei. Am. J. Hum.<br />
Genet. 48, 1–15.<br />
Van Devanter, D. R.; Yirdaw, G. (1993)<br />
Recombination between separate myc amplification<br />
structures in COLO320 cells. Genes Chrom. Cancer<br />
6, 190–197.<br />
Vernole, P. (1990) Digoxigenin-labeled probes can<br />
detect single-copy genes in human metaphase<br />
chromosomes. BioTechn. 9 (2), 200.<br />
Vourc’h, C.; Taruscio, D.; Boyle, A. L.; Ward,<br />
D. C. (1993) Cell cycle-dependent distribution of<br />
telomeres, centromeres, and chromosome-specific<br />
subsatellite domains in the interphase nucleus of<br />
mouse lymphocytes. Exp. Cell Res. 205, 142–151.<br />
Warbur<strong>to</strong>n, D.; Yu, M-T.; Tantravahi, U.; Lee, C.;<br />
Cayanis, E.; Russo, J.; Fischer, S. G. (1993)<br />
Regional localization of 32 NotI-HindIII fragments<br />
from a human chromosome 13 library by a somatic<br />
cell hybrid panel and in situ hybridization.<br />
Genomics 16, 355–360.<br />
Ward, D. C. (1990) New developments in non-iso<strong>to</strong>pic<br />
labeling and purification of nucleic acid probes.<br />
Clin. Biochem. 23, 307–310.<br />
CONTENTS<br />
INDEX
Wiegant, J.; Ried, T.; Nederlof, P. M.; van der Ploeg,<br />
M.; Tanke, H. J. Raap, A. K. (1991) <strong>In</strong> situ<br />
hybridization with fluoresceinated DNA. Nucl. Acids<br />
Res. 19 (12), 3237–3241.<br />
Wiegant, J.; Wiesmeijer, C. C.; Hoovers, J. M. N.;<br />
Schuuring, E.; D’Azzo, A.; Vrolijk, J.; Tanke, H. J.;<br />
Raap, A. K. (1993) Multiple and sensitive<br />
fluorescence in situ hybridization with rhodamine-,<br />
fluorescein-, and coumarin-labeled DNAs.<br />
Cy<strong>to</strong>genet. Cell Genet. 63, 73–76.<br />
Wienberg, J.; Stanyon, R.; Jauch, A.; Cremer, T.<br />
(1992) Homologies in human and Macaca fuscata<br />
chromosomes revealed by in situ suppression<br />
hybridization with human chromosome specific DNA<br />
libraries. Chromosoma 101, 265–270.<br />
Wyrobek, A. J.; Robbins, W. A.; Mehraein, Y.;<br />
Pinkel, D.; Weier, H.-U. (1994) Detection of sex<br />
chromosomal aneuploidies X-X, Y-Y, and X-Y in<br />
human sperm using two-chromosome fluroescence<br />
in situ hybridization. Am. J. Med. Gen. 53, 1–7.<br />
Yerle, M.; Goureau, A.; Gellin, J.; Le Tissier, P.;<br />
Moran, C. (1994) Rapid mapping of cosmid clones<br />
on pig chromosomes by fluorescence in situ<br />
hybridization. Mammalian Genome 5, 34–37.<br />
Zhang, F. R.; Heilig, R.; Thomas, G.; Aurias, A.<br />
(1990) A one-step efficient and specific nonradioactive<br />
non-fluorescent method for in situ<br />
hybridization of banded chromosomes.<br />
Chromosoma 99, 436–439.<br />
CONTENTS<br />
INDEX<br />
References<br />
197<br />
6
6<br />
198<br />
References<br />
4. Primed in <strong>Situ</strong> Labeling of Nucleic Acids<br />
Abbo, S.; Dunford, R. P.; Miller, T. E.; Reader,<br />
S. M.; King, I. P. (1993) Primer-mediated in situ<br />
detection of the B-hordein gene cluster on barley<br />
chromosome 1H. Proc. Natl. Acad. Sci. USA 90,<br />
11821–11824.<br />
Brandt, C. A.; Djernes, B.; Stromkjaer, H.; Petersen,<br />
M. B.; Pedersen, S.; Hindkjaer, J.; Brinch-Iversen,<br />
J.; Bruun-Petersen, G. (1994) Pseudododicentric<br />
chromosome 18 diagnosed by chromosome painting<br />
and primed in situ labeling (PRINS). J. Med.<br />
Genet. 31, 99–102.<br />
Brandt, C. A.; Kierkegaard, O.; Hindkjaer, J.; Jensen,<br />
P. K. A.; Pedersen, S.; Therkelsen, A. J. (1993) Ring<br />
chromosome 20 with loss of telomeric sequences<br />
detected by multicolour PRINS. Clin. Genet. 44,<br />
26–31.<br />
Cinti, C.; Santi, S.; Maraldi, N. M. (1993) Localization<br />
of single copy gene by PRINS technique. Nucl.<br />
Acids Res. 21 (24), 5799–5800.<br />
Gosden, J.; Hanratty, D. (1991) Comparison of<br />
sensitivity of three haptens in the PRINS (oligonucleotide<br />
primed in situ DNA synthesis) reaction.<br />
Techniques 3 (4), 159–165.<br />
Gosden, J.; Lawson, D. (1995) <strong>In</strong>stant PRINS:<br />
a rapid method for chromosome identification by<br />
detecting repeated sequences in situ. Cy<strong>to</strong>genet.<br />
Cell Genet. 68, 57–60.<br />
Hindkjaer, J.; Koch, J.; Mogensen, J.; Pedersen, S.;<br />
Fischer, H.; Nygaard, M.; Junker, S.; Gregersen, N.;<br />
Kolvraa, S.; Therkelsen, A. J.; Bolund, L. (1991)<br />
Primed in situ labeling of nucleic acids. BFE 8, (12)<br />
752–756.<br />
Hindkjaer, J.; Koch, J.; Terkelsen, C.; Brandt, C. A.;<br />
Kolvraa, S.; Bolund, L. (1994) Fast, sensitive<br />
multicolor detection of nucleic acids in situ by<br />
PRimed<br />
IN <strong>Situ</strong> labeling (PRINS). Cy<strong>to</strong>genet. Cell Genet. 66,<br />
152–154.<br />
Hindkjaer, J.; Koch, J.; Mogensen, J.; Kolvraa, S.;<br />
Bolund, L. (1994) Primed in situ (PRINS) labeling of<br />
DNA. Meth. Mol. Biol. 33, 95–109.<br />
5. <strong>In</strong> situ hybridization in suspension<br />
Brown, C. C.; Meyer, R. F.; Grubman, M. J. (1993)<br />
Use of digoxigenin-labeled RNA probe <strong>to</strong> detect all<br />
24 serotypes of blue<strong>to</strong>ngue virus in cell culture.<br />
J. Vet. Diagn. <strong>In</strong>vest. 5, 159–162.<br />
Timm, A.; Stewart, C. C. (1992) Fluorescent in situ<br />
hybridization en suspension (FISHES) using<br />
digoxigenin-labeled probes and flow cy<strong>to</strong>metry.<br />
BioTechn. 12 (3), 362–367.<br />
Koch, J.; Fischer, H.; Askholm, H.; Hindkjaer, J.;<br />
Pedersen, S.; Kolvraa, S.; Bolund, L. (1993)<br />
Identification of a supernumerary der(18)<br />
chromosome by a rational strategy for the<br />
cy<strong>to</strong>genetic typing of small marker chromosomes<br />
with chromosome-specific DNA probes. Clin. Genet.<br />
43, 200–203.<br />
Koch, J.; Hindkjaer, J.; Kolvraa, S.; Bolund, L.<br />
Construction of a panel of chromosome specific<br />
oligonucleotide probes (PRINS-primers) useful for<br />
the identification of individual human chromosomes<br />
in situ. Cy<strong>to</strong>gen. Cell Gen. submitted.<br />
Pelles<strong>to</strong>r, F.; Girardet, A.; Andréo, B.; Charlieu, J.-P.<br />
(1994) A polymorphic alpha satellite sequence for<br />
human chromosome 13 detected by oligonucleotide<br />
primed in situ labeling (PRINS). Hum. Genet. 94,<br />
346–348.<br />
Pelles<strong>to</strong>r, F.; Girardet, A.; Geneviève, L.; Andréo, B.;<br />
Charlieu, J. P. (1995) Use of the primed in situ<br />
labeling (PRINS) technique for a rapid detection of<br />
chromosomes 13, 16, 18, 21, X and Y. Hum. Genet.<br />
95, 12–17.<br />
Speel, E. J. M.; Lawson, D.; Hopman, A. H. N.;<br />
Gosden, J. (1995) Multi-PRINS: multiple sequential<br />
oligonucleotide primed in situ DNA synthesis<br />
reactions label specific chromosomes and produce<br />
bands. Hum. Genet. 95, 29–33.<br />
Terkelsen, C.; Koch, J.; Kolvraa, S.; Hindkjaer, J.;<br />
Pedersen, S.; Bolund, L. (1993) Repeated primed in<br />
situ labeling: formation and labeling of specific DNA<br />
sequences in chromosomes and nucleic. Cy<strong>to</strong>genet.<br />
Cell Genet. 63, 235–237.<br />
Therkelsen, A. J.; Nielsen, A.; Koch, J.; Hindkjaer,<br />
J.; Kolvraa, S. (1995) Staining of human telomeres<br />
with primed in situ labeling (PRINS). Cy<strong>to</strong>genet. Cell<br />
Genet. 68, 115–118.<br />
Volpi, E. V.; Baldini, A. (1993) Multiprins: a method<br />
for multicolour primed in situ labeling. Chrom. Res.<br />
1, 257–260.<br />
CONTENTS<br />
INDEX
6. PCR in situ technique<br />
Cinti, C.; Santi, S.; Maraldi, N. M. (1993) Localization<br />
of single copy gene by PRINS technique. Nucl.<br />
Acids Res. 21 (24), 5799–5800.<br />
Gosden, J.; Hanratty, D. (1993) PCR <strong>In</strong> situ: A rapid<br />
alternative <strong>to</strong> in situ hybridization for mapping<br />
short, low copy number sequences without<br />
iso<strong>to</strong>pes. BioTechn. 15 (1), 78–80.<br />
Gressens, P.; Martin, J. R. (1994) <strong>In</strong> situ polymerase<br />
chain reaction: localization of HSV-2 DNA<br />
sequences in infections of the nervous system.<br />
J. Virol. Meth. 46, 61–83.<br />
Li, S.; Harris, C. P.; Leong, S. A. (1993) Comparison<br />
of fluorescence in situ hybridization and primed in<br />
situ labeling methods for detection of single-copy<br />
genes in the fungus ustilago maydis. Experim.<br />
Mycol. 17, 301–308.<br />
Long, A. A.; Komminoth, P.; Lee, E.; Wolfe, H. J.<br />
(1993) Comparison of indirect and direct in situ<br />
polymerase chain reaction in cell preparations and<br />
tissue sections. His<strong>to</strong>chem. 99, 151–162.<br />
Moss, R. B.; Kaliner, M. A. (1994) Primed in <strong>Situ</strong> DNA<br />
Amplification (PIDA). J. Clin. Lab. Anal. 8, 120–122.<br />
Nuovo, G.; Direct incorporation of digoxigenin-11dUTP<br />
in<strong>to</strong> amplified DNA using the “Hot Start” PCR<br />
in situ technique.<br />
Nuovo, G. J.; Gallery, F.; MacConnell, P.; Becker, J.;<br />
Bloch, W. (1991) An improved technique for the<br />
in situ detection of DNA after Polymerase Chain<br />
Reaction amplification. Am. J. Pathol. 139 (6),<br />
1239–1244.<br />
CONTENTS<br />
INDEX<br />
References<br />
Patel, V. G.; Shum-Siu, A.; Heniford, B. W.; Wieman,<br />
T. J.; Hendler, F. J. (1994) Detection of epidermal<br />
growth fac<strong>to</strong>r recep<strong>to</strong>r mRNA in tissue sections<br />
from biopsy specimens using in situ polymerase<br />
chain reaction. Am. J. Pathol. 144 (1), 7–14.<br />
Pelles<strong>to</strong>r, F.; Girardet, A.; Lefort, G.; Andréo, B.;<br />
Charlieu, J. P. (1994) Détection rapide des<br />
chromosomes 21 in situ par la technqie PRINS.<br />
Ann. Génét. 37 (2), 66–71.<br />
Pestaner, J. P.; Bibbo, M.; Bobroski, L.; Seshamma,<br />
T.; Bagasra, O. (1994) Potential of the in situ<br />
polymerase chain reaction in diagnostic cy<strong>to</strong>logy.<br />
Acta Cy<strong>to</strong>l. 38, 676–680.<br />
Teyssier, M.; Carosella, E.; Gluckman, E.;<br />
Kirszenbau, M. (1994) PCR introcellulaire: nouvelle<br />
approche de diagnostic tissulaire et cy<strong>to</strong>genetique.<br />
Immunoanal. Biol. Spec. 9, 159–164.<br />
Tsongalis, G. J.; McPhail, A. H.; Lodge-Rigal, R. D.;<br />
Chapman, J. F.; Silverman, L. M. (1994) Localized<br />
in situ amplification (LISA): A novel approach <strong>to</strong><br />
in situ PCR. Clin. Chem. 40 (3), 381–384.<br />
Zehbe, I.; Hacker, G. W.; Rylander, E.; Sällström, J.;<br />
Wilander, E. (1992) Detection of single HPV copies<br />
in SiHa cells by in situ polymerase chain reaction<br />
(in situ PCR) combined with immuno-peroxidase<br />
and immunogold-silver staining (IGSS) techniques.<br />
Anticanc. Res. 12, 2165–2168.<br />
199<br />
6
6<br />
200<br />
References<br />
7. Apop<strong>to</strong>sis research using DIG-dUTP and terminal<br />
transferase<br />
Billig, H.; Furuta, I.; Hsueh, A. J. (1993) Estrogens<br />
inhibit and androgens enhance ovarian granulosa<br />
cell apop<strong>to</strong>sis. Endocrinol. 133 (5) 2204–2212.<br />
Billig, H.; Furuta, I.; Hsueh, A. J. W. (1994) Gonadotropin-releasing<br />
hormone directly induces apop<strong>to</strong>tic<br />
cell death in the rat ovary: Biochemical and in situ<br />
detection of deoxyribonucleic acid fragmentation in<br />
granulosa cells. Endocrinol. 134 (1), 245–252.<br />
Gold; R.; Schmied, M.; Rothe, G.; Zischler, H.;<br />
Breitschopf, H.; Wekerle, H.; Lassmann, H. (1993)<br />
Detection of DNA fragmentation in apop<strong>to</strong>sis:<br />
Application of in situ nick translation <strong>to</strong> cell culture<br />
systems and tissue sections. J. His<strong>to</strong>chem.<br />
Cy<strong>to</strong>chem. (in press).<br />
Gorczyca, W.; Bigman, K.; Mittelman, A.; Ahmed, T.;<br />
Gong, J.; Melamed, M. R.; Darzynkiewicz, Z. (1993)<br />
<strong>In</strong>duction of DNA strand breaks associated with<br />
apop<strong>to</strong>sis during treatment of leukemias. Leukemia<br />
7 (5), 659–670.<br />
8. Miscellaneous<br />
Schöfer, C.; Müller, M.; Leitner, M. D.; Wachtler, F.<br />
(1993) The uptake of uridine in the nucleolus occurs<br />
in the dense fibrillar component. Cy<strong>to</strong>genet. Cell<br />
Genet. 64, 27–30.<br />
Wansink, D. G.; Manders, E. E. M.; van der Kraan, I.;<br />
Aten, J. A.; van Driel, R.; de Jong, L. (1994) RNA<br />
polymerase II transcription is concentrated outside<br />
replication domains throughout S-phase. J. Cell Sci.<br />
107, 1449–1456.<br />
Gorczyca, W.; Gong, J.; Ardelt, B.; Traganos, F.;<br />
Darzynkiewicz, Z. (1993) The cell cycle related<br />
differences in susceptibility of HL-60 cells <strong>to</strong><br />
apop<strong>to</strong>sis induced by various antitumor agents.<br />
Cancer Res. 53, 3186–3192.<br />
Gorczyca, W.; Gong, J.; Darzynkiewicz, Z. (1993)<br />
Detection of DNA strand breaks in individual<br />
apop<strong>to</strong>tic cells by the in situ terminal deoxynucleotidyl<br />
transferase and nick translation assays. Canc.<br />
Res. 53, 1945–1951.<br />
Sgonc, R.; Boeck, G.; Dietrich, H.; Gruber, J.;<br />
Reicheis, H.; Wick, G. (1994) Simultaneous determination<br />
of cell surface antigens and apop<strong>to</strong>sis.<br />
TIG 10 (2), 41–42.<br />
CONTENTS<br />
INDEX
CONTENTS<br />
INDEX<br />
Ordering <strong>In</strong>formation
7<br />
202<br />
Ordering Guide<br />
Labeling and <strong>Hybridization</strong><br />
PRINS Reaction Sets<br />
Cat. No. Size<br />
DIG PRINS Reaction Set 1695 932 1 set (40 reactions,<br />
5 controls)<br />
Rhodamine PRINS Reaction Set 1768 514 1 set (40 reactions,<br />
5 controls)<br />
PRINS Oligonucleotide Primers<br />
Human Chromosome 1 specific 1695 959 100 µl (20 reactions)<br />
Human Chromosome 1 + 16 specific 1768 549 100 µl (20 reactions)<br />
Human Chromosome 3 specific 1695 967 100 µl (20 reactions)<br />
Human Chromosome 7 specific 1695 975 100 µl (20 reactions)<br />
Human Chromosome 8 specific 1695 983 100 µl (20 reactions)<br />
Human Chromosome 9 (SAT) specific 1768 565 100 µl (20 reactions)<br />
Human Chromosome 10 specific 1768 522 100 µl (20 reactions)<br />
Human Chromosome 11 specific 1695 991 100 µl (20 reactions)<br />
Human Chromosome 12 specific 1696 009 100 µl (20 reactions)<br />
Human Chromosome 14 + 22 specific 1768 557 100 µl (20 reactions)<br />
Human Chromosome 17 specific 1696 017 100 µl (20 reactions)<br />
Human Chromosome 18 specific 1696 025 100 µl (20 reactions)<br />
Human Chromosome X specific 1696 033 100 µl (20 reactions)<br />
Human Chromosome Y specific 1696 041 100 µl (20 reactions)<br />
All Human Chromosome specific 1699 172 100 µl (20 reactions)<br />
Human Telomere Specific 1699 199 100 µl (20 reactions)<br />
DNA probes, human chromosome<br />
1 specific, digoxigenin-labeled 1558 765 1 µg (50 µl)<br />
1 specific, fluorescein-labeled 1558 684 1 µg (50 µl)<br />
1 + 5 + 19 specific, digoxigenin-labeled 1690 507 1 µg (50 µl)<br />
1 + 5 + 19 specific, fluorescein-labeled 1690 647 1 µg (50 µl)<br />
2 specific, digoxigenin-labeled 1666 479 1 µg (50 µl)<br />
2 specific, fluorescein-labeled 1666 380 1 µg (50 µl)<br />
3 specific, digoxigenin-labeled 1690 515 1 µg (50 µl)<br />
4 specific, digoxigenin-labeled 1690 523 1 µg (50 µl)<br />
6 specific, digoxigenin-labeled 1690 531 1 µg (50 µl)<br />
7 specific, digoxigenin-labeled 1690 639 1 µg (50 µl)<br />
7 specific, fluorescein-labeled 1694 375 1 µg (50 µl)<br />
8 specific, digoxigenin-labeled 1666 487 1 µg (50 µl)<br />
8 specific, fluorescein-labeled 1666 398 1 µg (50 µl)<br />
9 specific, digoxigenin-labeled 1690 540 1 µg (50 µl)<br />
10 specific, digoxigenin-labeled 1690 558 1 µg (50 µl)<br />
10 specific, fluorescein-labeled 1690 655 1 µg (50 µl)<br />
11 specific, digoxigenin-labeled 1690 566 1 µg (50 µl)<br />
11 specific, fluorescein-labeled 1690 663 1 µg (50 µl)<br />
12 specific, digoxigenin-labeled 1690 574 1 µg (50 µl)<br />
12 specific, fluorescein-labeled 1690 671 1 µg (50 µl)<br />
13 + 21 specific, digoxigenin-labeled 1690 582 1 µg (50 µl)<br />
14 + 22 specific, digoxigenin-labeled 1666 495 1 µg (50 µl)<br />
14 + 22 specific, fluorescein-labeled 1666 401 1 µg (50 µl)<br />
15 specific, digoxigenin-labeled 1690 604 1 µg (50 µl)<br />
16 specific, digoxigenin-labeled 1699 091 1 µg (50 µl)<br />
17 specific, digoxigenin-labeled 1666 452 1 µg (50 µl)<br />
17 specific, fluorescein-labeled 1666 371 1 µg (50 µl)<br />
18 specific, digoxigenin-labeled 1666 509 1 µg (50 µl)<br />
18 specific, fluorescein-labeled 1666 428 1 µg (50 µl)<br />
20 specific, digoxigenin-labeled 1666 517 1 µg (50 µl)<br />
20 specific, fluorescein-labeled 1666 436 1 µg (50 µl)<br />
22 specific, digoxigenin-labeled 1690 612 1 µg (50 µl)<br />
X specific, digoxigenin-labeled 1666 525 1 µg (50 µl)<br />
X specific, fluorescein-labeled 1666 444 1 µg (50 µl)<br />
Y specific, digoxigenin-labeled 1558 196 1 µg (50 µl)<br />
Y specific, fluorescein-labeled 1558 692 1 µg (50 µl)<br />
Specific for all human chromosomes, digoxigenin-labeled 1558 757 1 µg (50 µl)<br />
Specific for all human chromosomes, fluorescein-labeled 1558 676 1 µg (50 µl)<br />
CONTENTS<br />
INDEX
CONTENTS<br />
INDEX<br />
Ordering Guide<br />
Detection<br />
Anti-Digoxigenin, Fab fragment<br />
Cat. No. Size<br />
AP conjugate 1093 274 150 U<br />
AMCA conjugate 1533 878 200 µg<br />
-Gal conjugate 1634 020 150 U<br />
fluorescein conjugate 1207 741 200 µg<br />
gold conjugate 1450 590 1 ml<br />
POD conjugate 1207 733 150 U<br />
POD poly conjugate 1633 716 50 U<br />
rhodamine conjugate 1207 750 200 µg<br />
unlabeled 1214 667 1 mg<br />
Anti-Digoxigenin, monoclonal 1333 062 100 µg<br />
Anti-Digoxigenin from sheep 1333 089 200 µg<br />
Anti-Biotin,<br />
AP conjugate 1426 303 150 U<br />
POD conjugate 1426 311 150 U<br />
unlabeled 1297 597 100 µg<br />
Anti-Fluorescein 1426 320 100 µg<br />
Anti-Fluorescein, Fab fragment<br />
AP conjugate 1426 338 150 U<br />
POD conjugate 1426 346 150 U<br />
DAPI, 4',6-Diamidine-2'-Phenylindole Dihydrochloride 236 276 10 mg<br />
DIG Quantification Teststrips 1669 958 50 strips<br />
DIG Control Teststrips 1669 966 25 strips<br />
DIG Nucleic Acid 1175 041 Detection of 40 blots<br />
Detection Kit, Colorimetric (10 x 10 cm)<br />
Streptavidin<br />
AP conjugate, MB grade 1093 266 150 U<br />
AMCA conjugate 1428 578 1 mg<br />
fluorescein conjugate 1055 097 1 mg<br />
POD conjugate 1089 153 500 U<br />
unlabeled 973 190 1 mg<br />
1097 679 5 mg<br />
DNA, COT-1, human 1581 074 500 µg (500 µl)<br />
DNA from herring sperm 223 646 1 g<br />
DNA, MB-grade from fish sperm 1467 140 500 mg (500 ml)<br />
RNA from yeast 109 223 100 g<br />
NBT/BCIP S<strong>to</strong>ck Solution 1681 451 8 ml<br />
BCIP 5-Bromo-4-chloro-3-indolyl-phosphate 1383 221 3 ml (150 mg)<br />
NBT 4-Nitroblue tetrazolium chloride 1383 213 3 ml<br />
Silver Enhancement Reagents 1465 350 1 set<br />
Blocking Reagent, for nucleic acid hybridization 1096 176 50 g<br />
HNPP Fluorescent Detection Set 1758 888 Set for 500<br />
FISH Detection Reactions<br />
Fluorescent Antibody Enhancer Set for DIG Detection 1768 506 1 Set<br />
203<br />
7
7<br />
**This product is sold under licensing<br />
arrangements with Roche<br />
Molecular Systems and the Perkin-<br />
Elmer Corporation. Purchase of<br />
this product is accompanied by a<br />
license <strong>to</strong> use it in the Polymerase<br />
Chain Reaction (PCR) process in<br />
conjunction with an Authorized<br />
Thermal Cycler.<br />
For complete license disclaimer,<br />
see inside back cover page.<br />
**This product or the use of this<br />
product may be covered by one<br />
or more patents of Boehringer<br />
Mannheim GmbH, including the<br />
following: EP patent 0 649 909<br />
(application pending).<br />
204<br />
Ordering Guide<br />
DNA Probe Labeling Cat. No. Size<br />
DIG DNA Labeling and Detection Kit 1093 657 25 labeling reactions<br />
and colorimetric detection<br />
of 50 blots (10 x 10 cm)<br />
DIG DNA Labeling Kit 1175 033 40 labeling reactions<br />
DIG DNA Labeling Mix 1277 065 50 µl (25 reactions)<br />
DIG-High Prime** 1585 606 160 µl (40 reactions)<br />
DIG-High Prime Labeling and Detection Starter Kit I** 1745 832 12 labeling reactions<br />
and colorimetric<br />
detection of 24 blots<br />
(10 x 10 cm)<br />
PCR DIG Probe Synthesis Kit* 1636 090 25 labeling reactions<br />
PCR DIG Labeling Mix* 1585 550 50 reactions (for<br />
detection applications)<br />
Nick Translation Mix for in situ probes 1745 808 200 µl (50 reactions)<br />
DIG-Nick Translation Mix for in situ probes 1745 816 160 µl (40 reactions)<br />
Biotin-Nick Translation Mix for in situ probes 1745 824 160 µl (40 reactions)<br />
Digoxigenin-11-dUTP, alkali-labile 1573 152 25 nmol (25 µl)<br />
1573 179 125 nmol (125 µl)<br />
Digoxigenin-11-dUTP, alkali-stable 1093 088 25 nmol (25 µl)<br />
1558 706 125 nmol (125 µl)<br />
1570 013 5 x125 nmol<br />
(5 x125 µl)<br />
DIG-labeled Control DNA 1585 738 50 µl<br />
Biotin-16-dUTP, solution 1093 070 50 nmol (50 µl)<br />
Biotin-High Prime** 1585 649 100 µl (25 reactions)<br />
PCR Fluorescein Labeling Mix* 1636 154 10 reactions<br />
Fluorescein-12-dUTP, solution 1373 242 25 nmol (25 µl)<br />
Fluorescein-High Prime** 1585 622 100 µl (25 reactions)<br />
Tetramethyl-rhodamine-6-dUTP, solution 1534 378 25 nmol (25 µl)<br />
AMCA-6-dUTP, solution 1534 386 25 nmol (25 µl)<br />
Oligonucleotide Probe Labeling Cat. No. Size<br />
DIG Oligonucleotide 3'-End Labeling Kit 1362 372 25 labeling reactions<br />
(100 pmol<br />
oligonucleotide each)<br />
DIG Oligonucleotide Tailing Kit 1417 231 25 tailing reactions<br />
(100 pmol<br />
oligonucleotide each)<br />
DIG Oligonucleotide 5'-End Labeling Set 1480 863 10 labeling reactions<br />
DIG-3'-end labeled Control Oligonucleotide 1585 754 50 µl (125 pmol)<br />
Digoxigenin-11-ddUTP, solution 1363 905 25 nmol (25 µl)<br />
DIG-NHS ester (Digoxigenin-3-0-methylcarbolyl-- 1333 054 5mg<br />
aminocaproic acid-N-hydroxysuccinimide ester)<br />
Biotin-16-ddUTP, solution 1427 598 25 nmol (25 µl)<br />
Fluorescein-12-ddUTP, solution 1427 849 25 nmol (25 µl)<br />
CONTENTS<br />
INDEX
CONTENTS<br />
INDEX<br />
Ordering Guide<br />
RNA Probe Labeling Cat. No. Size<br />
DIG (Genius 4) RNA Labeling Kit 1175 025 2 x 10 labeling reactions<br />
DIG RNA Labeling Mix 1277 073 40 µl (20 reactions)<br />
Digoxigenin-11-UTP, solution 1209 256 250 nmol (25 µl)<br />
Biotin-16-UTP, solution 1388 908 250 nmol (25 µl)<br />
Biotin RNA Labeling Mix 1685 597 40 µl (20 reactions)<br />
DIG-labeled Control RNA 1585 746 50 µl<br />
Fluorescein RNA Labeling Mix 1685 619 40 µl (20 reactions)<br />
Fluorescein-12-UTP, solution 1427 857 250 nmol (25 µl)<br />
205<br />
7